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Edwin S. Marks (1926-2003)
First and foremost a family man, Edwin Marks gave to others as he did to those nearest to
him. Successful in business, a generous philanthropist, provider of sound advice, and a man
with broad interests and intellect, Edwin Marks died on April 24, 2003. At the time of his
death, he was Vice Chairman of our Board of Trustees and a most devoted and valued advi-
sor.
Born and raised in Brooklyn on the same block as his future wife, Nancy, Edwin's forma-
tive years occurred as his father founded and developed a successful banking business.
Established in the year before Edwin was born, Carl Marks & Co. initially traded foreign secu-
rities but later, under Edwin's skilled leadership, expanded into a diverse banking enterprise
including venture capital, private equities, corporate development, real estate, and financial
advise and planning.
Despite-or perhaps because of-his father's success, upon entering college, Edwin did
not intend to pursue a career in banking. After schooling at Brooklyn's Poly Prep Country Day
School, Edwin initially studied at Princeton, but a yearning to enter into the diplomatic core
caused a change in direction that greatly influenced his future. Following the advice of a fam-
ily friend, he transferred to the United States Military Academy at West Point. This surprising
turn of events uprooted a potentially comfortable academic life at Princeton, but due to influ-
ences from both West Point and General Maxwell Taylor, Edwin stretched himself beyond his
upbringing. It was clear from discussions and e-mail correspondence with him that West
Point was a special place never to leave Edwin's universe. Upon graduating, he married
Nancy, and together, they set off on an adventure that lasted 54 years.
Initially stationed in El Paso, Texas and Anchorage, Alaska, environs far from the neigh-
borhood in Brooklyn, Edwin began to use his considerable skills in an eight-year military
career. His capabilities as an entrepreneur, leader, and diplomat emerged. He enjoyed serv-
ing his country.
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In 1953, when his father's health began to fail, Edwin's life took what must have been an
unexpected turn when he joined his father's Wall Street firm, working his way up from the
bottom to learn the business and eventually head the company. Although the country lost a
potential diplomat, it gained a very successful businessman who used his success and skills
for the greater good. Under his leadership for more than 40 years, Carl Marks & Co. expand-
ed and flourished. Its success enabled Edwin to achieve many other successes outside of
business and pursue extraordinarily broad interests.
Edwin was not a leader who dominated, but he was a good listener and not one who
stood on protocol. He was also modest and very astute. Known to answer his own tele-
phone at work, he listened to junior colleagues and invested in their ideas. His non-business
interests in music, nature, science, and medicine influenced his business as much as he
used his business success to pursue these outside interests. At Cold Spring Harbor
Laboratory, Edwin listened to science presentations and asked great questions of our scien-
tists. In one case, after hearing a public lecture by Judah Folkman on anti-angiogenesis treat-
ment for cancer, he invested in Entremed at a very early stage, an insight that eluded those
of us closest to the science. Later, upon selling the overpriced stock, he was generous in
making a large donation to Cold Spring Harbor Laboratory to support cancer research.
Edwin was interested in new ideas and technology. He was often one of the first to try out
a new gadget or device. Once, on his way to a meeting at Cold Spring Harbor, he pulled up
on the road in an electric car, one of the first on the broad commercial market. Edwin was
clearly pleased when those who paused to talk to him were surprised at the absence of noise
coming from the car engine. He then proceeded to impart the advantages of electric cars.
Having a great sense of humor, Edwin passed on e-mail messages with collections of
jokes and anecdotes, many originating from business associates or former army colleagues.
Occasionally, he would send an article or photograph that could only have come from mili-
tary colleagues, but it expressed his enormous pride in the military and America.
A collector of art, music, books, and artifacts, Edwin had numerous and broad interests,
many of them shared with his wife, Nancy. He loved boating, travel, and growing orchids. He
was also a most generous donor to many institutions, including Cold Spring Harbor
Laboratory. Edwin was Vice Chairman of Lincoln Center in New York and was particularly
interested in their summer festival and Mostly Mozart program. He was a former Chairman
of the North Shore-Long Island Jewish Research Institute and member of the Board of
Directors of the Hospital system. He also supported the Right from the Start 0-3 Center at
the North Shore Child & Family Guidance Center, the Smithsonian's Cooper Hewitt National
Design Museum, and West Point. Together with Nancy, Edwin was a strong supporter of the
Juilliard School. At Poly Prep Country Day School in Brooklyn, the Nancy and Edwin Marks
Center for Science and Technology was established. Together with his sister Marjorie Boas
Levins and his late brother-in-law and business partner Robert S. Boas, the Boas-Marks
Medical Research Institute at North Shore-Long Island Jewish Research Institute became
the focus of their clinical and basic research programs.
His long interest in medical research led Edwin to Cold Spring Harbor Laboratory in 1992
when, at the urging of then Trustee David Pall, he joined our Board of Trustees and, in 1998,
became a member of the Executive Committee of the Board as Vice Chairman. The enthu-
siasm that Edwin had for the Laboratory and its scientists was evident by his insatiable
appetite for knowing the latest research results. He understood how Cold Spring Harbor
Laboratory functioned more than most and marveled in the technology and the culture.
Edwin also listened to our needs and at a crucial time provided key support for the expand-
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ing neuroscience research program. Upon seeing the advantages of brain imaging at the cel-
lular level and hearing of our need to provide space for the powerful microscopes built by
neuroscientist Karel Svoboda, Edwin provided the seed funds for a capital campaign to sup-
port new infrastructure. In 1999, the Nancy and Edwin Marks Building was dedicated as a
research and teaching center for advanced neuroscience. The new space enabled us to
begin research aimed at understanding the links between brain architecture, the molecules
in the brain, and animal behavior. Edwin continued to provide support for neuroscience and
cancer research. His interest enabled the Laboratory to expand while maintaining the high-
est quality of research.
Edwin also played a key role in the laboratory's investment and finance committees. His
business experience and expert advice was offered in a calm and considered way, but had
great effect. He was not afraid to ask questions but, more importantly, he knew what ques-
tions to ask.
Edwin loved to be busy, even if he was just fishing in the waters in front of Nancy and his
beautiful King's Point home, listening to music or-best of all-spending time with his fami-
ly. Edwin was the center of an extraordinary family that included Nancy, daughters Carolyn,
Linda, and Connie, sister Marjorie Boas Levins, as well as sons-in-law and three grandchil-
dren.
Although Edwin did not serve America as a diplomat, he served his country and commu-
nity better than most. He remains an example to us all and he will be sorely missed.
Bruce Stillman
President and CEO
PRESIDENT'S
REPORT
Research in biological science is advancing so rapidly that those of us fortunate enough to
participate in discovery are swamped with information. As a result, we specialize, engaging
deeply in one or two areas of science and relying for the rest on other specialists who con-
dense complex ideas into short review articles in the journals. If motivated-perhaps by an
unexpected discovery-we can either read further in the literature or participate in confer-
ences and talk directly with experts in a field. Because this is how progress in science is
made, the approximately 24 research meetings held each year at Cold Spring Harbor
Laboratory add greatly to our intellectual environment and provide scientists working here
with a constant flow of new information and fresh ideas.
The rapid pace of modern research is also making a social impact as people try to under-
stand particular diseases or come to terms with issues that have an ethical or moral dimen-
sion, such as stem cell research. It is important for the public to keep abreast of developments
in science, but it is not easy. There is broad support for the use of tax dollars to fund medical
research, but many individuals want to know how research spending will help them directly. It
is often a hard question to answer. Research seldom yields advances that have a direct and
immediate impact on human lives. More often, practical benefits take years to develop.
Take as an example the recent outbreak of the SARS virus in 2003. Within a few months
of the first reports of infection and its subsequent spread to several widely separated coun-
tries, the virus was identified and its biology understood well enough to make possible its
containment. This success prevented what might have been the spread of a disease that, at
best, would have wreaked economic havoc and, at worst, could have been a global medical
tragedy. It is not widely enough appreciated that the ability to propagate coronaviruses and
identify the genetic makeup of the infectious agent relied on basic research done in the
1960s and 1970s. And this research was not specifically geared to tracking down an emerg-
ing virus. The ability to clone and sequence the virus genome, for example, came from can-
cer research as much as from infectious disease investigations.
Today, vigorous advocacy for disease-targeted research drives much of the funding for
basic research in biology. This phenomenon became a significant force in the 1980s, follow-
ing grassroots calls for special funding initiatives to deal with AIDS and breast cancer.
Although neither condition has been cured, anti-HIV drugs that emerged from an under-
standing of the basic biology of the virus have enabled people to live longer with chronic
infection, and breast cancer mortality is dropping, mostly due to early detection.
It is almost certain that public advocacy has driven the recent increases in federal research
spending. The National Institutes of Health (NIH), a collection of mostly disease-focused
research institutes, supports the vast majority of basic and applied biology and medical
research in the United States. The individual Institutes fund research that is done primarily in
universities or research institutions such as our own. From 1999 to 2003, the NIH budget
doubled to a level that is now about half the annual amount spent on defense research, not
including other defense-related research on space, energy, and transportation. But increas-
es in NIH appropriation have slowed and now are only just keeping up with inflation. Because
much of its funds are already committed to multiyear grants, there will be less money for new
research proposals in the next five years. Furthermore, the emerging large federal budget
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deficits will greatly reduce the ability and the will of Congress to support health-related
research. In such times, it is even more important for scientists to ensure that the public and
Congress understand and appreciate our research enterprise.
This probable decrease in funds comes at a time when there is much more to do in medical
research than even the current budgets will support. With the completion of the human genome
sequence in the past year, the pace of research is faster than ever. New and completely unex-
pected biological phenomena are being discovered. One extraordinary example is the ability of
short fragments of RNA-like DNA, a nucleic acid-to silence the expression of individual genes.
The emerging understanding of "RNA interference" or RNAi, in which Cold Spring Harbor sci-
entists are prominent, has caused us to reassess our ideas about how genes are regulated.
Eventually RNAi, like many of today's discoveries, is likely to revolutionize how medical con-
ditions such as cancer, diabetes, and obesity are treated. But the processes required to devel-
op drugs that are effective and safe to use take many years. With only a limitedunderstand-
ing of the path from the laboratory bench to the patient's bedside, the public needs a longer-
term perspective on basic research and scientists have largely failed to get this across.
A particularly informative example is the history of the development of monoclonal antibodies
as drugs. As part of their immune system's defense against infection, animals and humans have
a population of cells (B lymphocytes) capable of producing tens of thousands of different anti-
bodies. A single B cell secretes a single antibody that recognizes a small, specific part of a pro-
tein, and it was a long-held dream of scientists to isolate and clone one B cell and thus obtain
large quantities of its specific (monoclonal) antibody. In 1975, in Cambridge, U.K., Georges
Kohler and Cesar Milstein achieved this goal with a technical innovation that produced continu-
ously growing B cells secreting an antibody with a single specificity. Their work was immediately
hailed by the press and the scientific community as revolutionary and within ten years justifiably
gained KOhler and Milstein the Nobel prize. Almost as immediately, monoclonal antibodies were
talked about as "magic bullets" that could cure diseases by targeting proteins located exclusive-
ly on abnormal cells such as tumors. Optimism and expectations were high, but then reality set
in.
The first monoclonal antibodies were produced from mouse cells and some were approved
for human therapeutic use. The first was Orthoclone OKT3, intended to prevent cells of the
immune system from rejecting transplanted kidneys. But the mouse antibody, itself a protein,
was found to produce an immune reaction when injected into humans, limiting the value of
the therapy and possibly causing further disease. Much more work was needed, using recom-
binant DNA technology, to manipulate mouse antibodies and make them unrecognizable by
human immune systems. It was not until 1997, more than 20 years after the initial basic
research discovery, that true monoclonal antibody therapy became a reality.
A major application was in the treatment of the B-cell cancer non-Hodgkin's lymphoma
(NHL), in the form of a drug known as Rituxan®. Directed against a protein on the surface of
the lymphoma cells, the monoclonal antibody initiated selective destruction of the cells.
Recently, the drug Zevalin®, a monoclonal antibody linked to a radioactive molecule, has
been approved for the treatment of NHL. ReoPro®, also approved in 1997, was an early suc-
cess in preventing platelet cell clogging of arteries after angioplasty. The number of mono-
clonal-antibody-based drugs is growing and includes Enbrel® and Remicade® for rheumatoid
arthritis, Herceptin® for breast cancer, Erbitux® for colon cancer, and most recently, Avastin®
for blocking the blood supply to tumors of the colon. One of these drugs, Erbitux® is at the
center of the current insider-trading scandal that has seen a CEO imprisoned and a popular
media and television personality convicted. Yet despite considerable news coverage about
this drug, the public is largely ignorant of the real processes that produced it. Far removed
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from the headlines and misplaced euphoria about magic bullets is a much more complex
story involving the extensive search to find suitable applications for monoclonal antibodies,
the difficulty of academic laboratories to develop drugs all the way to the clinic, and the reluc-
tance of the pharmaceutical industry to pursue completely novel approaches to drug devel-
opment until the academic community provides proof of principle that the approach works.
Another example of the effective but lengthy translation of research discoveries into ther-
apeutics is the development of the remarkable drug Gleevec® for early stage chronic myeloid
leukemia (CML) and rare stromal tumors of the gastrointestinal tract. This "first in its class"
drug targets a protein produced as a result of a genetic abnormality in myeloid blood cell pre-
cursors in patients with CML. A translocation between two chromosomes (9 and 22) in
patients with CML was first observed in 1960, but it required the development of recombi-
nant DNA technology 13 years later to provide the tools that enabled identification the BCR-
ABL gene that resulted from the chromosome translocation. It took a further ten years, until
the mid 1980s, to show that the product of BCR-ABL was a tyrosine kinase, an enzyme that
modifies other proteins through addition of a phosphate group. And finally, in the mid-to-late
1990s, it took the focused efforts of a single dedicated clinical scientist, Brian Druker, with
access to drugs made by Novartis to demonstrate the therapeutic potential of compounds
that inhibit tyrosine kinase activity. It was not until 2001 that the FDA approved the use of the
inhibitor of BCR-ABL kinase activity known as Gleevec for human cancer treatment.
Gleevec's success has prompted a rush to develop other drugs based on the genetics of
human cancer. But it will take time, and unfortunately sometimes a long time, for cutting-
edge research to move into the clinic, despite help from the biotechnology industry in speed-
ing the process. Shortening the time will be a challenging task requiring improved interac-
tions between industry and academia, changes in how applied research is supported and
for such research, property from basic
research is handled. This last step could involve making it mandatory for basic research
patents to be licensed nonexclusively to industry, but since changes in the law would be
required, it is unlikely to happen.
The completion of the Human Genome Project and other recent advances have suffused
academia and industry alike with optimism about a renaissance in basic and clinical
research. Almost every day the popular press announces new discoveries that may lead to
new therapies. As scientists we should be careful not to over-hype the results we report.
Even if it doesn't sell newspapers or suit the needs of sound-bite television, it would be more
accurate if scientists, institutional public relations staff, and the media present "break-
throughs" in the clinic not as new discoveries but as the result of a long and often frustrat-
ing research process. This kind of public education about how science works must first and
foremost be the responsibility of scientists themselves. If we cannot set the tone for a broad-
er understanding of what we do, we risk losing credibility with a public that supports science
but is conditioned to expect immediate results. People must be better informed about the
painstaking journey of discovery, not just the results obtained and their future potential.
In this respect, Cold Spring Harbor Laboratory was particularly active in 2003. The year in
which we celebrated the 50th anniversary of Jim Watson and Francis Crick's discovery of the
structure of DNA was an opportunity to inform as well as rejoice. Our Dolan DNA Learning
Center created the DNA Interactive Web site (www.dnai.org) that accompanied a five-part
television series called DNA: The Secret of Life about the development of DNA science and
its impact on society. The series had an accompanying book of the same name, written by
Jim Watson and Harvard's Andrew Berry. These three projects, all inspired by Jim Watson,
reached for the same goals, not simply a celebration of the double helix and other great
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accomplishments in biology and medicine, but an imaginative and powerful demonstration
of science as a human activity that raises vital ethical, legal, and social issues.
The Dolan DNA Learning Center (www.dnalc.org), initially established in 1986 to teach
modern biology to nearby high school students, now has a global presence through its
Internet-based education programs. Its current suite of Web sites, and those that are
planned, permit students and their families to learn about research and its results. DNA From
The Beginning outlines in simple terms the history of genetics from Mendel to the Human
Genome Project (www.dnaftb.org). It profiles scientists who did important work, but more
importantly, it describes how they made their contributions. The Your Genes, Your Health
Web site (www.ygyh.org) is a striking collaboration between those affected by diseases, sci-
entists, clinicians, and the Learning Center's educators. Other Web sites deal with the origins
of humans and with the thorny history of science gone awry during the 20th century eugen-
ics movement. These individual sites complement each other and share material, and sev-
eral are in development, including one on cancer. Perhaps there should be a site describing
the time line for developing drugs from basic research to the bedside. Focusing on approved
and successful drugs and working back to the ideas and techniques that lead to treatment,
we would learn valuable lessons about how basic research and medicine intertwine and
about the time lines that are necessary to deal with complicated human diseases.
The type and level of biology and medicine now being taught in the middle grades of high
school with the assistance of the Dolan DNA Learning Center's Web sites are exactly what
the public at large must understand to participate effectively in national dialogs about disease
research and issues such as human stem cell use. These sites are supported through
numerous short-term grants because there is no endowment to support the Learning Center.
It is a priority to seek such support. The Learning Center is one of several means by which
Cold Spring Harbor Laboratory is pioneering science education, and whether or not you are
a scientist, browsing the virtual world of biology and medicine may be well worth your while.
Education about the research behind existing drugs will aid in public education, but it will not
advance current research. A recent Fortune magazine cover story by Clifton Leaf argues that
current research is not winning the fight. The claim is that academics are focusing on basic
research and not applied science. Leaf also argues that there is a lack of focus on the main prob-
lems such as metastasis and early detection. The academic community, however, is very well
aware of problems that need to be studied, and in this respect, the article presented little new
information. For example, it has been well known that early detection of cancer increases the
effectiveness of current therapy and because of this, the National Cancer Institute (NCI) leader-
ship initiated a large program on early detection in the mid-1990s, a point not made in the arti-
cle. I am now on an NCI committee to advise on the discovery and application of new technolo-
gies for cancer early detection, diagnosis, and therapy, and new approaches will emerge from
such deliberations.
We know what to do-the problem is how best to achieve results. Current NIH funding
mechanisms limit the amount of support each scientist can receive, and such funds cannot
be pooled to make the research enterprise more efficient or goal orientated. Each pot of
funding is restricted to the aims of individual grants. Funding mechanisms are needed that
allow teams of our scientists to join together and work with sufficient financial resources to
achieve defined goals. Without new NIH funding mechanisms, we must solely rely on long-
term and significant philanthropic support. With such support, scientists at Cold Spring
Harbor Laboratory can make a real difference.
4
HIGHLIGHTS OF THE YEAR
Research
Cancer
Scott Lowe has made an experimental breakthrough in "combination therapy" or the simul-
taneous use of two or more anticancer agents for treating the disease. Precancerous cells
can be eliminated from the body by a self-destruct mechanism called
programmed cell death or apoptosis. A hallmark of most cancers is a
defect in apoptosis that enables precancerous cells to survive and pro-
liferate. Because many traditional chemotherapy agents act in part by
triggering apoptosis, such agents are frequently ineffective against
tumors with defects in apoptosis.
Scott and his colleagues reasoned that using one drug to restore
apoptosis (e.g., the mTOR inhibitor rapamycin) and another drug to trig-
ger the process (e.g., doxorubicin) might be an effective way to treat
cancer. They have shown that whereas rapamycin or doxorubicin treat-
ment alone are ineffective against a mouse model of B-cell lymphoma,
a rapamycin/doxorubicin combination therapy leads to remission of the
disease. The study demonstrates that treatment decisions are best
guided by knowledge of which gene products are functional or non-
functional in a particular tumor, and it has produced a new paradigm for
understanding and overcoming drug resistance in cancer patients.
Mike Wigler and Scott Lowe have collaborated with David Mu and
Scott Powers of the Genomics Division of Tularik, Inc. to discover a previously unknown
oncogene. The gene, called KCNK9, is expressed at abnormally high levels in half of the
breast cancer specimens examined in the study and is similarly overexpressed in a large pro-
portion of lung cancers. The experimental overproduction of KCNK9 promotes tumor for-
mation in mice, suggesting that elevated KCNK9 levels may be sufficient to trigger the devel-
opment of cancer. The discovery of KCNK9 is significant because it reveals both a previously
unrecognized mechanism for oncogene action (namely, potassium channels) and an attrac-
tive target for the development of novel cancer therapies.
KCNK9 was discovered by using a method that compares two sets of DNA (e.g., normal
vs. cancer cell DNA) and reveals segments of DNA that are either deleted or amplified. The
method, called representational difference analysis (RDA), was previously developed by Mike
Wigler and Nikolai Lisitsyn. Recently, Mike, Rob Lucito, and their colleagues have devised a
new RDA-based technology that is one of the most powerful methods that now exists for
profiling the genetic basis of cancer. The method is called representational oligonucleotide
microarray analysis or ROMA. Mike and Rob have already used ROMA to uncover a striking
collection of chromosomal deletions and amplifications associated with breast cancer
through a collaborative study with Larry Norton of Memorial Sloan-Kettering Cancer Center
and Scott Powers. Mike and Rob intend to use ROMA to survey a large number of breast,
ovarian, and pancreatic tumors and cell lines, as well as leukemias and lymphomas.
Greg Hannon continues to make great strides toward developing RNA interference (RNAi)
as a tool for manipulating gene expression in mammalian cells. Greg and his colleagues have
demonstrated that they can use RNAi to efficiently and permanently silence the expression
Scott Lowe
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of virtually any gene (or genes) in cultured cells or in living animals. These
findings enable them to use RNAi to carry out in-depth studies of tumor
biology and treatment response, to design high-throughput screens to
discover and validate new therapeutic targets, and to pioneer the use of
RNAi itself as a potential therapy. As the first step toward opening that
broad pipeline of cancer therapy discovery, Greg's lab has constructed a
human genome-wide library of RNAi-based silencing vectors. In addition
to using the library for his own work, Greg has made-and will continue
to make-the library widely available for use by researchers throughout
industry and academia.
Genomics and Bioinformatics
Lincoln Stein is pioneering the development of several powerful computer-based methods
for analyzing a wide variety of biological data. For example, Lincoln's group has collaborat-
ed with the USDA and Cornell University scientists to create a database called Gramene*
(www.gramene.org). Rice, wheat, corn, barley, and rye provide humanity with some 90% of
its calories worldwide. All of these crop species are relatively closely related grasses with
similar genome structures bearing many blocks of "colinear" genes. Gramene enables
researchers to efficiently compare genome sequence data from these grasses and to iden-
tify genes of interest that may be used to develop new crop varieties with improved agri-
cultural characteristics. (*The name Gramene is based on the Latin "gramen" meaning
"grass" and on the Grameen Bank, which makes loans to the rural poor in emerging
economies.)
Lincoln is also a principal participant in the International Hap Map Project
(www.hapmap.org) which released its first results in 2003. The project involves mapping the
locations of variations in the human DNA sequence, many of which may
ultimately be found to underlie specific diseases or differential response to
therapeutic intervention. The goal of the project is to help researchers dis-
cover genes associated with cancer, heart disease, diabetes, neurological
disorders, and other ailments, as well as genes associated with treatment
response.
By applying a "methylation filtration" method they recently developed
that captures gene-rich regions and excludes the vast majority of repet-
itive, gene-poor DNA, Dick McCombie and Rob Martienssen have
achieved a dramatic shortcut to sequencing the genes of corn. The
approach should provide a similar boost to the sequencing and compar-
ative analysis of other genomes in a wide variety of biological, biomed-
ical, and biotechnological settings.
Lincoln Stein
Biochemistry
A Holy Grail of biochemistry is to reconstitute the activity of complex cellular machinery in the
test tube from highly purified components. Only when such purity is achieved can
researchers be sure that they have identified everything that is required-and nothing that
isn't-for cells to carry out all the steps of a particular biological process. After several years
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of productive effort, Nouria Hernandez and her colleagues recently
achieved the first such reconstitution of human RNA polymerase III
transcription.
RNA polymerase III uses the DNA of certain genes as a template
from which it builds RNA transcripts, which in turn carry out a variety
of essential cellular functions. Nouria's work has defined the entire
molecular machinery required to carry out all steps of the transcrip-
tion process (initiation, elongation, and termination) by human RNA
polymerase III. Moreover, her studies have revealed an unexpected
but intriguing role of another enzyme, called casein kinase II, in tran-
scriptional regulation. Nouria's lab has shown that by phosphorylat-
ing different components of the transcription machinery, casein
kinase II can either stimulate or inhibit transcription by RNA poly-
merase III. Cancer and many other diseases frequently stem from
defects in transcriptional regulation. Nouria's results are therefore sig-
nificant from both a basic research and a biomedical perspective.
Neuroscience
Nouria Hernandez
Most brain neurons are produced during embryonic development. However, several regions
of the adult brain continue to spawn large numbers of neurons through the proliferation of
neural stem cells. Moreover, it is becoming clear that these new neurons are integrated into
existing brain circuitry. Grisha Enikolopov and his colleagues have discovered that a mole-
cule called nitric oxide (NO) is a pivotal, natural regulator of the birth of new neurons in the
adult brain. Grisha, Mike Packer, and Yuri Stasiv have shown that blocking NO production
stimulates neural stem cell proliferation and hence dramatically increases the number of neu-
rons that are generated in the brains of adult rats.
Importantly, the new neurons that arise as a consequence of blocking NO production dis-
play properties of normal neurons, and they appear to contribute directly to the architecture
of the adult brain. Grisha's work suggests that modulating NO levels might be an effective
strategy for replacing neurons that are lost from the brain due to stroke or neurodegenera-
tive disorders such as Alzheimer's, Parkinson's, and Huntington's dis-
ease.
Thousands of odors that smell the same to us, or that we cannot per-
ceive at all, are quickly recognizable as distinct and potentially meaning-
ful odors to rodents and other animals. By studying how rodents can
rapidly and accurately discriminate one odor from another, Zach Mainen
is uncovering fundamental principles of brain function that apply in many
settings, including how our own brains work. Zach and his colleagues
use olfaction as a model system for exploring how groups of neurons
participate in perception, motivation, decision-making, and ultimately
consciousness.
Recently, Zach and Naoshige Uchida found that rats get a complete
sense of an odor with each sniff, and they speculated that rodents prob-
ably use a rapid series of such olfactory snapshots to solve complex
problems like tracking the source of an odor. Humans are far more I
attuned to the visual world. However, according to Zach, the neural zaci, Mainers
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mechanisms that enable rodents to identify an odor in a single sniff may be similar to those
that help humans take in an entire visual scene in a single glance. Part of Zach's work
involves mapping the patterns of nerve cell activity in a rat's brain when the animal smells
various odors. By discovering how the brain assigns identity and meaning to odors-and
guides behavior based on such information-Zach and his colleagues are revealing new
principles of neurobiology.
Linda Van Aelst studies the Ras and Rho family of proteins, which function-together with
regulatory proteins called GAPs-as molecular switches that control a wide variety of impor-
tant biological processes, including cell proliferation, cell morphogenesis, cell adhesion, and
cell migration. Linda and her colleagues have recently explored the role in brain development
of a particular RhoA GAP called oligophrenin-1. Loss of oligophrenin-1 function (e.g., as a
result of a mutation in the corresponding gene) has been previously associated with X-linked
mental retardation. In mouse RNA interference experiments, Linda has found that
oligophrenin-1 is required for nerve cell structures called dendritic spines to form normally in
a region of the brain required for learning and memory called the hip-
pocampus. Moreover, Linda and her colleagues showed that the effect
of decreased oligophrenin-1 on brain development can be mitigated by
a drug that inhibits RhoA signaling. The latter finding may ultimately lead
to treatments for X-linked mental retardation.
Humans obviously differ from the fruit fly Drosophila in many ways.
Nevertheless, because we have much in common with it (e.g., thou-
sands of very similar genes, a nervous system, and an ability to learn
and remember), studies with fruit flies have revealed a great deal of
information about human biology. Yi Zhong is now using the power of
Drosophila research to explore the causes of Alzheimer's
to drive therapeutic discovery.
Versions of proteins implicated in Alzheimer's disease (e.g., amyloid
precursor protein) are present in the Drosophila brain, suggesting that the
functions disrupted in Alzheimer's are conserved in the fly. Yi and scien-
tists at Novartis have taken advantage of this fact and have shown that
expressing a pathogenic fragment of amyloid precursor protein (human A(342) in the Drosophila
brain causes nerve cell death, plaque formation, and memory deficit reminiscent of Alzheimer's
disease. Research using mouse models of Alzheimer's are still essential. However, Y's work
establishes a powerful alternative for testing new theories about how the disease develops and
progresses, for identifying new gene or protein targets for treating Alzheimer's disease, and for
rapidly screening large numbers of drugs for their therapeutic potential.
Yi Zhong
Plant Molecular Biology and Genetics
Stem cells generate new organs and tissues throughout the lives of plants-sometimes for
centuries. The size, shape, location, and many other properties of such organs and tissues
are determined by a complex process called stem cell patterning. One aspect of stem cell
patterning involves the movement of regulatory proteins from cell to cell through channels,
unique to plants, called plasmodesmata. To begin to reveal the components, architecture,
and functions of plasmodesmata, Dave Jackson and his colleagues have isolated a number
of mutations that affect the transport of a test protein through plasmodesmata. Consistent
with the notion that transport through plasmodesmata is important for stem cell patterning,
some of the mutations display developmental phenotypes. In addition, because devastating
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Marja Timmermans
plant viruses frequently spread through plasmodesmata,
Dave's work may ultimately reveal new strategies for con-
trolling such viral infections.
Marja Timmermans is investigating the role of stem cell
patterning in the proper outgrowth of leaves and in generat-
ing the distinct top and bottom layers of leaves. She and her
colleagues have isolated the Rolled leaf1 gene and deter-
mined that the transcription factor it encodes specifies the
top layers of leaves by conveying patterning signals from
stem cells. Interestingly, Marja's lab has also shown that
Rolled leafl gene expression is spatially regulated-by RNA
interference-through the inhibitory effect of a microRNA
(miRNA166) that is complementary to a site in the Rolled
leaf1 messenger RNA. Marja's observations strongly support
the emerging idea that microRNAs constitute a vital and
widespread class of developmental signaling molecules in
plants and animals.
Cold Spring Harbor Laboratory Board of Trustees
As is customary each November, Cold Spring Harbor
Laboratory welcomed new members to the Board of Trustees.
David Botstein, Ph.D., director of the Lewis-Sigler Institute at
Princeton University, joined our Scientific Trustees. David was a
trustee at Massachusetts Institute of Technology in the 1980s.
Alan C. Stephenson, James M. Stone, Edward Travaglianti, and
Roy J. Zuckerberg were welcomed as individual trustees.
Edward Harlow and Lorne Mendell concluded their terms and were honored for
their outstanding service at the Board's November meeting. As noted in previous
pages, we were saddened to learn of the death of our Vice Chairman, Edwin Marks,
earlier in the year.
Ed Harlow
Laboratory Senior Management Restructured
After directing the Laboratory since 1994, I was named President of Cold Spring
Harbor Laboratory by vote of the Board of Trustees on November 8. I will maintain my
positions as the Chief Executive Officer and as Director of the CSHL Cancer Center.
Through a simultaneous vote, Jim Watson was named Chancellor, after serving as Cold
Spring Harbor Laboratory's President since 1994. This new position reflects his continuing
role in supporting the Laboratory's educational mission through its programs for high school,
undergraduate, and graduate students, especially through its Watson School of Biological
Sciences, named after him at its inception in 1998.
Following these new appointments, Dr. Hollis Cline accepted the position of Director of
Research. Holly is the Charles Robertson Professor at Cold Spring Harbor Laboratory and
has made major contributions to the understanding of brain development and function. Holly
has been serving as the Laboratory's Associate Director of Research since August 1, 2002.
She will continue to serve in similar capacities, with increased involvement in the future
research directions of the Laboratory.
Lorne Mendell
Edwin Marks
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Laboratory Employees
Long-term Service
The following employees celebrated milestone anniversaries in 2003.
35 years
30 years
25 years
20 years
15 years
New Staff
James Watson
Laura Hyman
Patricia Maroney, Christopher McEvoy, Charles Schneider, Beatrice To liver,
Jeanne Wiggins, Michael Wig ler
Joan Ebert, Margaret Falkowski, Winship Herr, Daniel Jusino
Margot Bennett, Francis Bowdren, Nancy Dawkins-Pisani, Maryliz Dickerson,
Grigori Enikolopov, Jeffrey Goldblum, Barbara Gordon, Jennifer Gordon,
Kim Gronachan, Lynn Hardin, Salvador Henriquez, Louis Jagoda,
Guy Keyes, Ronnie Packer, Jane Reader, Margaret Stellabotte,
Arne Stenlund, Regina Whitaker
Alexei Koulakov joined Cold Spring Harbor Laboratory as an Assistant Professor in May. Alex
came to us from the University of Utah where he was an Assistant Professor in the physics
department. He received his graduate degree in physics from the University of Minnesota
and was a fellow at the Sloan Center for Theoretical Neurobiology at the Salk Institute for
Biological Studies.
Partha Mitra was appointed to the position of Professor in August and will strengthen our
neuroscience program. Partha came from Bell Laboratories where he worked as a
researcher in the theoretical physics department. He received his graduate degree in physics
from Harvard University. Partha is also an adjunct associate professor at Cornell University
Medical School, an adjunct faculty member at both Princeton University and the New York
University Medical School, and a visiting associate at Caltech.
In December, Wolfgang Lukowitz was appointed to the position of Assistant Professor in
the plant genetics department. Wolfgang came from the Carnegie Institute's Plant Biology
Department at Stanford University. He received his graduate degree in genetics from the
University of Tubingen in Munich, Germany.
Cordula Schulz arrived at the Laboratory as a Research Investigator in December. Cordula
came from the Stanford University School of Medicine. She received her graduate degree in
biology from the Maximilian-Ludwig University in Munich, Germany. We were also pleased to
welcome Visiting Professors Matthew Ridley and William Benjamin this year.
Michael Townsend joined the Laboratory as Director of Information Technology in March.
Mike was previously with Lehman Brothers in New York where he managed numerous func-
tions and special projects including equity securities infrastructure, Y2K Disaster Recovery,
and Fixed Income E-Commerce Projects.
Promotions
A number of our staff were promoted in 2003, including Tatsuya Hirano to Professor; Yuri
Lazebnik to Professor; Josh Dubnau to Assistant Professor; Rusiko Bourtchouladze to
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Adjunct Professor; Ken Chang to Research Investigator; Diane Esposito to Research
Investigator; and Peter Sherwood to Director of Research Communications.
Departures
Shiv Grewal, Associate Professor; Douglas Conklin, Research Investigator; and Luca
Cartegni, Senior Fellow, all departed the Laboratory in 2003.
Chief Financial Officer G. Morgan Browne retired from the Laboratory on December 31
after 19 years of service. Although he has agreed to stay active at the Laboratory, we will
miss his day-to-day work on our finances. I wish to add my thanks to Morgan for his many
years of dedicated and outstanding service.
Robertson Research Fund
The Robertson Research Fund has been the primary in-house support for our scientists for
nearly three decades. During 2002, Robertson funds supported research in the labs of
Carlos Brody, Dmitri Chklovskii, Josh Dubnau, Grisha Enikolopov, Josh Huang, Eli Hatchwell,
Winship Herr, Yuri Lazebnik, Alea Mills, Vivek Mittal, Marja Timmermans, Linda Van Aelst, and
Yi Zhong. It also provided support to new investigators Alexei Koulakov,
Cordula Schulz, Partha Mitra, and Wolfgang Lukowitz.
Awards and Honors
On February 14, Terri Grodzicker was honored by the American Associ-
ation for the Advancement of Science (AAAS) for her distinguished con-
tributions to scientific discourse and standards as editor of Genes &
Development (published by the Cold Spring Harbor Laboratory Press)
and as Assistant Director for Academic Affairs at Cold Spring Harbor
Laboratory. Since 1974, the AAAS Council has been electing those
members to the rank of AAAS Fellow whose "efforts on behalf of the
advancement of science or its applications are scientifically or socially
distinguished."
DNA Interactive (www.DNAi.org), the newest addition to the Dolan
DNA Learning Center Web site family, was selected as a winner of a
Scientific American 2003 SciTech award for being one of the best scientific resources on the
Web for biology. The Web site was described as "ultra-sophisticated" and the award men-
tioned "the folks at Cold Spring Harbor Laboratory, the brains behind the site, are to be con-
gratulated for giving the fabric of our lives the rich treatment it deserves."
Scott Lowe, Deputy Director of the Cold Spring Harbor Laboratory Cancer Center, was
awarded a $5 million, 5-year Specialized Center of Research (SCOR) grant from The
Leukemia & Lymphoma Society® on October 1. With this grant, he will collaborate with
researchers at the University of Minnesota, the University of California, San Francisco, and
the University of Chicago to create leukemia treatments that are more effective and less toxic
to patients.
On October 6, Zhejiang University in China dedicated the "James D. Watson Institute of
Genome Sciences" on the Zijing Campus. It is their hope to create an "Oriental Cold Spring
Harbor Laboratory" by basing it on our model as an international institute integrating scientif-
ic research and academic exchanges. It will be operated jointly between Zhejiang University
Terri Grodzicker
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and the Hangzhou branch of the Beijing Genomics Institute.
Several members of the Cold Spring Harbor Laboratory staff
were in attendance, and Dr. Watson, who was unable to attend,
delivered a videotaped speech.
DNA-The Future, a documentary directed by David Glover
for Windfall Films in which Dr. Watson expresses his provoca-
ive views on DNA, science, and eugenics, was named the
"Best Documentary on Science or the Natural World" by
Grierson 2003. Grierson 2003 celebrates the best documen-
taries screened or broadcast in the U.K. between May 2002
and April 2003. The award was established in 1972, shortly
after the death of the filmmaker John Grierson, and has been run by the Grierson Memorial
Trust since its establishment in 1974. Grierson 2003 is an international event with awards in
nine categories. This year, there were a record number of entries: a shortlist of 76 titles, and
a final 36 nominations.
Dr. Roberto Malinow was selected to receive the 2003 MetLife Foundation Award for
Medical Research. The award, consisting of a personal prize to the researcher and an insti-
tutional award to Cold Spring Harbor Laboratory, was established by MetLife in an attempt
to treat and eventually cure Alzheimer's disease, which already affects 4 million Americans
and has the potential to affect as many as 14 million by 2050. It is awarded yearly to a "smart,
successful, dedicated researcher who has made significant contributions to the understand-
ing of Alzheimer's disease" and "provides them with the means to continue their work."
Z. Josh Huang, Assistant Professor, was awarded a 2003 EJLB Foundation Scholar
Research Award, totaling CAN$300,000 over three years. Up to seven outstanding young
researchers are awarded each year. The EJLB Foundation was established in 1983 as a
charitable corporation with an interest in medical and scientific research in all areas of neu-
roscience that pertain directly or indirectly to
schizophrenia and mental illness. 4
Two papers published in Science,
"Regulation of Heterochromatic Silencing and
Histone H3 Lysine-9 Methylation by RNAi" (13
September 2002) and "Establishment and
Maintenance of a Heterochromatin Domain"
(27 September 2002) were recipients of the
AAAS Newcomb Cleveland Prize this year.
Laboratory employees Ira M. Hall, Catherine
Kidner, Robert A. Martienssen, and Ken-ichi
Noma, former Laboratory scientists Shiv Grewal,
Shankaranarayana, and Thomas A. Volpe, and colleagues Grace Teng,
Nabieh Ayoub, and Amikam Cohen were all recognized as establishing
"a new landmark in epigenetic control" through these papers. This is the
oldest and largest of the AAAS awards, and it recognizes outstanding
papers published in the research articles or reports section of Science.
Each recipient receives a bronze medal and a share of the $25,000 prize.
Cold Spring Harbor Laboratory was named "Institute of the Year" in
the November/December issue of Genome Technology, which called
the Laurel Hollow research and educational powerhouse "Long Island's
Genomics Gem." The honor was determined based on Cold Spring
Ira Hall
Gurumurthy D.
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Harbor Laboratory's "recent advances in genomics," its share of star genomics scientists"
from James Watson to RNAi pioneer, Greg Hannon, Arabidopsis expert Rob Martienssen,
and cancer genomics researcher Mike Wig ler, and its broad research and educational mis-
sion. Cold Spring Harbor Laboratory Associate Professor Lincoln Stein was named "Most
Innovative in Bioinformatics" in the same issue. Genome Technology readers-more than
20,000 scientists, researchers, technologists, and managers in advanced science research
in drug discovery, molecular biology, genomics, proteomics, bioinformatics, and allied disci-
plining-are asked to submit nominations and votes for the "Institute of the Year" selection.
Building Projects
Several key scientific facilities were completed during the year. The Laboratory expanded its
Bioinformatics center, creating much-needed new workspaces in the Williams building. The
James Laboratory glassware kitchen was completely renovated and expanded to meet the
growing needs of the building's scientific staff. Other scientific facilities, including a new
Genome Center clean room for microarrayers and a new confocal microscopy suite in
Hershey, were constructed as well. Additionally, the Laboratory's new Flow Cytometry suite
was completed in the Hershey building.
The Laboratory's program to improve housing for students and sci-
entists has made considerable progress. The first phases of an ambi-
tious project to provide housing for 32 students at Uplands Farm have
been completed. A spacious, six-bedroom residence was completed at
the Uplands Field Station, and the existing Caretaker's Cottage was
completely renovated. Additionally, the foundations were laid for the
construction of a new structure that will provide high-quality housing for
half the total residents at the farm. We anticipate that this new structure
will be completed by the end of 2004. In addition to the projects under
way at Uplands Farm, the Laboratory has been systematically upgrad-
ing all of its existing housing. A tiny studio apartment in the Hershey
building was gutted and expanded to a spacious two-bedroom apart-
ment, and two apartments in Hershey were renovated and modernized.
Other facilities at the Laboratory received major improvements as
well. Significant emergency power and air-conditioning upgrades were
made to the Network Operations Center to help cope with the dramat-
ic increase in demand for computing resources at the Laboratory. The
Laboratory's Graphic Arts facility in the Hershey building was complete-
ly renovated and expanded to help facilitate its evolution into the new Media Arts and
Visualization (MAV) department. Other projects included the resurfacing of Bungtown Road
and a major renovation of the Russell Fitness Center in support of the Laboratory's recreation
and employee wellness programs.
Rare red-tail hawk watching
construction at Uplands Farm.
Education
Meetings and Courses
The high-quality production of the 27 courses and 19 meetings hosted at Cold Spring
Harbor Laboratory throughout the year was impressive as usual. Most notable this year,
however, was the entire Meetings and Courses, Facilities, and Food Services staffs' profes-
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Charlie Boone and Brenda Andrews on Bungtown road after the Blackout of 2003.
sional response to many unexpected and unusual challenges this year. With two very spe-
cial meetings-The Biology of DNA, in celebration of the 50th anniversary of DNA, and JDVV
A Celebration, in honor of Jim Watson's 35th anniversary at the Laboratory-on the agenda,
the staff was prepared for a busy year without dealing with a disease epidemic, a blackout,
and a major snowstorm as well.
For the first half of the year, the staff responsibly handled the dozens of questions, con-
cerns, and fears regarding the SARS outbreak, which caused more than 8000 illnesses and
more than 700 fatalities in two dozen countries, affecting the travel and safety of many of our
international and national meetings and courses participants.
On August 14, most of the Northeast and Midwest were left in the dark when the United
States suffered its largest blackout since 1977. For 22 hours we were without power and had
300 visiting biologists, all here for the Yeast Cell Biology meeting, on campus. Posters and
platform sessions were rearranged, and Food Services found enough charcoal to barbecue
the evening's meal. The Facilities staff worked through the night to pump fuel from the local
gas station to keep the emergency generators running.
Finally, a December 5th snowstorm dumped more than a foot of snow on the area and,
again, the staff ensured that disruptions to the Molecular Approaches to Vaccine Design
meeting were minimal.
Banbury Center
The year 2003 marked the 25th anniversary of Charles Robertson's gift of his Lloyd Harbor
estate of some 45 acres, the buildings on it, along with an endowment to contribute to the
upkeep of the estate to Cold Spring Harbor Laboratory, creating what is now known as
Banbury Center. The Silver Anniversary was celebrated with a small party on September 12.
Guests included Bill Robertson and Anne Meier (two of Charles and Marie Robertson's chil-
dren), former directors Victor McElheny (1978-1982) and Michael Shodell (1982-1986), and
14
friends from Lloyd Harbor. Harold Varmus, Nobel laureate, former Director of the National
Institutes of Health and current President of Memorial Sloan-Kettering Cancer Center, was
the guest of honor.
Throughout the rest of the year, there were 19 meetings at Banbury, with 654 participants.
Of these, 81% came from the United States, drawn from 33 states. The participants from
abroad came from 21 countries, once again showing the high esteem in which meetings at
Banbury are held throughout the world. As usual, the Banbury Center program dealt with
eclectic, interesting, and often controversial topics. Taxonomy and DNA; Taxonomy DNA,
and the Bar Code of Life; and Integrating Progress in the Genetics and Neuropharmacology
of Schizophrenia, were of the most notable.
Dolan DNA Learning Center
In 2003, the long-awaited second edition to David Mick los and Greg Freyer's DNA Science
was published. Now 100 pages longer, including two new lab projects and the first sub-
stantial treatment of eugenics available in a general biology text, this book is sure to contin-
ue to be largely responsible for bringing DNA experiments to advanced high school and
beginning college students.
On a more global scale, DNA Interactive (DNAO, the DNALC's newest addition to the
World Wide Web, has already received more than 375,000 visitors and has contributed to a
23% rise in visitation to the DNALC's family of award-winning Web sites, which received 4.85
million visitors in 2003.
Clemson University (South Carolina) and the Roberson Museum of Arts and Sciences
(Binghampton, New York) became the fourth and fifth licensees to use the DNALC teaching
methods, Internet technology, and intellectual property, while DNALC West, the Singapore
Ministry of Education, and the Science EpiCenter (New London, Connecticut) all fully devel-
oped their programs initiated in 2002.
In-house, the DNALC received four awards from the National Science Foundation to
develop educational programs that closely parallel the work of CSHL scientists David
Jackson, Dick McCombie, Marja Timmermans, and Lincoln Stein. These opportunities offer
unique laboratory experiences to students and faculty alike.
CSHL Press
The CSHL Press enjoyed a very productive year. Eleven new book titles were published and
a larger number of books-79,000 copies-were sold, in more countries around the world
than in any previous year. Among the laboratory manuals published for working scientists,
perhaps the most notable was RNA Interference, a guide to a new, powerful, and swiftly
adopted way of silencing genes. CSHL scientist Gregory Hannon edited what became the
first authoritative book on the biology and applications of this experimental approach. It has
been an instant success.
Textbooks for undergraduates are a recent addition to the publishing program. James
Watson's classic textbook Molecular Biology of the Gene-first published in 1965 and for 25
years the book of choice for advanced undergraduate teaching in genetics-was compre-
hensively revised and published to acclaim in December, in a fifth edition written by Richard
Losick, Tania Baker, Steve Bell, Alex Gann, and Michael Levine that seems likely to restore
the book to a central place in the curriculum.
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In a year in which many scientific conferences, cultural events, and news reporting around
the world were devoted to the 50th anniversary of Watson and Crick's proposal for the struc-
ture of DNA, the Press assembled a book to honor Jim Watson. With essays by more than
40 eminent people who have worked with Dr. Watson in all kinds of contexts, Inspiring
Science: Jim Watson and the Age of DNA, edited by John Inglis, Joe Sambrook, and Jan
Witkowski, succeeded handily in presenting a multidimensional view of its subject and his
diverse and extraordinary accomplishments.
Journal publishing at the Laboratory, which began with one journal in 1987, is now a core
competence of the Press. In its 16th year, the program grew to a list of five publications with
the addition of the journal of The RNA Society, RNA. In its first year with Cold Spring Harbor
Laboratory, the journal program's financial goals were achieved and its reputation enhanced
by incisive peer-review and editorial decision-making and the continued publication of high-
quality papers in molecular biology and genomics.
Watson School of Biological Sciences
James D. Watson raised the idea of a graduate school at Cold Spring Harbor Laboratory in
the fall of 1995. Just seven and one-half years later, the Laboratory awarded its first Ph.D.
degree. On May 13, 2003, Amy Caudy-of the entering class of 1999-became the first
Watson School student to defend her doctoral dissertation. This fall, Ira Hall defended his
thesis, after just over three years in the School.
When the Watson School established the goal of offering a four-year Ph.D. degree in the bio-
logical sciences, one concern raised was whether it would be possible for students to perform
substantive research. Four years later, it has proven possible. Caudy was one of 16 interna-
tional graduate students to receive the 2003 Harold M. Weintraub Graduate Student Award,
sponsored by the Fred Hutchinson Cancer Research Center, based on the quality, originality,
and significance of her work. During his studies, Ira Hall participated in two projects recognized
in 2002 by the journal Science as the "Breakthrough of the Year." This year, the American
Association for the Advancement of Science recognized these two studies with the 2003
Newcomb Cleveland Prize, which acknowledges an outstanding paper published in Science.
The 2003 student recruitment was also very successful. Of 13 offers made to applicants,
8 were accepted-more than a 60% acceptance rate. Students turned down offers from the
University of California, Berkeley, Massachusetts Institute of Technology, Stanford, and oth-
ers to join the School. With one deferral from 2002, there were nine entering students this
year. On August 25, Hiroki Asari, Rebecca Bish, Francois Bolduc, Monica Dus, Angelique
Girard, Christopher Harvey, Jeong-Gu Kang, Izabela Sujka, and Wei Wei began their adven-
ture in becoming scholars in the biological sciences.
CSHL Library and Archives
In 2003, the CSHL Library continued to provide information to its scientists, both traditional-
ly and electronically. In addition to the many new databases that the library had acquired in
2002, they tested and added several new databases and e-books-including Current
Protocols in nine subjects-to the collection this year. Inter Library Loans are now mostly
delivered in PDF format, and Web Cat, the on-line catalog, now includes most of the titles in
the Library's collection, including rare books. The library has continued to participate in the
Biolnformation Synthesis Collaborative (BISC), which the Harvard Libraries (Museum of
Comparative Zoology and Biological Laboratories Library) joined in 2003. The Archives has
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undergone tremendous growth and development as well. The Oral History Project, which
aims to document Cold Spring Harbor Laboratory history through the eyes of the scientists
who worked and visited here, grew to 40 interviews and will ultimately be made available
through our Web page. In conjunction with The Oral History Project, a second archival pro-
ject was initiated this year: the Memory Board. The Memory Board is an on-line forum that
paints a picture of the lab through the eyes of anyone who contributes their written recollec-
tions to the Web site. These are typically casual contributions that attempt to capture a com-
plete view of what makes Cold Spring Harbor Laboratory special.
50th Anniversary of the Double Helix
On the morning of Saturday, February 28, 1953, Jim Watson cleared his desk in the
Cavendish Laboratory at Cambridge University. His goal: To have a large, flat surface on
which to explore how cardboard cutouts representing the building blocks of DNA might fit
together to form the basic structure of the molecule of life. Although years of work by many
scientists laid the chemical and intellectual foundations for the discovery of the double helix,
the principal features of the now familiar DNA structure came together for Jim and Francis
Crick over a short period in 1953.
To mark the 50th Anniversary of the double helix, Cold Spring Harbor Laboratory hosted
or participated in several scientific, cultural, and celebratory events in 2003. Many of those
events explored how the discovery of the double helix has transformed science, medicine,
and society and rightly recognized the tremendous strides that were made in biology since
that time (see pages 31-46).
Events
Symposium
The 68th Annual Cold Spring Harbor Laboratory Symposium, "The Genome of Homo sapi-
ens," set a new attendance record, attracting nearly 500 scientists from around the world,
and represented a remarkable bookend to half a century. Fifty years prior, at a Cold Spring
Harbor Laboratory meeting in 1953, Jim Watson made the first public presentation of the
double-helix model for the structure of DNA. In 1986, Jim organized a Cold Spring Harbor
Laboratory meeting on "The Molecular Biology of Homo sapiens," during which arguments
for and against a proposal to sequence the entire 3-billion-letter human genome were pre-
sented. This year, that sequence was completed.
Marking this occasion, Dr. Francis Collins, who directed the United States' later efforts to
sequence the human genome, gave the 2003 Dorcas Cummings Memorial Lecture. Francis,
one of the leaders of the sequencing effort, escorted the audience on a brief tour of the
human genome and explained the surprises scientists found as they sequenced, namely,
that the genome is much more similar between individuals than expected and the genome
turned out to be much shorter than expected. CSHL Association President Trudy Calabrese
welcomed the audience, where meeting participants were joined by friends from the local
community, as tradition dictates. The endowed lecture is in memory of Dorcas Cummings, a
longtime Laboratory friend and former Director of the Long Island Biological Association.
After the lecture, scientists visited the homes of Laboratory neighbors to enjoy dinner and the
chance to learn from one another.
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Audience at 2003 Dorcas Cummings Memorial Lecture
Gavin Borden Visiting Fellows
On March 26, Dr. Randy Schekman, Howard Hughes
Medical Institute, University of California, Berkeley/
Department of Molecular and Cell Biology, delivered the
ninth annual Gavin Borden Visiting Fellows Lecture titled
"How proteins are sorted in the secretory pathway." The
annual Gavin Borden Lecture was started by Jim Watson in
1995 in memory of Gavin Borden, a publisher whose
Molecular Biology of the Cell and other books made a last-
ing impact.
Public Lectures Randy Schekman
This year's lectures, part of The Double Helix 50th Anniversary Cultural Series, focused on
the practical uses of the double helix and how it has benefited humanity for the past 50
years.
April 27 David Gallo, director of special projects, Woods Hole Oceanographic
Institution: Origins-Evolution Destiny: Clues from the Deepest Sea.
May 5 Oliver Sacks, renowned neurologist and best-selling author of Uncle
Tungsten and The Man Who Mistook His Wife for a Hat: Oliver Sacks: A Life
of Science.
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May 12 Barry Scheck, founder, The Innocence Project at
Cardozo Law School: Barry Scheck: The DNA
Defender.
May 27 Eric Lander, one of the principal leaders of the Human
Genome Project: Eric Lander: Living in a Genomic
World.
September 21 Tim Tully, Cold Spring Harbor Laboratory neuroscien-
tist, and Suzanne Nalbantian, C.W. Post English pro-
fessor: A Composition of Memory: From Literature to
the Brain.
October 7 Robert Shaler, director of forensic biology for the
Medical Examiner's office of New York City: Questions
Answered: DNA Identification at the World Trade
Center.
Other Lectures
Oliver Sacks
The West Side School lecture series moved to a new venue: the Arthur and Joan Spiro
Auditorium at the Dolan DNA Learning Center. Nouria Hernandez ("How We Read Our
Genes"), Senthil Muthuswamy ("Cells Gone Wild: A 3-D Approach to Studying Cancer"),
Elizabeth Thomas ("Why Two Is Better Than One: Gene Duplication in Evolution"), and Shirley
Chan ("Biology on the Web") delivered these lectures, which are geared toward 4th-7th
graders and their families.
As in the past, Cold Spring Harbor Laboratory hosted the Huntington Hospital Lecture
Series on cardiovascular health and related diseases in both the spring and the fall in Grace
Auditorium.
Concerts
Accompanying the lectures in The Double Helix 50th
Anniversary Cultural Series was a comprehensive lineup of con-
certs that included an eclectic mix of musical styles from clas-
sical cello to piano duets to singers and postmodern chamber
music performed by renowned young artists from around the
world. They were all equally enjoyed by Meetings participants,
CSHL Association members, and the general public.
April 26
May 3
May 10
May 17
September 6
September 13
September 20
October 4
Vassily Primakov, piano
Viviane Hagner, violin
Thomas Carroll, cello
Anton Belov, baritone
Ken Noda and Jennifer Frautschi, piano
and violin
Antonio Pompa-Baldi and
Emanuela Friscioni, piano
Tin Hat Trio, postmodern Chamber Music
Robert Belinic, guitar Emanuela Friscioni and Antonio Pompa-Baldi
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Exhibits
Matthew Schreiber, Cold Spring Harbor Laboratory's second artist-in-residence, returned on
June 28 to display the holograms he created during and after his visit to the Laboratory the
previous summer. The exhibit, which ran until July 16 and was open to the public, focused
on the history of genetics in conjunction with the 50th anniversary of the double helix and the
many important events that have taken place in Bush Lecture Hall.
After a hiatus in 2002, Foto Lab returned to Bush Lecture Hall this year. Thirty-eight
employees displayed their personal photography in Foto Lab II. An opening reception took
place on July 20, and the exhibit was open to the public until August 10.
Spend a Day with DNA
This summer, Cold Spring Harbor Laboratory teamed up with the Heckscher Museum of Art
and the Cinema Arts Centre in Huntington for the first time to present Spend a Day with DNA
on July 12, 26 and August 9, 23. Sponsored by Vytra Health Plans, the program was the
first-known attempt to relate how the discovery of DNA has served as an inspiration to artists
and filmmakers throughout the world.
Community Outreach
Once again, Betsy Panagot, Special Events Coordinator, organized our annual blood drive
on April 14, which collected 42 pints of blood for the New York Blood Center.
Cold Spring Harbor Laboratory was well represented at the 6th Annual 1 in 9: the Long
Island Breast Cancer Action Coalition 5K Walk/Run sponsored by Cigna Healthcare on
August 6. Forty-six employees participated, several of them placing, including Charles
CSHL Team at 1 in 9 Walk/Run
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Kopec, Shraddha Pai, Charles Prizzi, Laurence Denis, Cara Brick, Ingrid Ehrlich, Susan
Janicki, and Carla Margulies.
Institutional Advancement
Capital and Program Contributions
Private funding is critical to our research programs. Philanthropy enables the successful,
innovative projects that are not yet eligible to receive public funding. For this reason, we
especially appreciate our close supporters who make major gifts to our cancer and neuro-
science programs. We gratefully acknowledge donors of $100,000 or more to the cancer
program-the Lustgarten Foundation for Pancreatic Cancer Research, the Miracle
Foundation, the Louis Morin Charitable Trust, the Dana Foundation, Manyu Oga le, and the
Seraph Foundation-and donors of $100,000 or more to the neuroscience program-the
Dart Foundation, Ira Hazan, the estate of William L. Matheson, the G. Harold and Leila Y.
Mathers Charitable Foundation, the Simons Foundation, and the St. Giles Foundation.
Equally important to our research are the gifts with which we build and maintain our lab-
oratories. Shortly before former Trustee William Matheson passed away in late 2002, he and
his wife Marjorie announced their plans to make a gift for a future cancer building. With the
gift we received this year, we are sure to build a fitting tribute to Mardi and Bill's dedication
to the Laboratory's mission. Howard Solomon also gave $1 million to help fund new science
buildings.
We appreciate the Starr Foundation and the anonymous donor who made gifts of
$100,000 or more for the Cancer Genome Research Center. With these gifts, we will be able
to continue to make advances in cancer, neuroscience, and plant genomics research at our
outstanding Woodbury facility.
It is my pleasure to thank Jim Watson for his most generous donation of funds from lec-
tures that he has presented. The resulting "2003 Fund" is an important source of unrestrict-
ed funds to further our research and education programs.
Watson School of Biological Sciences
Now in its second phase of fund-raising, led by Robert D. Lindsay, the Watson School
received more than $2.4 million in gifts this year. These monies support the Dean's Chair, fel-
lowships, and lectureships so that the Watson School can continue to grow and influence
the biological sciences field. We appreciate the gifts of $100,000 or more made by the
Annenberg Foundation, Curt Engelhorn, Mr. and Mrs. Alan E. Goldberg, Mr. and Mrs. Robert
D. Lindsay and Family, the Ziering Family Foundation, and Joy and George Rathmann/The
Rathmann Family Foundation; the gifts of $200,000 or more made by the Arnold and Mabel
Beckman Foundation, the Lita Annenberg Hazen Foundation, the Florence Gould
Foundation, the Miller Family Foundation, Bristol-Myers Squibb, and the William Stamps
Farish Fund; and the gift in excess of $300,000 from the Charles A. Dana Foundation, Inc.
Carnegie Building
We are initiating plans to make the Carnegie Building fit for the 21st century, and for the first
time in 100 years, we are looking to renovate and expand the Library and Archives. To do
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so, a campaign was initiated this year to raise funds to add much-needed space and equip-
ment to the existing structure, so that current and future generations of scientists and histo-
rians will be able to access, preserve, and study valuable archival and research materials.
The new annex will include wheelchair accessibility; study space; storage, workshops, and
reading areas; computer workstations; display space for the extensive archives and rare
books collections; and the establishment of the Center for the History of Molecular Biology,
a new academic program to document research in the 20th and 21st centuries. We are
grateful to Waclaw Szybalski, Harold E. Varmus, Arnold J. Levine, Victor and Ruth McElheny,
and Hiro Nawa for making the first contributions to this important campaign.
Dolan DNA Learning Center
Thanks to a generous gift from Joan and Arthur M. Spiro, the Dolan DNA Learning Center
auditorium was dedicated as the Joan and Arthur M. Spiro Auditorium on September 9. Mr.
Spiro is a member of the Cold Spring Harbor Laboratory Board of Trustees, an Executive
Committee member, Chairman of the Dolan DNA Learning Center Committee, and Trustee
Liaison for the DNALC's Corporate Advisory Board. We also thank Laurie J. Landeau,
V.M.D., and Arrow Electronics for continued support of the DNALC's Biomedia addition. The
Dolan DNA Learning Center was also able to contribute to the five-part television series on
DNA and produce their DNA Interactive CD with a major grant from the Howard Hughes
Medical Institute.
President's Council
Laboratory supporters who donated $25,000 or more to the research of Cold Spring Harbor
Laboratory Fellows Drs. Lee Henry and Terrence Stick were invited to a weekend retreat May
President's Council birdwatching at Shelter Island.
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17-18. The theme was "The Mind of the Bird," and Council members were treated to lec-
tures on Saturday. This year, the topics were "How Birds Will Save the World" (John W.
Fitzpatrick, Ph.D.); "The Wonders of Bird Migration" (Sidney Gauthreaux, Ph.D.); "Courtship
and Mating in Birds" (Timothy Birkhead, Ph.D.); and "Developing Skills-Lessons from a
Grey Parrot" (Irene Pepperberg, Ph.D.). On Sunday morning, participants went bird watch-
ing through the Mashomack Preserve on Shelter Island with our speakers, David Sibley
(America's premier birder and best-known bird illustrator) and James Watson, who retains an
interest in ornithology he developed early in life.
Planned Giving
Bill Miller, Chairman of the Board of Trustees, and his wife, Irene, generously committed a
substantial charitable remainder trust which, upon maturity, will be used to fund Watson
School fellowships. We also received a further payment from the Estate of Elisabeth S.
Livingston. This gift has provided the means to build much-needed housing for postdoctor-
al researchers at Uplands Farm.
In the fall, the benefits of estate planning were the subject of two seminars for the gener-
al public, held at our Cancer Genome Research Center in Woodbury. The sessions were
oversubscribed and stimulated additional interest in the Laboratory. In November, we were
pleased to welcome Peter Stehli to spearhead the Laboratory's outreach for planned gifts,
including bequests in wills, trusts, and other planned giving to benefit the education and
research programs. A further meeting of the Cold Spring Harbor Laboratory Planned Giving
Advisory Board was held in December. This board consists of accountants, tax advisors,
trust officers, bank officers, investment advisors, investment bankers, and lawyers, repre-
senting firms located on Long Island, in New York City, and in Connecticut. The Board was
briefed on the Laboratory's activities and accomplishments and provided much-appreciated
advice in support of the Laboratory's goals.
Breast Cancer Groups
A crucial component to our breast cancer research program is the support we receive from
hardworking local grassroots breast cancer groups such as Long Islanders Against Breast
Cancer (L.I.A.B.C.); 1 in 9: The Long Island Breast Cancer Action Coalition; The Elisabeth
McFarland Fund; and Long Beach Breast Cancer Coalition. This year, we were happy to
become one of the beneficiaries of funds from F.A.C.T. (Find A Cure Today), a new fund-rais-
ing group based in Lloyd Harbor/Huntington. The Judi Shesh Memorial Foundation also
made their first gift to us this year. We also gratefully acknowledge being chosen as one of
the many recipients of funding from The Breast Cancer Research Foundation. The generous
support we receive from these groups year after year is truly propelling our breast cancer
research.
Alumni Association
This year, a Cold Spring Harbor Laboratory Alumni Association was formed, thanks to the
efforts of Terri Grodzicker, Assistant Director for Academic Affairs, and the 18 alumni who
agreed to serve on the board of the Alumni Association. The program aims to facilitate year-
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round, ongoing relationships between Cold Spring Harbor Laboratory and the thousands of
scientists who have worked or attended a meeting or course at the Laboratory. In this inau-
gural year, it is a particular pleasure to acknowledge the gifts of alumni committed to sus-
taining Cold Spring Harbor Laboratory as a special place for science.
Double Helix Gala and Exhibit
In honor of the 50th anniversary of the double helix, our generous supporters made addi-
tional contributions, which enabled us to present a celebratory gala at the Waldorf-Astoria on
February 28. The Dana Foundation provided a lead gift early-on and major support followed
from foundations and corporations, such as Forest Laboratories, Genzyme Corporation, Pall
Corporation, Pfizer, The Albert and Mary Lasker Foundation, and The Alfred P. Sloan
Foundation. An historical exhibit which highlighted the contributions of New York area
research to the discovery of the DNA double-helix was held at the New York Public Library's
Science, Industry, and Business Library from February until August. "Seeking the Secret of
Life: The DNA Story in New York" was generously funded by The Camille and Henry Dreyfus
Foundation, The Ellison Medical Foundation, Morgan and Finnegan LLP, and The Rockefeller
Foundation.
Cultural Programs
A group of Laboratory benefactors generously supported our efforts during the past year to
purchase a Steinway "B" piano for our concert series. Ownership of a piano will enable the
Laboratory to defray the high costs of renting a piano for individual concerts and will allow
for additional programming in the years to come. We thank Lucy and Mark Ptashne and the
Jefferson Foundation; Roger Hugh Samet; Victoria and Anthony Sbarro; Douchet and
Stephen Fischer for their gifts.
Concluding Remarks
The combined research and education programs at Cold Spring Harbor Laboratory are
unique and have become a model for how research can drive innovation in science educa-
tion. Close collaboration between our research and education programs allows the DNA
Learning Center and our advanced science courses to benefit from the latest advances in
research. The growth of these activities has been significant, but it is moderated by the desire
to remain the best at what we do and provide the highest quality of education. To maintain
our leadership position, we must increasingly rely on philanthropic support. For this reason,
I am most grateful to those who have helped us this year.
Bruce Stillman
President and CEO
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CHIEF OPERATING
OFFICER'S REPORT
As with the prior year, the Laboratory experienced an unsettling blend of highs and lows in
2003. The academic and research programs continue to be unmatched in their excellence
and in the promise they hold for solutions to major health problems. Endowment investment
performance was outstanding after two dismal years in the equity markets. On the other hand,
our operating results were disappointing.
It is easy to crow about the success of our various programs. The RNAi techniques devel-
oped by Greg Hannon and his colleagues are revolutionizing biology and are already provid-
ing pharmaceutical companies with RNAi libraries that target all human genes for therapeutic
drug discovery in cancer and other areas. The research in neuroscience is equally as exciting
as it branches into work on autism in addition to Alzheimer's disease and learning and mem-
ory. The success of the Watson School and its mission of providing a unique and accelerated
Ph.D. experience has been validated in convincing fashion with the recent theses defenses of
two outstanding graduate students, Amy Caudy and Ira Hall, both of whom completed the
program in less than four years. The Dolan DNA Learning Center continues to expand the
reach of its innovative laboratory program for secondary and high school students at the same
time that its biomedia group churns out award-winning educational Web sites. The Cold
Spring Harbor Laboratory Press, a distinguished publisher of scientific books, journals, and
manuals, released its first undergraduate textbook as part of a new effort in this area of pub-
lishing. Our meetings and courses programs are thriving in a competitive environment, and
Cold Spring Harbor remains the educational destination of choice for biologists from around
the world. It is by no means a stretch to say that Cold Spring Harbor Laboratory is the intel-
lectual capital of the world in the biological sciences.
Forecasting the Laboratory's operating revenue is a challenging task due to the varied
nature of the revenue streams and shifts in timing that are difficult to anticipate. The finance
and grants departments take a meticulous approach to analyzing and forecasting all existing
and pending grants from the public and private sectors. Hours are spent in this process with
Dr. Stillman, who personally assesses the likelihood of a particular grant being funded and the
timing of the research expenditures. Probabilities are assigned and the budget is built step-
by-step. We analyze our technology transfer activities and assess the likelihood and timing of
pending transactions. Judgments are made about new book sales and advertising revenue
trends. Meetings attendance must be forecasted and is subject to the vagaries of variables
such as SARS, terrorism, and inclement weather. Like all endowed institutions, we are also
affected by the financial markets and interest rate fluctuations.
Coming on the heels of two years of rising expenses and shrinking endowment funds, 2003
was a difficult year for most educational institutions. Many high-quality universities reported
budget deficits and layoffs. The goal at Cold Spring Harbor Laboratory has always been to
balance our operating budget after full depreciation expense. We knew that this would be a
difficult task in 2003, and, in fact, at the beginning of the year, we presented the Board of
Trustees with a forecasted deficit of $970,000 after $5.4 million in depreciation expense.
Expenses were closely managed over the course of the year. Administrative salary increases
were capped at 2.5%, and capital spending from operations was kept well below deprecia-
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tion expense in order to preserve cash. Our hope at the outset was that we might exceed our
grant revenue forecast and narrow the deficit by year-end. Unfortunately, things did not go our
way. A major unanticipated blow struck when a large biotechnology company, which had been
making substantial royalty payments on a Cold Spring Harbor patent for ten years, abruptly
ceased payments claiming they no longer believed they were infringing the patent. With this,
$1.2 million in revenue that would have dropped to the bottom line was gone, pending litiga-
tion, and $200,000 in unbudgeted legal expense was incurred. While we expect to prevail in
the legal process and recover this income in 2004, it was a problem we did not need in 2003.
The other large variance from revenue affecting the year was only a matter of timing. The
RNAi work referred to above has created substantial research support and licensing revenue
opportunities that have been deftly negotiated by our technology transfer department. To date,
agreements on this technology have been reached with OSI Pharmaceuticals and Merck. We
had expected and budgeted to close a third agreement with Genentech in 2003. In fact, nego-
tiations proved longer than expected and this revenue will not be realized until 2004.
The net effect is to report an operating deficit for the year of $2.0 million after depreciation
despite the fact that total revenues were up 11% year over year to a high of $88 million. Although
these results were largely event-driven, we are not satisfied and have taken action designed to
avoid a deficit in 2004. At year-end 2003, a freeze on all administrative salaries and hiring was
put into effect, and administrative department heads were asked to prepare to reduce budgets
by 10% across the board. While it is painful not to award annual raises to such a dedicated work-
force, we know that it is a necessary step for the time being. The Laboratory has a tradition of
sound and conservative financial management that our Board of Trustees and our supporters
have come to expect. Deficits of this magnitude must remain an exception to the rule.
The year was not without its bright spots. After two sub-par years, our endowment fund
performed exceedingly well, outperforming the strong stock market by a wide margin. As the
equity markets declined in the two prior years, the portfolio fell well below the equity/fixed
income percentage guidelines established by our Investment Committee. Instead of the cus-
tomary 60%/40% allocation, the portfolio shifted to 48%/52% early in 2003. Fortunately, the
Committee, chaired by Lola Grace, had the courage to recommit to equities in March, and we
reaped the benefits of a recovering stock market. Our three equity managers all outperformed
the S&P allowing our equity portfolio to appreciate 39% for the calendar year as compared to
28% for the S&P. The fixed income investments also performed well, appreciating 5%-slight-
ly ahead of the benchmarks. All in, our endowment funds grew nearly 26% for the year to a
total of $224 million. Although pleased with these results, the Investment Committee has not
lost sight of 2001-2002 and is not complacent. The Committee has recognized that our equi-
ty managers may be too highly correlated to one another, and an asset allocation and invest-
ment strategy review is in process.
The Laboratory continues to enjoy strong private support from friends in the local commu-
nity. The Cold Spring Harbor Laboratory Association, led this year by Trudy Calabrese, does
the all-important work of "friend-raising" and fund-raising for the Laboratory by organizing a
myriad of events, lectures, concerts and dinners. The volunteer Directors of the Association,
in concert with Trudy and CSHL Development Director Diane Fagiola, also manage the Annual
Fund which provides the Laboratory with a critical source of unrestricted funds for research.
We are pleased to report that this year, the fund exceeded its goal of $875,000 and crossed
the $1 million milestone for the first time.
The Laboratory cannot realize its dreams and fulfill its mission without major private dona-
tions for capital projects. Last year, in describing plans for several new research buildings, I
referred to an undisclosed gift toward "Phase I" of this project. We are deeply grateful to Mardi
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Matheson and her late husband, William Matheson, for a substantial donation to advance the
project, and we look forward to the day we dedicate the "William L. and Marjorie A. Matheson
Cancer Building." The funding of this gift has allowed the Laboratory to go forward with the
architectural and engineering plans for the project, work that is now very far along. Together
with the $20 million pledge from Governor Pataki and New York State, more than 50% of the
necessary funds have been raised. We are now in the process of applying to the Village of
Laurel Hollow for final approval of these important plans.
Two of our valued trustees, Edward Harlow, Ph.D. and Lorne Mendell, Ph.D., had their
terms expire at the end of the year. We are grateful for their years of service and will miss their
participation and advice. We will also miss our dear friend and long time trustee Ed Marks who
passed away in April (see Memorial on page viii). Fortunately, our Nominating Committee,
chaired by Bob Lindsay, has done a terrific job in identifying and recruiting five outstanding
new trustees to the board. We welcome David Botstein, Ph.D., James Stone, Alan
Stephenson, Edward Travaglianti, and Roy Zuckerberg.
The Laboratory is blessed with an unbelievably talented and dedicated staff. They were
given the opportunity to demonstrate their resourcefulness as well on August 14 when the
widespread northeastern blackout caused us to lose power for 22 hours. This came in the
midst of a meeting of 300 visiting cell biologists. With no stoves or elevators functioning in the
kitchen and hundreds of mouths to feed, Jim Hope and the Food Service staff went to work
by candlelight, retrieved the charcoal grills from the beach and prepared dinner as well as
breakfast and lunch the next day on makeshift grills. In emergencies such as these, the freez-
ers and refrigerators that preserve cell lines and other valuable research materials are powered
by diesel-fired generators. However, there is storage for only an eight-hour supply of diesel fuel
and beyond that, the situation can become dire especially when fuel vendors are also affect-
ed by the power outage. As the outage continued, Art Brings, Peter Stahl, and their col-
leagues in the Facilities Department convinced a local service station operator, whose pumps
were down, to allow them to wire his pumps to a portable generator. Having accomplished
this, our grounds crew shuttled back and forth to the Lab all night trucking tanks full of diesel
fuel to the generators on the main campus. Over 2000 gallons of diesel was transported and
burned before power was restored 22 hours later. We have become accustomed to seeing
our staff rise to the occasion, under challenging circumstances, with an unparalleled degree
of dedication and ingenuity.
No staff member has served the Laboratory with greater distinction than veteran leader
Morgan Browne who announced his retirement after 19 years as Administrative Director and,
most recently, Chief Financial Officer. During his tenure in these positions, Morgan guided the
Laboratory through a period of rapid growth and expansion. Annual operating income over the
period grew from $17 million to nearly $90 million. The endowment grew from $23 million to
over $200 million, and the employee headcount increased from 320 to 900. Throughout his
years here, Morgan consistently offered vision and sound judgment that served the Laboratory
exceptionally well. While we will miss Morgan on a daily basis, we are pleased that we will con-
tinue to benefit from his expertise as he has agreed to stay involved through several commit-
tees related to the future expansion of Laboratory programs. Morgan's first "post-retirement"
project is a historical documentation of the Laboratory's finances and endowment that
appears on page 433 of this report. We are most grateful to Morgan for all he has contributed
to Cold Spring Harbor Laboratory.
W. Dillaway Ayres, Jr.
Chief Operating Officer
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DNA 50 YEARS AGO AND TODAY
In Dublin, Ireland, just 60 years ago, the Austrian-born theoretical physicist, Erwin
SchrOdinger, gave a series of lectures under the title What Is Life? In them he made three
important points. Firstly, why we grow up to be human as opposed to, say, a dog
or tiger comes from information that is present in our chromosomes. Secondly, our
genetic information is likely encoded in some digital way on stable molecules held
together by covalent bonds. Thirdly, every time one chromosome becomes two
chromosomes, their gene- carrying information molecules must be almost exactly
copied.
Happily for me, Schrodinger transformed these lectures into a neat little book
published by Cambridge University Press. I read it early in 1946 when I was 17 and
a third-year student at the University of Chicago. It changed me from wanting to be
a naturalist like Charles Darwin to becoming a geneticist searching for the chemical
essence of the gene.
Just before I fell under What is Life's spell, a chemical bombshell appeared for which
Schrodinger had no forewarning-the molecule that carries genetic information is DNA
(deoxyribonucleic acid). This major discovery was made in New York at The Rockefeller
Institute by Oswald Avery, Maclyn McCarty, and Colin MacLeod. Their experiments, pub-
lished in 1944, were almost foolproof. But most biologists took little notice of them. They
remained wedded to the idea that proteins, being the most complex of biological molecules,
should be the bearers of genetic information. In contrast,
by the time I had my 1950 Ph.D. from Indiana University, I
was obsessed with DNA, seeing the elucidation of its 3-D
structure as the most important goal then before the bio-
logical world.
By then, the canny Scottish chemist, Alexander Todd,
then working in Cambridge, England, had put the
resources of his large laboratory toward establishing the
covalent structure of DNA. Long before Avery's experi-
ment, DNA was known to be a long polymeric molecule
containing large numbers of four different building
blocks-two purine nucleotides (A and G) and two pyrim-
idines (T and C). But how the nucleotide bases were linked
together was not known until Todd and his co-worker Dan
Brown established DNA's underlying 5"-3' phosphodiester
covalent bond. All DNA molecules possess the identical
sugar phosphate backbones.
Also seriously motivated by The Rockefeller Institute
results was the Austrian-born biochemist Erwin Chargaff
working at Columbia University. He reported in 1950 that
the number of purine bases in DNA molecules was very
similar to the number of pyrimidines. Even more impor-
tant, the purine adenine was similar in amounts to pyrim-
idine thymine with the purine guanine similar in amount to
pyrimidine cytosine. Equally crucial information came from
Oswald Avery Maclyn McCarty
Colin MacLeod
Photographs courtesy of the James D. Watson Collection,
CSHL Archives and The Rockefeller University Archives
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the Nottingham lab of the British physical chemist John Gulland.
He found that purine and pyrimidine bases were located within
DNA molecules in a way that prevented key hydrogen atoms
from freely popping on or off. Not one of these three clever
chemists, however, thought of themselves as going from their
data to the 3-D arrangement of DNA atoms. It was beyond their
field of expertise.
The main experimental technique for working out the 3-D
arrangement of atoms within molecules is X-ray crystallography,
a field first populated by physicists. Originally, proceeding from X-
ray diffraction patterns to a molecular structure was not straight-
forward. A year or two of sustained effort was usually required to
see atomic locations of small molecules like amino acids and
nucleotides. It then took much intellectual courage to pursue the
structure of much, much bigger molecules like proteins and DNA.
Leading the small postwar macromolecular crystallographic world
was a tiny group of physicists and chemists at Cambridge University.
Supported by the U.K. Medical Research Council, they worked at the
Cavendish Laboratory under the patronage of its head, Sir Lawrence
Bragg, the 1912 inventor of X-ray crystallography. Francis Crick had
been on its staff for two years working on new methods to attack
protein structure when I moved there in October 1951.
Soon the 35-year-old physicist Francis and I had desks in the
same office and set ourselves the task of building 3-D molecular
models of DNA. The great American chemist at
Caltech, Linus Pau ling, had six months before he used molecular model build-
ing to find the a-helical conformation of polypeptide chains without using
detailed X-ray data. So we thought, why not extend this approach to DNA?
Conceivably, sufficient experimental facts were known about DNA to let model
building get to the answer without the need for further X-ray analysis. Already
we knew from the King's College London lab that the DNA diameter was too
big for a single-chain molecule. Francis' physicist friend Maurice Wilkins
thought several chains were likely twisted around each other to form a multi-
chained helix. Our first DNA model, conceived in late November, proved all too
soon an embarrassment. It was incompatible with recent X-ray data obtained
by Maurice's colleague, the Cambridge-trained physical chemist Rosalind
Franklin. In our model, three sugar phosphate backbones formed a central
core with the purine (A+G) and pyrimidine (T-FC) bases facing outward.
Rosalind told us that the backbone, not the bases, were on the outside.
We only returned to model building after Linus Pau ling made his own move
on DNA. In December 1952, he devised a three-chain structure which incor-
rectly placed the purine and pyrimidine bases on the outside. When his manuscript arrived
in Cambridge, Francis and I read it with great disbelief. Instead of scooping the Cavendish
Lab, Pau ling had fallen on his face by proposing that the chains were held together by hydro-
gen bonds between phosphate groups. In our minds, his structure defied the basic laws of
chemistry. So Crick and I rushed over to Alex Todd's chemical laboratory to let him read
Pau ling's paper. He also decreed the Pau ling model impossible.
a-helical conformation of
polypeptide chains
Sir Lawrence Bragg
Linus Pau ling
Photographs courtesy of the James D. Watson Collect,
CSHL Archives and Oregon Sea University Archives
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Rosalind Franklin
Franklin's "B" form
Nobel Prize Ceremony, 1962
By this time, Crick and I were much better prepared chemically to move forward. The
essence of DNA had to lie in how two, not three, intertwined chains were held together by
hydrogen bonds between centrally located bases. Initially, we were held back by the wrong
textbook positions of key hydrogen atoms on the bases guanine and thymine. Only a day
passed between our knowing their correct locations and the finding of the Double Helix on
February 28, 1953. Until that day we never thought we'd get the DNA structure by ourselves.
We anticipated that help from the people at King's would be needed. To our relief, we soon
learned that new experimental data fit our model perfectly.
The double helix instantly revealed the answer to the two key dilemmas posed by
SchrOdinger How do you store and how do you
copy genetic information? Instantly, we knew
that DNA genetic information was digitally
encoded through the order of the four bases (A,
G, T and C) along DNA sugar phosphate back-
bones. In turn, DNA copying involves separating
the double helix's two strands. The resulting sin-
gle strands then serve as molds (templates) for
the formation of second strands using the base
pair rules-opposite an A you have to have a T
and opposite a G you find a C.
Our resulting three (Watson and Crick, Wilkins
and Wilson, and Franklin and Gosling) manu-
scripts went off to Nature on April 2, appearing in
print only three weeks later on April 25. In our one
page manuscript, we used a single sentence to
say, "It has not escaped our notice that the spe-
RNA Tie Club
Zitt=tZt=rgit-i::e're:\tim
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(Reprinted from Nature. Vol. 171, p. 73'7, April 25, 1953)
A Structure for Deoxyribose Nucleic Acid
WE wish to suggest a, structoo, for the salt
of deoxyribose nucleic acid (l ).N A.). This
structure has novel features which are of considerable
biological interest.
A structure for nucleic acid has already been
propospd by Boding and Corey'. They kindly made
their manuscript available to us in advance of
publication. "Their model consists of three inter-
twined chains, with the phosphates near the fibre
axis. and the base,s on the outside. In our opinion,
this structure is unsatisfactory for two reasons(1) We believe that the material which gives the
X-ray diagrams is the salt, not the free acid. Without
the acidic hydrogen atoms it is not clear what forces
would hold the structure together, especially as the
negatively charged phosphates near the axis will
repel each other. (2) Some of the van der Waals
distances appear to be too small.
Another threechain structure has also been sug-
gested by Fraser (in the press). In his model the
phosphates are on the outside and the bases on the
inside, linked together by hydrogen bonds. This
structure as described is rather ill -defined, and for
this reason we shall not comment on it.
We wish to put forward a radically different
stint:toe for the salt of deoxyribose nucleic. add,
This structure has two helical chants each coiled
round the same axis (see diagram). We have made
the usual chemical assumptions, namely, that each
chain consists of phosphate di-ester groups joining
(3-n-deoxyribofuranose residues with 3',5' linkages.
The two chains (but not their bases) are related by a
dyad perpendicular to the fibre axis. Both chains
follow right-handed helices, but owing to the dyad
the sequences of the atoms in the two chains run in
opposite directions. Each chain loosely resembles
Furberg'e model No. 1 ; that is. the bases are on
the inside of the helix and the phosphates on the
outside. The configtuation of the sugar and the
atoms near it is close to Furberg's 'standard' con-
figuration', the sugar being roughly perpoulicular to
the attached base. There is a residue on each chain
every 3.4 A. in the ...direction. We have assumed an
-
angle of 395 between adjacent residues in the same
chain, so that the structure repeats after 10 residues
on each chain, that is. after 34 A. The distance of a
phosphorus atom from the fibre axis is 10 A. As the
phosphates are On the O1118ide, cations have easy
access to them.
The structure is an open one, and its water content
is rather high. At lower water contents we would
expect the bases to tilt so that the structure could
become inure compact.
The novel feature of the structure is the mauler
in which the two chains are held together by the
purine and pyrimidine bases. The planes of the bases
are perpendicular to the fibre axis. They are joined
together in pairs, a single ban from one chain being
Nature paper
Courtesy of the James D. Watson Collection, CSHL Archives
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This figure Is purely
diegrameta le. The two
ribbons symbolise the
two phosphate--sugar
chains. and the herb
sontal roils the pairs of
buses holding the chains
together. The vertical
line marks the fibre axis
hydrogen-bonded to a single base from the other
chain, 'so that the two lie side by side with identical
s-co-ordinates. One of the pair must be a purine and
the other a pyrimidine for bonding to occur. The'
hydrogen bonds are made as follows purine position
1 to pyrimidine position 1 ; purine position 6 to
pyrimicline position 6.
If it is assumed that the bases only occur in the
structure in the most plausible tautomeric forms(that is, with the keto rather than the extol con-
figurations) it is found that only specific pairs of
bases can bond together. These pairs are: adenine(puine) with thymine (pyrimidine), and guanine
(purine) with cytosine (pyimidine).
In other words, if an adenine forms one member of
a pair, on either chain, then on these assumptions
the other member must be thymine ; similarly for
guanine and cytosine. The sequence of bases on a
singlet chain does not appear to be restricted in any
way. However, if only specific pairs of bases can be
formed, it follows that if the sequence of bases on
one chain is given, then the sequence on the other
chain is automatically determined,
It has been found experimentally,4 that the ratio
of the amotutts of adenine to thymine, and the ratio
of guanine to cytosine, are always very close to unity
for deoxyribose nucleic acid.
It is probably impossible to build this structure
with a ribose sugar in place of the deoxyribose, as
the extra oxygen atom would make too close a van
der Waals contact.
cific pairing we have postulated immediately suggests a possible copying mechanism for the
genetic material." I then wanted to say nothing about how DNA is duplicated. It was so obvi-
ous we didn't have to say anything. But Crick said some people might think we were stupid
and didn't see it. Soon after writing the first paper, we wrote a longer second paper, "The
genetical implications of the structure of DNA." It came out in late May. Few reprints of it still
exist, so it's more costly to buy than the first paper. I don't have any.
The 10 years following the finding of the double helix witnessed our learning how DNA
sequence information is used by cells to make proteins the main molecular actors of cells.
The two strands of the double helix temporarily separate to let single DNA chains be copied
into RNA chains of complementary sequences using the same base pairing rules involved in
copying DNA. The resulting single RNA chains provide the information for ordering amino
acids with successive groups of three bases along RNA chains
specifying successive amino acids along polypeptide chains. The
specific groups of three bases which specify the 20 different
amino acids comprise the Genetic Code. It is universally used by
all forms of life from bacteria to higher plants and animals.
During protein synthesis, very large RNA containing particles
known as ribosomes function as molecular factories which spin
polypeptide chains in an assembly-line fashion. When we first
worked on ribosomes, we thought their more than 100,000
atoms would preclude our ever knowing their precise structure at
the 3-D level. Happily, a long succession of technical advances
in X-ray crystallography recently let us see what they actually look
like. The first scientist to visualize the ribosome in its entirety was
Harry Noller at his lab in the University of California in Santa Cruz.
There he observed the complete absence of protein molecules
at the ribosomal site where peptide bonds are made. Atoms on
RNA chains, not protein chains, enzymatically promote the link-
ing together of the amino acids into polypeptide chains.
Before our current DNA dominated world came into existence,
there existed a simpler RNA world. How this RNA world arose we
shall never know. No surveillance cameras witnessed how the
first molecules of life arose. The earth's chemical components
moreover have been constantly evolving and what carbon- and
phosphorus-containing molecules existed when the RNA world
started always will be a mystery. So there is no way to disprove
the creationists' belief that life's origin was assisted by some God-
like action. I don't believe this nor do almost all of my fellow biol-
ogists. As scientists, we only concern ourselves with ideas that
can be experimentally tested. Truths only come from observations
and experiments not from religious revelations.
Our principal concern now is to study life as it now exists after wally
2-3 billion years of Darwinian evolution. In doing so, we benefit from two major experimen-
tal advances of the 1970s. The first was the working out Recombinant DNA procedures
which cut and paste DNA molecules. This powerful technology, devised just 30 years ago by
Herb Boyer of UCSF and Stanley Cohen at Stanford let specific genes be isolated. Soon
afterward, Wally Gilbert at Harvard and Fred Sanger at Cambridge devised rapid procedures
Harry Noller was the first to visualize
the ribosome.
Gilbert
Gilbert photograph courtesy of the Jam. D. Watson Collection, CSHL Archives
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to read DNA messages. Until these DNA sequencing technologies became available in 1975
only cells, not humans, could read DNA messages of genes.
By 1988, improvements in DNA sequencing technology allowed the starting of the Human
Genome Project. Its goal was to sequence the 24 very large DNA molecules present in each
of the 24 different human chromosomes (a total of three billion base pairs). Before tackling
the Human Genome itself, the genomes of a number of much smaller bacterial genomes
were sequenced. Each such genome sequence reveals the precise number of genes
involved in the growth and functioning of their respective bacteria. The smallest of these bac-
terial genomes code for only some 450 different proteins. With time, we will know the func-
tion of virtually every molecular actor in such simple bacterial cells. The life of a bacterium will
then approach being as describable as a Swiss watch.
Obviously what we most want to understand is ourselves. Through the recent finishing of
the Human Genome sequence, we now possess the location and exact structure of some
25,000 different genes. Using it, we have the potential to find out which combinations of the
some 250 different human cancer genes are responsible for specific cases of human cancer.
Equally explainable will be why and how some of us could come down with Alzheimer-like
brain dementias. Over the next decade, most of the major genetic changes that lead to
schizophrenia, bipolar diseases, unipolar depression, autism, and dyslexia will be found.
Stopping many of these human tragedies is at last a realizable human goal for medical
research. Though I'm already 75 years of age, I now have reason to hope that I may per-
sonally benefit from the Human Genome Project. When I helped start it 15 years ago, I
thought that my children would be its first major beneficiaries.
Over a slightly longer time framework, improvements in DNA technologies will lead to the
complete sequences for the biologically important portions of, say, 50,000 human genomes.
This massive sequencing effort will let us find the specific DNA base sequences that give us
much of our individual biological uniqueness. Why some of us in this room are left-handed
or have premature white hair or have no wrinkles at 60 is due to our respective genes as is,
say, much of our predisposition to being either thin or fat. Likewise many of our emotional
differences, say, being predisposed to being happy as opposed to sad, in part will reflect dif-
ferences in DNA sequences.
Increasingly, both what we as humans expect from ourselves and how we deal with other
human beings will be affected by genetic knowledge. Assigning genetic causation to human
capabilities and disabilities almost always has ethical consequences. Geneticists thus can no
longer have a largely hands-off attitude to how their results bear on the functioning of human
society. Likewise, moral philosophers, in their efforts to study the motivations behind human
conduct, will best move forward by partnering with human geneticists searching for the
genes that give to us our human nature. The Scotsman David Hume (1711-1770), in his pro-
found "Treatise on Human Nature," said that humans are motivated by their passions (emo-
tional feelings) as opposed to reason.
The main passion that led to the double helix was curiosity. All humans are curious to
varying extents about something or other. I, Francis, Maurice, and Rosalind focused on
DNA. There likely exist genetic reasons for why some of us seem to have so little curiosity
and others so much. You naturally want your children to have lots of curiosity. With it they
read books and learn about phenomena that need explanations. The passion for self-
advancement also led to the Double Helix. Francis and I wanted to get there before Pau ling.
In his Wealth of Nations, the equally important Scots intellect Adam Smith argued that the
freedom to work for your self-promotion promotes the well being of those about you.
Still highly argued today is the relative importance of nature and nurture in the expression
of these human passions. Great differences in opinion exist, for example, as to whether
human concern for the well-being of other humans is an innate or a learned response
acquired after birth. I come down on the side of nature through knowing that many acute
observers of human behavior believe we help others largely because we anticipate that those
helped in turn will help them. When I extend my hand to stop a nearby human losing his bal-
ance, I may be largely doing so because I was taught to so behave by my parents. Cultural
instructions, however, cannot explain the feeding and caring of young birds by their parents.
Such maternal (paternal) behavior ultimately must somehow go back to instructions encod-
ed in their genes. The feeding and care by human mothers of their newborn children are like-
wise easiest understood as being gene-initiated.
Already back in the early 18th century, the enlightened Presbyterian minister Francis
Hutchinson, whose career took him from Ulster to Dublin to Glasgow, argued that we are
born with a good feeling toward others. In Aberdeen, the moral philosopher Thomas Read
promoted a common sense approach to life basing it on his belief that humans are born with
an innate sense of right or wrong. Soon these ideas of the 18th century Scotch
Enlightenment flowed across the Atlantic to the British colonies giving to the American
Revolution its intellectual underpinnings-human beings have innate needs for life, liberty,
and the pursuit of happiness. To Tom Paine, common sense dictated that each human was
entitled to make their own decisions and not receive them from kings or bishops whose
authority did not come from those they ruled or presided over.
Common sense tells me that humans should proactively prevent as much genetic disease
as science lets us. The rare mistakes in the copying of DNA information that make evolution
possible of necessity leads to much individual genetic injustice. Random throws of the genet-
ic dice during the formation of sperm and egg take away from too many infants the oppor-
tunity to participate in a meaningful life. Those unfortunate individuals genetically pro-
grammed, say, to have cystic fibrosis or muscular dystrophy represent unambiguous
tragedies lacking in any compensatory side advantages. Common sense tells me that no one
is seriously harmed by steps taken to prevent the birth of such children. Once born, their
existences will of necessity generate many moments of anxiety, pain, and despair.
Common sense also dictates that prospective mothers should make the decisions as to
what lives are worth their bringing into the world. Obviously, they should share their thoughts
with the fathers, that is, if they are still about. Men, however, should have no veto over
women's decisions. Few men will willingly share the burden of looking after tiny infants. Likely
they are much less genetically programmed to give the necessary care. All such decisions
like "Do I want to find out whether my child will be badly handicapped?" should be the choice
of a woman. No one should force her either to be tested or not tested. But she should know
what genetic tests exist and how respective genetic diseases, say, Down Syndrome or
Fragile X disease will impact the future of those women that bear them.
How women will make these decisions will depend on their own sense of right and wrong
and from what culture and religion they come out of. Great care must be taken to keep gov-
ernmental and religious bodies from directly entering into genetics matters. We all know what
happened in Nazi Germany when it decided what lives were not worth living. Of course,
women occasionally will make decisions that they will later regret. Some of these may lead to
governments, charities, and religious groups caring for children whose disabilities prove too
great for their parents to handle. We should count on good common sense coming from most
women, particularly those with prior exposure to genetic issues. The power to the people idea
only really works when dealing with educated people. Unfortunately, current gene discovery
now moves forward much faster than genetic education programs for girls and their mothers.
Common sense also dictates that no one should look at someone else's DNA without their
explicit permission. I do not want others to know facts about my future that I myself do not
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want to know. Until, say, we can stop the course of Alzheimer's disease, I do not want to find
out whether I possess the Apo lipoprotein E gene variant that increases your odds of being
stricken with this dreadful dementia. Much harm to me might come from, say, my employer
having DNA knowledge that I don't want to have.
Over the next decade, there will come into existence more and more DNA tests which will
help our personal physicians prescribe better medicines which will improve our lives. In giving
them permission to so order such tests, it should be clear to all that no tests beyond those legal-
ly agreed to should be done without further permissions being given. There will of course be
occasions of medical emergency when physicians should be allowed to go ahead on their own.
Common sense also suggests there will be increasing times when DNA knowledge about
ourselves should be shared with others, say, our employers or insurance companies. There
likely exist individuals who should not work with specific chemical agents that pose no great
risk to most other human beings. Better to identify those at risk than to keep from human
deployment agents that will advance our lives. When we seek large amounts of life insurance,
we may find ourselves letting the respective companies look for DNA sequences that hint of
how long we will live into the future. In the absence of such knowledge, they may have to
assume that all of us are at high risk of early deaths. We must accept the fact that genetic
privacy laws, by themselves, cannot negate much of the unfairness resulting from bad
throws of the genetic dice.
We should also consider the still far off goal of improving human life by adding new genetic
material to our germ plasma. I am in favor of so going forward though most of my fellow sci-
entists, say, are afraid to do so. We don't yet know how to add genes safely, and why push
before the public explosive issues that may never exist. But by adding an appropriate gene, we
can improve the memory of mice. Why not the same with humans? To me it's common sense
to so give us more effective brains. I don't see who we're offending by trying to so enhance
ourselves. It goes against human nature to say that people should not try to improve the lives
of their children and those that follow them.
James D. Watson
Delivered at the Commonwealth Club of San Francisco, October 9, 2003
James Watson and Francis Crick, December 2002
Photograph courtesy of Kent Schceker, The Salk Institute
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Cold Spring Harbor Laboratory's
50th Anniversary Celebrations
DNA at 50: Finding the Double Helix
January 25 and February 8, 15, 2003
Dolan DNA Learning Center
Jim Watson gave three lectures on three separate days for a total
of nine rare, public talks about his role in solving the structure of
DNA, and then answered questions posed by the more than 900
people who attended these lectures. Visitors also had time to visit
the Dolan DNA Learning Center's museum exhibit, "The Genes
We Share," and purchase books authored by Dr. Watson.
Seeking the Secret of Life: The DNA Story in New York
February 24-August 29, 2003
New York Public Library-Science, Industry, and Business Library
DNA at 50: Finding the Double Helix
The Library and Archives of Cold Spring Harbor Laboratory, The Rockefeller Archive Center of The Rockefeller
University, and the New York Public Library's Science, Industry, and Business Library collaborated to present
an exhibition which tells the story of the role played by individuals and organizations based in New York before,
during, and after the 1953 discovery and presented an accompanying Web site, www.cshl.edu/
CSHLlib/DNAinNY/index.htm. Among the items contributed by CSHL were a 1953 offprint of Watson and
Crick's landmark Nature article, a photo of Watson and Crick with a large model they constructed of the DNA
molecule, and a model of the Waring Blender Al Hershey used to separate phage from DNA. The project, ini-
tiated by Mila Pollock, Director, Library and Archives at Cold Spring Harbor Laboratory, was created by an
Advisory Committee consisting of Pollock; Jan Witkowski, Director, Banbury Center at CSHL; Darwin
Stapleton, Executive Director, Rockefeller Archive Center; and John V Gan ly, Assistant Director for Collections,
The New York Public Library's Science, Industry, and Business Library, and their staffs.
Seeking the Secret of Life: The DNA Story in New York Seeking the Secret of Life opening
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Charlie Rose and Liz and Jim
Watson at DNA 50 Gala
Stacy Blechinger, Barry Scheck, Marvin Lamont Anderson,
Garnetta Bishop, Adele Bernhard, Peter Neufeld, and
Joan Anderson at DNA 50 Gala.
Kitty Carlisle-Hart and Jim
Watson at DNA 50 Gala
Nobel laureates at DNA 50 Gala
DNA 50 Gala
February 28, 2003
The Waldorf Astoria, New York City
An invitation-only, black-tie affair, scheduled 50 years to the day of the actual discovery by Watson and
Crick, was co-organized by Charlie Prizzi, director of events and special projects, Cold Spring Harbor
Laboratory; Columbia University; The Rockefeller University; and The Dana Alliance for Brain Initiatives to
recognize not only the discovery by Watson and Crick, but also the pioneering research conducted in New
York that led to the discovery. Charlie Rose hosted the evening, which included special appearances by
Senator Charles Schumer, Deborah Norville (Inside Edition), and Tony Randall (The Odd Couple). Joel Grey
(Cabaret) welcomed the more than 13 Nobel laureates and 700 guests who were in attendance with a
rousing rendition of "Wilkommen" and the indomitable Kitty Carlisle Hart performed "Just One of Those
Things" and "Here's to Life." Marvin Lamont Anderson, who with the help of Barry Scheck and Peter
Neufeld, founders of "The Innocence Project" at Cardozo Law School, became the 99th person to be
exonerated by DNA evidence, spoke of how his life was changed by genetics after he spent 15 years in
prison wrongly accused of rape. The evening would not have been complete, however, without the spe-
cial taped message from Francis Crick and Jim Watson's remarks on the discovery and its future impact.
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The Biology of DNA
February 26-March 2, 2003
Grace Auditorium
A four-day conference highlighting the
past, present, and future of DNA science
was organized by CSHL's David Stewart
and Jan Witkowski. Entitled "The Biology
of DNA," the meeting covered many top-
ics relating to the biology of DNA, rang-
ing from its replication, through the
Genetic Code, to the human genome.
Participants included a scientist from
each of the 1953 DNA papers-James
Watson, Herbert Wilson (who worked
with Maurice Wilkins), and Ray Gosling
(who worked with Rosalind Franklin), as
well as Maclyn McCarty who, in 1945,
with Avery and MacLeod, showed that DNA was the genetic material. Other participants included Nobel lau-
reates Sydney Brenner, Thomas Cech, Walter Gilbert, Arthur Kornberg, Marshall Nirenberg, Phillip Sharp, and
Hamilton Smith, and Francis Crick sent a special personal message via DVD. Other notable attendees were
Sir Alec Jeffreys, inventor of DNA fingerprinting, and Matthew Meselson and Frank Stahl who, in what has
been called the "most beautiful experiment in biology," showed how DNA is replicated.
(Right to left) P. Sharp, B. Stillman, J. Watson, and N. Zinder at The Biology of DNA
The Double Helix 50th Anniversary Cultural Series
April-October, 2003
Grace Auditorium
The 2003 cultural series, organized by CSHL's Charlie Prizzi, honored Jim Watson and his creativity and
cultural appreciation by bringing a wide variety of art, music, literature, and lectures to Cold Spring Harbor.
Many of the lectures focused on the practical uses of the double helix and how it has benefited humanity
for the past 50 years. Featured lecturers included Oliver Sacks, author of Awakenings, The Man Who
Mistook His Wife for a Hat, and Uncle Tungsten; Barry Scheck, who formed "The Innocence Project" at
Cardozo Law School and assisted in more than 100 cases where convictions were reversed or overturned
based on DNA evidence; Eric Lander, one of the principal leaders of the Human Genome Project; and
Robert Shaler, director of forensic biology for the New York City Medical Examiner's office, who has spent
the last two years identifying more than 650 World Trade Center victims. The comprehensive line-up of
concerts for the year also included an eclectic mix of musical performances; an art exhibit by Matthew
Schreiber, Cold Spring Harbor Laboratory's 2002-2003 artist-in-residence; and a book signing by Jim
Watson of his most recent book, DNA: The Secret of Life.
68th Cold Spring Harbor Symposium: The Genome of Homo sapiens
May 27-June 2, 2003
Grace Auditorium
Organized by Bruce Stillman and David Stewart, together with Jane Rogers and Eddy Rubin, the 68th Cold
Spring Harbor Laboratory Symposium, The Genome of Homo sapiens, represented a remarkable book-
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end to half a century of molecular biology. Fifty years prior, at a CSHL meeting in June 1953, Jim Watson
made the first public presentation of the double helix model for the structure of DNA. In 1986, Jim orga-
nized a CSHL meeting on The Molecular Biology of Homo Sapiens, during which arguments for and
against a proposal to sequence the entire 3-billion-letter human genome were presented. This year, the
genome community-who have been meeting annually at Cold Spring Harbor every spring since 1988 to
discuss ongoing progress and methods in genome science-were finally able to celebrate the completion
of the finished sequence of the human genome (completed in Spring 2003) and to share in the discover-
ies arising out of this remarkable achievement, perhaps the first example of "big science" in biology. Dr.
Francis Collins, who directed the United States' later efforts to sequence the human genome in collabora-
tion with colleagues from around the world, gave the 2003 Dorcas Cummings Memorial Lecture about the
human genome and the surprises scientists found as they sequenced it. This historic and notable
Symposium attracted more than 530 participants from some 20 countries.
Spend a Day with DNA
July 12, 26 and August 9, 23, 2003
Cold Spring Harbor Laboratory, the Cinema Arts Centre (Huntington, New York),
Heckscher Museum of Art (Huntington, New York)
The 50th Anniversary proved to be an excellent excuse to initiate a collaborative program with our neigh-
bors: the Heckscher Museum of Art and the Cinema Arts Centre in Huntington. Although events com-
memorating the anniversary were occurring throughout New York and around the world all year, Spend A
Day With DNA was truly an opportunity for Long Islanders to be a part of the festivities. More than 100
people from Cold Spring Harbor, Locust Valley, East Norwich, Glen Cove, Huntington, Northport, Roslyn,
Port Washington, and Ontario, Canada attended. The program was the first-known attempt to relate how
the discovery of DNA has served as an inspiration to artists and filmmakers throughout the world. Each of
the four days included a tour of Cold Spring Harbor Laboratory; a visit to Cold Spring Harbor Laboratory's
Dolan DNA Learning Center to explore its exhibition, The Genes We Share; a film at the Cinema Arts
Centre; and a tour of Genetic Expressions: Art After DNA at the Heckscher Museum of Art. The program
was sponsored by Vytra Health Plans.
Honest Jim: James D. Watson the Writer
September 22-December 31, 2003
New York Public Library-Science, Industry, and Business Library
The second of two exhibits created by CSHL's Mila Pollock, Jan Witkowski, the Cold Spring Harbor library
and archives staff, and a team from the New York Public Library, this exhibit focused on Dr. Watson as a
writer, displaying his letters, theses, books, essays, lectures, photographs, and other memorabilia. A series
of events accompanied "Honest Jim," including a lecture titled "My Life as a Writer," by Jim Watson and
Andrew Berry, co-author of Jim's newest book DNA: The Secret of Life, and a very well-received panel dis-
cussion titled "Writing Science: Creating a Best-Seller." Panelists included Bruce Alberts, president of The
National Academy of Science and author of Molecular Biology of the Cell; Robin Marantz Henig, author of
Monk in the Garden; Sylvia Nasar, author of A Beautiful Mind: The Life of Mathematical Genius and Nobel
laureate John Nash; Doron Weber, program director at the Sloan Foundation; and Jim Watson. The exhib-
it then moved to the University of Chicago.
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Unwinding DNA: Life at Cold Spring Harbor Laboratory
Ongoing
www.exploratorium.edu/origins/coldspring/
The Exploratorium is a museum of science, art, and human perception housed within the walls of San
Francisco's historic Palace of Fine Arts. Part of the Exploratorium's award-winning Web site, which hosts
12 million visitors per year, includes its Origins project. Through a collaboration with Peter Sherwood, Cold
Spring Harbor Laboratory director of research communications, the Exploratorium launched a new Origins
project called Unwinding DNA: Life at Cold Spring Harbor Laboratory. The project enabled the artists, writ-
ers, filmmakers, and producers of Unwinding DNA to explore many aspects of the history of Cold Spring
Harbor Laboratory, the role of CSHL in the birth and growth of molecular biology, the 50th Anniversary of
the double helix, and modern plant biology, genomics, and neuroscience research. In addition, through live
and archived webcasts of one-on-one interviews and other dispatches issued during the "The Biology of
DNA" meeting, the Exploratorium used Unwinding DNA to explain how scientific meetings fuel the process
of discovery.
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Worldwide 50th Anniversary Celebrations
The year-long celebration of the discovery of the structure of DNA began with a private, celebratory dinner
with Jim Watson and Francis Crick at the Salk Institute in January. Throughout the rest of 2003, a variety of
symposia, lectures, and other special events were held, many of which Jim Watson attended. A sampling of
these events is listed below.
EVENT
SYMPOSIA
Feb. 19-21 Time Inc: The Future of Life
Feb. 26-Mar. 2 The Biology of DNA
April 7-11 World Life Sciences Forum
April 8 Nobel's Conference: DNA's Day
April 13 Linking the Double Helix with Health: Genetics in
Nursing Research
April 14-15 From Double Helix to Human Sequence-and Beyond
(hosted by NHGRI)
April 15 Bringing the Genome to You
April 16 Genetic Variation and Gene-Environment (G-E)
Interaction in Human Health and Disease
April 16 Genes, Brain, Behavior: Before and Beyond Genomics
April 23-24 Royal Society Meeting: DNA Replication and
Recombination
April 25 DNA: 50 Years of the Double Helix
April 22-25 A Celebration of the DNA Double Helix at 50
April 28-29 Royal Institution: Molecular Biology in the 20th Century
April 28 DNA: 50 Years Ago and Today
May 27-June 2 The Genome of Homo sapiens
July 6-11 XIX International Congress of Genetics
Aug. 25-29 From the Lab to Everyday Life: Fifty Years of DNA
Oct. 10-11 Genetech/Tularik Celebration: 50th Anniversary.
Double Helix
Nov. 14-15 50th Anniversary Symposium
EXHIBITS
Feb. 6-April 11 From Code to Commodity: Genetics and Visual Art
Feb. 22-Mar. 22 Women in Science (Genomically Yours)
Feb. 25 PhotoGENEsis: Opus 2
TITLE LOCATION
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Monterey, California
Cold Spring Harbor Laboratory
Lyon, France
Lyon, France
Georgetown University,
Washington, D.C.
Natcher Conference Center,
Bethesda, Maryland
Smithsonian's National
Museum of Natural History,
Washington D.C.
National Institutes of Health,
Washington, D.C.
National Institutes of Health,
Washington, D.C.
London, United Kingdom
Cambridge, United Kingdom
Trinity College Dublin
London, United Kingdom
Trinity College Dublin
Cold Spring Harbor Laboratory
Melbourne, Australia
El Escorial (near Madrid,
Spain)
University of California,
Berkeley
University of California, San
Diego
New York Academy of
Sciences, Gallery of Art and
Science, New York
Art Exhibit Universal Concepts
Unlimited, New York
The Museum at the Graduate
Center, City University of
New York
Feb. 28May 25 How Human: Life in the Post-Genome Era
March 1-31 Brave New World
April 25 The Geee! in Genome
PUBLIC LECTURES
Feb. 2 Finding the Double Helix
Feb. 23
March 3
April 28
May 23
June 4
June 19
Aug. 5
Sept. 23
Sept. 30
Nov. 5
Nov. 11
OTHER EVENTS
Ongoing
January
Feb. 28
April
April 25
May 14
In the Round: A Conversation with Dr. James Watson
Moving Forward with the Double Helix
DNA: 50 Years Ago and Today
DNA at 50
DNA and Cancer
DNA and Our Futures
From the Double Helix to the Human Genome Project
From the Double Helix to the Human Genome Project
The Future of Medicine: From DNA to Angiogenesis
DNA: 50 Years Ago and Today
The Discovery of DNA and Its Implications on
Modern Medicine
Origins-Unwinding DNA: Life at Cold Spring Harbor
Laboratory (www.exploratorium.edu/origins/coldspring/)
An Uncirculated 22 Coin Commemorating the 50th
Anniversary (designed by John Mills) Issued
DNA 50 Gala
DNA: The Secret of Life, by James D. Watson and
Andrew Berry Published
National DNA Day
DNA: The Secret of Life Film Premiere
August Inspiring Science: Jim Watson and the Age of DNA
Published
October 6 James D. Watson Institute of Genome Sciences
Dedication
International Center for
Photography, New York
Organization of Independent
Artists, New York
Ottawa, Canada
Nature Biotechnology/
University of Miami Winter
Biotechnology Symposium,
Miami, Florida
The Cooper Union for the
Advancement of Science
and Art, New York
New York Public Library,
Science, Industry, and
Business Library, New York
Trinity College Dublin
Leipzig, Germany
Express Scripts/Outcomes
Conference, St. Louis
Pfizer, Groton, Connecticut
University of Michigan
Biological Station
North Shore University
Hospital, New York
Angiogenesis Meeting,
Cambridge, Massachusetts
Youngstown State University
AstraZeneca, Orlando, Florida
Produced by The
Exploratorium, San Francisco
British Royal Mint
Waldorf-Astoria, New York
Book tour took Watson all
over the United States and
the world
United States
Morehead Planetarium and
Science Center, The
University of North Carolina
at Chapel Hill
Cold Spring Harbor Laboratory
Press
Zhejiang University, China
45

'
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Sunita Gupta; Sarah Newey
Row 4: Supriya Gangadharan; Michael Kwofie; Tsai-Ling Lee; Jonathan Sebat
Row 5: Stephanie Muller; Hong Jie Shen; Mary Byrne; Anindya Bagchi;
Ping Hu; Inessa Hakker
Row 6: Ingrid Ehrlich; Jennifer Meth
Row 7: Takuya Takahashi; Jill Hemish; Khalid Siddiqui; Shanta Hinton
CANCER: GENE EXPRESSION
By identifying all the 40,000 or so proteins that govern human biology, the completion of the human
genome sequence has ushered in a new age of biological discovery. Assigning functions to this myri-
ad of proteins will involve several approaches. The lion's share of this functional characterization may
well stem from "proteomics" or the study of how proteins are modified in the complex and dynamic
environment of cells and tissues, and how they organize themselves into coherent, highly interactive
networks that determine cell function. Michael Myers' lab is focused on identifying the global architec-
ture of these protein networks. In particular, he is exploring the features of protein networks that make
them robust (error-tolerant) as well as how such networks are altered in diseases such as cancer. These
studies should provide key insights into which network components are promising targets for treating
cancer.
Jacek Skowronski's lab focuses on a protein encoded by the genome of the virus that causes AIDS.
The protein, called Nef, is an important determinant of HIV virulence and AIDS pathogenesis. By puri-
fying human proteins that specifically bind to Nef, Skowronski's lab has identified several factors that
are likely to control crucial events during AIDS pathogenesis. In so doing, they have uncovered poten-
tial new targets for therapies to combat this disease.
Leemor Joshua-Tor is collaborating with Greg Hannon and Rob Martienssen to determine the crys-
tal structure and biochemistry of key protein complexes involved in RNA interference (RNAi), a promis-
ing tool for cancer gene discovery. In collaboration with Martienssen's group, Shiv Grewal's lab has
shown how RNAi targets histone-modifying enzymes to specific regions of DNA, leading to the forma-
tion of an inactive heterochromatin structure. These studies have revealed an entirely unexpected con-
nection between RNAi and DNA structure and have profound implications for understanding many
aspects of gene regulation and the formation and stable inheritance of chromosome structure.
Like Joshua-Tor, Rui-Ming Xu focuses on determining the three-dimensional structure of proteins,
at the atomic level, by using X-ray crystallography. Xu's lab focuses on proteins that carry out RNA
splicing and on others that affect histone protein modification and thus the structure of DNA. By deter-
mining these protein structures, Xu's lab has uncovered several clues about how the proteins carry out
RNA splicing and chromatin remodeling.
On the way from gene to protein, information passes through two RNA forms. The first is called a
premessenger RNA transcript, which is a word-for-word translation of a gene's DNA. Premessenger
RNA transcripts are then spliced to create mature messenger RNAs, the templates that cells use to
make proteins. In many genetic diseases, gene mutations block RNA splicing. The resulting aberrant
messenger RNAs lead to the production of abnormal proteins that cannot perform their functions prop-
erly. Adrian Krainer's lab has developed compounds that correct such RNA splicing defects. These
compounds may ultimately be used as effective therapies for diseases as diverse as breast cancer,
muscular dystrophy, and cystic fibrosis.
Nouria Hernandez and Winship Herr lead groups of researchers that explore the precise biochemi-
cal mechanisms by which DNA is transcribed into RNA. Both groups have looked at how specific pro-
tein-protein interactions control the action of enzymes called RNA polymerases, which produce RNA
using the information coded in DNA. By examining how the herpes simplex virus prompts transcription
and cell proliferation, Herr's group has found that a cellular transcription factor called HCF-1 acts at two
key stages of the cell cycle and is now studying its role in processes that can lead to cancer.
William Tansey's lab studies the relationship between two processes that seem unrelated: tran-
scription and protein destruction. They have found that factors from the protein destruction system are
exploited in transcription, and hence actually help regulate genes. In particular, they are investigating
how and why a potent transcription factor called Myc is destroyed, and how the loss of Myc protein
destruction leads to cancer.
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EPIGENETIC CONTROL OF GENE EXPRESSION
S. Grewal I. Hall K. Noma
S. Jia A. Malikzay
G. Xiao
After spending more than four years at Cold Spring
Harbor Laboratory, I accepted a position at the National
Cancer Institute (NCI), National Institutes of Health
(NIH), in January this year and moved my laboratory to
the Bethesda NIH campus. I enjoyed my stay here at
CSHL and gained valuable experience thanks to many
friends and colleagues and strong support provided by
the Laboratory administration. An excellent and stimu-
lating environment at CSHL greatly facilitated the rapid
pace of our research. Our lab focused on the epigenetic
control of gene expression and higher-order chromatin
assembly. While at CSHL, we provided the first record-
ed evidence that Mendel's gene, in some instances, com-
prises DNA plus associated proteins. We also defined
key molecular events critical for the assembly of higher-
order chromatin structures. Studies from our lab and
others demonstrated that specific posttranslational mod-
ifications of histone tails act in concert to establish a his-
tone modification pattern, or "histone code," that sig-
nals for the establishment of heterochromatin, and dic-
tate the specific organization of chromosomes into dis-
crete structural and functional domains. More recently,
our work provided an important link between RNA
interference (RNAi) and heterochromatin assembly, a
discovery that was selected "Breakthrough of the Year"
by Science magazine. We continue to focus on the role
of small RNAs generated by the RNAi pathway and his-
tone-modifying activities in the dynamic regulation of
higher-order chromosome organization that govern
diverse cellular processes and have important implica-
tions for human diseases such as cancer.
RNA! AND HETEROCHROMATIN ASSEMBLY
The large genomes of higher eukaryotes suggest a
need for stable packaging, particularly as most of the
DNA does not code for proteins, and much consist of
repetitious sequences, including remnants of invading
transposons and other repeats. Studies from several
organisms have shown that these repeat sequences are
packaged preferentially into repressive heterochro-
matin complexes, which prohibit both transcription
and recombination. It is largely believed that cellular
defense mechanisms have evolved in higher eukary-
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otes to neutralize the invasion of these transposable
elements by forming heterochromatin structures.
However, the specific features of transposons that are
recognized by the heterochromatin formation machin-
ery are not fully understood. By using the fission yeast
Schizosaccharomyces pombe as a model system, we
recently showed that the RNAi pathway, in addition to
its role in targeted destruction of mRNAs, is involved
in initiating heterochromatin formation and silencing
at repeated sequences. In this fundamentally novel
process, RNA provides specificity to precisely target
particular genomic loci for the recruitment of hete-
rochromatin complexes. A key observation was that
deletions of the factors involved in RNAi such as
Argonaute (agol), Dicer (dcrl), or RNA-dependent
RNA polymerase (rdpl) in S. pombe cause defects in
heterochromatin assembly. Specifically, the establish-
ment of the heterochromatin-specific histone modifi-
cations such as methylation of histone H3 at Lys-9,
and the targeting of HP1 homolog Swi6 to cen-
tromeres and the silent mating-type region of S.
pombe, requires RNAi. Our analyses revealed that spe-
cialized repetitive DNA sequences and RNAi mecha-
nisms cooperate to nucleate heterochromatin assem-
bly. Furthermore, we discovered that, once nucleated,
heterochromatin spreads to sequences surrounding the
nucleation site in a Swi6/HP1-dependent manner,
causing epigenetic silencing of nearby genes.
An important feature of the RNAi-mediated hete-
rochromatin pathway is the generation of small inter-
fering RNA (siRNAs) molecules of approximately 22
nucleotides from longer double-stranded RNAs by
Dicer. Although siRNAs were known to be involved in
this pathway, it was not clear exactly how these small
RNAs promoted targeted assembly of heterochro-
matin. In our recent studies performed at NCI (in col-
laboration with the D. Moazed laboratory, Harvard
Medical School), we have identified an RNAi effector
complex called BITS (RNA-induced initiation of tran-
scriptional gene silencing), which links siRNAs to het-
erochromatin assembly. BITS contains an Argonaute
family protein, Agol, a heterochromatin-associated
chromodomain protein, Chpl, and a protein named
Tas3 (Verdel et al., Science 303: 672 [2004]). In addi-
tion to the three protein subunits, RITS also contains
siRNAs ranging from about 22 to 25 nucleotides.
Collectively, our analyses suggest that double-strand-
ed RNA generated from the repetitive sequences are
processed into siRNAs. siRNAs join the RITS com-
plex and guide the complex to homologous sequences,
which involves pairing of siRNAs to nascent RNA
transcripts or directly to DNA. The RITS-mediated
recruitment of histone-modifying activities establish-
es a "histone code" for the nucleation of heterochro-
matin proteins such as Swi6/HP1. In the RNAi-inde-
pendent spreading step, chromatin-bound Swi6/HP1
directly recruits histone-modifying enzymes such as a
H3 Lys-9 histone methyltransferase to methylate adja-
cent nucleosomes, thus creating additional Swi6/HP1-
binding sites. This process allows Swi6/HP1 and het-
erochromatin-specific histone modifications to spread
in cis in a sequential manner, leading to the epigenet-
ic silencing of genes surrounding the repeated
sequences (see Fig. 1).
We also demonstrated that RNAi machinery is
required for accurate segregation of chromosomes
during mitosis and meiosis. Deletion of genes encod-
ing Argonaute, Dicer, or RNA-dependent RNA poly-
merase causes a high incidence of chromosome mis-
segregation. We found that chromosome segregation
defects observed in RNAi mutant cells are due to loss
cohesin at centromeres. Cohesins involved in sister-
chromatid cohesion are preferentially enriched at S.
pombe centromeres in a heterochromatin-dependent
manner and have an essential role in the proper segre-
gation of chromosomes during cell division. Our
analyses also suggested the involvement of RNAi in
proper regulation of chromosome architecture.
ROLE OF SIR2 HISTONE DEACETYLASE IN
HETEROCHROMATIN ASSEMBLY
Hypoacetylated histones are a hallmark of heterochro-
matin in organisms ranging from yeast to humans.
Histone deacetylation is carried out by both NAD+-
dependent and NAD'- independent deacetylase
enzymes. In the budding yeast Saccharomyces cere-
visiae, deacetylation of histones in heterochromatic
chromosomal domains requires Sir2, a phylogenetical-
ly conserved NADtdependent deacetylase. In the fis-
sion yeast S. pombe, NAD+-independent histone
deacetylases are required for the formation of hete-
rochromatin, but the role of Sir2-like deacetylases in
this process had not been evaluated. In collaboration
with the D. Moazed laboratory (Harvard Medical
School), we found that spSir2, the S. pombe Sir2-like
4011 Repetitive DNA VP el Gene
Dicer
Silent
FIGURE 1 Model for RNAi-mediated targeting of heterochro-
matin. Double-stranded RNAs generated from repetitive
sequences are processed by Dicer to generate siRNAs. siRNAs
may serve as primers for RNA-dependent RNA polymerase
(RdRp) to produce additional double-stranded RNAs from sin-
gle-stranded transcripts. siRNAs join the RITS complex to pro-
vide specificity for localization of the complex to homologous
sequences. The recruitment of histone-modifying activities,
such as the C1r4 H3 Lys-9 histone methyltransferase, by the
RITS complex creates a "histone code" for the binding of the
chromodomain-containing proteins Chp1 and Swi6/HP1. The
binding of Chp1 serves to stabilize RITS to the loci, whereas the
binding of Swi6/HP1 results in heterochromatic spreading due
to the combined activity of the H3 Lys-9 methylation and asso-
ciated Swi6/HP1.
protein that is the most closely related to the S. cere-
visiae Sir2, is an NAD- dependent deacetylase that
efficiently deacetylates histone H3 Lys-9 and histone
H4 Lys-16 in vitro. In cells carrying deletions of sir2,
silencing at the mating-type region, telomeres, and the
inner centromeric repeats (imr) is abolished, whereas
silencing at the outer centromeric repeats (otr) and
rDNA is weakly reduced. Furthermore, Sir2 is required
for hypoacetylation and methylation of H3 Lys-9 and
for the association of Swi6 with the above loci in vivo.
In particular, we discovered that Sir2 appears to be dis-
pensable for RNAi-mediated initial nucleation of hete-
rochromatin at centromeric repeat sequences but has a
crucial role in spreading of H3 Lys-9 methylation and
Swi6 to regions surrounding the repeat sequences. Our
findings suggest that the NAD±-dependent deacetylase
Sir2 has an important and conserved role in hete-
rochromatin assembly in eukaryotes.
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HISTONE ACETYLATION AND MAINTENANCE OF
GENOMIC INTEGRITY
Distinct patterns of histone modifications established
by histone-modifying enzymes control diverse chro-
mosomal processes. Among these covalent modifica-
tions, the reversible acetyl modification at the lysine
residues of histone tails is most well-studied. S. pombe
contains three classical histone deacetylases, named
C1r3, C1r6, and Hdal. Among these deacetylases, C1r6
is essential for viability. A conditional mutation in clr6
also causes missegregation of chromosomes and ultra-
violet light sensitivity. It has been hypothesized that
C1r6 participates in global deacetylation of histones,
affecting chromatin maturation throughout the
genome. However, a detailed understanding of how
C1r6 affects chromatin assembly and genome organi-
zation is lacking. To gain insight into the C1r6 func-
tion(s), we purified C1r6 and identified its associated
proteins. We found that a chromodomain protein,
Alp13, which belongs to the conserved MRG protein
family linked to cellular senescence in humans, is
associated with C1r6. In addition, C1r6 interacts with
homologs of the mammalian transcriptional corepres-
sor Sin3, Pstl, and Pst2, and a WD40 repeat-contain-
ing protein, Prwl. Alp13, Pst2, and Prwl form a sta-
ble complex with C1r6 in the nucleus. Deletion of any
of these factors causes progressive loss of viability,
sensitivity to DNA-damaging agents, and impairs con-
densation/resolution of chromosomes during mitosis.
This is accompanied by hyperacetylation of histones
and a reduction in histone H3 Ser-10 phosphorylation
that correlate with chromosome condensation during
mitosis. Our analysis suggests that C1r6 and its inter-
acting proteins are required for establishment of spe-
cific histone modification patterns, or "histone code,"
that are essential for fundamental chromosomal
events, including gene regulation, recombination,
chromosomal condensation, and segregation. More-
over, our results link the MRG protein family to his-
tone deacetylation. Further analysis of the MRG pro-
tein family, as well as other HDAC components, may
reveal fundamental mechanisms underlying genome
integrity, cellular senescence, and aging.
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HETEROCHROMATIN BARRIERS
We previously showed that heterochromatin complexes
in S. pombe can spread along chromosomes and that
specialized DNA elements called boundary elements
protect the genes present in euchromatic regions from
the repressive effects of nearby heterochromatin. At the
mating-type region of S. pombe, two identical inverted
repeats (IR-L and IR-R) surrounding a 20-kb hete-
rochromatic domain prohibit heterochromatin spread-
ing into surrounding regions containing genes. In col-
laboration with Dr. Amikam Cohen's laboratory
(Hebrew University, Jerusalem), we characterized a
novel gene named epel, encoding a conserved nuclear
protein with a jmjC domain, suppresses formation of
heterochromatin in euchromatic regions. The jmjC
domain of Epel is essential for its antisilencing acivity.
Interestingly, Epel seems to disrupt heterochromatin
assembly by modulating histone modification patterns.
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MECHANISMS OF TRANSCRIPTION
N. Hernandez F. Emran T. Oztaskin Y. Sun
P. Hu K. Samudre S. Wu
B. Ma A. Saxena C.-C. Yuan
S. Mayilvahanan
Gene expression is regulated to a large extent at the
level of transcription. In eukaryotic cells, nuclear
transcription is carried out by three types of RNA
polymerases called RNA polymerases I, II, and
III. Each type of RNA polymerase transcribes a spe-
cific set of genes. RNA polymerase II transcribes
all the genes that encode proteins and is therefore the
most extensively studied. Several years ago, RNA
polymerase II transcription from a TATA-box-con-
taining promoter was reconstituted in vitro with well-
defined factors. Thus, at least in the case of a TATA-
box-containing promoter, the factors required for
RNA polymerase II basal transcription from a naked
DNA template are known.
RNA polymerase III transcribes the ribosomal 5S
RNA genes, transfer RNA genes, and other genes
including the U6 small nuclear RNA (snRNA) gene. It
recognizes three main classes of promoter structures.
Classes I and II are present in the 5S RNA and tRNA
genes, respectively, and are gene-internal. Class III is
present in the U6 snRNA gene and other genes and is
gene-external. The class III core promoters consist of
two essential elements, a proximal sequence element
(PSE) and a TATA box. Strikingly, in higher eukary-
otes, the factors required for transcription from any of
the classes of RNA polymerase III promoters have not
been defined.
In previous work, we characterized two factors
required for U6 transcription: the snRNA activating
protein complex (SNAP,), which is composed of five
types of subunits and binds to the PSE, and Brf2-
TFIIIB, which is composed of the TATA-box-binding
protein (TBP), the TFIIB-related factor Brf2, and
the SANT domain protein Bdp I , and binds to the
TATA box. We also obtained a highly purified human
RNA polymerase III fraction and characterized
its composition. Besides RNA polymerase III sub-
units, the fraction contained spectrin, a-myosin,
clathrin, a-actinin 4, HSC70, P-tubulin, 13-actin,
and calmodulin, as detected by mass spectrometry
analysis, and perhaps traces of other factors not
detectable by mass spectrometry.
In the past year, we combined recombinant SNAP
recombinant Brf2-TFIIIB, and the highly purified RNA
polymerase III fraction and tested whether these factors
were sufficient to direct transcription from the human
U6 promoter. Strikingly, this combination of factors
directed several rounds of accurately initiated and ter-
minated transcription. Omission of any of the factors
debilitated transcription, indicating that each factor was
required, and transcription was as efficient as that
directed by a crude extract from HeLa cells when nor-
malized for RNA polymerase III amounts.
The result was surprising, because U6 transcrip-
tion had been reported by other investigators to
depend on an ill-defined factor called TFIIIC1. We
therefore tested by immunoblot whether topoiso-
merase I, PC4, and NF-1, all of which had been report-
ed to participate in RNA polymerase III transcription
as part of the TFIIIC I fraction, were present in our
RNA polymerase III preparation, the only nonrecom-
binant factor in the transcription reaction. None of
these factors was detectable, nor was the La antigen,
which had been reported to be required for transcrip-
tion termination and recycling of RNA polymerase III.
This suggests that none of these proteins are required
for U6 transcription in the reconstituted system.
To examine the role of the proteins other than
polymerase III subunits detected by mass spectrome-
try in the highly purified RNA polymerase III fraction,
we subjected it to one additional purification step over
a "mini-Q" column. We found that of the factors other
than RNA polymerase III subunits, 13-actin, P-tubulin,
and calmodulin were the only ones to peak with RNA
polymerase III. Thus, these subunits appear to be
strongly associated with RNA polymerase III and may
have a role in transcription. On the other hand, spec-
trin, a-myosin, clathrin, a-actinin, and HSC70 were
all separated from the peak of RNA polymerase III,
indicating that none of these factors is strongly associ-
ated with the polymerase. Furthermore, we could not
detect a-myosin, spectrin, HSC70, and clathrin in the
active fractions, and it thus seems unlikely that any of
these four proteins is required for transcription.
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We also tested the mini-Q fractions for the presence
of CK2, which had been shown genetically to be
required for polymerase III transcription in yeast. We
found that traces of CK2 associate with RNA poly-
merase III. Furthermore, CK2 could be localized to U6
promoter sequences by chromatin immunoprecipita-
tions. This suggested that CK2 may have a role in U6
transcription. Indeed, we found that CK2 phosphoryla-
tion of RNA polymerase III was required for transcrip-
tion. On the other hand, phosphorylation of Brf2-
TFIIIB was inhibitory. Together, these results show
that, as summarized in Figure 1, transcription from the
U6 promoter can be reconstituted in vitro with recom-
binant SNAP, recombinant Brf2-TFIIIB, and highly
purified RNA polymerase III. Furthermore, they sug-
gest that CK2 can regulate RNA polymerase III tran-
scription both positively and negatively by phosphory-
lating different targets. The next challenges will be to
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Figure 1 A minimal transcription system that directs several
rounds of correctly initiated and terminated transcription from
the human U6 promoter. SNAP, with its subunits SNAP190,
SNAP50, SNAP45, SNAP43, and SNAP19 is shown bound to
the proximal sequence element (PSE). Brf2-TFIIIB with its sub-
units TBP, Brf2, and Bdp1 is shown bound to the TATA box
through the TBP subunit. SNAP, and TBP, and TBP and Brf2,
are shown contacting each other because they bind coopera-
tively to DNA. CK2 phosphorylation of the polymerase III com-
plex is required for transcription, whereas phosphorylation of
the TBP-Brf2-Bdpi factors is inhibitory.
identify the exact CK2 targets within the RNA poly-
merase III and the Brf2-TFIIIB complexes, to deter-
mine the role of these phosphorylation events in vivo,
and to determine how CK2 is signaled to phosphory-
late either RNA polymerase III and thus activate tran-
scription or Brf2-TFIIIB and thus repress transcription.
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TRANSCRIPTIONAL REGULATION
W. Herr D. Aufiero
F Bellouard
A. Bubulya
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H. Ding
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Y. Liu
M. Mangone C. Wu
C. Papazoglu J. Wysocka
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We all originate from a single cell that contains two
complete sets of instructions-one from each par-
ent-encoding how we should develop into a human
being. Those instructions direct the cells to proliferate
and at the appropriate time to differentiate into the
approximately 250 different types of cells that make
up an individual. Cells proliferate via repeated cycles
of cell growth and division, and they differentiate by
expressing specific sets of genes that permit them to
perform specific functions. Both processes involve
intricate patterns of regulation of gene expression,
which often result from the regulation of gene tran-
scription. In eukaryotes, the genes are packaged into
chromatin, and the regulation of gene transcription
involves the ability of transcriptional activators and
repressors to direct changes in the structure of chro-
matin and to recruit one of three nuclear RNA poly-
merases-pol I, pol II, and pol III-to specific pro-
moters.
Because viruses frequently target and reveal the
roles of critical cellular regulators of host-cell process-
es, we use herpes simplex virus (HSV), a prevalent
human pathogen, to probe transcriptional regulation in
human cells. The infecting HSV virion contains a pro-
tein called VP16 that initiates the viral lytic program
by activating viral gene transcription. Upon infection,
VP16 associates with two cellular factors-a POU-
homeodomain transcription factor called Oct-1 and
the host-cell factor HCF-1-to form a transcriptional
activating complex, called the VP16-induced complex.
In recent years, our efforts have focused on (1) how
the basal transcriptional machinery, including RNA
polymerase, respond to transcriptional regulators like
VP16; (2) the structure of the VP16-induced complex;
and (3) the cellular functions of HCF-1. Below are
described our studies reported this year.
ROLE OF THE INHIBITOR-OF-DNA-BINDING SURFACE
OF HUMAN TBP IN RECRUITMENT OF TFIIB FAMILY
MEMBERS
Historically, this project has made important contribu-
tions to our understanding of the mechanisms by
which the basal transcriptional machinery responds to
sequence-specific activators. Last year, we described
the identification of an inhibitor-of-DNA-binding
(IDB) surface on the human TATA-box-binding pro-
tein TBP. TATA-box recognition by TBP is a key step
in transcriptional initiation complex assembly on
TATA-box-containing pol II and III promoters. This
process is inhibited by the IDB surface, which lies on
the human TBP core domain (TBP.), and is stimu-
lated by promoter-specific basal transcription factors,
such as two human TFIIB family members-the pol II
factor TFIIB and the pol III factor Brf2, the latter
being required for transcription from TATA-box-con-
taining pol III promoters. In contrast, the third TFIIB
family member Brfl, which is required for transcrip-
tion from TATA-less pol III promoters, does not stim-
ulate TBP binding to the TATA box.
Xuemei Zhao has now shown to our surprise that,
in addition to its role in regulating TBP binding to a
TATA box, the IDB surface is involved in TBP associ-
ation with all three TFIIB family members.
Interestingly, loss of IDB function has specific and
diverse effects on each TFIIB family member. Indeed,
the IDB and prototypical TFIIB-contact surfaces of
TBP, which lie on opposite sides of the TBP., coop-
erate to form the wild-type TFIIBTBPTATA-box
complex. These results reveal how, through differen-
tial usage of opposite surfaces of the TBP,oRE, TBP
can achieve versatility in the assembly of pol II and
pol III promoter complexes with the TFIIB family pro-
teins.
PROTEOLYTIC PROCESSING IS NECESSARY TO SEPA-
RATE AND ENSURE PROPER CELL GROWTH AND
CYTOKINESIS FUNCTIONS OF HCF-1
Our studies of HCF-1 have been progressing rapidly
and are leading to a realization that HCF-1 has inde-
pendent roles in multiple aspects of cell proliferation.
It turns out that HCF-1 is a highly conserved and
abundant chromatin-associated protein. It exists as a
heterodimeric complex of associated amino- (HCF-
IN) and carboxy- (HCF-1,) terminal subunits that
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result from proteolytic processing of a large precursor
protein. Last year, we described studies using the tem-
perature-sensitive tsBN67 hamster cell line showing
that HCF-1 has a role in both G1 -phase progression
and cytokinesis. In tsBN67 cells, the one X-linked
copy of the HCF-1 gene carries a proline-to-serine
substitution at position 134 (P134S) in the HCF-1
Kelch domain, the region involved in VP16-induced
complex formation and cellular chromatin associa-
tion. This missense mutation does not grossly alter the
stability or processing of HCF-1 at the nonpermissive
temperature of 40°C, but it does induce HCF-1 disso-
ciation from chromatin and a subsequent Gi/Go-phase
cell-proliferation arrest. The cell-proliferation arrest is
accompanied by a conspicuous multinucleated (pri-
marily binucleated) phenotype in about 15% of the
arrested cells, indicating the associated cytokinesis
defect. Both tsBN67 defects can be rescued by the
HCF-1N subunit and are suppressed by transformation
with the DNA tumor virus SV40 early region, which
has suggested that these two defects are connected.
This year, Eric Julien reported the use of small-
interfering RNA (siRNA) to inactivate HCF-1 in an
array of normal and transformed mammalian cells and
thus to identify its cellular functions. Expanding upon
a strategy pioneered by P. Lassus and Y. Lazebnik here
at CSHL, Eric Julien designed recombinant siRNA-
resistant forms of HCF-1 deletion mutants and pre-
pared lines of HeLa cells stably expressing each dele-
tion mutant. The results show that HCF-1 is a broadly
acting regulator of passage through the G1 phase and
cytokinesis. Unexpectedly, given the close linkage
found in tsBN67 cells, the G1 -phase and cytokinesis
roles of HCF-1 are performed by separate HCF-1 sub-
units: the HCF -lN subunit promotes passage through
the G1 phase, whereas the HCF-1, subunit promotes
proper cytokinesis. Furthermore, HCF-1 proteolytic
processing is necessary for the ability of the HCF- 1
subunit to ensure proper cytokinesis. These results
suggest that HCF-1 links the regulation of exit from
mitosis as defined by proper cytokinesis and the G1
phase of cell growth, possibly by coordinating reacti-
vation of gene expression after mitosis.
HUMAN Sin3 DEACETYLASE AND TRITHORAX-RELATED
Set1/Ash2 HISTONE H3 LYSINE 4 METHYLTRANS-
FERASE ARE TETHERED TOGETHER SELECTIVELY BY
THE CELL-PROLIFERATION FACTOR HCF-1
This year, Joanna Wysocka, in collaboration with
Michael P. Myers here at CSHL, reported more than
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30 cellular proteins that associate with the HCF-1N
subunit in HeLa cells. The protein identities were
revealed by mass spectrometry, and we reported an
in-depth analysis of more than half of these proteins.
These studies, in collaboration with Carol Laherty
and Robert Eisenman (Fred Hutchison Cancer
Research Center), showed how two separate regions
of the HCF-1N subunit that are both critical for its role
in G1 -phase progression-the Kelch domain and a
neighboring "Basic" region-associate with a previ-
ously uncharacterized human trithorax-related
Setl/Ash2 histone methyltransferase (HMT) and the
Sin3 histone deacetylase (HDAC), respectively. HCF-
1 tethers the Setl/Ash2 and Sin3 transcriptional regu-
latory complexes together even though they are gen-
erally associated with opposite transcriptional out-
comes: activation and repression of transcription,
respectively.
The simultaneous association of HCF-1 with chro-
matin-modifying complexes apparently involved in
both activation and repression of transcription was
curious because, in the context of the VP16-induced
complex, HCF-1 is only known to be involved in acti-
vation of transcription. We therefore asked which, if
any, of these histone-modifying complexes is associat-
ed with HCF-1 when it is bound to VP16, as illustrat-
ed in Figure 1. We first prepared a HeLa cell line
ectopically synthesizing epitope-tagged versions of
VP16 (HA-VP16) and the HCF-1N subunit (f-HCF-1N)
shown in Figure 1A. To identify VP16 association with
the tagged HCF-1N subunit and its associated factors,
Joanna Wysocka first isolated tagged HCF-1N-con-
taining complexes by the two-step protocol that she
had developed to isolate HCF-1N complexes, perform-
ing a mock purification with VP16-only-containing
HeLa cells in parallel. She then separated VP16-bound
from VP16-free HCF-1N complexes by VP16 immuno-
precipitation as diagrammed in Figure 1B and ana-
lyzed corresponding amounts of the VP16-bound and
VP16-free f-HCF-1N fractions by immunoblot as
shown in Figure 1C.
Consistent with VP16 association with the HCF-
1N subunit, the VP16 protein was present in the puri-
fied HCF-1N subunit complexes. Furthermore, it was
effectively recovered in the VP16 immunoprecipita-
tion because all of the detectable VP16 was present in
the VP16-bound and not in the VP16-free fraction
(compare lanes 2 and 4, panel a). This VP16 immuno-
precipitation step resulted in recovery of about 25%
of the tagged HCF-1N molecules (compare lanes 2
and 4, panel b), indicating that a significant portion of
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FIGURE 1 Preferential VP16 association with HCF-1N-Set1/Ash2 HMT over HCF-1N-Sin3 HDAC complexes. (A) Schematic of epitope-
tagged VP16 and HCF-1N molecules. (8) Schematic of the VP16-bound and VP16-free f-HCF-1N complex fractionation. (C) Two-step
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with VP16 (panel a), HCF-1 (panel b), Sin3A (panel c), Sds3 (panel cl), Ash2 (panel e), and WDR5 (panel t) antibodies.
the HCF-1N molecules in the cosynthesizing cells is
associated with VP16. Of this portion, however, there
is little, if any, coassociated Sin3A molecules or Sds3
molecules, both members of the repressive Sin3
HDAC complex (compare lanes 2 and 4, panels c and
d). These results suggest that VP16 binds preferential-
ly to HCF-1N molecules that are not bound to the
repressive Sin3 HDAC complex. In contrast, a signif-
icant portion of the activating Setl/Ash2 HMT com-
plex members Ash2 and WDR5 cofractionate with the
VP16-bound fraction (compare lanes 2 and 4, panels
e and f). Thus, the prototypical transcriptional activa-
tor VP16 distinguishes between coregulatory com-
plexes bound to HCF-1, favoring association with the
histone-modifying complex implicated in activation
of transcription.
In toto, these results have suggested that HCF-1
can broadly but selectively regulate transcription,
both positively and negatively, through modulation of
chromatin structure depending on which specific
DNA-binding transcriptional regulator it is associat-
ed.
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STRUCTURAL BIOLOGY OF REGULATION OF NUCLEIC ACID
REGULATORY MOLECULES AND PROTEOLYSIS
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C. Grunwald
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N. Tolia
A. Tovkach
H. Zhou
R. Klajn (URP)
We study the molecular basis of cell regulatory
processes combining the tools of structural biology
and biochemistry to examine the molecular interac-
tions associated with these processes. X-ray crystal-
lography enables us to obtain the three-dimensional
structures of individual proteins and their complexes
with other molecules. We use biochemistry and mole-
cular biology to characterize properties that can be
correlated with protein structure, and we use informa-
tion from molecular biology and genetics to study pro-
tein function.
Our current efforts center around two distinct
themes. The first involves structural studies of protein
complexes involved in nucleic acid regulatory
processes. The second theme in the lab is the regula-
tion of proteolysis. Here, we are studying caspase acti-
vation in apoptosis and a conserved family of
oligomeric self-compartmentalizing intracellular pro-
teases, the bleomycin hydrolases, which are involved
in drug resistance.
DNA Binding and Assembly of the
Papillomavirus Initiator Protein El
E. Enemark, A. Auster [in collaboration with A. Stenlund,
Cold Spring Harbor Laboratory]
Papillomaviruses are a large family of closely related
viruses that give rise to warts in their hosts. Infection
of the genital tract by the human papillomaviruses
(HPVs) from this group represents one of the few
firmly established links between viral infection and
the development of cervical cancer, as HPV DNA is
found in practically all cervical carcinomas. The El
protein belongs to a family of multifunctional viral
proteins whose main function is related to viral DNA
replication. These proteins bind to the origin of DNA
replication, melt the DNA duplex, possess DNA heli-
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case activity, and recruit other cellular replication pro-
teins such as DNA polymerase a and replication pro-
tein A (RPA). Most likely, different oligomeric forms
of the two proteins are responsible for the different
activities, and the sequential assembly of T antigen
and El complexes ensures an ordered transition
between these different activities. Ultimately, El
forms a hexameric ring helicase on each strand that
functions as the replicative DNA helicases that
unwind the DNA in front of the replication fork.
In collaboration with Arne Stenlund's group here
at CSHL, we embarked on structural studies to provide
high-resolution structural information about El, its
DNA-binding activity and its assembly on DNA.
These would provide general insight into the bio-
chemical events that are involved in viral DNA repli-
cation, as well as a basis for the development of clini-
cal intervention strategies. Second, the viral DNA
replication machinery itself represents an obvious tar-
get for antiviral therapy, and detailed information such
as high-resolution structures of viral proteins required
for replication will greatly facilitate the development
and testing of antiviral agents.
Previously, we solved the structures of the El
DNA-binding domain from BPV both unbound and in
two stages of assembly on the origin (dimer and
tetramer). During the past year, we have extended our
characterization of DNA binding by El to include
human papillomavirus type 18 (HPV-18). HPV-18 is a
high-risk strain of papillomavirus that causes cervical
carcinoma, one of the most frequent causes of cancer
death in women worldwide. In particular, HPV-18
causes adenocarcinoma, which is associated with poor
prognosis. We determined the crystal structure of the
monomeric HPV-18 El DNA-binding domain refined
to 1.8-A resolution. We demonstrated biochemically
that the analogous residues required for El dimeriza-
tion in BPV-1 and the low-risk HPV type 11 are also
required for HPV-18 El. We also found evidence that
the HPV-18 El DNA-binding domain does not share
the same nucleotide and amino acid requirements for
specific DNA recognition as BPV-1 and HPV-11 El.
Mechanisms of RNAi
J.-J. Song, S. Smith [in collaboration with G.J. Hannon and
R.A. Martienssen, Cold Spring Harbor Laboratory]
The introduction of double-stranded RNA (dsRNA)
into a cell can trigger a gene silencing process called
RNA interference (RNAi). This evolutionary con-
served pathway, known also as post-transcriptional
gene silencing (PTGS) in plants and quelling in
Neurospora, is triggered either in response to dsRNA
that is introduced exogenously, for example, by viral
infection and targets endogenous RNAs for sequence-
specific degradation, or by endogenous non-coding
microRNAs (miRNA) which results in translational
inhibition. The RNAi machinery has also been linked
to the establishment of heterochromatin and proper
centromere function in fission yeast by managing
repetitive genomic elements, and it appears to have a
role in development. RNAi has taken experimental
biology by storm in recent years, since it has been
greatly exploited as an ever-increasingly effective tool
to study gene function by gene silencing through
RNAi, not only in worms and plants where it was orig-
inally discovered, but now in many other systems
including Drosophila and mammalian systems.
Central to the RNAi machinery are two protein fami-
lies, the Dicer and Argonaute proteins. Dicer, identi-
fied and characterized by Greg Hannon's laboratory
here at CSHL as an RNase-III-type nuclease, cleaves
dsRNA to generate short interfering RNAs (siRNAs)
which are dsRNA of 19-24 nucleotides with two-
nucleotide 3' overhangs and a 5' phosphate at each
end. Dicer also cleaves short hairpin miRNA precur-
sors which are in turn produced by a related nuclease
called Drosha, to generate miRNAs. These structures,
siRNAs or miRNAs, are incorporated into an effector
complex called RISC, the RNA-induced silencing
complex, to select its target. RISC contains an
Argonaute protein as its signature component, which
has two characteristic domains, PAZ, also found in
Dicer family proteins, and PIWI.
Although there has been remarkable progress in
unraveling the components of the RNAi machinery,
we still do not understand how they work at the mole-
cular level. Therefore, in collaboration with the
groups of Greg Hannon and Rob Martienssen here at
FIGURE 1 The PAZ domain resembles a right-handed baseball
glove. Aromatic residues lining the intersubdomain cleft are
involved in RNA binding.
CSHL, we embarked on structural and biochemical
studies of these proteins. We have determined the
crystal structure of the PAZ domain of Drosophila
melanogaster Argonaute 2 (Ago2-PAZ). The PAZ
domain is composed of two subdomains that are ori-
ented to form a cleft and resembles a baseball glove
(see Fig. 1). One subdomain is a variant of the OB
fold, a module that often binds single-stranded nucle-
ic acids. Although PAZ shows only low-affinity nucle-
ic acid binding, it appears to interact with the 3' ends
of single-stranded regions of RNA through the aro-
matic residues in the cleft. PAZ can bind to the char-
acteristic two-nucleotide 3' overhang of siRNAs, indi-
cating that although it may not account for the binding
affinity of Dicer or RISC, it may contribute to the spe-
cific and productive incorporation of siRNAs and
miRNAs into the RNAi pathway.
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MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE-mRNA SPLICING
RNA splicing is an essential step for the expression of
most eukaryotic protein-coding genes. The selection
and pairing of authentic splice sites within the spliceo-
some occur with extremely high fidelity, requiring
precise interpretation of limited and dispersed
sequence information present throughout introns and
exons. In humans, approximately 75% of genes are
expressed via alternative splicing, giving rise to multi-
ple protein isoforms. The choice of alternative splice
sites is commonly regulated to alter gene expression,
either tissue-specifically or in response to a develop-
mental program or to extracellular signals. The fact
that multiple protein isoforms can be expressed from
individual genes demonstrates that the classical "one
gene-one enzyme" paradigm is no longer valid and
provides an explanation for the unexpectedly small
number of genes uncovered by genome-sequencing
projects.
Both constitutive and alternative splicing mecha-
nisms involve multiple protein components, as well as
RNA components that are part of small nuclear
ribonucleoprotein (snRNP) particles. The work in our
lab focuses on the identification and molecular char-
acterization of protein factors and sequence elements
that are necessary for the catalysis and fidelity of
splicing and/or for the regulation of alternative splice-
site selection. We are interested in how the spliceo-
some correctly identifies the exons on pre-mRNA, and
how certain point mutations in either exon or intron
sequences cause aberrant splicing, leading to various
genetic diseases. A summary of the studies that we
have published in 2003 is given below.
SYNTHETIC MOLECULES THAT ACTIVATE EXON
INCLUSION
On the basis of current knowledge about exonic splic-
ing enhancer (ESE) elements and the SR proteins that
recognize them to activate splicing, we have designed
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synthetic molecules that can be specifically targeted to
weak exons to promote their inclusion (Fig. 1). This
approach was dubbed ESSENCE (Exon-Specific
Splicing ENnhancement by small Chimeric Effectors).
The synthetic molecules consist of an antisense moi-
ety covalently attached to a peptide that acts as a splic-
ing-activation domain. The antisense moiety binds to
the target exon by Watson-Crick base pairing, so its
sequence is chosen to be complementary to an exonic
region of interest. The activation domain peptide is a
simplified version of the natural RS domain of SR
proteins, and we found that simple repeats of arginine-
serine dipeptides are very effective. We have tested
activator molecules targeted to exon 18 in BRCA1 or
to exon 7 of SMN2, genes that have a role in
breast/ovarian cancer susceptibility and in spinal mus-
cular atrophy, respectively. In both cases, the mole-
cules restored correct splicing of transcripts from
exon-skipping mutants in a cell-free system, and
specificity was demonstrated by the fact that each
molecule was only effective with the cognate target
pre-mRNA. So far, we have used antisense moieties
based on peptide-nucleic acid (PNA) chemistry,
which offer the advantage of simple tandem synthesis
with a peptide moiety, high stability, high target speci-
ficity and melting temperature, as well as resistance of
the hybridized RNA target to RNase H. We found that
longer RS peptides are more effective in promoting
exon inclusion. The serines of the PNA-RS com-
pounds undergo phosphorylation under splicing con-
ditions, which together with the finding that the ser-
ines can be replaced by aspartic acid or glutamic acid,
but not by alanine, indicates that an effective splicing-
activation domain consists of alternating charges.
Three types of applications of these synthetic mol-
ecules can be envisaged. First, they can be used for
therapeutic purposes, e.g., to correct exon-skipping
defects due to mutations in a variety of genetic dis-
eases. Second, they can be used to manipulate the pat-
terns of alternative splicing of specific target pre-
mRNAs, e.g., to study the functional consequences of
switching from one isoform to another. Third, they can
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FIGURE 1 Synthetic compounds emulate the ESE-dependent function of SR proteins. (A) Diagram of
compound design. An SR protein (top) binds to an ESE through its RNA-recognition motif (RRM) and pro-
motes exon inclusion by recruiting the splicing machinery through its RS domain (RS). A point mutation
within the ESE (middle) abrogates SR protein binding, and the exon is skipped. An ESSENCE compound
(bottom) tethers a minimal RS domain to the exon by Watson-Crick base pairing and rescues splicing.
Any sequence along the exon can be chosen as the target site. The chemical structure of a portion of
the chimeric compound is shown at the bottom. It consists of a peptide with arginine-serine repeats
linked to a targeting peptide-nucleic acid (PNA) oligonucleotide mimetic. The PNA moiety is at the amino
terminus, and the recruiting peptide is at the carboxyl terminus to mimic the standard domain organiza-
tion of SR proteins. A two-glycine linker separates the two minidomains to provide flexibility. Uppercase
and lowercase letters indicate amino acids and nucleobases, respectively. (8) Dose-response curves
showing effect of ESSENCE and control compounds on inclusion of exon 18 in transcripts of a mutant
allele of BRCA 1 . (BR-RS10) A chimeric molecule consisting of a peptide with 10 RS repeats linked to a
12-nucleotide targeting PNA; (BR-pna) PNA with the same sequence but no peptide attached; (CON-
pna) PNA of unrelated sequence; (RS10) peptide with 10 RS repeats. (C) In vitro splicing assays.
Radiolabeled transcript with exons 16, 17, and 18, and introns 16 and 17, was spliced in HeLa cell
nuclear extracts with the indicated concentrations of each compound. The alternatively spliced mRNAs
resulting from inclusion or skipping of axon 18 were analyzed by denaturing polyacrylamide gel elec-
trophoresis; quantitative data obtained by phosphorimage analysis were used in panel B. Efficient exon-
18 inclusion requires both the peptide and exon-complementary PNA (BR-RS10); the PNA alone (BR-
pna) gave a lower level of inclusion, comparable to what BR-RS10 gave at an eightfold lower concen-
tration. A similar ESSENCE compound targeted to another gene (not shown), RS peptide alone (RS10),
or PNA of unrelated sequence (CON-pna) had no effect on exon-18 inclusion.
be used to study the detailed mechanisms of splicing
enhancement. Optimizing the delivery of these mole-
cules into cells to test their effectiveness in vivo is
now a major priority.
ANALYSIS OF EXONIC SPLICING ENHANCER MOTIFS
ESEs are cis-acting motifs that help guide spliceo-
some assembly to the splice sites flanking the exon in
which they are present. As such, they contribute to
exon definition, splicing fidelity, and altemative splic-
ing regulation, and they are often the target of natural
mutations that cause aberrant splicing, such as inap-
propriate exon skipping. Accurate identification of
ESEs should facilitate the correct prediction of exons
and introns in sequenced genomes, mechanistic stud-
ies of constitutive and alternative splicing, and inter-
pretation of the effects of mutations in coding exons.
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We are continuing to study ESE motifs recognized by
particular SR proteins using a combination of experi-
mental and bioinformatics methods (in collaboration
with Jinhua Wang and Michael Zhang here at CSHL).
ESEfinder (http://exon.cshl.edu/ESE/) is a Web-based
tool that facilitates rapid analysis of exon sequences to
identify putative ESEs responsive to the human SR
proteins, SF2/ASF, SC35, SRp40, and SRp55, and to
predict whether exonic mutations disrupt such ele-
ments. It provides quantitative measures and thresh-
olds that reflect the ability of any sequence to enhance
splicing in a defined exonic context, although not nec-
essarily in its natural context. ESEfinder has proved to
be especially useful for the analysis of coding-region
mutations that cause exon skipping and to identify the
splicing factors whose binding to the pre-mRNA is
impaired by the mutations.
COMPARISON OF AUTHENTIC AND CRYPTIC
SPLICE SITES
Cryptic splice sites are sequences that match the con-
sensus 5' splice-site or 3' splice-site motifs, but which
are used in splicing only when use of a natural splice
site is disrupted by mutation. To determine the features
that distinguish authentic from cryptic 5' splice sites,
we systematically analyzed a set of 76 cryptic 5' splice
sites activated by mutations in 46 human genes
involved in various genetic diseases (in collaboration
with Ravi Sachidanandam here at CSHL). These cryp-
tic 5' splice sites have a similar frequency distribution
in exons and introns and tend to be located close to the
authentic 5' splice site. Statistical analysis of the
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strengths of the 5' splice sites using the Shapiro and
Senapathy matrix (a weight matrix based on nucleotide
frequencies in natural 5' splice sites) revealed that
authentic 5' splice sites have significantly higher score
values than cryptic 5' splice sites, which in turn have
higher values than the mutant ones. P-globin provides
an interesting exception to this rule, so we chose it for
detailed experimental analysis. We found that the
sequences of the P-globin authentic and cryptic 5'
splice sites, but not their surrounding context, deter-
mine the correct 5' splice-site choice, although their
respective scores do not reflect this functional differ-
ence. Our analysis provides a statistical basis to explain
the competitive advantage of authentic over cryptic 5'
splice sites in most cases and should facilitate the
development of tools to reliably predict the effect of
disease-associated 5' splice-site-disrupting mutations
at the mRNA level.
PUBLICATIONS
Cartegni L. and Krainer A.R. 2003. Correction of disease-asso-
ciated exon skipping by synthetic exon-specific activators.
Nat. Struct. Biol. 10: 120-125.
Cartegni L., Wang J., Zhu Z., Zhang M.Q., and Krainer A.R.
2003. ESEfinder: A web resource to identify exonic splicing
enhancers. Nucleic Acids Res. 31: 3568-3571.
Domsic J.K., Wang Y., Mayeda A., Krainer AR., and Stoltzfus
C.M. 2003. Human immunodeficiency virus type 1 hnRNP
NB-dependent exonic splicing silencer ESSV antagonizes
binding of U2AF65 to viral polypyrimidine tracts. Md. Cell.
BioL 23: 8762-8772.
Roca X., Sachidanandam R., and Krainer A.R. 2003. Intrinsic
differences between authentic and cryptic 5' splice sites.
Nucleic Acids Res. 31: 6321-6333.
PROTEOMICS
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D. Perkowski
The completion of the human genome has ushered in
a new age of biological discovery. This accomplish-
ment has essentially identified all of the players gov-
erning human biology. The important work of assign-
ing functions to this myriad of proteins has become
one of the principal tasks of modern biology. Although
many functions will be assigned using genetics or
bioinformatics, the majority of this functional charac-
terization will be performed by proteomics.
The goal of our laboratory is to understand how
proteins and protein complexes regulate cellular
behavior. In the environment of a cell, almost all of the
proteins can be found in a highly interactive network.
We focus on understanding the global architecture of
this network and how this network generates robust-
ness (error tolerance) and adaptability to the system
and how this network is altered to produce and survive
complex diseases, such as cancer.
Optimization of Protein
Identification
D. Perkowski, L.L. Schmidt
Protein identification is the major tool of proteomics.
We have been optimizing mass spectrometry (MS) for
protein identification. MS has many advantages over
other techniques for protein identification, especially
its sensitivity. However, the improved sensitivity
comes at a price, as the sample preparation becomes
increasingly important to insure success. We have
been optimizing a number of parameters to increase
this success rate. Importantly, we have found that the
method of staining the proteins prior to analysis can
greatly affect the outcome of analysis, and we have
begun to systematically explore different methods for
high-sensitive protein visualization that do not
adversely affect downstream MS analysis. We have
found that fluorescent stains, such as SYPRO Ruby
Red, give the greatest sensitivity without adversely
affecting our analysis. However, we have found that
negative zinc staining gives the best mix of protein
visualization, ease of use, and MS sensitivity.
As part of the optimization, we have found that
nanoscale chromatography gives the best sensitivity.
Using convention chromatography media (packed
beds of small, functionalized beads), we have been
fabricating our own nanoscale (754tm internal diame-
ter) columns that operate at flow rates of 200-500
nl/min. The sensitivity and resolution of these
nanoscale columns are related to their internal diame-
ter. However, the internal pressures required for chro-
matography increase dramatically as diameter
decreases, limiting the practical utility of miniaturiz-
ing conventional chromatography media. To overcome
the pressure problem, we have developed a meso-
porous, monolithic chromatography media that is well
suited for miniaturization. The monolithic medium is
composed of a single, highly cross-linked entity that is
formed during the polymerization of silicas (sol-gels)
or organic polymers (plastics). Initially, we incorporat-
ed octadecyl (C18) or octyl (C8) functional groups
into our monoliths in order to create a reverse-phase
resin. However, we discovered that monoliths com-
posed of polymerized styrene and divinylbenzene cre-
ated an exceptional reverse-phase medium that does
not require further functionalization.
Monitoring Posttranslational
Modifications
L.L. Schmidt, D. Perkowski
One of the challenges in the postgenomic era is to
understand how proteins are regulated by posttransla-
tional modifications. These modifications are respon-
sible for controlling the activity of proteins and ulti-
mately determining how a cell responds to its environ-
ment. Phosphorylation is considered to be the most
common posttranslational modification, and its wide
use as a regulatory mechanism has been attributed to
its reversible nature. Alterations in protein phosphory-
lation have been shown to be the hallmark of many
pathological conditions including cancer and diabetes.
Therefore, efficient identification of phosphorylated
proteins, as well as mapping the specific phosphoryla-
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tion sites, has become one of the primary goals of pro-
teomics. We have been attempting to develop sensitive
and robust MS methods for characterizing this impor-
tant posttranslational modification. Characterization of
phosphorylated residues is complicated by three attrib-
utes of phosphorylation: (1) phosphorylation suppress-
es peptide detection by MS; (2) phosphorylation is
generally substoichiometric; and (3) phosphorylated
residues readily undergo neutral loss of the phosphoryl
group. A number of groups, including our own, have
found that the neutral loss can be used a diagnostic
event to automatically trigger further analysis of a pep-
tide. Our efforts have centered on developing reagents
for the affinity purification of phosphorylated proteins
and peptides. Initially, we tried immobilized metals as
our affinity reagents, as this has been shown to interact
strongly with phosphorylated residues. Using this
technology, we estimate that 500 fmoles of phosphory-
lated peptide is required for characterization and that
the major drawback of this technique is that the enrich-
ment is highly contaminated by acidic peptides. To cir-
cumvent this, we will be adapting the styrene divinyl-
benzene polymers to create monoliths with high affin-
ity toward phosphorylated peptides.
"Small World" Proteomics
C. van der Meijden, G. Pegoraro, A. Kleiner [in collaboration
with R. Sachidanandam and J. Faith, Cold Spring Harbor
Laboratory]
We have modeled the data from several high-through-
put protein interaction screens as a network. We have
chosen to model these data as a network because it is
one of the only ways to make sense of these large and
complicated data sets. In this model, each protein is
treated as a node, and the interactions are treated as
links between the nodes. In this way, the yeast protein
network ends up looking very similar to the network
of computers that make up the World Wide Web or the
network of human social interactions that make this a
"small world." On the basis of the network properties
of the yeast protein network, we have been able to
classify the yeast network as a scale-free network, in
which only a fraction of the proteins are responsible
for making the lion's share of the connections. One
prediction from the network model is that these high-
ly connected proteins are essential for yeast viability.
In fact, we find that this is the case, as essential pro-
teins are highly enriched in the pool of highly con-
nected proteins. Importantly, not all highly connected
genes are essential, and we are focusing on trying to
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understand the differences between these proteins and
those that are essential. The overall goal of this study
is to understand how these protein networks provide
adaptability either to changes in environmental condi-
tions or to genetic alterations, such as loss or duplica-
tion of a node (gene) that occurs during tumorigenesis.
We were hoping that our analysis of the yeast pro-
teome network would reveal properties of mammalian
networks and perhaps even how these networks get
reprogrammed during tumorigenesis. One of the
lessons from our work in yeast was that even this rela-
tively small-scale network (6000 genes) was incredibly
complex, suggesting that it would be difficult to make
inroads into the tumor-specific network. We have cho-
sen to take advantage of adeno-associated virus (AAV)
to help us get a handle on the tumor-specific network.
AAV has no known pathology in humans and has actu-
ally been described as having some tumor-suppressive
capacity. We hope that an exploration of AAV-depen-
dent tumor suppression would uncover important hubs
in the tumor-specific network. Using MS, we have
identified a number of host-cell proteins that associate
with AAV-Rep68, an AAV protein required for viral
replication. We have found that Rep68 associates with
a number of proteins involved in DNA damage
response (Ku70, Ku80, and DNA-dependent protein
kinase). We have also found that AAV-Rep68 associ-
ates with ANP32B, a poorly characterized protein of
uncertain function. Importantly, microarray data have
demonstrated that ANP32B and AAV-Rep68 act syner-
gistically to effect host-cell gene transcription.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski M. Gierszewska M. Kwofie
B. Hill Z. Thakkar
K. Hrecka T. Swigut
A. Janardhan
Our interest lies in understanding the molecular mech-
anisms underlying the pathogenesis of AIDS and, in
particular, understanding the functional consequences
of interactions between viral proteins and the cellular
regulatory machinery. The focus of our research is to
understand the functions of Nef, a regulatory protein of
human and simian immunodeficency viruses (HIV and
SIV) that is an important determinant of virulence. We
directed a major effort toward the identification of
mechanisms and downstream effectors that mediate the
effect of Nef on protein sorting and signal transduction
machineries, and our experiments have been focused in
two areas. First, we continued to study the mechanisms
that mediate the selective down-regulation of cell sur-
face receptors by Nef via the AP-2 clathrin adapter
pathway. We found that this involves cooperative inter-
actions between Nef, clathrin adapters, and cytoplasmic
domains of target cell-surface receptors. This likely pro-
vides a general mechanism for selective cargo recruit-
ment to the sites of endocytosis by this small viral pro-
tein. Second, we have focused heavily on the isolation
and identification of cellular proteins that mediate the
effects of Nef on signal transduction and endocytic
machineries. This has led recently to the purification
and microsequencing of several cellular factors that
associate with Nef in T lymphocytes. Among them are
factors that control critical events in the regulation of
protein sorting, signal transduction, and gene expres-
sion. We have begun to verify selected novel interac-
tions and to address their relevance to previously known
and possibly novel functions of Nef, as well as to AIDS
pathogenesis. Importantly, we found that Nef targets a
critical molecular switch that regulates Rac GTPases
downstream from chemokine- and antigen-initiated sig-
naling pathways. This interaction enables Nef to influ-
ence multiple aspects of T-cell function, and thus pro-
vides an important mechanism by which Nef impacts
pathogenesis by primate lentiviruses.
IDENTIFICATION OF PROTEINS ASSOCIATED WITH NEF
IN T LYMPHOCYTES BY MASS SPECTROSCOPY
Nef is a small adapter protein that acts through associ-
ations with large protein complexes. One such exam-
ple is that the complex(es) mediates the effects of Nef
on the protein-sorting machinery at the plasma mem-
brane and contains Nef and the AP-2 clathrin adapter,
we described previously. Another example is the poor-
ly characterized large complex(es) containing Nef and
p21-activated kinase (PAK) kinase. We have been
interested in identifying the targets of Nef in such
complexes as well as additional downstream effectors
of Nef that have escaped detection by previous studies.
The unbiased approaches that have been used so far to
identify immediate downstream effectors of Nef have
relied heavily on the ability to reconstruct the relevant
interactions in heterologous or in in vitro systems,
including the yeast two-hybrid interaction screen
(YTH) and chromatography of T-cell extracts on Nef-
affinity columns. These approaches have correctly
identified a subset of Nef ligands but have been used
exhaustively. Therefore, to bypass the limitations of
the previously used methods, we purified to near
homogeneity Nef and its associated protein complex-
es from T-cell lines stably expressing Nef, using an
immunoaffinity purification protocol. With this
approach, we detected a series of polypeptides with
apparent molecular weights ranging from 20 kD to
more than 250 kD that copurified with HIV-1 and SIV
Nef proteins from a model human T-cell line. Next, we
determined their sequences by mass spectroscopic
analysis, in collaboration with Michael Myers at the
CSHL Protein Chemistry Shared Resource. This led to
the identification of several common polypeptides
associated with both 7.AH Nef and 239.AH Nef.
NEF BINDS DOCK2 -ELMO1 -RAC COMPLEX
Two abundant Nef-associated proteins were identified
as DOCK2 and ELMO1. DOCK2 is a lymphocyte-
specific CDM family (CED5, DOCK180, Myoblast
City) protein that regulates the activity of Rac 1 and
Rac2 GTPases downstream from chemokine receptors
and the T-cell receptor (TCR) and is essential for lym-
phocyte migration and normal antigen-specific
responses of T cells. Rac GTPases are members of the
Rho subfamily of small GTP-binding proteins which
control several processes including cytoskeletal
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rearrangements during cell motility and T-cell activa-
tion. Recent studies showed that ELMO1 functionally
cooperates with CDM family proteins to activate Rac.
Significantly, our mass spectroscopic analyses of Nef-
associated proteins also detected peptides shared by
Racl and Rac2, raising the possibility that the ubiqui-
tously expressed Rac 1 and hematopoietic-cell-specif-
ic Rac2, which both regulate cytoskeletal dynamics
and gene expression in T lymphocytes, also associate
with HIV-1 Nef.
By analogy to previously described interactions
between Rac, ELMO1 and CDM family proteins, our
finding that DOCK2, ELMO1, and Rac2 copurified
with HIV-1 Nef suggested that DOCK2 forms a
ternary complex with ELMO1 and Rac2 and that Nef
binds this complex. We investigated these possibilities
by reconstituting these interactions in human embry-
onic kidney 293 (HEK 293) cells coexpressing
ELMO1, DOCK2, Rac, and Nef each tagged with a
different peptide epitope. We found that ELMO1 and
Rac copurify with DOCK2, indicating that DOCK2
complexes with ELMO1 (DOCK2-ELM01) and Rac.
Furthermore, we found that ELMO1 and Rac also
copurified with complexes containing both Nef and
DOCK2. These data support the possibility that HIV-
1 Nef binds DOCK2-ELMO1 complexes that contain
Rac.
NEF ACTIVATES RAC IN RESTING
HUMAN T LYMPHOCYTES
In nontransformed T lymphocytes, which are the
major target of infection by HIV, Rac activation
through DOCK2 is tied to chemotactic and antigenic
stimuli. To assess whether Nef can uncouple these
processes, we determined the effect of Nef on Rac
activation in primary CD4+ T lymphocytes in the
absence of stimulation with antigen and chemokines.
Resting T cells are normally refractory to productive
infection by lentiviruses and lentivirus-derived vec-
tors. However, a sizable fraction becomes permissive
for infection when cultured in the presence of
cytokines such as interleukin-7 (IL-7). We used this
procedure to infect primary resting CD4+ T lympho-
cytes with an HIV-1-derived vector expressing HIV-1
NA7 Nef (H-NA7) or a control nef-deleted vector (H-
D). env-defective, VSV-G-pseudotyped viruses were
used in these experiments because HW-1 Env protein
may activate DOCK2-controlled signaling pathways
through binding to chemokine receptors such as
CXCR4. As shown in Figure 1A, between 13% and
15% of CD4+ T cells were productively infected as
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revealed by flow cytometry analysis of CD4 expres-
sion on the cell surface and intracellular p24 Gag
expression. Cell extracts were prepared from the
infected populations and PBD-GST pulldown assays
were performed to determine the fraction of activated
Rac. Strikingly, infection with H-NA7 resulted in a
readily detectable increase in the steady-state level of
activated Rac (Fig. 1B). The activation of Rac was
specifically due to the expression of Nef and not other
viral gene products, as infection with the otherwise
isogenic H-D virus did not increase PBD-GST reac-
tive Rac. The effect of Nef was specific toward Rac,
because the activity of CDC42 GTPase, which also
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FIGURE 1 Nef activates Rac in resting CD4+ T lymphocytes. (A)
A flow cytometric analysis of Gag and CD4 expression in rest-
ing CD4+ T lymphocytes transduced with HIV-1-derived vectors
in the presence of IL-7. Percentages of cells productively infect-
ed with nef-deleted H-D vector (inset in middle panel), or with
HIV-1 NA7 nef containing the H-NA7 vector (right panel) are
shown. Results obtained with uninfected control CD4+ T cells
cultured in the presence of IL-7 are also shown (left panel). (8)
HIV-1 Nef specifically activates Rac in resting primary CD4+ T
lymphocytes. Racffn, and CDC42GW were precipitated with
PAK1 PBD-GST from extracts prepared from CD4+ T lympho-
cytes transduced with HIV-1-derived vectors, shown in A, and
analyzed by immunobloting with a-CDC42- and a-Rac-specific
antibodies.
uses PAK as a downstream effector, was not affected.
Therefore, we concluded that Nef primarily activates
Rac in CD4+ T lymphocytes in the absence of anti-
genic stimuli.
Nef was reported to lower the threshold signal
required for antigen-induced responses of T cells, and
this effect was proposed to be an important component
to stimulation of viral replication by Nef in vivo.
Notably, Rac activation by DOCK2 facilitates T-cell
responsiveness to antigen, as disrupted Rac activation
in DOCK2( -/-) and Rac2(-/-) mice is associated with
defective immunological synapse formation and
depressed antigen-specific responses. Therefore, it is
imperative to assess whether Nef promotes viral repli-
cation in T cells by activating Rac through association
with DOCK2- ELMO1.
NEF INHIBITS T-CELL MIGRATION
TO CHEMOKINES
DOCK2 regulates the activation of Rae proteins dur-
ing lymphocyte migration in response to chemokine
gradients. Therefore, we also asked whether Nef
affects lymphocyte chemotaxis. Jurkat T cells, which
constitutively express CXCR4, a major coreceptor for
T-cell tropic HIV and a receptor for stromal-derived
factor 1 (SDF-1), were transiently transfected with a
control plasmid expressing enhanced green fluores-
cent protein (GFP) alone or with a plasmid that coex-
presses Nef and a GFP marker protein from the same
bicistronic transcription unit. We then measured the
chemotaxis of transfected populations to SDF-1 using
a trans-well migration assay.
Notable, we found that chemotaxis of cells coex-
pressing Nef and GFP, but not GFP alone, was inhib-
ited in a dose-dependent manner. We also showed that
(1) Nef causes a general defect in T-cell migration to
chemokines and (2) the ability of Nef to inhibit T-cell
migration is genetically linked to its ability to activate
Rac via DOCK2- ELMO1.
One likely important consequence of inhibiting
chemotaxis of the infected T cells is disruption of the
immune response. The development and maturation of
the immune response require the ordered migration of
activated T cells to specific sites within lymphoid tis-
sue, to drive B cells toward antibody production, iso-
type switching, and the affinity maturation of the anti-
body response. Since a large fraction of HIV-1-infect-
ed CD4* T cells are specific for HIV-1 antigens, this
effect of Nef provides a new mechanism to suppress
the antiviral immune response. Taken together, the
functional interaction of Nef with DOCK2, ELMO1,
and Rac enables Nef to modulate multiple aspects of
T-cell function.
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TRANSCRIPTIONAL CONTROL AND THE UBIQUITIN-
PROTEASOME SYSTEM
W.P. Tansey A. Daulny F. Geng M. Muratani
C. Del Vecchio A. Herbst S. Salghetti
E. Ezhkova J. Kurland K. Tworkowski
The maintenance of normal cellular homeostasis
requires that cells synthesize proteins when they are
needed and destroy them when their function is no
longer appropriate. These two "bookends" that define
the life of any protein are, respectively, transcriptional
regulation and ubiquitin (Ub)-mediated proteolysis.
Despite the apparent dissimilarity of these processes,
a growing body of evidence suggests that components
of the Ub-proteasome system are intimately involved
in regulating gene activity. Work in our laboratory
takes advantage of the unexpected connection between
the transcription and Ub-proteasome systems to
achieve two objectives: To gain new insight into the
actions of the oncoprotein transcription factor Myc,
and to probe the depth with which the factors normal-
ly associated with protein destruction are involved in
regulating gene activity.
INTIMATE CONNECTION OF THE TRANSCRIPTION
AND UBIQUITIN-PROTEASOME SYSTEMS
Many transcription factors, particularly those involved
in the control of cell growth, are unstable proteins that
are destroyed by Ub-mediated proteolysis, a highly
specific process in which the covalent attachment of
Ub to target proteins signals their destruction by the
26S proteasome. Previous work in our laboratory has
revealed that the destruction of transcription factors
can be intimately connected to their ability to activate
transcription. Specifically, we have found that the
same domain in these proteins that allows them to acti-
vate transcription is responsible for their destruction.
We have also found that, in some cases, transcription
factors need to engage the Ub system and become
ubiquitylated in order to function. This intimate con-
nection between transcription factor activity and
turnover has two important ramifications. First, it pre-
dicts that components of the Ub-proteasome system
will be directly and intimately involved in the control
of gene expression. Second, it reveals that if we study
the destruction of transcription factors, we can learn
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not just about activator proteolysis, but also about acti-
vator function.
REGULATION OF Myc PROTEOLYSIS AND ACTIVITY
Myc is a basic helix-loop-helix leucine-zipper tran-
scription factor that features prominently in the con-
trol of cell growth. Capable of acting as both a tran-
scriptional activator and repressor, Myc controls the
expression of genes required for cell growth and divi-
sion. Consistent with the type of genes that it regu-
lates, Myc is also is a major human oncoprotein that is
related to approximately 70,000 cancer deaths in the
United States each year. The expression and activity of
Myc are tightly controlled at many levels, including
via Ub-mediated proteolysis. We have previously
shown that the destruction of Myc is connected to its
activity as a transcription factor: Not only does the
"transcriptional activation domain" (TAD) of Myc sig-
nal its ubiquitylation, but the ubiquitin-ligase Skp2-
itself an oncoprotein-stimulates both Myc's tran-
scriptional activity and its proteasomal destruction.
The interconnectivity of Myc function and
destruction allows us to use the proteolysis of Myc as
a tool toward understanding its activities. For example,
we recently identified an element within Myc that is
important for its rapid turnover. Unlike the amino-ter-
minal TAD, this element does not appear to function
by signaling Myc ubiquitylation, but rather by pro-
moting the destruction of ubiquitylated Myc species.
The involvement of this element-termed Myc box III
(MbIII)-in Myc proteolysis prompted us to deter-
mine whether this element might also be involved in
Myc activity. This analysis-performed in collabora-
tion with Scott Lowe's laboratory here at CSHL-
revealed that deletion of MbIII significantly reduced
the ability of Myc to drive cellular transformation in
vitro (Fig. 1). Because cellular transformation can be
thought of as a balance between proliferation and
apoptosis, we examined the ability of this mutant to
promote cell division and to sensitize cells to apopto-
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FIGURE 1 Loss of Myc box III decreases cellular transformation by enhancing the ability of Myc to induce apoptosis. (4)
Analysis of Myc box deletion mutants in an in vitro Ratl A cell transformation assay. Ratl A cells were transduced with retro-
viruses expressing the indicated Myc proteins alone (white bars) or in conjunction with a virus expressing the anti-apoptot-
ic protein BcI2 (black bars). Cells were grown in soft agar, and colony formation was scored 21 days after plating. (8) Deletion
of Mb III increases the ability of Myc to drive apoptosis in vitro. Ratl cells expressing the indicated Myc proteins were treat-
ed with the apoptosis-stimulating drug etoposide. Cellular viability was scored by trypan blue exclusion. Cell death by apop-
tosis was confirmed by Annexin-V staining (not shown).
sis. Much to our surprise, we found that the AMbIII
deletion mutant was as effective as wild-type Myc at
driving cell division, but was substantially more active
at stimulating apoptosis. To confirm that the decrease
in cellular transformation by the AMbIII deletion
mutant was indeed due to increased cell death, we
inhibited apoptosis by expression of the anti-apoptot-
ic factor Bc12. As shown in Figure 1, inhibition of
apoptosis rescued completely the transformation abil-
ity of the AMbIII protein, strongly suggesting that the
only relevant difference between this mutant and wild-
type Myc is the capacity to signal cell death.
Together, these data reveal that MbIII has an
important role in regulating cellular transformation by
Myc, and they support our notion that we can learn
about Myc function from studying its destruction.
Importantly, the data also reveal that Myc has an unex-
pected activity-the capacity to suppress its own abil-
ity to induce apoptosis. Thus, similar to strategies
employed by a number of cancer-causing viruses (such
as adenovirus), the Myc protein has evolved means to
limit the cell death that results from the proliferative
signal it provides. We speculate that this anti-apoptotic
activity will be important for regulating tumor devel-
opment in vivo, and may also represent a possible
route for therapeutic intervention, by promoting apop-
tosis in cancer cells overexpressing the Myc protein.
UNDERSTANDING HOW THE UBIQUITIN-PROTEASOME
SYSTEM CONTROLS GENE EXPRESSION
We are interested in understanding the fundamental
mechanisms that connect the transcription and Ub-
proteasome systems. In addition to studying the role
of activator ubiquitylation and destruction in tran-
scriptional control, we are also focusing on under-
standing how the proteasome itself can influence gene
activity. In Saccharomyces cerevisiae, subunits of the
19S regulatory complex of the proteasome appear to
have an important-and nonproteolytic-role in regu-
lating gene expression. Indeed, it is curious to note
that genes encoding two subunits of the 19S complex,
Sugl (Rpt6) and Sug2 (Rpt4), were first identified in
a genetic screen for mutations that could suppress loss
of the transcriptional activation domain of Ga14.
Subsequent studies by Johnston and colleagues at UT
Southwestern have shown that these effects are unre-
lated to Gal4 proteolysis, and that 19S proteins are
recruited to a transcriptionally active Gall gene in
yeast. These findings suggest that the proteasome
itself comes to chromatin and participates in some way
in the transcription process.
To understand the role of proteasomal proteins in
transcription, we first asked how the interaction of
these proteins with chromatin is influenced by tran-
69
A
1
Ytl
6
2
Raf
I I
Gal
visermipaot
B5
42' 4
it 3
ii
rL
2
c'T 1
H2B-K123R
via lartiralla \V
C 20
3 16
Tr' 12
T.=
FIGURE 2 Recruitment of proteasomal ATPases to chromatin is linked to histone modifications. (A) Association
of Rpt4 with the Gall 0 gene is modulated by gene activity. Yeast expressing HA-epitope-tagged Rpt4, or
untagged control yeast, were grown in raffinose-containing media perq, and either induced for 1 hr by growth
in galactose-containing media (Gal) or uninduced by growth in fresh raffinose-containing media (Ran. ChIP was
performed with an anti-HA antibody. Q-PCR was used to quantify association of Rpt4 with sequences corre-
sponding to the Gall 0 promoter, as well as the promoter-proximal (-+100) and 3' ends of the transcribed por-
tion of the gene. (8) H2B ubiquitylation is required for recruitment of Rpt4 to the active Adh1 gene. This experi-
ment was performed as in A, except that mutant yeast carried a single point mutation in histone H2B (K123R)
that blocks its ubiquitylation. Similar results were obtained when the gene encoding the Ub-conjugating enzyme
for H2B was disrupted (not shown). (C) The sug1-25 mutation disrupts inducible H3-K4 trimethylation at the
Gall 0 gene. Wild-type (WT) or sug1-25 yeast (containing a point mutation in the ATPase module of the protea-
somal protein Rpt4) were grown in raffinose-containing media at 37°C and induced for 1 hour by growth in galac-
tose-containing media; ChIP was performed with antibodies against trimethylated H3-K4, or a no antibody con-
trol. Q-PCR was used to detect association of precipitated material with the 5' (-+100) or 3' ends of the Gall°
coding sequence. Ga110 gene induction was not disrupted by this mutation (not shown).
scription. We used chromatin immunoprecipitation
(ChIP) to monitor the association of Rpt4 and Rpt6
with the Gall0 gene under conditions in which it was
either inactive or active. This analysis (Fig. 2) revealed
that Rpt4 and Rpt6 associate with the inactive Gall°
gene, but appear to be limited to a region immediately
surrounding the promoter element. Upon Gall0 gene
activation, there is a pronounced redistribution of pro-
teasome subunits throughout the transcribed portion
of the gene. These data raise the possibility that pro-
teasome subunits move either with or ahead of RNA
polymerase II (pol II), and we are currently investigat-
ing this possibility.
To determine the significance of proteasome asso-
ciation with the Gall° gene, we next attempted to
identify a signal that is required to recruit the protea-
some to chromatin. Curiously, we found that protea-
some binding to active genes is critically dependent on
the ubiquitylation of histone H2B at lysine residue 123
(K123; Fig. 2). This finding was intriguing because
ubiquitylation of H2B (Ub-H2B) is part of the "his-
tone code" and is essential for signaling the methyla-
tion of histone H3 (Me-H3) at lysine residues K4 and
K79. Ub-H2B/Me-H3 is an unusual example of the
histone code because it involves modifications on two
distinct histones (as opposed to modifications within a
single histone "tail"). Nonetheless, like other modifi-
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cations in the histone code, it is essential for establish-
ing epigenetic patterns of gene expression. The methy-
lation of histone H3 occurs at transcriptionally active
regions of the genome, and likely establishes a barrier
that repels the Sir proteins, restricting them to their
sites on silenced genes. The observation that H2B
ubiquitylation is also required to recruit the protea-
some to chromatin led us to postulate that proteasomal
proteins may function to stimulate H3 methylation.
Indeed, we found that mutations in Rpt4 and Rpt6-
but not other subunits of the proteasome-specifical-
ly disrupted 113 methylation at K4 and K79, but left
H2B ubiquitylation intact (Fig. 2). Consistent with
their effects on H3 methylation, mutations in these
subunits also resulted in a widespread upregulation of
silenced gene activity (data not shown). Together,
these data suggest that proteasomal ATPases function
to link the ubiquitylation of histone H2B to the methy-
lation of histone H3. This link appears to be indepen-
dent of the established role of the proteasome in pro-
tein destruction and is essential for the maintenance of
normal patterns of silenced gene activity.
On the basis of our data, we speculate that ubiqui-
tylation of histone H2B recruits the proteasome to the
promoter of genes that have the capacity to be tran-
scribed. When these genes are activated, we suggest
that proteasomal proteins move with pol II and utilize
their protein chaperone functions (normally associat-
ed with the unfolding of proteasome substrates) to
remodel the chromatin structure, permitting access of
the Setl and Dotl methyltransferases to their target
sites in histone H3. Regardless of the mechanism,
however, we are excited to learn that subunits of the
proteasome, which just a few years ago was thought of
as an exclusively proteolytic machine, bind to chro-
matin and regulate the histone modifications that
establish epigenetic gene control.
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STRUCTURAL BIOLOGY
R.-M. Xu H.-C. Hsu P.-C. Lin
Y. Huang J. Min
Z. Li H. Shi
Our research focuses on understanding the mechanism
and regulation of eukaryotic gene expression, at both
the transcriptional and posttranscriptional levels. We
use X-ray crystallography as our main tool to study the
structure and function of key players in eukaryotic
gene expression in atomic resolution detail. In partic-
ular, we continued to focus our attention on structural
studies of proteins involved in mRNA processing and
proteins that affect chromatin structure and dynamics.
Our main accomplishments during 2003 include the
following: (1) structure determination of human
UAP56 (56-kD U2AF associatedprotein) alone and in
complex with ADP. UAP56, which contains a DECD
RNA-dependent ATPase/helicase motif, is an essential
splicing factor and a major nuclear export factor. (2)
Solving the structure of the chromodomain of
Polycomb in complex with a histone H3 peptide
trimethylated at Lys-27. These two projects are
described in detail below.
UAP56
The spliceosome is a complex molecular machine
responsible for the removal of noncoding introns and
the joining of exons. Although the two transesterifica-
tion reactions of pre-mRNA splicing do not require
ATP, the spliceosome is an energy-consuming
machine. A number of ATP-utilizing enzymes are
required for the assembly, remodeling, and disassem-
bly of the spliceosome. More than a dozen spliceoso-
mal proteins containing characteristic DExD/H
ATPase/helicase motifs have been identified, yet no
atomic resolution structure of any of the spliceosomal
ATPase/helicases have been determined.
To discover the molecular mechanisms by which
these spliceosomal "engines" work, we have deter-
mined the crystal structure of human UAP56 alone
and in complex with ADP. Human UAP56 has an
essential role in pre-mRNA splicing. The precise
mechanism by which UAP56 functions in splicing is
not known, although the characteristic DECD and
other conserved sequence motifs are indicative of
being an RNA-dependent ATPase/helicase. In addition
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to its function in pre-mRNA splicing, UAP56 also has
important roles in the export of mRNA from the
nucleus to the cytoplasm. Reduction of cellular
UAP56 levels by RNAi (RNA interference) in
Drosophila or Caenorhabditis elegans resulted in the
retention of significant fractions of mRNAs in the
nucleus. Similar results were observed in sub2
(encodes a yeast UAP56 homolog) temperature-sensi-
tive (ts) mutants in yeast.
UAP56 comprises two a/f3 fold domains (Fig. 1):
an amino-terminal domain containing a seven-strand-
ed parallel 13-sheet with eight a-helices packed against
the 13-sheet on both sides, and a carboxy-terminal
domain that also contains seven parallel 13-strands but
sandwiched between two a-helices on one side and
FIGURE 1 Crystal structure of UAP56 bound to Mg.ADP. The
protein is shown as a ribbon diagram, and the magnesium ion
and ADP are shown in a ball-and-stick model. The bottom lobe
of the protein is the amino-terminal domain where ADP is
bound, and the top lobe is the carboxy-terminal domain. The
two domains are connected via a relatively flexible linker.
three helices on the other side. Both the amino- and
carboxy-terminal domain structures resemble those of
other RNA helicases exemplified by the structure of
the yeast eukaryotic initiation factor 4A (eIF4A).
Most importantly, the relative positioning of the two
domains in UAP56 differs significantly from that
observed in all other DExD/H -box ATPases/helicases.
The binding of ADP does not introduce large domain
movements, but the ADP-bound structure reveals that
the P-loop in the Walker A motif undergoes transition
from a "closed" to an "open" conformation to accom-
modate the binding of ADP. A comparison with the
structure of single-stranded DNA-bound hepatitis C
RNA helicase suggests that the ATPase activity of
UAP56 may be stimulated by RNA bound to proteins
that interact with UAP56, such as U2AF65, and
UAP56 may function to displace proteins from the
bound RNA during pre-mRNA splicing-a structure-
based model that we are currently testing.
POLYCOMB SPECIFICITY TOWARD HISTONE
H3 METHYLATED AT LYS-27
Polycomb (PC) mediates the assembly of repressive
higher-order chromatin structures in conjunction with
the methylation of Lys-27 of histone H3 by a
Polycomb group repressor complex. A similar mecha-
nism in heterochromatin assembly is mediated by
HP1, a chromodomain protein that binds to histone
H3 methylated at Lys-9. The structure of the HP1
chromodomain in complex with a methyl-Lys-9 his-
tone H3 peptide has been determined recently. The
structure greatly advanced our understanding of
methylated histone tail-chromodomain interactions.
However, the HP1 structure offered no insights into
the molecular mechanism of specific binding of the
highly homologous PC chromodomain to histone H3
tails methylated at Lys-27.
To understand the molecular mechanism of the
methyl-Lys-27 histone code recognition, we have
determined a 1.4-A resolution structure of the chro-
modomain of the Polycomb in complex with a histone
H3 peptide trimethylated at Lys-27 (Fig. 2). The struc-
ture reveals a conserved mode of methyl-lysine bind-
ing and identifies Polycomb-specific interactions with
FIGURE 2 Structure of the Polycomb chromodomain in com-
plex with a histone H3 peptide trimethylated at Lys-27. The
chromodomain is shown in a ribbon representation and the his-
tone peptide is shown as a ball-and-stick model.
histone H3. The structure also reveals a dPC dimer in
the crystal lattice that is mediated by residues specifi-
cally conserved in the Polycomb family of chromod-
omains. The dimerization of dPC can effectively
account for the histone binding specificity and pro-
vides new mechanistic insights into the function of
Polycomb. We are currently pursuing further structur-
al and biochemical characterization of Polycomb-his-
tone H3 interactions aimed at pinpointing the precise
determinants for Polycomb specificity.
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CANCER: GENETICS
Cancer is caused by gene mutations. Mutations come in many forms: a change in the DNA sequence
of a gene, the movement of a chromosome segment to an abnormal location, the complete or partial
removal of a gene (deletion), or the addition of more than one copy of a gene (amplification). Michael
Wig ler and Rob Lucito have developed a method of unprecedented precision and power-called
ROMA-for scanning the entire human genome to detect deletions and amplifications. By pinpointing
regions where amplifications or deletions have occurred in DNA isolated from tumor biopsies, these
researchers have identified dozens of candidate cancer genes from a variety of tumor types. Work by
Masaaki Hamaguchi, Wig ler, and Lucito has identified such genes in breast, ovarian, pancreatic, and
other cancers. These genes are prime targets for the development of greatly improved diagnostic mea-
sures and more effective cancer therapies.
Scott Lowe continues to make important discoveries concerning the role of the p53 tumor sup-
pressor in programmed cell death, a natural process that rids the body of precancerous cells by trig-
gering such cells to commit suicide. By developing powerful mouse models of cancer, and using RNA
interference (RNAi) to explore p53's functions, Scott and his colleagues have created a new paradigm
for studying the heterogeneous responses of tumor cells to chemotherapy, with the hope of identifying
improved cancer treatments. Working toward that goal, they have found a concrete example of a spe-
cific combination of drugs that can reverse resistance in tumor cells with a certain genetic makeup, thus
highlighting a drug treatment strategy that might work for hard-to-treat cancers.
Alea Mills has developed a "chromosome engineering" system for creating mouse models of human
disease. This approach allows her lab to generate mice with precise chromosome rearrangements that
mimic alterations found in human diseases such as cancer. Mill's lab has also created a mouse model
in which they control when and where a particular gene called p63 is turned active, thus revealing the
role of this important cancer-related gene in stem cell maintenance, cancer, and aging.
Greg Hannon and his colleagues have pioneered the study of RNAi as well as the application of
RNAi to cancer research. RNAi leads to the silencing of gene expression, in part through the binding
of small RNA molecules corresponding to particular messenger RNAs and the subsequent enzymatic
destruction of the messenger RNAs (which blocks protein production). The researchers have discov-
ered several of the molecules and mechanisms that carry out RNAi, including, recently, a protein that
matches one that is silenced in a common form of X-linked mental retardation. They have shown that
they can use RNAi to permanently silence the expression of virtually any gene in cultured cells, in living
animals, or in organs reconstituted from stem cells (the latter in collaboration with Michael Hemann of
Lowe's group). These findings have opened the door for them to use RNAi to discover new targets for
cancer therapy, or to use RNAi itself as a therapy.
Through a process called angiogenesis, the Idi and Id3 genes are involved in forming blood ves-
sels that supply growing tumors with the nutrients they need. Therefore, Id genes and their targets are
attractive candidates for antiangiogenic cancer therapies designed to kill tumors by cutting off their
blood supply. Vivek Mittal's lab is using DNA microarray technology, RNAi, and mouse tumor models
to identify antiangiogenesis targets. They recently identified two new pathways that, when obstructed,
cut off tumor blood supply and have thus uncovered additional weak points that can be exploited for
cancer therapy. Mittal's group has also created a genome-wide method for rapidly identifying the pieces
of double-stranded RNA that are most effective at silencing any particular gene through RNAi.
Yuri Lazebnik is exploring ways to use the programmed cell death machinery to improve the effi-
ciency and selectivity with which cancer treatments kill tumor cells. Paradoxically, although the hallmark
of oncogenes is that they are associated with causing cancer, oncogenes also sensitize cancer cells to
the lethal effects of chemotherapy drugs by inducing programmed cell death. This observation means
that oncogenes might provide a way to induce the programmed cell death machinery specifically in
cancer cells. Recently, Yuri's group has shown that chemotherapy activates an enzyme called caspase-
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2, which in turn activates other caspases, leading to cell death. These findings reveal crucial informa-
tion about how programmed cell death works, and how it might be used against cancer.
Approximately 1-2% of newborns have symptoms of sporadic genetic disease, or genetic disease
that neither parent suffered from but rather arises de novo as a result of a genetic change in a parent's
sperm or egg cell DNA. Eli Hatchwell's lab is developing methods for detecting subtle changes in DNA
that cause such sporadic human genetic disease. In one study, the researchers have managed to
detect a tiny deletion in human chromosome 2, which may be associated with mental retardation. The
methods developed by Hatchwell's group should be useful for many applications, including cancer
research.
Sihem Cheloufi, graduate student in the Mills lab.
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TUMOR SUPPRESSOR GENES INVOLVED IN BREAST
CANCER DEVELOPMENT
M. Hamaguchi N. Kobayashi R. Shudo
J. Meth V Siripurapu
Our lab is interested in the discovery and characteriza-
tion of cancer-related genes, especially tumor suppres-
sor genes that are ablated in cancer cells. The identifi-
cation of these genes and subsequent studies into their
biological functions have provided vast new insights
into the development of cancer. A great deal is now
known about the relationship between cancer develop-
ment and cellular functions. In the case of breast can-
cer, the isolation of tumor suppressor genes BRCA1
and BRCA2 has had an impact on several aspects of
cancer treatments as well as cancer research. BRCA1
and BRCA2 genes can be utilized for identification of
individuals at high risk of developing breast cancers.
This has been crucial in the development of risk
assessment. However, tumor suppressor genes respon-
sible for sporadic breast cancer remain to be discov-
ered. We have isolated a previously uncharacterized
gene, DBC2 (deleted in breast cancer 2), that is likely
to be a tumor suppressor gene for sporadic breast can-
cer. Activation of DBC2 in a breast cancer cell line
resulted in growth arrest of the cells, whereas natural-
ly occurring DBC2 mutants do not suppress tumor
growth. The ultimate goal of our research is the eluci-
dation of the tumor suppression mechanisms of DBC2
and development of new cancer therapy based on the
findings.
DBC2 and Gene Expression
M. Hamaguchi, V Siripurapu [in collaboration with
S. Powers, Tularik Inc.]
Clarification of the physiological functions of DBC2
will provide clues for understanding the mechanisms
of breast cancer development, since more than half of
breast cancers were found to exploit inactivation of
DBC2. To identify biological pathways that involve
DBC2, the functions of cellular genes are monitored
while DBC2 activity is artificially altered. We apply
two molecular biological technologies to control
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DBC2 activity, an inducible gene expression system
and RNA interference (RNAi). In the inducible gene
expression system, DBC2 is placed under a promoter
that can be activated by an insect hormone, ecdysone
or its homolog, Muristerone A. When the inducer is
administered, DBC2 will be expressed. The gene
expression level can be controlled by altering the
quantity of the inducer. Since these chemicals do not
normally exist in mammalian cells, they will not
affect expression of the other mammalian genes. We
are studying the effects of DBC2 expression in can-
cer cells by using this system. Reversely, DBC2
expression can be knocked down by using RNAi. We
have demonstrated that carefully designed short
RNA fragments can inhibit DBC2 translation effec-
tively in various types of cells, resulting in inactiva-
tion of DBC2. We can now study consequences of
DBC2 ablation at the cellular level by using this sys-
tem.
One of our approaches is a microarray analysis
that allows us to monitor thousands of genes at the
same time. The microarray we use is a microscope
slide carrying 46,000 spots in a 1 x 2-inch area. Each
spot contains a DNA probe representing a gene.
When a color-labeled sample is incubated with the
microarray, DNA fragments in the sample seek
matching with the probe. As a result, the color inten-
sity of a probe corresponds to the amount of the
matching sequences in the sample. When cDNA from
a specimen is used, the color intensity indicates the
expression level of the gene represented by the probe.
This is particularly useful when we want to isolate
genes that are expressed differently in the two speci-
mens. The microarray analysis has isolated 108 genes
that are up-regulated by DBC2 activation.
Additionally, consequences of DBC2 knockdown by
RNAi are also investigated by this approach. We are
currently studying how DBC2 regulates the expres-
sion of these genes (directly or indirectly) and what
role DBC2 has in the biological pathways involving
these genes.
Resources for DBC2 Analysis Analyzing Functional Domains
of DBC2
M. Hamaguchi, N. Kobayashi [in collaboration with Antibody
Shared Resource, Cold Spring Harbor Laboratory]
Antibodies are fundamental materials to study a new
protein. We have raised polyclonal and monoclonal
antibodies against DBC2. These antibodies are used
for immunobloting and immunoprecipitation, reveal-
ing valuable information.
We have generated various DBC2 mutants for
functional analysis. Some are a recreation of somatic
mutations discovered in breast cancers. They are used
to determine if the mutants are capable of suppressing
tumor growth. Dysfunctional mutants are then tested
for other biological functions including protein-
protein binding and GTPase activity. Mutants lacking
each functional domain were also generated. They are
used to verify functions of the domain.
Expression of DBC2
M. Hamaguchi, J. Meth [in collaboration with D. Broek,
University of Southern California]
Tumor suppressor genes are inactivated by transcrip-
tional suppression in some cases. In fact, DBC2
expression is extinguished in approximately half of
breast and lung tumors, whereas its expression is
detected in other types of cancer. Modification of the
promoter region has been shown to cause transcrip-
tional inactivation. The most common mechanism for
such modification is methylation. A number of cancer
cell lines derived from breast and lung cancers were
found to possess hypermethylated promoter regions.
Transcriptional inactivation by hypermethylation can
be reversed in many cases when methylation is chem-
ically blocked. A commonly used chemical for this
purpose is 5- aza- 2'- deoxycytidine (5-Aza-C). We cul-
tured these cells with 5-Aza-C and demonstrated that
DBC2 expression was restored. Our findings suggest
that methylation of the DBC2 promoter is the main
mechanism for silencing.
M. Hamaguchi, N. Kobayashi, R. Shudo [in collaboration
with L. Van Aelst, Cold Spring Harbor Laboratory]
Computational analysis revealed that DBC2 contains
putative protein-protein interaction domains (BTB).
We utilized immunoprecipitation and a yeast two-
hybrid system to isolate five candidate proteins. Many
of them are known to participate in carcinogenic cel-
lular pathways. We are currently trying to understand
how DBC2 is involved in these pathways in the hope
that we may be able to discover good targets for new
therapy.
Generation of DBC2
Knockout Mice
M. Hamaguchi, J. Meth [in collaboration with the Genomic
Targeting and Transgenic Mouse Facility, Cold Spring Harbor
Laboratory, and M. Zhang, Cold Spring Harbor Laboratory]
Analysis of a mouse model has advantages. First,
more information has been accumulated from mouse
genetics than that of any other vertebrate. Second,
gene functions can be studied in vivo. Analysis of
tumor suppressor genes has often been facilitated by
studies of tumor-suppressor deficient mice.
Mouse embryonic stem (ES) cells were genetical-
ly engineered so that they had a disrupted DBC2
allele. These ES cells were used to produce chimeric
mice that are partially originated from the ES cells.
The chimeric mice were examined and successful
introduction of the engineered DBC2 allele was con-
firmed. We were able to generate heterozygous knock-
out mice from the chimeric mice. However, homozy-
gous knockout mice were proven to be lethal, forcing
us to seek alternative strategies such as long-term
observation of heterozygous knockout mice, promot-
ing carcinogenesis in heterozygous knockout mice,
and generation of conditional knockout mice. We are
continuing our efforts to establish mouse models for
future research.
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RNA INTERFERENCE: MECHANISMS AND APPLICATIONS
G. Hannon M. Carmel'
A. Dent
J. Du
L. He
I. Hoffa
J. Liu
C. Marsden
L. Murchison
P.J. Paddison
F. Rivas
Y. Seger
J.M. Silva
D. Siolas
Several years ago, work in a free-living nematode,
Caenorhabditis elegans, uncovered a previously
unknown biological response through which an organ-
ism exposed to double-stranded RNA specifically
silenced genes that share homology with that nucleic
acid. This phenomenon, called RNA interference
(RNAi), has since been shown to be an evolutionarily
conserved pathway, present in organisms ranging from
fungi to plants to mammals. We have striven to under-
stand the mechanistic basis of this response using bio-
chemical approaches in several systems, including
Drosophila and mammalian cells. We have identified
numerous components of this pathway, including the
key initiating enzyme, Dicer and components of the
RISC (RNA-induced silencing complex) effector
machinery. These efforts continued last year, leading to
the identification of a new element of the pathway, a
micrococcal nuclease relative, TSN-1, which is a RISC
component in Drosophila, C. elegans, and mammals.
Two of the signature components of the pathway, Dicer
and Argonaute proteins, share a common domain that
is found only in these protein families, the PAZ
domain. Last year, we worked with Leemor Joshua-Tor
here at CSHL to understand this domain both struc-
turally and biochemically. These studies led to the
hypothesis that this domain functions to bind to the
specific terminal structures of the small interfering
RNAs (siRNAs) that are central to the RNAi response.
Our efforts to understand the biological function of the
RNAi machinery in mammals have begun to bear fruit
with the creation of genetically modified mice that lack
the Dicer enzyme. These mice die early in development
and are characterized by a depletion of multipotent
stem cells from the early embryos. This work shows for
the first time that the integrity of the RNAi machinery
is essential for mammalian development. As we con-
tinue to understand the mechanism and function of the
RNAi machinery, we gain the opportunity to develop
ways to exploit this response for experimentally manip-
ulating gene expression in mammals. Last year began
with our demonstration that we could use RNAi to gen-
erate heritable loss of function in mice. Parallel studies
with Scott Lowe's lab here at CSHL showed that we
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could use RNAi in engineered stem cells to create
mosaic animals in which those cells gave rise to genet-
ically defined tumors in mice. Taking these experi-
ments from the single-gene level to a point at which we
could use RNAi to address the function of every gene
in the human and mouse genome has been our long-
term goal. Last year, with the help of Dick McCombie
here at CSHL, Steve Elledge at Harvard, and col-
leagues at Merck (CSHL alumnus, Michele Cleary)
and OSI (Julie Kan), we have developed a large-scale
library of RNAi-inducing vectors that presently covers
approximately one third of known human genes. We
have validated this library in pilot screens and are now
beginning to use this tool to search for new targets for
cancer therapy. Examples of specific projects are elab-
orated in more detail, below.
Last year saw the departure of several valued col-
leagues. Emily Bernstein was granted her Ph.D. from
Stony Brook University, New York, and Amy Caudy
became the first graduate of the Watson School of
Biological Sciences. Long-time associate Doug
Conklin accepted a faculty position in Albany. We
were visited during the year by Dave Kuppersmith,
Hana Mizuno, Bas Tops, and Jonathan Schneiderman
and were joined by a research associate, Ken Chang,
postdocs Jidong Liu, Faby Rivas, and Lin He, and
graduate students Liz Murchison and Despina Siolas.
Control of Centrosome Replication
and Function
J. Du
During the last year, we continued our efforts to dis-
sect the genetics of the role of the Aurora-A kinase in
human tumorigenesis. Following 2002's work to puri-
fy the Aurora-A complex (SAF) from mammalian
cells and characterize its components, we found
pl6OROCK to be a genetic suppressor of the inactiva-
tion of Aurora-A (Du and Hannon, submitted). We
therefore focus now on astrin, an Aurora-A-interacting
protein isolated by a two-hybrid screen. Astrin is a
mitotic-spindle-associated protein that is co-overex-
pressed with and localized together with Aurora-A
temporally and spatially at the mitotic spindles from
the beginning of prophase to anaphase. Astrin also
associates with the kinetochore at mitosis, as shown
by colocalization with CENP-E. Astrin coimmunopre-
cipitates not only with Aurora-A, but also with a-
tubulin, a building block of mitotic spindles.
Corresponding to the astrin expression level at mito-
sis, this association of astrin with a-tubulin is more
prominent in mitotic cells, and its localization is sen-
sitive to microtubule dissipation reagents, such as
Nocodazole. Depletion of astrin by RNAi in He La
cells showed a moderate G2/M cell cycle delay, simi-
lar to the G2 /M arrest phenotype in siAurora-A-treat-
ed cells. This prolonged G2/M delay eventually leads
to apoptosis. Immunofluorescence examination
showed that the G2/M delay in siAstrin-treated cells is
caused by mislocation of cyclin B1 to centrosome and
mitotic spindles in mitotic cells, and subsequently the
inactivation of CDK1 kinase activity. Astrin inactiva-
tion by RNAi induces the formation of multiple mitot-
ic spindles when cells progress into prometaphase.
Only two of the resulting 7-tubulin-positive spots con-
tain centrin2, a marker of authentic centrosomes, sug-
gesting that the other multipolar spindles irradiate
from de novo
existing r-tubulin. A kinesin Eg5 inhibitor, monastrol,
suppresses the multipolar spindle phenotype, suggest-
ing its formation in the absence of astrin requires Eg5
motor protein. Inactivation of astrin decreases Aurora-
A localization at centrosome in interphase cells and
depletes it from microtubule spindles, although it does
not affect its centrosome localization and phosphory-
lation at Thr-288 in mitotic cells. The mitotic arrest
phenotype in double depletion of Aurora-A and astrin
plus the Aurora-A dislocation from the mitotic spindle
in siAstrin-treated cells all suggest that astrin is a
upstream regulator of Aurora-A. Overexpression of
astrin causes senescence in primary human fibroblast
IMR90 cells because it significantly elevates the p53
level in the cells.
Human Cell Transformation
Y. Seger
Our knowledge of the transformation process has
emerged largely from studies of primary rodent cells
and animal models. In primary rodent fibroblasts, the
transformation process is well-defined and usually
requires two genetic alterations. However, rodent
transformation models do not perfectly recapitulate
the transformation process in humans as it is impossi-
ble to transform normal human cells into tumor cells
using the same oncogene combinations that are effec-
tive in rodent cells. One obvious difference between
rodent and human cell models is the requirement for
telomerase, the enzyme responsible for maintaining
telomeres. In rodent cells, transformation is indepen-
dent of exogenous telomerase induction due to
promiscuous telomerase expression and constitutively
long telomeres. The potential importance of telom-
erase in human transformation processes has been
supported by the fact that a majority of human tumors
are telomerase-positive. In addition, previous reports
have indicated that the direct expression of the telom-
erase catalytic subunit hTERT is a vital component of
the human cell transformation equation.
Our work over the past several years has resulted in
the development of a human cell transformation system
that is independent of direct induction of hTERT or a
gene previously shown to be capable of activating
telomerase. We have shown that the combined expres-
sion of adenovirus E1A, Ha-RasV12, and MDM2
(ERM) is sufficient for the conversion of a normal
human cell into a cancer cell. Notably, these cells are
upon injection into nude mice, and
the resultant tumors are also negative for telomerase
activity. As a result, we see continuous telomere short-
ening and chromosomal abnormalities similar to those
seen in telomerase-null mice. This suggests that alter-
ations in telomere biology must be viewed similarly to
genomic instability as catalysts of transformation, rather
than central components of the transformed phenotype.
This ERM transformation model is now function-
ing as a highly tractable system within which several
RNAi-based approaches can be applied. Most notably,
we are currently utilizing stably expressed short hair-
pin RNA (shRNA) constructs to knock down expres-
sion of E1A targets in order to rescue functional dele-
tion mutants of E1A and restore transforming func-
tion. Similarly, a hairpin rescue screen could eventual-
ly identify additional genes whose silencing con-
tributes to E1A-mediated transformation.
Genetics of miRNA Function
L. He
microRNAs (miRNAs) are a family of 21-25 -
nucleotide small RNAs that negatively regulate gene
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expression at the post-transcriptional level. To date,
several hundred miRNAs have been identified in
mammals, fish, flies, worms, and plants, about one
hundredth of the protein encoding genes in each
organism. Functional studies have only touched upon
a handful of miRNAs-all in model organisms, which
have an important role in regulating developmental
timing and cell proliferation. To study the functions of
mammalian miRNAs, I am constructing an expression
library that directs ectopic synthesis of both the mouse
miRNAs and the human miRNAs. This library will be
used to search for oncogenic miRNAs using well-
established transformation systems in vitro and will be
used in vivo to search for roles of miRNAs in regulat-
ing development and differentiation, particularly in
the hematopoietic compartment.
Building a Better Hairpin
D. Siolas
My work currently focuses on miRNA processing and
enhancing applications of shRNA gene silencing in
mammalian cells. Long primary (Pri)-miRNAs are
processed intracellularly by the enzyme Drosha into
shorter approximately 70-nucleotide pre-miRNAs that
are hairpin structures with a 3' two-nucleotide over-
hang. These premiRNAs are processed by an RNase
III enzyme, Dicer, into mature 22-nucleotide
miRNAs. In vitro studies using human recombinant
Dicer have revealed that Dicer processes 29-mer
shRNA into distinct 22-mer siRNA from its stem end
in a single cleavage event, thus determining where an
siRNA is produced in a given shRNA. A two-base 3'
overhang is necessary for efficient generation of 22-
mer siRNA, and 22-mer processing is greatly reduced
in hairpins with no overhang or with a 5' overhang. In
addition, hairpins of different lengths were examined,
and although 29-mer hairpins were processed effi-
ciently into 22-mers, hairpins of 21 nucleotides were
processed inefficiently, resulting in products of vary-
ing sizes; 19-mer hairpins were not processed. These
insights allowed us to devise methods to design spe-
cific shRNAs that would produce predictable siRNAs
in vivo. In collaboration with Michelle Cleary (CSHL
alumnus now at Rosetta Inpharmatics), we tested the
ability of algorithms that predict effective siRNAs to
predict similarly effective shRNAs. Strikingly, when
siRNAs are provided to the cell in the context of a 29-
nucleotide shRNA, it is more effective than if deliv-
ered directly as an siRNA, with shRNAs showing not
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only more potent inhibition (better silencing per
nanogram delivered to cells), but also more complete
endpoint inhibition. These studies have permitted us to
develop a new type of more effective RNA-based trig-
ger of RNAi and also to design the next generation of
genome-wide RNAi libraries.
RNAi and the Genome
A. Denli
RNA has recently become the centerpiece of gene
silencing after the discovery that double-stranded
RNAs trigger gene silencing through different effector
complexes. Even though the discovery of this phe-
nomenon (RNAi) has been through using exogenous
dsRNA, further studies revealed that cells use RNAi
for endogenous gene regulation and even heterochro-
matin formation. My interest has been the mechanism
of these endogenous processes. Data from my work
suggest that the RNAi machinery is biochemically
conserved in the fission yeast Schizosaccharomyces
pombe, and some novel interactions observed between
RNAi proteins may help bring the blurry picture of
RNAi-heterochromatin interplay into better focus. My
other project involves miRNA biogenesis, in which I
am trying to purify complexes involved in primary-
miRNA processing. I believe my studies, and the work
of my colleagues in the lab and elsewhere, will allow
us to better characterize the RNAi pathway, to reveal
its connections to other phenomena, and to use RNAi
as an even better tool to silence genes in numerous
organisms, most importantly mammals.
Biological Functions of RNAi
in Mammals
M. Carmell
Argonauts (Ago) family members have been shown to
be essential for RNAi/PTGS (post-translational gene
silencing) in several organisms, including Neurospora
(QDE-2), Arabidopsis (AGO1), and C. elegans (rde-
1). Argonautes are core components of RISC com-
plexes, and function both in mRNA destruction and
translational inhibition. Interestingly, Argonaute genes
have also been implicated in control of development in
several organisms. It is unknown what roles of the
RISC complex are mediated by Argonaute family
members, and whether developmental phenotypes
result from loss of discrete regulatory functions or
from a more general misregulation of silencing mech-
anisms. To address the role of Argonautes in the mam-
malian system, we have undertaken a comprehensive
analysis of mouse mutants engineered to lack individ-
ual Argonaute family proteins. Thus far, three of seven
mammalian Ago genes have been disrupted, and infor-
mative phenotypes are beginning to emerge.
The Agog mutant embryos display severe develop-
mental defects and survive only halfway through ges-
tation. The phenotype includes a neural tube closure
defect and a probable heart defect. Current studies are
examining whether these phenotypes are due to per-
turbation of embryonic patterning pathways or to
genome-wide silencing issues.
Embryos homozygous for Miwi2, which is an
Argonaute gene primarily expressed in the testes,
exhibit defects in spermatogenesis. Miwi2-deficient
males are sterile, as the testes lack all postmeiotic cell
types. Studies of Ago] and Ago3 are also under way.
RNAi in Mammals: The Quest
for Illuminating Gene Function
P.J. Paddison, J.M. Silva
Since the 1970s, the war on cancer has been based on
the notion that studying the disease will lead to the dis-
covery of vulnerabilities, which can be exploited in the
clinic. Many underlying genetic determinants of can-
cer have been identified, but this knowledge has failed
to translate into new therapeutic strategies, with only a
handful of exceptions. This is largely due to the genet-
ically intractable nature of cultured mammalian cells.
The immergence of RNAi as a technology to
silence gene expression in virtually every experimental
eukaryotic system, including mammals, holds promise
for identifying cancer lethal targets. Our work has
revolved around (1) demonstrating that double-strand-
ed RNA induces sequence-specific gene silencing in
mammalian cells (Paddison et al., Proc. Natl. Acad.
Sci. 99: 1443 [2002a]); (2) refining the method of trig-
gering RNAi so that it can be applied in most cellular
contexts (Paddison et al., Genes Dev. 16: 948 [2002b];
Paddison and Hannon Cancer Cell 2: 17 [2002];
Hemann et al. 2003); and (3) constructing genome-
wide RNAi libraries to make genetic screens feasible
in mammals (Paddison et al. 2004).
During the past year, we have constructed a mam-
malian RNAi library targeting approximately 12,000
human genes and about 8,000 mouse genes. This
library is presently composed of about 30,000
sequence-verified shRNA expression cassettes con-
tained within multifunctional vectors, which permit
shRNA cassettes to be packaged in retroviruses,
tracked in mixed cell populations via DNA "bar
codes," and shuttled to customized vectors by bacteri-
al mating. For library validation, we employed a genet-
ic screen designed to report defects in human protea-
some function. Our results suggest that our large-scale
RNAi library can be used in specific genetic applica-
tions in mammals and will likely become a valuable
resource for gene analysis and discovery.
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SPORADIC HUMAN GENETIC DISEASE
E. Hatchwell S. Kantarci S. Mehra
T. Lee P. Slomiany
We are interested in the application of modern
methodologies to the analysis of sporadic human
genetic disorders. Many disorders are now known to
be associated with de novo mutations; this knowledge
has been gleaned almost exclusively as a result of
serendipitous observations of cytogenetic abnormali-
ties in unique individuals with the relevant disease. It
is no surprise that many disorders are associated
almost exclusively with de novo mutations as affected
individuals do not reproduce (for a variety of reasons).
The technology to detect de novo point mutations is
some way off (i.e., this would require whole-genome
sequencing in a rapid and cost-effective manner), but
we now have tools to detect a class of mutations that
are known to be relevant to this group of disorders,
namely, copy-number abnormalities. The mainstay of
whole-genome analysis historically has been chromo-
some analysis, but this suffers from a lack of resolu-
tion (abnormalities smaller than 10 Mb are not rou-
tinely detectable).
Genome-wide copy-number array analysis at high
resolution is now available using a number of different
formats, including large clone, cDNA, and oligo arrays.
Our preference is for large-clone genomic arrays, using
material amplified from well-characterized bacterial
artificial chromosomes (BACs), because these have
been shown to be both robust and capable of detecting
very subtle copy-number abnormalities, including 3:2
(such as result from heterozygous duplications).
During the last year, we have consolidated our use of
BAC arrays in a variety of disease groups and have also
initiated relatively novel methodologies for the valida-
tion of array detected copy number abnormalities. We
continue to be interested in a variety of disease groups:
Congenital heart disease (CHD) in collaboration
with pediatric cardiologists both in the United States
and the United Kingdom to search for copy-number
variations in children with CHD who are 22q11 nor-
mal (22q11 deletions are the most common current-
ly known cause of CHD).
Complex phenotypes, mostly involving mental
retardation in association with physical anomalies,
in individuals with normal karyotypes.
Individuals with sporadic phenotypes in association
with de novo balanced translocations, as a collabo-
ration with the Mendelian Cytogenetics Network
(MCN).
Autistic spectrum disorder, in collaboration with
workers at the Cody Center, Stony Brook Univer-
sity, New York.
Essential thrombocytosis (ET) in collaboration with
workers at Stony Brook University. We shall be per-
forming genomic analysis in individuals with ET. It
is known that many ET patients have large deletions
of 5q, and we are planning to both map these more
precisely and also uncover smaller deletions in
patients without obvious cytogenetic abnormalities.
Genome-wide BAC Arrays
T. Lee
We have generated BAC arrays using a combination of
available protocols and universal amplification meth-
ods that we have developed in-house. Our initial arrays
were based on two distinct sets of BACs isolated by
two independent groups:
1. The Cheung laboratory (http://genomics.med.
upenn.edu/genmapdb/). This set consists of approx-
imately 4200 BACs isolated by STS screening of
regularly spaced markers in the genome. Most of
these BACs were not FISH-mapped. These arrays
(with an average resolution of <1 Mb) have been
instrumental in detecting a number of interesting
copy-number abnormalities in our patient groups
(see below).
2. The Cancer Chromosome Aberration Project
(CCAP; http://cgap.nci.nih.gov/Chromo some s/
CCAP_BAC_Clones). This set consists of approxi-
mately 1300 FISH-mapped BACs selected on the
basis that they had been either completely
sequenced or anchored to the human genome by
virtue of end-sequence information. The resolution
of these arrays is relatively low, but their utility lies
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in the knowledge that all elements recognize a unit-
ed genomic address.
This year, we have generated 27,000 element BAC
arrays (9000 BACs arrayed in triplicate) that com-
bine the two sets described above and also the set from
the Sanger Centre, Cambridge, UK, which contains
-3000 BACs which have been fingerprinted. Our cur-
rent arrays therefore have an average resolution of 300
kb and will be used in 2004 for analysis of the patient
groups described above.
Characterization of a Novel Gene in
Joubert Syndome
S. Kantarci
We have previously mapped the chromosome 2q13
breakpoint in an individual with a de novo balanced
translocation t(2;22)(q13;q11.1) associated with
Joubert Syndrome (JS) (OMIM 213300). JS is a rare
disorder that is associated with mental retardation,
hypoplasia of the cerebellar vermis, respiratory abnor-
malities, and occasional renal and retinal anomalies.
Genes for this disorder have not yet been isolated.
Using BAC array analysis of flow-sorted chromo-
somes , we were able to rapidly map the breakpoint on
chromosome 2 and have recently isolated a novel 10-
exon gene, which spans more than 500 kb of the
genome. The translocation directly interrupts this
gene (between exons 1 and 2) and is currently being
Chromosome 2
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FIGURE 1 Output for chromosome 2 in a patient with a com-
plex phenotype (see text). The 3 spots with an elevated ratio
are from the same BAC, which was subsequently shown to be
deleted (ratios are Cy5/Cy3, the patient was labeled with Cy3
and the control with Cy5).
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considered as a candidate for JS in those patients with
no obvious cytogenetic abnormality, in whom linkage
has not excluded 2q13.
Characterization of a De Novo
Microdeletion at 2Q31
P. Slomiany
Using our genome-wide BAC arrays, we have detect-
ed a submicroscopic deletion in a patient with a phe-
notype reminiscent of velocardiofacial syndrome
(VCF, associated in the majority of cases with a het-
erozygous microdeletion at 22q11). This patient pre-
sented with microcephaly, developmental delay, and
short stature, as well as dysmorphic facies. Routine
cytogenetic analysis was reported as normal. The
microdeletion detected is at 2q31, and we have now
shown that this microdeletion is de novo, making it
extremely likely that the deletion is causative in this
individual (his parents are phenotypically normal and
neither is deleted in this region). The initial detection
of the deletion was made using BAC arrays with an
average resolution of 1 Mb (based on the Cheung set).
We subsequently generated a tiling path array using 40
BACs from chromosome 2q31, in an attempt to nar-
row down the deletion end points. This region-specif-
ic array was generated using a personal microarrayer:
the SpotBot from Telechem. The SpotBot is a 1-foot
cube arrayer, which is controlled by software from a
laptop and which can generate up to 12 arrays in about
2 hours. It is ideal for region-specific arrays and for
testing out novel array chemistries/probe types.
2g31
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F GURE 2 Closer view of the chromosome 2 output shown in
Figure 1.
Our region-specific microarrays have allowed us
to determine the endpoints of the deletion to within
100 kb. Furthermore, we have isolated the deleted
chromosome 2 from our patient after fusion of lym-
phoblastoid cells with hamster cells and analysis of
hybrid clones using STRs from chromosome 2. We are
now in a position to completely map the deletion and
determine which genes are contained therein, in order
to try and draw phenotype-genotype correlations.
It is likely that a 2q31 microdeletion exists in other
individuals with similar phenotypes, and we are cur-
rently analyzing 22811 negative VCF look-alikes for
the presence of this deletion. We fully expect to be
able to delineate a new 2q31 microdeletion syndrome
once our studies are complete.
Validation of Array-detected
Copy-number Abnormalities
S. Mehra
Although it is clear that array analysis has revolution-
ized much of molecular biology, little attention has
been given to the validation of ratiometric changes
detected by array analysis, whether using genomic or
expression arrays. The mainstay of validation of copy-
number abnormalities is quantitative (real-time) poly-
merase chain reaction (PCR), but this method is inad-
equate for subtle changes (namely, 2:1 or less). Few
alternatives exist to address this problem:
2q31 tiling path array
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FIGURE 3 Tiling path array of the 2q31 region implicated in a
deletion in our patient. This array has an approximate resolution
of 100 kb and has allowed us to delineate more precisely the
endpoints of the deletion. The "dip" in the middle is likely due
to homology with another region in the genome.
1. FISH (fluorescence in situ hybridization) analysis
is useful for confirming heterozygous deletions
(2:1) and (usually) heterozygous duplications (3:2)
but suffers from a number of drawbacks, namely,
the necessity for cells and the limitations in con-
firming small heterozygous duplications, which
often appear as a single "spot," rather than two dis-
tinct signals. Since FISH is not quantitative, it is
impossible to differentiate between the brighter sig-
nal obtained when a small tandem duplication is
present from a normal signal.
2. Dosage analysis using Southern blots is labor-inten-
sive, requires large amounts of material, and very
accurate determinations of DNA concentration.
3. STR (short tandem repeat) analysis may be useful
but cannot formally differentiate between homo-
and hemizygosity when attempting to validate dele-
tions. Furthermore, useful STRs may not be avail-
able for very short regions. Finally, when attempt-
ing to confirm heterozygous duplications, STRs
are only useful if three distinct alleles are observed
(unlikely to be present routinely), or if suitable
methods are available for dosage analysis of the
two distinct bands (when the STR is informative).
We have determined that the most effective meth-
ods for validating suspected copy-number changes
involve "counting" single molecules from regions of
interest and from control regions. Theoretically, this
approach should be able to validate very subtle
changes (say <10%), such as occur in mosaic states. A
number of methodologies exist for single molecule
counting, but we have chosen polony technology, as
we believe this to be the most practical. The basic prin-
ciple is simple: Limiting dilutions of genomic DNA
are added to a polyacrylamide matrix containing PCR
reagents on a slide, and the slides are then subjected to
thermal cycling. Amplification of the cognate
sequences on single molecules results in PCR colonies
(i.e., polonies), which can then be detected using fluo-
rescently labeled DNA probes. If this is done in paral-
lel on test and control samples, using control primers
and primers from the region of interest, it should be
possible to obtain very accurate ratios of the number
of molecules represented, respectively, by the two
regions being compared. For example, a mosaic dele-
tion analyzed on an array may be associated with a
ratio of about 0.8, which might reasonably be consid-
ered close enough to 1 to ignore, whereas the ratio
obtained from a polony experiment would be, say
about 80/100, where these numbers correspond to the
number of molecules amplified.
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REGULATION OF APOPTOSIS AND NUTRIENT METABOLISM IN
CANCER CELLS
Y. Lazebnik C. Cormier A. Matapurkar
D. Duelli X. Opitz-Araya
S.-C. Lin M. Yuneva
Treatment of cancer relies on differences between nor-
mal and cancer cells that allow for selective or prefer-
ential killing of cancer cells. In a search for these dif-
ferences, we have been focusing on apoptosis, and
recently, on the requirement for nutrients.
Apoptosis is a type of cell death that is carried out
by specialized cellular machinery. The current knowl-
edge is sufficient to design and implement tools that
kill cells quickly and efficiently by inducing apopto-
sis. However, the major problem is how to induce
apoptosis in cancer cells selectively. One approach to
solving this problem is to learn how apoptosis is
induced by oncogenic transformation. This approach
is based on a paradoxical observation that some onco-
genes, including myc and adenovirus E1A, either
induce apoptosis or sensitize cells to cytotoxic agents,
including those used for chemotherapy. One implica-
tion of this observation is that some oncoproteins
exhibit proapoptotic activities specific for transformed
cells. If true, then understanding how the apoptotic
machinery is regulated by oncogenes may help to
develop ways to kill cancer cells selectively.
Caspases are proteases that are activated at the
onset of apoptosis and cause death by cleaving a num-
ber of proteins in a coordinated manner. Caspase acti-
vation occurs in two steps. At the first step, pro-apop-
totic signals lead to autocatalytic activation of caspas-
es that are called initiators. Activated initiator caspas-
es process effector caspases, which in turn cause cell
collapse by cleaving a specific set of substrates. Each
initiator caspase is activated in response to a subset of
signals, indicating that a prerequisite for understand-
ing how a specific signal activates apoptosis is finding
the initiator caspase that mediates it. We have been
investigating which caspases are involved in apoptosis
and studying how they are activated, how this activa-
tion leads to cell death, and what prevents this acti-
vation in drug-resistant cells. The ultimate goal is to
understand how caspases can be activated selectively
in cancer cells.
To investigate how caspases are regulated by
oncogenes, we previously developed a cell-free sys-
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tem that mimics apoptosis dependent on expression
of E1A, an adenoviral oncogene. Using this system,
we found that E1A- dependent apoptosis is mediated
by caspase-9 and that the expression of E1A sensitizes
cells to apoptosis by facilitatating activation of this
caspase. This is achieved by at least two ways: facili-
tating the release from mitochondria of cytochrome c,
a cofactor required for caspase-9 activation, and reg-
ulation of an unidentified subsequent step in caspase-
9 processing.
This model was consistent with the prevailing
view that cytotoxic stress, such as DNA damage,
induces apoptosis by regulating permeability of mito-
chondria. Mitochondria sequester several proteins
that, if released, kill by activating caspases, the pro-
teases that disassemble the cell. Another way to acti-
vate caspases, which is used by cytokines, is to assem-
ble receptor complexes that
although the subsequent mitochondrial permeabiliza-
tion accelerates cell disassembly by amplifying cas-
pase activity. We found that cytotoxic stress causes
activation of caspase-2 and that silencing expression
of this caspase with a small interfering RNA (siRNA)
prevents permeabilization of mitochondria and, subse-
quently, apoptosis. Therefore, we concluded that
cytokine and stress-induced apoptosis act through
conceptually similar pathways in which mitochondria
are amplifiers of caspase activity, rather than initiators
of caspase activation.
During the last year, however, we found that
silencing caspase-2 with a different siRNA has no
effect on apoptosis. This result questioned our previ-
ous conclusion and suggested three possibilities: (1)
These siRNAs differentially silence caspase-2 iso-
forms, which alters the outcome of drug-induced
apoptosis; (2) one of the two siRNAs silences an
unidentified gene(s), whose product is involved in
apoptosis; and (3) one of the two siRNAs has some
effect unrelated to RNAi. We have been investigating
all these possibilities, but have yet to determine which
of them is correct.
Our studies of the link between apoptosis and
oncogenes have recently led us to focus on the
changes that these oncogenes make in cell metabo-
lism, and how these changes affect cell viability.
These studies are just beginning to provide interesting
results that we hope may open new opportunities for
manipulating cell viability to selectively kill cancer
cells.
During this year, we have also continued to
expand our observation, which is consistent with a
body of largely forgotten literature, that cell fusion is
linked to cancer. We have summarized existing argu-
ments in favor of this idea and reported some of our
hypotheses in an opinion letter that argues that this
link should not be ignored without investigating it. We
also continued our collaborations with several labora-
tories. Overall, our studies continued to investigate
how to kill cancer cells selectively.
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REGULATION OF APOPTOSIS AND SENESCENCE BY CANCER
GENES
S. Lowe A. Bric R. Dickins S. Nunez
D. Burgess M. Hemann S. Ray
E. Cepero M. McCurrach C. Rosenthal
E. de Stanchina M. Narita C. Scott
Apoptosis is a genetically controlled form of cell
death that is important for normal development and
tissue homeostasis. Senescence produces "genetic
death" in that the senescent cell is incapable of further
propagation. Both processes are frequently disrupted
in cancer cells, implying that each can limit tumor
development. Moreover, radiation and many
chemotherapeutic agents can induce either apoptosis
or senescence, raising the possibility that the integrity
of these programmed responses influences the out-
come of cancer therapy in patients. The goal of our
research is to understand how cancer genes control
apoptosis and senescence in normal cells, and how
mutations that disrupt these processes impact tumor
development and therapy. Our approach emphasizes
genetics, and we typically exploit
tems to study cancer gene function. We also study ani-
mal models and human tumors to confirm the rele-
vance of our simple systems for tumor development
and cancer therapy in vivo.
Control of Apoptosis by Oncogenes
and Tumor Suppressor Genes
A. Bric, D. Burgess, E. Cepero, E. de Stanchina,
M. Hemann, M. McCurrach, J. Zilfou [in collaboration
with C. Cordon-Cardo and P. Pandolfi, Memorial
Sloan-Kettering Cancer Center, New York; also with
former laboratory member J. Fridman]
Normal cells possess natural fail-safe mechanisms
that limit the consequences of aberrant proliferation.
For example, deregulated expression of c-Myc or dis-
ruption of the Rb (retinoblastoma) pathway in normal
cells can force aberrant S-phase entry and predispose
cells to apoptotic cell death. This increased sensitivity
to apoptosis acts in part via the p53 tumor suppressor
pathway and limits tumor development. We have pre-
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viously shown that oncogenes can engage the ARF-
p53 pathway to promote apoptosis, and that disruption
of this pathway cooperates with oncogenes to promote
oncogenic transformation in vitro and tumor develop-
ment in vivo (for review, see Lowe and Sherr 2003).
We are currently interested in identifying additional
components of these programs and understanding how
they function in a "tumor suppressor network."
p53 acts via transcription-dependent and -indepen-
dent mechanisms that act in concert to target multiple
levels in order to promote efficient cell death
(Fridman and Lowe 2003). This year, we identified the
promyelocytic leukemia (PML) gene product as a new
factor that modulates p53-dependent apoptosis (de
Stanchina et al. 2004). Specifically, we showed that
Myc-expressing defective in
apoptosis, albeit not as defective as p53-null cells.
Interestingly, PML appears to modulate p53-depen-
dent apoptosis, at least in part, by acting as a direct
p53 effector (see below). PML, in turn, cooperates
with other p53 effectors to promote efficient cell
death. How this occurs remains to be determined and
is a topic of current research.
The Mdm2 oncoprotein physically associates with
p53 and antagonizes its tumor suppressor functions.
Interestingly, some human and murine tumors express
high levels of alternatively or aberrantly spliced
Mdm2 variants that are unable to bind p53, but
whether these actively contribute to carcinogenesis or
are a byproduct of cancer progression has been
unclear. This year, we examined the ability of full-
length Mdm2 and several tumor-derived splice vari-
ants to modulate tumor development in Ei-myc trans-
genic mice (Fridman et al. 2003). We showed that sev-
eral tumor-derived Mdm2 splice variants promote
tumorigenesis in a =surer that is comparable to that
of full-length Mdm2. Our results imply that the cur-
rent paradigm for understanding Mdm2 action during
oncogenesis is incomplete and that human Mdm2
splice variants can contribute to human cancer.
We also are involved in several collaborative stud-
ies with CSHL scientists. For example, with William
Tansey, we are dissecting the function of the Myc
oncoprotein using mouse models of leukemia and
lymphoma and are comparing and contrasting the
mechanisms by which the E1A and Myc oncopro-
teins promote apoptosis. With Gregory Hannon, we
are using libraries of murine "short hairpin" RNAs to
dissect the apoptotic network in cultured cells and in
animals (see below). These studies have enormous
potential to produce new insights into p53 function
and the control of apoptosis over the next several
years.
Control of Cellular Senescence
E. de Stanchina, M. Narita, M. Narita, S. Nunez, J. Zilfou
[in collaboration with G. Hannon; also involving former
laboratory members E. Querido and G. Ferbeyre]
Cellular senescence was originally described as the
process that accompanies replicative exhaustion in
cultured human fibroblasts and is characterized by a
series of poorly understood markers. Senescent cells
remain metabolically active, but they are unable to
proliferate and display changes in gene expression
that could alter tissue physiology. As such, they are
genetically "dead" and cannot contribute to tumor
development. Although "replicative" senescence is
triggered by telomere attrition and can be prevented
by telomerase, an identical endpoint can be produced
acutely in response to activated oncogenes, DNA
damage, oxidative stress, and sub-optimal cell culture
conditions. These observations have led us to propose
that senescence acts in parallel to apoptosis as a cellu-
lar response to stress. Indeed, based on this analogy,
much of our work on senescence is guided by our past
experience on apoptosis.
One focus of our efforts is to identify new com-
ponents that regulate senescence. We previously
used microarray technology to identify the PML
gene which is up-regulated during senescence. Until
recently, most studies suggested that PML acts
upstream of p53 to enhance its transcription of tar-
gets by recruiting p53 to nuclear bodies (NBs).
However, this year, we show that PML is a p53 tar-
get gene that also acts downstream from p53 to
potentiate its antiproliferative effects (de Stanchina
et al. 2004). Hence, p53 is required for the induction
of PML and NBs in response to oncogenes and DNA
damaging chemotherapeutics. Furthermore, the
PML gene contains consensus p53-binding sites that
confer p53 responsiveness to a heterologous reporter
and are capable of binding p53 in vitro and in vivo.
Finally, cells lacking PML show a reduced propensi-
ty to undergo cellular senescence or apoptosis in
response to p53 activation, despite the efficient
induction of several p53 target genes. These results
identify a new element of PML regulation and estab-
lish PML as a mediator of p53 tumor suppressor
functions.
We are also actively studying the effector mecha-
nisms involved in executing cellular senescence. This
year, we described a distinct heterochromatic structure
that accumulates in senescent human fibroblasts,
which we designated senescence-associated hete-
rochromatic foci (SAHF) (Narita et al. 2003). SAHF
formation coincides with the recruitment of hete-
rochromatin proteins and the Rb tumor suppressor to
E2F-responsive promoters and is associated with the
stable repression of E2F target genes that normally
promote proliferation. Notably, both SAHF formation
and the silencing of E2F target genes depend on the
integrity of the Rb pathway and do not occur in quies-
cent cells that are capable of resuming proliferation
with an appropriate stimulus. Therefore, our results
provide a molecular explanation for the stability of the
senescent state, as well as new insights into the action
of Rb as a tumor suppressor (for review, see Narita and
Lowe 2004]. We are currently expanding on these
results in an effort to gain new insights into this potent
tumor suppressive mechanism.
New Mouse Models of Cancer
E. Cepero, R. Dickins, M. Hemann, S. Ray, C. Rosenthal,
H. Wendel, M. Yang, J. Zilfou [in collaboration with
G. Hannon, Cold Spring Harbor Laboratory and
C. Cordon-Cardo, Memorial Sloan-Kettering Cancer
Center; also with former laboratory member J. Fridman]
During the last several years, we have developed rapid
methods for producing transgenic and "knockout" ani-
mals as an alternative to germ-line methods. In one
approach, we introduce genes into stem cells and then
reconstitute the hematopoietic compartment of lethal-
ly irradiated mice. As a consequence, normal mice are
produced that contain a "transgenic" hematopoietic
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system. Both the transgene and the genotype of the
stem cells can be varied, allowing one to rapidly pro-
duce chimeric animals with multiple genetic changes
at much more rapid rates than would be possible with
traditional germ-line methodology. Moreover, since
our retroviral vectors often co-express a green fluores-
cence protein (GFP) reporter, it is possible to track the
infected cells in vivo by whole-body fluorescence
imaging We have used this system to study the action
of various oncogenes and tumor suppressor genes on
the development and treatment of leukemia and lym-
phoma.
In collaboration with G. Hannon, we investigated
whether RNA interference (RNAi) technology could
be used to suppress gene expression in stem cells and
produce phenotypes in reconstituted mice (Hemann et
al. 2003). As a proof-of-concept experiment, we asked
whether short hairpin RNAs (shRNAs) against p53
could recapitulate the phenotype of complete p53
deficiency during Myc-induced lymphomagenesis.
We introduced several p53 shRNAs into hematopoiet-
ic stem cells derived from Eg -myc mice and moni-
tored tumor onset and overall pathology in lethally
irradiated recipients. Different p53 shRNAs produced
distinct phenotypes in vivo, ranging from benign lym-
phoid hyperplasias to highly disseminated lymphomas
that paralleled the nullizygous setting. In all cases, the
severity and type of disease correlated with the extent
to which specific shRNAs inhibited p53 activity.
Therefore, RNAi can stably suppress gene expression
in stem cells and reconstituted organs derived from
those cells. Moreover, intrinsic differences between
individual shRNA expression vectors targeting the
same gene can be used to create an "epi-allelic series"
for dissecting gene function in vivo.
Based on the success of these "proof-of-concept"
studies, we are conducting a number of RNAi-based
projects to dissect tumor phenotypes. One set of these
involves experiments aimed at disrupting specific
components of tumor suppressor networks and then
examining how this affects tumor onset, pathology,
and resistance to various therapies (see below). In
another approach, we are collaborating with the
Hannon laboratory to develop a library of murine
"short hairpin" RNAs and have begun to use these in
"forward genetic" screens for genes that influence
tumor behavior. As our system is tractable, we hope to
make rapid progress in this area. Finally, in addition to
lymphoid models of malignancy, we are beginning to
use these methods to model other cancers including
acute and chronic myelogenous leukemias.
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Molecular Genetics of Drug
Sensitivity and Resistance
E. Cepero, M. Hemann, S. Ray, C. Rosenthal, A., C. Scott,
M. Spector, H. Wendel, M. Yang, J. Zilfou [in collaboration
with C. Cordon-Cardo, Memorial Sloan-Kettering Cancer
Center; J. Pelletier, McGill University; S. Kogan, University
of California, San Francisco; also with former laboratory
member J. Fridman]
A major goal of our research is to understand the bio-
logical and molecular basis of drug sensitivity and
resistance in tumors (e.g., see Soengas and Lowe
2003). Conventional approaches to identify factors
that dictate treatment sensitivity rely on human tumor
cell lines treated in vitro or as ectopic xenografts. As
an alternative approach, we are using transgenic
mouse models to study drug action in spontaneous
tumors. Our system exploits the Ep. -myc transgenic
mouse, which develops B-cell lymphomas at short
latency with high penetrance. Using this system, we
have identified a number of biologic and genetic
determinants of treatment sensitivity in vivo.
In addition to characterizing drug resistance mech-
anisms, our most important goal is to use information
from our models to develop and test better strategies to
treat cancer. This year, we had our first major success
in this effort, providing evidence that reversing apop-
totic defects acquired during tumorigenesis could also
overcome drug resistance (Wendel et al. 2004).
Specifically, using the Eg -myc model, we showed that
the Akt oncogene accelerates tumorigenesis and pro-
motes drug resistance in a manner comparable to the
strictly anti-apoptotic protein Bcl -2. Remarkably, Akt-
mediated drug resistance is reversed by the mTOR
inhibitor rapamycin, which induces massive apoptosis
and sustained responses, but only when combined
with conventional chemotherapy. In contrast, rapa-
mycin was unable to reverse drug resistance in Bc1-2-
expressing lymphomas, despite their similar pathology
to those expressing Akt. These results establish Akt-
mediated apoptotic defects as an important mecha-
nism of oncogenesis and drug resistance in vivo and
reveal how targeting survival pathways can restore
drug sensitivity in a genotype-dependent manner.
Clearly, it will be important to determine whether sim-
ilar rules apply in cancer patients.
Current efforts are focused at further dissecting
Akt signaling and how it influences tumor develop-
ment, drug resistance, and rapamycin sensitivity. In
this regard, we have enlisted Dr. Jerry Pelletier
rapamycin + chemotherapy
Figure 1 Tailoring chemotherapy based on cancer genetics.
Mice harboring lymphomas of the indicated genetic back-
ground were treated with the combination of rapamycin and
chemotherapy. Lymph nodes were isolated 6 hours later and
lymphoma sections were stained with hematoxylin/eosin. This
drug combination induces massive apoptosis in lymphoma
expressing Akt but not those overexpressing BcI2 or the con-
trols, despite an overall similar pathology.
(McGill University) as a collaborator. We also are test-
ing a number of novel "targeted" therapies in the Eli-
myc model in order to determine whether any can
reverse or circumvent the drug resistance produced by
p53 loss. Finally, we have initiated a multi-institution-
al program (also involving scientists at UCSF, U.
Minn., and U. Chicago) aimed at understanding and
overcoming drug resistance in acute myelogenous
leukemia (AML). Our program uses mouse AML
models to uncover drug resistance mechanisms and to
evaluate new therapies, with the goal of translating
this information to human patients. We are excited
about the potential of the SCOR, as it provides all of
the elements necessary to validate the use of new
mouse models as preclinical test systems.
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GENOMIC MICROARRAY ANALYSIS OF CANCER
R. Lucito A. Brady C. Hutter
S. Chen 0. Dovirak
This work was carried out in collaboration with M.
Wig ler, J. Healy, A. Reiner, B. Mishra, and R. McCombie
here at CSHL. Mutation of the genome is central to the
development and progression of cancer. Mutations occur
in the genome of the precancerous cells and accumulate,
altering gene function until the growth of these cells goes
unchecked. The genes responsible for cancer must be
identified if we are to understand the cellular pathways
that get subverted to allow the cell to become cancerous.
We have begun surveying the genome of several cancer
types to identify regions that have undergone increased
or decreased gene copy number, namely, amplifications
or deletions, since these changes can be used as markers
for the location of oncogenes or tumor suppressor genes,
respectively. Regions are being informatically searched
for gene candidates, and then functional analysis of these
candidates is being carried out to determine which genes
have oncogenic potential. Once identified, these genes
functions can be investigated to understand their role in
the path to tumorigenesis. In addition by analyzing the
regions alongside clinical data, we will determine if there
are any regions or combination of regions that correlate
to clinical outcome.
We have developed a genomic microarray tech-
nique, called representational oligonucleotide microar-
ray analysis (ROMA), to identify copy-number fluctua-
tions, which borrows the methodology of complexity
reducing representations developed for RDA (represen-
tational difference analysis) to increase hybridization
efficiency and increase signal to noise. A representation
is a reproducible sampling of the genome, produced by
first cleaving the genome with a restriction enzyme
such as BglII, ligation of adaptors, and polymerase
chain reaction (PCR) amplification. Bg111 representa-
tions of tumor and normal that are differentially labeled
are compared on such an array to identify copy-number
fluctuations. The array is composed of oligonucleotides
based on the sequence of the human genome. We are
using microarrays photochemically synthesized by
Nimblegen Systems Inc. Currently, we are using arrays
with 85,000 probes distributed throughout the genome
and soon will be moving to an array of 191,000 probes.
The application of this type of an array spans many
areas of biology, from cancer to genetic diseases. We
will be using this microarray method to categorize the
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mutations that occur in primarily two tumor types ini-
tially, pancreatic and ovarian cancer.
PANCREATIC CANCER
There will be an estimated 30,000 cases of pancreatic
cancer this year. Of these, 29,700 patients will succumb
to the disease. Although the number of cases is low, in
comparison to several other cancers such as colon, lung,
or breast cancer, the survival rate for pancreatic cancer
is one of the lowest. Treatments can extend survival or
alleviate pain but seldom cure the patient. In fact, the
mean survival time is approximately 6 months. Because
the lifespan after diagnosis is very short, the number of
patients that receive tumor resections is very low. This
translates to few samples available for analysis. Because
of this, we are collaborating with many clinicians to put
together a useful tumor bank of pancreatic tissue for
analysis by ROMA. We are currently collaborating with
Dr. Ralph Hruban of Johns Hopkins, Dr. Daniel Von
Hoff of the Arizona Cancer Center, Dr. Vijay Yajnic of
Massachusetts General Hospital, and Dr. Murray
Abrams of Memorial Sloan-Kettering Cancer Center,
who will be providing pancreatic specimens and invalu-
able clinical information and expertise. We will be ana-
lyzing as many as 200 pancreatic tumor specimens. Due
to several other issues involving pancreatic tumor spec-
imens, approximately 25% of the samples will be
xenograft samples or tumor specimens that have been
grown in mice to passage then to a size that can be stud-
ied. ROMA will be performed for this tumor set to iden-
tify regions of the genome that have undergone copy-
number fluctuations. We have analyzed close to 30 sam-
ples already and have confirmed the fact that the
INK4a-ARF locus, DPC4, p53, and c-myc are all
lesions commonly identified in this type of tumor. In
addition, there are other less-characterized regions
deleted (2p23, 3p, 8p23, 10p15, and 12p) and amplified
(1q12, 1q42-43, 2q32, 3q26, 8q, and 12q) frequently in
this cancer, and we are continuing to study these regions
to identify possible gene candidate tumor suppressors
and oncogenes. Eventually, the results from this study
will be combined with clinical information associated
with the patient to determine if there are any parameters
that associate with specific tumor mutation patterns.
OVARIAN CANCER
We are also focusing on the analysis of ovarian cancer
using ROMA. Ovarian cancer has a relatively high inci-
dence and approximately 50% survival rate. In many
patients, the cancer is diagnosed late, often having
metastasized, the first symptoms being an accumulation
of fluid in the abdominal cavity. There have been few
genes discovered that are involved in the progression of
ovarian cancer. We will be collaborating with Dr.
Michael Pearl of Stony Brook University, New York, for
access to tissue and clinical information. We will also be
performing ROMA on a tumor set of approximately 200
ovarian cancer samples to identify gene-copy-number
fluctuations to identify candidate tumor suppressor and
oncogenes. Ovarian cancer samples are more readily
obtainable, and it is likely that all 200 samples analyzed
will be primary tumor samples. We will be comparing
samples of the primary cancer, tissue metastatic from
the cell wall, tissue metastatic found in the fluid in the
abdominal cavity, and in some cases, the metastatic tis-
sue after chemotherapy. We intend to analyze the tumors
to trace the accumulation of mutations from primary to
metastasis with the hope of identifying not only genes
involved in the development of the primary tumor, but
also those genes that may increase metastatic capability
and genes involved in chemotherapy resistance.
At present, we have analyzed 50 tumors and have
compiled the data to identify regions commonly
amplified or deleted. We have identified uncharacter-
ized regions commonly amplified (1q21, 3q26, 6p,
11813, 12p, and 20p13) and regions that are deleted
frequently (1p35, 3p26, 4p15, 4q34, 5q14, 5q34,
6q22, 9q22, 12q, 13q13, 16q, 19p, and 22q13). We
have characterized these regions for gene content and
have chosen several to move further for gene charac-
terization as described below.
Gene Candidate Characterization
C. Hutter, S. Chen [in collaboration with S. Powers, Tularik,
Inc.; M. Wigler, R. McCombie, and L. Van Aelst, Cold
Spring Harbor Laboratory]
Regions identified from the above studies are moving
forward to the identification and the functional charac-
terization of gene candidates. If we are to characterize
the candidate genes' abilities to affect cellular growth, it
is imperative that we have the full-length genes and are
aware of splice variants. If one gene were being studied,
this could easily be handled by more standard tech-
niques. However, this approach will not be sufficient for
multiple regions, each with multiple candidate genes.
We are collaborating with Dr. Richard McCombie who
has extensive experience in genomic sequencing, and
his group has developed a systematic approach in which
gene discovery is performed by integrating existing
gene annotation and gene predictions into an experi-
mental pipeline geared to (1) confirm the existence of
genes, (2) identify the transcription start site and termi-
nation site, and (3) determine if the gene annotation is
correct regarding possible splice variants.
We are also studying the gene expression of the can-
didates since if a gene is involved in cancer, whether it
is a tumor suppressor or oncogene, it is likely that the
expression of that gene is altered in a tumor. We have
compiled a large set of tumors that we have analyzed
and are aware of the copy number in each tumor. We
then test this set of tumors to identify by quantitative
reverse transcriptase (RT)-PCR to determine the
expression level of the gene candidate. We are collabo-
rating with Scott Powers' and his group at Tularik
Genomics Division, to determine the expression level
of several candidates. The first, EED, is amplified
genomically in approximately 20% ovarian cancer
cases. It has a polycomb domain, and a close family
member (EZH2) is amplified in breast cancer and has
been shown to have oncogenic potential. In addition,
overexpression of EED in fibroblasts increases prolifer-
ation, suggesting it may also have oncogenic potential.
A second gene is PAK4, which is amplified in pancreat-
ic cancer in approximately 25% of cases. This gene is in
the P21-activated kinase family. PAK1, a family mem-
ber, has oncogenic potential. We will be collaborating
with Dr. Linda Van Aelst on the characterization of this
gene. Finally, the gene DKK3 is deleted in pancreatic
cancer, and we have also shown that its expression is
decreased in pancreatic-tumor-derived samples. DKK3
is a family member of DKK1 and DKK2, all of which
are antagonists of the WNT signaling pathway, mem-
bers of which have been shown to have oncogenic
potential and are amplified and/or overexpressed in sev-
eral cancers. We intend to perform assays to determine
the oncogenic potential of these candidates.
Methylation-specific Oligonucleotide
Microarray Analysis
0. Dovirak, A. Brady
In addition to genetic mutation such as amplification
and deletion, there are epigenetic mechanisms within
the cell that are used to influence the transcriptional
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activity of a gene. One such way is methylation of the
cytosines present in the DNA of the transcriptional con-
trol region, which often suppresses the expression of the
gene. It has been known that methylation of DNA has
been involved in the silencing of gene expression in
imprinting and in cancer. Recent advances including
technical and the sequencing of the genome have made
detection of methylation at loci more reliable and accu-
rate. However, few methods can identify methylation
changes over the entire genome. We have adapted
ROMA to methylation detection oligonucleotide
microarray analysis (MOMA). Currently, we are utiliz-
ing this to survey the changes that occur in cancer, but
in principle, this method would have applications for
identifying methylation differences involved in imprint-
ing or other syndromes which do not involve genetic
mutation.
We have taken advantage of an enzyme McrBC
that cleaves at methylated cytosines, more specifical-
ly, (G/A) "C (N40_3000) (G/A)mC. Representations from
tumor and normal are prepared as standard for
ROMA, but the representations are treated with
McrBC to remove fragments that are methylated. The
samples that have are treated with McrBC are then
compared to identify the fragments or regions of the
genome that are differentially methylated. These
regions are then searched for candidate genes.
We have tested this method on several samples and
are verifying the regions identified as being differential-
ly methylated. We are continuing to develop this method.
Presently, we are redesigning the array to represent
known CpG islands, as well as CG-rich regions of the
genome, to make an array that is more specific for
methylation detection. It is becoming clear that methyla-
tion silencing has an important role in cancer, and we
intend to many both ROMA and MOMA techniques.
Both mutation and methylation have an effect on the level
of gene transcription, and by analyzing those regions of
the genome that have been physically mutated whether
amplified or deleted and those regions of the genome that
are differentially methylated, we will get a more complete
picture of the cancer cell. Ultimately, all of these data will
be incorporated together and analyzed alongside the clin-
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ical information to determine if any genetic or epigenet-
ic factors correlate to clinical outcome.
Maize Mutagenesis Library Screening
R. Lucito [in collaboration with R. Martienssen and
P. Rabinowicz, Cold Spring Harbor Laboratory]
The development of a high-throughput microarray
screen of a maize insertion mutagenesis library is the
focus of this work. The probes on the array are picked
from a gene-enriched methyl-filtering library. The
basis of this library relies on the fact that gene-rich
regions of the maize genome are not methylated, but
repetitive regions are methylated. The methyl-filtered
clone library was further screened to remove clones
with remaining repetitive content and redundant
clones, and approximately 20,000 clones have been
amplified and are being arrayed. A mutant plant
library was produced by random insertion of a trans-
posable element. DNA from these plants was isolated,
and pooling was performed. Representations are pre-
pared from these samples by PCR amplification using
the sequence of the transposable element. The repre-
sentations are then used for hybridization to the arrays
which individual plants have a gene inser-
tion. This information will be cross-referenced to phe-
notypic data to identify the gene regions with transpo-
son insertions. We are optimizing the representational
procedure and labeling procedures to improve the
accuracy of the technique to identify pools with
mutants.
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MAMMALIAN FUNCTIONAL GENOMICS
A. Mills A. Bagchi M. Golub
S. Cheloufi W. Keyes
E. Garcia Y. Wu
Our laboratory is focused on investigating the genetic
basis of human disease. We study both normal devel-
opment and the tumorigenic process. By gaining
insight into how specific genes normally function dur-
ing embryogenesis, we are able to better understand
how alterations in these genes affect pathways that
cause human disease. The link between mammalian
development and cancer is key in being able to design
better anti-cancer therapies in the future.
We use the mouse as a model system to probe the
function of human genes. The mouse provides an
excellent opportunity for exploring gene function
because its reproductive system, its anatomy and phys-
iology, and even its genome are very similar to that of
humans. In addition, we are able to tailor-make mouse
strains in an effort to model specific human diseases.
For example, we can add or remove genes, we can
"cut, copy, and paste" specific regions of a chromo-
some, and we can even make subtle changes within a
chosen gene. This ability to manipulate the mouse
genome makes it possible to address a diverse array of
biological questions to investigate gene function. In
addition, these mouse models are invaluable for
understanding pathogenesis and for designing novel
treatments for human disease.
In our laboratory, we use gene targeting in embry-
onic stem cells to generate mouse strains that have pre-
cise modifications of the genome. We are using two dif-
ferent approaches to achieve this goal: (1) analyzing the
role of groups of genes within specific regions of the
genome, and (2) analyzing the role of individual genes
known to be associated with human disease. The first
approach uses chromosome engineering to generate
mouse strains that have precise chromosome rearrange-
ments that correlate with those found in human dis-
eases. These mouse strains are useful for providing dis-
ease models and for determining the function of genes
within specific regions of the genome. The second
research emphasis in the laboratory is to perform an in-
depth exploration of a single gene known to be causal
in several human disease syndromes. This gene, p63, is
related to the p53 tumor suppressor gene-a gene that
is mutated in approximately one half of all human can-
cers. Understanding the molecular and genetic mecha-
nisms ofp63 action will allow us to gain insight into the
processes of development, differentiation, stem cell
maintenance, and cancer.
Generation of Megabase
Chromosome Rearrangements:
Human Chromosome 1p
A. Bagchi, M. Golub, Y. Wu
How do large-scale chromosome abnormalities lead
to disease? What are the roles of genes mapping to the
short arm of human chromosome 1?
Chromosome rearrangements such as deletions, dupli-
cations, and inversions are associated with a multitude
of human diseases. These chromosome abnormalities
are complex because they affect large numbers of
genes within specific chromosomal regions. To under-
stand how these rearrangements cause disease, we are
generating mouse strains that have the same
rearrangement as those found in human patients.
Defined chromosome rearrangements are made using
chromosome engineering-an approach that com-
bines the power of gene targeting with Crel loxP tech-
nology. The similarities between the human and mouse
genomes make it possible to generate mouse models
of hereditary and spontaneous diseases. We are cur-
rently using this approach to generate models of
hereditary cancer syndromes. We are focusing our
efforts on human chromosome 1p-a region contain-
ing several as yet unidentified tumor suppressor
genes. A diverse array of human tumors have deletions
at 1p, suggesting that genes underlying the tumori-
genic process are located in this region of the genome.
We are creating models of hereditary cancer by creat-
ing mouse strains that have the same deletions as those
found in human tumors. We first make specific dele-
tions in embryonic stem cells, and then use these cells
to generate mouse models that transmit the modified
allele to their progeny. To make this approach feasible
on a genome-wide scale, we have created a system that
greatly reduces the effort required for generating
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gene-targeting constructs. This system is composed of
two genomic libraries of essentially pre-made gene-
targeting vectors that contain all of the features
required for generating Cre-induced chromosome
rearrangements. In addition, constructs isolated from
these libraries contain genes that alter the coat color of
mice that harbor them; this feature has the advantage
that mice containing a specific rearrangement in their
genomes are visibly distinguishable from normal
mice. This greatly reduces the cost and labor required
for maintaining these mouse colonies, and also allows
these models to be implemented in genetic screens.
In addition to generating mouse strains with dele-
tions, we have also generated several large inversions
that span the portion of the mouse genome that corre-
lates to human 1p. This work is a collaborative effort
with Allan Bradley's lab at the Sanger Center. These
inversion strains are currently being used in a large-
scale ENU mutagenesis screen in collaboration with
Monica Justice at Baylor College of Medicine. This
region-specific screen will be extremely valuable for
generating mouse models that will elucidate the func-
tion of disease genes mapping to human 1p.
Analyzing the Role of Specific
Disease Genes: The p63 Gene
S. Cheloufi, E. Garcia, W. Keyes
What is the consequence of p63 loss in vivo? How do
specific p63 mutations cause human disease?
The p53 tumor suppressor gene plays an important
role in human cancer. Indeed, approximately one half
of all human cancers either have lostp53 altogether or
have inactivated it by mutation. Mice designed to lack
p.53 are viable and develop tumors at a very early age.
Thus, p53-deficient models are extremely valuable for
investigating the molecular and genetic events associ-
ated with tumor formation.
We discovered p63-a gene that has striking sim-
ilarity to the p53 tumor suppressor gene. We used
gene targeting to create mice that lack p63; these mice
have severe developmental defects that affect cranio-
facial, limb, and skin development. Mice that inherit a
nonfunctional p63 gene are lacking all structures that
are normally derived from the ectodermal cell lineage,
such as hair, teeth, mammary and sebaceous glands
and nails. These observations provided an important
clue that led to the discovery that mutations in p63
cause five different human developmental disease
96
syndromes that are characterized clinically by a spec-
trum of malformations affecting development of the
limbs, skin, and craniofacial region. How mutations in
p63 bring about the striking abnormalities in these
patients is currently unknown.
We are investigating the role ofp63 in morphogen-
esis of the ectoderm and its related structures. Mice
lacking p63 altogether have been useful for determin-
ing that p63 is essential for embryogenesis, but these
mice have such profound developmental abnormalities
that they die shortly after birth. To be able to determine
how p63 functions in the adult, specifically with regard
to aging and cancer, we have generated a conditional
p63 model that allows us to first generate viable mice,
and then to ablate p63 within specific tissues at partic-
ular stages of development. Using this approach, we
are able to inactivate p63 within specific tissues. This
is the first system that provides a tool for directly ana-
lyzing the role ofp63 in the adult.
We have also generated mouse models that mimic
the human developmental disease syndrome
Ectrodactyly, Ectodermal dysplasia, Clefting (EEC)
syndrome. EEC is caused by specific mutations in the
DNA-binding domain ofp63; interestingly, these muta-
tions correlate precisely with cancer-causing mutations
in the p53 gene. To model EEC, we used gene targeting
to replace the normal copy ofp63 with a version ofp63
that has an EEC mutation. Mice carrying the EEC
mutation have a phenotype that correlates with the clin-
ical features found in EEC patients (Fig. 1). Further
FIGURE 1 EEC mice display severe tooth defects. EEC
patients with p63 mutations often have an abnormal number of
teeth. Similarly, mice engineered to have the same mutation in
p63 that causes human EEC have hyperdontia (extra teeth).
characterization of this model will allow us to more
thoroughly understand the underlying cause of the
pathogenesis of EEC, and will form a basis for better
treatment of patients afflicted with this disease.
Within the last year, we have also collaborated
with Dennis Roop's lab at Baylor College of Medicine
in generating mouse models that overexpress specific
isoforms ofp63. By creating "gene switch" transgenic
mice that use the keratin 14 promoter to overexpress
p63 specifically within proliferating keratinocytes of
stratified epithelia of the skin, we found that p63 has a
dual role in vivo: It initiates epithelial stratification
during embryogenesis and maintains the proliferative
potential of basal keratinocytes in the mature epider-
mis.
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A brief break from the bench. The Mills lab attends the
Inaugural Symposium for the Developmental Biology Program
at the Sloan-Kettering Institute at Memorial Sloan-Kettering
Cancer Center in New York. Elvin Garcia (second from left), a
graduate student in the lab, presented his unpublished work to
colleagues. Other members of the lab that attended this meet-
ing include Bill Keyes (left), Alea Mills (middle), Anindya Bagchi
(second from right), and Ying Wu (right).
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TUMOR NEOVASCULARIZATION
V. Mittal J. Egan
S. Gupta
R. Kumar
The growth and metastasis of a majority of tumors
depends on the formation of new blood vessels by a
process called angiogenesis. The process by which
endothelial cells (ECs) neovascularize a tumor to support
its continuous growth and metastasis is an area of intense
investigation. Identification of the molecular pathways
that direct EC proliferation, migration, and functional
vessel formation in tumors is of fundamental importance
for developing rational antiangiogenic therapies.
Genetic approaches have established an absolute
requirement for helix-loop-helix (HLH) Idl and Id3
transcription factors in the formation of functional
tumor neovascularization. Given this critical function,
it is surprising that to date no systematic search for Id-
regulated genes has been performed. Our research is
geared toward identifying downstream components of
the Id gene network, analyzing the mechanism of
action of these components, and determining their rel-
ative impact on EC proliferation, migration, and func-
tional neovascularization in both xenografts and spon-
taneously arising tumors in vitro and ultimately in vivo.
We apply functional genomic approaches, such as
genome-wide transcription profiling and RNA interfer-
ence (RNAi)-mediated gene silencing, to mouse genet-
ic models to dissect Id- mediated cellular pathways.
Our major focus is to determine at the molecular and
genetic levels the mechanism by which ECs neovascu-
larize a tumor, to support its continuous growth and
metastasis. The identification and functional analysis
of Id transcriptional targets will not only provide fun-
damental insights into the role of Id as a transcription
modulator, but also impact development of rational
antiangiogenic therapeutic interventions that disrupt
Id-mediated tumor growth in humans.
Role of Id in Tumor-mediated
Angiogenesis
S. Gupta [in collaboration with M. Ruzinova, Memorial
Sloan-Kettering Cancer Center]
Angiogenesis results from the outgrowth of neighbor-
ing preexisting vessels and the recruitment of bone-
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marrow-derived endothelial precursor cells (EPCs). To
understand these processes, we use a mouse model
that lacks transcription factors Idl and Id3 and
exhibits defective tumor vasculature leading to
impaired growth and metastasis.
The HLH Id proteins are key players in regulating
angiogenesis in a majority of tumors. In adult mice,
Idl and Id3 are overexpressed in the endothelium of
the tumor vasculature but not in the surrounding tumor
cells or in preexisting vessels. Idl and Id3 are also
essential for the expansion and mobilization of bone-
marrow-derived vascular endothelial growth factor
receptor 2 (VEGFR2) and VEGFR1-positive cells
from the bone marrow to the sites of tumor neovascu-
larization. Loss of Idl and Id3 causes severe defects in
tumor-induced neovascularization and impairs growth
and metastasis of both xenografts and spontaneous
tumors. What are the downstream consequences of Id
loss that lead to the observed defects in postnatal
angiogenesis? Since Id itself controls the transcription
of other genes, it will be important to determine both
the immediate-early transcriptional effect of Id loss
and secondary transcriptional effects to fully under-
stand the phenotype. Additionally, Ids and their target
genes would be ideal candidates for antiangiogenic
therapy. Our broad specific aims are to identify Id -reg-
ulated genes in the ECs of tumors, analyze their mech-
anism of action, and determine their relative impact on
tumor progression.
In last year's Annual Report, we mentioned the
identification of the components of an integrin path-
way that is up-regulated in the endothelium, infiltrat-
ing the Id wild-type spontaneously growing tumors.
Candidate genes, including integrin ot6, integrin pa,
fibroblast growth factor receptor-1 (FGFRI), metallo-
protease-2 (MMP2), and laminin 5, are all up-regulat-
ed in the presence of Id. Interestingly, it is known that
FGFR2 engagement of FGFR1 leads to an up-regula-
tion of a6134, and MMP2 cleaves laminin 5 to produce
a ligand for a6134. Although x6[34 integrin expression
in ECs has been documented, not much is known
about their function in vivo. However, a6134 integrin
promotes stable adhesion of epithelial cells to the
extracellular matrix (ECM) during proliferation and
migration of invasive epidermal carcinoma, suggest-
ing that it may also facilitate EC invasion and migra-
tion across the ECM during tumor vascularization
(note that MMP2, another key player for ECM degra-
dation is also up-regulated in Id wild-type endothelia).
Identification of integrins as Id targets is not unex-
pected, given the central role of integrins aVI33,
aV135, and a501 in supporting pathological angio-
genesis. Blocking the activity of these integrins results
in a dramatic inhibition of angiogenesis. In our
screens, only a6 and P4 integrins were differentially
regulated, increasing the probability that they may be
regulated by Id. We hypothesize that loss of Id affects
several players in this pathway and thus prevents func-
tional vessel formation by the EC. This hypothesis is
currently being experimentally tested both in in vitro
and in vivo.
We performed transcription-profiling analysis
directly on intact tumors extracted from Id wild-type
and Id mutant animals. It is possible that the nonen-
dothelial components of tumors decrease signal/noise
ratios for endothelium-specific genes, and therefore,
subtle changes in gene expression can be missed. We
thus purified ECs from lymphoid lesions of Id wild-
type and Id mutant animals and analyzed Id gene
expression profiles from a relatively pure population
of cells (the purity of isolated ECs was 90-95% as
assessed by immunofluorescence with CD31 and von
Willebrand factor). A number of other angiogenesis-
related genes were down-regulated twofold to sixfold
in the Id1-7- ECs such as members of ephrin, the
insulin-like growth factor (IGF), and transforming
growth factor p (TGF-(3) families, as well as genes
encoding ECM proteins and cell adhesion factors. In
addition, sixfold up-regulation of Hifla was detected
in Id1-1-- ECs. Ephrin Al and its receptor EphA2,
which are both expressed in xenograft and sponta-
neous tumor vasculature, have been shown to induce
EC migration and in vitro capillary assembly, as well
as corneal and tumor neovascularization. IGF2 and its
receptor, down-regulated in Id14- ECs, also possess
angiogenic properties. IGF2 induces EC migration
and tube formation as well as up-regulates expression
of MMP2. Thus, down-regulation of these factors in
the Id14- ECs may be contributing to the observed
phenotype. Up-regulation of Hifl a mRNA in the Id
mutant endothelium suggests a possible direct tran-
scriptional effect since the Hifl a promoter has four
conserved E-box consensus sequences, which are rec-
ognized by basic HLH transcription factors.
Current experimental work is geared toward estab-
lishing connections between different angiogenic
pathways disregulated in an Id mutant background in
order to gain a more thorough understanding of their
contribution to the final phenotype. Inhibitory short
hairpin RNAs (shRNAs) to Id target genes will be
introduced into ECs, and the impact of loss of gene
function on blood vessel formation will be monitored
in rapid in vitro matrigel assays and in more physio-
logically relevant in vivo model systems. We are con-
fident that this strategy will work because combined
suppression of Idl and Id3 results in a dramatic phe-
notypic change, associated with defects in EC migra-
tion and tube formation (see below). Alternatively, we
will attempt rescue of the Id loss-of-function pheno-
type by introducing and activating potential Id down-
stream targets in Idl, Id3 null ECs. Together, these
approaches will determine the role of Id downstream
components in neovascularization.
We are also examining the role of Idl and Id3 in
the mobilization and recruitment of the bone marrow
precursor to the sites of the tumor and subsequent for-
mation of the neovasculature. Delivery of shRNAs to
the bone marrow using lentiviruses will be employed
to inhibit the activity of genes, which may contribute
to the Id phenotype. Our approach provides a flexible
platform where effective shRNA probes can be rapid-
ly generated against any gene (see below) and deliv-
ered in vivo directly to the site of the tumor vascula-
ture. Site-specific expression of shRNA will be
achieved by employing an innovative design where an
EC-specific gene regulatory element drives expres-
sion of shRNA which mediates suppression of genes
that are deregulated specifically in the tumor endothe-
lium. This strategy ensures minimal affects of gene
suppression on normal vasculature or surrounding
tumor cells. Overall, our approach has unlimited
potential in inactivating any proangiogenic gene in
vivo.
Identification of Effective siRNAs for
Gene Silencing and Their Inducible
Delivery in Mammalian Cells
R. Kumar, S. Gupta
Although improved rational designs have enhanced
the ability to generate effective small interfering
RNAs (siRNAs), they do not still ensure that a single
predicted siRNA will silence the target gene with
utmost accuracy. To utilize RNAi for systematically
suppressing expression of any Id target gene, we have
developed a screening method for the identification of
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the most potent siRNA. The efficacy of siRNA
sequences is monitored by their ability to reduce the
expression of cognate sequences in an ectopically
expressed target mRNA that is fused to a reporter gene
in conventional transfection experiments. The
approach allowed not only the identification of the
most effective siRNAs, but also those that display par-
tial suppression of target gene expression. Such
siRNAs would be useful where varying degrees of
gene silencing might result in unique phenotypes. To
automate this screening process so that effective
siRNA probes can be identified in large-scale screens,
a microarray-based cell transfection ("RNAi microar-
rays") method was developed. Using RNAi microar-
rrays, we demonstrated an unlimited potential of this
approach in high-throughput screens for identifying
effective siRNA probes for silencing genes in mam-
malian systems. The screening method was used to
identify effective shRNA probes for murine Id] and
Id3, and sRNA-mediated loss of Id gene function in
adult ECs phenocopied the angiogenic defect
observed in Id knockout mice in matrigel assays. ECs
stably expressing Idl, Id3, and combined Idl and Id3
shRNAs marked with a green fluorescent protein
(GFP) reporter appeared to lose their flat endotheli-
um-like morphology and ability to form endothelial
tubes in the VEGF impregnated three-dimensional
matrigel. Thus, shRNA-mediated loss of Id gene func-
tion in adult EC phenocopies the angiogenic defect
observed in the Id knockout mice.
The existing methods of gene suppression by the
constitutive expression of shRNAs allow analysis of
the consequences of stably silencing genes, but signif-
icantly limits the analysis of genes essential for cell
survival, cell cycle regulation, and development.
Besides, gross suppression of a gene over longer peri-
ods can result in compensatory or even nonphysiolog-
ical responses that mask the true biological conse-
quence of a functional knockdown. Generating
inducible regulation of RNAi should be able to cir-
cumvent this problem. Several groups have developed
inducible siRNAs whose expression is controlled by
the tetracycline- or doxycycline-regulated form of
RNA polymerase III (pol III) U6 or fl I promoter. A
limitation of the tetracycline-inducible system is a rel-
atively high background of expression in the unin-
duced state in certain cell lines, and toxicity problems
in some cases limit studies involving both cultured
cells and animals. Considering these limitations, we
have recently developed ecdysone-inducible synthesis
of shRNAs under the control of a modified pol III-spe-
cific U6 promoter in both human and murine cells.
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FIGURE 1 Response of ecdysone-inducible RNAi. (A) Stable
cell lines carrying p53-specific shRNA (p53-SP) and nonspecif-
ic shRNA (NON-Sp) were induced with 0.0 (lane 1), 0.5 (lane 2),
2.0 (lane 3), 3.0 (lane 4), and 5.0 (lane 5) gm murA. Whole-cell
extracts were prepared after 72 hr and analyzed by western
blotting for p53, p21, and D-tubulin (control). Fold-reduction in
p53 protein level is 30% (lane 2), 64% (lane 3), 90% (lane 4),
and >95% (lane 5) relative to uninduced sample (lane 1). (B)
Time course of ecdysone-inducible RNAi. Stable cells carrying
shRNA for p53 were induced with 5 gm murA and analyzed for
p53 levels at indicated time points, and fold-reduction of p53
protein level is 60% (+murA at 48 hr), whereas (+murA at 96 hr)
is >95%. Fold-reduction of protein level was based on densito-
metric measurement.
Cells containing stably integrated shRNA expression
constructs demonstrate stringent dosage- and time-
dependent kinetics of induction with undetectable
background expression in the absence of the inducer
ecdysone (Fig. 1). Inducible suppression of human
p53 in glioblastoma cells shows striking morphologi-
cal changes and defects in cell cycle arrest caused by
DNA damage, as expected. A major limitation of con-
stitutive shRNA expression systems is the irreversible
suppression of gene expression that could result in
nonphysiological responses. Remarkably, the
inducibility is reversible following withdrawal of the
inducer as observed by reappearance of the protein
and a restoration of the original cell phenotype (Fig.
2). The generation of an inducible pol III promoter
opens up the possibility of tissue- or cell-specific reg-
ulation of shRNAs by virtue of expressing the GAL4
trans-activator under the control of defined tissue-spe-
cific promoters. This is likely to have widespread
applications in both cultured cells and living animals.
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FIGURE 2 RNAi-mediated inducible gene suppression is reversible. (Left) Western blot analysis
shows 93% fold-reduction in p53 protein levels in cells induced with 5µM murA (+murA) relative
to uninduced (-murA) at 72 hr. Following murA removal, the fold-recovery in p54 levels is 20% (48
hr) and >90% (96 hr). (Right) Phase contrast microscopy shows morphology of U87MG cells either
uninduced (-murA) or induced with 5 p.m murA (+murA) for 72 hr and at 48 and 96 hr following
murA removal.
Role of an Immunomodulatory Drug in
Maturing Human Dendritic Cells
J. Egan [in collaboration with Immuno-Rx, Farmngdale,
New York]
Dendritic cells (DCs) are antigen-presenting cells that
have vital dual roles in initiating primary (innate)
immune responses as well as being critical mediators
and directors of subsequent adaptive immune respons-
es. Following exposure to a pathogen, DCs rapidly
ingest and display antigens from the foreign organism
and undergo maturation into potent antigen-presenting
cells, capable of efficiently stimulating T cells.
Maturation is coupled to their migration to lymphoid
organs where they encounter naive T cells and initiate
an immune response, including cytokine and
chemokine production. Their phenotypic and function-
al characteristics are intimately linked to their stage of
maturation. We are currently investigating the
immunomodulatory compound inosine-5 "-methyl
phosphate (MIMP) and its role in dendritic cell matu-
ration. We are using a DC system derived from human
peripheral blood monocytes that are induced to differ-
entiate into immature DCs following incubation with
interleukin-4 and granulocyte-macrophage colony-
stimulating factor. Flow cytometry analysis of surface
antigen markers of those cells treated with MIMP typ-
ically revealed an increase in the kinetics of the transi-
tion from monocytes to immature dendritic cells, as
well as an increase in the maturation-specific marker
CD86. MIMP also induced morphological changes in
those cells that correlate with a mature phenotype.
Additionally, functional studies revealed that MIMP-
treated DCs more effectively activate lymphocytes than
untreated cells. DNA microarray analysis is being per-
formed to attempt to elucidate the global gene expres-
sion profile changes induced by MIME. A further
understanding of the molecular pathways involved in
DC maturation as well as compounds that regulate this
process will allow for the design of more powerful vac-
cines to combat infectious diseases and cancer.
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MAMMALIAN CELL GENETICS
M. Wig ler J. Alexander
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I. Hall
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J. Healy
L. Muthuswamy
U. Nath
N. Navin
A. Reiner
M. Riggs
I liked the start of my section of last year's annual
report so much, that I have decided to use the first two
paragraphs again. I apply the adage I first heard from
Sol Spiegelman, "any thing worth saying, is worth say-
ing twice." Here it is.
It is a poor and unnecessary gamble to act as
though either our theory or our knowledge of cancer is
complete. Future progress in detection, prognosis, and
treatment of cancer will depend on the accuracy and
completeness of our understanding of its specific mol-
ecular causes. This knowledge is likely to become
increasingly important as cancers, or suspected can-
cers, are detected at earlier and earlier stages.
There are simple tests for the completeness of our
understanding of how cancers survive in and kill their
hosts. If our knowledge were complete, we would see
a plateau in the number of genes commonly found
mutated in cancers. If the principles were few, even
advanced cancers with a large number of accumulated
genetic lesions would show only a small number of
commonly affected pathways. It follows from this that
if mutation in a single gene were sufficient to affect a
given pathway, then even advanced cancers would
show only a small number of commonly affected
genes, the remainder of lesions being more-or-less
random.
To approach the question of a "complete" under-
standing of cancer, we have developed a microarray-
based method, called ROMA (representational
oligonucleotide analysis). ROMA is based on part on
our previous technique called RDA (representational
difference analysis). Unlike cDNA microarrays, which
can describe the "transcriptional" state of the cell,
ROMA measures changes in "gene copy number" at
loci that undergo amplifications and deletions, hall-
marks of oncogenes and tumor suppressor genes,
respectively. Although there are many other possible
mechanisms that alter critical genes, such as point
mutations, many if not most oncogenes and tumor
suppressor genes will eventually be found in the types
of lesions that we can readily detect. In principle, our
method can also detect changes in the methylation of
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DNA, imbalanced translocations, origins of replica-
tion, and long-range features of chromatin structure.
Our basic assumption is that if a locus is recur-
rently found altered in cancers, that region harbors a
candidate cancer gene. Therefore, the application of
our method to a large series of cancers, and the com-
prehensive comparative analysis of such data, should
reveal the position and number of candidate cancer
genes in cancers. We have progressed reasonably on
the task of collecting the data from cancer cells that
will lead to the definition of these recurrently abnor-
mal regions.
Using our methodology, we have also determined
that there are many copy-number differences in the
human gene pool, i.e., large regions of the human
genome that are present in individuals in unequal
amounts. These variations are germ-line, Mendelian in
inheritance, distributed throughout the genome, and
rich in genes. Many are common polymorphisms,
found in almost equal numbers throughout the human
gene pool. It seems likely to us that many of these
regions are under selective pressure and will be shown
to be associated with disease resistance and sensitivi-
ty. In any event, it is necessary to make a database of
these variations, so as not to mistake them for cancer
lesions, and we are well under way to accomplish this.
THE TECHNOLOGY
The basis of our ROMA technology has been
explained over the past years. It involves making com-
plexity-reducing representations of genomic DNA and
hybridizing these representations to microarrays of
oligonucleotide probes designed informatically, from
the published human genome assembly, to be comple-
mentary to the representations (Lucito et al. 2003).
The probes are chosen from the genome so that they
have a minimal overlap with unrelated regions of the
genomes. The method for making this computation
was published this year (Healy et al. 2003) and has
been a tool in the discovery of a new feature of mam-
malian genomes by a graduate student, Elizabeth
Thomas (see below). The algorithms allow counts of
exact matches of sequences of any length throughout
a sequenced genome and are based on a Burrows-
Wheeler transform of the genome sequence.
We use two forms of oligonucleotide microarrays:
the printed form that we make ourselves, and a form
in which oligonucleotides are synthesized in situ on
the array surface using laser-directed photochemistry.
A company called NimbleGen Systems makes the lat-
ter, and their technology has given us substantially
greater flexibility in the design of arrays and the selec-
tion of representations. Pictures of these microarrays
are shown in Figure 1, with the printed array on the
left and the Nimblegen array on the right. We have
shown that each format yields very similar measures,
probe for probe. This work was conducted in collabo-
ration with Robert Lucito here at CSHL, and a report
of our findings was published this year (Lucito et al.
2003). With NimbleGen, we typically array 85,000
probes (85K format), averaging one probe per 30kb,
but even greater densities can now be achieved, near-
ly 200,000 probes per chip. To facilitate our close rela-
tionship with NimbleGen, which fabricate their chips
in Reykjavik, CSHL has set up an Icelandic subsidiary
with personnel trained by our laboratory.
CANCER LESIONS
We have applied our method to both tumor biopsies
and cancer cell lines and have observed gross chro-
mosomal copy-number alterations, and highly local-
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ized amplification, imbalanced chromosome breaks,
and deletions. In the latter case, we expect that we
have observed both hemizygous and homozygous
deletions. In our data analysis, we have used algo-
rithms for statistical segmentation. The first version of
this was designed by Adam B. Olshen and E.S.
Venkatraman of the Memorial Sloan-Kettering Cancer
Center (Olshen et al. 2003). Subsequent versions were
designed in collaboration with Kenny Ye of the
Department of Applied Mathematics and Statistics at
Stony Brook University, and are based on minimiza-
tion of variance and an assumption of log normal dis-
tribution of ratio data.
We observe a large number of lesions, of varying
sizes, per cancer. Breast cancers appear to divide into
two types: those with large numbers of genomic
changes and those with very few. The former also fur-
ther divide into two types: those that appear to be
evolving lesions slowly and those that appear to be
evolving rapidly. Virtually all of the known lesions
have been seen, as well as many new ones. We are now
in the stage of accumulating data and performing com-
parative analysis. We expect this study to give us a
good estimate of the number of pathways involved in
the development of breast cancer, while identifying
those major pathways.
NORMAL VARIATION
We have applied our method to the comparison of nor-
mal genomes and discovered that there are a large
number of extensive regions of copy-number variation
FIGURE 1 Two forms of oligonucleotide microarrays.
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between any two humans. We have made 24 compar-
isons and have noted on the order of 240 differences at
about 80 specific loci. Of these, nearly half of differ-
ences are recurrent, indicating that they arise from
common polymorphisms in the human gene pool. The
regions showing copy number are rich in genes and are
distributed fairly uniformly across the human genome,
with the exception of the X chromosome. We have
confirmed these variations by polymerase chain reac-
tion (PCR), interphase fluorescence in situ hybridiza-
ton (FISH) (a collaboration with Anders Zetterberg of
the Karolinska Institute, Sweden, and Barbara Trask,
University of Seattle, Washington), and independent
ROMA using Hindlll (as opposed to BglII) represen-
tations. The regions arise by both polymorphic gene
duplications and deletions. These regions must be cat-
egorized, as otherwise they will be mistaken for recur-
ring cancer lesions in our cancer surveys.
Furthermore, these normal variations may be associat-
ed with inherited disease susceptibility or resistance.
In a collaboration with Conrad Gilliam of Columbia
University College of Physicians & Surgeons, we are
conducting a large survey of normal genomes and
genomes from families with children with autism syn-
dromes.
CANCER GENES
In the previous year, we have described the discovery
of new oncogenes (Mu et al. 2003) and tumor sup-
pressors (Hamaguchi et al., Proc. Natl. Acad. Sci. 99:
13467 [2002]) using RDA or array-based methods.
Although this work is continuing by our collaborators,
and we are continuing research on PTEN, we are
focusing presently on the accumulation of massive
amounts of copy-number data from cancer cell lines
and tumors, and we have demonstrated our ability to
obtain this information from clinical material archived
as either frozen or formalin-fixed. We have seen
promising cancer genes in tumor amplifications,
encoding proteins such as kinases, transcription fac-
tors, receptors, and antiapoptotic factors and have
observed interesting candidate tumor suppressor
genes in regions of loss, encoding cellular components
such as checkpoint control proteins and ubiquitin lig-
ase subunits. But our general approach has been to
hold off on the difficult task of functional validation
until we have collected a sufficient amount of copy-
number profiles to winnow the candidates and deter-
mine priorities. In future work, it will also be a priorty
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to correlate patterns of gene loss and gain with clini-
cal outcomes.
GENOMES AND EVOLUTION
In collaboration with Bud Mishra and Will Casey at
the Courant Institute for Applied Mathematics at New
York University, we developed the algorithmic basis
for the use of microarray hybridizations to map
genomes (Casey et al., Lect. Notes Comput. Sci. 2149:
52 [2001]). Joe West and John Healy in my lab col-
lected a full set of data in a model organism,
Schizosaccharomyces pombe, which has a complete
sequence assembly and is putting these ideas to test.
We are finding that the empirical data fit the mathe-
matical model closely, and apart from the difficulty of
assembling centromeric and telomeric regions, and
additional hybridization data needed because of
"noise" in the system, the probes by and large map
into long linear or only slightly branched structures.
We predict from this work that array hybridization is a
feasible way to validate a sequence assembly or to
obtain a rough "local" probe map of a new organism.
Elizabeth Thomas, a Watson school graduate stu-
dent, in collaboration with John Healy here at CSHL,
Nathan Srebro at the Massachusetts Institute of
Technology, and Bud Mishra of the Courant, has used
our exact matching algorithms to discover a new and
fundamental feature of genomes. Mammalian
genomes are densely populated with "doublets," short
duplications between 25 and 100 bp, distinct from pre-
viously described repeats. Each doublet is a pair of
exact matches, separated by some distance. The distri-
bution of these intermatch distances is strikingly non-
random. One interesting characteristic of nearby dou-
blets is that both exact matches tend to occur in the
same orientation. By comparing doublets shared in
human and chimp or mouse and rat, we can see that at
least nearby doublets seem to arise by an insertion
event that does not affect the neighboring sequence.
Most doublets in humans are shared with the chim-
panzee, but many new pairs, especially adjacent ones,
arose after the divergence of the species. New doublets
are most likely to be adjacent, whereas older doublets
are almost equally likely to be nearby or adjacent,
indicating that adjacent doublets may be unstable, dis-
appearing over time. A genomic mechanism that gen-
erates short, local duplications while conserving
polarity could have a profound impact on the evolution
of regulatory and protein-coding sequences.
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CANCER: CELL BIOLOGY
In their efforts to understand and treat cancer, CSHL scientists are exploring how cells become can-
cerous and searching for specific vulnerabilities in cancer cells that might provide targets for effective
therapeutic strategies. To comprehend the complex mechanisms by which cells form tumors,
researchers study the normal properties of healthy cells and determine how these properties are altered
in cancer cells.
To better grasp how genes direct cell function, David Spector's lab has engineered a cell line that
allows them to watch DNA, RNA, and proteins in concerted action. Carefully designed molecules allow
them to see RNA transcribed from DNA and then to visualize proteins translated from the RNA. In this
way, Spector and his colleagues have provided the first glimpses of the entire process of gene expres-
sion in living cells.
Arne Stenlund focuses on the events that trigger DNA replication and is working to unravel the cru-
cial first steps during the replication of papillomavirus DNA. Papillomavirus is associated with virtually
all cases of cervical cancer. By studying the biochemical and structural changes that initiate viral DNA
replication, Stenlund has revealed key details not only about this cancer-causing virus, but also about
the process of DNA replication in general. Moreover, these studies have uncovered specific molecular
targets for the development of drugs to prevent or treat cervical cancer.
Bruce Stillman's lab explores events that initiate cellular rather than viral DNA replication. One focus
of their research is a protein complex called ORC that attaches to DNA and both triggers DNA repli-
cation and silences gene expression. Recently, Stillman's lab has discovered new roles for ORC in chro-
mosome segregation (the sorting of chromosomes during cell division such that each cell receives a
complete set of chromosomes) and in cytokinesis (the process in which cells divide as one cell
becomes two). As the researchers piece together the multiple roles of ORC and its various protein part-
ners, they are uncovering vital clues concerning how the control of DNA replication and cell prolifera-
tion is lost in cancer cells. Stillman's group also studies how the large-scale architecture of chromo-
somes (called chromatin) is duplicated, and how chromatin assembly is coupled to DNA replication.
They have discovered that when a protein required for chromatin assembly is depleted from human
cells, DNA replication ceases, a system that monitors DNA damage is triggered, and the cells die due
to a protective mechanism called programmed cell death. That finding is intriguing because it reveals
a connection between chromatin assembly and the replication of human DNA, and it suggests that the
proper assembly of newly replicated DNA into chromatin is necessary for DNA replication to continue.
If a telephone cord is twisted continuously in either direction, after a few turns, kinks or "supercoils"
will form. Similar kinds of supercoils form in DNA within cells as it participates in many processes, but
the presence of supercoils is strictly regulated by enzymes and other proteins that can add or remove
them. CSHL Fellow Terence Strick uses single-molecule biophysics to directly measure supercoiling
and other structural transitions in DNA and, in turn, to deduce the properties of enzymes and other pro-
teins that alter DNA structure.
Most cancers arise from epithelial cells, which line organs and body cavities. Senthil Muthuswamy's
lab is investigating how cells in healthy breast epithelium form hollow spherical structures, and how
cancer-causing genes, called oncogenes, cause the cells in these structure to proliferate out of control
and metastasize.
David Helfman's lab is working to understand how oncogenes disrupt a cell's cytoskeleton, the inter-
nal framework that gives a cell its shape and strength and controls its interactions with neighboring
cells. Cancer is due in part to the loss of such controlled interactions among neighboring cells, a loss
of control, which enables cells to break free from their biological moorings and become metastatic.
Linda Van Aelst's lab is trying to understand how genetic mutations cause changes in intracellular
signaling molecules which then trigger disease. They have been working with proteins called Ras and
Rap, known to affect cell growth and to play a normal role in wound healing, but also contribute to can-
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cer when mutated. This year, in collaboration with Roberto Malinow's lab, they discovered that the
same proteins also have roles in brain development, learning, and memory. The discovery helps explain
why mutations in another protein that controls Ras function called NF1 can lead both to cancer and to
cognitive defects. Van Aelst has also revealed the involvement of proteins called RhoA GTPase and
oligophrenin-1 (which regulates RhoA GTPase) in X-linked mental retardation.
Tatsuya Hirano's lab studies the function of proteins that act to modulate large-scale chromosome
structure and behavior. One of these proteins, called condensin, is required for the condensation or
compaction of chromosomes that occurs prior to cell division. Hirano's team was working with a type
of condensin that is found in organisms from yeast to humans. But this year they discovered that ver-
tebrate cells have a second type of condensin (condensin II) that helps shape chromosomes. By study-
ing this newly discovered protein, Hirano's group hopes to better understand how the architecture of
chromosomes is established and maintained.
Nicholas Tonks' lab studies how enzymes called protein tyrosine phosphatases (PTPs) function to
counteract the affects of growth factors and hormones, and thereby help control cell growth. Some
PTPs have been linked to diseases including cancer and diabetes. As one of several projects this year,
Tonks' lab continues to study the involvement of "dual specificity" phosphatases, including JSP-1 and
DEP-1, in cancer and other diseases. In addition, they are exploring the importance of a novel form of
protein modification as a general physiological mechanism for regulating PTP function.
Christian Speck, postdoc in the Stillman Lab
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THE CYTOSKELETON AND ONCOGENIC TRANSFORMATION
D.M. Helfman E. Araya S.-W. Lee
L. Connel G. Pawlak
E. Kim
We are interested in understanding the molecular
mechanisms underlying the regulation and function of
the actin cytoskeleton in oncogenesis. Alterations in
the actin-based cytoskeleton are an established part of
the neoplastic phenotype. These alterations result from
activation of specific signaling pathways that are part
of the oncogenic program. Oncogene-mediated
changes in actin filament dynamics and associated
adhesive interactions contribute to enhanced motility
and invasiveness of tumor cells. These changes in the
cytoskeleton are a result of changes in the expression
of both specific cytoskeletal proteins and signaling
proteins, e.g., small GTPases and kinases. The changes
in the expression of cytoskeletal proteins are more than
simply a generic consequence of cell reorganization
characteristic for oncogenic transformation. For exam-
ple, work by our lab and others has shown that ectopic
expression of specific cytoskeletal proteins can sup-
press many features of transformation, including dis-
ruption of microfilament bundles and focal adhesions,
loss of contact-inhibited cell growth, ability to grow in
soft agar, and tumorigenicity in nude mice, indicating
that the loss of specific cytoskeletal proteins has a
direct role in oncogenesis. However, the mechanisms
by which specific components of actin structures are
targeted and deregulated by oncogenes are poorly
understood, and, more importantly, how the accompa-
nying changes in actin filament organization contribute
mechanistically to oncogenesis remains to be estab-
lished. Below is a brief description of our studies dur-
ing the year to better understand the regulation and role
of the actin cytoskeleton in oncogenesis.
Alterations in Tropomyosin Isoform
Expression in Human TCC
of the Urinary Bladder
G. Pawlak [in collaboration with T.W. McGarvey,
T.B. Nguyen, J.E. Tomaszewski, R. Puthiyaveettil,
and S.B. Malkowicz, University of Pennsylvania]
Previous studies of transformed rodent fibroblasts
have suggested that specific isoforms of the actin-
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binding protein tropomyosin (TM) could function as
suppressors of transformation, but analysis of TM
expression in patient tumor tissue is limited. The pur-
pose of this study was to characterize expression of the
different TM isoforms in human transitional cell car-
cinoma (TCC) of the urinary bladder by immunohis-
tochemistry and western blot analysis. We found that
TM1 and TM2 protein levels were dramatically
reduced and showed more than 60% reduction in 61%
and 55% of tumor samples, respectively. On the other
hand, TM5, which was expressed at very low levels in
normal bladder mucosa, exhibited aberrant expression
in 91% of tumor specimens. The western blot findings
were confirmed by immunohistochemical analysis in a
number of tumors. We then investigated the mecha-
nism underlying TM expression deregulation in the
T24 human bladder cancer cell line. We showed that
levels of TM1, TM2, and TM3 are reduced in T24
cells, but significantly up-regulated by inhibition of
the mitogen-activated protein kinase-signaling path-
way. In addition, inhibition of this pathway was
accompanied by restoration of stress fibers. Overall,
changes in TM expression levels appear to be an early
event during bladder carcinogenesis. We conclude that
alterations in TM isoform expression may provide fur-
ther insight into malignant transformation in transi-
tional cell carcinomas of the bladder and may be a use-
ful target for early detection strategies.
The Actin Cytoskeleton and
Apoptosis
L. Connell
Adhesion of cells to the extracellular matrix (ECM)
via integrins generates signals required for cell growth
and survival. When normal epithelial cells are
deprived of these survival signals, i.e., when detached
from the ECM, they undergo a specialized form of
apoptosis, termed anoikis. In contrast, transformed
cells are resistant to anoikis, presumably through con-
stant activation of survival signals.
The cytoskeleton has an important role in the reg-
ulation of cellular functions linked to transformation,
including proliferation, anchorage-independent cell
growth, and apoptosis. Actin filaments have a critical
role in the activation of integrins, and subsequent gen-
eration of survival signals. Myosin light-chain kinase
(MLCK) and Rho-kinase (ROCK) regulate actin fila-
ment assembly and myosin II, and myosin II is known
to have a role in stress fiber formation and integrin
signaling. To determine if myosin and actin contribute
to survival signals, we studied whether inhibition of
myosin or disruption of actin filaments leads to apop-
tosis in normal and transformed epithelial cells
(MDCK, MDCK Ras, MCF-7, MCF10A, MCF10
Ras, and DU145 cells). Using agents that target actin
filaments, we found that both normal and transformed
epithelial cells undergo apoptosis following disrup-
tion of actin filaments. Using agents that inhibit
myosin II, we studied the role of myosin-dependent
pathways on cell survival. Interestingly, treatment of
cells with of myosin II or MLCK inhibitors led to
apoptosis in both normal and transformed cells. In
contrast, treatment of cells with the ROCK inhibitor
did not induce apoptosis. These results suggest that
actin filaments and myosin II have an important role
in the generation of survival signals. Finally, our
results suggest that MLCK has an essential role in the
regulation cell growth of
transformed cells and further highlight the functional
diversity between Rho-kinase and MLCK-dependent
function.
Cytoplasmic p210P1 Is Involved in
Ras-induced Inhibition of the
ROCK/LIMK/Cofilin Pathway
S.W. Lee
p21c'P' is best known for its ability to directly block
the kinase activities of a broad range of cyclin/CDK
complexes in response to antimitogenic signals or
DNA damage. Despite its function as a cell cycle reg-
ulator, elevated levels of p21c'P' in the cytoplasm of
tumor cells have been reported to be critical for pro-
moting cell transformation and survival. Strikingly,
the level of p21c'P' expression is highly increased in
various human cancers such as breast cancer, bladder
cancer, pancreatic cancer, and glioblastoma. It
remains unclear how elevated cytoplasmic p21','
might contribute to tumorigenesis. During the past
year, we have found that expression of cytoplasmic
p21c'P' is an essential factor in the signaling pathways
that mediate Ras-induced alterations of the actin
cytoskeleton. We found that oncogenic Ha-RasV12
contributes to the alterations in actin filament dynam-
ics by inducing cytoplasmic localization of p2
which uncouples Rho-GTP from activating the
ROCK/LIMK/cofilin pathway by inhibiting Rho-
kinase. Our findings define a novel mechanism for
coupling the cytoplasmic p21c'P' to the control of actin
cytoskeleton remodeling by oncogenic Ras.
Furthermore, our studies demonstrate that localization
of p21c'P' to the cytoplasm in transformed cells con-
tributes to pathways that favor not only cell prolifera-
tion, but also cell motility, thereby contributing to
invasion and metastasis.
Characterization of the
Metastasis-associated
Protein, S100A4
E. Kim
Elevated levels of S100A4, also referred to the metas-
tasis-associated protein, is associated with metastatic
tumor progression by enhancing cell motility.
S 100A4 is a calcium-binding protein that is known to
form homodimers and interact with several proteins
in a calcium-dependent manner, including
tropomyosin and myosin IIA. The interaction of
myosin IIA is believed to disrupt myosin self-assem-
bly and inhibit protein kinase C or casein kinase II
phosphorylation of the heavy chain. Because of its
proposed role in the regulation of myosin function, we
carried out an extensive analysis of the myosin-II-
binding functions of S100A4, including an analysis of
its calcium-binding domains, dimerization properties,
and cellular localization. Interestingly, our studies
show that S100A4 localizes to lamellipodia structures
in a migrating breast-cancer-derived cell line and
colocalizes with a known S100A4-interacting protein,
heavy chain IIA (MHC-IIA) at the leading edge. We
also demonstrate that S 100A4 mutants that are either
defective in their ability to dimerize or calcium-bind
are unable to interact with MHC-IIA. An S100A4
mutant that is deficient for calcium binding retains
the ability to form homodimers, suggesting that
S100A4 can exist as calcium-free or calcium-bound
dimers in vivo. However, a calcium-bound S100A4
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monomer only interacts with another calcium-bound
monomer and not with an S100A4 mutant that does
not bind calcium. Interestingly, despite the calcium
dependence for interaction with known protein part-
ners, calcium binding is not necessary for localization
to lamellipodia. Both wild type and a mutant that is
deficient for calcium binding colocalize with known
markers of actively forming leading edges of lamel-
lipodia, Arp3 and N-WASP. These data suggest that
S100A4 localizes to the leading edge in a calcium-
independent manner, and identification of the pro-
teins that are involved in localizing S100A4 to the
lamellipodial structures will provide novel insight
into the mechanism by which S100A4 participates in
metastasis.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano 0. Cuvier A. Losada
P. Gillespie T. Ono
M. Hirano
The long-term goal of our research program is to
understand the molecular mechanisms of chromosome
segregation, an essential process for maintaining
genome stability during mitosis in eukaryotes. Our
current efforts are focused on studying two multipro-
tein complexes, cohesin and condensin, that have cen-
tral roles in sister chromatid cohesion and condensa-
tion, respectively. At the heart of the two complexes lie
members of a large family of chromosomal ATPases,
the structural maintenance of chromosome (SMC)
family. SMC proteins are also conserved in bacterial
and archaeal species, providing us with an excellent
opportunity to address the evolutionarily conserved,
fundamental aspects of chromosome mechanics. We
take multidisciplinary approaches including biochem-
istry, cell biology, genetics, and biophysics.
Distinct Contributions of
Condensins I and II to
Mitotic Chromosome Assembly
and Segregation
T. Ono, A. Losada, M. Hirano, T. Hirano [in collaboration with
M.P. Myers and A.F. Neuwald, Cold Spring Harbor Laboratory]
Accumulating lines of evidence demonstrate that con-
densin is one of the key regulators in mitotic chromo-
some assembly and segregation. The canonical con-
dentin complex (henceforth condensin I) was origi-
nally identified in our laboratory as a major chromo-
somal component required for the establishment and
maintenance of mitotic chromosomes in Xenopus lae-
vis egg extracts. Subsequent studies in a number of
model organisms showed that the structure and func-
tion of this complex are highly conserved from yeast
to humans. During the past year, we have discovered a
second class of condensin (termed condensin II) from
HeLa cells and Xenopus egg extracts. Condensins I
and II share the same pair of SMC core subunits
(SMC2 and SMC4), but they contain different sets of
non-SMC subunits (HEAT and kleisin; Table 1).
Condensin -Il- specific subunits are widespread in ani-
mals and plants but are not found in yeast.
Intriguingly, however, condensin II apparently substi-
tutes for condensin I in the nematode Caenorhabditis
elegans.
To address how the two complexes contribute to
the establishment of mitotic chromosome architec-
ture, we have used a combination of two powerful
functional assays, small interfering RNA (siRNA)-
mediated depletion in HeLa cells, and immunodeple-
tion from Xenopus egg extracts. Depletion of con-
densin I- or II-specific subunits in HeLa cells causes
a distinct, highly characteristic defect in chromosome
morphology, i.e., "swollen" or "curly" chromosomes,
respectively. In the absence of both complexes, mitot-
ic chromosomes display a very fuzzy appearance in
which sister chromatids are no longer discernible.
Not surprisingly, such morphological defects result
in a number of abnormalities in chromosome align-
TABLE 1 Distribution of condensin subunits in model organisms
Subunits Complexes H. sapiens X. laevis A. thaliana D. me/anogaster C. elegans S. pombe S. cerevisiae
SMC2 I, II hCAP-E XCAP-E AtCAP-E1&-E2 DmSMC2 MIX-1 Cut14 Smc2
SMC4 I, II hCAP-C XCAP-C AtCAP-C DmSMC4/gluon SMC-4 Cut3 Smc4
HEAT I hCAP-D2 XCAP-D2 CAB72176 CG1911 - Cnd1 Ycs4
HEAT I hCAP-G XCAP-G BAB08309 CG17054 - Cnd3 Ycs5/Ycg1
Kleisin y I hCAP-H XCAP-H AAC25941 Barren - Cnd2 Brn1
HEAT II hCAP-D3 XCAP-D3 At4g 15890.1 CG31989 HCP-6
HEAT II hCAP-G2 XCAP-G2 At1g64960.1 ? F55C5.4 - -
Kleisin p II hCAP-H2 XCAP-H2 At3g16730.1 CG14685 C29E4.2
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ment and segregation during mitosis. In Xenopus egg
extracts, condensin I has a predominant role (i.e., no
individual chromosomes are assembled in its
absence), whereas condensin II has a minor yet
important role in shaping the chromosomes. In the
absence of condensin II, individual chromosomes are
assembled, but they display an abnormal morpholo-
gy, reminiscent of the curly chromosomes observed
in human cells depleted of condensin II.
Correspondingly, condensin I is more abundant than
condensin II in the egg extracts, whereas the two
complexes are equally abundant in HeLa cells.
Immunofluorescence studies reveal that condensins I
and II show distinct distributions along the axis of
chromosomes assembled both in vivo (in HeLa cells)
and in vitro (in Xenopus egg extracts). We speculate
that the relative abundance of the two complexes
could act as a key determinant of the size, shape, and
physical properties of mitotic chromosomes in dif-
ferent organisms or at different stages of develop-
ment.
Role of BimD Proteins in the
Regulation of Sister
Chromatid Cohesion
A. Losada, T. Hirano
Cohesin is a multisubunit complex that constitutes the
molecular "glue" between the sister chromatids.
Given its fundamental importance, the temporal and
spatial association of cohesin with chromatin during
the cell cycle must be tightly regulated. One candidate
for proteins that regulate cohesin is BimD/PdsS,
which was originally identified by genetic screens in
yeast and other fungi. To study the function of this
class of proteins in Xenopus egg extracts, we screened
a Xenopus cDNA library and found that this organism
possesses two BimD-like proteins (termed XBimD1
and XBimD2) encoded by two different genes.
Preliminary data suggest that XBimD1 and XBimD2
display distinct chromatin-binding properties.
XBimD1 binds to both interphase and mitotic chro-
matin with similar efficiency, in the presence or
absence of cohesin. In contrast, XBimD2 targets inter-
phase chromatin in a cohesin-dependent manner and,
like cohesin, most of it dissociates during mitotic
prophase. Depletion of XBimD1 or XBimD2, or both,
has little effect on the association of cohesin with
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chromatin during interphase, but partially compromis-
es cohesin's dissociation at the onset of mitosis. No
clear defects in cohesion or condensation are observed
in mitotic chromosomes assembled under this condi-
tion. To better understand the function of BimD pro-
teins, we have also prepared antibodies against their
human orthologs. In nuclear extracts prepared from
HeLa cells, most hBimD1 and hBimD2 appear to be
physically associated with cohesin. This robust inter-
action may reflect a more intimate cooperation
between cohesin and BimD proteins in somatic cells
than in embryonic extracts. RNA interference experi-
ments are under way to gain additional insights into
this possibility.
Scc2 is Required for the Establishment
of Sister Chromatid Cohesion
in Xenopus Egg Extracts
P. Gillespie, T. Hirano
The establishment of sister chromatid cohesion
involves at least two separable steps. The first is the
binding of cohesin to chromatin prior to the initiation
of DNA replication, and the second is the construc-
tion of a cohesin-mediated linkage during or immedi-
ately after DNA replication. Previous genetic studies
in yeast suggested that a conserved protein, Scc2, is
required for the loading of cohesin onto chromatin in
vivo. To gain mechanistic insights into the function of
Scc2 by using Xenopus egg cell-free extracts, we first
cloned cDNAs corresponding to the Xenopus
ortholog of Scc2. Our sequence analysis shows that
Xenopus have two distinct Scc2 isotypes, XScc2a
(245 kD) and XScc213 (260 kD). The two isotypes,
which are also present in humans, are distinguished
by their different carboxyl termini that arise by alter-
nate splicing of a single gene. We raised a set of anti-
bodies that specifically recognize XScc2a or XScc2r3
or both, and used them for immunodepletion experi-
ments. We find that simultaneous depletion of
XScc2a and XScc2[3 from an egg extract inhibits the
association of cohesin with chromatin, although indi-
vidual depletion of each isotype has only a limited
effect. Thus, at least one of the XScc2 isotypes is
required for the efficient loading of cohesin onto
chromatin in the extract. Salt extraction experiments
suggest that once cohesin is loaded onto chromatin,
XScc2 proteins are no longer required to maintain the
cohesin-chromatin interaction. Finally, and most
importantly, we find that metaphase chromosomes
assembled in the absence of XScc2 show a gross
defect in chromatid pairing, a phenotype indistin-
guishable from that observed in cohesin-depleted
extracts. These results indicate that Scc2 has a direct
role in the establishment of sister chromatid cohesion
in higher eukaryotes.
Regulation of a Bacterial
SMC Protein Complex
M. Hirano, T. Hirano
The genome of the gram-positive bacterium Bacillus
subtilis encodes a single SMC gene whose disruption
causes multiple phenotypes including decondensation
and missegregation of chromosomes. Its gene prod-
uct, BsSMC, is a homodimer that adopts a V-shaped
structure with an ATP-binding catalytic domain at
each end. Recent studies involving genetics and
bioinformatics suggested that two small proteins,
called ScpA and ScpB, might function together with
BsSMC in vivo. During the past year, we have puri-
fied ScpA and ScpB and have shown that they asso-
ciate with the catalytic domains of BsSMC in an
ordered fashion in vitro. When combined with the
"transition state" mutant of BsSMC, ScpA promotes
stable engagement of two catalytic domains in an
ATP-dependent manner. In solution, this occurs
intramolecularly, thereby closing the DNA-transport-
ing gate of an SMC dimer. ScpB further stabilizes this
conformation and prevents BsSMC from binding to
double-stranded DNA (dsDNA). In contrast, when the
mutant BsSMC is first allowed to interact with
dsDNA, subsequent addition of ATP and ScpA leads
to assembly of large nucleoprotein complexes, possi-
bly by facilitating intermolecular engagement of cat-
alytic domains from different SMC dimers. Our
results show that ATP, ScpA, and ScpB cooperate to
modulate the engagement/disengagement cycle of
BsSMC and have both positive and negative roles in
regulating its interaction with DNA. These findings
have broad implications in our understanding of how
the dynamic behavior of condensin and cohesin might
be regulated in eukaryotic cells.
DNA Nano-manipulation to
Probe the Action of Condensin
T. Hirano hin collaboration with T. Strick, Cold Spring Harbor
Laboratory]
In collaboration with Terence Strick's group here at
CSHL, we have used a DNA nano-manipulation tech-
nique to monitor in real-time the interactions between
a single DNA molecule and the condensin complex
(condensin I). In these experiments, a linear DNA
molecule is tethered at one end to a glass surface and
at the other end to a small magnetic bead. Permanent
magnets are used to pull on and rotate the bead, allow-
ing us to quantitatively control the mechanical con-
straints applied to the DNA. The three-dimensional
position of the magnetic bead is determined using
video-microscopy and real-time particle tracking algo-
rithms, allowing us to determine the end-to-end exten-
sion of the DNA. By monitoring the DNA extension as
a function of time in the presence of condensin I puri-
fied from Xenopus egg mitotic extracts, we are now
starting to catch a glimpse of how condensin utilizes
the energy of ATP hydrolysis to "condense" dsDNA in
a highly dynamic fashion.
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EPITHELIAL CELL BIOLOGY AND CANCER
S. Muthuswamy C.-M. Chen M. Moore
T. Haire A. Rosenberg
A. Lucs B. Xiang
EARLY EVENTS IN BREAST CANCER
Disruption of epithelial architecture and loss of
growth control are thought to be early events in cancer.
Nevertheless, how oncogenes coordinately deregulate
cell architecture and growth control to initiate trans-
formation of epithelial cells in vivo is not known.
In epithelial cells lining glandular structures (e.g.,
breast, prostate, pancreas, thyroid, endometrium, and
cervix), proteins and cell-cell junction complexes are
distributed asymmetrically in the apical-basal axis, a
property referred to as epithelial cell polarity. Various
aspects of epithelial polarity are lost early duing car-
cinogenesis. Moreover, highly metastatic carcinomas
display a complete loss of apical-basal polarity.
Identification of the mechanisms that govern loss of
epithelial architecture will provide us with important
insights into the steps that regulate carcinoma initia-
tion and progression and will lead to identification of
novel targets for diagnosis and treatment of early-stage
carcinomas.
Loss of proliferation control is a critical step in
cancer. Normal breast epithelial cells, present in aci-
nar structures in vivo, have low proliferation rates,
whereas epithelial cells present in hyperplastic lesions
or carcinoma of the breast have higher proliferation
rates, suggesting that proliferation control is lost early
in carcinoma. Normal mammary epithelial cells
(MEC) grown in three-dimensional (3-D) matrices
form acini-like structures with low proliferation rates
as observed in a resting normal breast tissue. In con-
trast, breast-tumor-derived cells neither form acini-
like structures nor undergo proliferation arrest when
placed under 3-D culture conditions, suggesting that
the mechanisms that regulate cell cycle control during
3-D morphogenesis are lost during transformation.
The ErbB family of oncogenic receptor tyrosine
kinases contains four members, namely, ErbB1 (epi-
dermal growth factor receptor/human epidermal
growth factor receptor [HER-1]), ErbB2 (HER-
2/Neu), ErbB3, and ErbB4. ErbB2 overexpression
and/or amplification has been implicated in a number
of epithelial cancers including that of the breast, ovary,
and prostate. Amplification of ErbB2 is observed in
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20-30% of breast cancers and is correlated with poor
clinical prognosis in node-positive patients. Herceptin,
an antibody targeted against ErbB2, is used as a ther-
apeutic agent in adjuvant settings for patients who
have breast cancers that express high levels of ErbB2.
Despite the compelling evidence for the role of ErbB
family in breast cancer, it has been challenging to
decipher the signaling and biological specificities of
ErbB receptor activation because ligand binding
induces both homo- and heterodimerization among the
ErbB receptors, thus resulting in combinatorial inter-
actions and complicating our ability to determine how
different ErbB dimers transform mammary epithelia.
We have developed a method to control dimeriza-
tion and activation of ErbB receptors without contri-
bution from endogenous receptors; we have also mod-
ified a cell culture approach where nontransformed
MECs form 3-D acini-like structures containing a sin-
gle layer of polarized growth-arrested epithelial cells
when grown within a matrix rich in laminin and colla-
gen (Matrigel). By combining the controlled dimer-
ization strategy and the 3-D cell culture system, we
have recently shown that inducible activation of
ErbB2, in growth-arrested 3-D organized mammary
epithelial acini, reinitiates proliferation, disrupts
epithelial cell polarity, and induces formation of non-
invasive multiacinar structures that share several prop-
erties with early-stage lesions in vivo. We plan to iden-
tify the mechanisms by which oncogenes such as
ErbB2 transform polarized, 3-D organized, epithelial
cells.
How Does ErbB2 Reinitiate
Proliferation in Growth-arrested
3-D Acini?
B. Xiang
The mechanism by which ErbB2 promotes G1 pro-
gression has received much attention. Yet, our under-
standing of the molecular mechanism by which ErbB2
promotes cell cycle in epithelial cells is not clear.
Overexpression of ErbB2 in human mammary epithe-
lial cells or tumor-derived epithelial cells lines
induces G, progression by inducing down-regulation
or mislocalization of the Cip/Kip family of cyclin-
dependent kinase inhibitor (CKI) p27 and/or by up-
regulating the levels of the G, cylcin and cyclin Dl
and by activation of cyclin-dependent kinase 2
(CDK2). Studies using mouse models suggest that
cyclin Dl has a critical role in ErbB2-induce mam-
mary tumorgeneisis.
In primary breast tumors, cyclin Dl overexpres-
sion correlates with estrogen-receptor (ER)-positive
status and good clinical prognosis whereas, overex-
pression of cyclin El and cyclin E2 correlates with
ER-negative status and poor clinical prognosis, sug-
gesting that E-type cyclins may have a more critical
role in aggressive breast cancers. Since ErbB2 over-
expression correlates with ER-negative status and
poor clinical prognosis, the conclusions derived from
mouse model studies are confusing.
We are investigating how mammary epithelial
cells undergo proliferation arrest during morphogene-
sis in the 3-D matrix, and how activation of ErbB2
reinitiates proliferation. It is likely that inducible acti-
vation of ErbB2 in 3-D acini will provide novel
insights into the mechanisms by which the cell cycle
is regulated during tumorigenesis.
How Is Epithelial Cell Polarity
Lost during Transformation?
T. Haire, C.-M. Chen
The early stages of epithelial cell-derived cancers
(carcinoma) are characterized by abnormal cellular
proliferation and loss of tissue organization, resulting
in multilayered or filled ductal structures referred to
as hyperplasia or ductal carcinoma in situ. The epithe-
lial cells within the multilayered lesions are surround-
ed by cell-cell interactions and possess no apical sur-
face or apical polarity. Many oncogenes that are impli-
cated in the development of carcinomas induce gross
morphological changes when overexpressed in epithe-
lial cells in vitro. For instance, we and others have
shown that activation of ErbB2, Ki-Ras Raf, Fos, Jun,
Rho and Rac, CDC42, and v-Src disrupts polarity of
epithelial cells in culture. Although loss of epithelial
cell polarity and tissue organization are common
events in carcinoma, very little is known about the
mechanisms that regulate these events.
In normal polarized epithelia, the boundary
between the apical and basolateral membranes is
defined by the presence of at least three classes of
transmembrane proteins, namely, occludins, claudins,
and junctional adhesion molecules (JAMs), collective-
ly referred to as the apical junction complex (AJC).
The mechanism by which AJCs are positioned during
polarization of epithelial cells involves a molecular
complex containing the mammalian homolog of
Caenorhabditis elegans partitioning-defective 3
(mPar3)/mPar6/atypical protein kinase C/CDC42 or
Rac (referred to as the Par complex). Consistent with
this view, formation of AJC is affected by overexpres-
sion of mPar6, expression of inactive forms of aPKC,
or expression of active versions of CDC42 or Rac.
Although the Par protein complex is critical for estab-
lishment of cell polarity, it is not known whether it is
affected by oncogenic changes that disrupt polarity
during cancer progression.
We have previously established that activation of
ErbB2 induces disruption of apical-basal polarity in
epithelial cells, we are now investigating the mecha-
nisms by which oncogenes such as ErbB2 disrupt
epithelial cell polarity.
Role of the Rho Family of GTPases
in ErbB2-induced Transformation
of 3-D Epithelial Acini
M. Moore
The Rho family of GTPases are known to regulate the
cytoarchitecture of epithelial cells in culture by affect-
ing the actin cytoskeleton, cell-cell junction proteins
such as cadherins, and apical-basal polarity. Although
the Rho family of proteins are only weak oncogenes
themselves, they are thought to have an important role
by cooperating with other oncogenes. Overexpression
of Rho family of proteins are thought to regulate each
of the multiple steps during tumorigenesis, such as
proliferation, loss of cell architecture, and cell inva-
sion. In fact, Rho family members are overexpressed
in many epithelial tumors including that of breast,
colon, and pancreas, suggesting that they may have a
role in transformation of epithelial cells.
Since activation of ErbB2 regulates cell prolifera-
tion and apical-basal polarity of epithelial cells, we are
investigating the role of the Rho family of GTPases in
ErbB2-induced transformation of polarized epithelial
cells.
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How Does ErbB2 Induce Disruption
of Epithelial Cell Polarity and
Reinitiation of Proliferation?
A. Lucs
We have previously shown that activation of ErbB2
induces reinitiation of cell cycle progression and loss
of epithelial cell polarity as monitored by expression
of a proliferation-associated antigen ki-67, and local-
ization of the tight junction-associated protein, ZO-1.
To understand how ErbB2 reinitiates proliferation in
polarized epithelial cells, we have mutated the five
autophosphorylation sites present in the cytoplasmic
tail of ErbB2 that are known to have important roles in
receptor function. We have generated ten mutant vari-
ants of ErbB2, five of which have four of five tyrosine
residues mutated, leaving one residue as wild-type,
and five variants that have one of five tyrosine
residues mutated, leaving four tyrosines wild type. We
plan to use these mutants to investigate how ErbB2
regulates reinitiation of proliferation and determine
whether a relationship exists between ErbB2's ability
to affect proliferation and its ability to disrupt epithe-
lial cell polarity.
Do ErbB Homodimers and
Heterodimers Differentially
Regulate Epithelial Cell Polarity?
C.-M. Chen, B. Xiang
Several ErbB ligands such as EGF, TGFa,
Amphiregulin, NRG1, and Cripto and receptors
ErbBl, ErbB2, and ErbB3 have been shown to be
overexpressed in a number of carcinomas, including
those of the breast and prostate. Expression of high
levels of ErbB2 is thought to favor homodimeric inter-
actions among ErbB2 receptors. However,
ErbB2/ErbB3 heterodimers have been shown to be
more aggressive in their transforming ability, and
more recent observations suggest that ErbB2 and
ErbB3 are co-overexpressed in breast cancer, suggest-
ing a strong role for the ErbB2/ErbB3 heterodimer.
It is not known whether ErbB dimers differ in their
ability to transform polarized, proliferation-arrested
epithelial cells. We have modified our dimerization
strategy such that we can induce formation of het-
erodimers between two members of the ErbB receptor
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family using small-molecule ligands. We have gener-
ated cell lines where we can induce either homodimers
or heterodimers within a single cell by chosing differ-
ent types of dimerizing ligands. We plan to investigate
whether receptors dimers differentially regulate
epithelial cell polarity and proliferation.
Generation of Rapid Mouse Models
to Study Oncogene-Tumor
Suppressor Gene Interactions
in the Mammary Gland
A. Rosenberg
Mouse models expressing oncogenes in genetic back-
grounds that lack tumor suppressor genes will serve as
valuable tools to study tumor initiation, progression,
and treatment. Although there are several studies high-
lighting the importance of genetic interactions in
mouse mammary epithelium, it is well appreciated that
both strain variations and promoters used for overex-
pression complicate the interpretation of these analy-
ses. For instance, accelerated occurrence of salivary
tumors in a mouse mammary tumor virus (MMTV)
LTR-ras1p53-1- genetic background impaired the analy-
ses of mammary tumors. Moreover, promoters used to
express oncogenes (MMTV or whey acidic protein
[WAP]) may not target all subtypes of mammary
epithelia (stem cell and nonstem cells) and hence
resulted in cell bias for tumor initiation. We propose to
generate a system that will offer three major advan-
tages over the existing systems: (1) use of an ubiqui-
tous promoter to express oncogenes in all cell types of
mammary epithelium (stem cell and nonstem cell com-
partments), (2) use of the shRNA to down-regulate
expression of tumor suppressor genes and hence allow
analyses of hypomorphic alleles, and (3) use of a mam-
mary gland reconstitution approach to analyze genetic
interactions between oncogenes and tumor suppressor
genes for a fraction of the cost and time.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector P. Bubulya L. Denis S.M. Janicki
G. Chan Y. Fang P. Kannanganattu
Y.-C.M. Chen S. Hearn I. Kumaran
Most cellular processes can trace their beginnings to
the nucleus where a gene is activated resulting in the
production of an RNA molecule which must get
processed and transported to the cytoplasm. Although
many genes are constitutively expressed, a large num-
ber are up-regulated and down-regulated at various
times during the cell cycle and development. Trans-
acting factors have the daunting task of locating and
gaining access to specific genes within the three-
dimensional nuclear space. Altering the transcription-
al status of a particular gene involves a series of
events, including chromatin remodeling and the
recruitment of a large number of factors involved in
either transcription/RNA processing/export or silenc-
ing events. However, a failure of the correct set of fac-
tors to associate with their target substrates at the cor-
rect time will result in changes in the gene expression
program which can lead to a disease phenotype.
Although much biochemical information is available
regarding some of the factors involved in these
processes, the spatial and temporal aspects of the reg-
ulation of gene expression/silencing and the dynamics
of the nuclear domains that they occupy are less well
understood. During the past year, we have focused a
significant amount of our efforts on two main areas:
(1) characterizing chromatin structure as a gene tran-
sits from an inactive heterochromatic state to an active
euchromatic state, and (2) characterization of the dis-
tribution and expression of SR pre-mRNA splicing
factors in the plant Arabidopsis thaliana.
VISUALIZING GENE EXPRESSION IN
LIVING CELLS
We have previously developed a mammalian cell line
that allows us to directly visualize a stably integrated
inducible genetic locus as well as its RNA and protein
products in living cells. The locus is based on a 20-kb
plasmid that contains at its 5 '-end lac operator repeats
that when bound by a cyan fluorescent protein (CFP) -
lac repressor fusion protein allows the integration site
to be visualized. A tetracycline-responsive element
enables the minimal cytomegalovirus (CMV) promot-
er to be regulated. Transcription by RNA polymerase
II (pol II) results in an RNA containing stem loop
structures that are specifically recognized by the bac-
teriophage MS2-binding protein. Expression of MS2-
binding protein fused to yellow fluorescent protein
(YFP) containing a nuclear localization signal allows
us to see the RNA as it is being transcribed. The RNA
encodes CFP with a peroxisome-targeting signal to
allow the protein product of this transcription unit to
be visualized as it concentrates in cytoplasmic peroxi-
somes. Using this system, we have observed the
dynamics of proteins associated with inactive (i.e.,
HP1, Suv39h1) as well as active (i.e., VP-16, RNA pol
II) chromatin.
As YFP-HPla was dynamically depleted from the
locus during the induction of transcription and we
could not detect the histone H3 tri-MeK9 modification
at transcriptionally active loci (2.5 hr postinduction),
we were interested in understanding how this modifi-
cation is removed from the chromatin during tran-
scriptional activation. As a histone demethylase has
not yet been identified and the histone H3 variant,
H3.3, has been shown to be deposited into active ribo-
somal DNA in a replication-independent manner
(Ahmad and Henikoff Mol. Cell 9: 1191 [2002]), we
were interested in determining whether histone
exchange may be a general mechanism through which
a heterochromatic region of chromatin is transformed
into the active state.
Before the induction of transcription, H3.3-YFP
did not show any specific deposition at the locus.
However, a small spot of H3.3-YFP was first observed
approximately 7.5 minutes after the induction of tran-
scription adjacent to the region marked by CFP-lac
repressor. Significant incorporation of H3.3-YFP
appeared around the periphery of the locus and subse-
quently progressed into the interior. Over time, H3.3-
YFP deposition became highly concentrated at the
locus and did not completely overlap with the regions
marked by CFP-lac repressor, suggesting that deposi-
tion may specifically occur in the regions associated
with the transcription machinery. As significant depo-
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sition of H3.3 at the locus is not seen until later time
points (75-150 min postinduction), it is possible that
histone exchange is a late event in the transition of
heterochromatin to the active state, perhaps having
more of a role in changing and maintaining the epige-
netic state of a gene than in aiding in the progression
of transcription. It is also possible that in order for
transcription to begin, histone exchange must first
occur in specific sequence elements, such as promot-
ers; we are not able to detect deposition in such small
regions. Subsequently, histones may be exchanged
throughout the entire coding region resulting in the
significant accumulation visualized at later time
points. Nucleoli were also labeled by H3.3-YFP, as
confirmed by double labeling with an antibody to fib-
rillarin, which is consistent with the deposition of
H3.3 into rDNA. Therefore, histone exchange appears
to be part of the mechanism by which heterochro-
matin can be converted to active chromatin.
DYNAMIC ORGANIZATION AND TISSUE-SPECIFIC
EXPRESSION OF SR SPLICING FACTORS
IN ARABIDOPSIS
The organization of the pre-mRNA splicing machinery
has been extensively studied in cultured mammalian
and yeast cells and far less is known about its dynam-
ics in living plant cells and in different cell types of an
intact organism. During the past year, we examined the
expression, organization, and dynamics of pre-mRNA
splicing factors (SR33, SR1/atSRp34, and atSRp30)
under control of their endogenous promoters in
Arabidopsis thaliana. Distinct tissue-specific expres-
sion patterns were observed, and in addition, differ-
ences in the distribution of the respective proteins
within the nuclei of different cell types were identified.
These differences may be a reflection of the organiza-
tion of chromatin and the amount of interchromatin
space within the respective cell types. In addition, the
metabolic state of the cells, including the distribution
of active genes and their transcriptional levels, may
also affect the distribution of SR proteins. As a higher
metabolic level correlates with more active chromatin
and/or more transcription sites, a larger amount of SR
proteins will therefore be recruited to these transcrip-
tion sites from speckles, resulting in a lower ratio of
splicing factors in speckles to that in the diffuse nucle-
°plasmic population. Future studies will directly
examine the relationship of the compaction state of
chromatin to the organization of the pre-mRNA splic-
ing machinery in different Arabidopsis cell types.
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Leaf epidermal pavement cell nuclei, which have
an obvious speckled pattern of pre-mRNA splicing
factors, were used to visualize the dynamics of splic-
ing factors in vivo by time-lapse three-dimensional
microscopy. A region of rosette leaf (-0.5 cm') was cut
and mounted in water, and a 60x/1.20 N.A. water
immersion objective lens was used to follow the
dynamics of nuclear speckles at room temperature.
Data sets were collected at 15-second intervals over a
30-minute time period. During periods of up to 30
minutes, most speckles were observed to be moving
within a constrained volume of -1 p.m' with respect to
the total nuclear volume of -280 lim3. Some speckles
were observed to fuse or bud from each other during
the imaging period. A few speckles moved into anoth-
er nearby area and then resumed their constrained
movement. Other speckles disassembled into the
nucleoplasm or formed at new sites. Some adjacent
speckles were connected by less intensely labeled flu-
orescent signals. The SR splicing factors appeared to
dissociate/associate with speckles or to exchange
between nearby speckles, resulting in changes in the
shape of these speckles. In about 5% of the leaf epi-
dermal pavement cells, 1-3 speckles entered into the
nucleoli, and moved rapidly within this nuclear
domain. Identical dynamic events of speckles were
observed in SR1/atSRp34-YFP SR33-YFP, and
atSRp3O-YFP transgenic plants. The dynamic organi-
zation of plant speckles was found to be closely relat-
ed to the transcriptional activity of the cells and could
also be modulated by the phosphorylation state of the
splicing factors.
To further determine the dynamics of SR proteins
in speckles, we used fluorescence recovery after pho-
tobleaching (FRAP) analysis. A region of leaf (-0.5
cm') from SR1/atSRp34-YFP or SR33-YFP transgenic
plants was mounted in water. After five single scans
were acquired, a 1.7 x 1.7 lam' nuclear region that con-
tains a speckle was photobleached, and a series of
images were acquired immediately after bleaching.
Subsequently, the relative intensity of fluorescence
within the photobleached area was calculated. In addi-
tion, the level and rate of the fluorescence recovery, as
fluorescent molecules from outside the photobleached
zone migrated into the bleached area, were deter-
mined. Consistent results were obtained from leaves of
plants containing the transgene SR1/atSRp34-YFP or
SR33-YFP; the SR proteins exchange from the speck-
le with a half time of recovery of approximately 2.5
seconds. The organization and dynamic behavior of
speckles in Arabidopsis cell nuclei provide significant
SR33-YFP SR1-YFP atSRp3O-YFP
0
FIGURE 1 Expression patterns of SR33-YEP, SR1/atSRp34-YFP, and atSRp30 -YFP in Arabidopsis.
Projections of a series of confocal optical sections of influorescence stems, anthers, roots and leaves are
shown. (A, F, K) Basal section of primary root; (8, G, L) tip section of primary root; (C, H, (1.4) leaf; (D) anther;
(D) enlarged view of a pollen grain; (E, J, 0) inflorescence stem. Different cell types are highlighted with arrows:
(Tri) trichomes; (Gu) guard cells; (LEP) large (C) and small (H) leaf epidermal pavement cells; (RH) root hairs;
(RM) root meristematic cells; (RE) root epidermal cells. Bar, 1001.1m; (inset 0) 10 p.m.
insight into understanding the functional compartmen-
talization of the nucleus and its relationship to chro-
matin organization within various cell types of a sin-
gle organism.
In addition to observing SR protein dynamics, we
observed differences in SR protein expression levels
in different cell types, tissues, and developmental
stages (Fig. 1). For example, in the vascular bundle of
the primary root tip section, atSRp30 is highly
expressed, and SR33 and SR1/atSRp34 are expressed
at significantly lower levels. In contrast, SR33 is
expressed throughout the root meristem, elongation
zone, and specialization zone, whereas SR1 expres-
sion drops off significantly in the specialization zone.
In leaves, we observed high expression of SR33 and
SR1/atSRp34 and minimal expression levels of
atSRp30; in pollen grains, all three proteins were
expressed at similar levels. At later flowering stages,
SRI/atSRp34 expression decreased to a lower level
than SR33. Finally, in the inflorescence stems, SR1 is
expressed at extremely high levels throughout the
stem, whereas SR33 and atSRp30 are expressed at
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progressively lower levels. In pSR33:SR33-YFP
transgenic plants, we observed fluorescence in nearly
all tissues or organs and at all developmental stages.
This implies that SR33, a SC35-like splicing factor, is
active in the processing of most pre-mRNAs in
Arabidopsis, whereas atSRp30, a tissue-specific
SF2/ASF-like splicing factor, may be involved in
generating tissue-specific transcripts within cells of
the vascular system. In contrast, the high level of
expression of SR1 in the inflorescence stems and
leaves may be indicative of a more global role in con-
stitutive pre-mRNA splicing, as well as a potential
role in alternative pre-mRNA splicing. Further stud-
ies are necessary to elucidate the roles of specific
splicing factors in regulating different aspects of
plant development.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund G. Karger S. Schuck
A. Lee T. Denkenberger
The papillomaviruses are a group of viruses that infect
and transform the basal epithelium inducing prolifera-
tion of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usu-
ally regress after some time, but certain types of
human papillomaviruses (HPVs) give rise to tumors
that are prone to progress toward malignancy, espe-
cially frequently cervical carcinoma. Indeed, HPV
infection appears to be a necessary cause of invasive
cervical carcinoma and thus represents one of the few
firmly established links between viral infections and
the development of cancer.
An impediment to the study of papillomaviruses
has been the inability to define simple in vitro cell cul-
ture systems for analysis of the viral life cycle. These
viruses normally require specialized differentiating
cells that only with difficulty can be generated in cell
culture. However, for a bovine papillomavirus (BPV-1),
a convenient cell culture system exists where viral gene
expression, oncogenic transformation, and viral DNA
replication can be studied. Thus, BPV has become a
useful model for these aspects of the viral life cycle.
The DNA replication properties of the papillomavirus-
es show some unique and interesting characteristics. As
part of their normal life cycle, these viruses can exist in
a state of latency, which is characterized by mainte-
nance of the viral DNA as a multicopy plasmid in
infected cells. The copy number of the viral DNA is
tightly controlled, and the viral DNA is stably inherited
under these conditions. Papillomaviruses therefore
provide a unique opportunity to study plasmid replica-
tion in mammalian cells. In addition, the viral DNA
replication machinery represents one of the most
promising targets for antiviral therapy.
In previous years, we have reported the character-
ization of the papillomavirus replicon and the identifi-
cation of the viral components that are required for
viral DNA replication. In recent years, we have direct-
ed our attention toward the biochemical events that are
associated with initiation of DNA replication. We are
studying the biochemical properties of the viral E1
and E2 proteins and how these two proteins interact
with the viral origin of DNA replication and with the
cellular replication machinery to generate initiation
complexes. Our studies demonstrate that the E1 pro-
tein has all the characteristics of an initiator protein,
including on recognition, DNA-dependent ATPase
activity, and DNA helicase activity. The transcription
factor E2, whose precise function has remained more
elusive, appears to serve largely as a loading factor for
El. Through direct physical interactions with both El
and the ori, E2 provides sequence specificity for the
formation of the initiation complex.
We are currently attempting to elucidate how the
El and E2 proteins orchestrate the precise biochemi-
cal events that precede initiation of DNA replication at
the viral ori. These events include binding of the ini-
tiator to the ori, the initial opening of the DNA duplex,
as well as the assembly and loading of the El replica-
tive helicase at the replication fork. Our studies so far
indicate that these activities are generated in an
ordered process that involves the sequential assembly
of El molecules on the ori. This sequential assembly
generates different complexes with different proper-
ties that in turn recognize ori, destabilize the double
helix, and function as the replicative DNA helicase.
GENERATION OF SEQUENCE SPECIFICITY
FOR INITIATOR DNA BINDING
Viral initiators of DNA replication are dependent on
the ability to find and recognize the viral origin of
DNA replication in a vast excess of host-cell DNA in
the infected cell. Interestingly, many viral initiators
appear to bind DNA with modest to low selectivity,
raising the question of how the ori is recognized. For
the papillomaviruses, the E2 protein contributes to
highly selective DNA binding by binding cooperative-
ly with El to the ori. We, as well as others, have
believed that the role of E2 is to recruit E1 to the ori.
Interestingly, we have recently determined that the E2
protein functions by an entirely different molecular
mechanism. By analyzing the DNA-binding properties
of the E 1 protein, we found that although the full-
length El protein binds DNA with low specificity, the
DNA-binding domain (DBD) of El binds with high
specificity. The explanation for this apparent paradox
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is that two different DNA-binding activities are pre-
sent in the full-length El protein. The El DBD is
capable of highly sequence-specific DNA binding,
but a different DNA-binding activity, present in the
helicase domain of the El protein, binds DNA non-
specifically. The net result of the presence of both a
nonspecific and a specific DNA-binding activity is
that full-length El binds DNA with low specificity.
We now also understand how E2 acts to provide high
specificity DNA binding. E2 interacts with the E1
helicase domain and prevents this domain from con-
tacting DNA. As a result, in the presence of E2, El
binds DNA only via its DBD, resulting in highly spe-
cific DNA binding. As E2 is displaced, the El helicase
domain is free to engage the sequences flanking the
El- binding sites, generating a complex with intrinsi-
cally low sequence specificity, but bound to a specif-
ic site. The reason for this complex arrangement is
clearly that the nonspecific DNA-binding activity
which resides in the El helicase domain has an impor-
tant role in later events where the El protein melts and
unwinds the ori DNA. This raises the interesting pos-
sibility that initiator proteins in general may employ
similar procedures for generation of highly sequence-
specific DNA binding. Furthermore, this mode of E1
binding provides us with a simple model for how larg-
er initiator complexes are assembled on the ori. By
addition of El dimers in an ordered fashion, the final
form, a double hexamer of El, can be assembled with-
out rearrangement of the individual subunits.
MUTATIONAL ANALYSIS OF THE El DBD SURFACE
The DBD of the E1 protein clearly is responsible for
the highly site-specific DNA binding that the El pro-
tein is capable of, which in turn is responsible for
recognition of the origin of DNA replication in the
viral genome. Furthermore, on the basis of both struc-
tural and biochemical studies of the E1 DBD, the
DBD also provides the dimerization surface for the E 1
protein and also contains an interaction surface for the
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DBD from the E2 protein. In addition, based on imag-
ing analysis of, for example, SV40 T antigen, it is like-
ly that the El DBD takes an active part in formation of
large complexes such as the double hexamer, which
appear to be the entity that melts and unwinds the ori-
gin of DNA replication. To identify additional func-
tions in the DBD, we have performed a complete sur-
face mutagenesis of the El DBD. Based on the high-
resolution structure of the El DBD, we have substitut-
ed approximately 70 surface residues for alanine,
avoiding areas known from the structural analysis to
be involved in DNA binding and dimerization. After
screening these El mutants for expression and for in
vivo DNA replication activity, we were able to identi-
fy 18 mutants with defects in DNA replication. Six of
these were defective for interaction with E2, whereas
the remaining 12 mutants showed unimpaired interac-
tion with E2 and consequently were defective for
DNA replication for other reasons. To determine what
biochemical functions might be defective in these
mutants, we expressed and purified the 12 mutant El
proteins and tested them in five different in vitro
assays related to DNA replication. None of the
mutants showed a defect in either the ATPase or the
nonspecific DNA helicase activities, indicating that
the protein structure was not greatly affected by the
mutations and that most likely, the ability to form
hexameric structures is unaffected by the mutations.
However, all 12 mutants had severe defects for in vitro
DNA replication, as well as defects in melting activity
and in fragment unwinding activity. These results indi-
cate that the ability to form double hexamers might be
impaired since both melting and unwinding activities
require formation of the double hexamer.
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DNA REPLICATION AND CHROMATIN INHERITANCE
B. Stillman K. Braun A. Mazurek C. Speck M. Rossmann
A. Chabes J. Mendez Z. Zhang K. Siddiqui
V. Ellison S.G. Prasanth S. Vadivelu P. Wendel
M. Hoek Y.-J. Sheu
The research focuses on three aspects of the inheritance
of genetic material from one cell generation to the next.
DNA in chromosomes replicates during S phase in
eukaryotic cells and concomitant with DNA synthesis is
the assembly of nucleosomes onto the DNA and dupli-
cation of epigenetically determined chromatin struc-
tures. We have been studying the mechanism of DNA
replication and how this is linked to cell cycle control,
chromatin inheritance and chromosome segregation
during mitosis.
ROLE OF ORC IN THE INITIATION OF DNA
REPLICATION IN MAMMALIAN CELLS
The origin recognition complex (ORC) is a six-sub-
unit protein complex that was initially identified from
the yeast Saccharomyces cerevisiae, but it has
orthologs in all eukaryotes and even in archaeal
species. ORC binds to origins of DNA replication and
in yeast is a stable six-subunit protein complex. On the
other hand, ORC composition in human cells is
dynamic, with the largest subunit being degraded as
cells enter into S phase. We have also shown that the
bulk of the Orc6 subunit is primarily not associated
with the other ORC subunits, but it is associated with
centromeres and the cytokinesis furrow during mitosis
and cytokinesis. Disruption of Orc6 using siRNA
(short interfering RNA) methods causes cells to either
stop DNA replication or fail to execute cytokinesis,
depending on where in the cell cycle the lack of Orc6
had its effect.
In the last year, we have investigated one of the
other subunits of the human ORC, the Orc2 subunit.
Using multiple antibodies directed against this pro-
tein, we have shown that Orc2 localizes at multiple
locations in interphase cells, including small punctate
foci that most likely correspond to sites of DNA repli-
cation and to larger heterochromatic foci that also con-
tain the heterochromatin protein HP1. Both of these
structures are present in cells in the G, phase of the
cell cycle, but as cells enter and progress thorough S
phase, Orc2 is lost from both of these structures, even
though HP1 still remains associated with heterochro-
matin. During prophase as cells enter mitosis, Orc2
localizes to centric heterochromatin. Interestingly, we
also find a fraction of Orc2 associated with centro-
somes at all stages of the cell division cycle, including
interphase and all stages of mitosis.
The function of Orc2 was investigated by deplet-
ing the protein from various human cell lines using
RNA interference (RNAi) genetics. Cells lacking
Orc2 arrested in the cell cycle at two separate stages,
probably depending on when during the cell cycle the
Orc2 was depleted. About 70% of the cells arrested
with a block to DNA replication and remained
attached to the culture dish. In these cells, all HP1
localization to heterochromatic foci was disrupted. On
the other hand, about 30% of the cells arrested with a
rounded mitotic-like appearance, and in these cells,
chromosomes were abnormal and the mircotubule
spindle was disorganized, with many cells having mul-
tiple centrosomes. The chromosomes in such cells
were not properly condensed, and they did not attach
to the disorganized mitotic spindle. Such observations
suggest that Orc2, like the Orc6 subunit, has a role in
chromosome structure and segregation, in addition to
the expected role in initiation of DNA replication. We
are following up these interesting studies to examine
how mitosis is disrupted and why such cells do not
complete chromosome segregation.
CLAMP LOADERS: DNA REPLICATION
AND DAMAGE CONTROL
In previous years, we have characterized the proteins
from human cells that are essential for replication of
simian virus 40 (SV40) DNA in the presence of the
virus-encoded T antigen. One of the proteins we found
is a five-subunit protein complex called RFC (replica-
tion factor C) that is an ATP-dependent clamp loader.
RFC loads the DNA polymerase clamp proliferating
cell nuclear antigen (PCNA) onto DNA to initiate
DNA synthesis at origins of DNA replication and at
the start of every Okazaki fragment. RFC contains
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four small subunits that are shared with other protein
complexes in the cell, including one that contains the
Rad17 protein. The new complex has been designated
RSR (Rad17-RFC2-5). In last year's Annual Report,
we described the purification of RSR and the demon-
stration that it can load another clamp onto DNA. The
new clamp is a heterotrimer containing the Radl ,
Husl, and Rad9 proteins that form a complex called
RHR. The RSR loads the RHR clamp onto DNA in a
ATP hydrolysis-dependent manner much like RFC
loads the polymerase clamp PCNA.
Mutations in the yeast genes encoding Radl 7 and
the genes encoding the RHR proteins show phenotypes
of increased sensitivity to DNA-damaging agents and
a lack of checkpoint control of the cell division cycle
that arrests cell division when chromosomes are dam-
aged in interphase. Thus, it was likely that the RHR
clamp did not function like the PCNA polymerase
clamp. We further investigated the mechanism of RSR
loading RHR onto DNA and made the unexpected
finding that RHR is loaded onto DNA that contains a
recessed 5' end at a junction between double-stranded
and single-stranded DNA (see Fig. 1). In contrast, our
previous studies have demonstrated that RFC loads
PCNA onto 3'-recessed ends of DNA, consistent with
DNA Replication
Stalled Fork
Fork Rescue
its role in recruiting a DNA polymerase to the 3'
primer for processive DNA replication. The observa-
tion that RHR loads on to a 5 '-recessed end of DNA is
not consistent with RHR acting as a DNA polymerase
clamp. Rather, we suggest that the recessed 5' ends are
generated during the process of repair of damage in the
DNA and at telomeres during elongation of telomere
repeats. We also demonstrated that the loading requires
the single-stranded DNA-binding protein RPA (repli-
cation factor A), suggesting that RPA has to be associ-
ated with single-stranded DNA before the RSR can act
to load RHR onto DNA. Such a scenario implies that
the RSR-RHR machinery functions after DNA damage
recognition and not as an initial sensor of DNA dam-
age, as was previously thought.
CHROMATIN ASSEMBLY DURING
DNA REPLICATION
As the DNA replication forks copy DNA to produce
the two sister chromatids for each chromosome, the
DNA must be reassembled into a nucleosome-contain-
ing chromatin structure. The parental nucleosomes are
disrupted during DNA replication, but the epigenetic
modifications that they contain must be inherited so
Telomere Maintenance Recombination Coupled
DNA Repair
RHR
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5
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FIGURE 1 Possible substrates onto which the checkpoint clamp loader RSR may load its clamp (RHR)
DNA maintenance pathways, including those depicted here, generate intermediates containing free
and/or recessed 3' ends that are processed by a variety of proteins. These structures also contain
recessed 5' ends, whose fate in these reactions is unclear. Given that RSR loads RHR (depicted as a ring
or donut encircling the DNA) onto recessed 5' ends in vitro, recessed 5' ends generated in vivo in the
depicted pathways can be considered potential substrates. They all contain adjacent single-stranded
DNA that could be bound by RPA. RHR has been shown to be required for checkpoint signaling in
response to DNA replication fork arrest, double-stranded breaks, and improper telomere maintenance.
The RHR clamp is proposed to protect the recessed 5' end from extensive degradation by exonucleas-
es and to promote resolution of these structure back to duplex DNA. (Reprinted from Ellison V. and
Stillman B. 2003. PLoS Biol. 1: 231-243.)
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that gene expression states from one cell generation to
the next can be remembered. One protein that partici-
pates in the inheritance of nucleosomes is the chro-
matin assembly factor-1 (CAF-1), a three-subunit pro-
tein that binds histones and can assemble them onto
DNA after passage of a DNA replication fork. CAF-1
is tethered to the DNA replication fork by interaction
with PCNA.
The S. cerevisiae CAF-1 is not essential, but cells
lacking this protein are sensitive to DNA damaging
agents, probably reflecting the fact that chromatin
assembly must also occur on repaired DNA and CAF-
1 is known to couple DNA repair and nucleosome
assembly in vitro. Yeast is unusual in that it lacks sub-
stantial amounts of heterochromatin found in cells
from metazoan species and only contains one form of
histone H3, the form associated with transcribed DNA
in mammalian cells. Mammalian cells contain an
additional form of histone H3 that is primarily associ-
ated with nontranscribed DNA, including heterochro-
matin. We therefore tested if CAF-1 is essential for
cell cycle progression in human cells, to determine if
DNA replication and nucleosome assembly are cou-
pled, as we originally found during SV40 DNA repli-
cation in vitro.
Expression of the largest subunit of CAF-1 was tar-
by selective siRNA treatment. When
depleted from human cells grown in culture, the cells
arrested either in the Gi phase or in early S phase, with
very little DNA synthesis occurring. A Chk2- mediated
(but not Chkl -mediated) DNA damage checkpoint was
triggered in these cells, which was unexpected since
Chkl is thought to be the intra-S-phase checkpoint that
monitors DNA damage. The activation of the Chk2 pro-
tein kinase suggests that chromatin assembly is direct-
ly linked to later events that regulate entry into mitosis.
Eventually, however, the CAF-1-depleted cells died of
apoptosis. Thus, in human cells, CAF-1 is essential and
is necessary for coupling chromatin assembly to DNA
replication. We are further investigating the mechanism
of this coupling.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
SIGNAL TRANSDUCTION
N.K. Tonks J.N. Andersen N. Gorovits A. Piccini
D.A. Buckley R. Hecker Z. Yao
H.H. Chen S. Hinton M. Ye
R.L. Del Vecchio T.C. Meng L. Zhang
T. Fukada H.L. Palka
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects the activity of the kinases
that phosphorylate it and the protein phosphatases that
catalyze the dephosphorylation reaction. We study the
expanding family of protein tyrosine phosphatases
(PTPs), which, like the kinases, comprise both trans-
membrane, receptor-linked forms and nontransmem-
brane, cytoplasmic species and represent a major fam-
ily of signaling enzymes. We are utilizing a variety of
strategies to characterize the physiological function of
members of the PTP family. Disruption of normal pat-
terns of tyrosine phosphorylation has been implicated
in several human diseases. Therefore, insights into the
mechanisms involved in modulating PTP function
may ultimately yield important information to help
counter such diseases.
During the last year, there have been several
changes in laboratory personnel. Toshi Fukada left to
take up a faculty position at the RIKEN Research
Center for Allergy and Immunology at Osaka
University; T.C. Meng took up a faculty position at the
Institute of Biological Chemistry, Academica Sinica,
Taiwan; and Helena Palka accepted a position on the
Research Faculty in the Department of Biochemistry
and Molecular Genetics, University of Illinois,
Chicago. We have been joined by Naira Gorovits, who
conducted her Ph.D. research in Maureen Charron's lab
at Albert Einstein College of Medicine; and Zhong Yao,
who obtained his Ph.D. working with Dr. Rony Seger at
The Weizmann Institute of Science, Israel. Most recent-
ly, Antonella Piccini joined the lab after completing
postdoctoral studies with Robert Malinow here at
CSHL. Finally, Regina Hecker worked in the lab during
the summer on an intership during which she conduct-
ed research for a Diploma Thesis from the University of
Applied Sciences Oldenburg, Emden, Germany.
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PTP: A THERAPEUTIC TARGET FOR TREATMENT OF
DIABETES AND OBESITY
It is now apparent that the protein tyrosine phos-
phatase (PTP1B) is a major regulator of signaling
events induced by insulin and leptin. In fact, PTP1B is
now recognized in the pharmaceutical industry as an
important target for development of novel strategies
for therapeutic intervention in diabetes and obesity.
The active site of members of the PTP family is high-
ly charged, consistent with its recognition of a charged,
phosphorylated residue as substrate. This, and the fact
that the essential Cys residue at the active site is prone
to oxidation, has presented challenges to the design of
therapeutic inhibitors, suggesting that alternative
methods for manipulating the activity of PTP1B may
be of benefit.
We have identified two elements that are important
in the regulation of transcription from the PTP I B pro-
moter. Expression of PTP1B is induced by the
p210BcrAbl oncoprotein, a PTK (protein tyrosine
kinase) that is responsible for the initial manifestations
of chronic myologenous leukemia. We identified a
p210BcrAbl-responsive sequence (PRS) in the PTP1B
promoter and showed that is recognized by Egr-1 and
Sp C2112 zinc-finger transcription factors, which act in
a reciprocal manner to regulate expression of PTP1B
in response to p210BcrAbl. We have identified an
enhancer sequence upstream of the PRS which func-
tions as a binding site for Y-box-binding protein-1
(YB- I) and have shown that the levels of PTP I B could
be manipulated by altering the levels of YB-1.
Depletion of YB-1, by expression of a specific anti-
sense construct, led to an approximately 70% decrease
in expression of PTP IB, without alteration of the lev-
els of TCPTP (the closest relative of PTP1B), and
resulted in increased sensitivity to insulin and
enhanced signaling through the cytokine receptor
gp130. Nevertheless, attempts to manipulate insulin
signaling and the levels of blood glucose in animals,
by administration of antisense oligonucleotides direct-
ed against YB-1, proved unsuccessful, with complica-
tions most likely arising from the known pleiotropic
actions of YB- 1 .
REGULATION OF PTP FUNCTION BY OXIDATION
We have also investigated the regulation of PTP1B
function by reversible oxidation. In general terms, the
signature motif [IiI/]HCXXGXXR[S/T], which
defines the PTP family of enzymes, contains an
invariant Cys residue, which functions as a nucle-
ophile in catalysis. Due to the unique environment of
the PTP active site, this Cys residue displays an
unusually low plS, which enhances its nucleophilic
properties but renders it susceptible to oxidation.
Once oxidized, the active-site Cys can no longer func-
tion as a nucleophile. A wide variety of physiological
stimuli that result in stimulation of tyrosine phospho-
rylation are also accompanied by the production of
reactive oxygen species (ROS), which is required for
an optimal tyrosine phosphorylation response. Work
from several labs has demonstrated that PTPs are an
important target of ROS in this context. The operating
principle is that the stimulus (hormone, growth factor,
etc.) enhances tyrosine phosphorylation directly, by
activation of a PTK, and/or indirectly, by inactivation
of a PTP. Therefore, one function of ROS produced
following agonist stimulation is to inactivate tran-
siently the critical PTP that provides the inhibitory
constraint upon the system, thus facilitating the initia-
tion of the signaling response to that stimulus.
We have demonstrated that stimulation of Ratl
fibroblasts with insulin led to the production of ROS,
in particular H202. Expression of catalase inhibited
both tyrosine phosphorylation of the insulin receptor
(IR) and downstream signaling to PKB/Akt, thus
highlighting the importance of ROS production for
optimal signaling. Using a modified in-gel phos-
phatase assay we have developed, we showed that two
PTPs were rapidly and reversibly oxidized in response
to insulin, and we have identified these as PTP1B and
TC45. A role for PTP1B in the regulation of IR sig-
naling is now well established, validating our strategy
of using reversible oxidation as a method to tag those
PTPs that are oxidized in response to a defined stim-
ulus, thereby revealing those PTPs that may be critical
for down-regulating the signaling response to that
stimulus. We have now investigated the oxidation of
PTP from a structural perspective, as part of a long-
standing collaboration with David Barford (ICR,
London, U.K.). For reversible oxidation to represent a
mechanism to regulate PTP function, it is essential
that the active-site Cys residue is not oxidized further
than the sulfenic acid (-SOH) form. Higher oxidation
to sulfinic acid (S0211) or sulfonic acid (SO3H) is an
irreversible modification that would be inconsistent
with a regulatory mechanism. We incubated crystals
of PTP1B with stoichiometric quantities of H202 in
order to determine the structure of the oxidized,
sulfenic acid form of the enzyme. Surprisingly, we
never detected the sulfenic acid; instead, a sulfenyl-
amide species was observed, in which a covalent bond
was formed between the sulfur atom of the active-site
Cys and the main-chain nitrogen of the adjacent
residue, Ser-216, leading to formation of a novel 5-
atom ring structure at the active site. The conse-
quences for the architecture of the active site are pro-
found (Fig. 1). The PTP loop, containing the signature
motif, and Tyr-46, from the pTyr loop, which are nor-
mally buried in the structure, flip out of the active site
to adopt solvent exposed positions. It is important to
note that these effects are readily reversible upon incu-
bation of the crystals with reducing agent. This novel
oxidation-dependent post-translational modification,
which also occurs in solution, disrupts substrate recog-
nition by PTP1B and renders Tyr-46 susceptible to
phosphorylation, possibly explaining some of the
reports in the literature of tyrosine phosphorylation of
members of the PTP family. Furthermore, the confor-
mational change in PTP1B that accompanies sulfenyl-
amide bond formation exposes the oxidized Cys to
reducing agents, thereby facilitating reduction to the
active form of the enzyme. Therefore, the discovery of
this novel sulfenyl-amide-modified PTP1B reveals a
mechanism by which generation of higher oxidized
forms of the active-site Cys is prevented and reduction
back to the active state is facilitated. It will be inter-
esting to ascertain whether this represents a general
mechanism for the regulation of PTP function by
reversible oxidation. If so, stabilization of the oxi-
dized, inactive form of PTPs, such as PTP1B, by
small-molecule drugs, may offer a novel strategy for
therapeutic intervention in diseases associated with
aberrant PTP activity.
We have also investigated the role of TC45 in the
regulation of insulin signaling. Ablation of TC45
expression by RNA interference in Ratl fibroblasts
and HepG2 cells led to hyperphosphorylation of the
insulin receptor and stimulation of insulin-induced
activation of PKB /Akt. In addition, in collaboration
with Tony Tiganis (Monash University, Australia), we
observed that insulin-induced phosphorylation of the
insulin receptor and activation of PKB/Akt were
enhanced and sustained in immortalized mouse
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Reduced Oxidized
FIGURE 1 Oxidation of PTP1 B is accompanied by profound conformational changes at the active site. Incubation of PTP1B
with stoichiometric amounts of H202 generated an unexpected covalent modification at the active site. Upon oxidation to
sulfenic acid, nucleophilic attack by the backbone N atom of Ser-216 on the Sy atom of Cys-215 generates a cyclic sulfe-
namide, which is a puckered five-membered ring. As a result, two critical H-bonds, which are responsible for the integrity of
the active site, are broken, resulting in profound conformational changes in which the active site springs open, resulting in
inhibition of substrate binding. The signature motif which normally forms the base of the active-site cleft loses its helical con-
formation. In this motif, Gly-218 shifts by 7 A and, most importantly, Cys-215 now becomes exposed to the environment,
thereby facilitating reduction back to the active state. In addition, Tyr-46, which is normally buried in the active site, where it
defines the depth of the cleft and determines specificity for tyrosyl residues in substrates, now becomes exposed. In this
conformation, Tyr-46 is susceptible to phosphorylation which may introduce a further tier of control over the regulation of
members of the PTP family. It is important to stress that although these conformational changes are dramatic, they are
nonetheless reversible. This modification suggests a mechanism for redox regulation of the PTPs that will facilitate fine-tun-
ing of tyrosine phosphorylation-dependent signaling pathways.
embryo fibroblasts (MEFs) generated from TCPTP4-
mice compared to control TCPTP-Et+ animals.
Therefore, this study, which was initiated by the obser-
vation of transient insulin-induced oxidation of TC45,
has illustrated that, in addition to PTP1B, TC45 is a
negative regulator of signaling in response to insulin.
RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES
We identified a receptor PTP termed DEP-1 (density
enhanced PTP-1), the expression of which is increased
in cells in culture approach confluence, suggesting a
role as an inhibitor of cell proliferation. DEP-1 has
recently been identified by the lab of Peter Demant as
the product of a tumor suppressor gene that is mutat-
ed in colon, lung, and breast cancers. Using substrate-
trapping mutant forms of DEP-1, we have identified
two physiologically important substrates: p120 catenin
and the hepatocyte growth factor/scatter factor recep-
tor Met. p120 catenin, which was originally identified
as a substrate of the protein tyrosine kinase Src, regu-
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lates cadherin-based cell adhesion. In addition to the
cadherin-associated pool of p120, there is also a cyto-
plasmic pool of the protein that has been implicated in
the regulation of Rho, Rac, and Cdc42 small GTP-
binding proteins. The distribution between these pools
is regulated by cell confluence, with the bulk of p120
catenin found at cell-cell junctions in confluent cul-
tures, and also potentially by phosphorylation of p120
catenin. In the case of Met, ligand-induced tyrosine
phosphorylation of particular sites within the PTK
underlies the regulation of mitogenic, motogenic, or
morphogenic responses. We observed that DEP-1
preferentially recognized signaling sites in Met,
including the Gab 1-binding site (Y1344) and a car-
boxy-terminal site implicated in morphogenesis
(Y1365), whereas tyrosine residues in the activation
loop of the kinase (Y1230, 1234, 1235) were not pre-
ferred targets of the PTP. The ability of DEP-1 prefer-
entially to dephosphorylate particular tyrosine
residues that are required for Met-induced signaling
suggests that DEP-1 may function in controlling the
specificity of signals induced by this PTK, rather than
as a simple "off-switch" to counteract PTK activity.
This functional interaction between Met and DEP-1
raises the possibility that up-regulation of Met may be
coupled with down-regulation of DEP-1 in the pro-
gression of certain human tumors. We are currently
exploring the signaling function of DEP-1 in cell lines
that express the phosphatase in an inducible manner.
We have also been studying a distinct PTP, termed
PTPI.t, which is expressed primarily in endothelial
cells and is also increased in expression following the
formation of cell-cell contacts. This receptor PTP was
the first for which a ligand was identified, with our
demonstration that it participates in homophilic bind-
ing interactions, i.e., a molecule of PTI.t on one cell
binds to another PTI4t molecule on an adjacent cell.
The immunoglobulin domain in the extracellular seg-
ment is critical for this binding function. Our most
recent analyses have highlighted the importance of the
homophilic binding site regulating the level and sub-
cellular location of PT14t, thereby controlling the
function of the enzyme and the maintenance of nor-
mal cell physiology.
THE DUAL SPECIFICITY PHOSPHATASES (DSPs)
The PTP family of enzymes, which are defined by the
presence of the signature sequence (I/VHCxxGxxR
[SIT]), can be divided into two broad categories, the
Tyr-specific or classical PTPs and the dual specificity
phosphatases (DSPs), which have the capacity to
dephosphorylate Ser/Thr and Tyr residues on proteins,
in addition to nonprotein substrates such as inositol
phospholipids. An obvious major difference between
the enzymes in these two categories is the design of
the active site. In the classical PTPs, the active site is
present as a deep cleft on the surface of the protein,
the depth of which is defined by a conserved Tyr
residue that restricts specificity only to phosphotyro-
sine residues. In the DSPs, this Tyr residue is absent
and the active-site cleft is shallower, allowing it to
accommodate the shorter side chains of phospho-Ser
and phospho-Thr. The first DSP to be described was
the enzyme VH1, which is essential for infectivity of
the virions of Vaccinia virus. In mammals, the DSPs
have been implicated in the regulation of various fun-
damental physiological functions, including prolifera-
tion, differentiation, survival, and transition through
the cell cycle. We have searched the completed human
genome sequence to identify the complement of
DSPs. This proved to be a greater challenge than our
similar analysis of the classical PTPs because,
although they contain the active-site signature motif,
the DSPs are less well conserved overall and are there-
fore harder to identify on the basis of sequence than
the pTyr-specific members of the PTP family. We
identified a minimal DSP catalytic domain, and our
search yielded 43 DSPs that are related to VH1 and
contain this domain, several of which are currently
uncharacterized. Each of these DSP genes was also
found in mouse. These VH1-like DSPs can be divided
into three classes on the basis of structural similarity.
Within each class, subcategories have also been delin-
eated, each of which is represented in Drosophila and
most were observed in Caenorhabditis elegans.
We have begun to explore the structure, regulation,
and function of several of these DSPs. Our studies
have revealed two related enzymes, Jspl and DSP18/
Jsp2, that may underlie a novel tier of control of the
Jnk family of MAP kinases, which are activated in
response to pro-inflammatory cytokines and environ-
mental stresses and are implicated in the regulation of
proliferation and apoptosis. We have identified two
novel DSPs that appear to be more highly expressed in
tumor tissue and cell lines than normal. Such overex-
pression may indicate a direct link between the DSP
and the etiology of the disease. Finally,
tified a locus from which two distinct, but closely
related, DSPs are expressed from alternative reading
frames of a single gene. This gene organization is con-
served in the mouse. The situation is reminiscent of
that reported for the pl 6Ink4/p19Arf locus; however,
unlike that example in which two structurally and
functionally distinct proteins are produced from the
same gene, the gene we have identified yields two
closely related members of the same enzyme family.
These DSPs, which we term DSP7 and DSP17, dis-
play highly restricted tissue expression patterns and
are expressed predominantly late in development in
adult tissues. Their functions are currently under
investigation.
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RAS AND RHO GTPASES AND THE CONTROL OF SIGNAL
TRANSDUCTION
L. Van Aelst B. Boettner R. Packer
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J. Janas V Velamoor
S. Newey M. Zhao
Research in my laboratory focuses on signal transduc-
tion pathways involving members of the Ras and Rho
GTPases and the physiological processes that they
regulate. Ras and Rho family members encode low-
molecular-weight guanine nucleotide-binding proteins
that function as binary switches by cycling between an
active GTP-bound state and an inactive GDP-bound
state. It is only in their GTP-bound state that they are
able to interact with downstream effector molecules,
which mediate their effects. The ratio of the two forms
is regulated by the opposing effects of guanine
nucleotide exchange factors (GEFs), which promote
the exchange of bound GDP for GTP, and the GTPase-
activating proteins (GAPS), which stimulate hydroly-
sis of bound GTP. Alterations that affect normal Ras
and Rho function have been found to result in the
development of several disease processes including
cancer, as well as inflammatory and neuropathological
disorders. To understand how alterations in Ras and
Rho signaling components contribute to these disease
processes, it is essential to comprehend their normal
functions both at a molecular and at a cellular level.
Efforts in my laboratory have focused on defining the
role and mechanisms by which Ras and Rho family
members exert their effects on specific aspects of
tumorigenesis and on neuronal development.
During the past year, we have made significant
progress toward understanding the molecular basis by
which the Ras-related GTPase, Rapl, exerts its effects
on epithelial morphogenesis and how the RasGAP-
associated protein, p62"k, affects cell proliferation.
Furthermore, we have provided additional insights into
the role of Ras and Rho GTPases in neuronal develop-
ment and function. Specifically, we have uncovered a
role for the X-linked mental retardation protein,
oligophrenin-1, in dendritic spine development.
THE AF-6 HOMOLOG CANOE ACTS AS A RAP1
EFFECTOR DURING DORSAL CLOSURE OF THE
DROSOPHILA EMBRYO
Our studies in Drosophila and in mammalian systems
support a role for Rapl proteins in the control of
epithelial cell-shape changes, coordinated movements
of epithelial cells, and celllextracellular matrix (ECM)
adhesion. These are pivotal events governing tumor
progression and wound healing processes; yet the sig-
naling pathways mediating these effects of Rapl
remain unknown. Previously, we identified the mam-
malian junctional protein AF-6 as a Rapl-interacting
protein. However, the functional analyses of mam-
malian Rap I and AF-6 proteins have been hampered by
the fact that these proteins are largely refractory to
loss-of-function and/or gain-of-function analysis.
Hence, we decided to gain insights into their functions
using Drosophila, a genetically more tractable model
system (in collaboration with Dr. U. Gaul, of The
Rockefeller University). The morphogenetic dorsal
closure (DC) process in Drosophila, which relies on
elongation and migration of epithelial cells, has proven
to be an excellent model for the study of the molecular
mechanisms regulating epithelial cell-shape changes.
We found that both DRap 1 and Canoe (the
Drosophila orthologs of Rapl and AF-6) are essential
in the DC process and provide evidence that Canoe
acts as a downstream effector of DRapl in this devel-
opmental step. Specifically, we found that Canoe
binds to the activated form of DRapl in a yeast two-
hybrid assay and that the two molecules colocalize to
the adherens junction. We also observed that DRapl
and canoe mutants display very similar phenotypes in
DC. Finally, our genetic interaction experiments
showed that DRapl and Canoe act in the same molec-
ular pathway during DC, with DRapl acting upstream
of Canoe, and that the function of both molecules
depends on their ability to interact. Taken together,
these experiments demonstrate that Canoe is a "bona
fide" effector of DRap 1 in the context of DC.
Interestingly, we also obtained evidence that Canoe
has a dual function during DC. The first function is
controlled by DRapl and is independent of JNK sig-
naling, whereas the second function is not activated by
DRapl but feeds into JNK signaling. We have initiat-
ed screens to identify additional Canoe-interacting
proteins to obtain further insights into Canoe's mode
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of action in dorsal closure. To complement these stud-
ies, we will also assess a role for the mammalian
counterparts of these Drosophila proteins in mamma-
ry epithelial polarity and invasive behavior. The infor-
mation gained from our studies in Drosophila will
facilitate the design of experiments addressing the
role of the mammalian orthologs in epithelial cells.
P62 ° °" FUNCTIONS AS A NEGATIVE REGULATOR OF
MITOGENIC AND ONCOGENIC P2105..-.. SIGNALING
p62" is a protein initially identified as a 62 -kD con-
stitutively tyrosine-phosporylated RasGAP-associated
protein, in p210bc"bi-expressing cells. This protein
was termed dok (downstream of kinases), since it was
also found to be a common substrate of many recep-
tor and cytoplasmic tyrosine kinases. Subsequently,
four additional dok family members have been identi-
fied. Among them, p62" and dok-2 share in common
the ability to bind to RasGAP. To investigate the role
of p62", we utilized different cell types derived from
p62" null mice, generated by P.P. Pandolfi (Memorial
Sloan-Kettering Cancer Center, New York). In collab-
oration with Pandolfi's group, we obtained evidence
that p62d" acts as a negative regulator of growth-fac-
tor-induced cell proliferation. We observed that
p62d"-deficient cells possess a significantly higher
proliferation rate in response to growth factors and
that this increase in cell proliferation can be sup-
pressed by ectopic expression of p62"k. Our subse-
quent studies demonstrated that p62" exerts its nega-
tive effect on growth-factor-induced cell proliferation
at least in part by negatively influencing the
Ras/MAPK (mitogen-activated protein kinase) path-
way. Moreover, for p62" to act as a negative regula-
tor of the Ras/MAPK pathway, we have shown that
p62" must be recruited to the membrane. The
growth-factor-triggered translocation of p62" to the
plasma membrane involves the activation of phos-
phatidylinositol-3 kinase (PI3-kinase) and binding of
its plekstrin-homology (PH) domain to 3"-phosphory-
lated phosphoinositides.
Using p210bcr-abl mouse model systems, we
observed that p62" inactivation causes a significant
shortening of the latency of the fatal myeloprolifera-
tive disease induced by p210ber-kbl. We also found that
ectopic expression of p62'k in Mo7 myeloid cells
markedly decreases the growth potential of these
cells. These findings implicate a role for p62d" in the
negative regulation of p210""-kb' signaling and leuke-
mogenesis. How p62d" opposes the leukemogenic
potential of p210bc"am remains to be defined. We are
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currently undertaking proteomic and genetic
approaches to address this question. Notably, we
observed that p62" null mice do not show gross aber-
rant phenotypes and display normal steady-state
hemopoiesis. This may be due to the fact that other
dok family members can compensate for the loss of
p62" function. In collaboration with Pandolfi's
group, we are currently analyzing the phenotypes of
p62" and dok-2 double knockout mice.
RAS AND RHO GTPAsEs REGULATE KEY ASPECTS OF
NEURONAL FUNCTION AND DEVELOPMENT
Accumulating data demonstrate that members of the
Ras and Rho GTPases control important aspects of
neuronal development and function. This is further
highlighted by the findings that several diseases caus-
ing cognitive impairment (including neurofibromato-
sis, autism, and mental retardation) are associated with
mutations in members of the Ras and Rho GTPases or
in the molecules (GEFs and GAPs) that control their
activity. A major challenge remains to unravel how
these molecules affect neuronal development and
function and how perturbing their activities can cause
cognitive deficits.
In collaboration with Drs. J. Zhu and R. Malinow
here at CSHL, we have investigated the role of Ras
and Rapl in activity-dependent synaptic plasticity,
which is believed to underlie key aspects of brain
development, learning, and memory. Recent studies
have revealed that AMPA (a-amino-hydroxy-5-
methy1-4-isoazole) receptor (AMPA-R) trafficking is
important in synaptic plasticity; however, the signal-
ing pathways regulating this trafficking are poorly
understood. We found that Ras mediates activity-
induced synaptic enhancement by driving synaptic
delivery of AMPA-Rs containing long cytoplasmic
tails requiring p42/p44 MAPK activation. In contrast,
we observed that Rap I mediates activity-induced
synaptic depression by removing synaptic AMPA-Rs
containing short cytoplasmic tails requiring p38
MAPK activation. Taken together, these studies indi-
cate that Ras and Rapl serve as independent regula-
tors for potentiating and depressing central synapses.
We are currently investigating the contribution of the
immediate downstream effectors of the Ras and Rap
GTPases to AMPA-R trafficking.
My lab has also embarked on the functional char-
acterization of oligophrenin-1, which encodes a Rho-
GAP, and whose loss of function is associated with
nonsyndromic or nonspecific X-linked mental retar-
dation (MRX). MRX is characterized by mental
impairment without any other distinctive clinical fea-
tures. Eight genes involved in MRX have been cloned
to date, and importantly, three of these genes encode
regulators or effectors of the Rho GTPases. This has
led to the hypothesis that abnormal Rho GTPase sig-
naling may be a prominent cause of MRX, although it
has been unclear how mutations in these Rho-linked
genes lead to MRX since studies on the effects of loss
of these genes on neuronal development have not been
reported. We found that oligophrenin-1 is required for
normal dendritic spine morphogenesis. Using RNA
interference (RNAi) and antisense RNA approaches,
we demonstrated that down-regulation of oligo-
phrenin-1 levels in CAI hippocampal neurons in
organotypic slices resulted in a significant decrease in
dendritic spine length. Importantly, spine morphologi-
cal changes of the same magnitude have been report-
ed for a mouse model of Fragile X, indicating that
such changes can compromise synaptic plasticity.
We further obtained evidence that the RhoA/Rho-
kinase signaling pathway mediates the action of
oligophrenin-1 knockdown on dendritic spine length.
First, the effect of oligophrenin-1 knockdown on spine
length most closely mimics the phenotype observed
upon expression of a constitutively active RhoA
mutant, rather than an activated Racl or Cdc42 mutant.
Second, the effect of oligophrenin-1 knockdown on
spine length can be rescued by inhibition of Rho
kinase, a major downstream target of RhoA. Treatment
of oligophrenin-1 small interfering RNA (siRNA)-
transfected hippocampal slices with the Rho kinase
inhibitor Y-27632 resulted in a significant increase in
spine length in CA1 neurons compared to
oligophrenin-1 siRNA-transfected neurons in nontreat-
ed slices. Notably, Y-27632 treatment of hippocampal
slices transfected with control duplex siRNA did not
significantly increase spine length compared to
untreated slices. This observation suggests that the
RhoA/Rho- kinase pathway is repressed under physio-
logical conditions, which is consistent with studies by
Luo and colleagues. Our findings that full-length
oligophrenin-1 did not increase spine length further
supports this repression model, since overexpression of
a negative regulator of a primarily inactive pathway
would not be expected to result in a detectable pheno-
type. Taken together, our data support a model in which
oligophrenin-1 normally acts to repress the RhoA/Rho
kinase pathway to maintain spine length. Upon
removal of oligophrenin-1, inhibition of RhoA is
relieved, resulting in activation of Rho kinase and a
concomitant decrease in spine length (see Fig. 1). More
recently, we have identified an interaction between
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FIGURE 1 Model of the pathway through which knock down of
oligophrenin-1 levels results in a reduction in spine length.
Under normal physiological conditions in CA1 neurons in hip-
pocampal slices, RhoA activity, and as a result Rho-kinase
activity, is repressed in the presence of oligophrenin-1 in order
to maintain normal spine length (top panel). Knockdown of
oligophrenin-1 relieves negative regulation of oligophrenin-1 on
RhoA activity, causing an increase in RhoA and Rho-kinase
activities, and ultimately a reduction in spine length (middle
panel). When this pathway is interfered with in cells with
reduced oligophrenin-1 levels by using Y-27632 to inhibit Rho
kinase, the reduction in spine length
oligophrenin-1 levels can be rescued (bottom panel).
oligophrenin-1 and Homer, placing oligophrenin-1
within a postsynaptic complex that potentially links
oligophrenin-1 to glutamate receptor signaling. Our
findings provide insights into how mutations in a Rho-
linked MRX gene may compromise neuronal function
and demonstrate that RNAi is a valuable tool for study-
ing gene function in hippocampal slices.
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BIOINFORMATICS AND GENOMICS
Computers have an indispensable role in the rapidly progressing arena of biomedical research. CSHL
scientists working in the allied disciplines of genomics and bioinformatics use computer science and
mathematics to explore the molecular basis of life from many angles. By developing sophisticated soft-
ware and novel databases, these scientists are creating tools that are vital for interpreting the volumes
of information that are emerging with increasing speed from many studies of genes, genomes, proteins,
and proteomes.
Lincoln Stein's lab uses computer science to give meaning to the tremendously large data sets that
are resulting from a variety of genome research projects. One of several databases they have devel-
oped allows researchers to compare the genomes of rice, wheat, and corn and to identify genes that
might be used to engineer hardier, more productive varieties. Another, still a work in progress, is a
searchable database of fundamental processes in human biology called Genome Knowledge Base.
Stein's lab, in collaboration with researchers from around the world, also published a study this year
that details their plans to map the regions of common genetic variability in the human genome by com-
paring three major world populations. The resulting map will cut cost and effort in the search for genes
that indicate susceptibility to cancer and other disorders with genetic components.
W. Richard McCombie's lab continues to contribute significantly to several genome sequencing pro-
jects. This year, McCombie's lab collaborated with U.S. colleagues to sequence chromosome 10 of the
world's most important food source, rice. The scientists are continuing work to finish sequences of
parts of three other rice chromosomes. In collaboration with the Martienssen lab, they continued to
develop a new technique ("methylation filtration") for capturing gene-rich sequences of the corn
genome, proving it to be a superior method for finding new genes. They continued collaborating with
the Martienssen, Zhang, and Hannon labs to identify the positions of genes within plant and animal
genomes, including the mouse genome, which McCombie's lab recently helped sequence.
Bud Mishra's lab is bringing mathematics and computer science to bear on a challenging new field
known as systems biology. One of his lab's projects is to create a unified theoretical framework within
which scientists can understand life's biochemical pathways and the evolutionary processes that mold
them. These researchers merge math and biology to develop models of how genomes evolve and to
explore how evolution generates particular networks and modules of interacting components that func-
tion as biochemical pathways.
Michael Zhang's lab has created software for identifying signature sequences within DNA that reveal
the presence of important genetic elements such as promoters (DNA segments that control gene activ-
ity) or exons (DNA segments likely to code for proteins). They have compared the human and mouse
genomes and created a database of closely related DNA sequences shared by humans and mice. They
are currently using newly developed tools to compare differences in specific pieces of DNA between
prostate cancer and normal cells, in a method that can be applied to other diseases, improving our
understanding of cancer and generating possible targets for treatment.
Andrew Neuwald's lab has applied the power of statistical analysis to the prediction of protein struc-
ture and function. These researchers have developed a technique for identifying the most distinctive
molecular features of any particular family of proteins. Once identified among closely and moderately
related proteins, such features can be used to track down the most distant relatives of a protein fami-
ly. As a result, the scientists can infer the properties of poorly characterized proteins by assigning them
to protein families with known functions. Such analysis has revealed previously unrecognized roles for
certain proteins in human disease.
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GENOME SEQUENCE ANALYSIS
W.R. McCombie V. Balija M. Katari
M. de la Bastide F. Katzenberger
N. Dedhia B. Miller
S. Dike S. Muller
We have been working to develop strategies and tech-
nologies to extract biological information from plant
and animal genomes. The problems in the plant
genome are surprisingly different from those in the
animal genome. One of the major challenges in plant
genomics is to extract sequence information from the
genes out of a background of repeat sequences, which
can comprise 80-90% of the genome. The genes
themselves are quite compact in plants, but there are a
large variety of genomes that are important to
sequence. This is complicated by recent observations
that even different strains of plant species can have
very different genome structures. As a result, efforts
have been directed at developing methods to select,
sequence, and order the genes of large plant genomes
while bypassing the nongene regions. These strategies
are critically important to compare the sequences of
model genomes. We have
in these areas as described below.
In the animal world, there are several mammalian
genome sequences available. We have been focusing
our efforts on the experimental determination of gene
structure in the mouse. In particular, we have been
focusing on the determination of transcriptional start
sites and alternate first exons in mouse genes.
Rice Genome Sequencing
W.R. McCombie, V Balija, M. de Is Bastide, N. Dedhia, S.
Dike, M. Katari, F. Katzenberger, B. Miller, S. Muller,
L. Nascimento, A. O'Shaughnessy, L. Palmer, L. Spiegel,
T. Zutavern
We have continued our efforts as part of the
International Rice Genome Sequencing Consortium to
sequence the genome of rice. In collaboration with
Rod Wing's lab at the University of Arizona, we com-
pleted our regions of chromosome 10 in 2002. In
2003, we finished our regions of chromosome 3 ahead
of schedule. We were funded in 2003 to continue
sequencing by finishing regions of chromosomes 5, 9,
and 11. We sequenced almost 5 Mb of rice in 2003.
L. Nascimento L. Spiegel
A. O'Shaughnessy M. Yu
L. Palmer T. Zutavern
In addition to continuing the sequencing of rice,
we carried out an analysis of the whole of chromo-
some 10 which we finished sequencing last year.
Working with collaborators who sequenced other
areas of chromosome 10, we published an analysis of
this chromosome in 2003.
Sequencing and Analysis
of Gene Rich Regions
of the Maize Genome
W.R. McCombie, V. Balija, M. de Is Bastide, N. Dedhia,
M. Katari, F. Katzenberger, B. Miller, S. Muller, L. Nascimento,
A. O'Shaughnessy, L. Palmer, T. Zutavern
In collaboration with Rob Martienssen's lab here at
CSHL, we have previously raised the possibility of
selectively enriching whole-genome clone libraries for
genes and developed methods to do this (Rabinowicz
et al. 2003). Subsequently, we and others have been
working to carry out a large-scale test of these strate-
gies, as well as to develop additional methods and
strategies to use these data as a starting point in the
generation of a set of sequences corresponding to the
maize genes, which have been ordered, oriented, and
linked to the physical map of maize.
We sequenced about 100,000 sequence reads from
methyl-filtered libraries which are enriched for genes.
We also used additional sequences of methyl-filtered
reads from GenBank (mostly generated by The Maize
Sequencing Consortium) in our analysis. Since the
corn genome is not complete, we chose to use the
sequence of the closely related rice genome as a surro-
gate for the corn genome in our analysis. We also com-
pared the publicly available set of maize expressed
sequence tags (ESTs) and rescue-Mu sequences avail-
able from GenBank with gene predictions from the rice
genome. Figure 1 shows that after a relatively small
number of sequence reads (about 60,000), methyl-fil-
tered reads become more efficient at detecting genes
than are ESTs. The data show that the methyl-filtered
approach is obtaining a large percentage of the maize
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FIGURE 1 Comparative gene discovery. Random sets of maize
reads (closed squares) MFRS; (closed triangles) ESTs; (closed
diamonds) RMs. The random sets were selected and the total
number of distinct rice BAC/PAC FGENESH predictions over-
lapped by the reads were plotted.
genome and can serve as a basis for an overall strategy
to sequence large plant genomes. These results were
published in 2003. We are currently refining and test-
ing strategies to link the methyl-filtered reads to the
physical map of corn and finish the genes to high qual-
ity. This strategy has the potential to produce a highly
valuable, complete sequence of the corn "genespace"
for a fraction of the cost of even a low-quality draft
sequence of the com genome.
Detection of Transcripts and
Transcriptional Start Sites
in the Mouse Genome
W.R. McCombie, V. Balija, S. Dike, F. Katzenberger,
B. Miller, S. Muller, L. Nascimento, A. O'Shaughnessy,
L. Palmer, T. Zutavern
Last year, we began a project to experimentally con-
firm the presence of mouse genes predicted by com-
putational methods as well as to determine their tran-
scriptional start sites. After our initial work last year,
we expanded the number of genes under study and the
tissues in which we assayed for their presence. A total
of 300 mouse gene predictions was selected for analy-
sis. Although some of these were well-characterized
genes, a number of the predictions were not considered
to be part of the canonical gene set (based on the
ENSEMBL pipeline). We then placed these genes in
one of five different categories based on the quality
and quantity of supporting evidence for the gene
model. The categories, the definitions, and the number
of genes tested in each group are shown in Table 1.
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TABLE 1 Description of Gene Categories
Number of
Category genes tested Definition
EPD 13 Genes found in the Eukaryotic
Promoter Database having
experimentally verified tran-
scriptional start sites.
RefSeq 27 NCBI's curated nonredundant set
of genes.
Category B 23 Automated NCBI predictions
covered by multiple ESTs.
Category C 169 Gene predictions covered by a
single EST.
Category D 68 Gene predictions that do not
overlap any EST, mRNA,
cDNA, ENSEMBLE, or GENIE
evidence.
Three hundred mouse genes or gene predictions were classified into five
categories based on the quality of associated evidence. The definition
column describes the basis for the classification. Genes in the EPD cat-
egory have the highest-quality evidence and were used as positive con-
trol for all experiments. Predicted genes in Category D are considered to
be based on evidence with the least amount of confidence.
Gene sequences and sequences obtained using the
RACE-PCR (polymerase chain reaction) method were
aligned to the mouse genome using BLAT (Kent et al.,
Genome Res. 12: 656 [2002]). A RACE-PCR sequence
was counted as a positive hit if it satisfied all of the fol-
lowing criteria: (1) alignment indicated a spliced prod-
uct, (2) mapped to the same region of the genome as the
gene sequence, (3) could be mapped uniquely to the
genome with >98% identity for >95% of the sequence,
(4) at least two clones were obtained with similar exon
structure (cases where only one clone was obtained for
a particular variant were also considered a hit if the vari-
ant sequence matched an EST or cDNA deposited in
GenBank), and (5) the sequence contained the RACE-
specific primer sequence. Sequences for 15 genes (in C
and D categories) did not produce spliced products but
agreed with all of the other criteria mentioned above.
Careful analysis indicated that for all of these cases, the
exon that contained the primer sequences was itself the
first exon. For two of these cases, spliced products were
obtained using additional primers and amplifying the 3'
end of the gene using 3' RACE-PCR. This indicates that
these are real genes and therefore counted as positive
hits.
The result of 5' RACE-PCR on a set of 15 mouse
tissues/stages is shown in Figure 2 (top). The genes in
the EPD set serve as our internal positive control. All
13 genes in the EPD category were detected. For all of
these genes, at least one splice variant was detected
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FIGURE 2 Detection of 5' ends of genes using RACE-PCR.
(Top) 5' RACE-PCR was performed on 15 mouse tissues/
stages. The percentage of genes detected by this method and
satisfying the criteria are shown for different categories.
(Bottom) Percentage of detected genes where the reference
sequence annotation was found to be incomplete at the 5' end
is shown for each category.
that agreed with the annotated first exon for the corre-
sponding gene in the Eukaryotic Promoter Database.
A majority of the well-characterized and curated
genes (100% in the EPD and 74% in the REFSEQ cat-
egories) produced spliced products.
As expected, a significantly lower percentage of
class C and D genes were amplified. In the case of the
RefSeq genes, of the seven genes not detected, four
produced a nonspecific amplification product. This
indicates a lack of primer specificity due to a related
sequence elsewhere in the genome. An alternative in
these cases is that the primer did not match an exon
and the amplified product represents background
amplification. In either case, it is likely in these cases
that alternate primer selection will resolve the prob-
lem.
The simplest explanation for not detecting more of
the RefSeq genes tested may be that the transcripts
were absent in the tissues/stages tested or that the
annotated gene structures contained sufficient errors
to interfere with selecting useful primers for amplifi-
cation. Initial trials using four mouse tissues (7- and
17-day embryos, total brain and testes) resulted in the
detection of only 91 genes. The detection rate
improved by 5% when the number of tissues tested
was increased to 15, indicating that tissue distribution
is clearly an issue. For class C and D genes, many of
the failures probably were due to attempts to amplify
something that really is not a gene. Since the class C
and D genes are not considered to be "real" in that
they are not in the canonical gene set, their detection
even at this level is somewhat astonishing, suggesting
that there are a significant number of genes not cur-
rently annotated. Moreover, Figure 2 (bottom) shows
the percentage of gene annotations which agree with
the experiemental data. It shows that even in the case
of RefSeq genes, a substantial number of genes have
transcriptional start sites that differ from those shown
in the current database. In some cases, these likely
represent alternative 5' exons, perhaps expressed in a
tissue-specific manner. In a number of cases, however,
the discrepancies likely represent errors in the data-
bases. These discrepancies are highly problematic for
future bioinformatics analyses of the mammalian tran-
scriptome. Ideally, one would like to correlate the
sequences of the promoters of genes with their expres-
sion based on microarrays or other data. This requires
an accurate determination of the transcriptional start
site of the gene, and our data indicate that this may fre-
quently be lacking in the current databases.
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ADVANCED COMPUTING TOOLS FOR BIOLOGY
B. Mishra M. Antoniotti J. Feng
P. Barbano 0. Gill
F. Chen I. lonita
V. Cherepinsky J. McQuown
R. Daruwala
S. Paxia C. Tignor
A. Rudra N. Ugel
M. Spivak M.P. Venkatesh
B. Sung Y. Zhou
Modern biological research has primarily focused on
our capability for generating massive amounts of syn-
tactic information from genomics and functional
genomics data, but it has been slow in exploiting this
capability to unravel their semantics. This deciphering
requires a powerful information technology infrastruc-
ture for translating our understanding of the part lists
to a deeper understanding of their interactions at a sys-
tems level.
Tools that are capable of uncovering subtle and
universal biological principles at play will enable rev-
olutionary progress in the biomedical sciences.
Creating these tools has become one of the grand chal-
lenges in computer science today.
This group has focused its efforts on building
tools across the gamut of modern computational
biology. Our core tool for biological discovery is a
multi-scripting environment called Valis. Valis allows
bioinformatics researchers to collaborate by provid-
ing core bioinformatics tools and access to numerous
statistical, numerical, and visualization libraries
through simple scripting languages. In fact, a single
program can call routines written by other
researchers in other languages with no extra coding
necessary. Valis now incorporates the Simpathica
"systems biology" tool-set created for the study of
biological pathways and evolutionary processes. The
group also has created NYUMAD (Micro Array
Database) a tool for collecting, analyzing, and dis-
tributing microarray data.
The introduction of information technology into
biology and biotechnology has already transformed
and accelerated the nature of biological research. The
impact of this transformation has been felt in the areas
of agriculture, pharmacology, disease diagnosis and
prognosis, forensics, defense against bio-warfare, and
biometry, and ultimately affects how we interact with
our immediate natural environment. Drawing on ideas
from systems sciences, dynamical systems, logic,
computer science, and many other physical sciences,
there is now an opportunity to build tools that are
mathematically precise, sound, and exhaustive, com-
putationally efficient, and scalable.
VALIS
One of the central efforts of the group has been to cre-
ate a bioinformatics environment that will make it eas-
ier for biologists to develop their own computational
tools. This environment, called Valis, includes tools
for visualization of biological information, design and
simulation of in silico experiments, and storage and
communication of biological information. Listed
below are novel features in the Valis environment.
Language-independent Architecture: The Valis
advanced scripting engine can integrate research
from multiple groups into a single environment.
Researchers using the Valis framework can share
both the data and the algorithms for the analysis of
that data. The language-independent architecture of
Valis allows research groups to leverage programs
written in different languages.
Whole-genome Analysis: New data structures and
algorithms make it possible to perform whole-
genome analysis on commodity hardware. As the
throughput of sequencing efforts increases, Valis is
likely to become the only tool available that allows
analyses to be performed on entire genomes.
Valis, which is slowly being rolled out to the larg-
er scientific community, has recently been used to
develop a set of methods that can validate and find
discrepancies in recently released human genome
sequence data.
These methods will have an immediate and direct
impact on the biological community: creating algo-
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FIGURE 1 Image of a simple genome browser created in the Valis environment. Bands above show
genes, mer-frequency analysis, and Gibbs free-energy along a segment of the genome. Using modern
computer science techniques and seamless integration with cluster-computers, the genome browser
allows whole-genome analyses to be performed on the fly.
rithms for understanding and extracting information
from genomic and transcriptomic data in a coordinat-
ed manner; building, modifying, and correcting exist-
ing models to understand biological processes; and
creating a common and unified language for biolo-
gists to communicate, exchange data, design, and dis-
seminate experimental protocols.
SIMPATHICA
The Simpathica system allows biologists to construct
and simulate models of metabolic and regulatory net-
works and analyze their behavior. Metabolic pathways
can be drawn on the screen through a visual program-
ming environment or, in a specialized XML format, a
language originally designed to promote information
exchange between multiple systems and programs.
The system allows a biologist to combine simple
building blocks representing well-known objects: bio-
chemical reactions and modulations of their effects.
The system then simulates the pathways thus entered.
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Coupled with a natural language system, the
Simpathica tool allows a user to ask questions, in plain
English, about the temporal evolution of the pathways
previously entered.
Collaborators at Cold Spring Harbor Laboratory
have recently used Simpathica to explore a Caspase
cascade model for apoptosis, cell death. Using the sys-
tem, a rough topological model was constructed and
analyzed. This simple model pointed out the possible
presence of several unmodeled processes, without
which the core model could not explain various well-
known threshold effects.
Using modeling tools like Simpathica to simulate
biological processes in silico, a biologist can model
and study the behavior of complex systems, exploring
many different scenarios rapidly without relying sole-
ly on experimentation. Tools like Simpathica will
allow researchers to formulate a hypothesis and
design better experiments, drastically cutting down
the time for research. Simpathica now includes a nat-
ural language interface to allow the system to be
queried in plain language.
lular communication processes (e.g., cell signaling
involved in cancer and development).
Analyzing genomic information from microbes to
humans and the evolutionary forces that shaped them.
Using genomic, proteomic, and biochemical infor-
mation to aid in the process of understanding dis-
ease processes.
This interdisciplinary group places an equal
emphasis on computational techniques and biology
and therefore attracts researchers and students from
mathematics, statistics, computer science, and biology
who collaborate with physicians, physicists, and
chemists from leading national laboratories in bioin-
formatics and in industry. Through the consilience of
many disciplines, this group hopes to advance the
entire biological community through its software
(Valis, NYUMAD, Simpathica, etc.).
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FIGURE 2 Image of NYU MicroArray Database Application.
Our group has also developed a sophisticated software
system to maintain and analyze biological abundance
data (e.g., microarray expression levels or proteomic
data) along with associated experimental conditions
and protocols. The prototypic system is called the
NYU MicroArray Database (NYUMAD) and is being
expanded to deal with many other related experiments.
It uses a relational database management system for
the storage of the data and has a flexible database
schema designed to store any type of abundance data,
along with general research data such as experimental
conditions and protocols.
The database schema is defined using standard
SQL (Structured Query Language) and is therefore
portable to any SQL database platform. NYUMAD
supports the MAGE-ML standard for the exchange of
gene expression data, defined by the Microarray Gene
Expression Data Group (MGED) and is accessible via
the Web.
NYUMAD is a secure repository for both public
and private data. Users can control the visibility of
their data. Initially, the data might be private, but after
publication of the results, the data can be made visible
to the larger research community. Data analysis tools
are supplemented with visualization tools. The goal is
of existing techniques, but to
incorporate ever more sophisticated and mathemati-
cally robust methods in the data analysis and to pro-
vide links and integration with our other tools such as
the Valis system.
Our goal for NYUMAD is to create a set of central-
ized repositories allowing researchers to search for pat-
terns in gene behavior over large samples collected at
many different sites. We hope that NYUMAD will be-
come a comprehensive resource for biological abundance
data that is as easily queried as the World Wide Web.
SUMMARY
In the "postgenomic" frontier of biological research,
computer science has a critical role in advancing bio-
logical discovery, and the group intends to stay on the
cutting-edge of this research. We aim to create better
computational biology tools by focusing on more
accurate and efficient mathematical methods for ana-
lyzing genetic data.
A summary of the biological problems the group
tackles include the following:
Understanding regulatory, metabolic and intercel-
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EVOLUTIONARY CONSTRAINTS AS PROTEIN PROPERTIES
REFLECTING UNDERLYING MOLECULAR MECHANISMS
A.F. Neuwald N. Kannan
Our understanding of protein function comes through
analyses of their basic properties, such as their
sequences, structures, and subcellular locations.
Rather than examining physical properties, however,
our focus is on quantifying and characterizing a pro-
tein's evolutionary properties, namely, the sequence
constraints imposed by natural selection during evolu-
tion. Such constraints are evident as sequence patterns
conserved in representative members of a protein fam-
ily that have diverged from a common ancestor at least
a half billion years ago. Such proteins would have lost
all sequence similarity if not for the selective pressures
maintaining underlying mechanisms important for
their biological functions.
Because we focus on classes of proteins for which
vast amounts of sequence, structural, and other exper-
imental data are available, powerful statistical proce-
dures can be used to detect subtle yet significant char-
acteristics. These are applied along with other proce-
dures to (1) detect and align distantly related
sequences, (2) categorize the conserved patterns pre-
sent in those sequences, (3) quantify the associated
selective constraints, and (4) interpret these con-
straints in light of available structural, biochemical,
taxonomic, and genetic data. We term this approach
contrast hierarchical alignment and interaction net-
work (CHAIN) analysis, an initial description of
which was published early this year. In this publica-
tion, we also illustrate the application of CHAIN
analysis to Ras-like GTPases, a family of proteins
important to our understanding of cancer.
A MATHEMATICALLY RIGOROUS DESCRIPTION
OF EVOLUTIONARY CONSTRAINTS
This work was done in collaboration with Jun Liu
(Department of Statistics, Harvard University).
Although even a qualitative description of selective
constraints is informative, a mathematically rigorous
description can reveal subtle aspects of protein func-
tion that might otherwise be missed. For this reason,
we developed a statistical description of protein con-
straints analogous to that formulated for Gibbs-free
energy in statistical thermodynamics. Just as the ener-
gy of a chemical reaction is defined by the degree to
which reactants are shifted toward products, we have
mathematically defined selective constraints by the
degree to which the proteins of interest have been
shifted away from related proteins during evolutionary
divergence. We similarly define differences in selec-
tive constraints between related subgroups of proteins
in a manner roughly analogous to free-energy changes
between thermodynamic states. Important aspects of
our statistical description are algorithmic inasmuch as
valid quantification of selective constraints strongly
depends, for example, on the accuracy of the multiple
sequence alignments used to measure them. In a sub-
mitted manuscript, we describe these statistical and
associated algorithmic procedures, including a hidden
Markov model, an algebraic system, and Monte Carlo
sampling strategies for gapped multiple alignment of
protein sequence motifs. This work corrects certain
misaligned regions (associated with proteins harbor-
ing sizable insertions) that were encountered when
using the PSI-BLAST multiple alignment method
originally implemented for CHAIN analysis (see Fig.
1). This paper also describes intervention strategies
that improve a multiple alignment based on expert
knowledge provided by the user. Several programs
implementing these procedures are being made avail-
able, including GISMO (Gibbs-like sampling with
multiple operations) and GARMA (genetic algorithm
for recombinant multiple alignment). Another signifi-
cant algorithmic breakthrough implemented in the
GARMA program is a statistical procedure that auto-
matically optimizes gap penalties.
CHAIN ANALYSIS OF DNA POLYMERASE III
CLAMP LOADING
The prokaryotic DNA polymerase III clamp loader
complex loads onto DNA and unloads the 13-clamp,
which links the replication complex to DNA during
polynucleotide synthesis. The minimal complex nec-
essary for clamp loading consists of one 8, one 8', and
three y subunits, which are evolutionarily related,
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FIGURE 1 Correction of a protein multiple alignment error within a G-GTPase harboring an inserted GTPase activation
protein (GAP) domain. (A) Corrected CHAIN analysis alignment using our new procedures. Both the Walker A and the
Walker B (unlabeled) motifs are correctly aligned. (8) Uncorrected alignment generated using PSI-BLAST. Note that the
Walker A motif is misaligned against the carboxy-terminal region of the GAP domain.
although only the y subunit exhibits ATPase activity.
We have applied CHAIN analysis to the 13-clamp and
to they and 8' clamp loader subunits. A paper describ-
ing the 13-clamp analysis has been published. This
analysis reveals conserved residues that appear to be
associated with various aspects of 13-clamp loading
onto and unloading from DNA. This, in turn, suggests
corresponding mechanisms, including, for example,
how binding to DNA may be coupled to closing of the
clamp. Although CHAIN analysis is at present typi-
cally applicable only to very large classes of proteins,
the 13-clamp paper illustrates that it nevertheless
sometimes works for a relatively small set of proteins
(-50 distinct (3 clamps). This was achieved by struc-
turally aligning three homologous domains present in
13-clamp monomers (which thus increased the effec-
tive number of (3 domain sequences aligned to 150).
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This supports our conviction that CHAIN analysis will
be more widely applied as we better understand the
principles involved in identifying and interpreting
evolutionary constraints. CHAIN analysis of the DNA
polymerase III y and 8' subunits similarly reveals
selective constraints acting upon the clamp loader
complex. Categorization of these constraints points to
specific residues likely involved in contacts between
subunits of the 7 complex, in coordinated conforma-
tional changes associated with clamp loading, and in
coupling binding to DNA with ATP hydrolysis.
CMGC PROTEIN KINASE STRUCTURAL
MECHANISMS
Eukaryotic protein kinases propagate and amplify
extracellular and intracellular signals and thus have
important regulatory roles in diverse cellular process-
es, such as metabolism, transcription, cell cycle pro-
gression, apoptosis, and neuronal development. We
have continued to apply CHAIN analysis to various
classes of protein kinases, including the MAP, CDK,
GSK, and SR protein kinase families. This has
revealed both important family-specific mechanistic
features, including a possible role for conserved
buried waters in substrate specificity, and group-spe-
cific mechanisms, including a network of conserved
interactions that appears to couple CMGC kinase acti-
vation to regulatory factors that bind via a characteris-
tic insert region. We were invited to present this analy-
sis at the 2003 Protein Phosphorylation Workshop in
Asilomar, California. The organizers of this meeting
have asked us to incorporate the results of this and
similar analyses into the Protein Kinase Resource
(http://pkr.sdsc.eduihtml/index.shtml).
r
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COMMUNITY ACCESS TO GENOME RESOURCES
L. Stein
GRAMENE: A COMPARATIVE MAPPING
RESOURCE FOR GRAINS
The Gramene database (www.gramene.org) is a com-
parative mapping resource for rice and other grains.
Gramene allows researchers to compare the genetic
and physical maps of the major monocot crops,
namely, maize, barley, oats, sorghum, and wheat, to
the emerging rice genomic sequence. This allows
researchers to identify candidate genes in the rice
genome that correspond to genetically mapped
mutants and quantitative traits in the non-rice crop
they are studying. Hence, the resource grants
researchers studying traits in maize, barley, and so
forth the benefit of genomic sequencing without
waiting for the sequencing of these much larger
genomes.
In addition to comparative maps, Gramene offers
up-to-date genomic annotation of the rice genome,
including both predicted and confirmed genes, and the
current physical maps of rice and sorghum. We have
mapped more than 1 million monocot ESTs
(expressed sequence tags) to the rice genome, allow-
ing gene predictions to be further refined based on
cross-species comparisons. During this year, we devel-
oped a new integrated map of the rice and maize
genomes that allows researchers to move back and
forth between various genetic and physical maps of
these species in order to apply the knowledge devel-
oped in one organism to finding functionally signifi-
cant genes in the other.
Curation is an important component of Gramene.
In collaboration with Susan Mc Couch's laboratory in
Cornell, we have curated more than 12,000 rice pro-
teins, assigning them classifications in the Gene
Ontology (www.geneontology.org). In addition, we
have classified more than 700 rice mutants using a
trait ontology that we have developed. We are current-
ly curating the rice biological literature, much of
which is in non-English languages, and making this
information available via Gramene as well.
During the past year, Gramene increased its hold-
ing substantially by adding a variety of important
comparative mapping resources, including high-
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throughput gene-rich sequences from maize and
sorghum, and a series of mapped transposon insertions
useful for functional genomics. Our work culminated
this year in coauthorship in a Science paper on the
sequencing of Rice Chromosome 10.
WORMBASE: A RESOURCE FOR C. ELEGANS
GENOME AND BIOLOGY
Our lab continues to be a major developer and main-
tainer of the WormBase database, an on-line informa-
tion resource for the small free-living nematode,
Caenorhabditis elegans. This organism is favored as a
simple model animal because of its small genome
size, experimental malleability, and well-understood
cellular anatomy. WormBase is a curated model organ-
ism database developed as part of an international col-
laboration that includes the California Institute of
Technology, Washington University at St. Louis, and
the Sanger Centre. Our lab is responsible for the Web
site, user interface, and software architecture for the
project.
The resource, which is available to the public at
www.wormbase.org, contains the complete C. elegans
genome and key annotations, including predicted
genes, alternative splicing patterns, oligonucleotide
probes, and evolutionarily conserved segments. It also
contains many other types of biological information,
including the C. elegans cell pedigree, the organism's
neuroanatomy, its genetic map, and the physical map
from which the genomic sequence was derived.
Our major work during 2003 was to use
WormBase as a platform to analyze the genome
sequence of C. briggsae, a sister species of C. elegans
that diverged approximately 100 million years ago.
Our work on C. briggsae has resulted in new insights
into the evolution of genomes and gene families, par-
ticularly with respect to the functionally important
chemsensory receptor family of genes (Fig. 1). The
analysis also allowed us to add approximately 1000
new genes to C. elegans and to correct and improve
several thousand others. This work resulted in a major
publication in the new journal PLoS Biology.
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FIGURE 1 Tree view of all chemosensory receptor genes in the
sra subfamily. C. elegans is shown in white background and C.
briggsae in light gray background. The arrows indicate regions
of C. e/egans-specific expansion of the family. (Inset) Schematic
of the region of C. elegans chromosome I corresponding to the
sra expansion in the upper right of the tree. C. briggsae genes
are named using the prefix CBG, whereas C. elegans genes are
numbered consecutively across the cosmid on which they
were first identified. This analysis shows evolution in action: The
chemosensory receptor gene family is actively growing in C.
elegans by a process of tandem duplication.
GENOME KNOWLEDGEBASE
The Genome KnowledgeBase (GKB) is a collabora-
tion with the European Bioinformatics Institute (EBI)
and the Gene Ontology Consortium to develop a Web-
accessible resource for curated information about bio-
logical processes.
The GKB is organized like a review journal.
Experimental biologists are invited to create "summa-
tions" that summarize a particular aspect of their field.
Currently, summations include "DNA Replication,"
"Protein Translation," and the basic pathways of inter-
mediate metabolism, such as the TCA cycle. New
modules for "RNA Splicing" and "Cycle Checkpoints"
are in progress. Summations are similar to mini-
reviews, except that each paragraph of text is reduced
to a series of logical assertions that is entered into a
database of processes and macromolecules. The data-
base is then used to drive a Web site. The Web site can
be browsed like a textbook or searched with queries to
discover pathways and connections.
During 2003, we roughly doubled the number of
modules described in GKB, thereby covering about
80% of intermediate metabolism and 75% of the
Central Paradigm. We held a total of five "annotation
jamborees" in New York and London, meetings at
which researchers and GKB curators worked side-by-
side to create new modules and troubleshoot existing
ones. In parallel with this work, we significantly
improved the visualization tools available on the GKB
Web site. In particular, the "Constellation Viewer"
(Fig. 2) provides a birds-eye view of all macromolec-
ular reactions known to the database, simultaneously
providing a navigation tool for researchers and an
advanced visualization tool for hypothesis generation.
In the near future, it will be possible to superimpose
large-scale data sets, such as microarray experiments,
onto the Constellation Viewer in order to see at a
glance which pathways are affected.
GENERIC MODEL ORGANISM DATABASE PROJECT
In collaboration with the model organism system data-
bases FlyBase, SGD, and MGD, the Generic Model
Organism Database (GMOD) project is developing a
set of database schemas, applications, and interfaces
suitable for creating a model organism system data-
base. The hope is to significantly reduce the time and
expense required to create new databases to curate
genomic information coming out of various model
organism system sequencing projects (e.g., rat,
Dictyostelium, and Plasmodium).
The end of calendar 2003 saw the first alpha release
of the GMOD package, consisting of a modular data-
base, Chado, a genome browser, GBrowse, and a
genome editor, Apollo. The package includes documen-
tation, installer scripts, and example data and is cur-
rently being tested and scrutinized by a number of aca-
demic and commercial groups. Partially in recognition
of the value of the GMOD project, Stein was awarded
the Benjamin Franklin Award in Bioinformatics, given
annually by Bioinformatics.org, for his promotion of
open source and open standards tools.
THE HUMAN HAPLOTYPE MAP
The International Human HapMap Project (http://
www.hapmap.org) seeks to map out regions of com-
mon genetic variability in the human genome by geno-
typing three major world populations at a resolution of
1 marker per 5 kbp. When complete, the resulting
"haplotype map" will greatly reduce the cost of genet-
ic association studies to find cancer susceptibility
genes and other disorders with genetic components.
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The 5i-ends of all eukaryotic pre-mRNAs studied thus tar are converted to cap structures. The cap is thought
to influence splicing of the first intron, and is bound by 'cap-binding' proteins, CBP80 and CBP20, in the
nucleus. The cap is important for translation initiation, and it also interacts with the poly(A)terminus, via
proteins, resulting in circularization of the mRNA to facilitate multiple rounds of translation. The cap is also
important for mRNA stability, protecting it from 5' to 3' nucleases, and is required for mRNA export to the
cytoplasm.
The capping reaction usually occurs very rapidly on nascent transcripts; attar the synthesis of only a few
nucleotides by RNA polymerase II. The capping reaction involves the conversion of the 5i-end of the nascent
transcript from a triphosphate to a diphosphate by a RNA 5.-triphosphatase, followed by the addition of a
guanosine monophosphate by the mRNA guanylyltransferase, to form a 5,5'-triphosphate linkage. This cap
is then methylated by 2,0-methyltransferases.
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FIGURE 2 Visualizing pathways with the Genome KnowledgeBase. Shown is a page from the Cell Cycle Checkpoints
module. At the top is the Constellation View. All pathways known to the Knowledgebase are displayed in gray, and those
relevant to cell cycle checkpoints are highlighted. As the user magnifies the Constellation View, more detail appears. At the
bottom is the main page, where the user is shown detailed information on the first steps of the pathway.
Our lab is a central participant in this project in our
role as the Data Coordinating Center (DCC). We man-
age the central database for the project, allocate SNPs
to the 11 genotyping centers, coordinate data submis-
sion, quality checks, and quality control, and mange
the public release of project data. The HapMap Web
site, which was developed in our lab, describes the
project in the four languages of the project participants
(English, French, Chinese, Japanese, Yoruba) and pro-
vides access to the data both for bulk download and
for interactive querying and browsing using the
GMOD tools.
A policy paper describing the project, its goals,
and the data management issues was published in a
December 2003 article in Science.
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COMPUTATIONAL GENOMICS
M.Q. Zhang N. Banerjee R. Das
Y. Benita N. Hata
G.X. Chen H. Lin
D. Das K. Mamoru
D. Schones
F. Wang
J.H. Wang
Z.Y. Xuan
Our research interest continues to be the identification
and characterization of the genetic elements in nucleic
acid sequences by computational means. This last year,
our main focus was to continue building our own large-
scale genome analysis infrastructure. After the first-
pass annotation of the human promoters, we have been
further developing our promoter annotation pipeline to
include comparative genomics; it can combine FirstEF
prediction, mRNA/EST (expressed sequence tag) data,
and other mammalian genomic sequences to annotate
promoters and first exons for human, mouse, and rat
simultaneously and automatically. We built the first
version of CSHL Mammalian Promoter Database and
a promoter data set for Affymetrix gene chip
HGU133A. We have also been doing genome-wide
comparative analyses of alternatively spliced tran-
scripts between human and mouse and constructing a
Mammalian Alternatively Spliced Transcript Database.
In collaboration with the Krainer lab here at CSHL, we
have built ESEfinder, a Web resource, to identify exon-
ic splicing enhancers. We have developed new compu-
tational methods for transcription factor binding-site
motifs by taking all three large-scale resources: com-
parative genomic sequences, ChIP-chip and expression
microarray data. First of all, we developed a novel
motif-finding algorithm called BEAST, which allows
users to identify differentially "expressed" motifs
between two arbitrary (target and control) sequence
sets. This tool has been successfully applied to find
cooperative motifs when combining sequence, expres-
sion, and ChIP-chip data or to find functionally more
relevant motifs when combining expression and GO
annotation data. We have also demonstrated that coop-
erative transcription factors may also be identified
directly without using sequence data. In collaboration
with the Ren lab at the University of California, San
Diego (UCSD), we have found a global transcriptional
regulatory role for c-Myc in Burkitt's lymphoma cells.
In collaboration with the Fu lab at UCSD and the Fan
lab at Illumina, we have collected the data from our
first alternative splicing chip experiments to compare
transcript isoform differences between prostate cancer
and normal cells; analysis is still being carried out at
the moment. Below are more detailed descriptions of
some finished projects in 2003.
We (Z.Y. Xuan and M.Q. Zhang) are also collabo-
rating with the McCombie and Hannon labs here at
CSHL to systematically examine gene predictions in
the mouse genome.
Annotation of Promoters and
First Exons in the Human Genome
I. Grosse, M.O. Zhang [in collaboration with R. Davuluri,
Ohio State University]
The human genome contains a vast number of cis-reg-
ulatory regions responsible for directing spatial and
temporal patterns of gene expression, and delineating
their locations is of paramount importance for our
understanding of gene expression and regulation.
However, due to the absence of full-length 5"-untrans-
lated regions for many of the cDNAs, the identification
and annotation of these functional regions are behind
that of coding regions. Here, we present an initial com-
putational annotation of promoters and first exons for
the 24 chromosomes of the human genome. Using
expressed sequence databases and an automated anno-
tation pipeline, we have annotated promoter and first
exons for a total of 53,645 different transcripts in
34,255 genes. In current annotations, 80% of the iden-
tified genes are supported by RefSeq/mRNA or spliced
EST transcripts; and 30% of the genes have two or more
alternative first exons and associated splice variants.
Identification of Cooperativity
Among Transcription Factors
Controlling Cell Cycle in Yeast
N. Banerjee, M.Q. Zhang
Transcription regulation in eukaryotes is known to
occur through the coordinated action of multiple tran-
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scription factors (TFs). Recently, a few genome-wide
transcription studies have begun to explore the com-
binatorial nature of TF interactions. We propose a
novel approach that reveals how multiple TFs cooper-
ate to regulate transcription in the yeast cell cycle.
Our method integrates genome-wide gene expression
data and chromatin immunoprecipitation (ChIP-chip)
data to discover more biologically relevant synergis-
tic interactions between different TFs and their target
genes than previous studies. Given any pair of TFs A
and B, we define a novel measure of cooperativity
between the two TFs based on the expression patterns
of sets of target genes of only A, only B, and both A
and B. If the cooperativity measure is significant,
then there is reason to postulate that the presence of
both TFs is needed to influence gene expression. Our
results indicate that many cooperative TFs that were
previously characterized experimentally indeed have
high values of cooperativity measures in our analysis.
In addition, we propose several novel, experimentally
testable predictions of cooperative TFs that have a
role in the cell cycle and other biological processes.
Many of them hold interesting clues for cross-talk
between the cell cycle and other processes, including
metabolism, stress response, and pseudohyphal dif-
ferentiation. Finally, we have created a Web tool
where researchers can explore the exhaustive list of
cooperative TFs and survey the graphical representa-
tion of the target genes' expression profiles. The
interface includes a tool to dynamically draw a TF
cooperativity network of 113 TFs with user-defined
significance levels. This study is an example of how
systematic combination of diverse data types, along
with new functional genomic approaches, can pro-
vide a rigorous platform to map TF interactions more
efficiently.
A Global Transcriptional
Regulatory Role for c-Myc in
Burkitt's Lymphoma Cells
M.Q. Zhang [in collaboration with the Ren lab, University
of California, San Diego]
Overexpression of c-Myc is one of the most common
alterations in human cancers, yet it is not clear how
this transcription factor acts to promote malignant
transformation. To understand the molecular targets of
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c-Myc function, we have used an unbiased genome-
wide location-analysis approach to examine the
genomic binding sites of c-Myc in Burkitt's lymphoma
cells. We find that c-Myc together with its het-
erodimeric partner, Max, occupy >15% of gene pro-
moters tested in these cancer cells. The DNA binding
of c-Myc and Max correlates extensively with gene
expression throughout the genome, a hallmark
attribute of general transcription factors. The c-
Myc-Max heterodimer complexes also colocalize
with transcription factor HD in these cells, further sup-
porting a general role for overexpressed c-Myc in
global gene regulation. In addition, transcription of a
majority of c-Myc target genes exhibits changes cor-
related with levels of c-myc mRNA in a diverse set of
tissues and cell lines, supporting the conclusion that c-
Myc regulates them. Taken together, these results sug-
gest a general role for overexpressed c-Myc in global
transcriptional regulation in some cancer cells and
point toward molecular mechanisms for c-Myc func-
tion in malignant transformation.
ESEfinder: A Web Resource
to Identify Exonic Splicing
Enhancers
J.H. Wang, Z.W. Zhu, M.Q. Zhang [in collaboration
with the Krainer lab, Cold Spring Harbor
Laboratory]
Point mutations frequently cause genetic diseases by
disrupting the correct pattern of pre-mRNA splicing.
The effect of a point mutation within a coding sequence
is traditionally attributed to the deduced change in the
corresponding amino acid. However, some point muta-
tions can have much more severe effects on the struc-
ture of the encoded protein, for example, when they
inactivate an exonic splicing enhancer (ESE), thereby
resulting in exon skipping. ESEs also appear to be espe-
cially important in exons that normally undergo alter-
native splicing. Different classes of ESE consensus
motifs have been described, but they are not always eas-
ily identified. ESEfinder (http://exon.cshl.edu/ESE/) is
a Web-based resource that facilitates rapid analysis of
exon sequences to identify putative ESEs responsive to
the human SR proteins SF2/ASF, SC35, SRp40, and
SRp55 and to predict whether exonic mutations disrupt
such elements.
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NEUROSCIENCE
The human brain is able to solve certain computations that remain far beyond today's most sophisti-
cated computers. Anthony Zador's lab is probing the brain's unique computational style by examining
how the brain processes complicated auditory input we call sound. Zador's lab has uncovered a code
that neurons use to represent sound and is working to sort out the different excitatory and inhibitory
components that generate the code.
Dmitri Chklovskii's lab uses mathematics and physics to examine constraints on brain structure and
function. By uncovering such limits, they hope to delineate the "engineering" principles that govern
brain evolution. The scientists ask how neurons are connected and are working to understand how
neurons organize themselves into circuits and how those circuits produce behavior. By comparing the
patterns of brain structure between animals, they have begun to pinpoint features that are fixed and
characteristics that can vary. This year, they made great progress in determining the rules that specify
several different brain characteristics, including those that govern where neurons are placed and how
they are connected to each other.
Partha Mitra and his colleagues are pioneering the field of neuroinformatics, which involves the
development of software and mathematical algorithms for interpreting large amounts of data from elec-
trophysiological, brain imaging, and animal behavior studies. Another of Mitra's interests is "theoretical
engineering" in which he attempts to comprehend specific biological phenomena-such as the corn-
paritively high metabolic rates found in neural tissue-by using mathematical tools from traditional engi-
neering disciplines.
By focusing on a part of the brain that is variable or "plastic," Hollis Cline's lab examines how sen-
sory experience shapes the ways neurons connect during development. Cline and her colleagues
study the development of the visual system in amphibian tadpoles. They address how sensory activity
stimulates mechanisms within brain neurons and thereby guides visual system development. This year,
they found that normal development of links between the eye and the central nervous system requires
the activity of one specific receptor after visual stimulation. Many animals share mechanisms of brain
development. Therefore, Cline's research is revealing fundamental processes that govern brain devel-
opment in a wide range of species, including humans.
Karel Svoboda's lab investigates how sensory experience triggers the long-term changes in brain
architecture believed to underlie memory. Using custom-made state-of-the-art imaging technology, the
scientists have taken pictures of synaptic connections between neurons in the brains of adult mice.
Svoboda and his colleagues have found that as animals age, synapses in a particular brain region lose
their ability to change shape and rewire themselves in response to input, providing specific, direct evi-
dence for the basis of age-related memory loss.
Roberto Ma linow's lab studies how the molecular composition of synapses changes in response to
sensory experience. Perhaps their most exciting recent finding was their demonstration, using intact
animals, that experience drives neurotransmitter receptor proteins called AMPA receptors into synaps-
es. This is the first experience-induced specific molecular modification of a synapse to be discovered.
The Malinow lab is now elucidating the roles of proteins called PSD-95 and NR2B in AMPA receptor
trafficking or movement into synapases. Malinow's findings indicate that dynamics of AMPA receptor
replacement at synapses is likely to be a principal mechanism of learning and memory.
Josh Huang's lab has focused on a specific type of inhibitory synapse or "off switch" defined by a
molecule that it releases (GABA). They have developed techniques for studying these special synaps-
es in animals and in cell cultures, which allow them to investigate how a myriad of crucial "off" switch-
es are built into complex brain circuitry during development. They have made great progress in reveal-
ing the relative contributions of a "hard-wired" genetic program versus experience-dependent sensory
inputs to the placement, molecular composition, and connectivity of neurons that respond to GABA as
the brain develops.
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Because the same proteins implicated in human Alzheimer's disease are present in the fruit fly brain,
Yi Zhong is using the power of fruit fly genetics to unravel the causes of Alzheimer's disease in humans.
Zhong's group has found that buildup of one particular protein (A(342) is sufficient to cause nerve cell
death and memory loss in flies. Now they are trying to find genes that can prevent or reverse the dam-
age. Zhong's "Alzheimer's Flies" can be used to identify new molecular targets for treating the disease
or to screen large numbers of drugs for those that might slow or prevent nerve cell death in the brain
of Alzheimer's patients.
Tim Tully's lab studies learning and memory by using genetics to isolate fruit fly mutants ("Pavlov's
Flies") that display defects in memory formation. They have also used DNA microarrays to uncover
genes that might be involved in memory. In this way, Tully, Josh Dubnau, and their colleagues have
identified dozens of genes that function to form memories in flies. Many of the memory genes have
counterparts in mice and humans, confirming that Tully has tapped into the genetic basis of a funda-
mental memory mechanism.
Dubnau also uses fruit flies as a powerful "model system" for investigating the fundamental mech-
anisms that govern learning and memory. By using a variety of approaches, his lab is investigating sev-
eral genes and corresponding biochemical pathways that affect memory. Moreover, to identify and bet-
ter understand the complicated individual neural circuits involved in the different stages of memory,
they are using a technique that enables them to switch specific groups of neurons in the fly brain on
and off at will.
Jerry Yin's lab investigates a process believed to underlie memory called synaptic tagging. Yin's lab
is interested in how the interaction of particular proteins during synaptic tagging drives the formation
and maintenance of memory. They have characterized several proteins that might control memory for-
mation and have investigated how neurons might confine proteins to particular synapses via synaptic
tagging.
Alexei Koulakov is working to mathematically model components of brain circuitry that act not in
sensing (sensory neurons) or in acting on information (motor neurons), but rather in deciding what to
do (decision-making neurons). His lab has successfully modeled some of the key properties that such
decision-making neurons are predicted to have, and Koulakov has designed a real-world experimental
strategy for studying such neurons in vivo.
Carlos Brody uses a combination of mathematics, animal experiments, and human psychophysical
approaches to explore short-term memory including how short-term memory is linked to decision-
making processes, and how the brain senses and represents time. Brody and his colleagues have
developed a number of mathematical models that have enabled them to reveal the probable neuro-
logical basis of a variety of real-world perceptual and cognitive processes.
Zachary Mainen's lab studies rodent behavior that is influenced by smell to explore awareness,
motivation, and decision-making. The group studies small and large-scale events, from how single
olfactory neurons send out signals, to how large ensembles of neurons enable rats to make decisions
based on what they smell. Ultimately, Mainen will apply the insights learned from this research to psy-
chiatric diseases in humans, especially schizophrenia.
Taste buds are so familiar to us that they are easily taken for granted. Nevertheless, they are com-
plex sensory organs with a unique pattern of development about which little is known at the molecu-
lar level. CSHL Fellow Lee Henry investigates the molecular mechanisms that control taste receptor cell
development. By using DNA microarray technology to profile gene expression in taste bud cells, Henry
has begun to decipher new principles of sensory cell development and function.
By studying adult stem cells, or unspecialized cells that can develop into many different cell types,
Grigori Enikolopov's lab has found that the compound nitric oxide can instruct stem cells to stop divid-
ing and become neurons and that decreasing the amount of nitric oxide in the brain can increase the
number of stem cells and neurons. Enikolopov's studies support the notion that coaxing stem cells
down particular developmental pathways might be an effective strategy for treating brain disease or
injury.
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COMPUTATIONAL SYSTEMS
C.D. Brody S. Chakraborty C. Machens
C. Hollweg A. Penel
Our lab is interested in how neurons interact with each
other to form networks that underlie behaviors such as
decision-making and short-term memory. We are also
interested in how time and temporal patterns are sensed
and represented in the brain. During 2003, Carlos
Brody (PI) and Christian Machens (postdoc) developed
a theoretical framework for understanding how neu-
ronal responses can be rapidly and easily modulated
from short-term memory responses to decision-making
responses during a sequential discrimination task.
Santanu Chakraborty (Watson School graduate stu-
dent), continued his collaboration with David Tank
(Princeton), studying network properties of neurons in
the goldfish brain that support the short-term memory
of eye positions. Amandine Penel (postdoc), working
with Christopher Hollweg (intern), continued her
investigation of how temporal patterns, defined as a
train of brief sound pulses, are perceived by humans.
Finally, in separate projects, Machens collaborated
with the Zador lab here at CSHL to complete a paper,
now in press, on the use of natural sounds to discover
the structure of receptive fields of cortical auditory
neurons. Brody, collaborating with John Hopfield
(Princeton), completed a paper, now in press, on the
learning of spike-timing-dependent plasticity rules.
A Neural Model of Sequential
Discrimination
C. Machens, C.D. Brody
Sequential discrimination tasks are widely used in
psychophysical studies. In a typical such task, a sub-
ject is presented with a first stimulus (fl) and then
after a delay of a few seconds, with a second stimulus
(f2), after which the subject must make a decision
based on a comparison of the two (f2 > fl ?). Although
simple, this task requires at least three different com-
ponents: (1) loading a stimulus with a particular value
(fl) into a short-term memory system; (2) maintaining
that memory value over a few seconds; and (3) when
stimulus f2 is presented, computing a comparison
between 12 and the memory of fl. Neurons that par-
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ticipate in all three components of a somatosensory
sequential discrimination task have been found in the
prefrontal cortex of macaques (C.D. Brody, R. Romo
et al., unpubl.). On the basis of two mutually inhibit-
ing classes of neurons, we have constructed a simple
network model of prefrontal cortical neurons designed
to maintain a short-term memory of fl. Surprisingly,
we find that the model, built to account for the mem-
ory component of the task, also accounts for the load-
ing and stimulus comparison components of the task.
This simple model thus agrees with key aspects of the
electrophysiological evidence and is able to carry out
all three components of the task (loading, storing, and
making a decision based on a comparison) within a
single, integrated framework. The model also suggests
how the experimentally observed memory-dependent
and time-dependent activities may coexist with each
other without disturbing the content of the memory
and makes a series of experimental predictions.
Correlations between Persistent
Activity Neurons in the Oculomotor
System of the Goldfish
S. Chakraborty [in collaboration with D. Tank, Princeton
University]
Persistent activity, defined as stimulus-dependent
neural activity that persists after the end of a transient
stimulus that initiates it, is thought to be the neural
basis of short-term memory-memories that last on
the order of several seconds. Such activity has been
found in many brain areas in primates and rodents and
is also found in area I of the brain stem of goldfish. In
this area, persistent activity is thought to encode the
memory of eye position during fixations and between
saccades (rapid eye movements), which in the goldfish
occur every few seconds. Neurons in area I have firing
rates that, above a certain minimum threshold that
varies with each neuron, are proportional to eye posi-
tion. Some neurons have firing rates that increase as
the eye fixation position is increasingly to the right,
whereas other neurons have firing rates that increase
as the eye fixation position moves further to the left.
These two types of neurons are segregated into the
two sides of the brain. If the persistent activity in these
neurons is due to reverberating interactions between
them, we would expect positive firing-rate correla-
tions between like-signed neurons and negative corre-
lations between unlike-signed neurons. We are mea-
suring correlations between neurons and investigating
their sign and other characteristics.
Representation of Temporal
Patterns in Humans
A. Penel, C. Hoilweg, C.D. Brody
We have begun to investigate the question of temporal
pattern representation using a very simple class of stim-
uli: 1-second-long patterns, each composed of three
brief pulses of sound, with the first and the last pulse
always 1 second apart. We will later use more complex
stimuli, composed of more pulses. We have developed a
task in which participants, after hearing such a three-
pulse sequence, must indicate their estimate of the tim-
ing of the middle pulse by positioning a vertical line
within a horizontal bar on a computer screen, i.e., par-
ticipants have to translate into space what they per-
ceived temporally. The timing of the second sound pulse
varies randomly between trials. We have observed that
subjects tend to categorize stimuli presented around 500
msec as being 500 msec (which corresponds to a subdi-
vision of the 1-second interval into two equal intervals):
middle pulse timings that were either slightly longer or
slightly shorter than 500 msec were both reported as
being closer to 500 msec than they actually were. In
addition, participants were most consistent in their
reponses for stimuli close to 500 msec and for those
corrresponding to very short first or last intervals. Our
hypothesis is that results obtained in this temporal-to-
spatial task indicate tendencies in the subjects' temporal
perception; we will validate this hypothesis by using the
data to generate predictions about biases in more canon-
ical temporal discrimination tasks. If correctly validat-
ed, we will then extend the method to more complex
temporal patterns, of four or more pulses.
Influence of Rhythmic Grouping
on Time Perception
A. Penel
Events in temporal patterns are not perceived inde-
pendently from each other. Two perceptual organiza-
tional processes have been proposed: the extraction of
a temporal regularity (of which the categorization at
500 msec for a 1-second interval in the previous pro-
ject may be an example), and the sequential grouping
of events into perceptual and mnemonic chunks, for
example, according to temporal proximity. Previous
work (Penel and Drake 2004) has suggested that the
last short interval of such groups (preceding the long
between-group interval) is perceived shorter than it is.
This was demonstrated with musical sequences, pro-
fessional musicians having to adjust (increase or
decrease) all temporal intervals so that the sequences
were perceived as temporally regular: This last short
interval was adjusted longer than others. This needed
to be replicated and further explored, however, using
simpler sequences of identical tones and less musical-
ly trained participants. Indeed, one explanation for this
perceptual bias is that it results from "musical" expec-
tations about what is usually produced (performers
usually slow down toward the end of groups). Our
experiment confirmed previous data, and also showed
a systematic lengthening of the already long between-
groups interval, with no difference between nonmusi-
cians and amateur musicians. These perceptual biases
were observed at a fast tempo (300 msec), but not at a
slow one (600 msec). This, together with the similari-
ty of the results for professional,
and nonmusicians, suggests that the time perception
effect is due to obligatory rhythmic grouping rather
than musical expectations, as obligatory grouping is
more likely to occur at a fast tempo than at a slow
tempo. A critical test of the obligatory rhythmic
grouping versus musical expectations origin of the
effect will involve testing other sensory modalities
(vision and touch). If the effect is due to musical
expectations, it should not be observed there, but it
should be observed if the phenomenon is purely tem-
poral. Thus, we plan to conduct similar experiments
using sequences of flashes and of mechanical impuls-
es on the finger tip.
Finding Optimal Stimulus
Ensembles
C. Machens In collaboration with A. Herz, Berlin]
A central aim of theoretical neuroscience is to develop
general principles that explain the processing of stim-
uli in sensory systems. One such principle has been
formulated in the Efficient Coding Hypothesis, which
states that sensory neurons strive to represent infor-
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mation about natural stimuli as efficiently as possible.
However, since different stimuli come with different
behavioral relevance, the representational capacity of
sensory neurons might be biased toward the more rel-
evant stimuli. In a collaboration with the group of
Andreas Herz, Berlin, we have analyzed this potential
bias in grasshopper auditory receptor neurons. The
optimal ensemble of stimuli was searched for using
on-line electrophysiological experiments. Although
grasshopper songs are well-mapped by the auditory
receptor neurons, there is no one-to-one correspon-
dence with the optimal stimulus ensemble. Rather, our
results show that specific aspects of the songs (such as
gaps or syllable onsets and offsets) are encoded better,
suggesting that the system is more selective at its ear-
liest stage than previously thought.
Linearity of Receptive Fields in the
Auditory Cortex
C. Machens [in collaboration with A. Zador, Cold Spring
Harbor Laboratory]
Despite years of research, the auditory cortex remains
elusive territory. Apart from its basic tonotopology, not
much is understood about its computational properties.
Based on recordings with simple artificial sounds, sev-
eral recent studies have proposed that cortical neurons
decompose sounds into a set of simple, linear receptive
fields. However, in collaboration with Mike Wehr and
Anthony Zador here at CSHL, we have shown that the
success of the linear receptive field largely depends on
the kind of stimuli used. Focusing on natural sounds,
i.e., the sounds that the auditory cortex is built to
process, we found that cortical responses often cannot
be predicted by the linear receptive field model. To
understand the nonlinear response properties of corti-
cal neurons, we have studied several enhancements of
the basic linear model. Including some simple nonlin-
earities in the model, we could show that the failure of
the model cannot be attributed to rectification, satura-
tion, or adaptation to mean intensity. Rather, the high-
ly nonlinear response properties of auditory cortical
neurons must be attributable to nonlinear interactions
between sound frequencies and time-varying proper-
ties of the neural encoder.
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Deriving Spike Timing
Learning Rules
C.D. Brody [in collaboration with J. Hopfield, Princeton
University]
Plasticity in connections between neurons allows
learning and adaptation, but it also allows noise to
degrade the function of a network. Ongoing network
self-repair is thus necessary. We describe a method to
derive spike-timing-dependent plasticity rules for self-
repair, based on the firing patterns of a functioning
network. These plasticity rules for self-repair also pro-
vide the basis for unsupervised learning of new tasks.
The particular plasticity rule derived for a network
depends on the network and task. Here, self-repair is
illustrated for a model of the mammalian olfactory
system in which the computational task is that of odor
recognition. In this olfactory example, the derived rule
has qualitative similarity with experimental results
seen in spike-timing-dependent plasticity. Unsuper-
vised learning of new tasks by using the derived self-
repair rule is demonstrated by learning to recognize
new odors.
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PRINCIPLES OF BRAIN DESIGN
D.B. Chklovskii B. Chen A. Stepanyants
S. Song Q. Wen
Understanding brain function requires unraveling
synaptic connectivity in neuronal circuits. Con-sequent-
ly, the main goal of our laboratory is to help assemble
the brain wiring diagram. We pursue this ambitious goal
from several directions. First, we analyze physical con-
straints on brain design and function in order to deter-
mine "engineering" principles that governed brain evo-
lution. These principles, like the laws of conservation in
physics, can narrow down the set of possible circuits
and help focus our efforts in the search for the models
of brain function. Second, we assemble a probabilistic
description of neuronal circuits based on light
microscopy data. Although light microscopy does not
establish synaptic connectivity conclusively, it is, cur-
rently, the only feasible approach to complex neuronal
networks, such as the cortical column. Third, we are
developing an algorithm for automatic reconstruction of
the brain wiring diagram from serial section electron
microscopy. This may be the most promising approach
to describing smaller networks, such as invertebrate
brains or smaller subsets of vertebrate nervous system.
In addition, we are analyzing assembled wiring dia-
grams to make a connection between anatomy and
behavior. In 2003, we made excellent progress in all of
these research directions.
Assembling the Complete Wiring
Diagram of the C. elegans
Nervous System
B.L. Chen, D.B. Chklovskii [in collaboration with D. Hall,
Albert Einstein College of Medicine]
Despite common claims to the contrary, the full wiring
diagram for the Caenorhabditis elegans nervous sys-
tem has not been assembled. We take advantage of
existing and newly obtained electron microscopy pho-
tographs to complete the project started 30 years ago
by S. Brenner's group at Cambridge. Completion of
the project will provide a unique data set, which can be
used to understand the function of neuronal networks.
In addition to recording neuronal pairs making synap-
tic connections, we also tabulate the location of indi-
vidual synapses.
Why Are Most Neurons
in the Head?
B.L. Chen, D.B. Chklovskii
We pursue the hypothesis that the placement of neu-
rons in an animal minimizes wiring costs for given
functional constraints. Using the available wiring dia-
gram of the C. elegans nervous system, we solve for
the optimal layout of its nonpharyngeal neurons.
Rather than enumerating an exponentially large num-
ber of placements, we use a quadratic cost function
that can be solved exactly. The solution demonstrates
that (1) neurons in the same ganglion cluster together,
(2) the calculated ordering of neurons follows actual
anterior to posterior order, and (3) the predicted coor-
dinates of neurons within the worm resemble their
actual locations. In addition, we find that rare neurons
deviate strongly from our predictions, suggesting the
existence of other yet unknown functional constraints.
These results not only prove the importance of wiring
cost minimization in neuronal placement, but also
spotlight neurons whose functional role is not cap-
tured simply by the wiring diagram.
Synaptic Connectivity and
Neuronal Morphology:
Two Sides of the Same Coin
D.B. Chklovskii
Among the cells of the body, neurons stand out by the
intricate shape of cell processes, or axonal and dendrit-
ic arbors. What is the functional role of these process-
es? To answer this question, I considered wiring up a
large highly interconnected neuronal network, such as a
cortical column. Implementation of such network in the
allotted volume requires all of the salient features of
neuronal morphology: the existence of dendrites as well
as axons, their branching, and the existence of dendrit-
ic spines. Therefore, these features are adaptations that
make a large highly interconnected network possible.
Moreover, actual dimensions of axons and dendrites are
highly optimized, suggesting that high interconnectivity
is essential for cortical function.
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To Myelinate or Not to Myelinate?
Q. Wen, D.B. Chklovskii
Myelinated and nonmyelinated axons coexist in the
brain. What determines whether a given axon is myeli-
nated or not? Rushton argued that, for a given conduc-
tion delay, the thinner axon is chosen from myelinated
and nonmyelinated alternatives. If the required propa-
gation speed is below critical value, nonmyelinated
axons are thinner. Otherwise, myelinated axons should
be used. This argument leads to the prediction of a crit-
ical axon diameter, which segregates myelinated and
nonmyelinated axons. Since the critical diameter is not
observed experimentally, we decided to revisit the
issue. We show that different requirements on conduc-
tion delay do not necessarily lead to the critical diame-
ter. By considering two optimization scenarios, we
show that the appearance of an axon diameter spectrum
depends on the relative cost per volume between myeli-
nated and nonmyelinated axons. Both scenarios suggest
that if cost per volume of myelinated axons is signifi-
cantly less than that of nonmyelinated axons, there
would be a gap between the distributions of nonmyeli-
nated and myelinated axon diameters. If myelinated
axons are costlier than nonmyelinated, the diameter dis-
tributions would overlap. In addition, the second sce-
nario predicts a gap in the conduction velocity spec-
trum, independent of the relative cost. By comparing
our predictions with data from the corpus callosum,
which shows overlap of the diameter distributions, we
conclude that myelinated axons are costlier than non-
myelinated axons. Prediction of a gap in the conduction
velocity spectrum needs to be tested experimentally. In
conclusion, distribution of diameters for myelinated
and nonmyelinated axons depends on the relative cost
of myelination. Overlap between the two distributions
in the corpus callosum suggests that myelinated axons
are costlier than nonmyelinated axons.
Understanding Segregation of the
Cortical Neuronal Network into
Gray and White Matter
Q. Wen, D.B. Chklovskii
A ubiquitous feature of the mammalian cerebral cortex
is the segregation of gray matter, containing mostly
local circuits, and white matter, containing mostly long-
range myelinated axons. Why does such segregation
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occur and why is the gray matter confined to a narrow
sheet on the surface of the cortex? We propose that the
observed architecture is the result of maximizing neu-
ronal connectivity while minimizing conduction time
delays. We start from building a neuronal network
roughly corresponding to the cortical column. This net-
work contains k neurons with all-to-all connectivity.
Conduction time delay increases with k and limits the
number of neurons in a fast-functioning highly inter-
connected network. To construct a larger fast neuronal
network containing neurons, it is necessary to give up
the all-to-all connectivity and use a small-world net-
work architecture. In this architecture, each neuron con-
nects with k local neurons and sends one long-range
myelinated axon to another locale. We determined opti-
mal parameters for this model of the cortical network.
Search for Motifs in
Mammalian Neocortex
D.B. Chklovskii, M. Reigl, S. Song [in collaboration
with J. Sjostrom and S. Nelson, Brandeis University]
In the quest for basic rules of synaptic connectivity, we
measure statistics of connections among layer-5 pyra-
midal neurons from the rat visual cortex. Connectivity
was established electrophysiologically in several hun-
dred simultaneous quadruple whole-cell recordings.
First, we determined the probability for a pair of neu-
rons to be unconnected -83%, unidirectionally con-
nected -12%, bidirectionally connected -5%. These
results confirm previous reports that bidirectional
connections are overrepresented relative to the expec-
tations based on the independence of synaptic connec-
tions. Second, we determined the probability of
encountering triplets belonging to each of the 16 pos-
sible connectivity classes and compared it with the
theoretical predictions based on the doublet connectiv-
ity statistics. We found several classes with significant
deviations in the numbers of triplets. Most of the devi-
ations fit the following rule: Triplets with all-to-all
connections (either unidirectional or bidirectional) are
overrepresented by several hundred percent. Assayed
neurons were always within 100 [n of each other,
thus assuring significant overlap between their arbors.
Therefore, the locality of connectivity cannot account
for this rule. In conclusion, connectivity among layer-
5 pyramidals is inhomogeneous: All-to-all connected
triplets and bidirectional pairs are highly overrepre-
sented. This may reflect the action of learning rules in
the course of development, which could be inferred by
analyzing the statistics of synaptic strength.
Optimal Stimulus Design Relationship between Potential
and Actual Synapses
D.B. Chklovskii, A. Stepanyants
Neurons in the brain respond to sensory stimuli by fir-
ing action potentials. The firing rate of a particular
neuron depends on which stimulus is presented to the
animal. Stimulus to which a neuron responds with the
highest firing rate is called the optimal stimulus.
Therefore, a neuron can be thought of as a detector for
an optimal stimulus. Although we know what the opti-
mal stimulus is for some neurons, for majority of neu-
rons, it remains unknown. Our goal is to design a com-
puter algorithm that would perform a search for an
optimal stimulus automatically. This is a very difficult
task because the dimensionality of the stimulus space
is extremely high. Currently, we are designing an
appropriate algorithm and testing it against a comput-
er model of a neuron with a known optimal stimulus.
A. Stepanyants, D.B. Chklovskii [in collaboration
with A.M. Thomson, University of London]
To take advantage of potential connectivity calculations
in unraveling the function of cortical circuits, it is
important to establish a link between potential and actu-
al connectivity. We are testing a hypothesis that a pair of
synaptically connected excitatory neurons has a
synapse at all potential synaptic sites. In other words,
connectivity between excitatory neurons is "all or
none," where if two neurons connect, they convert all
their potential synapses into actual ones. We use the
Neurolucida system to trace pairs of synaptically con-
nected neurons (determined through electrophysiolo-
gy), identify all potential synaptic sights, and look for
the presence of spines and/or boutons at these locations.
Domains of Potential Connectivity
of Cortical Neurons
A. Stepanyants, D.B. Chklovskii [in collaboration
with J. Hirsch, University of Southern California;
Z. Kisvarday, Bohum]
Synaptic connectivity among cortical neurons may
vary with time due to the growth and retraction of den-
dritic spines. This suggests that the invariant descrip-
tion of cortical circuits should be formulated on the
level of potential synapses, i.e., locations in the neu-
ropil where an axon of one neuron is present within
spine length (-2 pm) from a dendrite of another. The
number of potential synapses between two neurons can
be determined from the overlap region of their dendrit-
ic and axonal arbors and branch densities. On the basis
of three-dimensional reconstructions of axonal and
dendritic arbors, we evaluated the expected number of
potential synapses among spiny neurons from the cat
visual cortex. Typically, any two neurons with signifi-
cant arbor overlap are potentially connected, i.e., have
at least one potential synapse. For spiny neurons from
different cortical layers, we compute local domains,
which contain potentially connected spiny neurons.
These columnar domains may be an essential element
of the cortical architecture. Their size is in between the
minicolunins (Peters and Payne, Cerebral Cortex 3:
69-78 [1993]) and the hypercolumns (Hubel and
Wiesel, Proc. R. Soc. Lond. B. 198: 1-59 [1977]). In
these domains, connections between most spiny neu-
rons can be implemented by local synaptogenesis.
Mechanisms of Subcellular
Domain Specificity in
GABAergic Neurons
A. Stepanyants [in collaboration with J.Z. Huang,
Cold Spring Harbor Laboratory]
Axons of GABAergic basket cells exhibit affinity
toward the somata of pyramidal cells. We help to parse
developmental mechanisms leading to such affinity by
analyzing the time course of axonal trajectories. The
Huang lab here at CSHL has developed an ideal prepa-
ration for investigating this question. By using cell-
type-specific promoters and BAC (bacterial artificial
chromosome) engineering, they are able to visualize
different GABAergic intemeurons and postsynaptic
pyramidal cells in transgenic mice and in organotypic
cortical slice cultures. Confocal images of these sys-
tems are being collected for different developmental
stages. We are in the process of analyzing these images
by using our newly developed correlation analysis. This
approach will provide us with the developmental time
course of correlations between axons of basket cells and
pyramidal somata. By comparing this time course with
the time course of morphological changes of the cells,
we should be able to identify developmental mecha-
nisms involved in the formation of these correlations.
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BRAIN DEVELOPMENT AND PLASTICITY
H.T. Cline C. Aizenman K. Burgos A. Javaherian E. Rial Verde
C. Akerman S.-L. Chiu K. Jensen E. Ruthazer
J. Bestman R. Ewald K. John P. Sharma
K. Bronson K. Haas V. Thirumalai
Sensory input into the brain is essential for organizing
brain connectivity and circuit function during devel-
opment and for modifying neuronal circuits with
learning in the mature nervous system. My lab is
working to determine the cellular and molecular
mechanisms that operate to establish and modify brain
connections during development. Nervous system
dysfunction may arise from failure of these mecha-
nisms to operate during development or in the mature
nervous system. We address this issue by examining
the structural and functional development of the visu-
al system in amphibian tadpoles. These animals are
transparent, which allows us to observe directly the
development of the brain in living animals. In addi-
tion, we assess neuronal function using electrophysio-
logical assays of synaptic connectivity and synaptic
plasticity. We combine these studies with gene transfer
methods, which allow us to test the function of the
genes of interest in brain development. One of the
highlights of our research this year was the demon-
stration that glutamate receptor activity following
visual stimulation is required for the normal develop-
ment of topographically organized connections from
the eye to the central nervous system. This study lays
the groundwork for future work intended to identify
specific mechanisms by which brain connectivity
develops in the intact animal. Given the high degree of
conservation of mechanisms related to brain develop-
ment and plasticity, our work will identify key regula-
tory mechanisms governing brain plasticity across
species. Below are highlighted a few projects carried
out in the laboratory during the last year.
STRUCTURAL DEVELOPMENT
OF NEURONS USING TIME-LAPSE
IN VIVO IMAGING
Excitatory and inhibitory interneurons have a key role
in the establishment of neuronal responses and circuit
properties in the brain. Despite their importance in
brain function, the structural development of interneu-
rons has not been well studied. We used in vivo time-
lapse imaging in intact anesthetized Xenopus tadpoles
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to determine the morphological events underlying the
development of interneuron dendritic arbor structure.
Single optic tectal neurons were labeled with DiI and
imaged at daily intervals over 4 days in intact albino
Xenopus tadpoles. The same neurons were also
imaged at shorter intervals to determine the dynamic
rearrangements in arbor branches that accompany
large-scale arbor growth. Tectal interneurons, like pro-
jection neurons, develop from neuroepithelial cells
located near the ventricular layer. They elaborate com-
plex dendritic arbors over a period of 2 days. Short-
interval time-lapse images reveal that tectal interneu-
ron arbors have rapid rates of branch additions and
FIGURE 1 In vivo time-lapse images of optic tectal neurons
collected at the intervals stated. Note the variety of patterns of
arbor development and final structure of local interneurons
within the Xenopus optic tectum. We are interested in deter-
mining the cellular and molecular mechanisms that control the
development of dendritic arbors. These mechanisms will in turn
control the development of neuronal circuits with receive and
process visual information.
retractions. We identified four patterns of interneuron
arbor development, based on the cell morphology and
types of structural rearrangements that occur over the
development of the neuronal arbor. A surprising fea-
ture of interneuronal development is the large extent
of structural rearrangements: Many interneurons
extend transient processes so that the neuronal struc-
ture is dramatically different from one day to the next.
Because the majority of synaptic contacts are formed
on dendrites, the structural changes we observed in
interneuronal dendritic arbors suggest that optic tectal
circuits are extremely plastic during early stages of
development.
ACTIVITY-DEPENDENT MODIFICATIONS
OF VISUAL RESPONSIVENESS IN VIVO
Carlos Aizenman carried out a series of electrophysiol-
ogy experiments testing the effect of visual stimulation
on retinotectal synaptic responses. We find that gluta-
matergic synaptic responses are regulated in an activi-
ty-dependent manner by intracellular poly-amines.
Subsequent experiments demonstrated that visual
activity also affects tectal cell excitability. This
increase is correlated with enhanced voltage-gated Na'
currents. Because the same visual stimulation protocol
also induces a polyamine synthesis-dependent reduc-
tion in Ca"- permeable, AMPA-R (a-2-hydroxy-5-
methy1-4-isoazole receptor)-mediated synaptic drive,
the increased excitability may compensate for this
reduction. Accordingly, the change in excitability was
prevented by blocking polyamine synthesis during
visual stimulation and was rescued when Ca"- perme-
able AMPA-R-mediated transmission was selectively
reduced. Colin Akerman and Carlos Aizenman found
that these changes in excitability also rendered tectal
cells more responsive to synaptic burst stimuli,
improving visual stimulus detection. The synaptic and
intrinsic adaptations function together to keep tectal
neurons within a constant operating range while mak-
ing the intact visual system less responsive to back-
ground activity, yet more sensitive to burst stimuli.
STRUCTURAL DYNAMICS IN RETINAL
AXONS ARE REGULATED BY
CORRELATED ACTIVITY
A requirement for patterned visual activity during
visual system development has been demonstrated in
a number of experimental systems; however, it was not
clear whether afferent coactivity had a role in topo-
graphic map formation at early stages of development.
To address this question, Ed Ruthazer resurrected the
dually innervated tectum preparation in albino
Xenopus. Unilateral tectal ablation in young tadpoles
results in the convergence of retinal inputs from both
eyes onto the remaining tectal lobe. Initially, the inputs
from the two eyes are largely overlapping, and they
gradually sort out into eye-specific zones. This exper-
imental system allowed Ed to test whether afferent
coactivity, quantified as the relative intensity of
labeled inputs from one eye compared to the other, has
a role in the axon arbor rearrangements that contribute
to the eye-specific segregation of the inputs. Ed
imaged single dye-labeled retinal axons at 2-hour
intervals over 8 hours and mapped the distribution of
branches that were added and retracted from the arbor
over the 8-hour period. At the end of the imaging ses-
sion, retinal inputs from both eyes were bulk-labeled
with different colors. Dual imaging of the inputs from
both eyes provided a quantitative measure of the
degree of convergence of inputs from the two eyes,
and this was taken as a measure of afferent coactivity.
We found that axon branches are added independent of
the degree of innervation by one eye or the other, but
that branch stabilization was significantly increased in
regions that were innervated by axons originating
from the same eye as the imaged axon. This suggested
that afferent coactivity was a key factor in branch sta-
bilization. To test this, we exposed animals to MK801,
the NMDA-R (N-methyl-D-aspartate receptor) antago-
nist. Interestingly, MK801 blocked the selective elim-
ination of branches in territory dominated by the
opposite eye, suggesting NMDA-R-dependent branch
elimination from noncoactive sites. This mechanism,
combined with NMDA-R-dependent selective stabi-
lization of branches in coactive regions would result in
the formation of topographic maps.
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GENETICS OF MEMORY IN DROSOPHILA
J. Dubnau A. Blum
T.W. Jung
The long-term goal of our research is to understand
memory. Dissection of complex behaviors such as
memory and learning will require a multidisciplinary
approach that will include discovery and manipulation
of the relevant genetic, cellular, and anatomical path-
ways, as well as computational modeling of how infor-
mation is processed in the brain. Work in genetic
model systems such as Drosophila can contribute to
our understanding in two main ways. First, by enabling
the discovery of genes and genetic pathways underly-
ing behavior, genetic model systems provide entry
points for subsequent interventionist experiments.
Second, systematic manipulation of gene function in
relevant anatomical loci of the brain allows a concep-
tual integration of findings from cellular and behav-
ioral neuroscience.
We use the Drosophila model system, which
offers an economy of scale to discover and develop
hypotheses in a relatively cost-effective and rapid
manner. Then, given the remarkable evolutionary con-
servation of genetic, cellular, and behavioral func-
tions, these hypotheses can be pursued in mammalian
model systems.
Gene Discovery with DNA
Microarrays
J. Dubnau [in collaboration with A.S. Chiang, Taiwan,
and J. Barditch, L. Grady, F. Bolduc, and T. Tully,
Cold Spring Harbor Laboratory]
In collaboration with the lab of T. Tully here at CSHL,
we have used a combination of behaviorally specific
training protocols and expression profiling with DNA
chips to identify transcriptional responses during
memory consolidation. We have used this approach to
compare gene expression profiles after spaced train-
ing, which induces both short-term and protein-syn-
thesis-dependent long-term memory, and massed
training, which only induces short-lived memory. We
have identified a large number of candidate memory
genes differentially expressed at three different reten-
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Lion intervals after spaced versus massed training.
Using real-time polymerase chain reaction (PCR) fol-
low-up assays, and an independent microarray, we
have confirmed differential expression for 42 of these
candidates, establishing the validity of this approach.
Ultimate confirmation that a gene is involved in
memory formation rests with the demonstration that in
vivo modulation (disruption) of the gene alters that
process with some specificity. With that aim in mind,
we are focusing on local translational control, one of
several pathways suggested from the array experi-
ments. Our genetic studies already support a role in
memory for several components of this pathway.
These include staufen and oskar-known components
of a cellular mRNA localization machinery, pumilio-
which is a translational repressor protein, and thor,
which encodes a fly homolog of 4EBP, a translational
regulator.
We now are using existing molecular genetic
reagents to investigate the role of this pathway in
memory and to visualize local translation in neurons
of the adult brain.
Genetic Dissection of
Anesthesia-resistant Memory
A. Blum, J. Dubnau [in collaboration with A.S. Chiang
and Y.S. Chen, Taiwan; J. Barditch, S.L. Chiu, M. Regulski,
and T Tully, Cold Spring Harbor Laboratory; and
J.D. Armstrong, Edinburgh]
In both vertebrate and invertebrate animals, anesthetic
agents cause retrograde amnesia for recently experi-
enced events. In contrast, older memories are resistant
to the same treatments. In Drosophila, anesthesia-
resistant memory (ARM) and long-term memory
(LTM) are genetically distinct forms of long-loved
memory that exist in parallel for at least a day after
training. ARM is disrupted in radish mutants but is
normal in transgenic flies overexpressing a CREB
(cAMP response-element-binding protein) repressor
transgene. In contrast, LTM is normal in radish
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FIGURE 1 thor is a long-term memory mutant. thor mutant ani-
mals display normal levels of memory measured 2 minutes after
a single training session. In contrast, thorl mutants exhibit
defective long-term memory. Memory is reduced in thorl
mutants when measured 24 hours after ten sessions of spaced
training (20XSp), but not after ten sessions of massed training
(10XMa).
mutants but is disrupted in CREB repressor transgenic
flies. Until now, nothing was known about the molecu-
lar, genetic, or cellular biological pathways underlying
ARM. We have identified radish as a phospholipase-
A2, providing the first clue about signaling pathways
underlying ARM in any animal. An enhancer-trap
allele of radish (C133) also provides an entry point to
study the anatomical circuits underlying ARM. rshc33
driven reporter expression does not label mushroom
bodies, which are the primary anatomical focus of
olfactory memory research in Drosophila. Instead, it
reveals a novel anatomical pathway. Transgenic
expression of PLA2 in this pattern restores normal lev-
els of ARM to radish mutants, whereas transient dis-
ruption of neural activity in rshci" neurons inhibits
memory retention. Identification of radish as a phos-
pholipase-A2 and the neural expression pattern of this
enhancer trap significantly broaden our understanding
of the biochemistry and anatomy underlying olfactory
memory in Drosophila. These findings also are consis-
tent with pharmacological studies of PLA2 signaling in
memory formation in vertebrate animals.
Reversible Disruption of Synaptic
Transmission
J. Dubnau [in collaboration with A.S. Chiang, Taiwan]
We are using a temperature-sensitive dynamin trans-
gene, which disrupts synaptic transmission reversibly
and on the time scale of minutes, to investigate the
temporal requirements for ongoing neural activity dur-
ing learning, memory consolidation/storage, and
retrieval. We are using a panel of Gal4 enhancer dri-
vers to focus expression of this dynamin transgene
within specific subpopulations of neurons. With this
approach, we are now able to reversibly silence repro-
ducibly specific groups of neurons in vivo. This strat-
egy permits a dissection of the anatomical circuitry
underlying memory. We already have demonstrated a
role for synaptic transmission in mushroom body neu-
rons during memory retrieval, but surprisingly not
during acquisition or storage of early memory. These
data suggest that the synaptic plasticity underlying
olfactory associative learning reside in mushroom
body dendrites and/or upstream of the mushroom
body and that resulting alterations in synaptic strength
modulate mushroom body output during memory
retrieval.
More recently, we have used a series of Gal4
enhancer lines identified by transposon insertion in
memory genes to spatially restrict the dynamin block
to additional functionally relevant subcomponents of
the memory circuit. We have demonstrated an anatom-
ical dissection of the requirements for neural activity
during formation and storage of anesthesia-sensitive
versus anesthesia-resistant memory (Fig. 2). We now
are extending this approach to a panel of Ga14 driver
lines that yield expression in additional neuronal pop-
ulations.
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FIGURE 2 Anatomical dissection of anesthesia-sensitive and
anesthesia-resistant memory (ARM). (Top panels) GFP reporter
expression in several neurons that participate in the circuitry
underlying olfactory memory. (Left panel) Dorsal paired medial
neuron massively innervates the axonal outputs of the mush-
room bodies. (Middle panel) Dorsal-anterior-lateral neuron
sends fibers into parts of the posterior superior protocerebrum,
including mushroom body dendritic field. (Right panel) Ventral-
anterior-medial neurons innervate the alpha lobes of the mush-
room bodies. (Bottom panel) Expression of the temperature-
sensitive dynamin transgene under control of Ga14 drivers per-
mits focused transient inhibition of dynamin-dependent activity
in specific neuronal subtypes. Three Ga14 lines were used: one
which expresses in DPM and DAL, one which expresses in
VAM, and a third which expresses in mushroom bodies. In the
case of the DPM and DAL line as well as the VAM line, transient
heating to the restriction temperature (H) causes a partial
amnesia measured 3 hours after training (compare control
treatment [C] with heat shifted [H]) . In contrast, this heat shift 0
has no effect on a control strain or on a line that expresses the
dynamin transgene in mushroom bodies. Application of a cold-
shock anesthesia cold-shock treatment completely erases
anesthesia-sensitive memory, providing a pure measure of
ARM. Use of cold shock in combination with heat-shift (HC)
reveals an anatomical dissection of anesthesia-sensitive mem-
ory from anesthesia-resistant memory. In the DPM/DAL-
expressing animals, this combination treatment erases all
memory, suggesting that the memory disrupted by dunamin
alone (1-0 is ARM. In contrast, the combined treatment in VAM
neurons reveals that a significant portion of the memory remain-
ing after the dynamin effect is ARM. Thus, inhibition of VAM-
dynamin mostly disrupts anesthesia-sensitive memory.
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SIGNAL TRANSDUCTION, STEM CELLS, AND DIFFERENTIATION
G. Enikolopov J. Encinas T. Michurina K. Ravi
J. Hemish B. Mish J. Roig
B. Kuzin N. Peunova V Scheinker
M. Maletic-Savatic
Stem and progenitor cells receive specific cues that
control their self-renewal and their transition through
differentiation cascades. Our laboratory is interested in
stem cells in the adult organism and the signaling mol-
ecules that control the division of stem and progenitor
cells and guide them toward their differentiated fate.
Our efforts have been focused on the versatile signaling
molecule nitric oxide (NO). NO has a wide range of
effects in humans, from regulating blood pressure to
modulating brain activity. We have discovered that NO
has yet another crucial role: It regulates division of stem
and progenitor cells and mediates their progression
through differentiation cascades. Part of this regulation
is due to the antiproliferative properties of NO: Division
of stem and progenitor cells can be manipulated by sup-
plying or removing the source of NO. For instance, we
have found that NO acts as an important negative regu-
lator of cell division in the adult brain, such that it is
possible to increase the number of neural stem cells by
suppressing the production of NO in the brain.
This year, we have been focusing on the molecular
interactions of NO with key regulatory pathways in
the cells, particularly those that control cell division.
Using transcriptional profiling as a test, we have iden-
tified several signaling pathways that are required for
the NO signal to induce gene expression and cell cycle
arrest. We have also shown that NO mediates the
homeostasis of hematopoietic stem cells in the bone
marrow. Finally, we have generated several animal
models to study neural stem cells and the action of NO
on adult neurogenesis.
NO Is an Important Negative
Regulator of Neurogenesis
in the Adult Brain
M. Packer, Y. Stasiv, J.M. Encinas [in collaboration with
S. Goldman, Cornell Medical School, and H. Westphal,
National Institutes of Health]
The vast majority of neurons in the mammalian brain
are produced during embryonic development.
However, there are several restricted zones in the adult
brain where new neurons are constantly generated
from a resident population of neural stem and progen-
itor cells. At the same time, it is possible to detect
neural progenitors throughout the adult nervous sys-
tem (e.g., in ex vivo experiments), suggesting the exis-
tence of negative regulators of neurogenesis in the
adult brain. None of the postulated negative regulators
have been identified so far in the adult nervous sys-
tem. We found that NO is used as a negative regulator
to control the generation of new cells in the neuro-
genic areas of the adult brain. In a pharmacological
approach, we suppressed production of NO by intro-
ducing inhibitors of NO synthase (NOS) into the ven-
tricles of the adult brain. In a genetic approach, we
generated a null mutant for the neuronal NOS gene. In
both models, the number of new cells generated in
neurogenic areas, the olfactory subependyma and the
dentate gyrus, was strongly augmented. Importantly,
increased proliferation of progenitor cells did not alter
the fate of the extra cells. Our results reveal a role for
NO as an essential regulator of neural stem/progenitor
cells in the adult brain. They also suggest a strategy for
enhancing neurogenesis in the damaged central ner-
vous system. Our current efforts are to determine the
subclass of stem/progenitor cells that is controlled by
NO in the adult brain.
NO Is a Regulator of
Hematopoietic Stem
Cell Activity
T. Michurina, P. Krasnov [in collaboration with
R.C. Mulligan, Harvard Medical School]
Hematopoietic stem cells give rise to various multipo-
tent progenitor populations, which expand in response
to cytokines and which ultimately generate all of the
elements of the blood. We found that it is possible to
increase the number of stem and progenitor cells in the
bone marrow by suppressing the activity of NOS.
Exposure of mice to NOS inhibitors either directly or
after irradiation and bone marrow transplantation
increases the number of stem cells in the bone marrow.
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In the transplantation model, this increase is followed
by a transient increase in the number of neutrophils in
the peripheral blood. Thus, our results indicate that NO
is important for the control of hematopoietic stem cells
in the bone marrow. They further suggest that suppres-
sion of NO synthase activity may allow expansion of
the number of hematopoietic stem and progenitor cells
for therapeutic purposes.
NO Regulates Cell Proliferation
and Cell Motility in Early
Xenopus Development
N. Peunova, V Scheinker
NO has been implicated in cell differentiation and
organism development. However, the interconnection
between NO signaling and the major developmental
pathways remains unknown. We investigated the role
of NO in early Xenopus development using both gain-
of-function and loss-of-function approaches. We
examined changes in embryonic development after
microinjecting either mRNA encoding Xenopus NOS
(XNOS1) or the NO donor SNAP; conversely, we
blocked NOS activity by injecting either mRNA
encoding a dominant-negative form of the protein,
dnXNOS, or chemical inhibitors of NOS. Excess NO
production decreases cell proliferation in the embryo.
In contrast, deficits in NO production result in exces-
sive cell proliferation and distort cell motility.
Inhibition of NOS activity prevents normal axis exten-
sion and neural tube closure during gastrulation and
neurulation. Thus, at early stages of embryonic devel-
opment, NO coordinates cell proliferation and mor-
phogenetic cell movement. A deficit of NO also leads
to profound defects in organogenesis. Further investi-
gation of the signaling pathways affected by NO in the
Xenopus embryo points to a critical role of small
GTPases in the function of NO during development.
Using specific inhibitors, we have identified molecular
targets and pathways used by NO to control cell cycle
and cell motility during embryonic development.
NO and Drosophila Development
B. Kuzin, Y. Stasiv, V. Scheinker [in collaboration with
M. Regulski and T Tully, Cold Spring Harbor Laboratory]
NO is an essential regulator of Drosophila develop-
ment and physiology: It has been implicated in visual
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system development, immunity, behavior, response to
hypoxia, and regulation of cell cycle progression dur-
ing development. We found a novel mode of regulation
of NOS function that employs endogenously produced
truncated protein isoforms of Drosophila NOS
(DNOS). These isoforms inhibit NOS enzymatic
activity in vitro and in vivo, reflecting their ability to
form complexes with the full-length DNOS protein.
Truncated isoforms suppress the antiproliferative
action of DNOS1 in the eye imaginal disc by impact-
ing the retinoblastoma-dependent pathway, yielding
hyperproliferative phenotypes in pupae and adult flies.
Our results indicate that endogenous products of the
DNOS locus act as dominant-negative regulators of
NOS activity during Drosophila development. They
also point to a novel mechanism for the regulation of
NO production in animal cells.
In a related study, Michael Regulski carried out a
wide screen for lethal DNOS mutants and demonstrat-
ed an essential function for NO during early
Drosophila development. He now sequences a panel
of mutant DNOS genes to position the mutations and
thus provide insights into the crucial sites in the
DNOS protein molecule.
Mechanisms of NO Action
J. Hemish, N. Nakaya, K. Ravi [in collaboration with
V. Mittal, Cold Spring Harbor Laboratory]
One approach to reveal the targets of NO action is to
identify the genes that are activated by NO and to
deduce the pathways that NO uses to activate tran-
scription. We employed transcriptional profiling using
microarrays to determined the temporal order of gene
activation induced by NO. We then used that informa-
tion to gain insights about the signaling pathways that
mediate the action of NO: Applying inhibitors of par-
ticular signaling pathways, and using cells from ani-
mals with a deleted p53 gene, we were able to define
groups of genes that require PI3 kinase, protein kinase
C, NF-K.13, p53, or their combination, for activation by
NO. Our results demonstrate that NO utilizes several
independent signaling pathways to induce gene expres-
sion.
Having determined several major signaling cas-
cades that are activated by NO, we are now trying to
determine whether NO can directly modify the crucial
members of these pathways by S-nitrosylation.
Furthermore, we used cells from a panel of mouse
mutants to show that NO affects several independent
checkpoints to induce cell cycle arrest. Finally, we
study the action of a novel NO-inducible gene, noxin,
that we have identified in the screen for NO-inducible
genes. We have generated a knockout mutant of noxin
and are now investigating whether noxin serves as a
link between NO signaling and the cell cycle control.
Neural Stem Cells in the
Adult Nervous System
J. Mignone, M. Maletic-Savatic, A. Vaahtokari, J. Roig,
B. Mish, C. Matthews [in collaboration with A.-S. Chiang,
Tsing Hua University, Taiwan; D. Steindler, University of
Florida; R. Hoffman, Anti Cancer; and S.Y. Kim,
Cold Spring Harbor Laboratory]
To follow the transition of neural stem and progenitor
cells along the differentiation cascades, we generated
a series of transgenic reporter mouse lines. In several
of them, neural stem cells of the embryonic and adult
brain are marked by the expression of green, cyan, and
red fluorescent proteins (GFP, CFP, RFP), expressed
under the control of the nestin gene regulatory ele-
ments. Stem and progenitor cells can be isolated from
these animals with high purity using FACS (fluores-
cence-activated cell sorter) and can generate multipo-
tential neurospheres. In the adult brain of nestin-GFP
animals, GFP-expressing cells are more than 1400 -
fold more efficient in generating neurospheres than
GFP-negative cells and, despite their small number,
give rise to 70 times more neurospheres than the GFP-
negative population; thus, our data show that nestin-
GFP-expressing cells encompass the majority of the
neural stem cells in the adult brain. These cells can be
divided into two groups which represent distinct class-
es of neuronal precursors in the adult brain and may
reflect different stages of neuronal differentiation.
We also found that in some tissues of our model
animals, GFP expression may mark stem/progenitor
cells for these tissues. For instance, we found that
nestin-GFP cells can be found in the bulge region of
the hair follicle, where stem cells for the follicle are
thought to be located. By a number of criteria, these
cells indeed behave as progenitor population of the
follicle outer-root sheath; in addition, these cells can
generate progeny of diverse lineage, including neu-
ronal. We now study the ability of nestin-expressing
cells from non-neural tissues to reveal their neural
potential both in vitro and in vivo, after transplantation
into adult mouse brain.
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CONSTRUCTION AND PLASTICITY OF GABAERGIC CIRCUITS
Z.J. Huang F. Ango T. Pal
B. Chattopadhyaya Q. Wang
G. diCristo C. Wu
S. Kulhman H. Yang
My laboratory is studying the assembly, plasticity, and
function of the GABAergic inhibitory network in the
brain. The GABAergic network consists of a rich array
of cell types with distinct morphology, physiological
properties, and synaptic connectivity patterns and may
constitute a scaffold that organizes local neuronal con-
nectivity and activity. The "design" and function of the
GABAergic system are strikingly different from that
of the glutamatergic excitatory system. Increasing evi-
dence suggests that GABAergic transmission is par-
ticularly effective in regulating the precise timing of
electrical signaling both within a principal neuron and
among populations of principal neurons. Networks of
GABAergic interneurons have been hypothesized to
entrain populations of principal neurons and thus
impose a coordinated "context" for the "content" car-
ried by networks of principal neurons during percep-
tion, cognition, movement control, learning, and mem-
ory. Aberrant GABAergic functions have been impli-
cated in devastating neurological and psychiatric dis-
orders such as epilepsy and schizophrenia. The diverse
and distinct GABAergic functions result in part from
the pattern of GABAergic connectivity. A prominent
feature of GABAergic connectivity is the targeting of
different classes of GABAergic synapses to subcellu-
lar compartments of principal neurons (spines, den-
drites, soma, and axon hillock). Our understanding of
the construction and plasticity of GABAergic circuits
has thus far been hampered by their complexity and
heterogeneity.
Progress in our laboratory in the past year is begin-
ning to define the logic and a sketch of the construc-
tion of GABAergic circuits in the mammalian central
nervous system. First, by combining genetic engineer-
ing and high-resolution imaging, we have established
both in vivo and in vitro methods to visualize and
quantify the targeting of specific classes of
GABAergic synapses onto restricted subcellular com-
partments of principal neurons. We discovered that
subcellular targeting of GABAergic synapses in the
primary visual cortex does not require instructions
from sensory input and thus is largely guided by
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genetically encoded mechanisms and experience-inde-
pendent forms of neuronal activity. Second, we are
beginning to define the molecular signals underlying
subcellular synapse targeting. We discovered that the
ankyrin-G-based membrane cytoskeleton is the key
molecular machinery that, through subcellular recruit-
ment of the LI family immunoglobulin cell adhesion
molecules (CAMs), directs GABAergic innervation to
the axon hillock-the site of action potential initia-
tion. Since both ankyrins and L1CAMs contain multi-
ple members localized to distinct subcellular compart-
ments, we hypothesize that L1CAMs may function as
subcellular compartmental labels, which direct
GABAergic synapse targeting (Fig. 1). Third, we dis-
covered that, following the initial targeting
GABAergic axon to a defined subcellular domain,
there is a prolonged period of maturation, character-
ized by elaboration of multiple axon terminals and
proliferation of synapses. This maturation process in
the primary visual cortex is potently regulated by neu-
ronal activity and sensory experience during a postna-
tal critical period (Fig. 2), which may have profound
impact on neuronal receptive field properties and the
construction of functional cortical circuits. Fourth, we
continue to make progress in studying the role of
GABAergic inhibition in decoding the temporal pat-
tern of neuronal input, and in regulating activity-
dependent synaptic competition in the visual cortex.
Experience-independent Subcellular
Synapse Targeting in the Primary
Visual Cortex
G. diCristo, C. Wu, Z.J. Huang
The subcellular locations of synaptic contacts signifi-
cantly impact their contributions to the integration and
firing of postsynaptic neurons. Subcellular synapse
targeting is especially prominent among different
classes of GABAergic interneurons, which direct their
synapses to restricted compartments of principal neu-
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FIGURE 1 A hypothetical model of subcellular molecular labels on a principal neuron which contribute
to subcellular targeting of GABAergic synapses. The L1 family immunoglobulin cell adhesion molecules
and ankyrin family membrane skeleton are differentially localized to subcellular compartments. A subcel-
lular gradient of neurofascin directs basket synapes to the axon initial segment (AIS). (8) Molecular orga-
nization at AIS. Neurofasci 186 is recruited to AIS by binding to the ankyrin G and (3 -IV Spectin complex.
rons. Such spatial organization of GABAergic inner-
vation is crucial for the temporal precision in their
regulation of neuronal excitability, integration, and
synchrony. The mechanism of subcellular synapse tar-
geting is not well-defined, but it has been shown, in
some species, to involve experience-driven synapse
pruning. By combining cell-type-specific promoters,
BAC (bacterial artificial chromosome) engineering,
A. Subcellular synapse targeting
and two-photon imaging, distinct classes of
GABAergic synapses and their postsynaptic pyrami-
dal neurons were visualized in the primary visual cor-
tex and in organotypic cultures of transgenic mice. We
show that the subcellular organization of perisomatic
and dendritic-targeted GABAergic innervations in
organotypic cultures was indistinguishable compared
to that in the primary visual cortex. Therefore, subcel-
B. Maturation of perisomatic C. Maturation of perisomatic
innervation in organotypic culture innervation in visual cortex
spontaneous activity
A A I
sensory input
FIGURE 2 Experience-dependent maturation
of perisomatic GABNAergic innervation in pri-
mary visual cortex. (Triangles) Pyramidal cells;
(circles) basket interneurons; (black dots) peri-
somatic synapses. After initial targeting of
basket axons to pyramidal cell soma, the for-
mation of high.y distinct perisomatic synapses
proceeds in organotypical culture and is regu-
lated by neuronal spiking. In visual cortex, the
maturation and pattern of perisomatic innerva-
tion may reflect differential activation of pyra-
midal neurons by visual input (represented by
the thickness of upward arrows).
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lular targeting of GABAergic synapses in the primary
visual cortex is likely guided by cell surface molecu-
lar labels and experience-independent forms of neu-
ronal activity.
Role of the Ll Family Immunoglobulin
CAM Neurofascin in Synapse
Targeting to the Axon Initial Segment
F. Ango, H. Yang, Z.J. Huang
Subcellular synapse targeting is most striking at the
axon initial segments (AISs) of large projection neu-
rons such as pyramidal and Purkinje neurons.
Although only one micron in diameter and tens of
microns in length, AIS is both the site of initiation of
regenerative sodium spikes and the target of strong
GABAergic inhibition. The degree of the spatial pre-
cision for this class of synaptic connection is striking
as well as puzzling: How do GABAergic axons reach
and recognize such a minute piece of cell membrane
among all other possible targets in a highly heteroge-
neous tissue? Our study suggests that synapses target-
ing to AIS is achieved through a series of develop-
mental events, each sequentially and cumulatively
contributing to the final exquisite precision.
Using BAC transgenic mice that label basket
interneurons during cerebellar circuit formation, we
found that basket axons first contacted Purkinje soma
before innervating AIS and forming the "pinceau
synapses." Furthermore, we discovered a subcellular
gradient of neurofascin, an Ll family immunoglobulin
CAM, along the Purkinje AIS-soma membrane during
the process of basket cell synapse targeting. The neu-
rofascin gradient is dependent on ankyrin G, a mem-
brane adapter protein exclusively localized to Purkinje
AIS. In the absence of neurofascin gradient, basket
axons lost directionality in their growth along Purkinje
cells, were mistargeted, and precisely followed neuro-
fascin distribution to ectopic locactions. Furthermore,
formation of "pinceau synapses" was severely reduced
along mistargeted basket axons. These results impli-
cate an anIcyrin-based subcellular gradient of neuro-
fascin as a molecular determinant in directing axon
targeting and GABAergic innervation at Purkinje AIS
by cerebellar interneurons (Fig. 1). To provide further
support for this conclusion, we are developing in vivo
electroporation and viral infection procedures to
directly manipulate neurofascin in the cerebellum.
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Subcellular Molecular Labels
and Their Receptors
Underlying Synapse Targeting
F. Ango, H. Yang, Z.J. Huang
Our discoveries have raised many more questions than
answers regarding the molecular mechanisms of sub-
cellular synapse targeting. For example: Is the
L1CAM neurofascin 186 involved in GABAergic
innervation of neocortical pyramidal neurons, in addi-
tion to cerebellar Purkinje neurons, and therefore rep-
resents a general mechanism for synapse targeting to
AIS? What is the mechanism for GABAergic synapse
targeting to the dendritic compartment of principal
neurons? What are the membrane receptors in
GABAergic axon terminals, which interact with and
"recognize" L1CAMs on principal neurons? We have
evidence that both ankyrins and L1CAMs are also
expressed in the developing and mature neocortex and
hippocampus and are localized to axon initial seg-
ments of pyramidal neurons. We are testing the notion
that the ankyrin-G-based neurofascin subcellular
localization contributes to GABAergic synapse target-
ing in the neocortex, and thus represent a general
mechanism for GABAergic synapse targeting to axon
initial segment of principal neurons in the mammalian
central nervous system (CNS). In addition, we are test-
ing the hypothesis that another L1CAM, Close
Homologue of L1 (CHL1), is involved in directing
specific classes of GABAergic synapses to the den-
dritic compartment of principal neurons. Finally, we
have initiated an effort to identify receptors for
L1CAMs in GABAergic axon terminals by testing
candidate genes and by characterizing gene expression
profiles, especially that of CAMS, in defined classes
of GABAergic intemeurons.
Role of Glia Cells and Fyn Kinase
Signaling in Subcellular Synapse
Targeting
F Ango, Z.J. Huang
At the pinceau synapses in the cerebellum, basket
axon terminals at Purkinje AIS are closely surrounded
by Bergmann glia processes and opposed by oligoden-
drocytes (myelin). We have found that defects in bas-
ket cell synapse targeting are closely associated with
defects in the development and organization of glia
processes. We are studying the role of glia cells in the
subcellular targeting and maturation of pinceau
synapses. In Fyn-deficient mice, there are both a
delayed myelination and a persistent atrophy of
Bergmann glia processes. The delayed myelination is
correlated with an ectopic localization of neurofascin
along Purkinje axons and ectopic targeting of basket
cell axons. The atrophy of Bergmann glia processes is
correlated with significantly reduced complexity of
basket axon terminals. We are testing whether and
how Fyn function is required in basket interneuron,
Purkinje cells, or glia cells for the development of
pinceau synapses.
Activity and Experience-dependent
Maturation of GABAergic
Innervation in Primary Visual Cortex
during a Postnatal Critical Period
B. Chattopadhyaya, G. diCristo, Z.J. Huang [in
collaboration with K. Svoboda, Cold Spring Harbor
Laboratory; G. Knott, University of Lausanne,
Switzerland]
In the primary visual cortex, a single basket interneu-
ron innervates hundreds of pyramidal neurons, and
each pyramidal neuron receives inputs from multiple
basket cells. At each postsynaptic target, a basket cell
axon extends multiple terminals with large boutons
clustered around pyramidal cell soma and proximal
dendrites, forming the characteristic perisomatic
synapses. Using BAC transgenic mice that specifical-
ly label perisomatic synapses from basket interneu-
rons, we have characterized the development of peri-
somatic innervation in the primary visual cortex and
studied the role of visual experience in the maturation
of perisomatic innervation. We show that, following
subcellular synapse targeting and initial synaptic con-
tacts, there is a prolonged period of maturation of
perisomatic innervation, characterized by elaboration
of multiple axon terminals and proliferation of
synapses among pyramidal neurons. Interestingly,
perisomatic synapses formed in cortical organotypic
cultures, through a stereotyped process involving the
extension of distinct terminal branches and prolifera-
tion of perisomatic boutons.
Neuronal spiking was necessary for the prolifera-
tion of boutons and the extension but not the mainte-
nance of terminal branches, thereby influencing the
pattern of perisomatic innervation among pyramidal
neurons. In the primary visual cortex, perisomatic
innervation matured during a protracted period after
eye opening and was significantly reduced by visual
deprivation during the third but not the fifth postnatal
week. Therefore, our data show that perisomatic
synapse formation is driven by mechanisms intrinsic
to cortical circuits, whereas the maturation and pattern
of perisomatic innervation in the visual cortex are reg-
ulated by neuronal activity and sensory experience
during a postnatal critical period (Fig. 2).
Molecular Mechanisms Underlying the
Maturation and Plasticity of
GABAergic Synapses in Neocortex
G. diCristo, B. Chattopadhyaya, C. Wu, Z.J. Huang
Although the mechanisms of activity-dependent plas-
ticity at the glutamatergic synapses have been exten-
sively studied and increasingly well understood, little
is known about the mechanisms of morphological
plasticity at the GABAergic synapses. The recapitula-
tion of perisomatic GABAergic innervation in our
organotypic culture systems establishes an efficient
preparation to dissect the cellular and molecular
mechanisms underlying the maturation and structural
plasticity of GABAergic synapses. We have started to
chronically image the dynamics and developmental
process of somatic innervation using 2-photon
microscopy. We are testing whether and how
GABAergic axonal and synaptic morphogenesis can
be induced and modified by electrical stimulation.
Furthermore, using dominant-negative constructs and
single-cell gene knockout, we are testing the role of
GABAergic synaptic transmission, bone-derived neu-
rotrophic factor (BDNF)/trkB signaling, and CAMs in
the maturation and plasticity of GABAergic synapses.
GABAergic Mechanism of Critical
Period Plasticity in Visual Cortex
S. Kuhlman, Z.J. Huang
The cellular mechanisms by which GABAergic cir-
cuits regulate ocular dominance plasticity and the crit-
ical period are unknown. We hypothesize that during
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the critical period, maturation of synaptic inhibition
allows cortical circuits to detect the difference
between the temporal patterns of open and closed eye
inputs, and engage spike-timing-dependent plasticity
rules to drive synaptic competition and ocular domi-
nance (OD) plasticity.
We have made the following observations using in
vitro visual cortical slice preparations which support
our hypothesis: First, we demonstrated that the
strength of synaptic inhibition converging onto layer-
2/3 pyramidal cells increases with the progression of
the critical period. Second, we developed a two-path-
way stimulation paradigm to demonstrate that supra-
threshold input from one pathway (mimicking the
open-eye input) preceding subsequent input from a
second, independent pathway (mimicking closed-eye
input) actively suppresses the second pathway from
driving postsynaptic spikes. This effect of spike sup-
pression does not occur at early postnatal ages, and the
onset of suppression correlates with the maturation of
GABAergic transmission and peak of the critical peri-
od. Third, initial experiments suggest that repeated tri-
als of input-specific spike suppression leads to a per-
sistent decrease in spike probability, consistent with
the idea that a spike-timing-dependent plasticity
mechanism induces long-term depression (LTD) at
synapses, which are actively excluded from contribut-
ing to postsynaptic spike generation. The time interval
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of spike suppression between the stimulation of the
two pathways (-40-60 ms) suggests that the recruit-
ment of heterosynaptic inhibition by the preceding
pathway may mediate suppression. To test this notion,
we are developing tools to specifically reduce synap-
tic inhibition in single pyramidal cells by disrupting
the GABA-A receptor y2 subunit, a critical component
required for the clustering of functional GABA recep-
tors at synapses. We are using a strain of conditional
knockout mice in which the y2 subunit is flanked by
loxP sites. Preliminary results suggest that adeno-
associated virus-mediated expression of Cre recombi-
nase in combination with green fluorescent protein
(GFP) in layer-2/3 cortical neurons in vivo may be an
effective method to delete genes in neurons and to
mark these neurons for electrophysiologic recording in
a background of wild-type neurons. This strategy thus
allows the role of synaptic inhibition to be specifical-
ly studied within an otherwise normally functioning
network. We expect spike suppression to be absent in
neurons with disrupted y2.
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THEORETICAL NEUROBIOLOGY AND QUANTITATIVE PRINCIPLES
OF CORTICAL DESIGN
A. Koulakov D. Tsigankov
This year we concentrated on the role of the brain as a
"statistical" computational device. The premise is that
in many instances the nervous system acts as a
Brownian ratchet, which rectifies stochastic behavior
of its components to yield deterministic responses. In
this general direction, we have made two advances this
year. First, we understood how to identify components
causally linked to behavior in statistical computation-
al devices, such as brain networks. The definitions we
have designed are not quite useful to be directly
applied experimentally. Yet, we have cleared the
ground for more links to experiment with next year.
Second, we created a mathematical model for devel-
opment of sensory maps in the brain, which involves
random search directed by molecular cues. This model
can account for several intriguing experimental find-
ings. Our next step is to understand how neuronal
activity contributes to refinement of neuronal connec-
tivity and competition in a way consistent with exist-
ing experimental data.
Decision-making Analysis
D. Tsygankov, A. Koulakov [in collaboration with
D. Rinberg, Monell Chemical Senses Center,
Philadelphia, Pennsylvania]
The nervous system often faces the problem of classi-
fying stimuli into discrete groups and responding on
the basis of these classifications. Neurons involved in
these tasks can be separated into three groups: senso-
ry elements, whose activity is highly correlated with
the stimulus; decision-making (DM) elements, which
are responsible for classifying the stimuli; and motor
elements, which implement the results of such classi-
fications. Although sensory and motor groups can be
identified experimentally, e.g., by studying correla-
tions with stimulus and response, there is no accept-
able definition for DM elements. In this project, we
develop a mathematical definition of DM components
and design experimental strategies, which allow deter-
mination of DM elements from anatomical and physi-
ological data. Such decision-making analysis (DMA)
has practical importance, since once units involved in
making a particular decision are located, further
efforts can be concentrated on uncovering the under-
lying neuronal mechanisms.
Localization of DM elements and, more generally,
localization of brain function have a long history.
Perhaps, the first important step was the transition
from cardiocentric to encephalocentric views on
behavior. Thus, ancient Egyptians thought that the
heart was the most important organ in the human
body, the seat of the mind, the center of intellectual
activities. To emphasize this, in the process of mum-
mification, they carefully embalmed the heart, liver,
and other organs, whereas the brain was scooped out
through the nostrils. By the second-century A.D.,
Greeks realized that the nervous system must include
two fundamental components: sensory and motor
limbs. DM occurs on the interface between them and
is accomplished by an intermediate nonphysical
process called the soul. The argument was raging
about the location of the point between the sensory
and motor limbs, which is the seat of the soul. Some,
following Aristotle, defended the cadiocentric sys-
tem, while others agreed with Plato and Hippocrates
that the soul is located within the ventricles of the
brain. Only in the second-century A.D. did the Greek
physiologist Galen conduct experiments showing the
critical importance of the brain for behavior.
However, it was not until the age of Enlightenment
that the encephalocentric views were universally
accepted.
The next important step was the distinction
between two types of DM elements, made by Rene
Descartes. He suggested that some responses could be
explained materialistically by the processes in net-
works of fibers passing through the brain. The deci-
sions in this case are deterministic and amenable to
physiological study. In other cases, decisions are not
deterministic and involve intervention of a nonmateri-
al soul, in which case, they could be considered vol-
untary. The distinction between deterministic and sto-
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chastic behaviors forms the foundation for the current
understanding of DM.
Recently, we initiated a theoretical study of local-
ization of decision makers in neural networks. The
goal of this study is to discover a mathematical defin-
ition of DM. Such a definition would allow us to mea-
sure and locate the network components responsible
for a given function, which would move the dispute
between holistic and localized views on brain function
to the domain of empirical science. At the heart of our
definition is the stochastic component of behavior,
which was emphasized by Descartes. As the main
tool, we assume the use of observational noninvasive
techniques. Therefore, we aim our studies at the
human nervous system, where anatomical, MRI,
MEG, and other techniques could be used. At the
same time, since network architecture is universal in
biology, our analysis could be applied to molecular,
neuronal, and social networks.
Models for Molecular Development
of Sensory Maps
D. Tsygankov, A. Koulakov
We examined results of gain-of-function experiments
on retinocollicular maps in knockin mice (Brown et
al., Cell 102: 77 [2000]). In wild-type mice the tem-
poral-nasal axis of the retina is mapped to the rostral-
caudal axis of the superior colliculus (SC). The estab-
lished map is single-valued, which implies that each
point on the retina maps to a single termination zone
(TZ) in the SC. In homozygous Is12/EphA3 knockin
mice, the map is double-valued, which implies that a
single point on the retina maps to two TZs in the SC
(Fig. 1). This is a reflection of the fact that only about
50% of the cells in the retina express Is12. In het-
erozygous Is12/EphA3 knockins, the map is interme-
diate between the homozygous and wild type: It is
single-valued in temporal and double-valued in the
nasal parts of retina.
We study map formation using a stochastic model
based on Markov chains. In our model, the map
undergoes a series of reconstructions with probabili-
ties dependent on a set of chemical cues. Our model
suggests that the map in heterozygotes is single-val-
ued in the temporal region of the retina due to a
reduced gradient of ephrin-A in the corresponding
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FIGURE 1 Model for retinocollicular map development. The top
row shows anterograde "labeling spots" in the retina. The fol-
lowing three rows display the corresponding distribution of
labels in the superior colliculus. The size of both retinal and col-
licular arrays is 100 x 100 cells. The three rows show results for
wild-type, heterozygous knockins, and homozygous Is12/EphA3
knockins, as marked on the left. Notice the doubling transition,
when going from temporal to nasal injection in heterozygotes.
(D) Dorsal; (V) ventral; (N) nasal; (1) temporal; (C) caudal; (R) ros-
tral; (L) lateral; (M) medial.
region of the SC. The remaining map is double-valued
since the gradient of ephrin-A is high there. We there-
fore predict that if the gradient of ephrin-A is reduced
by a genetic manipulation, the single-valued region of
the map should occupy a larger portion of the tempo-
ral retina; i.e., the point of transition between single-
and double-valued maps should move to a more nasal
position in Is12-EphA3 heterozygotes. We also dis-
cuss the importance of the inhomogeneous EphA gra-
dient.
We therefore present a theoretical model for
retinocollicular map development, which can account
for intriguing behaviors observed in gain-of-function
experiments by Brown et al. (Cell 102: 77 [2002])
including map bifurcation in heterozygous Is12/
EphA3 knockins. The model is based on known chem-
ical labels, axonal repulsion/competition, and stochas-
ticity. Mapping in Is12/EphB knockins is also
addressed.
Repulsion Induced
by Attraction: A Role
of Ephrin-B1 in
Retinotectal Mapping
D. Tsygankov, A. Koulakov
We study the role of EphB receptors and their ligand
ephrin-B1 in dorsalventral retinotectal mapping. It
was suggested earlier that ephrin-B1 may act as an
attractant of EphB+ axons of retinal ganglion cells. We
addressed the results of a more recent experiment with
chicks (McLaughlin et al., Development 130: 2407
[2003]) in which axons of retinal ganglion cells were
shown to be repelled by high ephrin-B 1 density. It was
therefore proposed that ephrin-B1 might act as both
attractant and repellent. We showed that the same
axonal behavior may follow from attraction to ephrin-
B1 density and axonal competition for space.
Therefore, we showed how apparent repulsive interac-
tion can be induced by a combination of attraction to
the target and competitive interactions between axons.
We suggested experimental tests that may distinguish
repulsive interaction with the target from repulsion
induced by attraction and competition.
Combinatorial Model
for Olfactory Coding
D. Tsygankov, A. Koulakov [in collaboration with
D. Rinberg, Monell Chemical Senses Center,
Philadelphia, Pennsylvania]
We analyzed a model for olfactory coding based on
spatial representation of glomerular responses. In this
model, distinct odorants activate specific subsets of
glomeruli, dependent on the odorant's concentration.
The glomerular response specificities are understood
statistically, based on experimentally measured distri-
butions of odor detection thresholds. A simple version
of the model, in which glomerular responses are bina-
ry (the on-off model), allows us to quantitatively
account for the following results of human/rodent psy-
chophysics: (1) just noticeable differences in per-
ceived concentration of a single odor (Weber ratios)
are dC/C '- 0.1; (2) the number of simultaneously per-
ceived odors can be as high as 12 clinks and Laing,
Perception 28: 395 [1999]); (3) extensive lesions of
the olfactory bulb do not lead to significant changes in
detection or discrimination thresholds. A more
detailed model allows us to reproduce closely the con-
ditional probabilities obtained in human psychophysi-
cal experiments on perception of complex odors.
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THE NEURAL ORGANIZATION OF OLFACTORY BEHAVIOR
Z.F. Mainen V Egger A. Kepecs D. Sosulski
C. Feierstein M. Quirk N. Uchida
E. Friedman S. Ranade H. Zariwala
H. Gurden
Our laboratory is interested in the neural basis of
mammalian behavior. We focus on understanding the
nature of the electrical activity of single neurons, the
chief currency through which genes and molecules
express themselves in the functioning brain. We are
using the rodent olfactory system as a model for
studying neural coding, the problem of how informa-
tion is represented in neuronal spike trains. We view
neural coding in the broader framework of decision-
making, i.e., how neurons work together to select one
of a repertoire of possible motor actions on the basis
of experience, current goals, and sensory data. We are
especially interested in the temporal coordination of
activity between neurons and between regions of the
brain that is necessary for coherent and directed
action. Our principal experimental technique is chron-
ic multi-electrode recordings in rodents trained to per-
form sensory discrimination tasks. We are actively
developing new ways of monitoring and controlling
both behavior and neural activity. We are also using
intrinsic optical imaging to study the link between
electrical activity (information) and metabolic activity
(energy) in the brain and 2-photon imaging and whole-
cell recording to study the synaptic and electrical
properties of individual neurons.
To help understand the relationship between neur-
al phenomena and behavioral phenomena, we are
using neural network and statistical theories that can
be expressed in computational models and thereby
related to our data. Our long-term goal is to apply
these approaches and insights toward human psychi-
atric disease, especially schizophrenia.
Psychophysical Constraints
on Olfactory Coding
N. Uchida
How is odor information coded in the brain?
Psychophysical experiments can have an important
role in elucidating neural coding because behavior is
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the ultimate readout of the neural code. Reaction time
experiments, in which the time it takes to make a deci-
sion is measured, can provide particularly crucial con-
straints on the temporal aspects of neural coding.
Olfaction is sometimes thought of as a slow sense, and
thus it has been proposed that relatively slow temporal
processing might have a role in odor coding. We
recently tested this idea using an odor mixture dis-
crimination task in rats (Fig. 1). We found that across
a wide range of conditions, rats discriminated odors
very rapidly, with a median odor sampling duration of
<300 msec (Uchida and Mainen 2003). More surpris-
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FIGURE 1 Two-alternative-odor mixture discrimination task. (A)
A rat performing odor discrimination task. Rats can perform this
task with -200 ms of odor sampling regardless of discrimina-
tion difficulties. (8) Mixture stimuli. Two odors were mixed with
various proportions, and rats were trained to report the domi-
nant component by making left or right choice. (C) Typical per-
formance in odor mixture discrimination task.
ingly, measurement of the rats' sniffing revealed that
optimal performance was achieved with only one sniff
at theta frequency (-7 Hz). These results tell us that
the neural code for odors must evolve very quickly, on
the time scale of tens of milliseconds. Such a rapid
process might utilize synchrony or phase information
for coding. The results also suggest to us that the sniff-
ing (theta) cycle may be important in coordinating the
neural activity during olfactory perceptual decisions
in the rat. We have been investigating these ideas by
recording electrical activity using chronic recordings
from behaving rats.
Concentration Invariant Odor
Quality Discrimination
N. Uchida
Any odor, whether a single chemical or a complex
mixture, activates a specific combination of odorant
receptors. It has therefore been postulated that combi-
nations of activated receptors can define odor quality
("combinatorial coding"). However, changes in con-
centration produced by changes in distance from an
odor source will also generally lead to changes in the
identities of activated receptors, as higher concentra-
tions will recruit new lower-affinity receptors. It
would be useful for a creature to be able to recognize
these different combinations as belonging to the same
source. But do animals in fact perceive odor quality in
a concentration-invariant fashion? Although anecdotal
evidence exists, this issue has not been investigated
quantitatively.
Using the two-alternative odor mixture discrimi-
nation task (Fig. 1), we tested explicitly the idea that a
rat perceives mixture qualities to be invariant to the
ratios of their components. After training, rats were
tested using probe stimuli with identical ratios as the
training set but at different absolute concentrations.
Performance was predicted by a ratio-based discrimi-
nation strategy but not by alternatives such as an
intensity-based discrimination strategy. This result
indicates that molar ratios of the components of a
mixture are the critical determinants of choice in this
task. We propose that odor quality is coded by the
ratios of ligand coverage of odorant receptors, "ratio
coding." To understand how ratio coding might arise
from ensemble activity in the olfactory bulb and cor-
tex, we are currently recording spike activity in behav-
ing rats using multi-electrode techniques.
Effects of Sensory and Reward
Experience on Olfactory Decisions
H. Zariwala, N. Uchida, A. Kepecs
One might think of the job of the rat in our task as
determining the identity of the odors it is presented, but
behavioral ecology suggests that the rat is really just
interested in getting as much water as fast as it can, i.e.,
animals make foraging decisions so as to maximize
reward and minimize work. Therefore, to understand
the decisions that rats make in this task, sensory infor-
mation must be considered in the context of the incen-
tives afforded by the task. For example, if more water
is being delivered from the right choice port than the
left, this will bias a rat's choices to the right when the
stimuli are ambiguous. With the eventual goal of eluci-
dating the underlying neural mechanisms, we are
investigating how olfactory decisions are affected by
the animal's experience with stimuli and rewards.
For example, in a recent study, we examined the
effect of changing the stimulus context on a rat's per-
formance. We found that rats substantially improved
their performance when a single difficult stimulus pair
was presented repeatedly in a session compared to the
standard condition in which the whole range of easy
and difficult mixtures is interleaved. This effect
reversed immediately when stimulus context was
switched back, indicating a rapid and transient under-
lying plasticity. Interestingly, the performance gain
was achieved without an increase in response time-
there was no speed-accuracy tradeoff. We are current-
ly designing experiments to tease apart the possible
roles of feed-forward sensory adaptation from reward-
dependent learning in this phenomenon.
Single-neural Correlates of
Olfactory Behavior in
Olfactory and Prefrontal Cortex
C. Feierstein, M. Quirk
To investigate the neural substrates of olfactory-guid-
ed decisions, we are using chronic multi-electrode
recording techniques to monitor the activity of ensem-
bles of neurons in rats while they perform the two-
alternative-odor discrimination task (Fig. 1). Our stud-
ies have focused on the primary olfactory or piriform
cortex and the orbitofrontal cortex, a secondary olfac-
tory area that is part of the rodent prefrontal cortex.
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Neurons in both orbitofrontal and piriform cortex
display a wide range of different behavioral correlates.
In both areas, some neurons respond in an odor-selec-
tive fashion during the delivery of the stimulus,
whereas many other respond selectively to other
aspects of the task such as the delivery of water
reward. In this way, both of these areas appear to be
well-suited to a role in linking the different kinds of
information necessary to learn and execute olfactory
perceptual decisions. What then distinguishes their
respective roles in these processes?
Our preliminary results provide a number of clues
to this question. These recordings show that during the
course of the odor-sampling period, odor-selectivity
develops more rapidly in the piriform cortex than in
the orbitofrontal cortex. On the other hand, there is a
richer representation of reward information in
orbitofrontal cortex. Both areas contain a large portion
of neurons that fire selectively during the response
period. These observations are consistent with a sce-
nario in which the piriform cortex is specialized for
rapid responding, whereas the orbitofrontal cortex is
specialized for rapid learning.
Local Competitive Interactions in Rat
Prefrontal Microcircuits during
Binary Olfactory Decisions
M. Quirk, C. Feierstein
Although much is known about the cellular and synaptic
components of cortical circuits, considerably less is
known about how these circuits behave in the function-
ing brain. Using multi-electrode recordings, we are able
to isolate action potentials arising from multiple cells
within a small local volume of tissue (diameter <100
1.trn) corresponding to a cortical microcolumn. By apply-
ing these recordings to the prefrontal cortex of rats per-
forming our two-alternative olfactory discrimination
task (Fig. 1), we are studying how behaviorally relevant
information is represented within cortical microcircuits
during the formation of a binary perceptual decision. In
contrast to the typical columnar organization of primary
sensory areas, even nearby cells display diverse response
properties. The heterogeneity of responses across cells
recorded in the same electrode was comparable to that of
cells across electrodes, indicating that the salient task
variables represented in prefrontal cortex are available
locally within individual microcolumns. Analysis of the
interactions between simultaneously recorded neurons
shows that nearby cells are often anticorrelated, suggest-
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ing competition between neighboring neurons whereby
functionally distinct subsets of cells actively suppress the
firing of other local neurons. Such competitive interac-
tions within prefrontal cortical microcircuits suggest a
mechanism for the creation of diverse local responses
and provide a potential substrate for "winner-take-all"
computations that may be essential components of neur-
al computation of decisions.
Role of the Theta Cycle in
Coordinating Brain Regions
during Perceptual Decisions
A. Kepecs
Rhythmic oscillations in the theta frequency band (4-10
Hz) are observed in local field potentials recorded from
many different cortical and subcortical brain regions in
rodents. The presence and amplitude of theta oscillations
is correlated with specific behavioral states, being par-
ticularly prominent during active, exploratory behaviors.
In addition, the phase of theta oscillations can be reset by
behaviorally relevant stimuli. Theta oscillations may
have different functional roles in different brain regions
and behavioral contexts, but anatomical and physiologi-
cal evidence suggests that theta oscillations can coordi-
nate information flow between brain regions underlying
sensorimotor integration. To elucidate the neural mech-
anisms behind this coordination, we are recording local
field potentials (LFPs) simultaneously in the olfactory
bulb, olfactory cortex, and hippocampus in rats per-
forming an olfactory discrimination task (Fig. 1). We
observe both theta (4-10 Hz) and higher-frequency
(beta: 15-25 Hz and gamma: 30-50 Hz) oscillations at
several recording sites. Currently, we are analyzing how
different spectral features of LFPs correspond to differ-
ent behavioral epochs and the nature of the relationship
between oscillations in different brain regions.
Neural and Metabolic Activity
in Olfactory Glomeruli
H. Gurden, S. Ranade, N. Uchida
Neural activity is mirrored by metabolic activity which
in turn causes physiological signals that can be detect-
ed using functional imaging techniques. The mecha-
nisms that link these processes are the subject of
intense interest. We are investigating the link between
odor-evoked neural activity and intrinsic optical sig-
nals (IOSs) in the olfactory glomeruli. IOSs are used
for studying the representation of odors, but we hope
to clarify how to interpret IOS as a readout of glomeru-
lar activity and the mechanisms that link neural activi-
ty to metabolism and functional imaging signals.
We measure odor-evoked IOSs bilaterally in the
dorsal olfactory bulb of the acutely anesthetized rat.
Odor stimulation evokes three types of changes in the
reflectance of red light. The first two components are
a punctate and a diffuse transient decrease in reflec-
tion whose spatial localization is odor-specific. The
third component is a complex, oscillatory signal (-0.1
Hz) that is present in the absence of stimulation. To
examine the cellular mechanisms that link neural
activity to IOS, drugs are applied to one bulb and
another bulb serves as a control. Odor-evoked IOS are
blocked by the Na' channel blocker TTX, confirming
that they are triggered by neuronal activity. IOSs are
reduced by dopamine and GABA-B agonists but are
not blocked by glutamate receptor antagonists
(NBQX+APV). Taken together, our data indicate that
IOS in the olfactory glomeruli depends on presynap-
tic transmitter release but not on transmission through
postsynaptic excitatory synapses. The results also
indicate that periglomerular cells could control the
gain of receptor neuron input to the olfactory bulb.
We are currently working to adopt these imaging
methods to chronic recording in the awake rat. In this
preparation, we will examine the impact of active
sampling (sniffing) and begin to dissect how brain
states (sleep, wakefulness), attention, and learning
modulate odor representations and their coupling to
metabolic activity.
Calcium Dynamics Underlying
Dendritic Integration in
Olfactory Bulb Granule Cells
V. Egger [in collaboration with K. Svoboda, Cold Spring
Harbor Laboratory]
In the mammalian olfactory bulb, granule cells
(GCs) mediate lateral inhibition, the main form of
synaptic processing in the olfactory bulb. Although
GCs can fire action potentials (APs), they lack an
axon and may therefore rely on various forms of den-
dritic signaling to couple their synaptic input to the
release of inhibitory neurotransmitter. To better
understand signal integration in these cells, we have
been using 2-photon microscopy in rat brain slices to
monitor calcium transients in GC apical dendrites
and spines. We find that APs produce robust calcium
influx uniformly throughout the dendritic tree and
spines of GCs and hence contribute to a kind of glob-
al lateral inhibition. Interestingly, these global signals
are carried in large part by T-type calcium channels
(Egger et al. 2003). When GCs are activated synapti-
cally (through extracellular stimulation in the
glomerular layer), global calcium signals can also be
produced in the absence of APs. This global sub-
threshold signal is entirely T-channel-mediated and
appears to reflect a low-threshold calcium spike. It
represents a novel pathway for AP-independent later-
al inhibition in the olfactory bulb. Finally, at the level
of individual responsive synapses, robust calcium
transients are strictly localized to the spine and do not
invade the parent dendrite. These signals are carried
by a mixture of NMDA (N-methyl-D-aspartate)
receptors and voltage-dependent calcium channels.
In addition, they are substantially boosted by calci-
um-induced calcium release from thapsigargin-sensi-
tive internal stores. This local synaptic activity can
interact with the global signals evoked by APs or
synaptic events, sometimes producing supralinear
calcium transient amplitudes.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN CENTRAL
SYNAPSES
R. M al i now A. Barria N. Dawkins F. Kamenetz A. Piccini
C. Becamel I. Ehrlich C. Kopec K. Seidenman
J. Boehm H. Hsieh B. Li T. Takahashi
This laboratory is directed toward an understanding of
learning and memory by studying the physiology of
synapses. We study synaptic transmission and plastic-
ity in rodent brains, and use both in vitro brain slices
and in vivo brains. The brain slice preparation is suffi-
ciently complex to show glimpses of emergent proper-
ties, as well as simple enough to allow hard-nosed bio-
physical scrutiny. We apply the knowledge and
reagents gained from these studies to test models of
neural plasticity in brain/behavior paradigms. To mon-
itor and perturb the function of synapses, we use a
combination of electrophysiology, microscopic imag-
ing and molecular transfection/infection techniques,
which allows us to examine the cellular and molecular
basis for changes in electrophysiological function.
Last year, we added a new preparation, in which we
acutely deliver genes of interest into living animals
with viruses and examine the impact of experience on
the subcellular distribution of these gene products. We
are now testing the role of specific forms of synaptic
plasticity in various brain regions during behavioral
paradigms. Such experiments provide support to our
philosophy that synapses have key properties whose
understanding will provide insight into phenomena at
higher levels of complexity. Below are discussed
examples of projects recently published and their sub-
sequent progress.
PKA PHOSPHORYLATION OF AMPA-R
SUBUNITS CONTROLS SYNAPTIC
TRAFFICKING UNDERLYING PLASTICITY
The regulated incorporation of a-amino-3-hydroxy-5-
methy1-4-isoazole (AMPA) receptors (AMPA-Rs) into
synapses is important for synaptic plasticity. Here, we
examine the role of protein kinase A (PKA) in this
process. We found that PICA phosphorylation of the
AMPA receptor subunits G1uR4 and GluRl directly
controlled the synaptic incorporation of AMPA recep-
tors in organotypic slices from rat hippocampus.
Activity-driven PICA phosphorylation of G1uR4 was
necessary and sufficient to relieve a retention interac-
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tion and drive receptors into synapses. In contrast,
PICA phosphorylation of G1uR1 and the activity of
calcium/calmodulin-dependent kinase II (CaMKII)
were both necessary for receptor incorporation. Thus,
PKA phosphorylation of AMPA-R subunits con-
tributes to diverse mechanisms underlying synaptic
plasticity.
We are currently identifying additional phosphory-
lation sites on AMPA-Rs that control plasticity. Our
current view is that multiple phosphorylation steps are
involved in various aspects of receptor trafficking,
such as relief from extrasynaptic retention, integration
into the dendritic surface, access to the perisynaptic
region, integration into the synapse, anchoring to the
synapse, and removal from the synapse. For instance,
by mimicking phosphorylation at four sites on the
AMPA-R cytoplasmic tail, we can drive receptors into
synapses. We are also taking a proteomic approach to
determine what protein-protein interactions are
enhanced/removed by phosphorylation events.
GLUTAMATERGIC PLASTICITY BY SYNAPTIC
DELIVERY OF GLUR-2(LONG)-CONTAINING
AMPA-Rs
Activity-driven delivery of AMPA-Rs is proposed to
mediate glutamatergic synaptic plasticity, during both
development and learning. In hippocampal CA1 prin-
cipal neurons, such trafficking is primarily mediated
by the abundant GluR-1 subunit. We now report a
study of GluR-2(long), a carboxy-terminal splice vari-
ant of the GluR-2 subunit. G1uR-2(long) synaptic
delivery is regulated by two forms of activity.
Spontaneous synaptic activity-driven GluR-2(long)
transport maintains one third of the steady-state
AMPA-R-mediated responses, whereas GluR-2(long)
delivery following the induction of LTP is responsible
for approximately 50% of the resulting potentiation at
the hippocampal CA3 to CAI synapses at the time of
GluR-2(long) peak expression, the second postnatal
week. Trafficking of GluR-2(long)-containing recep-
tors thus mediates a GluR-1-independent form of glu-
tamatergic synaptic plasticity in the juvenile hip-
pocampus.
CONTROL OF NMDA-R TRAFFICKING TO
SYNAPSES BY THE NR2 SUBUNIT
To elucidate mechanisms controlling the number and
subunit composition of synaptic N-methyl-n-aspartate
receptors (NMDA-Rs) in hippocampal slice neurons,
the NR1, NR2A, and NR2B subunits were optically
and electrophysiologically tagged. The NR2 subunit
directs delivery of receptors to synapses with different
rules controlling NR2A and NR2B. NR2B-containing
receptors incorporate into synapses in a manner that is
not limited by synaptic transmission nor enhanced by
increased subunit expression. NR2A-containing
receptors, whose expression normally increases with
age, replace synaptic NR2B-containing receptors.
Replacement is enhanced by increased NR2A expres-
sion, requires synaptic activity, and leads to reduced
NMDA-R responses. Surprisingly, spontaneously
released transmitter acting on synaptic NMDA-Rs is
sufficient for replacement. Thus, as with AMPA-Rs,
synaptic trafficking of NMDA-Rs is tightly regulated
and has unique rules.
We are currently testing the impact of the NR2B to
NR2A switch on synaptic plasticity. Our preliminary
results indicate that driving this switch reduces the
generation of LTP. This reduction in plasticity is large-
ly due to differences in affinity by NR2A and NR2B
to CaMKII.
HOMEOSTATIC FEEDBACK BETWEEN NEURONAL
ACTIVITY AND APP PROCESSING
A large body of work implicates the accumulation of
A13's disease. However, little is known regarding the
relation between neuronal electrophysiological func-
tion and APP processing. We find here that neuronal
activity controls the formation of AP. Furthermore,
increased formation of AP reversibly depresses sriap-
tic function. These results suggest that APP cleavage
products act as negative feedback homeostatic regula-
tors that keep neuronal hyperactivity in check.
Pathology that disrupts this homeostatic system could
increase the production of AP and/or produce neu-
ronal hyperactivity, events that may contribute to
Alzheimer's disease.
We are currently examining the synaptic process
affected by A13 responsible for depressed transmis-
sion. Our preliminary evidence indicates that AMPA-
R trafficking is affected.
EXPERIENCE STRENGTHENS TRANSMISSION BY
DRIVING AMPA-Rs INTO SYNAPSES
To elucidate the mechanisms underlying experience-
dependent plasticity in the brain, the trafficking of the
AMPA subclass of glutamate receptors into synapses
was examined in the developing rat barrel cortex. In
vivo gene delivery was combined with in vitro record-
ings to show that experience drives recombinant
G1uR1, an AMPA-R subunit, into synapses formed
between layer 4 and layer 2/3 neurons. Furthermore,
expression of the GluR1 cytoplasmic tail, a construct
that inhibits synaptic delivery of endogenous AMPA-
Rs during long-term potentiation, blocked experience-
driven synaptic potentiation. In general, synaptic
incorporation of AMPA-Rs in vivo conforms to rules
identified in vitro and contributes to plasticity driven
by natural stimuli in the mammalian brain.
We are currently testing whether a similar process
occurs during learning paradigms such as fear condi-
tioning and cross-modal plasticity in adult animals.
PSD-95 AS A CRITICAL SYNAPTIC SCAFFOLD
REQUIRED FOR LTP
The regulated delivery of AMPA-type glutamate
receptors (AMPA-Rs) to synapses is an important
mechanism underlying synaptic plasticity. Here, we
ask whether the synaptic scaffolding protein PSD-95
(postsynaptic density 95) participates in AMPA-R
incorporation during two forms of synaptic plasticity.
In hippocampal slice cultures, the expression of PSD-
95-green fluorescent protein (PSD-95-GFP) increases
AMPA-R currents by selectively delivering glutamate
receptor 1 (GluR1)-containing receptors to synapses,
thus mimicking long-term potentiation (LTP).
Mutational analysis shows that the amino-terminal of
PSD-95 including the first two PDZ [PSD-95/Discs
large (Dlg) /zona occludens-1 (ZO-1)] domains is nec-
essary and sufficient to mediate this effect. Further
supporting a role in synaptic plasticity, wild-type
PSD-95 occludes LTP, and dominant-negative forms
'block LTP. Moreover, we demonstrate that PSD-95
also participates in AMPA-R delivery during experi-
ence-driven plasticity in vivo. In the barrel cortex
from experience-deprived animals, the expression of
PSD-95-GFP selectively increases AMPA-R currents,
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mimicking experience-driven plasticity. In nonde-
prived animals, PSD-95-GFP produces no additional
potentiation, indicating common mechanisms
between PSD-95-mediated potentiation and experi-
ence-driven synaptic strengthening. A dominant-neg-
ative form of PSD-95 blocks experience-driven
potentiation of synapses. Pharmacological analysis in
slice cultures reveals that PSD-95 acts downstream
from other signaling pathways involved in LTP. We
conclude that PSD-95 controls activity-dependent
AMPA-R incorporation at synapses via PDZ interac-
tions not only during LTP in vitro, but also during
experience-driven synaptic strengthening by natural
stimuli in vivo.
Currently, we are employing RNAi (RNA interfer-
ence) techniques with viruses to knock down PSD-95
levels in neurons and determine the effect on synaptic
transmission and plasticity in in vitro and in vivo
preparations.
In conclusion, we are continuing to elucidate the
basic mechanisms involved in central synaptic trans-
mission and plasticity and testing how these mecha-
nisms participate in experience-driven plasticity.
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COMPUTATIONAL AND SYSTEMS NEUROBIOLOGY
P. Mitra R. Baptista
H. Bokil
H. Maniar
This research effort began in the fall of 2003 when
Partha Mitra joined the faculty at CSHL. Partha was
previously located at Bell Laboratories, Lucent
Technologies. Hemant Bokil, previously a postdoctor-
al fellow at Bell Laboratories working jointly with
Partha and Richard Andersen at Caltech, also moved
here to CSHL. Hemant continues his work on signal
processing applications to neurobiological time series
with special emphasis on neural prostheses. Rafael
Baptista, a professional software developer who start-
ed out with some work on the Human Genome Project
and has more recently been working in the video game
industry, joined the research team in late August and
will be performing the dual role of providing software
infrastructure for the group and participating in the
open source software project Chronux to develop soft-
ware for neurobiological data analysis. Hiren Maniar
also joined the group in August as a postdoctoral fel-
low, working as part of a consortium funded by the
Human Frontiers Science Foundation to work on the
role of neural synchrony in cross-modal integration.
Apart from this group of core personnel, our
research effort includes close collaborative ties with
multiple research groups in the area. A collaborative
effort with Niko Schiff and Keith Purpura at the Weill
Medical School of Cornell University, where Partha is
an adjunct associate professor, involves electrophysi-
ology in the awake behaving macaque, and members
of the research team there include Alexander Polyakov,
a postdoctoral member of the laboratory, and David
Menzer, a graduate student at Weill Medical School. A
second research effort on how zebra finches learn
their song vocalizations is being carried out in collab-
oration with Ofer Tchernichovski at City College of
New York. A third collaboration is with the group of
Rodolfo Llinas and Urs Ribary at New York
University Medical College, involving dynamic brain
imaging using magnetoencephalography as the probe.
A fourth consortium-based research effort to study
cross-modal integration between the senses is funded
by the Human Frontiers Science Program, including
the laboratories of Shinsuke Shimojo (Caltech), Pascal
Fries (EC. Donders Research Center at Nijemegen),
Shiny'a Nishida at the Nippon Telegraph and
Telephone Corporation labs in Japan, and Alan
Johnston at the University College, London.
Our basic research philosophy is to bring computa-
tional and theoretical tools to bear on biological ques-
tions in general, and neurobiological questions in par-
ticular, to make sense of biological complexity and to
provide understanding and potential therapies for dis-
ease. There are two basic branches to the research:
Neuroinformatics and Theoretical Engineering. The
former involves the application of statistical and com-
putational tools to neurobiological data, primarily sin-
gle-channel and multichannel time series, including
point processes (spike trains) and brain imaging data.
The applications are geared toward exploratory analy-
sis of large volumes of data, as well as confirmatory
analysis for testing of specific hypotheses. This is a
continuing research effort that reflects several years of
work and is associated with a course entitled
"Neuroinformatics" held each summer at the Marine
Biological Laboratories in Massachusetts. The second
branch of research deals with the question of theoreti-
cal principles underlying the design of biological sys-
tems. Since biological organisms are evolved to per-
form their tasks robustly under uncertain circum-
stances, in terms of both the environment and paramet-
ric uncertainty in components making up the system, it
is expected that the mathematical theories developed by
engineers to help design man-made systems that per-
form under similarly challenging circumstances may
also apply to these systems. The goal of this research is
to identify the engineering principles most germane to
biology and to study selected examples drawn from dif-
ferent levels of the organizational hierarchy.
Chronux: Open Source Software for
Analyzing Neurobiological Time Series
Data
R. Baptista, H. Bokil
The nervous system stores and executes behaviors and
adapts these behaviors to the environment through
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sensory monitoring. Studies of the activity of the ner-
vous system consist primarily of monitoring the
dynamics of units at different levels of hierarchy of the
system: ranging from single neurons measured electri-
cally to large groups of neurons monitored indirectly
through a variety of imaging methodologies. The rele-
vant measurements consist of single or multichannel
time series data, in the form of continuous or point
processes. Therefore, the statistical analysis of time
series data is central to studying the nervous system.
During the last several years, our research has
involved the development of algorithmic and compu-
tational tools for the analysis of multichannel time
series data from the neurosciences. We are now encod-
ing these tools into an open source software package
entitled Chronux. This project will proceed in stages
and will involve the development of a high-quality
numerical analysis library, data I0 and management
utilities, and a user interface that gives experimental
neuroscientists access to advanced analysis tools. The
project will proceed in stages, where we move from
the current implementation of the relevant routines as
MATLAB toolboxes to a fully open source and self-
contained software. Although a number of signal pro-
cessing libraries are available, the goal of this effort is
to develop domain-specific tools that will aid neuro-
science research. We expect that such tools will be
critical to advancing our understanding of systems
neuroscience.
Neural Prosthetics: Local Field
Potential Measurements
H. Bokil
A number of current research efforts aim at develop-
ing invasive neural prosthetics, which will use electri-
cal signals measured from microelectrodes implanted
into appropriate brain regions to infer the motor or
cognitive intentions of patients with peripheral neu-
ropathology to drive a prosthetic device, or potential
to stimulate a limb. Previously, these efforts have
focused on spiking activity measured using micro-
electrodes. However, unit activity is not necessarily
robust over periods of days, and gliosis at the elec-
trodes may further degrade the measured signals. We
have previously found that the local field potential
(LFP) signal, i.e., low-frequency electrical recordings
reflecting the extracellular currents flowing in the
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vicinity of the microelectrode tip, may be used as a
robust alternate source of information about the
underlying neural signals. In collaboration with
Richard Andersen at Caltech, we have been working
on utilizing these LFP signals for prosthetic applica-
tions. We have recently finished development of an
event detection and classification framework for this
purpose and have tested it on a set of recordings from
the intraparietal sulcus in macaque performing a
working memory task. We find that for the signals in
this brain region (relating to saccadic eye movements),
the LFPs are equally informative, and more robust,
than the unit activity measured by individual micro-
electrodes.
Temporal Structure in Neural Activity
During Working Memory
P. Mitra [in collaboration with K. Purpura and N. Schif
at WMC, Cornell University; A. Polyakov, and D. Menzer,
Cornell University]
Holding items in short-term memory is thought to cor-
respond to appropriate holding patterns of electrical
activity in the brain. An experimental model system
much studied in this regard involves memory saccades
in awake behaving macaques, where the subject
remembers a target location during a memory period
and performs a visual saccade to the target on an
appropriate cue. Area LIP, on the lateral bank of the
intraparietal sulcus, is known to encode intended sac-
cade directions. Individual neurons may be found in
this area which show a transiently elevated firing rate
during the memory period of a saccade memory task,
with tuning to the direction of the intended saccade.
In collaborative work with the laboratory of
Richard Andersen at Caltech, we have previously dis-
covered that in addition to the firing rates, the dynam-
ics of the neural activity also shows tuning to intended
saccade direction. We are currently studying how this
tuned dynamics is represented along the cortical sur-
face, and if the dynamics is correlated across distant
parts of the circuitry known to participate in the sac-
cade memory task. In the previous year, we have
moved this research effort to the laboratory of K.
Purpura and N. Schiff at the Weill Medical College of
Cornell University. The setup phase of this transition
is largely complete, and we are beginning to acquire
data from the new location for the study.
Song Learning in the Zebra Finch
P. Mitra [in collaboration with Ofer Tchernichovski, CCNY]
The neural substrate and evolutionary origins of lin-
guistic behavior in humans is of great biological inter-
est, but difficult to study, since there are no other
species where the acoustic communication behavior is
seen to exhibit the same level of syntactic complexity.
Therefore, there has been great interest in studying
what has been termed the faculty of language in a
broad sense, one aspect of which is the ability to learn
vocalizations. This last is itself infrequently found in
animals: a reason songbirds, which exhibit learning of
complex vocal repertoires, have been the subject of
intensive study. The species of choice in this research
is the zebra finch, where all aspects of the song system
have been scrutinized, ranging from the sensory-motor
circuitry in the brain to the production apparatus. We
have developed techniques for detailed quantification
of song development, through the analysis of continu-
ously acquired acoustic signals from birds subjected to
a controlled training protocol.
In this ongoing research project, in the previous
year, we have made a number of new observations. We
developed a segmentation and clustering procedure
that allows us to track the emergence and development
of individual song elements, as well as to monitor the
development of the sequential structure of these ele-
ments in the mature song. This procedure has con-
firmed our earlier observation that the process of song
development is highly structured and may not be
described by a simple minimization of an overall
acoustic error. In studying the effect of age at which
the song model is first presented to the learner, we
have found that adult learners are able to quickly learn
the acoustic structure of individual notes, but they
have more difficulty with the overall sequential pat-
tern of the song: This is apparently in contrast with the
corresponding observation in humans. Sebastien
Dergnaucourt, a postdoc in the Tchernichovski labora-
tory, has demonstrated that sleep affects song learning,
particularly in the early stages; it appears that song
performance degrades after night sleep during the first
few weeks after exposure to the song model. This
"morning deterioration" is absent in the adult bird.
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EXPERIENCE-DEPENDENT PLASTICITY OF SYNAPSES AND
SYNAPTIC CIRCUITS
K. Svoboda B. Burbach E. Nimchinsky V. Scheuss
I. Bureau T. O'Brien G. Shepherd
V. De Paola L. Petreanu A. Sobczyk
A. Holtmaat T. Pologruto G. Tervo
A. Karpova
The functional properties of the brain must change in
response to salient sensory experiences. The nature of
these changes at the level of synapses, neurons, and
their networks, also known as the engram, is unknown.
Our laboratory is searching for the substrates of expe-
rience-dependent plasticity in the developing and
adult neocortex.
Neocortical tissue is dauntingly complex: 1 mm3
contains nearly a million neurons, each of which con-
nects to thousands of other neurons. To probe neurons
and synapses within the intact network, we build and
use sensitive tools. 2-photon laser-scanning
microscopy (2PLSM) allows us to image single
synapses in intact tissues and to track changes in intra-
cellular calcium and signal transduction events.
Excitation of neuronal elements by focal uncaging of
neurotransmitters allows us to probe the connectivity
of neural networks with high efficiency. We combine
these optical methods with electrophysiological mea-
surements of synaptic currents and potentials and
molecular manipulations of neurons.
We use both in vivo measurements to address sys-
tem level questions and in vitro methods to get at
detailed mechanisms. As a model system we use the
rodent barrel cortex. Here, whiskers are represented in
a topographic manner, with information from each
whisker represented by a small cortical region (barrel).
Whisker maps are shaped by experience during devel-
opment and reshaped in the adult. The cellular mech-
anisms underlying sensory map plasticity are likely to
share mechanisms with those underlying learning and
memory in other brain regions and other species.
[Ca21 Signaling in Single
Dendritic Spines
V. Scheuss, A. Sobczyk
Long-term changes in synaptic efficacy are triggered
by increases in [Ca"] in the postsynaptic neuron. We
are working toward a complete understanding of the
186
L. Wilbrecht
R. Yasuda
C. Zhang
K. Zito
life cycle of Ca" ions in dendritic spines. We have
developed a variety of assays to learn about the mole-
cular pathways of Ca" influx, including the counting
of individual Ca" permeable channels and receptors in
spines. Recently, we have discovered that Ca" extru-
sion is inhibited by long-duration Ca" elevations,
which could be an important factor underlying the
induction of synaptic plasticity. In addition, we are
probing the 2. messenger cascades involved with mod-
ulation of Ca" handling in small neuronal microcom-
partments.
Optical Studies of Single Synapses
R. Yasuda, E. Nimchinsky
Central nervous system (CNS) synapses release gluta-
mate to activate postsynaptic channels. Activated
channels can be detected at single synapses using
[Cal imaging in postsynaptic spines. Using a novel
statistical analysis of these [Cal signals, we counted
the number of receptors opened by synaptic transmis-
sion and found this number to be small (1-5). Only a
small fraction of receptors open during low-frequency
synaptic transmission, and the dynamic range of
synapses is large. Furthermore, stochastic interactions
between ligand and receptor as well as molecular fluc-
tuations of synaptic channels and receptors contribute
to noise in synaptic transmission. Using techniques
based on fluorescence energy transfer, we have begun
to image the signal transduction cascades activated by
synaptic transmission in dendrites.
Experience-dependent Plasticity
in the Adult Cortex In Vivo
A. Holtmaat, L. Wilbrecht, V DePaola
Sensory representations in the adult brain are stable,
yet we are able to learn. What is stable and what is
plastic in the adult brain? We have succeeded in
imaging dendrites, axons, and synapses over time
scales of months in the adult cortex. We find that
layer-5 dendrites and axons are stable over months.
Changes in synaptic networks therefore must be
local. We have imaged synaptic structure and found
that a fraction of transient dendritic spines appeared
and disappeared over a few days whereas other stable
spines persisted for months. The stable fraction grew
gradually during development and into adulthood,
providing evidence that synaptic circuits continue to
stabilize even in the mature brain. A direct compari-
son in adult mice revealed that a larger fraction of
spines are stable in the visual cortex than in the
somatosensory cortex, possibly reflecting differ-
ences in the capacity for experience-dependent plas-
ticity in these brain regions. We further analyzed the
ultrastructure of new spines at the level of electron
microsocopy, providing evidence that synapses are
formed in the adult brain. Induction of experience-
dependent plasticity by manipulating the whiskers
was associated with synaptic growth, suggesting that
novel experiences are encoded by new synapses.
Presynaptic boutons are also turning over in the adult
brain with frequencies similar to those of dendritic
spines.
Experience-dependent
Development of
Neocortical Circuits
G. Shepherd, I. Bureau, L. Petreanu
We have adopted and improved laser scanning pho-
tostimulation (LSPS) to rapidly and efficiently
probe the structure of neural circuits. Sensory cor-
tex is ordered into columns, each tuned to a specif-
ic subset of peripheral stimuli. To identify the prin-
ciples underlying the construction of precise colum-
nar architecture, we monitored the development of
functional circuits in the rat barrel cortex using
LSPS. Circuits impinging onto layer-2/3 neurons
from layers 4 and 2/3 developed in a monotonic,
precise progression. Anatomical reconstructions
show that axonal arbors grow in a directed manner.
We find little evidence for transient hyperinnerva-
tion at the level of cortical columns. Consistently,
synaptic currents measured in layer-2/3 neurons just
after these neurons cease to migrate (PND 8),
revealed already spatially well-tuned receptive
fields.
We used LSPS to determine the locus of experi-
ence-dependent plasticity. Layer-2/3 neurons differed
in their spatial distributions of presynaptic partners:
Neurons directly above barrels received, on average,
significantly more layer-4 input than those above the
septa separating barrels. Complementary connectivi-
ty was found in deprived cortex: Neurons above septa
were now strongly coupled to septal regions, where-
as connectivity between barrel regions and layer 2/3
was reduced. These results indicate competitive
interactions between two thalamocortical circuits,
the VPM-barrel and POm- septal pathways, in the
establishment of precise intracortical circuits. We are
beginning to apply these techniques to test for the
role of inhibitory circuits in experience-dependent
plasticity.
Cellular and Molecular
Mechanisms of Dendritic
Spine Morphogenesis
K. Zito, C. Zhang
Most of the excitatory synapses in the cortex occur on
dendritic spines, small protrusions extending from
neuronal dendrites. Spines are highly motile during
development, suggesting a role for spine dynamics in
synapse formation. We searched for molecules that
altered the dynamics of spine morphogenesis by
examining the effects of overexpression of wild-type,
activated, and dominant negative versions of candidate
genes on spine number, density, morphology, and
dynamics. We are studying Neurabin-I (NrbI), a neu-
ronal-specific actin-binding protein. NrbI is a 122-kD
protein that contains an amino-terminal actin-binding
domain, a protein phosphatase I (PPI)-binding site, a
PDZ domain that binds p70S6K, and a carboxy-termi-
nal coiled-coil dimerization domain. Green fluores-
cent protein (GFP)-tagged NrbI localized specifically
to dendritic spines in neurons in slice culture, and this
localization required an intact actin-binding domain.
Remarkably, a severely truncated GFP-NrbI caused a
dramatic increase (more than twofold) in the number
of spines. Using electron microscopy, we found that
Nrb is concentrated at sites of cell-cell contact and that
morphological changes reflect an increase in the num-
ber of synapses.
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FIGURE 1 Coronal section through one olfactory bulb of a
transgenic mouse expressing a modified VAMP protein and
GFP. The bulb-like structures on the circumference are individ-
ual glomureli, the termination zones of receptor neurons
expressing particular olfactory receptors.
Molecular Methods to
Reversibly Inactivate
Synapses In Vivo
A. Karpova, G. Tervo, B. Burbach
A major roadblock in gaining an understanding of
neural networks is our inability to modulate selected
circuit elements in vivo with temporal control and
specificity. We have begun a research program to har-
ness recent insights about the molecules that regulate
neurotransmitter secretion to design genetically deliv-
erable systems that can interfere with synaptic func-
tion in a rapidly inducible manner. Interference is
achieved with dimerization induced by rapamycin-like
compounds. The first two systems, based on synapto-
physin and VAMP, are currently being tested in in vitro
systems. One system based on VAMP has also been
targeted to specific subsets of neurons in the olfactory
bulb (Fig. 1) and in the cerebellum for testing in the
intact brain.
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Genetically Encoded [Ca21 Indicators
T. Pologruto
A major breakthrough in functional imaging was the
development of genetically encoded Ca" indicators
based on fluorescent proteins. These indicators couple
Ca' binding to a calmodulin domain to a conforma-
tional change in the fluorescent protein and an optical
signal. Because of the complicated nature of Ca"
binding to calmodulin in the presence of calmodulin
substrate, the dynamics of these indicators are not
understood. We express genetically encoded indicators
in brain slices and explore their responses to physio-
logical Ca" concentration changes in neurons. We
combine these measurements with quantitative Ca'
imaging in a second fluorescence channel using syn-
thetic Ca' indicators. This will allow us to construct
detailed kinetic models of genetically encoded indica-
tors. These studies will also teach us about the signals
activating calmodulin in intact neurons.
Instrumentation
K. Svoboda, T. Pologruto, T. O'Brien, R. Yasuda
in collaboration with R. Eifert, Cold Spring Harbor
Laboratory]
Our hardware development efforts during the past year
have focused on developing new approaches to study-
ing signaling in synaptic microcompartments. We
have developed a microscope combining 2-photon
microscopy with fluorescence lifetime imaging
(FLIM). FLIM facilitates quantitative imaging of flu-
orescence resonance energy transfer (FRET), allowing
detection of protein-protein interactions in situ. We
have also set up a microscope that allows simultane-
ous 2-photon imaging and uncaging with single
synapse resolution. We have also written software to
control a laser-scanning microscope with two lasers
(one for imaging and the other for uncaging) and
FLIM detection.
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NEUROGENETICS OF MEMORY IN DROSOPHILA
T. Tully J. Barditch J. Kui S. Rachakondra
F. Bolduc C. Li M. Regulski
B. Chen J. Luo S. Xia
L. Grady J. O'Neil
We are using the fruit fly model system to discover
genes involved in memory formation. Given its econ-
omy of scale (simpler genome and nervous system,
rapid generation cycle, cheap husbandry) and the
genetic tools available, this model system offers the
possibility to identify a large part of the gene network
that participates in this complex emergent property of
the animal. Enough past work already has established
that similar genes likely will participate in mammalian
memory formation. Thus, our gene discovery in
Drosophila represents the first step of a broader exper-
imental strategy to delineate the genetic basis of cog-
nitive (dys)function in humans.
MUTANTS AND MICROARRAYS
Past studies of single-gene mutants have suggested a
genetic dissection of memory formation into five dis-
tinct temporal phases: initial acquisition or learning
(LRN) of an odorfoot shock association, short-term
memory (STM), middle-term memory (MTM), anes-
thesia-resistant memory (ARM), and long-term memo-
ry (LTM). In essence, any given mutation yields a pri-
mary disruption of just one memory phase, sometimes
with secondary disruptions of temporally "down-
stream" phases. Further evidence for the biological
validity of these memory phases accumulates. In col-
laboration with Dr. Minoru Saitoe and co-workers at the
Tokyo Metropolitan Institute, for instance, we recently
have shown that age-associated memory impairment
(AAMI) results specifically in the loss of MTM.
Consistent with this notion, AAMI does not occur in
amnesiac mutants, in which MTM is defective.
Evidence for functionally independent memory
phases also is clear. Mutation of the CREB gene dis-
rupts LTM without affecting ARM, for instance,
whereas mutation of the radish gene disrupts ARM
without affecting LTM. These observations argue that
distinct biochemical pathways or anatomical sites
underlie the various memory phases. Our recent gene
discovery has begun to clarify these alternative
hypotheses (see below).
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We have identified 60 new memory mutants from a
behavioral screen, which define 51 new genes. This
approach is designed to identify genes that function
either during development to give rise to relevant brain
structures or during memory formation to give rise to
the physiological response. Such mutations may exert
their effects anywhere within the five phases of mem-
ory formation. A limitation of this approach, however,
is that the mutations must yield homozygous-viable
adults, thereby preventing the identification of any
essential genes. We also have identified 3971 candidate
memory genes (CMGs) from DNA microarray experi-
ments. These CMGs are differentially regulated in nor-
mal flies subjected to spaced versus massed training.
Previously, genetic experiments have established that
the only difference between these two training proto-
cols is the induction of transcription-dependent LTM
by the former. This approach is designed to identify
essential or nonessential genes involved specifically in
the physiology of LTM formation, and it can reveal the
involvement of essential genes. Strikingly, 17 of the
memory mutants carry molecular lesions in or near
CMGs from microarray experiments.
This convergence of our two approaches identified
the pumilio /staufen pathway to be involved in memo-
ry formation. This pathway participates in the subcel-
lular compartmentalization of mRNAs and the regula-
tion of their translation locally. We hypothesize that
the pumilio/staufen pathway participates in modifica-
tions of specific synapses during memory formation.
Continued focus on these convergent data promises
the identification of further novel cellular processes
involved in behavioral plasticity.
CIRCUITS AND PHASES
This work was done in collaboration with Dr. A.-S.
Chiang (Tsing Hua National University, Taiwan) and
Dr. J. Dubnau here at CSHL. These 60 new memory
mutants were generated using "enhancer-trap" trans-
posons-jumping genes that not only disrupt the func-
tion of endogenous target genes, but also appropriate
ruslan (D417) 50 Spaced FIGURE 1 CREB-dependent long-term memoryformation occurs in an anatomically distinct site
outside mushroom bodies. (Left panel) The ruslan
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focal optical sections in whole-mount adult brain.)
(Right panels) Expression of a repressor form of
CREB (CREB) was driven by various enhancer-trap
transposon insertions, including ruslan (D417). In
such transgenic flies (D417/CREB), 1-day memory
after spaced training (Spaced) was disrupted,
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nature of specific disruptions of LTM. In contrast, expression of CREB repressor in enhancer-trap lines showing preferential expression
in mushroom bodies had no effect on 1-day memory after spaced training (data not shown). Since ruslan does not express in mush-
room bodies, these data indicate that LTM forms at an anatomical site distinct from mushroom bodies.
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the target genes' endogenous enhancers to drive
expression of a reporter gene. With such a genetic
tool, we were able to visualize the neural circuits that
expressed each of the "memory genes." Many of these
genes showed relatively complex patterns of expres-
sion in various brain anatomies, including the mush-
room bodies-neuropillar structures already known to
be required for the proper formation of olfactory
memory. Some memory genes, in contrast, showed
patterns of expression that did not include mushroom
bodies, thereby suggesting a broader neural circuitry
involved in olfactory memory. One of these informa-
tive memory mutants is ruslan (Fig. 1).
In collaboration with Dr. Carla Margulies in Jerry
Yin's lab here at CSHL, we have used these enhancer-
trap lines to express a repressor form of CREB
(CREB-r) in different anatomical regions of the brain.
In this manner, we are identifying anatomical regions
of the brain that may or may not participate in the for-
mation of LTM. Much to our surprise, expression of
CREB-r in mushroom bodies did not disrupt LTM
(data not shown). Instead, expression of CREB-r by the
ruslan enhancer-trap disrupted LTM specifically (Fig.
1). Importantly, the ruslan expression pattern does not
include mushroom bodies, thereby indicating that
LTM forms outside of mushroom bodies, even though
LRN and early memory (STM and MTM) require nor-
mal mushroom body function. More generally, these
data suggest a "transference" of memory over time
from one anatomical region of the brain to another-a
phenomenon also known to exist in humans.
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LONG-TERM MEMORY FORMATION IN DROSOPHILA
J. Yin K. Ando C. Margulies
E. Drier E. Paniagua
V. Gupta P. Wu
J. Horiuchi H. Zhou
The Biology of DaPKM
E. Drier, E. Paniagua, J. Yin
In neurons, the truncated form of DaPKC (DaPKM) has
been shown to be a critical player in memory formation
and synaptic plasticity. Is the truncated isoform unique
to neurons? We have isolated 45 new imprecise exci-
sions of the 1(2)k06403 P-element insertion. This P-ele-
ment is inserted into the promoter region of Transcript
B, which codes for one of the DaPKM isoforms
(DaPKMp60). Complementation analysis shows that
these new insertions complement both the original P-
element mutation and the deficiency that uncovers the
DaPKC gene. Phenotypic characterization of homozy-
gous mutations show that the excisions can be grouped
into classes that affect fertility, ranging from a wild-type
mother to mutants that are mildly or severely affected
for egg laying. Western analysis of ovaries shows that
there is an inverse correlation between the severity of
the mutation's oogenesis phenotype and the amount of
a DaPKMp45 protein. The different classes of mutants
make similar amounts of full-length protein
(DaPKCp73). Mutations that are mildly affected result
in almost wild-type levels of the protein, whereas
mutants that make little or no protein are severely com-
promised. These data establish the importance of
DaPKM isoforms in oogenesis, and suggest that the p45
isoform, which is barely detectable in head extracts,
participates in oogenesis. Light microscopic analysis of
ovaries from mutant mothers suggests that the excisions
affect a relatively early stage in oogenesis, prior to Stage
10. It will be interesting to determine if the decrease in
DaPKMp45 is somehow disrupting a maintenance
function in one of the localization processes that is
important in oogenesis, consistent with our interpreta-
tion of DaPICMp60's function in neurons.
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DaPKM and Synaptic
Tagging
P. Wu, H. Zhou, J. Yin
We have continued to analyze proteins that interact
with DaPKMp60 and DaPKMp47 in head extracts.
When fly head extracts are made, there are three pre-
dominant protein isoforms that we can detect:
DaPKCp73, DaPKMp60, and DaPKMp47. These
can be separated using traditional biochemical
approaches. When a partially enriched extract is run
over Superose 6 gel-filtration columns, DaPKMp60
and DaPKMp47 are found in fractions that contain
different-sized protein complexes. The DaPKMp47-
containing fraction is larger and runs consistent with
a 440 -kD complex. The DaPKMp60- containing frac-
tion runs around 150 kD. An interesting array of pro-
teins can be found in the 150-1cD fraction, including
Dlg, SAP97, dFXR, and other proteins that are con-
nected with RNA metabolism and translational regu-
lation. These proteins are known to interact with
DaPKC in other developmental contexts (oogenesis,
asymmetric cell division, cell polarity) and are con-
sistent with subcellular functions involving receptor
trafficking, localized translation, and cytoskeletal
rearrangements. The same proteins are found in a
DaPKMp60- containing fraction that is eluted from
an antibody affinity column. This argues that many
of these proteins may actually interact with
DaPKMp60, since they coelute on gel-filtration and
affinity chromatography. Interestingly, the 440-1cD
fraction that contains DaPKMp47 does not contain
any of these proteins, suggesting isoform specificity
in the interactions. We are continuing to purify these
fractions in anticipation of obtaining fractions clean
enough for mass spectrometry.
Functional Anatomy of Long-term
Memory Formation
C. Margulies, V. Gupta, J. Yin [in collaboration with
A.-S. Chiang and T. Tully, Cold Spring Harbor Laboratory]
The traditional Ga14/UAS bipartite system has been
used to ask where dCREB2-b expression results in
effects on long-term memory (LTM), but not learning
or memory after massed training. A number of the
commonly used driver lines that express in the mush-
room body do not result in any effects on LTM for-
mation, although pan-neuronal or ubiquitous expres-
sion of the particular dCREB2-b transgenes specfi-
cially affect memory after spaced training. Using a
number of driver lines that resulted from the Hartford
screen, and which do not express at very significant
levels in the mushroom bodies, LTM can be specfi-
cally disrupted. Because it is difficult to know if the
mushroom bodies have a higher threshold for
dCREB2-b-mediated disruption, or if chronic expres-
sion of the dCREB2-b transgene allows compensation
during development, it is difficult to conclude that the
mushroom bodies are not needed for LTM formation.
The spatial pattern of expression has been examined
using high-resolution treatment of head tissue, green
fluorescent protein (GFP) expression and confocal
microscopy, and the emerging impression is that the
anatomical regions required for LTM formation may
lie outside of the mushroom bodies. However, use of
the tetracyline-inducible system will be needed to
definitively rule in other anatomical regions, and per-
haps help rule out the involvement of the mushroom
bodies in LTM formation.
dCREB2 and Neurodegeneration
K. Ando, J. Yin
Huntington's disease results from a polyglutamine
expansion in the coding region of the huntingtin gene.
Recently, it has been shown that expanded polygluta-
mine runs interfere with the response-element-bind-
ing protein (CREB)-binding protein (CBP) and
CREB-mediated transcription in cells. We find that
polyQ-expanded flies are compromised for viability
and have decreased dCREB2 activity and that this
lethality is sensitive to the gene dosage of the dCREB2
gene. When the S162 (loss-of-function) mutation is
combined with polyQ-expressing transgenes, toxicity
is increased. Genomic transgenes of dCREB2 partial-
ly suppress the lethality in a dose-dependent manner,
suggesting that the effects of polyQ can be reversed by
increasing dCREB2 activity. This is consistent with the
interpretation that much of the effects of polyQ in flies
occur at the transcriptional level. Transgenes that over-
produce PKA also suppress both lethality and the
effects that polyQ have on dCREB2 activity, suggest-
ing that it is also suppressing through the same path-
way as dCREB2-b and CBP. The ability of this single
pathway to partially suppress the toxic effects of
polyQ expansion and overproduction has interesting
therapeutic implications.
Regulation of dCREB2 Activity
J. Horiuchi, J. Yin [in collaboration with R. Kwok,
University of Michigan]
Previous work showed that dCREB2 is regulated at the
level of DNA binding and that casein kinase phospho-
rylates one or more sites in the KID domain of the pro-
tein to inhibit binding. These potential casein kinase
sites are conserved on mammalian CREB, and the pro-
to the same regulation. In mouse tis-
sue, we detect two pools of protein, one that contains
unphosphorylated CREB, and fits the Scientific
American view of the protein and the other that is
phosphorylated and inhibited from binding DNA. This
latter pool may not require 5133 phosphorylation for
transcriptional activation and may instead use a coac-
tivator which does not require 5133 phosphorylation
for protein:protein interaction. It is unknown if there
are ever two comparable pools in Drosophila. In the
steady state, we can only detect protein totally phos-
phorylated on both 5231, the Drosophila equivalent to
S133, and protein phosphorylated on one or more of
the putative casein kinase sites.
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NEURAL SUBSTRATE OF SELECTIVE AUDITORY ATTENTION
IN THE CORTEX
A. Zador M. Deweese G. Otazu L.-H. Tai
T. Hromadka S. Rumpel M. Wehr
We use a combination of theoretical and experimental
approaches to study how the brain computes. The
brain is able to solve hard computations that remain
far beyond the reach of the fastest computers. Our goal
is to understand this computation at the synaptic, cel-
lular, behavioral, and algorithmic levels.
One example of such a hard computation is the
"cocktail party problem." When we tune in to one voice
at a cocktail party, and tune out the others-a task that
remains beyond the capacity of modern computers-
we are engaging in a form of selective auditory atten-
tion. Our ability to attend selectively is not limited to
the auditory domain: Analogous tasks demand selec-
tive attention in the visual and even somatosensory
domains. In monkeys, visual attention selectively
enhances neural activity even in the earliest stages of
visual cortical processing. This enhancement is sur-
prising because the areas associated with these first
stages of visual processing have traditionally been
thought of as representing the sensory world faithfully,
in a way that depends only on the properties of the sen-
sory input itself. The discovery of attentional modula-
tion overturns the notion that the peripheral sensory
cortex is a passive "TV screen" available for viewing
by a "homunculus" buried deep within the cortex.
The specific projects in our laboratory fall into two
main categories. First, we are interested in how neurons
represent auditory stimuli, and how these representa-
tions are computed from the cochlear inputs half a dozen
synapses away. To address these questions, we are using
electrophysiological and imaging approaches in anes-
thetized rats as well as computational approaches to
characterize the properties of natural sounds. Second, we
are interested in how these representations are modified
dynamically-within seconds-in awake behaving rats
by the demands imposed by attentional tasks.
Variability of Coding in the
Auditory Cortex
M. Deweese
Computers rely on extremely precise, low-noise
components to compute, whereas the components
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that make up neural circuits appear to be very noisy.
Nevertheless, brains outperform computers on the
kinds of hard computational problems required for
survival in the real world. To understand how brains
compute in the presence of such high levels of appar-
ent noise, we are characterizing the sources of vari-
ability (i.e., noise) in single neurons. Using in vivo
whole-cell patch-clamp recording techniques, we are
examining the trial-to-trial variability of the postsy-
naptic potential (PSP) elicited by brief tone pips. In
some neurons, trial-to-trial variability in the PSP is
small, consistent with "private" sources limited to
only the neuron under study; but for other neurons,
"shared" sources of variability produce circuit-wide
fluctuations in the synaptic drive to the neuron and
its neighbors, greatly increasing the apparent noise in
the PSP. These stimulus-independent correlations
could provide a substrate for feedback underlying
cognitive processes, such as attention and motiva-
tion.
In Vivo Whole-cell Patch-clamp
Recordings of Sound-evoked
Synaptic Responses in
Auditory Cortex of Awake
Restrained Rats
M. Deweese, T. Hromadka
Neurons in the auditory cortex respond to some
sounds but not to others. What determines this
selectivity? We are using whole-cell patch-clamp
recording methods in vivo to measure the synaptic
currents elicited by simple and complex auditory
stimuli. Patch-clamp recordings provide a much
richer source of information than do conventional
single-unit extracellular recordings because they
allow us to monitor not just the output of the neu-
ron-the spike train-but the input as well. These
data provide clues about the representations with
which the cortex solves hard problems in auditory
processing.
Optimal Stimulus for Auditory Cortex
T. Hromadka [in collaboration with M. Chklovskii,
Cold Spring Harbor Laboratory]
Single neurons in auditory cortex respond differently
to different sounds. What are the sound features that
evoke the strongest response? To answer these ques-
tions, we use in vivo cell-attached recordings in awake
Mongolian gerbils in combination with evolutionary
algorithms to search for the most appropriate stimulus
for the individual neurons. In addition, we are charac-
terizing the responses of single neurons to a wide vari-
ety of conventional stimuli, including pure tone pips,
sweeps, and moving ripples.
Separation of Sound Sources by
Awake Behaving Animals
G. Otazu, L.-H. Tai
Sounds in the natural world rarely occur in isolation, but
rather as part of a mixture. To survive, the auditory sys-
tem must be able to selectively attend to one sound
source and ignore others-and it does so more effective-
ly than any artificial system yet devised. To understand
are using multi-electrode
recording (tetrode) technology to monitor the activity of
many neurons simultaneously in awake, behaving
rodents performing an auditory discrimination task.
Analysis of AMPA-R Trafficking
during Learning-induced
Reorganization of the Auditory Cortex
S. Rumpel [in collaboration with R. Malinow, Cold Spring
Harbor Laboratory]
Does learning change the strength of neuronal con-
nections in the brain? Insertion of new postsynaptic
AMPA (a-2-hydroxy-5-methyl-4-isoazole) receptors
(AMPA-R) has been identified as a major process
leading to increased synaptic strength. However, these
results have been obtained primarily in cultured neu-
rons, and the relationship of these processes to learn-
ing in the intact animal has remained unclear. We have
been investigating whether reorganization of the audi-
tory cortex induced by classical conditioning leads to
increased insertion of AMPA-Rs. We are using virus-
mediated overexpression of specially engineered
recombinant AMPA-Rs as a marker of this in vivo
plasticity. These properties will enable us to detect
added recombinant receptors after a learning protocol
and thereby establish the role of AMPA insertion in
vivo. If the molecular rules of learning identified in
cultured neurons should apply in vivo, we will also
have developed a valuable tool for identification of
synaptic circuits involved in memory formation.
Responses to Complex Stimuli
M. Wehr [in collaboration with C. Machens and C. Brody, Cold
Spring Harbor Laboratory]
How do neurons in the auditory cortex encode com-
plex stimuli, such as animal calls or the sound of rain
falling on leaves? Sensory physiologists often ignore
this question, dismissing it as too difficult to approach
in a systematic fashion. Instead, they often limit their
inquiries to simple stimuli, such as (in the auditory
system) brief tone pips or sweeps. We have instead
tackled this problem head-on by measuring the
responses of neurons in the auditory cortex to a wide
variety of natural sounds. We then use these responses
to construct and test models of how cortical neurons
encode natural sounds.
Inhibitory and Excitatory Contributions
Underlying Synaptic Responses
M. Wehr
The cortical responses to sensory stimuli such as
sounds consist of a mix of excitation and inhibition.
Conventional extraceullular recording techniques
using tungsten electrodes provide information only
about excitatory responses. We have developed an
approach using whole-cell patch-clamp recording in
vivo in voltage clamp mode to tease apart the tempo-
ral dynamics of the excitatory and inhibitory drive
underlying responses to auditory stimuli.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong H.-F. Guo K. lijima
I. Hakker A. Mamiya
F Hannan Y. Wang
I. Ho
We are interested in the neural basis of learning and
memory and are taking an approach of combining
functional analyses and genetic manipulation in the
study of Drosophila. Currently, we are pursuing two
major projects. First, we are establishing Drosophila
models for studying genes involved in human neuro-
disorders that impair learning and memory. In partic-
ular, we are interested in genes known to contribute to
neurofibromatosis 1 (Nfl) and Alzheimer's disease.
Nfl patients are identified by neurofibromas and other
symptoms, including learning defects. We are investi-
gating a hypothesis that the tumor-suppressor gene
Nfl not only acts as a Ras-specific GTPase-activating
protein (GAP), but also is involved in mediating G-
protein- and Ras-stimulated activation of adenylyl
cyclase (AC); NF1-dependent AC pathways are
required for learning and memory. In the case of
Alzheimer's disease, our study has been limited to
examining how presenilin and accumulation of Af3
affect the age-dependent decline of learning ability.
This approach, on the one hand, serves as a new way
to identify biochemical cascades underlying learning
and memory in Drosophila. On the other hand, it may
also provide insights into pathogenesis of the diseases.
Second, we are investigating how odors are encoded
by population neuronal activity in the fly brain and
will ultimately study learning and memory at the level
of population neural activity. Such study is carried out
in living flies via optical recordings. The specific pro-
jects are described below.
Genetic Dissection of NPI-regulated
Pathways in Drosophila
E Hannan, I. Ho, I. Hakker
Neurofibromatosis type I (NF1) is an inherited disor-
der which affects 1 in 3500 people worldwide. A large
number of different mutations are seen in NF1
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patients, including some changes that only alter a sin-
gle amino acid out of the whole NF1 protein, yet still
result in NF1 disease. Several of these missense muta-
tions have been reconstructed in our lab and intro-
duced into Nfl mutant Drosophila. These mutated
human NF 1 s can overcome some cAMP-dependent
defects in Nfl mutant flies, including small body size
and learning defects, indicating that the cAMP path-
way is not affected by these mutations.
Two mutations in the GAP-related domain (GRD),
however, show defective long-term memory even
though learning is normal in these flies. This suggests
that learning and memory may be differentially regu-
lated in flies by NF1 acting through the cAMP and Ras
pathways, respectively. Verification of this hypothesis
will provide important insights into the mechanism
whereby NF1 affects learning. We propose to generate
further missense mutants and some large deletion
mutants, and look at their effects in Nfl mutant flies,
to try to pinpoint the region(s) associated with cAMP
activity versus Ras activity.
We have also recently identified a novel pathway
for NF1-dependent adenylyl cyclase (AC) activation
in flies that involves growth factor stimulation of Ras.
This pathway requires both Ras and NF1 activity to
stimulate cAMP production. A second pathway requir-
ing NF1 but not Ras activates the rutabaga AC which
is critical for learning in flies. The mutant human
NF 1 s provide an important resource for studying the
role of NF1 in this new pathway because many other
components of the pathway cannot be fully knocked
out in flies since they have lethal effects.
Finally, the new technology of DNA microarrays
has allowed us to look at all of the genes in Drosophila
and identify about 100 genes whose expression
appears to be controlled by NF1 activity. The expres-
sion of many of these genes is also affected by human
NF1 when it is expressed in flies. We hope to look at
flies expressing mutated human NF 1 s to see if there
are any differences that may be related to the pathway
affected by the mutations.
The basic research ideas proposed here promise to
discover and delineate new pathways and proteins
both upstream and downstream from the NF 1 protein
in Drosophila and should stimulate experiments in
mammals to verify the generality of these pathways.
Ultimately, this should lead to new ideas for treatment
strategies that may be of direct benefit to NF 1
patients.
A Drosophila Model of
Alzheimer's Disease
K. lijima
Alzheimer's disease (AD) is a neurodegenerative dis-
order characterized clinically by the progressive
decline in memory accompanied by histological
changes, including neuronal loss and the formation of
neurofibrillary tangles (NFTs) and senile plaques
(SPs). The accumulation of A342 peptide, the major
component of SPs, has been hypothesized as the pri-
mary event in AD pathogenesis. Multiple pathogenic
mutations have been identified in P-amyloid precursor
protein (APP), Presenilin 1 (PS1), and Presenilin2
(PS2) genes in familial AD (FAD), and all of these
mutations caused excessive accumulation of 442.
However, it has not yet been shown in any animal
models that the accumulation of A342 is sufficient to
induce AD phenotypes.
We used Drosophila as a model organism to
address this question. To determine whether
Drosophila can be used as a model to study the mole-
cular basis of AD pathogenesis, we examined the
effects of A342 in the Drosophila brain using the
GAL4-UAS system. The expression of A342 in the fly
nervous system led to the formation of diffused amy-
loid deposits, age-dependent learning defects, loco-
motor disability, extensive neurodegeneration, and
premature death. These results strongly suggest that
excessive accumulation of AP is sufficient to cause
memory defects and neurodegeneration resembling
AD and that the molecular basis underlying the AP
toxicity is conserved over different organisms. Using
this fly AD model, we are currently conducting genet-
ic and pharmacological screening for AD therapeutics
targeting AP-induced neurotoxicity and A3 catabo-
lism, as well as for understanding the molecular and
cellular basis of AD pathogenesis.
Stereotyped Representation
of Odors in Mushroom Bodies
Y. Wang, A. Mamiya
To study the representation of olfactory information in
higher brain centers, we have developed transgenic flies
that express the green fluorescent protein (GFP)-based
Ca++ sensor, G-CaMP, specifically in the mushroom
body (MB), a higher olfactory center known to have an
important role in olfactory memory formation. With
the help of two-photon microscopy, we were able to
examine how the MB neurons (Kenyon cells) respond
to odor stimulation at a single cell resolution. Odors
evoked large fluorescence transients in the somata of
MB neurons (Kenyon cells) and in the calyx, the neu-
ropil of the MB. According to their response to differ-
ent concentrations of an odor, we were able to classify
Kenyon cells into two groups: one with a broad recep-
tive concentration range that spanned several magni-
tudes and one with a narrow receptive range. The latter
group responded only to a specific concentration of an
odor. Different odors appeared to activate different sub-
sets of Kenyon cells. The spatial distributions of these
cells seemed to be conserved across individuals for
each odor. In some cases, a Kenyon
odor could be found in similar locations of the brain in
different flies with a precision of the size of one or two
Kenyon cell somata. These results indicate a stereo-
typed distribution of odor-evoked activities in the MB.
Although 2-photon imaging using G-CaMP allows
monitoring of the activity of multiple neurons at a
very high spatial resolution, it lacks temporal resolu-
tion. We have begun to combine electrophysiological
recordings with the imaging in order to study the odor-
evoked activities at a much higher temporal resolution.
The combination of electrophysiological recordings
and imaging should help provide a better understand-
ing of how the olfactory information is processed at
higher olfactory centers.
Role of Akt in Synaptic Plasticity
and Learning
H.-F. Guo
Long-term changes in synaptic function, such as long-
term potentiation (LTP) and long-term depression
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(LTD), are widely believed to be the cellular mecha-
nism for refining neural circuits and for learning and
memory. Serine/threonine protein kinases, such as
PKA, PKC, CAMKII and MAPK, have critical roles
in long-term synaptic plasticity. Akt, known as PKB, is
one of the major targets of the PI-3 kinase activated by
signaling from Ras and multiple receptor tyrosine
kinases, such as the insulin receptor. The activation of
Akt leads to phosphorylation of an array of target pro-
teins mediating diverse physiological functions.
Numerous studies have focused on the essential role of
Akt in glucose metabolism, anti-apoptosis, and cell
proliferation and cell survival, including neuronal sur-
vival. Accumulating evidence, however, suggests that
Akt may also have a function in the synaptic physiol-
ogy. We examined the function of Akt in synaptic
transmission and synaptic plasticity at the Drosophila
neuromuscular junction (NMJ).
The NMJ is the only preparation in Drosophila
available for quantitative analysis of synaptic trans-
mission at identifiable synapses. It has been exten-
sively used for studying functions of proteins involved
in synaptic vesicle release and genes involved in learn-
ing and memory. However, genetic analyses have been
limited to short-term plasticity on this preparation;
long-term synaptic plasticity, such as LTP and LTD,
has not been shown. We characterized a form of long-
term synaptic plasticity, long-term depression (LTD),
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at the Drosophila larval NMJ. We found that Akt is
specifically involved in mediating LTD, but not short-
term synaptic plasticity. We also found that olfactory
learning is disrupted in flies, and the learning defect is
rescued by induced expression of akt transgene.
Therefore, Akt is required for mediating both long-
term synaptic plasticity and learning in Drosophila.
We will characterize the role of Akt- related signaling
in synaptic plasticity and learning and memory.
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PLANT DEVELOPMENT AND GENETICS
Like animals, plants use unspecialized stem cells to create new organs and tissues. One question fun-
damental to all multicellular life is how organisms trigger stem cells to proliferate and subsequently
adopt special properties characteristic of a particular organ or tissue, a process called stem cell pat-
terning. CSHL scientists are investigating the signals plants use to guide stem cell patterning. Their
findings are shedding light on some processes that are common to plant and animal development, and
on others-unique to plants-that could ultimately have significant impacts on agriculture, horticulture,
and forestry.
One mechanism that appears to be involved in stem cell patterning, and that is unique to plants, is
the movement of proteins between cells through structures called plasmodesmata. David Jackson and
his colleagues have created several methods for investigating how proteins move through plasmodes-
mata to carry out stem cell patterning. That understanding could also help block the spread of devas-
tating plant viruses, which travel along the same intercellular highways. Additionally, they have created
a genome-wide method to help reveal the locations and functions of some 7000 proteins encoded by
the genome of the mustard relative Arabidopsis, a powerful model organism for the study of plant
growth and development.
Genes and proteins studied by Marja Timmermans' lab are also emerging as key players in guiding
stem cell patterning and organ development. She has identified several proteins that act in a complex
way to turn key genes on or off at the correct time and in the correct location as plants develop, a
process that is required, for example, for the proper outgrowth of leaves and for differentiating the top
layers versus the bottom layers of leaves. Timmermans' lab has also uncovered evidence that leaf pat-
terning is controlled by RNA interference (see below).
Part of Rob Martienssen's interest in exploring plant genetics and development has focused on a
specialized type of DNA structure called heterochromatin. By virtue of the fact that heterochromatin is
typically rich in "transposable elements" (segments of DNA that usually stay put but can move to other
chromosomal locations), most often stays tightly packaged, and has few canonical protein-coding
genes, heterochromatin has a unique impact on chromosome structure and function. Martienssen's lab
is exploring the activity of genes located within heterochromatin and how such genes are silenced
through the influence of transposable elements (or ancient remnants of such elements). In both plants
and yeast, the lab has found that RNA molecules transcribed from remnants of transposable elements
trigger the formation of heterochromatin, and hence establish gene silencing, through RNA interfer-
ence.
199
PLANT DEVELOPMENTAL GENETICS AND FUNCTIONAL
GENOMICS
R. Martienssen J.M. Arroyo
M. Byrne
D. Goto
C. Kidner
Z. Lippman
N. Marinsek
B. May
P. Rabinowicz
D. Roh
M. Ronemus
J. Simorowski
R. Shen
A. Tang
Epigenetic mechanisms regulate transposon silencing,
gene control, and stem cell function in plants, which
provide a useful model for higher eukaryotes. Using
Arabidopsis chromosome-4 microarrays, we have
shown that small RNA and chromatin remodeling reg-
ulate heterochromatin through transposons. In fission
yeast, RNA interference (RNAi) of centromeric tran-
scripts regulate chromosome behavior via histone
modification, and we have found similar transcripts in
plants. Stem cell function in plants depends on asym-
metric leavesl, bellringer, ramosal, and argonaute.
Argonaute has an important role in RNAi, and we have
demonstrated that spatially restricted small RNA can
guide leaf polarity. During the year, we were joined by
postdoc Derek Goto, as well as by our URP Nina
Marinsek. We said goodbye to Erik Vollbrecht and
Tom Volpe who left Cold Spring Harbor for faculty
positions at Iowa State and Northwestern.
Transposable Elements, Epigenetic
Control, and the Origin of
Heterochromatin
Z. Lippman, M. Vaughn, B. May, and R. Martienssen
[in collaboration with W.R. McCombie and V. Mittel,
Cold Spring Harbor Laboratory; J. Carrington,
Oregon State University; R.W. Doerge, Purdue
University; and V Colot, INRNCNRS Evry, France]
Heterochromatin is a major component of the genome
that remains condensed throughout the cell cycle and
influences gene expression. Heterochromatin in
Arabidopsis is derived from euchromatin by insertion of
transposable elements (TEs) and related tandem
repeats. We have used genomic tiling microarrays to
profile heterochromatic modifications such as DNA
methylation and histone H3 Lys-9 dimethylation
(H3mK9), and we have found that these marks are
restricted to TEs. TEs are distinguished from genes by
the chromatin remodeling ATPase DECREASE IN DNA
200
U. Umamaheswari
M. Vaughn
E. Vollbrecht
T. Volpe
METHYLATION 1 (DDM1). Small interfering RNAs
(siRNAs) correspond to TEs and repeats, providing a
basis for their distinction. Genes are mostly insulated
from the silencing effects of heterochromatin, but TEs
can control genes epigenetically when inserted within
them. The euchromatic, imprinted gene FWA resembles
such genes in that its promoter is provided by a TE
which contains tandem repeats associated with siRNA
and is silenced epigenetically by DDM1 and the DNA
methyltransferase MET1. Thus, TEs and related repeats
define heterochromatin and likely have major regulato-
ry roles in repeat-rich genomes.
Arabidopsis Centromeric Repeats
Are Transcribed
B. May, Z. Lippman, R. Martienssen
Centromeres are responsible for the inheritance of a
complete set of chromosomes following cell division, via
kinetochore assembly and spindle attachment. In plants
and animals, centromeres comprise thousands of short,
tandem 150-180-bp repeats with interspersed retrotrans-
posons. Pericentromeric repeat sequences differ between
closely related species, indicating that chromatin rather
than DNA sequence determines kinetochore assembly.
As in fission yeast, the centromeric repeats of
Arabidopsis are transcribed and give rise to small RNA
via RNA interference (RNAi). By examining centromer-
ic chromatin in Arabidopsis mutants defective in DNA
methylation, histone modification, and RNAi, we have
found that the centromeric repeats differ in their regula-
tion. Some are silenced by DNA methyltransferase
MET1 and the chromatin remodeling ATPase DDM1,
whereas others are controlled by RNAi genes DCL1 and
AGO], the histone methyltransferase KYP1, and the
DNA chromomethylase CMT3. Thus, centromeres may
be composed of subdomains that are transcriptionally as
well as posttranscriptionally regulated.
Presetting and Methylation of
Transposable Elements Is
Associated with Small RNA
and Histone Modification
Z. Lippman, B. May, R. Martienssen
The inheritance of active (preset) transposons is a clas-
sical model for epigenetics first studied by Barbara
McClintock in maize. In Arabidopsis, mutants in the
DNA methyltransferase MET1, the chromatin remod-
eling ATPase DECREASE IN DNA METHYLATION]
(DDM1), and the histone deacetylase gene SILENC-
ING] (SIL1) activate most transposons with a con-
comitant loss of both DNA methylation and H3mK9.
In contrast, mutations in the H3mK9 methyltransferase
KRYPTONITE (KYP), the RNAi gene ARGONAUTE
(AG01), and the CNG methyltransferase CHRO-
MOMETHYLASE (CMT3) regulate only a subset of
transposons. Following backcrosses with wild type,
activated transposons were inherited from met] and
ddml, which lost corresponding siRNA unlike the
other mutants. This indicates a role for siRNA in de
novo silencing by MET1 and DDM1. Thus, two distinct
mechanisms are involved in transposon silencing via
siRNA: one involving DDM1, MET1, and SILl, and
the other involving KYP and AGO], that directs DNA
methylation via CMT3.
Genomic Consequences of
RNAi in Fission Yeast
T. Volpe, D. Goto, N. Marinsek, R. Martienssen [in
collaboration with T. Cech, University of Colorado;
J. Bah ler, Sanger Centre, U.K.; and G. Thon,
University of Copenhagen]
We previously demonstrated that RNAi of centromer-
ic repeat transcripts was required for chromatin modi-
fication and centromere function in fission yeast
(Volpe et al., Science 297: 1833 [2002]). We have
extended these studies to the entire genome using
microarrays. All three mutants in RNAi, agol- (arg-
annotation
WT 5mC
WT mK9
WT mK4
ddnil 5mC
ddml mK9
ddml mK4
1940k 1950k1920k 1930k
FIGURE 1 Chromatin profiling with tiling genomic microarrays. A 35-kb region from the heterochro-
matic knob on chromosome 4 is displayed using Genome Browser. Transcription (mRNA) is indicat-
ed for wild-type (WT) (light gray) and ddml seedlings (dark gray). Annotation includes four tracks:
open reading frames (ORFs), repeats, gene-trap insertions, and small RNA. ORFs are annotated as
known genes (light gray), retrotransposons, and DNA transposons (dark gray). Repeats are from
RepBase, gene-trap insertions are indicated by arrows, and small RNA matches by black lines. DNA
methylation (5mC) and histone H3 methylation of lysine-9 (mK9) and lysine-4 (mK4) significantly
above or below the average level found in euchromatic features are highlighted. Euchromatic levels
of each modification are light gray. Two genes (boxed) are expressed, unmethylated and free of
H3mK9, despite their close proximity to silent transposons.
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onaute), dcrl- (dicer), and rdrl- (RNA-dependent
RNA polymerase), have very similar microarray pro-
files: Apart from centromeric repeats, few genes are
up-regulated. This indicates a limited role, if any, for
microRNA (miRNA) in fission yeast, although cen-
tromeric siRNA may silence some genes near the
telomere. Interestingly, coding transcripts from retro-
transposable elements are only very slightly up-regu-
lated despite the loss of H3mK9 from their long ter-
minal repeats (LTRs). Microarray profiles were simi-
lar to those from the histone H3 lys-9 methyltrans-
ferase clr4-, supporting this conclusion, but profiles
from other silencing mutants had more widespread
effects. These results are in agreement with our obser-
vations in Arabidopsis that transposon silencing can
be maintained independently of RNAi.
Genes and Transposons Are
Differentially Methylated in
Plants But Not in Mammals
P. Rabinowicz, R. Martienssen [in collaboration
with W.R. McCombie and S. Lowe, Cold Spring
Harbor Laboratory]
We have studied the methylation of plant and animal
genomes using polymerase chain reaction (PCR).
Repetitive elements are methylated in both organ-
isms, but although 85% of mammalian exons are
methylated, 95% of plant exons are not. Sequencing
strategies that depend on differential methylation are
therefore predicted to have different outcomes in
plant and mammalian genomes. Methylation filtra-
tion results in more comprehensive representation of
maize genes than do expressed sequence tags (ESTs).
Less than 7% of the repetitive DNA is unmethylated
and thus selected in our libraries, but potentially
active transposons and unmethylated organelle
genomes can be identified. Gene-enriched sequences
from the Maize Genomics Consortium provide almost
twofold coverage of the maize gene space.
Simulations using sequenced bacterial artificial chro-
mosomes (BACs) predict that fivefold coverage of
gene-rich regions and onefold coverage of BAC con -
rigs will generate high-quality mapped sequence. By
sequencing several inbred strains, unusually high lev-
els of structural polymorphism will shed light on
hybrid vigor, or heterosis (Fu and Dooner, Proc. Natl.
Acad. Sci. 99: 9573-9578. [2002]).
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Spatially Restricted miRNA
Directs Leaf Polarity via
ARGONAUTE1
C. Kidner, R. Martienssen
miRNAs are endogenous small RNA molecules that
regulate the expression of matching genes via RNAi. In
animals, this regulation occurs by translational control,
but in plants, more perfectly matched miRNAs promote
site-specific cleavage of the target. The homeodomain
HD-ZIP III genes PHABULOSA (PHB) and PHAVO-
LUTA (PHV) are expressed on the adaxial (upper) side
of leaf primordia where they direct cell fate. They are
targets of the miRNAs miR165 and miR166. We have
used in situ hybridization to show that miR165 accu-
mulates on the adaxial side of the leaf primordia where
it cleaves PHB and PHV mRNA. This pattern of
expression changes during development, implicating
the miRNA in signaling between the meristem and the
leaf primordium. argonautel (agol) mutants are defec-
tive in RNAi and have a pleiotropic phenotype. Leaves
and flowers are adaxialized and PHB mRNA accumu-
lates throughout the leaf primordium, whereas miR165
is ectopically expressed in the adaxial domain. Thus,
AGO1 regulates both the accumulation and function of
miRNA, perhaps accounting for enhancement of both
loss-of function and gain-of-function alleles of PHB-
related genes in agol.
Mechanisms of miRNA Targeting via
ARGONAUTE1
M. Ronemus, R. Martienssen
Double-stranded RNA can silence genes that share the
same sequence via 20-24-nucleotide small RNA inter-
mediates and RNAi. These intermediates include
miRNA encoded by hairpin precursors in animals and
plants. In Arabidopsis, the RNAi genes ARG-
ONAUTE1 (AGO]) and DICER-LIKE1 (DCL1) are
required for normal development, and we have exam-
ined the expression of thousands of genes in normal
and mutant lines of Arabidopsis using microarrays.
Several families of related genes have substantially
altered expression in the RNAi mutants, and many of
these genes match miRNA. However, not all miRNA
targets are altered in abundance, perhaps reflecting the
stability of cleavage products. Up-regulated genes
appear to be silenced by second-strand synthesis and
degradation in addition to mRNA cleavage.
Leaf Polarity and Stem Cell Fate
Are Determined by
ASYMMETRIC LEAVES1
M. Byrne, J.M. Arroyo, R. Martienssen
Lateral organs such as leaves arise on the flanks of the
shoot meristem via repression of stem cell fate, deter-
mination of founder cells, and elaboration of the
incipient primordium. Development of lateral organs
proceeds along proximodistal, dorsoventral, and
mediolateral planes. It is thought that lamina out-
growth relies on juxtaposition of dorsal and ventral
leaf domains. The Myb domain protein ASYMMET-
RIC LEAVES] (AS1) mediates a genetic interaction
between the developing leaf and stem cells of the
meristem via homeobox transcription factor genes.
Modifiers of AS1, called PIGGYBACK, mediate
ectopic lamina outgrowths on the adaxial leaf surface
in as1 but have little effect on leaf development on
their own. We are cloning these modifiers and charac-
terizing interactions with leaf patterning genes. pgy
modifiers appear to confer proximodistal lamina out-
growth in response to disruption of dorsoventral pat-
terning in asl. A second modifier generates a pheno-
type reminiscent of a palmate compound leaf, but only
in the absence of ASI.
Genetic Control of Inflorescence
Architecture in Grasses
E. Vollbrecht, R. Martienssen [in collaboration with W.R.
McCombie, Cold Spring Harbor Laboratory]
ramosal encodes a zinc finger transcription factor
that controls inflorescence architecture in maize by
limiting the proliferative potential of shoot apical
meristems. rarnosa2 positively regulates ral transcript
levels, such that increasing levels of ral mRNA pro-
gressively inhibit a meristem's capacity for continued
growth, thereby dictating final branch length in the
inflorescence. ral was targeted by selection during
recent evolution, suggesting an important role in grass
inflorescence architecture. In support of this, two
cases of higher branch number correlate with delayed
or reduced ral mRNA expression. First, a quantitative
trait locus (QTL) maps nearby and fails to comple-
ment ral. Sequence evidence leads us to speculate that
this heterochronic allele may be due to epigenetic
effects. Second, in the highly branched inflorescence
of Sorghum bicolor, diverged from maize approxi-
mately 20 mya, expression of the ral ortholog (ral-
Sb) is delayed and reduced. A tandem duplication of
ral-SB and promoter rearrangement suggest a basis
for its delayed RNA expression. In this region of the
genome, microcolinearity between sorghum and rice
is conserved with only one exception: ral is absent
from rice, whose inflorescence branches are long con-
sistent with its absence.
Functional Genomics with Transposons
in Maize and Arabidopsis
B. May, M. Vaughn, D. Roh, J. Simorowski, J.-M. Arroyo,
R. Shen, A. Tang, U. Umamaheswari, R. Martienssen
[in collaboration with Dick McCombie and Lincoln Stein,
Cold Spring Harbor Laboratory]
We continue to serve the maize community through
MTM (maize-targeted mutagenesis), an efficient sys-
tem for site-selected transposon mutagenesis. MTM
insertions in genes of interest from a library of
45,000 plants using PCR. Pedigree, knockout,
sequence, phenotype, and other information are stored
in a powerful interactive database (mtmDB) that
enables analysis of the entire population as well as
handling knockout requests. By monitoring Mutator
activity, we conclude that more than one half of all
mutations arising in this population are suppressed on
losing Mutator activity. Our collection of Arabidopsis
gene-trap and enhancer-trap transposon lines has
grown to more than 33,000 individual insertions,
about half of which have been mapped to the genome
by PCR and sequencing. The resulting knockouts,
along with phenotypic and expression data, are made
available to the public via TRAPPER, an interactive
database and ordering system. More than 200 orders
were filled for maize and Arabidopsis lines in 2003.
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PLANT CELL SIGNALING AND GENETICS
D. Jackson S. Alabaster W. Deleu J. Linder
U. Au L.A. Haller A. Mohanty
R. Chaudhury J.Y. Kim N. Satoh
M. Cilia K. Lau J. Wang
We are interested in mechanisms of development and
morphogenesis, and we use plants as a model system.
Patterning of stem cells is a fundamental mechanism
used by animals and plants to generate new organs and
tissues throughout their development. Although some
stem cell regulatory mechanisms are conserved, one
patterning mechanism that is unique to plants is the
intercellular transport of regulatory proteins through
channels called plasmodesmata. We are studying the
mechanism of transport through these elusive chan-
nels, using a combination of genetic screens and cell
biology. We have also started to investigate the molec-
ular basis of cytokinin action. This plant hormone was
first isolated in the 1950s, but its mechanism of action
remains elusive. Through the characterization of a
novel morphological mutant, we are beginning to
understand the role of cytokinin responsive genes in
plant development.
A Novel Screen for KNOTTED1
Intercellular Transport
K. Lau, D. Jackson, J.Y. Kim
A novel mechanism of cell-cell communication is the
direct intercellular trafficking of regulatory proteins
and mRNAs through plasmodesmata (PD). We have
developed a novel assay for protein trafficking by fus-
ing the nonautonomous KNOTTED1 (KM) home-
odomain protein to GLABROUS] (GL1), a gene
required for epidermal hair production. When this
fusion protein is expressed in mesophyll tissues, it is
able to traffic into the epidermis and complement hair
production in a glabrousl mutant. Expression of GL1
alone in mesophyll fails to rescue hair formation,
because GL1 itself is cell-autonomous. This system
provides a powerful visual screen, and we have used
it to dissect regions of KN1 required for trafficking.
We found that the homeodomain of KN 1 is necessary
and sufficient for trafficking, and residues flanking
the homeodomain significantly affect trafficking
activity. We also confirmed earlier microinjection
data showing KN1 is able to specifically transport its
mRNA from cell to cell. Although the significance of
this transport for normal development is not known, it
provides a potential for powerful nonautonomous
control of plant development by long-range signaling,
e.g., in signaling by mRNAs that are transported in
the circulatory phloem stream. We are also using the
GL1 system to screen for mutants impaired in cell-to-
cell trafficking of KN1, by screening for lines in
which hair formation is no longer complemented.
Such mutants will help dissect the mechanism of
KN1 transport.
Isolation and Characterization of
Plasmodesmata Mutants
M. Cilia
Using a genetic approach to understand PD structure
and function, we have isolated a number of mutants
that affect the intercellular movement of the green flu-
orescent protein (GFP). The GFP is small enough to
move nonselectively through PDs in immature "sink"
tissues, such as in the root meristem. We used this
property to screen for mutants that restrict GFP move-
ment, and which presumably have a decreased PD
size-exclusion limit. Interestingly, some of the mutants
have developmental phenotypes, supporting the idea
that plasmodesmal transport is important in develop-
mental regulation. For example, one mutant, called "5-
12," has a complete loss of GFP movement out of the
phloem (Fig. IA). This mutant is seedling lethal, sup-
porting the idea that PD transport is essential for nor-
mal development. Other mutants define tissue bound-
aries for PD transport, supporting a model of develop-
mental specificity in PD transport. We are currently
mapping the mutants with the aim of isolating the cor-
responding genes.
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FIGURE 1 Plasmodesmata mutant (A) shows an early seedling lethal phenotype. In B, the ramosa3 mutant of maize, with
abnormally branched ears. Localization of a fluorescent protein reference gene reporter to the vacuolar membrane (C).
Fine Mapping of the ramosa3
Locus of Maize
N. Satoh
ramosa3 (ra3) is a classical morphological mutant of
maize in which the female inflorescence becomes
abnormally branched, resembling the male inflores-
cence structure (Fig. 1B). In order to isolate the RA3
gene, we embarked on a chromosome walk using a
large F2 mapping population. We have narrowed the
RA3 locus to a region smaller than one BAC (bacteri-
al artificial chromosome), which is currently being
sequenced (in collaboration with Hajime Sakai,
Dupont). The syntenic region in rice contains only
hypothetical genes, suggesting that RA3 may encode
a gene of previously uncharacterized function.
Following BAC sequencing, we plan to identify the
RA3 gene by characterization of several independent
mutant alleles that we isolated in targeted screens.
An Arabidopsis "Localizome" Project
J. Wang, S. Alabaster, A. Mohanty
Approximately one third of all plant genes identified
in sequencing projects have no known function. Some
are plant-specific, whereas others match genes in
other organisms where their function also is unknown.
As a first step in understanding their function, we
developed a high-throughput procedure to tag full-
length genes in their native genomic context using flu-
orescent reporters. These constructs are subsequently
transformed into Arabidopsis, and the transgenic
progeny are analyzed for protein localization. We pro-
pose to characterize several thousand genes of
unknown function and to integrate our results with
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other proteomics and mutational approaches to under-
stand the function of all plant genes. An example of a
control tagged protein, which localizes to the vacuolar
membrane, is shown in Figure 1C.
Characterization of the ABPHYL1
Phyllotaxy Regulator
J. Wang, D. Jackson
Plants initiate lateral organs, such as leaves, in regular
geometric arrangements, as seen, for example, in the
spiral patterns of sunflower heads. The way in which
these patterns are established in presently unknown. We
have characterized a phyllotaxy mutant of maize called
abphyll. In this mutant, leaves are initiated in opposite
symmetry, a pattern never seen in maize or other grass-
es. We isolated abphl using transposon tagging, and it
encodes a cytokinin-inducible response regulator.
Recent studies implicate auxin, another plant hormone,
in maintenance of phyllotactic patterns. Our results sup-
port a model whereby the initial pattern is set up by
localized cytokinin signals, and we have shown that
exogenously applied cytokinin can change the pattern
of ABPH1 mRNA accumulation in the shoot meristem.
Further details and updates can be found at http://
j acksonlab. c shl. edu/index.html.
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PLANT DEVELOPMENTAL GENETICS
M. Timmermans G. Collins
M. Juarez
T. Phelps-Durr
J. Thomas
ANALYSES OF GENES INVOLVED IN MERISTEM
FUNCTION AND LEAF INITIATION
This work was done in collaboration with M Scanlon
(University of Georgia, Athens); P Schnable (Iowa
State University, Ames); B. Buckner and D. Janick-
Buckner (Truman State University, Kirksvile, Missouri).
Plants have the unique property to be able to initiate
new organs, such as leaves and flowers, throughout their
lifetime, which frequently extends over many years. The
growing tips of plants are called meristems. The vege-
tative shoot apical meristem (SAM) exhibits distinctive
histological and functional domains. For instance, the
SAM comprises distinct epidermal and subepidermal
cell layers and includes a small population of indeter-
minate stem cells as well as more determined daughter
cells from which lateral organs arise. Traditional genet-
ic analyses have identified several
required for meristem function or for the development
of lateral organs from the SAM. Such studies have also
shown the importance of this meristematic organization
for normal plant development.
To identify novel and potentially redundant or
essential genes that function in discrete domains of the
SAM or developing leaf primordia, we are using a
technique called laser-capture microdissection
(LCM), which allows the isolation of transcripts from
specific cell types within a particular tissue or organ.
For use in LCM, target tissues are fixed, sectioned, and
immobilized onto microscope slides. Cells of interest
are dissected and separated from the rest of the tissue
using a laser beam. RNA is then extracted from the
captured cells and used in microarray analyses to com-
pare global gene expression patterns between different
cell populations.
We are currently optimizing the LCM technique,
which was originally designed for the dissection of
animal cells, for use on the small-cell-wall-encapsu-
lated cells within the plant SAM. We are using maize
as our experimental system because of the relatively
large size of its vegetative meristem when compared
to, for instance, Arabidopsis. We have found that fixed
and paraffin-embedded tissues can be used as effi-
ciently as frozen tissues for LCM. RNA collected
from as few as a thousand cells was sufficient for the
preparation of cDNA for use in microarray analyses of
gene expression. Although maize is a particularly
tractable model system for LCM of meristems, maize
has the disadvantage that its genome project is still at
an early stage. To identify genes that should be repre-
sented on the long-oligo microarrays, we have also ini-
tiated a "small" expressed sequence tag (EST) project.
The goal is to generate approximately 35,000 3' ESTs
from meristem-enriched cDNA libraries.
We intend to compare global expression patterns
between approximately 20 different functional meris-
tematic and leaf primordia domains, or experimental
conditions. These include the following comparisons:
stem cells versus more determined daughter cells,
meristematic cells versus leaf initials, cells in the
leaf's upper/adaxial surface versus its lower/abaxial
surface, epidermal versus subepidermal cells, and
between apices of normal and a variety of develop-
mental mutants.
Genes that exhibit differential expression in a vari-
ety of developmental domains, mutations, and growth
conditions will be identified and verified by real-time
reverse transcriptase-polymerase chain reaction (RT-
PCR) and in situ hybridization analyses. Even though
this project is still in its infancy, it will soon provide a
novel insight into meristem function and organogene-
sis.
REPRESSION OF STEM CELL FATE DURING
ORGAN DEVELOPMENT
This work was done with contributions from Josh
Egan and Jason Pellegrino (Manhasset High School)
and Arooba Alam (Locust Valley High School).
The knox (knottedl-like homeobox) gene family is
known to be required for indeterminate growth, i.e.,
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stem cell function, in a wide variety of plant species.
Mutations in several knox genes affect meristem initi-
ation and/or maintenance. Significantly, in simple-
leaved plants such as maize and Arabidopsis, KNOX
proteins accumulate in the indeterminate cells of the
SAM but are excluded from determinate leaf founder
cells. Moreover, in these species, down-regulation of
knox genes is essential for normal leaf development.
Misexpression of knox genes within developing sim-
ple leaves leads to cell division and differentiation
defects, which can be compared to tumor formation in
animals. The rough sheath2 (rs2) gene from maize
and the ASYMMETRIC LEAVES] (ASI) gene from
Arabidopsis encode orthologous MYB-domain pro-
teins that act as negative regulators of knox gene
expression. On the basis of our previous expression
and genetic analyses, we proposed that rs2 acts as an
epigenetic regulator to keep knox genes in an "off"
state in developing lateral organs, thus preventing dif-
ferentiating cells from reverting into indeterminate
stem cells.
We have shown that RS2 is part of a large protein
complex that likely includes protein phosphatase 2A
regulatory subunits A and B', a zinc-finger transcrip-
tion factor, the homolog of ASYMMETRIC
LEAVES2 (AS2) from Arabidopsis, a highly con-
served DEAD-box helicase, histone 2B (H2B), and a
known nucleosome assembly protein. By transiently
expressing chimeric proteins between these RS2 -
interacting proteins (RS2-IPs) and green fluorescent
protein (GFP) in leaf tissue, we have shown that all
seven proteins are targeted to the nucleus, consistent
with a role in transcriptional regulation. The fusion
protein between GFP and the DEAD-box helicase
colocalized with chromosomes in dividing cells, sug-
gesting that it is associated with chromatin.
Interestingly, the nucleosome assembly protein was
found to accumulate within specific subnuclear struc-
tures; however, the nature and function of these struc-
tures remains to be determined.
The presence of a nucleosome assembly protein
and a DEAD-box helicase in the RS2 complex, as well
as its potential interaction with H2B and protein phos-
phatase 2A, suggests that this complex may indeed
maintain knox genes silenced by altering the organiza-
tion of chromatin at these loci.
Actively transcribed genes usually have a more
open chromatin structure, i.e., a lower nucleosome
density, due to the presence of specific modifications
at the tails of the different histone proteins that make
up the nucleosome. For instance, phosphorylation is
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one of the histone tail modifications associated with
actively transcribed genes. We are currently analyzing
the binding sites of the RS2 complex at the knox loci
and are testing whether chromatin organization or his-
tone modifications at these loci are affected in the rs2
mutant.
Last year, we also isolated Arabidopsis homologs
for most of the RS2-IPs and found that the AS1 com-
plex is very similar to the maize RS2 complex. One
striking difference between the two complexes is that
the Arabidopsis homolog of the zinc-finger transcrip-
tion factor does not appear to interact with AS1. We
are using the reverse genetic resources available in
Arabidopsis, to determine the roles of the AS1/RS2-
IPs in plant development, particularly in stem cell
function. Loss-of-function mutations in AS2 are
known to affect knox gene silencing during leaf devel-
opment, but our results indicate that AS2 acts in the
same complex as AS1/RS2.
We have isolated mutations in the Arabidopsis
orthologs of the DEAD-box helicase and the nucleo-
some assembly protein. Loss-of-function mutants in
the DEAD-box helicase are indistinguishable from
wild type.
In contrast, loss of the nucleosome assembly pro-
tein causes embryo lethality, indicating that it has an
essential role. However, we have generated transgenic
plants that have reduced levels of the nucleosome
assembly protein using an RNA-interference-like
approach. These transgenic plants have defects in leaf
and floral development that resemble the defects
observed in the asl and as2 mutants. The sepals,
petals, and stamens of the flower are reduced in size,
such that the carpel is prematurely exposed. Leaves of
these transgenic plants are asymmetrically lobed and
like as1 and as2, they misexpress three of the four
Arabidopsis knox genes. AS2 expression is unaffected
in these mutants, but ASI transcript levels are
increased, indicating that the defects in these trans-
genic plants do not result from loss of ASI or AS2.
Double-mutant analysis revealed that reduced levels of
the nucleosome assembly factor enhance the asl and
as2 mutant defects. Such double mutants develop
extremely lobed leaves.
Taken together, our observations suggest that
AS1/RS2 and AS2 assemble into a protein complex
which targets a nucleosome assembly factor and pos-
sibly other chromatin remodeling proteins to the knox
loci in organ founder cells. As a result, stem cell fate
remains repressed in determinate, differentiating cells
of developing lateral organs.
ROLE OF THE RS2/AS1/PHAN COMPLEX IN
COMPOUND LEAF DEVELOPMENT
This work was done in collaboration with M. Kim and
N Sinha (University of California, Davies) and S.
McCormick (Plant Gene Expression Center, Albany,
California).
Many plants species develop compound rather than
simple leaves. Compound leaves comprise multiple
units of blade tissue called leaflets and can be pinnate,
with leaflets arranged in succession on the rachis
("stem" of the leaf), or palmate, with leaflets clustered
together at the leaf tip. Palmate compound leaves are
divided into two groups. Peltate palmate leaves devel-
op leaflets around the whole circumference of the
rachis, whereas nonpeltately palmate leaves form an
incomplete circle of leaflets. The mechanisms that
generate these various compound leaf forms are large-
ly unknown, but compound leaves differ from simple
leaves in that they remain partially indeterminate and
express knox genes. Nonetheless, the genomes of
many compound-leafed species include one or more
closely related homologs of rs2 and AS1.
In tomato, which develops pinnately compound
leaves, this homolog, LePHAN, was found to be
expressed in the SAM and on the adaxial/upper leaf
surface of developing leaf primordia. This expression
pattern thus partially overlaps with the knox expres-
sion domain, suggesting that LePHAN has a different
role during development. To determine this role, our
collaborators used antisense technology to reduce the
levels of LePHAN expression. They obtained trans-
genic plants that developed palmate compound, sim-
ple, or radially symmetric abaxial leaves, and these
phenotypes were correlated with a progressive reduc-
tion in LePHAN transcript levels. This suggested that
RS2/AS1/PHAN in tomato is required for the adaxi-
al/upper cell fate consistent with the LePHAN expres-
sion pattern and for compound leaf shape.
Analysis of pinnate, non-peltately palmate, and
peltately palmate leaves from several hundred species
from a variety of taxa revealed that the rachis of pin-
nate leaves contained adaxial/abaxial asymmetry.
Similarly, the rachis of non-peltately palmate leaves
had adaxial/abaxial polarity, and no leaflets were
found to develop in the adaxial domain.
In contrast, the petioles of peltately palmate leaves
were abaxial and had radial symmetry. This suggested
that the absence of the adaxial domain in the proximal
region of the rachis or petiole is important for gener-
ating peltately palmate compound leaves. To test
whether RS2/AS1/PHAN homologs may have had a
role in the evolution of compound leaf forms, mem-
bers of this gene family were cloned and their expres-
sion domains determined using an affinity-purified
polyclonal antibody that we had generated against
RS2. Sequence analysis revealed that alterations in the
coding region of PHAN did not have a role in the evo-
lution of compound leaf morphology. However, we
found that variation in the pattern of PHAN expres-
sion may have had a crucial role in this evolutionary
process. PHAN was expressed along the entire adaxi-
al face of leaf primordia in pinnate compound-leafed
species. In contrast, we observed PHAN expression
only at the distal tip of leaf primordia in species with
peltately palmate leaves.
Interestingly, the PHAN expression pattern in non-
peltately palmate leaf primordia resembled that in pin-
nate leaves. Using scanning electron microscopy, we
showed that leaflet development at early stages was
almost identical in pinnate and non-peltately palmate
compound leaves and that final leaf morphology was
determined by secondary morphogenesis later in leaf
development. This suggested that non-peltately
palmate leaves are a developmental variation of pinnate
compound leaves and are morphogenetically distinct
from peltately palmate leaves. These data also indicate
that RS2/AS1/PHAN proteins have distinct functions
in simple and compound-leafed species. In the latter,
RS2/AS1/PHAN specifies the adaxial domain.
The boundary between adaxial and abaxial
domains seems to be required for leaflet formation,
such that in peltately palmate compound leaves,
leaflets arise in a whorl in the distal region of the leaf
primordium because an adaxial domain is present only
in this region. Moreover, the control of leaf morphol-
ogy by regulating PHAN expression seems to be
reused over time, suggesting that there may be limited
ways to alter compound leaf morphogenesis.
ADAXIAL/ABAXIAL PATTERNING OF LATERAL
ORGANS IN MAIZE
This work was done with contributions from Jonathan
ICui (Watson School of Biological Sciences, CSHL,
rotation student) and Bradley Heller (Princeton
University, New Jersey).
Recruitment of leaf founder cells from the SAM coin-
cides with programs of development and differentia-
tion along three axes, comprising the mediolateral
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FIGURE 1 Complementary hd-zipIll and miRNA166 expres-
sion. 0) Transverse section through a wild-type apex showing
rldl expression in the SAM, vasculature, and on the adaxial
side of leaf primordia (arrows). (8) rldl misexpression on the
abaxial side of Rld1-0 leaf primordia (arrow). (C) miRNA166
expression in leaf primordia but not in the SAM. Arrows mark
regions with just abaxial miRNA166 expression. (D,E)
Longitudinal sections through wild-type apices showing rldl
expression (D) at the site of leaf initiation and miRNA166
expression (E) on the abaxial side (arrow) and below the incipi-
ent leaf. Arrowheads mark the top of the P1 disk of insertion.
(F)rld1 misexpression near the incipient leaf in Rld1-0 (arrows).
phb (G) or miRNA166 (H) expression in wild-type vascular bun-
dles. (X1 Xylem; (P) phloem.
(margin to margin), proximodistal (base to tip), and
adaxial/ abaxial (upper to lower) axes of the leaf pri-
mordium. We are using forward and reverse genetic
approaches to analyze the genetic pathways leading to
adaxial/ abaxial polarity in lateral organs in maize.
The Rolled leafl-Original (R1d1-0) mutant is semi-
dominant and is characterized by an upward curling of
the leaf blade due to adaxialization or partial reversal
of leaf polarity. We recently cloned the rldl gene. It
encodes a member of the class III homeodomain-
leucine zipper (HD-ZIP III) family of proteins, which
are known to specify adaxial fate in Arabidopsis. We
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found that rldl is expressed in the SAM, vasculature,
and, consistent with a role for rldl in adaxial cell-fate
specification, nondetermined cells on the adaxial side
of leaf primordia (Fig. 1A,D). The meristematic
expression pattern of rldl was unaffected in Rld1-0.
However, we observed that rldl is misexpressed on the
abaxial side of Rld1-0 leaf primordia and persists in a
broader domain during Rld1-0 primordium develop-
ment (Fig. 1B,F).
Transcripts of the Arabidopsis HD-ZIP III genes
contain a complementary site for microRNA165
(miRNA165) and miRNA166, which can direct their
cleavage in vitro. We found that this miRNA165/166
complementary site is conserved in the maize rldl
gene and that all four dominant Rldl alleles result
from a single nucleotide change in this site. This,
together with the misexpression of rldl in the Rld1-0
mutant, suggests that miRNAs may mediate the post-
transcriptional repression of rldl on the abaxial side of
leaf primordia. In other words, miRNA165/166 may
specify abaxial cell fate by restricting expression of
rid] and other hd-zipIII genes to the adaxial side.
miRNAs are processed from larger imperfect hair-
pin precursors (pre-miRNA) by the double-stranded
ribonuclease DICER-LIKE1. Arabidopsis contains two
potential pre-miRNA165 (MIR165) and seven
MIR166 loci. The rice genomic sequence includes at
least six loci with the potential to generate miRNA166
homologs.
We identified several sequence motifs outside the
predicted hairpin structures that are conserved
between Arabidopsis MIR166 family members. Some
of these motifs were also conserved in two rice
MIR166 genes, suggesting that they constitute part of
the pre-miRNA transcript or contain elements impor-
tant for miRNA166 regulation which may also be con-
served in maize. Using degenerate primers derived
from these conserved sequence motifs, we cloned
fragments from four maize mir166 loci.
These fragments were used as probes in in situ
hybridization experiments to examine whether
miRNAs can indeed establish patterns of tissue differ-
entiation during development. Consistent with the rel-
atively low abundance of precursor transcripts, we
only detected hybridization using probes directed
against the miRNA. We did not detect any miRNA166
expression in the SAM, suggesting that the meristem-
atic rldl expression domain is controlled at the tran-
scriptional level (Fig. 1C,E). However, rldl and
miRNA166 exhibited complementary expression pat-
terns in developing leaf primordia consistent with a
role for miRNA166 in the spatial regulation of rldl
transcripts.
miRNA166 was expressed immediately below the
incipient primordium and formed a gradient into the
abaxial side of the incipient leaf (Fig. 1E). In older leaf
primordia, miRNA166 accumulated in a progressively
broader domain extending laterally and adaxially (Fig.
1C). This dynamic expression pattern and the possible
gradient of miRNA166 expression in leaf primordia
are reminiscent of a movable signal, suggesting that
expression of the miRNA166 precursor could be under
such control or, alternatively, that miRNA166 can
move between cells.
hd-zipIII genes function also in adaxial/abaxial
patterning of vascular bundles. We found that vascular
hd-zipIII expression is indeed limited to the adaxial
pro-xylem cells (Fig. 1G), whereas miRNA166 accu-
mulates in the abaxial phloem tissue (Fig. 1H). This
suggests that specification of adaxial/abaxial polarity
during leaf and vascular development is in part gov-
erned by the same mechanism. Moreover, the accumu-
lation of miRNA166 in phloem led us to propose that
miRNA166 may move from the site of mir166 expres-
sion. miRNA165/166 thus constitutes an important
highly conserved polarizing signal that may emanate
from a signaling center below the incipient leaf. Early
surgical experiments suggested that specification of
adaxial cell fate requires a meristem-borne signal, as
separation of incipient primordia from the SAM by
incision causes formation of radially symmetric abax-
ialized leaves. In addition to the DNA-binding
domains, HD-ZIP III proteins contain a START-like
lipid-sterol-binding-like domain, suggesting that they
may specify adaxial fate by conveying this meristem-
borne signal. Thus, rldl and other hd-zipIII genes may
specify adaxiaUabaxial polarity by perceiving and
integrating two positional signals: the meristem-borne
signal and the miRNA signal emanating from below
the incipient leaf.
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of up to three years on
proj-ects of their own choosing. Fellows are provided with a salary, research support, and technical
assistance so that they can accomplish their goals free of distraction. The interaction among research
groups at the Laboratory and the program of courses and meetings on diverse topics in biology con-
tribute to a research environment that is ideal for innovative science by these Fellows.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1987) and Scott Lowe (1995) are
currently members of the faculty at the Laboratory. After 9 years at the Laboratory, Carol Greider (1988)
left to join the Department of Molecular Biology and Genetics at Johns Hopkins University School of
Medicine. Eric Richards (1989) is currently in the Department of Biology at Washington University. After
finishing his fellowship, David Barford (1991) returned to the Laboratory of Molecular Biophysics at
Oxford University. Ueli Grossniklaus (1994) was a member of our faculty before leaving to join the
Friedrich Miescher Institut in Basel, Switzerland in 1998. Marja Timmermans, who joined us from Yale
in 1998, ended her fellowship in June of 2002, when she became an assistant professor at the
Laboratory.
The two current CSHL Fellows, Gilbert (Lee) Henry and Terence Strick, joined the Laboratory in
2000. Their reports are listed below. Lee joined us from Doug Melton's laboratory at Harvard University
where he earned his Ph.D. for studies on Xenopus development. Lee is studying taste bud develop-
ment and the role of innervation in this process. Terence joined us after earning his Ph.D. in molecular
and cellular biology at Ecole Norma le Superieure in Paris with David Bensimon and Vincent Croquette.
Terence is using single-molecule biophysics to study the mechanical response of DNA to stretching
and twisting by enzymes that alter DNA topology, thus elucidating the properties of these enzymes.
L. Henry
T. Strick
Structural and Functional
Studies of the Vertebrate
Taste Bud
L. Henry, Y. Zhu, M. Siddiqui
The goal of our research is to understand the molecu-
lar mechanisms required for the formation of taste
buds during embryogenesis and the maintenance of
their structure and function in the adult. The sensory
cells of gustation are housed within ovoid structures
called taste buds which are embedded in the epitheli-
um of the tongue, and to a lesser extent the epithelium
of the palate and upper pharynx. Consisting of 70-100
cells, the vertebrate taste bud is a highly dynamic
structure that possesses both epithelial and neuronal
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qualities. Like all other sensory cell types, the taste
receptor cell membrane depolarizes in the presence of
a suitable stimulus. Similar to the epithelial cells that
line the intestine and other areas of the gut, cells with-
in the bud turn over at a rapid rate (-8-10 days in
rodents). Unlike the olfactory system, where the axons
of newly formed receptor cells project for some dis-
tance back toward and synapse on to neurons in the
glomeruli of the olfactory bulb, newly formed taste
receptor cells lack classical projections and synapse
on to sensory afferents associated with the taste bud.
Mammalian taste buds are embedded in epithelial
specializations called papillae. On the surface of the
tongue, three classes of papillae are easily distin-
guished. Toward the back of the tongue, there is a cen-
trally located circumvallate papilla, two groups of foli-
ate papillae are found to the lateral extremes of the
posterior tongue, and scattered over the anterior
tongue are reddish colored fungiform papillae. The
papillae form late during embryogenesis in the mouse
(E13-E16) as the tongue begins to bud away from the
pharynx. Soon after their formation, sensory afferents
enter the papillae, and approximately eight to ten days
after birth (P8-P10), taste buds form. In rodents, there
is a single bud per fungiform papillae, tens of buds
within the two foliate papillae, and hundreds of buds
are found in the single circumvallate.
An intimate relationship between both the devel-
oping papillae and the mature taste bud with innervat-
ing sensory afferents has been established through a
number of denervation studies. Papilla formation does
not require innervation; however, the maintenance of
these structures does in some way require contact with
sensory afferents. Similarly, in adult animals, dener-
vation of the tongue leads to the loss of taste buds. We
are currently trying to understand the molecular basis
for this neuroepithelial interaction. However, before
regulatory mechanisms can be understood, it is first
necessary to understand exactly what is being regulat-
ed. Toward this end, a primary aim of our current work
is to understand, in molecular detail, how many differ-
ent types of cells reside in the developing papilla and
adult taste bud. What, if any, lineage relationships
exist among these cell types? Is the distribution of the
different cell types that reside in these structures spa-
tially patterned?
DEVELOPMENT OF A QUANTITATIVE METHOD FOR
THE ANALYSIS OF mRNA IN SINGLE CELLS?
A prerequisite for much of our work is the develop-
ment of a quantitative method for the analysis of
mRNA expression in single or small numbers of cells.
A typical eukaryotic cell contains picogram amounts
of mRNA, whereas the vast majority of the analytical
procedures that we use to analyze gene expression
require microgram amounts of material. Thus, the
mRNA expressed in a single cell must be amplified
before it can be studied. We have developed a novel
scheme for performing such amplifications. In this
technique, mRNA is bound to a magnetic bead, cova-
lently coupled cDNA is produced, and after a series of
molecular manipulations, the cDNA is released and
amplified by either polymerase chain reaction (PCR)
or in vitro transcription. The advantage of performing
such manipulations in the solid phase is that precipi-
tation and chromatographic steps are not required
between manipulations, which allows the user a great
deal of flexibility in modifying the cDNA so that it can
be amplified. We have successfully amplified mRNA
from single adult taste receptor cells and taste buds.
Additionally, we are using microarray technology to
assess the quantitative abilities of our procedure.
These experiments simply involve comparing the
expression profiles of diluted and amplified material
versus undiluted material. An additional concern
relates to the ratio of signal and noise observed in our
amplifications. For example, it is not uncommon when
amplifying eDNA from single cells to find material in
the amplified product that is not derived from the cell
of interest. We have established the source of this
noise and have devised a method to eliminate it from
the amplified product. We expect and are currently
testing the idea that the sensitivity of our assay will be
aided by a reduction in amplification noise.
HOW DIVERSE ARE BOTH THE MATURE
RECEPTOR CELL POPULATION
AND THE PROGENITOR POOL FROM
WHICH IT IS DERIVED?
Our goal is to develop a molecular fingerprint for each
of the different cell types that reside in the adult taste
bud. By fingerprint, we essentially mean a transcrip-
tional profile. From the perspective of cell division,
there are two types of cells within the adult taste bud:
mitotically active progenitor cells at the base of the
bud and differentiated quiescent cells at the apex.
Mature taste receptor cells fall into the later category.
In addition, the differentiated cells of the taste bud are
highly elongated as compared to the progenitors and
can release neurotransmitter onto the sensory afferent
network with which they form multiple synapses.
These properties allow basal cells to be distinguished
from their mature, apically located, daughter cells by
the presence of mRNA transcripts that encode proteins
that support the aforementioned processes. For exam-
ple, there are a small number of genes known that are
only expressed in dividing cells, and the production of
certain neurotransmitters requires biosynthetic
enzymes that are only expressed by the cells that make
and release the transmitter. Altogether, we have isolat-
ed just over 100 cDNA clones that can be used to pre-
sort cells. Each of these clones has been spotted onto a
low-density microarray which is hybridized to ampli-
fied and labeled eDNA derived from single cells. This
pre-sorting hybridization allows progenitor and mature
cells to be distinguished, as well as bitter-, sweet-,
sour-, and salt-responsive cells.
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FIGURE 2 Observation of promoter melting by a single RNA polymerase. (Left) Sketch of the experiment.
DNA containing a single bacterial promoter site is negatively supercoiled, causing it to form supercoiled loops
and reducing the end-to-end extension. When RNA polymerase unwinds the promoter site, topological cou-
pling in the DNA causes a supercoil to disappear and the extension increases, When the promoter site rean-
neals, the supercoil reappears and the extension decreases. (Right) In the presence of RNA polymerase, the
DNA extension does indeed fluctuate between a low-extension/closed promoter state and a high-exten-
sion/open promoter state.
studies of the interactions between RNA polymerase
and DNA (Revyakin et al. 2003, 2004). We have been
particularly interested in how DNA supercoiling
affects the process of transcription initiation, a funda-
mental step in the regulation of gene expression. A
sketch of single-molecule detection of promoter melt-
ing is provided Figure 2.
For these experiments, we prepared a 4-kb DNA
molecule containing a single bacterial promoter site.
Upon addition of bacterial RNA polymerase holoen-
zyme, we are able to observe large-scale fluctuations
in the DNA end-to-end extension. These fluctuations
are consistent with promoter unwinding/rewinding
(see Fig. 2). Since these fluctuations are not observed
if the DNA does not contain the promoter site, they
must be due to interactions between an RNA poly-
merase and the promoter site. By measuring the
amplitude of these fluctuations, we can estimate the
extent of DNA untwisting which takes place during
promoter opening, as well as observe bending of the
promoter DNA by the RNA polymerase.
Since these observations are performed in real-
time, we are able to directly determine the kinetics of
formation and destruction of the RNA polymerase/
unwound promoter complex. We find that the time-
scale of the RNA polymerase/DNA intearction is
extremely sensitive to the degree of supercoiling of
the nanomanipulated DNA. Since the kinetics of a
reaction reflect its energetic cost, we determined that
it is the torque generated by DNA supercoiling which
affects the rate of transcription initiation. The RNA
polymerase/promoter complex literally behaves like a
torque sensor. Since DNA supercoiling is actively reg-
ulated in vivo by the topoisomerase enzymes, this sug-
gests that DNA topology constitutes a means for the
cell to regulate gene expression.
This work shows that single-molecule DNA
nanomanipulation is a robust methodology for the
study of protein-DNA interactions and, in particular,
those involved in transcription initiation. In principle,
processes such as the initiation of DNA replication
could also be studied using this technique. In the
future, we will combine this nanomanipulation tech-
nique with single-molecule fluorescence detection in
order to measure protein conformational changes in
parallel with our measurements on DNA topology.
DNA Compaction by SMC Proteins
T. Kawaguchi, M. Hirano, T. Hirano, T. Strick
A second project that we have been pursuing involves
the study of DNA compaction by the SMC (structural
maintenance of chromosome) proteins such as Bacillus
subtilis SMC and Xenopus laevis condensin complex.
Using DNA nanomanipulation, we are able to
observe large-scale, rapid and yet reversible conden-
sation of the DNA upon addition of purified X lae-
vis condensin and ATP. Control experiments using
ATP analogs and condensin purified from different
phases of the cell cycle show that both mitotic phos-
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HOW MANY TYPES OF CELLS ARE CONTAINED
WITHIN THE DEVELOPING PAPILLAE?
To understand how papillae are formed and innervat-
ed, it is imperative that we first ask what are papillae,
at the molecular level. The papillae of the tongue are
very similar in structure to the various ectodermal pla-
codes that cover the epidermis and give rise to hair,
feathers, and teeth. The secreted signaling factor sonic
hedgehog (shh) is expressed in cells that will form
these structures and that expression is maintained after
the papilla or placode has formed. We plan to exploit
this finding by using the shh locus to ectopically
express GFP in developing papillae. Bacterial artifi-
cial chromosome (BAC) clones carrying the shh gene
have been isolated, and using a recently described
recombination technique, a GFP cassette has been
inserted into this locus. Transgenic mice will be gen-
erated using the modified BACs. Single GFP-positive
cells from the lingual epithelium of E12-E17 embryos
will be isolated and transcriptionally profiled using a
single-cell cDNA synthesis method (see below).
Profiles will be obtained by screening microarrays and
direct sequencing of cDNAs. From this work, we hope
to determine the molecular diversity of the papillae
during its formation and innervation. Once we can
"fingerprint" the cells of the papillae in this manner, it
should be possible to analyze the mechanisms that reg-
ulate this diversity, in particular, the contribution of
innervation to the development of papillae.
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Protein-DNA Interactions
T.R. Strick
During the past year, we have made significant
progress in our efforts to understand the physical basis
of protein-DNA interactions. Because the cell contin-
uously regulates the level of mechanical strain to
which its DNA is subjected (e.g., via supercoiling), we
have been investigating the ways in which this
mechanical strain is used to regulate protein-DNA
interactions. In particular, we have been using single-
molecule nanomanipulation techniques to modify and
study the structure and topology of DNA in processes
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processes such as gene transcription or the packaging
of DNA into mitotic chromosomes.
The single-molecule experiment we have imple-
mented is depicted Figure 1. A 4-kb linear DNA mole-
cule (-1 i.tm long) is shown anchored at one end to a
glass surface and at the other end to a 1-pm-diameter
magnetic bead. The field generated by magnets located
above the sample is used to pull on and rotate the mag-
netic bead, thus stretching and twisting the tethered
DNA. The stretching force applied to the DNA via the
bead is calibrated as a function of magnet position (the
closer the magnets, the higher the force). The torsion
imparted to the DNA is exactly equal to the number of
clockwise or counterclockwise rotations performed by
the magnets and imposed on the bead. The double helix
is thus quantitatively and reversibly supercoiled while
held under tension. By determining the position of the
magnetic bead, one measures and calibrates the end-to-
end extension of the DNA molecule, and thus its
mechanical response to stretching and twisting.
Single-molecule Studies of
Transcription Initiation
A. Revyakin, R.H. Ebright, T. Strick
During the past year, we have made progress in using
single-DNA nanomanipulation to perform real-time
FIGURE 1 Depiction of the experimental setup. (Inset) DNA is
tethered at one end to the wall of a glass capillary tube and at
the other to a magnetic bead. (Overview) The capillary tube is
mounted on an inverted microscope whose focus is controlled
by a computer. The computer also controls the displacements
(translation and rotation) of the magnets used to manipulate the
bead. A CCD camera connected to the microscope relays
video images of the magnetic bead to the computer. The com-
puter extracts from these images the mean position and the
Brownian fluctuations of the bead, which can be used to deter-
mine the DNA's end-to-end extension / which results from an
applied stretching force F and a supercoiling of n turns.
phorylation of condensin and ATP hydrolysis are
required for enzyme activity. Control experiments
performed in the absence of ATP show that under
these conditions, the condensin complex binds
reversibly to DNA but does not cause its condensa-
tion. At low protein concentration, the incremental
compaction of DNA can be observed as large (-60
nm) and discrete changes in DNA extension and pre-
sumably corresponds to the association and dissocia-
tion of a single condensin complex from DNA.
Surprisingly, DNA supercoiling does not appear to
alter the length-scale of DNA condensation events.
This suggests that condensin compacts DNA by
altering global DNA topology, rather than local DNA
topology, possibly by driving the formation of large-
scale loops along the DNA.
Torque-induced Structural
Transitions in DNA
T. Strick, R. Sachidanandam
These experiments aim to better understand the phys-
ical properties of DNA. We have observed that an
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unwinding torque applied to DNA induces transient
alterations of the molecule's secondary structure.
Analysis of these conformational changes could help
us understand how DNA supercoiling affects process-
es such as the initiation of DNA replication or the ter-
mination of transcription. We are currently working to
determine the way in which the DNA sequence affects
these structural transitions, and expect in this way to
learn more about the kinetics and energetics of forma-
tion of alternative DNA structures such as cruciforms
and denaturation bubbles.
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Brie, A., 88 Dike, S., 135 Hearn, S., 117 Klajn, R., 58
Brody, C.D., 154 Ding, H., 55 Hecker, R., 126 Kleiner, A., 63
Bronson, K., 160 Douglas, J., 102 Helfman, D.M., 108 Kobayashi, N., 76
Bubulya, A., 55 Dovirak, 0., 92 Hemann, M., 88 Kopec, C., 180
Bubulya, P., 117 Drier, E., 192 Hemish, J., 165 Koulakov, A., 173
Buckley, D.A., 126 Du, J., 78 Henry, L., 212 Krainer, A.R., 60
Burbach, B., 186 Dubnau, J., 162 Herbst, A., 68 Kui, J., 190
Bureau, I., 186 Duelli, D., 86 Hernandez, N., 53 Kulhman, S., 168
Burgess, D., 88 Herr, W., 55 Kumar, P.R., 58
Burgos, K., 160 Egan, J., 98 Hicks, J., 102 Kumar, R., 98
Byrne, M., 200 Egger, V., 176 Hill, B., 65 Kumaran, I. ,117
Ehrlich, I., 180 Hinton, S., 126 Kurland, J., 68
Carmell, M., 78 Ellison, V, 123 Hirano, M., 111 Kuzin, B., 165
Cartegni, L., 60 Emran, F., 53 Hirano, T., 111 Kwofie, M., 65
Cepero, E., 88 Encinas, J., 165 Ho, I., 196
Chabes, A., 123 Enemark, E., 58 Hoek, M., 123 Lau, K., 205
Chabes, A.L., 55 Enikolopov, G., 165 Hoffa, I., 78 Lazebnik, Y., 86
Chakraborty, S., 154 Esposito, D., 102 Hollweg, C., 154 Lee, A., 121
Chan, G., 117 Ewald, R., 160 Holtmaat, A., 186 Lee, S.-W., 108
Chang, K., 102 Ezhkova, E., 68 Horiuchi, J., 192 Lee, T., 83
Chattopadhyaya, B., 168 Hrecka, K., 65 Li, B., 180
Chaudhury, R., 205 Fang, Y., 117 Hromadka, T., 194 Li, C., 190
Cheloufi, S., 95 Feierstein, C., 176 Hsieh, H., 180 Li, Z., 72
Chen, B., 157, 190 Feng, J., 139 Hsu, H.-C., 72 Lin, H., 149
Chen, C.-M., 114 Friedman, E., 176 Hu, P., 53 Lin, P.-C., 72
217
Lin, S.-C., 86 Nunez, S., 88 Schones, D., 149 Uchida, N., 176
Linder, J., 205 Schuck, S., 121 Ugel, N., 139
Lippman, Z., 200 O'Brien, T., 186 Scott, C., 88 Umamaheswari, U., 200
Liu, J., 78 O'Farrell P., 58 Sebat, J., 102
Liu, Y., 55 O'Neil, J., 190 Seger, Y., 78 Vadivelu, S., 123
Losada, A., 111 O'Shaughnessy, A., 135 Seidenman, K., 180 Van Aelst, L., 131
Lowe, S., 88 Okunola, H., 60 Sharma, P., 160 van der Meijden, C., 63
Lucito, R., 92 Ono, T., 111 Shaw, S., 60 Vaughn, M., 200
Lucs, A., 114 Opitz-Araya, X., 86 Shen, R., 200 Velamoor, V., 131
Luo, J., 190 Otazu, G., 194 Shepherd, G., 186 Venkatesh, M.P., 139
Oztaskin, T., 53 Sheu, Y.-J. ,123 Vollbrecht, E., 200
Ma, B., 53 Shi, H., 72 Volpe, T., 200
Machens, C., 154 Packer R., 131 Shudo, R., 76
Mainen, Z.F., 176 Paddison, P.J., 78 Siddiqui, K., 123 Wang, F., 149
Maletic-Savatic, M., 165 Pal, T., 168 Silva, J.M., 78 Wang, J. 205
Malikzay, A., 50 Palka, H.L., 126 Simorowski, J., 200 Wang, J.H., 149
Malinow, R., 180 Palmer, L., 135 Siolas, D., 78 Wang, Q., 168
Mamiya, A., 196 Paniagua, E., 192 Siripurapu, V., 76 Wang, Y., 196
Mamoru, K, 149 Papazoglu, C., 55 Skowronski, J., 65 Wehr, M., 194
Manche, L., 60 Pawlak, G., 108 Slomiany, P., 83 Wen, Q., 157
Mangone, M., 55 Paxia, S., 139 Smith, P., 60 Wendel, H., 88
Maniar, H., 183 Pegoraro, G., 63 Smith, S., 58 Wendel, P., 123
Margulies, C., 192 Penal, A., 154 Sobczyk, A., 186 West, J., 102
Marinsek, N., 200 Perkowski, D., 63 Song, J.-J., 58 Wigler, M., 102
Marsden, C., 78 Petreanu, L., 186 Song, S., 157 Wilbrecht, L., 186
Martienssen, R., 200 Peunova, N., 165 Sosulski, D., 176 Wu, C., 55, 168
Matapurkar, A., 86 Phelps -burr. T, 207 Speck, C., 123 Wu, R, 192
May, B., 200 Piccini, A., 126, 180 Spector, D.L., 117 Wu, S., 53
Mayilvahanan, S., 53 Pologruto, T., 186 Spector, M., 88 Wu, Y., 95
Mazurek, A., 123 Prasanth, S.G., 123 Spiegel, L, 135 Wysocka, J., 55
McCombie, W.R., 135 Spivak, M., 139
McCurrach, M., 88 Quirk, M., 176 Stein, L., 146 Xia, S., 190
McQuown, J., 139 Stenlund, A., 121 Xiang, B., 114
Mehra, S., 83 Rabinowicz, P., 200 Stepanyants, A., 157 Xiao, G., 50
Mendez, J., 123 Rachakondra, S., 190 Stillman, B., 123 Xu, R.-M., 72
Meng, T.C., 126 Ranade, S., 176 Strick, T., 212 Xuan, Z.Y., 149
Meth, J., 76 Ravi, K., 165 Sun, Y., 53
Michurina, T., 165 Ray, S., 88 Sung, B., 139 Yang, H., 168
Miller, B., 135 Regulski, M., 190 Svoboda, K., 186 Yang, M., 88
Mills, A., 95 Reiner, A., 102 Swigut, T., 65 Yao, Z., 126
Min, J., 72 Rial Verde, E., 160 Yasuda, R., 186
Mish, B., 165 Riggs, M., 102 Tai, L.-H., 194 Ye, M., 126
Mishra, B., 139 Rivas, F., 78 Takahashi, T., 180 Yin, J., 192
Mitra, P., 183 Roca, X., 60 Tang, A., 200 Yu, M., 135
Mittal, V., 98 Rodgers, L., 102 Tansey, W.R, 68 Yuan, C.-C., 53
Mohanty, A., 205 Roh, D., 200 Tervo, G., 186 Yuneva, M., 86
Moore, M., 114 Roig, J., 165 Thakkar, Z., 65
Muller, S., 135 Ronemus, M., 200 Thirumalai, V, 160 Zador, A., 194
Muratani, M., 68 Rosenberg, A., 114 Thomas, E., 102 Zariwala, H., 176
Murchison, L., 78 Rosenthal, C., 88 Thomas, J., 207 Zhang, C., 186
Muthuswamy, L., 102 Rossmann, M., 123 Tignor, C., 139 Zhang, L., 126
Muthuswamy, S., 114 Rudra, A., 139 Timmerman, M., 207 Zhang, M.O., 149
Myers, M., 63 Rumpel, S., 194 Tolia, N., 58 Zhang, Q.-S., 60
Ruthazer, E., 160 Tonks, N.K., 126 Zhang, Z., 60, 123
Narita, M., 88 Tovkach, A., 58 Zhao, M., 131
Nascimento, L., 135 Salghetti, S., 68 Troge, J., 102 Zhao, X., 55
Nath, U., 102 Samudre, K., 53 Tsigankov, D., 173 Zhong, Y., 196
Navin, N., 102 Satoh, N., 205 Tubon, T., 55 Zhou, H., 58, 192
Neuwald, A.F, 143 Saxena, A., 53 Tully, T., 190 Zhou, Y., 139
Newey, S., 131 Scheinker, V., 165 Tworkowski, K., 68 Zilfou, J., 88
Nimchinsky, E., 186 Scheuss, V., 186 Zito, K., 186
Noma, K., 50 Schmidt, L.L., 63 Uchida. M., 131 Zutavern, T., 135
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN'S REPORT
May 13, 2003 saw the Watson School achieve perhaps the most important landmark of its young exis-
tence. On that date, Amy Caudy of the first entering class in the fall 1999 became the first Watson
School student to defend her doctoral dissertation. The defense occurred in Bush
Auditorium, where James D. Watson first publicly presented the structure of DNA
50 years earlier. Present as the external examiner was Nobel laureate Phillip Sharp,
an alum of Cold Spring Harbor Laboratory. It was a truly momentous occasion.
The idea of a graduate school at Cold Spring Harbor Laboratory was raised by Jim
Watson in the fall of 1995. Just seven and a half years later, the Laboratory award-
ed its first Ph.D. degree. It now truly is a degree-granting institution.
And Amy Caudy set a benchmark for many to follow. As a Howard Hughes
Medical Institute Predoctoral Trainee and in the process of her doctoral research in
Gregory Hannon's laboratory, she participated in seven published studies and was
the primary author on publications in Genes & Development and Nature, all pertain-
ing to her research on mechanisms of RNA interference or RNAi. But that was not
enough for Amy. She was also a coauthor on publications arising from the research
she performed in each of two six-week research rotations during her first year of
study. It was perhaps not surprising-but certainly gratifying nonetheless-that, as described further below,
Amy was awarded the Harold Weintraub award by the Fred Hutchison Cancer Research Center.
Amy is now at Washington University in St. Louis for her postdoctoral studies in immunology with
John Atkinson. She is also coauthor of a new revision of the book Recombinant DNA together with
James Watson, Richard Myers, and Jan Witkowski. Then again, all of this success is perhaps not that
surprising-when in college, Amy was selected as one of the top ten women undergraduates of 1998
by Glamour Magazine!
Amy Caudy was not the only Watson School student to graduate this year.
This fall, Ira Hall defended his thesis for his studies with Shiv Grewal after only just
over three years in the School. We were most pleased that our colleague Rolf
Sternglanz from Stony Brook University participated as the external examiner.
Cold Spring Harbor Laboratory faculty members have participated in Stony Brook
University thesis defenses for more than 25 years, so it was truly a pleasure to
have the roles reversed! Like Amy, Ira Hall has been extremely successful as a stu-
dent. During his doctoral studies, Ira coauthored two publications that were cited
as the foundation of the 2002 "Breakthrough of the Year" by Science magazine.
These two publications have also just this fall been awarded the Newcomb
Cleveland Award for being the most important publications in Science magazine
in 2002. Impressive achievements indeed!
A very pleasing fallout to the Watson School's involvement in thesis defenses has
been our becoming more engaged in promoting the thesis defenses of students from
other institutions, particularly Stony Brook University. Thus, whereas in the past, the-
sis defenses were often poorly publicized and attended, the Watson School now
ensures that they are announced labwide and are often held in Bush Auditorium
where attendance has been outstanding. This development is just one example of
how Cold Spring Harbor Laboratory is transforming itself into an academic institution.
The first Watson School graduation is scheduled for April 25, 2004 exactly
51 years after the publication of the structure of DNA by Watson and Crick! Amy
and Ira are likely to be joined by other Watson School graduates at what will be a
most festive occasion.
Amy Caudy
Ira Hall
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THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 1999
Amy A. Caudy, May 13, 2003
Mechanism and Applications of RNA Interference
Thesis Examining Committee
Chair: Adrian R. Krainer
Research Mentor: Gregory Hannon
Academic Mentor: Hollis Cline
Committee Member: Robert Martienssen
Committee Member: Bruce Stillman
External Examiner: Phillip A. Sharp, Massachusetts
Institute of Technology
ENTERING CLASS OF 2000
Ira M. Hall, November 20, 2003
A Role for RNA Interference in Heterochromatic Silencing
and Chromosome Dynamics
Thesis Examining Committee
Chair: Rui-Ming Xu
Research Mentor: Shiv Grewal
Academic Mentor: Alexander A.F. Gann
Committee Member: Scott Lowe
Committee Member: Michael Wigler
External Examiner: Rolf Sternglanz, Stony Brook
University
Student Awards
When the Watson School established as a founding principle the goal of offering a four-year Ph.D.
degree in the biological sciences, one concern raised by all involved in establishing the School was
whether it would be possible for students to perform substantive research within such a timeframe.
Now, just over four years since the first students entered the School, the early results suggest that it is
imminently possible and how! The first two Watson School students to defend their theses, Amy Gaudy
and Ira Hall, have received international recognition for their doctoral studies.
IDID IT IN
oLNEARS
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Amy celebrating a four-year Ph.D.
Amy Caudy Receives the Harold M. Weintraub Graduate
Student Award
This spring, Amy Gaudy was one of 16 graduate students from North
America and Europe to be selected to receive the 2003 Harold M.
Weintraub Graduate Student Award, which is sponsored by the Fred
Hutchinson Cancer Research Center. The award, established in 2000,
honors the late Harold M. Weintraub, Ph.D., a founding member of
Fred Hutchinson's Basic Sciences Division, who in 1995 died from
brain cancer at age 49. Weintraub was an international leader in the
field of molecular biology. Among his many contributions, he identified
genes responsible for instructing cells to differentiate, or develop, into
specific tissues such as muscle and bone. Nominations for the award
were solicited internationally, and the winners were selected on the
basis of the quality, originality, and significance of their work. Amy
received her award for her seminal studies on the mechanisms of RNAi.
Ira Hall's Studies Recognized by the American Association for the Advancement of Science
During his doctoral studies, Ira Hall participated in two collaborative studies that were recognized in
2002 by the journal Science as the "Breakthrough of the Year." This year, the American Association for
the Advancement of Science (AAAS) recognized these two studies with the award of the 2003
Newcomb Cleveland Prize. The AAAS Newcomb Cleveland Prize acknowledges an outstanding paper
published in the journal Science. It is the oldest and largest of the AAAS awards and was established
in 1923. The AAAS noted that the two papers recognized in the 2003 Newcomb Cleveland Award
established a new landmark in epigenetic control. They added a giant step to our knowledge by show-
ing how RNA molecules directly control gene expression by modifying chromatin structure and func-
tion. The HAAS noted that these elegant experiments have laid the basis for new understanding of a
wide range of "textbook" processes that have arisen from classical genetic studies, including imprint-
ing and dosage compensation through X-inactivation.
One of the reasons for the success of researchers at Cold Spring Harbor Laboratory is the high
degree of interaction and collaboration among its scientists. Ira's studies are no exception. They
involved collaborations with other members of Shiv Grewal's laboratory and in one of the two cases
with members of Robert Martienssen's laboratory.
Catherine Cormier Receives a National Science Foundation
Graduate Research Fellowship
In addition to the recognition of graduating Watson School stu-
dents' research, Catherine Cormier (entering class of 2001)
became the first Watson School student to receive the National
Science Foundation (NSF) Graduate Research Fellowship. This
year, the Howard Hughes Medical Institute regrettably terminated
its prestigious predoctoral fellowship program, a program that
awarded four of its fellowships to Watson School students: Amy
Gaudy, Emiliano Rial Verde, Dougal (Gowan) Tervo, and Elizabeth
Thomas. Now that this program has been terminated, it is our hope
that more students will be awarded the NSF fellowship like Cathy.
Recruiting a 2003 Entering Class
Each year, the Watson School puts itself forward in the hopes that
the best and the brightest will select it for their doctoral studies in the
biological sciences. In 2003, these hopes were satisfied. Of 13 offers
of admission made by the Watson School to applicants, 8 were
accepted-a greater than 60% acceptance rate. Students turned
down offers from University of California, Berkeley; Massachusetts Institute of Technology; and Stanford
University, among others, to join the Watson School. The five students who went elsewhere decided to
go to prestigious institutions: Cambridge University (U.K.), Harvard University, Massachusetts Institute of
Technology, The Rockefeller University, and University of California at San Francisco. With one student
deferral from 2002, there were nine entering students this year (see photo and box), more than our orig-
inal goal of seven to eight students. The increased size of the 2003 entering class required more effort
by the teaching faculty, but this change was most welcome!
The recruitment of a new class is the result of the efforts of the Admissions Committee, Watson School
administration, faculty, and students. The School is most appreciative of Nouria Hernandez' efforts these
past three years as chair of the Admissions Committee. Her dedication to the recruitment effort is an
important reason for this year's success. Her position as chair of the Admissions Committee has now
been filled by Marja Timmermans. The School looks forward to continued recruitment successes under
her direction, especially with the help of Ms. Dawn Meehan, the School's new recruitment specialist (see
below).
Catherine Cormier
The Fifth Entering Class
It is hard for me to believe that it is only four years ago that the Watson School first opened its doors
to students. I still remember vividly Lilian Gann and I working until late in the evening of September 6,
1999 to get things ready for that first entering class. This year, on August 25, the Watson School
opened its doors for the fifth time to welcome a new class of students. Nine studentsHiroki Asari,
Rebecca Bish, Francois Bolduc, Monica Dus, Angelique Girard, Christopher Harvey, Jeong-Gu Kang,
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Izabela Sujka, and Wei Wei-all began together their adventure in learning how to do science and
become scholars in the biological sciences. As is typical for the Watson School, the entering students
hailed from around the world (see box). With nine students, this class matches in size our previously
largest class, the entering class of 2000. We hope that this larger size portends well for the Watson
School beginning to have on the order of 10-12 students per year.
Student Amenities
To attract such outstanding students, some important changes were made this year in student ameni-
ties. First and foremost, the Watson School student annual stipend increased from $21,500 to
Student
DOCTORAL THESIS RESEARCH
Academic
Mentor
Research
Mentor Thesis Research
ENTERING CLASS OF 1999
Amy Anne Caudy
George A. and Marjorie H. Anderson Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Thesis defense: May 2003
Michelle Lynn Cilia
William R. Miller Fellow
Ahmet M. Denli
David H. Koch Fellow
Emiliano M. Rial Verde
David and Fanny Luke Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Elizabeth Ellen Thomas
Farish-Gerry Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Niraj H. Tolia
Leslie C. Quick, Jr Fellow
ENTERING CLASS OF 2000
Santanu Chakraborty
George A. and Marjorie H. Anderson Fellow
Elena S. Ezhkova
Engelhom Scholar
Rebecca C. Ewald
Engelhorn Scholar
Ira Hall
Beckman Graduate Student
Thesis defense: May 2003
Zachary Bela Lippman
Beckman Graduate Student
Marco Mangone
Charles A. Dana Foundation Fellow
Masafumi Muratani
George A. and Marjorie H. Anderson Fellow
Patrick J. Paddison
Beckman Graduate Student
Hollis Cline Gregory Hannon The biological function of RNA interference
Nouria Hernandez David Jackson Mechanisms of intercellular trafficking via
plasmodesmata
Adrian R. Krainer Gregory Hannon Biochemical analysis of RNA-induced
gene silencing
Jan A. Witkowski Hollis Cline Arc role in synaptic function
William Tansey Michael Wigler A de nova approach to identifying repetitive
elements in genomic sequences
David Hellman
Michael Wigler
Jan A. Witkowski
Bruce Stillman
Alexander A.F. Gann
William Tansey
Linda Van Aelst
Nouria Hernandez
Adrian R. Krainer
Leemor Joshua-Tor Structural analysis of a malarial surface antigen
Carlos D. Brody
William Tansey
Hollis Cline
Shiv Grewal
Mechanisms of robust short-term memory in
biological networks
Role of the proteasome in transcription
NMDA receptor trafficking and its impact on
neuronal functionality and morphology
Initiation, assembly, transfer, and genome-wide
distribution of heterochromatin in
Schizosaccharomyces pombe
Robert Martienssen Comprehensive analysis of chromatin status on
Arabidopsis chromosome 4
Winship Herr
William Tansey
Gregory Hannon
The role of HCF-1 in cell proliferation
Gene regulation by ubiquitin-mediated
proteolysis
An RNAi-based screen in mouse embryo fibro-
blasts for transformation-lethal gene targets
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$25,000. This stipend level is more in line with those of the schools with which we compete for stu-
dents. In addition to stipends, Cold Spring Harbor Laboratory has made serious efforts at improving
housing accomodations for all students and postdocs. A new Housing Office has been established in
the Facilities Department. Additionally, owing to the support of the Board of Trustees, excellent hous-
ing is being renovated and constructed de novo at the Uplands Farm site, providing living space for 32
students and postdocs. Already four Watson School and two Stony Brook University students are shar-
ing the first renovated residence at the site. As an indication of the importance of housing to the Watson
School, I became chair of a housing committee to establish a defined housing program for the
Laboratory. I have enjoyed working closely with Art Brings, the Laboratory's Chief Facilities Officer, on
this very important issue.
Student
DOCTORAL THESIS RESEARCH
Academic
Mentor
Research
Mentor Thesis Research
ENTERING CLASS OF 2001
Catherine Y. Cormier David J. Stewart
Beckman Graduate Student
Claudia E. Feierstein
George A. and Marjorie H. Anderson
Fellow
Tomai Hromadka
Enge thorn Scholar
Charles D. Kopec
Goldberg-Lindsay Fellow
Ji-Joon Song
Bristol-Myers Squibb Fellow
Dougal G.R. (Gowan) Tervo
George A. and Marjorie H. Anderson
Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
ENTERING CLASS OF 2002
Linda Van Aelst
William Tansey
Anthony Zador
Scott Lowe
Carlos D. Brody
Sun Lazebnik Caspase activation in unidentified apoptotic
pathways
Zachary Mainen Odor coding and neural correlates of behavioral
choice in the olfactory cortex
Anthony Zador Stimulus optimization in the auditory cortex
Roberto Malinow Mapping the trafficking of AMPA receptors in
dendritic compartments
Leemor Joshua-Tor Structural studies of RNAi
Karel Svoboda
Allison L. Blum Leemor Joshua-Tor Josh Dubnau
Barbara McClintock Fellow
Darren Burgess
Engelhom Scholar
Beth L. Chen
George A. and Marjorie H. Anderson Fellow
Beckman Graduate Student
Shu-Ling Chiu
Elisabeth Sloan Livingston Fellow
Nicholas Tonks
Senthil K. Muthuswamy
Alea A. Mills
Scott Lowe
Dmitri Chklovskii
Hollis Cline
Jonathan Kui David Jackson Tim Tully
Alfred Hershey Fellow
Elizabeth Murchison John Inglis Gregory Hannon
Elisabeth Sloan Livingston Fellow
An inducible and reversible lesion of the
corticothalmic projection
Genetic, behavioral, and anatomical characteri-
zation of Radish-dependent memory
Mammalian RNAi genetic screens: Discovery
and characterization of genes mediating the
response to cancer therapy
Neuronal network of C. elegans: From anatomy
to behavior
To be determined
Identification and characterization of candidate
memory genes in Arleekin, a Drosophila
memory mutant
The role of Dicer in mammalian development
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ENTERING CLASS OF 2003
Hiroki Marl, The University of Tokyo, Japan
Famish-Gerry Fellow
Rebecca A. Bish, Massachusetts Institute of Technology
David H. Koch Fellow
Francois Bolduc, M.D., Universite de Sherbrooke, Canada; University
de Montreal, Canada; McGill University, Canada
William R. Miller Fellow
Monica Dus, University of Redlands, California
Engelhom Scholar
Angelique Girard, Ecole Polytechnique, France; Corps des Mines,
France
Florence Gould Fellow
Christopher D. Harvey, Vanderbilt University, Tennessee
David and Fanny Luke Fellow
Jeong-Gu Kang, Seoul National University, Korea
Watson School Fellow
Izabela A. Sujka, Stony Brook University, New York
Beckman Graduate Student
Wei Wei, University of Melbourne, Australia
Leslie C. Quick, Jr Fellow
Standing (left to right): Rebecca Bish, Francois Bulduc, Monica Dus, Izzabela Sujka, Hiroki Arari.
Seated (left to right): Christopher Harvey, Angelique Girard, Wei Wei, Jeong-Gu Kang.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES 2003
UNDERREPRESENTED MINORITY RECRUITMENT EVENTS
Greater Baltimore Consortium Graduate School Fair
Loyola College, Baltimore, Maryland
September 22, 2003
Society for Advancement of Chicanos and Native Americans in
Science (SACNAS)
Albuquerque, New Mexico
October 2-5, 2003
Annual Biomedical Research Conference for Minority Students
(ABRCMS)
San Diego, California
October 14-18, 2003
University of Maryland, Baltimore County
Meyerhoff Program, Baltimore, Maryland
October 29, 2003
State University of New York Manhattan Career Day Fair
SUNY Manhattan, New York City
November 5, 2003
Ronald E. McNair Scholars Conference
Milwaukee, Wisconsin
November 7-9, 2003
National Association of African American Honors Program (NAAAHP)
Orlando, Florida
November 13-15, 2003
Recruitment of Students from Underrepresented Minorities
The Watson School is dedicated to the recruitment, support, and success of individuals from underrep-
resented minority groups in the biological sciences. The School is taking a very active role in ensuring
success in this endeavor as evidenced by the large number of underrepresented minority recruitment
events attended by the Watson School this fall (see box). In the most significant event, October saw the
Watson School staff go in full force (only Postdoctoral Program Officer Alyson Kass-Eisler stayed behind
to hold down the fort!) to the Annual Biomedical Research Conference for Minority Students (ABRCMS)
in San Diego, where it manned a booth. Dawn Meehan put together a slide show of Cold Spring Harbor
Laboratory and the Watson School, which-along with Jim Watson's picture on display!- attracted
much attention. We were very pleased to learn by year's end that these efforts resulted in a fourfold
increase in the number of underrepresented minority applicants to the Watson School.
In addition to the conferences, I visited the Meyerhoff Program, an elite undergraduate program
involving many first-rate minority students at the University of Maryland, Baltimore County (UMBC). I
had on this occasion the opportunity to meet with UMBC President Freeman Hrabowski Ill, who was
responsible for establishing the Meyerhoff Program. One of our topics of discussion was how to men-
tor students to success in their doctoral studies. Dr. Hrabowski was very interested in the Watson
School's extensive mentoring programs.
As has so often been the case in the past, the Undergraduate Research Program is aiding the
School to recruit underrepresented minority students. Last summer, a participant from the Meyerhoff
Program, Keisha John, worked with Hollis Cline. Keisha generously helped us recruit students to the
Undergraduate Research Program at our booth at the ABRCMS conference in San Diego. She addi-
tionally hosted me during my visit to the UMBC campus. We were very happy that Keisha was the first
student to have a completed application to the Watson School this fall. And we are even more excited
to learn, as of this writing, that she will be joining us in the Fall 2004 for her doctoral studies.
William Randolph Hearst Scholars Award
This year, with the support of the William Randolph Hearst Foundation, the Watson School established the
William Randolph Hearst Scholars Award for exceptional Watson School doctoral candidates from under-
served or underrepresented groups. The philanthropist William Randolph Hearst established the William
Randolph Hearst Foundation in 1945. William Randolph Hearst was born on April 29, 1863, in San
Francisco, California. In 1887, at 23 he became "Proprietor" of the San Francisco Examiner, which his father,
George Hearst, accepted as payment for a gambling debt! He went on to be a newspaper magnate.
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The William Randolph Hearst Foundation provides education opportunities in science at the under-
graduate and graduate levels. In particular, it assists institutions in supporting students from under-
served and underrepresented populations and, with this in mind, has provided the Watson School with
an endowment to support such students.
The William Randolph Hearst Scholars Award provides the recipient with $2500 for each of four
years in the form of an educational supplement. The funds are to further the recipient's graduate stud-
ies, and their use is specifically designed to be flexible. The School hopes that this award will help diver-
sify its student population, an important national imperative.
Visit to Warsaw and France
The United States was not the only country the School visited this year. In May, I took advantage of
the thesis defense of Joanna Wysocka, a student from the University of Warsaw who performed her
doctoral research in my laboratory, to visit Poland. I was given the opportunity to meet with faculty
and to describe the Watson School to undergraduates. I also made similar presentations in a tour of
French schools-the Claude Bernard University of Lyon, the Ecole Norma le Superieure in Lyon, and
the Eco le Polytechnique outside Paris. The visit to the Ecole Polytechnique followed on my visit in July
2002 to participate in Angelique Girard's-the current Watson School Florence Gould Fellow-
description of her "Stage d'Option" (a research internship) studies in my laboratory that spring. This
time, I had an opportunity to meet directly with the third-year students. It must have gone well. We
will have not just one but two students from the Eco le Polytechnique for the Stage d'Option this
upcoming spring.
Curriculum
By being a small school and at a flexible institution like Cold Spring Harbor Laboratory, the Watson
School can offer a well-integrated curriculum, but it needs to be so organized. To aid in the organiza-
tion of the curriculum, last spring saw the establishment of the Curriculum Development and Integration
Committee (CDIC) with the charge to integrate the course instruction and monitor and balance student
workload, particularly during the fall course term. I am pleased to report that, in its first year, this com-
mittee, consisting of William Tansey (Chair), Lilian Gann, David Spector, and Nicholas Tonks, had a sig-
nificant impact on equilibrating the student workload this fall. In past years, there was often an occa-
sion during the biweekly Dean's Teas of the fall term that the students would complain to me about
work overload. With the improved equilibration engineered by the CDIC, I am happy to report that there
were no tumultuous Dean's Teas this fall!
The CDIC additionally solved a long-standing problem with the Watson School curriculum by
recruiting Tim Tully to develop and lead a new course on Genetics co-taught by Josh Dubnau and
Lincoln Stein. The course was very highly rated by the students. Its success addressed a recurring
issue raised by the School's External Advisory Committee on how to teach our students genetics
effectively. It is very pleasing to see the success brought by the involvement of new faculty in the
School's curriculum.
A Complete Set of Topics in Biology Courses
This spring saw the fourth Topics in Biology course presented by the Watson School-a one-week-
long course organized by Jan Witkowski and Lilian Gann and taught at the Banbury Center. H. Kern
Reeve from Cornell University taught a course on animal behavior. With this course, the Watson School
completed a set of four Topics in Biology courses to be taken by students in each of their four years in
the School: Immunology, Evolution, Microbial Pathogenesis, and Animal Behavior (see box). This year,
Nipam Patel, now at the University of California, Berkeley, also returned to teach his course on evolu-
tion. Both the new Animal Behavior course and returning Evolution course were well received by both
students and instructors alike. These results make the Topics in Biology courses among the most suc-
cessful and very special parts of the Watson School curriculum.
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FOUR TOPICS IN BIOLOGY COURSES
ANIMAL BEHAVIOR IMMUNOLOGY
H. Kern Reeve, Cornell University Hidde Ploegh, Harvard Medical School
EVOLUTION
Nipam Patel, University of California, Berkeley
MICROBIAL PATHOGENESIS
Stanley Maloy, San Diego State University
Ronald Taylor, Dartmouth College
Graduate Student Seminar Series
One of the most important but often overlooked elements of the graduate student experience at Cold
Spring Harbor Laboratory is the weekly Graduate Student Seminar Series. The Laboratory is special in
the way it has a diverse multi-institutional graduate student community, especially mixing Stony Brook
University and Watson School students. The graduate student seminars, which are held each Tuesday
evening from September to May over dinner (kindly arranged by Yvette Seger), bring all graduate stu-
dents studying at the Laboratory to hear seminars from their colleagues.
Students present their research once a year, with two students presenting each week. In attendance
are the graduate students and two members of a core set of four faculty mentors whose attendance
rotates each week. The seminar series serves three important roles. First, it gives students an oppor-
tunity to hone their oral presentation skills. Second, it provides the students with an opportunity to
defend their research in the absence of their research mentors, such that they experience standing on
their own two feet as they will have to throughout their careers. Third, the students in the audience have
an opportunity to ask questions within their own peer group, thus learning the important roles of audi-
ence participation for the advancement of research. At the end of the evening, the two faculty mentors
provide each presenting student a critique of the seminar and sometimes provide feedback to the stu-
dent's research mentor.
Illuminating Life book signing
Left to right: Jan Witkowski, Monica Dus, Izabela Sujka, and Elizabeth Murchison
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This seminar program has been spearheaded and organized for many years by David Helfman with
the help of Madeline Wisnewski. David has been steadfast in insisting that students have a scholarly
approach to their education and take an interest in a broad range of subjects as well as in their col-
leagues' welfare. David stepped down from this important role this year and handed over the organi-
zational responsibilities to Mark Beavers and me in the Watson School, a change that emphasizes the
importance the School places on this seminar series. Terri Grodzicker, Alea Mills, and Arne Stenlund
continue as faculty mentors, and, to fulfill David Helfman's role, they are joined by our new faculty mem-
ber Josh Dubnau. Josh brings a broad range of expertise in genetics, molecular biology, and neurobi-
ology.
Academic Mentoring
The Watson School takes great pride in the level of mentoring that it offers to its students. One of the
very special aspects in this regard is the Watson School academic mentoring program, led by William
Tansey. In this program, entering students select by mutual agreement a member of the research or
nonresearch faculty to serve as an academic mentor-a guardian angel to look over and encourage
the student through the sometimes trying process of a doctoral education. This program continues to
receive much support from the faculty who volunteer to be academic mentors, and it has rightfully
become a vital ingredient in the Watson School's success. This year's new academic mentors for the
entering class of 2003 are:
Hiroki Asari Z. Josh Huang
Rebecca Bish Linda Van Aelst
Francois Bolduc Hollis Cline
Monica Dus John Inglis
Angelique Girard Nouria Hernandez
Christopher Harvey Adrian R. Krainer
Jeong-Gu Kang Scott Lowe
Izabela Sujka Marja Timmermans
Wei Wei Jan A. Witkowski
New Faculty
Four new research faculty joined the Laboratory this year. Josh Dubnau, who came to Cold Spring
Harbor Laboratory as a postdoctoral fellow with Tim Tully, became an assistant professor at the begin-
ning of the year and immediately became involved in the Watson School. He was an instructor in the
highly acclaimed Fall Term Genetics course led by Tim Tully and became a faculty mentor in the grad-
uate student seminar series. He is also Allison Blum's research mentor. Josh studies learning and mem-
ory in the fruit fly Drosophila melanogaster.
Josh was joined during the year by two other neurobiologists: Alexei Koulakov as assistant profes-
sor and Partha Mitra as professor. Both Alexei and Partha use computational methods to address how
the brain works. At the end of the year, the most recent Cold Spring Harbor Laboratory recruit,
Wolfgang Lukowitz, joined the faculty as assistant professor in the plant genetics group. Wolfgang
studies cell division polarity in the early plant embryo.
With all these comings, regrettably, there was also someone going. Shiv Grewal, who had great suc-
cess in his studies of epigenetic control of gene expression in the fission yeast Schizosaccharomyces
pombe at the Laboratory, became Principal Investigator at the National Cancer Institute. I, in particu-
lar, felt the loss caused by his departure as Shiv and I had co-instructed the Chromosome Structure
and Function week of the Scientific Reasoning and Logic course for the past two years. Shiv was sore-
ly missed this fall when I had to teach the same topic. Fortunately, I was rescued by Shiv's student Ira
Hall, who gave a lovely lecture on S. pombe epigenetic inheritance.
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Graduate Student and Postdoctoral Fellow Departures
With each year come not only new arrivals, but also new departures. This year saw the following grad-
uate students and postodoctoral fellows depart from the Laboratory.
Graduate Students
Anitra Auster
Brian Chen
Brian Hill
Asra Malikzay
Thomas Tubon
Postdoctoral Fellows
Katherine Braun
Kim L. Farina Graham
Naoya Hata
Guy A. Karger
Patrice Lassus
Kenichi Noma
Xiaokang Pan
Tomasz Swigut
Erik W. Vollbrecht
Canzhu Yang
Emily Bernstein
Amy Caudy
Ajit Janardhan
John Mignone
Joanna Wysocka
Oliver Cuvier
Toshiyuki Fukada
Songtao Jia
Jae-Yean Kim
Tzu-Ching Meng
Thomas Oertner
Geraldine Pawlak
Joshua T Trachtenberg
Thomas Volpe
Zhiguo Zhang
Alyssa Carlberg
Carmine Chiariello
Edward Kim
Zaher Nahle
Veronica Egger
No Grosse
Eric Julien
Rajeev Kumar
Esther Nimchinsky
Helena L. Palka-Hamblin
Kenneth J. Seidenman
Anne Vaahtokari
Qun Wang
Partners for the Future Program
The Watson School oversees educational programs that extend from the Nature Study Program for
youngsters to the postdoctoral training program. The oldest of the programs in the Watson School, the
Nature Study Program, runs on its own without intervention from the Watson School. In contrast, the
Partners for the Future Program, a collaboration between the Watson School and the Public Affairs
Department, has benefited in recent years from the efforts of Yuri Lazebnik, who has taken a hands-on
approach to increase the educational value of the program. The Partners for the Future Program pro-
vides high school students an opportunity to experience laboratory research. High school seniors work
side by side with postdoctoral fellows or professors from October to March. Changes instigated by Yuri
to increase camaraderie among the high school students include get-togethers at which the students
present their research through oral presentations. These get-togethers offer the students an opportu-
nity (1) to learn how to explain their research efforts, (2) to expand their awareness of different research
areas through their colleagues' presentations, and (3) to get to know one another. Yuri's contributions
to the Partners for the Future Program are only one example of how some of the Laboratory's faculty
contribute to the academic environment of the Laboratory with the only reward being the knowledge
that they may influence the early careers of future scientists.
Undergraduate Research Program
The summer Undergraduate Research Program continues to be a cornerstone of the Watson School.
This year, nearly 500 students applied to the program (476 to be exact!) from across the country and
around the world. The participants-called URPs, participate in the ten-week program extending from
the second week of June to the middle of August. They possess a strong esprit de corps that brings
the closest thing to an undergraduate feel to the Laboratory.
This program, together with its offshoot, the Undergraduate Scholars Exchange Program, which
provides undergraduate research opportunities during the nonsummer months, also continues to be a
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WSBS student Elena Ezhkova (left) and
URPS Jonathan Schneiderman, Keisha
John, Catherine Del Vecchio, and Galen
Collins (left to right) modeling DNA Stuff
merchandise.
rich source of students for the graduate school. Thus, in this year's entering class, Hiroki Asari was an
URP, and Angelique Girard, Wei Wei, and Francois Bolduc were exchange scholars. Once students get
a sense of the wonderful interactive intellectual community at the Laboratory, it is much easier to con-
vince them to return for their doctoral studies. Given the importance of the Undergraduate Research
Program to the graduate school, this year I met all of the 25 URPs, five at a time, for lunch in Blackford
Hall. The discussions were wonderful. These lunches were among my favorite part of being dean last
year. Fortunately, by year's end, seven former URPs had applied to the School for admission in the fall
2004.
The program this summer was again expertly directed by Leemor Joshua-Tor, who has had a major
impact on the excellence of the program and developed new elements for it. Indeed, it was in discus-
sions with Leemor about how I might get to know the URPs better that the idea of the lunches came
up. Her dedication to the program has had a major impact on the Watson School and the Laboratory
in general. Unfortunately, as this year's summer season came to a close, Leemor decided that she
needed to focus more on her research and therefore has taken a leave of absence from being direc-
tor. Fortunately, Senthil Muthuswamy has agreed to take over for this year. I am confident that, with his
energy and outstanding abilities, the program will continue to thrive.
Postdoctoral Program
As announced last year, a new postdoctoral program was initiated at the beginning of this year direct-
ed by Nicholas Tonks together with Associate Dean Lilian Gann and our new Postdoctoral Program
Officer Alyson Kass-Eisler, the mainstay of the postdoctoral program operation. The postdoctoral pro-
gram arose from the efforts of a postdoctoral working group, which recommended that the Laboratory
take a more hands-on approach to the education of postdoctoral fellows. Importantly, with the help of
the Postdoctoral Program Office, the resident postdoctoral fellows established a Cold Spring Harbor
Laboratory Postdoctoral Association. This "Postdoc" Association has organized subcommittees
focused on such issues as career development, housing, postdoc Web site, immigration, and general
welfare. An important benefit of the Postdoc Association is that it empowers Laboratory postdoctoral
fellows with the ability to influence their own collective experience at the Laboratory.
In its first year, the Postdoctoral Program Office has rapidly established the role of aiding new post-
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doctoral fellows to identify fellowship opportunities to support their research. The preparation of appli-
cations for postdoctoral fellowships is an integral part of the postdoctoral experience. Besides poten-
tially providing financial support, the postdoctoral fellowship application is an outstanding mechanism
for postdoctoral fellows and their mentors to become actively engaged in defining a research program
that will lead to a successful postdoctoral research experience. There are a myriad of postdoctoral fel-
lowship opportunities that are appropriate for different fellows. By developing-and now maintaining-
a coherent and well-organized database, Alyson has greatly enhanced the ability and ease with which
new postdoctoral fellows can identify potential fellowship opportunities. Such efforts will help the
Laboratory finance its research program.
For me, one of the most exciting aspects of the establishment of the Watson School has been how
its doctoral program can take advantage of all the diverse elements of Cold Spring Harbor Laboratory.
This aspect has now extended to the postdoctoral program. One of the recent efforts of the Cold
Spring Harbor Laboratory Press has been in the realm of publishing books that deal with the practical
aspects of doing science. Thus, in collaboration with the author Kathy Barker, the Laboratory Press has
produced two books-At the Bench and At the Helm-that deal with how to do research at the bench
and how to lead a research laboratory. The Postdoctoral Program has taken advantage of this effort by
providing, with financial support from the Laboratory President Bruce Stillman, each postdoctoral fel-
low at the Laboratory with a copy of these two books. Additionally, Alyson Kass Eisler was able to get
Kathy Barker herself to present a seminar entitled "Lessons from labheads: Making your lab work for
you," which covered aspects of directing a research laboratory. Such efforts greatly aid the future suc-
cess of the Laboratory's postdoctoral fellows.
Perhaps most important to postdoctoral fellows is developing the wherewithal to obtain a job after
the postdoctoral experience. With this in mind, the Postdoctoral Program Office sponsored a workshop
on the mechanisms of obtaining a research grant. Thus, Adrian Krainer and Grants Department
Director Susan Schultz described how a research grant, especially one submitted to the National
Institutes of Health, is reviewed and funded. By emphasizing the mechanics of how grants are
reviewed, it was also possible to describe how to best prepare the written document.
Alyson also had the idea to arrange a very interesting series of get-togethers in the spring for post-
docs to share their experiences in searching for jobs. There is no better to way to learn but to hear from
those who have firsthand experience. Obtaining a job as a research leader, particularly an academic
position, requires a diverse set of talents from presenting an interesting research seminar, to engaging
interviewing faculty during one-on-one discussions, to negotiating an offer. By sharing experiences,
postdoctoral fellows who had been on the "job circuit" could pass along their acquired expertise. What
is so special to me about this aspect of the newly developed postdoctoral program is that by simply
getting people together to share their acquired knowledge, we are able to enhance the postdoctoral
experience at the Laboratory.
This year, Alyson helped me inaugurate a new custom in the Watson School. Now, about three
times a year, I invite new postdoctoral arrivals to join me for tea to discuss the postdoctoral experience
at the Laboratory. At these teas, I get to describe my own experience as a postdoctoral fellow at the
Laboratory-some 20 years ago! -and how to take advantage of all the very special resources of the
Laboratory, from the Meetings and Courses to the Blackford Bar! These teas also provide an opportu-
nity for the new postdocs to identify their colleagues who are also recent arrivals, colleagues with whom
they can share their experiences as they progress as postdoctoral fellows at the Laboratory. And I like-
wise get to know members of the largest segment of the Laboratory's research community. In this vein,
I was very pleased that Bruce Stillman could continue having his annual meeting with all of the post-
doctoral fellows at the Laboratory in the fall. These annual meetings provide postdoctoral fellows with
an opportunity to influence the direction of the Laboratory. Indeed, the Postdoctoral Program Office has
its origins in early postdoctoral meetings between Bruce Stillman and postdoctoral fellows.
These are good beginnings, but the Laboratory needs to develop a more coherent postdoctoral
training program. With this concern in mind, a second postdoctoral working group was established
this year to recommend the structure of a comprehensive postdoctoral training program. I was very
pleased to recruit a strong group of faculty, postdoctoral fellows, and Watson School staff for the
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NEW STUDENTS FROM SHARED STONY BROOK UNIVERSITY GRADUATE PROGRAMS
Student CSHL Research Mentor Program
Kasandra Burgos Hollis Cline Genetics
Pei-Chun Lin Rui-Ming Xu Genetics
Christopher Maher Lincoln Stein Biomedical Engineering
Cristian Papazoglu-Statescu Winship Herr Genetics
Avi Z. Rosenberg Senthil Muthuswamy Genetics
Mar lies Rossmann Bruce Stillman Genetics
Dustin Schones Michael Zhang Physics
Despina Siolas Gregory Hannon Genetics
Aleksander Sobczyk Karel Svoboda Physics
Zankhana Thakkar Jacek Skowronski Molecular Genetics and Microbiology
Quan Wen Dmitri Chklovskii Physics
committee. In addition to me as chair, they include Lilian Gann and Alyson Kass-Eisler from the
Watson School, postdoctoral fellows Kurt Haas, Michael Hemann, Sarah Newey, Vatsala Thirumalai,
and Michael Weher, and faculty members Leemor Joshua-Tor, Adrian Krainer, Senthil Muthuswamy,
and Nicholas Tonks. The committee will present a series of recommendations to the Laboratory pres-
ident by summer 2004.
Interinstitutional Academic Interactions
Cold Spring Harbor Laboratory relies heavily on good interactions with neighboring academic institu-
tions, particularly Stony Brook University. To enhance these interactions, I hosted individual lunches
with Lawrence Martin, Dean of the Graduate School, and Peter Gergen, Todd Miller, and Michael
Frohman, who lead the Genetics, Molecular and Cellular Biology, and M.D./Ph.D. programs, respec-
tively. In addition to helpful discussions over lunch, these meetings also provide the program leaders
an opportunity to meet with their respective students.
It is important to always keep in mind that most of the graduate students studying at the Laboratory
are not Watson School students. Indeed, the largest percentage of students are from Stony Brook
University. It is therefore important to make sure that these students feel a part of the Laboratory com-
munity and to help them as much as possible with the difficulties of performing doctoral research away
from their parent institutions. This year, Lilian Gann and I held the first of what will become an annual
"How is it going?" meeting with the non-Watson School students to hear of any concerns. We had an
open and frank discussion that Lilian and I found most helpful.
New York Academy of Sciences Alliance
In spring 2003, again at the generosity of the Laboratory's president Bruce Stillman, all graduate stu-
dents and postdoctoral fellows at the Laboratory were enrolled in a new initiative of the New York
Academy of Science, the Science Alliance. The Science Alliance for graduate students and postdoc-
toral fellows is a consortium of 14 universities, teaching hospitals, and independent research facilities
in the New York City metro area that have formed a partnership with the New York Academy of
Sciences. Through the Alliance, each institution sponsors Academy membership dues for all of its first-
year graduate students and postdoctoral fellows. The aim of the Alliance is to provide career and pro-
fessional development mentoring for graduate students and postdoctoral fellows in the sciences and
engineering. Representatives from each of the participating institutions form a Steering Committee,
which helps shape and develop Alliance events, programs, and Web content. Cold Spring Harbor
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Laboratory's representatives are Zachary Lippman (graduate student) and Sarah Newey (postdoctoral
fellow).
Executive Committee
A large measure of the Watson School's success can be traced to the sage advice and guidance of
the School's Executive Committee. As the year came to a close, the Committee underwent some
important changes. In 2002, I stepped down as the Laboratory's assistant director. Up until that time,
I was able to wear two hats at the Executive Committee as both dean and assistant director.
Fortunately, my role as assistant director was filled by Hollis Cline, who was already a member of the
Executive Committee, so one hat only had to move around the table! This year, however, was the last
of Holly's two three-year terms. Rather than lose the very important input of the Director of Research,
the Executive Committee made the Director of Research an ex officio member of the Executive
Committee, beginning in 2004. I am very pleased that the School will continue to receive Holly's valued
input.
With the new year, the Executive Committee will lose a most valued member, David Helfman. David
Helfman was one of those faculty who was very engaged in the Watson School's inception, joining in
the original series of faculty teas at which the outlines of the Watson School were laid out. Throughout
it all, among many contributions, David emphasized the importance of training scholars. He was a
founding member of the Watson School's Executive Committee, and the School will sorely miss his
involvement in the Executive Committee discussions. At year's end, the Executive Committee was
pleased that W. Richard McCombie and Nicholas Tonks agreed to join the Committee as faculty mem-
bers starting in 2004.
As happens each year, there was also turnover among the student representatives. Watson School
representative Zachary Lippman was replaced by Catherine Cormier, and Stony Brook University rep-
resentative Sabrina Nunez was replaced by Marissa Moore. The School is indebted to their frank, hon-
est, and thoughtful advice.
External Advisory Committee
Since its inception in 1998, the Watson School has relied heavily on advice from the External Advisory
Committee (EAC). With the program reaching the time when it must begin having its students complete
their thesis work in earnest to meet the four-year goal, I was most pleased that when the EAC, led by
Keith Yamamoto, came in May for a site visit, they left feeling that the Watson School was in its best
shape ever. Indeed, in pointing out that the Watson School is really showing itself, they mentioned that
they were impressed with the remarkable number of Watson School concepts that were working as if
"we knew all along that they would work!"
New Staff
The Watson School staff continued to evolve. This year, Janet Duffy, the founding Admissions and
Academic Records Administrator, left the School to join the Facilities Department as Housing Manager.
Although Janet left the School, in her important new role, she will still greatly aid the School by helping
the graduate students and postdoctoral fellows with housing.
With Janet's departure, the Watson School recruited Dawn Meehan as the new Admissions and
Curriculum Administrator. Dawn arrived with considerable experience in student recruitment. A gradu-
ate of Milton Academy and Wellesley College in Massachusetts, she spent time at both places in the
admissions programs and with student recruitment. Thus, with Dawn's arrival, the School acquired
firsthand experience from well-established academic institutions in the art of recruiting students. I have
no doubt that Dawn will have a large impact on the success of the School by leading the effort to attract
the very best students from across the nation and around the world to the School.
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New Arrival
The Watson School had another "first" this year. One of its students,
Zachary Lippman, was the first to have a child while enrolled in the
School. His wife Shira gave birth to a lovely daughter, Nava Esther, on
August 1, weighing in at 8 lb. 7 oz. Congratulations!
The Watson School Continues to Benefit from Generous
Benefactors
The Watson School has been fortunate to be the beneficiary of many
generous benefactors who have provided support to the School's
endowment for student, faculty, and administrative support. The School
was particularly pleased this year to learn of Curt Engelhorn's continu-
ing support of the Engelhorn Scholars Program with the appointment of Monica Dus, a 2003 Entering
Class student who was born and raised in Italy. The Engelhorn Scholarships support European stu-
dents in the Watson School and are essential to maintaining an exciting international student body in
the Watson School.
I was most pleased to host Mr. Engelhorn and his daughter Caro lin for a visit to Cold Spring Harbor
Laboratory this fall, with the help of Vice President for Institutional Advancement Rod Miller. During the
visit, Mr. and Ms. Engelhorn had an opportunity to meet four of the five Engelhorn Scholars, Monica,
Darren Burgess, Rebecca Ewald, and Tomat Hromadka (unfortunately, the fifth Engelhorn Scholar,
Elena Ezhkova, could not participate because she was stuck in Russia for four months waiting for
renewal of her U.S. student visa!). We all greatly enjoyed the occasion.
Nava Esther Lippman
WSBS Staff: (Left to right) M. Beavers, A. Kass-Eisler, D. Meehan, L. Gann, W. Herr
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Dean Herr's 50th Birthday Celebration.
The Watson School has also benefited from the continued efforts of the Laboratory Trustees, par-
ticularly Robert Lindsay, who, having taken over from David Luke last year, is leading the second phase
of the Watson School Campaign. To lay the groundwork for the second phase, Robert Lindsay host-
ed a series of dinners at the Links Club in Manhattan to introduce the Watson School to potential bene-
factors. I found the dinners most enjoyable as they offered benefactors an opportunity to meet students
and faculty and to learn about what an exciting enterprise the Watson School is. All these development
efforts were spearheaded and greatly aided by the efforts of Rod Miller and his staff, for which the
School is indebted.
As we progress from one day to the next, dealing with each day one at a time, it is sometimes dif-
ficult to realize how much is actually accomplished in a year. Each year, preparing this report offers me
an opportunity to reflect on the year's accomplishments. I very much hope that the readers of this
report will agree that the Watson School continues to be an exciting adventure that is breaking new
ground in doctoral education in the biological sciences. It is an adventure that is succeeding owing to
the efforts of the faculty, students, administration, and the entire Cold Spring Harbor Laboratory insti-
tution and its friends. The upcoming inaugural graduation on April 25, 2004 will be a most special occa-
sion to celebrate all these efforts.
Winship Herr
Dean
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SPRING CURRICULUM
TOPICS IN BIOLOGY
ARRANGED BY Lilian Gann
Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship; The David Pall Visiting Lectureship;
The Fairchild Martindale Visiting Lectureship; The Lucy and Mark Ptashne Visiting
Lectureship; The Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer seven-day courses at the Banbury Conference
Center to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory facul-
ty. These courses include morning or evening lectures as well as afternoon sessions during which stu-
dents read assigned papers. These intensive courses are modeled on the Cold Spring Harbor
Laboratory Lecture Courses held each summer at the Banbury Conference Center. In spring 2003,
there were two such courses: Evolution and Animal Behavior.
Evolution
Attended by the entering classes of 2001 and 2002
INSTRUCTOR Nipam Patel, University of Chicago
GUEST LECTURERS Rob De Salle, American Museum of Natural History
Neil Shubin, University of Chicago
Michael Palopoli, Bowdoin College
TEACHING FELLOWS
Danielle Liubicich, University of Chicago
Marcus Davis, University of Chicago
Left to right: Gowan Tervo, Charles Kopec, Claudia Feierstein, Allison Blum, Casey Bergman, Shu-Ling Chiu,
Jonathan Kul, Elizabeth Murchison, Catherine Cormier, Tomg Hromadka, Danielle Liubicich, Marcus Davis,
Darren Burgess, Nipam Patel, Beth Chen
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The field of evolutionary biology touches upon all other areas of the biological sciences, since every
form of life and every biological process represents an ongoing evolutionary "experiment." The aim of
this course was both to discuss our understanding of the mechanisms of evolution and to explore how
evolutionary data can be used to further our understanding of various biological problems.
The course ran from Sunday to Saturday, April 6-12, and was organized and largely taught by
Nipam Patel. Three guests-Rob De Salle, Neil Shubin, and Michael Palopoli-also lectured in the
course, and three teaching fellows participated in all aspects of the course. As in previous years, the
course was highly rated by all of the students
Animal Behavior
Attended by the entering classes of 1999 and 2000
INSTRUCTOR H. Kern Reeve, Cornell University
In this course, strong emphasis was placed on developing an understanding of the general principles
governing the evolution of animal behavior, with particular emphasis on animal social behavior. The
behavior of both vertebrate and invertebrate taxa was analyzed within this theoretical framework.
Topics included group and individual-level selection, the units of behavioral selection, the evolution of
sex, sexual selection (including intrasexual and intersexual competition), mating systems, kin selection
and nepotism, game theory, reciprocity, communication, cooperative breeding and eusociality, repro-
ductive skew within societies, and principles of cooperation and conflict between and within organisms.
The course ran from Sunday to Saturday, May 4-10 and was organized and solely taught by H. Kern
Reeve. Once again, the course was highly rated by the students, many of whom had little prior aware-
ness of the subject.
Left to right: H. Kern Reeve, Elizabeth Thomas, Zachary Lippman, Ahmet Den li, Elena Ezhkova, Santanu
Chakraborty, Michelle Cilia, Ira Hall, Rebecca Ewald, Marco Mangone, Masafumi Muratani, Emiliano Rial
Verde, Patrick Paddison, Niraj Tolia
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Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Mick los
INSTRUCTORS Scott Bronson
Jenny Eisenman
Trisha Maskiell
Amanda Mc Brien
As science has an increasing role in society, there is also an increasing need for biologists to educate
nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral program
offers its students unique teaching experiences through the Laboratory's Dolan DNA Learning Center,
where students teach laboratory courses to high school and middle school students. From these
teaching experiences, they learn how to communicate with nonbiologists and to inspire and educate
creative young minds. The teaching module entailed pairs of students teaching one morning or after-
noon a week for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors taught the
Watson School students the didactic process-it was not until the fifth week that the graduate stu-
dents taught on their own. At the end of the 12 weeks, the students were very excited about their
teaching experience.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research that
leads to a unique contribution to human knowledge. After the fall course term, students participate in
laboratory rotations. These rotations provide students and faculty the opportunity to get to know each
other and to explore possibilities for doctoral thesis research. At the end of each rotation, students
make short presentations of their studies to the other students and their rotation advisors. These talks
give students an opportunity to share their laboratory experiences and to learn how to give a scientif-
ic presentation. With this latter goal in mind, in addition to the research mentors, the instructors of the
Scientific Exposition and Ethics core course attend the talks and give individual feedback to students
on their presentations. This year, 14 faculty members served as rotation mentors, some mentoring
more than one student.
ROTATION MENTORS
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Dmitri Chklovskii
Hollis Cline
Josh Dubnau
Shiv Grewal
Gregory Hannon
Eli Hatchwell
Leemor Joshua-Tor
Scott Lowe
Zachary Mainen
Senthil K. Muthuswamy
Maria Timmermans
Tim Tully
Linda Van Aelst
Anthony Zador
FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific
Reasoning and Logic
FUNDED IN PART BY The Beckman Foundation
INSTRUCTORS Gregory Hannon (Lead)
Hollis Cline
Winship Herr
Leemor Joshua-Tor
Senthil K. Muthuswamy
Arne Stenlund
GUEST LECTURERS Alexander A.F. Gann
Ira M. Hall
Nouria Hernandez
David Jackson
Adrian R. Krainer
Scott Lowe
Zachary Mainen
Robert Martienssen
VISITING LECTURER
Alea A. Mills
Michael P. Myers
Bruce Stillman
William Tansey
Marja Timmermans
Nicholas Tonks
Tim Tully
Michael Hengartner, University of Zurich
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the Fall Course curriculum, students (1) acquired a broad base of knowledge
in the biological sciences, (2) learned the scientific method, and (3) learned how to think critically about
biological concepts. This course consisted of 12 weekly segments, each of which had a different
theme. Each week, students read an assigned set of research articles (generally four articles) and pro-
vided written answers to a problem set that guided them through two (or, occasionally, one) of the arti-
cles. Twice weekly, students attended lectures related to the week's topic, which included concepts
and experimental methods. During the week, the students met to discuss the assigned papers not
covered by the problem set among themselves. At the end of each weekly segment, the students sub-
mitted their problem sets and spent the evening discussing with faculty the articles not covered by the
problem set. The course culminated in the 13th week with a final exam. Studying for the final exam
gave the students the opportunity to synthesize and integrate what they had learned over the course
of the fall term. The weekly topics were:
Week 1 Genetics Week 8 Mobile genetic elements
Week 2 Macromolecular Structure Week 9 Cancer genes
Week 3 Transcriptional regulation Week 10 Cell-cell communication
Week 4 Chromosome structure and function Week 11 Development
Week 5 Post-transcriptional regulation Week 12 Neurobiology
Week 6 Signal transduction Week 13 Final Exam
Week 7 Cell division cycle
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The Darrell Core Course on Scientific
Exposition and Ethics
FUNDED IN PART BY
INSTRUCTORS
The Beckman Foundation
The John P. and Rita M. Cleary Visiting Lectureship
The Seraph Foundation Visiting Lectureship
The Susan T. and Charles E. Harris Visiting Lectureship
William Tansey (Lead)
Adrian R. Krainer
Jan A. Witkowski
GUEST LECTURERS Terri Grodzicker
Winship Herr
VISITING LECTURERS Richard Burian, Ph.D.,Virginia Polytechnic Institute and State University
Robert P. Charrow, Esq., Greenberg Traurig LLP
John Doll, United States Patent and Trade Office
Richard Harris, National Public Radio
Philip Reilly, J.D., M.D., CEO of Interleukin Genetics
This core course offered instruction about the fundamental elements of scientific exposition-writing
skills and public speaking-and ethics. The ability to communicate effectively and to appreciate the
intricacies of ethical issues are essential skills for biologists; both subjects were taught in a series of
example-based lectures and discussion groups. This year, the course continued a novel format
established in 2000 in which the course was organized around the scientific process, starting with
how the ideas for an experiment develop and covering execution of the experiment, presentation of
the results at seminars and in publication, funding, and the implications of the experimental results on
scientists and society. As a part of learning how to make oral presentations, together with the instruc-
tors, the students also critiqued formal seminar presentations at the Laboratory. A primary objective
of the course was for students to consider exposition and ethics as an integral part of scientific
research.
Research Topics
ARRANGED BY Lilian Gann and Dawn Meehan
This core course provided students with an in-depth introduction to the fields of research that the
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics semi-
nar, at which faculty members presented their current research topics and methods of investiga-
tion each Wednesday evening over dinner. The students learned how to approach important prob-
lems in biology. These seminars, together with the annual fall Laboratory In-House symposium,
provided students with a basis for selecting laboratories in which to do rotations. The weekly
speakers were:
Week 1 Eli Hatchwell, W. Richard McCombie, Gregory Hannon
Week 2 Rui-Ming Xu, Linda Van Aelst, Dmitri Chklovskii
Week 3 Nouria Hernandez, William Tansey, Scott Lowe
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Week 4 Winship Herr, Senthil K. Muthuswamy
Week 5 Carlos Brody, Lincoln Stein, Michael Q. Zhang
Week 6 Grigori Enikolopov, Leemor Joshua-Tor, Michael P. Myers
Week 7 Zachary Mainen, Josh Dubnau, Roberto Malinow
Week 8 Partha Mitra, Alexei Koulakov, Anthony Zador, Nicholas Tonks
Week 9 Bruce Stillman, Arne Stenlund, Jacek Skowronski, Adrian R. Krainer
Week 10 Robert Martienssen, Hollis Cline, Andrew Neuwald
Week 11 Michael Wig ler, Alea Mills, Tatsuya Hirano
Week 12 David L. Spector, Masaaki Hamaguchi, Karel Svoboda
Week 13 David Jackson, Marja Timmermans, Robert Lucito
Week 14 Tim Tully, Yi Zhong, Z. Josh Huang
Week 15 Jerry Yin, Vivek Mittal, Yuri Lazebnik
SPECIALIZED DISCIPLINES COURSES
Cellular Structure and Function
FUNDED IN PART BY
INSTRUCTORS
GUEST LECTURERS
The Mary D. Lindsay Lectureship
The Sigi tiering Lectureship
The Martha F. Gerry Visiting Lectureship
David L. Spector
David Helfman
Linda Van Aelst
Tatsuya Hirano
Yuri Lazebnik
VISITING LECTURERS Fred Maxfield, Weill Medical College
Graham Warren, Yale University
With the complete set of instructions available for many organisms-i.e., their genome sequence-
there is now an increasing emphasis on understanding the function of the gene products. This under-
standing will require an increasing appreciation of the structure and function of the cell. This course
provided a basic overview of the structural and functional organization of cells with particular empha-
sis on cellular compartmentalization and communication. In addition, it provided insight into the basic
toolbox of the cell biologist of the twenty-first century.
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Genetics
FUNDED IN PART BY
INSTRUCTORS
The Edward H. and Martha F. Gerry Lectureship
The Pfizer Lectureship
The George B. Rathmann Lectureship
The Edward H. Gerry Visiting Lectureship
Tim Tully
Josh Dubnau
Lincoln Stein
VISITING LECTURER Bambos Kyriacou, University of Leicester, UK
The human genome sequence and continued advances in molecular biological techniques have initi-
ated a paradigm shift in the biological sciences, from phenomenological description to genetic per-
spective. Genes now can be manipulated in experiments, permitting interventionist studies of their
roles in various aspects of biological function. These experimental data were integrated "vertically" to
understand how causal models of gene function are inferred across various levels of biological organi-
zation and lead to molecular mechanisms. Data were also integrated "horizontally" to understand how
genetic pathways have been conserved evolutionarily as variations on a theme.
This course placed classical organismal genetics into the context of modern molecular biology
and genomics. History, perspective, and technique were described around four levels of analysis:
phenotype, genotype, variation, and genome. How do gene mutations disrupt phenotypic process-
es? How are complex traits genetically dissected into functional components? What concepts and
techniques are used to organize genes into pathways and networks? How are genes mapped,
cloned, and engineered to identify functional domains of proteins? What gene variation exists in nat-
ural populations? What are the functional consequences of gene variation? How are they detected?
How are genomes organized and coordinately regulated? How can genomic information be cata-
loged, organized, and mined? These questions and concepts were fleshed out using examples from
the literature.
Systems Neuroscience
FUNDED IN PART BY The George W. Cutting Lectureship
The Klingenstein Lectureship
The William Stamps Farrish Lectureship
INSTRUCTORS Zachary Mainen
Carlos D. Brody
Dmitri Chklovskii
GUEST LECTURERS Hollis Cline
Roberto Malinow
Anthony Zador
Cognition and behavior arise from complex interactions between billions of neurons. This systems neu-
roscience course examined fundamental properties of neurons, including synaptic transmission and
plasticity, and how in higher-order organization they give rise to brain functions such as visual percep-
tion.
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UNDERGRADUATE RESEARCH PROGRAM
Program Director: Leemor Joshua-Tor
Associate Program Director: Gregory Hannon
Program Administrator: Jane Reader
An important aspect of the summer program at the Laboratory is the participation of college under-
graduate students in active research projects under the supervision of full-time faculty members. The
program was initiated in 1959. Since that year, 629 students have participated in the course and many
have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental princi-
ples of biology; (2) an increased awareness of experimental approaches to science; (3) a deeper under-
standing of the major issues in the fields of biochemistry, genetics, molecular, cellular and structural
biology, neuroscience, and genomics; and (4) a personal acquaintance with research, research work-
ers, and centers for study.
During the program, the students are housed together on the Laboratory grounds. Nearly all of the stu-
dents arrive at the same time and share the entire experience. For programmatic reasons, we limit the
number of students to 25. In this manner, we ensure a cohesive program with substantial scientific and
Left to right: (Front row) Emily Anderson, Catherine Del Vecchio, Daniel Jones, Chris Brown, Shraddha Pai Jessica Cardenas-
Navia, Gabriel Orebi Gann, John McIntyre, Christine Wu, Maria Zhadina, Margaret Wat.
(Middle row) Nicholas Manicke, Jonathan Schneiderman, John Wallach, Peter Slomiany, Lieven van der Veken, Mollie Biewald,
Gediminas Luksys, Galen Collins, Keisha John, Michael Minder, Rafal Klajn.
(Back row) Henry Lin, Nina Marinsek. Missing: Rittik Chaudhuri.
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social interactions among the students. The students are required, at the beginning of the program, to present to their
peers a concise oral description of the background and the design of the experiments they will be performing. At the end
of the 10-week program, the undergraduates present a 20-30-minute seminar describing the background, design, and
results of their experiments during the course of a two-day undergraduate symposium. During their stay, the participants
attend a series of Faculty Talks given by both young and established scientists at the Laboratory. These seminars are
attended by only the students and Program Directors to assure that the seminars remain at a level appropriate for the
undergraduates. It also encourages questions in an informal and comfortable setting. In addition to scientific discussion,
these presentations cover important issues such as personal experiences and choices that led the scientists to their cur-
rent area of research and position. The following students, selected from 478 applicants, took part in the 2003 program:
Emily Anderson, Grinnell College
Advisor: Dick McCombie
Sponsor: National Science Foundation
Gene prediction: An assessment of tools.
Mollie Biewald, Columbia University
Advisor: Josh Dubnau
Sponsor: National Science Foundation
Oskar-GFP: In vivo imaging of RNA transport during memory.
Christopher Brown, Clemson University
Advisor: Rob Lucito
Sponsor: National Science Foundation
Detecting gene copy number changes in ovarian cancer.
Jessica Cardenas-Navia, Yale University
Advisor: Yuri Lazebnik
Sponsor: National Science Foundation
Development and implementation of a cell fusion tracking
assay.
Rittik Chaudhuri, Duke University
Advisor: David Jackson
Sponsor: National Science Foundation
Potential plasmodesmatal receptors and an associated traf-
ficking protein in Arabidopsis.
Galen Collins, Wabash College
Advisor: Marja Timmermans
Sponsor: Von Stade Foundation
Asymmetric leavesi: Regulation of stem cell differentiation.
Catherine Del Vecchio, Bowdoin College
Advisor: Bill Tansey
Sponsor: National Science Foundation
An investigation into mediator factor Med8 and its potential
role in ubiquitin-mediated proteolysis.
Gabriel Orebi Gann, Cambridge University
Advisor: Dmitri Chklovskii
Sponsor: Burroughs Wellcome
Connectivity and interaction strength of paired neurons.
Keisha John, University of Maryland
Advisor: Holly Cline
Sponsor: Bliss Fund
Localization of RNAi machinery.
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Daniel Jones, Pomona College
Advisor: Josh Huang
Sponsor: Jephson Educational Trust
Characterization of GABAergic interneuron connectivity in neo-
cortex.
Rafal Klajn, University of Warsaw
Advisor: Leemor Joshua-Tor
Sponsor: Read Fund
Towards the crystal structure of BPV protein E2.
Henry Lin, Harvard College
Advisor: Michael Zhang
Sponsor: Garfield Fund
Comparative genome analyses.
Gediminas Luksys, Intl. University Bremen
Advisor: Tony Zador
Sponsor: Glass Fund
Psychophysical approaches in solving the cocktail party problem.
Nicholas Manicke, University of Evansville
Advisor: Alea Mills
Sponsor: National Science Foundation
Investigating the role of p63 in the skin.
Nina Marinsek, Cambridge University
Advisor: Rob Martienssen
Sponsor: Libby Fund
Role of RNAi in chromatin modification and its interaction with
DNA methylation.
John McIntyre, National University Ireland
Advisor: Senthil Muthuswamy
Sponsor: Shakespeare Fund
Gene silencing and growth control in 3D epithelial cells.
C. Michael Minder, University of North Carolina
Advisor: Rui-Ming Xu
Sponsor: National Science Foundation
Exploring the axon junction complex.
Shraddha Pai, University of Waterloo
Advisor: Lincoln Stein
Sponsor: Olney Fund
Chemoreceptor genes in C. elegans and C. briggsae.
Jonathan Schneiderman, Tel Aviv University
Advisor: Greg Hannon
Sponsor: Burroughs Wellcome
A species at RISC: Characterizing the recruitment of small
interfering RNA in the RNAi pathway.
Peter Slomiany, Connecticut College
Advisor: Eli Hatchwell
Sponsor: Burroughs Wellcome
Mapping a microdeletion using a myriad of methods, including
microarrays and polymorphisms.
Lieven Van der Veken, Leuven Catholic University
Advisor: Linda Van Aelst
Sponsor: Emmanuel Ax Fund
Oligophrenin, a study of interactions.
John Wallach, Massachusetts Institute of Technology
Advisor: Karel Svoboda
Sponsor: Jephson Educational Trust
Role of neural actin-binding protein in dendritic spines mor-
phogenesis.
Margaret Wat, Duke University
Advisor: Masaaki Hamaguchi
Sponsor: Burroughs Wellcome
RNAi knockdown of DBC2.
Christine Wu, University of California, Berkeley
Advisor: Winship Herr
Sponsor: Jephson Educational Trust
Investigating the role of HCF-1 in mouse F9 cell differentia-
tion.
Maria Zhadina, Brandeis University
Advisor: David Helfman
Sponsor: Burroughs Wellcome
Characterization of p21 function in cell motility.
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PARTNERS FOR THE FUTURE
Program Director: Yuri Lazebnik
Program Administrator: Lynn Hardin
The Partners for the Future program, established in 1990, brings Long Island high school students into
Cold Spring Harbor laboratories and gives them a taste of the real world of biomedical research. The
program is open to all Long Island high school students entering their senior year; each high school
science chairperson may nominate three students from his or her school during their junior year. Twelve
student semi-finalists are interviewed by Laboratory scientists and the six or more winners go on to
spend a minimum of ten hours per week, September through March of their senior year, doing original
research under the watchful eye of a scientist mentor. At the conclusion, the winning students give oral
presentations of their research projects to an enthusiastic audience of the students' scientific mentors,
Lab administrators, parents, and teachers. While the students learn a great deal about molecular biol-
ogy and state-of-the-art research techniques, the main advantage of the program is in exposing the
students to day-to-day life in a working lab. Debunking the mythical scientist in a lab coat image, the
students are introduced to a world of relatively young scientists and their interactive support staff in a
relaxed, problem-solving atmosphere. The 2003-2004 Partners for the Future are:
Partner High School CSHL Mentor Laboratory
Jeremy Allen Roslyn High School Diane Esposito Mike Wigler
Marissa Anto St. Anthony's High School Frances Hannan Yi Zhong
Molly Fox Friends Academy Yalin Wang Yi Zhong
Matthew Golub Cold Spring Harbor High School Anindya Bagchi Alea Mills
Emily Greenberg Island Trees High School Masaaki Hamaguchi
Sean Mehra Jericho High School Eli Hatchwell
Melissa Teixeira Syosset High School Michael Regulski Tim Tully
(From left to right) Melissa Teixeira, Molly Fox, Matthew Golub, Emily Greenberg, and Sean Mehra. (Missing)
Marissa Anto and Jeremy Allen.
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NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to acquire
a greater knowledge and understanding of their environment. Through a series of specialized field cours-
es, younger students can engage in introductory programs such as Nature Bugs, Nature Detectives, and
Nature Discovery and older students can enroll in more advanced programs such as Marine Biology.
During the summer of 2003, 286 students participated in 26 courses within the program. The classes
were held outdoors, weather permitting, at the Southdown School. The Laboratory has equipped and main-
tains classroom and laboratory facilities at this location. It is used as a base for the students' exploration of
the local environment. Field classes are held on Laboratory grounds, St. John's Preserve, Fire Island National
Seashore, the Nature Conservancy, the Cold Spring Harbor
Fish Hatchery and Aquarium, as well as other local preserves
and sanctuaries.
In addition to the three, two-week sessions, the Adventure
Education course met on July 25, 2003, for a six-mile canoe trip
on the Nissequogue River in Smithtown to navigate and explore
the waters of Long Island. The course emphasizes the plant
and animal life indigenous to the area as well as historic points
of interest.
This year, we were able to bring back Nature Photography.
The course focuses on taking pictures out in the field as well as
in the studio and allow students to experiment with different
photographic techniques. A darkroom is set up for students to
develop and print their own black and white film.
PROGRAM DIRECTOR: William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR: Sharon Bense, Cold Spring Harbor Laboratory
INSTRUCTORS: Jessica Badalucco, B.S. in Biology, Ade 1phi University
Amy Friedank, B.S. in Marine Science, Long Island University, Southampton College
Jimmie Hamilton, Pratt Institute, Graphic Design/Photography
Ann Marie LaRuffa, B.A in Natural Science, Ade 1phi University
Michael Zarzicki, B.A. in English, Ade 1phi University
COURSES
Nature Bugs (Kindergarten): Exploration, games, stories, and dramatics are used to introduce the young child to the
variety of natural habitats.
Nature Detectives (Grades 1-2): An introductory course in nature study, stressing interrelationships between plants
and animals. A variety of habitats are explored.
Nature Discovery (Grades 1-2): Students continue their discovery of nature through activities and concepts.
Ecology Explorers (Grades 3-4): Natural communities, food webs, and the succession of communities are studied.
Students study the diversity of plant and animal forms native to the Cold Spring Harbor area.
Pebble Pups (Grades 3-4): Elementary geology for students interested in making a basic study of rocks and minerals
available on Long Island. Each student completes a rock and mineral collection. Dinosaurs and fossils are featured
themes. Some of the highlights of this course include field trips to local museums.
Frogs, Flippers, and Fins (Grades 3-4): Program designed for younger students as an introduction to aquatic ecosys-
tems. Fresh water and marine habitats are explored.
Seashore Life (Grades 5-7): Children examine plant and animal life found below the tidemark. Fish, marine worms,
algae, shellfish, beach plants, and shore birds are studied.
Freshwater Life (Grades 5-7): Study of the vertebrate, invertebrate, and plant life found in area bogs, ponds, lakes,
and streams.
Nature Photography (Grades 5-7): Students take pictures and use the darkroom to learn techniques of printing and
developing. Photographic techniques relating to nature photography are emphasized.
Adventure Education (Grade 6-10): This course is a six-mile canoe trip up and down the Nissequogue River explor-
ing the flora and fauna of the waterway.
Marine Biology (grades 8-10): This course offers a more sophisticated study of plants and animals native to the inner
and outer harbors and provides field trips, dissection, use of the microscope, and laboratory experiments.
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ACADEMIC AFFAIRS
The academic program of meetings and courses represents a diversified year-round effort. It includes
advanced laboratory courses; summer lecture and workshop courses held at the Laboratory's Banbury
Center; large meetings and winter biotechnology conferences held in Grace Auditorium; and short
bioinformatics courses that take place at the Woodbury campus. Scientists attending these events
range from graduate students and postdoctoral fellows to senior faculty.
In 2003, 27 laboratory and lecture courses were held. These covered a diverse array of topics in
molecular biology, neurobiology, structural studies, and bioinformatics. The primary aim of the courses
remains to teach students the latest advances in technologies and concepts that can be immediately
applied to their own research. Courses are always being evaluated and updated to include the latest
concepts and approaches. For example, the course on Advanced Techniques in Molecular
Neuroscience (formerly Advanced Cloning of Neural Genes) has taken advantage of sophisticated in
vivo methods to affect and analyze gene function in neural cells. The course proved to be immensely
popular and was heavily oversubscribed. In plant molecular biology, Arabidopsis has become an
extremely useful model system. However, application of molecular genetic techniques to other plant
systems has produced much valuable information. Thus, the Arabidopsis Molecular Genetics course
has added significant work on other plants and will continue to emphasize this new direction.
Instructors, course assistants, and course lecturers come from universities, medical schools,
research institutes, and companies around the world to teach at Cold Spring Harbor. Their excellence
and dedication make the course program work so well. The full program of 2003 courses and instruc-
tors follows this report.
Grants from a variety of sources support the courses, including multiple awards from the National
Institutes of Health and the National Science Foundation. We also have a valuable large education grant
from the Howard Hughes Medical Institute for the support of neurobiology courses and new courses,
as well as a neurobiology course grant from the Esther and Joseph A. Klingenstein Foundation. The
courses also depend on equipment and reagents that are loaned or donated by a large number of
companies. These are invaluable for making it possible to keep up with the latest technologies.
The Laboratory held 19 meetings this year, which brought together more than 6000 scientists from
around the world to discuss their latest research. A prime feature of the meetings is that there are very
few invited speakers. Meetings organizers select talks from abstracts that are submitted. This format
ensures that the latest findings will be presented and that young scientists will have the chance to
describe their work.
The meeting season started with a special conference on The Biology of DNA, held to celebrate the
50th anniversary of the double helix. As often happens, many meetings were oversubscribed. These
included Retroviruses and Mechanisms of Eukaryotic Transcription as well as the annual Symposium,
which was held on the topic of The Genome of Homo sapiens. Many of the meetings have become
essential for those in the field and are held on a biannual basis. Partial support for individual meetings
is provided by grants from the National Institutes of Health, National Science Foundation, Department
of Energy, foundations, and companies. Core support for the meetings program is provided by the
Laboratory's Corporate Benefactors, Sponsors, Affiliates, and Contributors.
The Symposium continues to be central to the meetings program. This year's meeting on The
Genome of Homo sapiens addressed many aspects of genome science and featured 79 talks and 178
poster presentations. Opening night speakers included Jane Rogers, David Page, David Botstein, and
David Cox, and Maynard Olson gave the summary. Clare Fraser presented the Reginald Harris lecture
on "Microbial Genome Sequencing: Insights into Physiology, Infectious Disease, and Evolution." Francis
Collins gave the Dorcas Cummings lecture on "The Human Genome Project: Where Do We Go from
Here?" to a mixed audience of scientists and lay friends and neighbors of the laboratory.
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The success of the very large number of meetings and courses is also due to the skilled work of
many Cold Spring staff and faculty who contribute their expertise, efforts, and good humor to the pro-
gram. Challenges in 2003 included the extra work associated with the 50th anniversary of the double
helix, the threat of SARS, and two meetings that coincided, respectively, with the great August black-
out and a major December snowstorm.
Terri Grodzicker
Assistant Director for Academic Affairs
David Stewart
Executive Director Meetings and Courses
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68TH COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
The Genome of Homo sapiens
May 28-June 2 536 participants
ARRANGED BY Jane Rogers, Wellcome Trust Sanger Institute
Edward Rubin, DOE Joint Genome Institute
Bruce Stillman, Cold Spring Harbor Laboratory
David Stewart, Cold Spring Harbor Laboratory
In the history of biology throughout most of the 20th century, the Cold Spring Harbor Symposia on
Quantitative Biology have served an almost unique purpose by every summer bringing together groups
of the world's leading scientists irrespective of race or nationality, to discuss and debate particular top-
ics at times when those fields are making rapid progress. At each Symposium, scientific advances in
the chosen field were celebrated not only among attending participants, but also through publication of
the conference proceedings, to a wider audience of researchers.
The 1986 Cold Spring Harbor Symposium on "Molecular Biology of Homo sapiens" witnessed the first
public discussion of the proposal to sequence the entire human genome and marked the start of the
global initiative leading to the current Human Genome Project. For 15 years since, genome scientists
have been gathering annually at Cold Spring Harbor for four days in early May to discuss progress in
mapping, sequencing, and analyzing genomic information. In 2001, after discussion with leading genome
scientists including Francis Collins, current head of the Human Genome Project, Cold Spring Harbor
Laboratory decided that in 2003 the annual genome meeting and the annual Symposium should be
merged into a single meeting. The 2003 Symposium was therefore chosen to focus on "The Genome of
Homo sapiens," aimed to coincide with the completion of the finished sequence of the human genome,
the spectacular culmination of a vast amount of work in major genome centers and countless laborato-
ries around the world. Furthermore, this Symposium also marked the 50th anniversary of the discovery
of the double-helical structure of DNA in 1953. While this anniversary was celebrated through multiple
events in the United States, the United Kingdom, France, and Australia, the Cold Spring Harbor
Symposium was almost unique in combining celebrations of that anniversary
together with the completion of the human genome.
The 2003 Cold Spring Harbor Symposium witnessed extraordinary
advances in the annotation of the human genome, providing revealing mol-
ecular insights about the origins of Homo sapiens, the structure and dynam-
ics of our genome, the global regulation of gene expression, and the under-
lying genetic component of many human diseases. Held over a six-day peri-
od at the beginning of June, the Symposium hosted 536 scientists from
more than 30 countries. Topics at the Symposium included The Human
Genome Sequence; Genome Structure; Genome Evolution; Comparative
Genomics and Human Evolution; Genetic Polymorphisms and Disease;
Functional Genomics and Proteomics; Co-Evolution of Human Pathogens;
and Bioinformatics.
The Symposium program included 80 oral presentations, including keynote
talks given by Jane Rogers, David Botstein, David Cox, David Page, and Claire
Fraser; a fascinating round-table panel discussion on Genes, Genomes, and
Society; as well as 180 posters in two sessions. The hour-long Dorcas
Cummings lecture to the meeting and the local community was given by
Francis Collins and attracted over 800 people in total. At the conclusion of the
Symposium, Maynard Olson of Washington University provided a masterly F. Collins, Dorcas Cummings Lecture
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Summary of the current state of the field (delivered to a spell-bound audience in near darkness because
of a power outage).
Essential funds to run this meeting were obtained from the National Genome Research Institute and
the National Cancer Institute (branches of the National Institutes of Health) and the U.S. Department of
Energy. In addition, financial help from the corporate benefactors, sponsors, affiliates, and contributors of
our meetings program is essential for these Symposia to remain a success and we are most grateful for
their continued support. Corporate Benefactors: Amgen, Inc.; Aventis Pharma AG; Bristol-Myers Squibb
Company; Eli Lilly and Company; GlaxoSmithKline; Novartis Pharma AG; Pfizer Inc. Corporate Sponsors:
Applied Biosystems; AstraZeneca; BioVentures, Inc.; Cogene BioTech Ventures, Ltd.; Diagnostic
Products Corporation; Forest Laboratories, Inc.; Genentech, Inc.; Hoffmann-La Roche Inc.; Johnson &
Johnson Pharmaceutical Research & Development, LLC; Kyowa Hakko Kogyo Co., Ltd.; Lexicon
Genetics, Inc.; Merck Research Laboratories; New England BioLabs, Inc.; OSI Pharmaceuticals, Inc.; Pall
Corporation; Schering-Plough Research Institute; Wyeth Genetics Institute. Plant Corporate Associates:
Mead Westvaco Corporation; Monsanto Company; Pioneer Hi-Bred International, Inc. Corporate
Affiliates: Affymetrix, Inc. Corporate Contributors: Biogen, Inc.; ImmunoRx, Inc.; Key Gene. Foundations:
Albert B. Sabin Vaccine Institute, Inc.
B. Vincent, P. Callisan, J. Myers
P. Good, G. Rubin
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J. Bertranpetit, D. Botstein
PROGRAM
Introduction
J.D. Watson, Cold Spring Harbor Laboratory
Human Genome Sequence
Chairperson: E. Ostrander, Fred Hutchinson Cancer Research
Center, Seattle, Washington
Genome Structure and Evolution
Chairperson: E. Lander, Whitehead Institute/MIT Center for
Genome Research, Cambridge, Massachusetts
Genomics of Nonhuman Species
Chairperson: E. Rubin, Joint Genome Institute, Berkeley
California
Forum on Genes, Genomes, and Society
Chairperson: J. Witkowski, Cold Spring Harbor Laboratory
Reginald G. Harris Lecture: Bioinformatics/Genome
Annotation
Chairperson: J. Rogers, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Human Genetic Variation
Chairperson: R. Gibbs, Baylor College of Medicine, Houston,
Texas
Of Microbes and Men
Chairperson: E. Green, NHGRI, National Institutes of Health,
Bethesda, Maryland
Comparative Functional Genomics
Chairperson: L. Stubbs, Lawrence Livermore National
Laboratory California
Genetic Variation and Disease
Chairperson: K. Frazer, Perlegen Sciences, Mountain View,
California
Comparing Genomes
Chairperson: R. Waterston, Washington University School of
Medicine, St. Louis, Missouri
Dorcas Cummings Lecture: The Human Genome Project:
Where Do We Go from Here?
Speaker: Francis Collins, National Human Genome Research
Institute
Human Evolution
Chairperson: A. Chakravarti, Johns Hopkins University School
of Medicine, Baltimore, Maryland
Genome Biology
Chairperson: S. Lewis, University of California, Berkeley
Summary
Maynard Olson, University of Washington, Seattle
E. Lander, F. Collins, J. Watson
R. Waterston, L. Hood, B. Stillman
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MEETINGS
The Biology of DNA
February 26-March 2 310 participants
ARRANGED BY David Stewart, Cold Spring Harbor Laboratory
Jan Witkowski, Cold Spring Harbor Laboratory
The Double Helix 50th Anniversary celebration at Cold Spring Harbor Laboratory took the form of a four-
day scientific conference, "The Biology of DNA," that highlighted the past, present, and future of DNA sci-
ence. The meeting opened with introductory remarks from Jan Witkowski, followed by Bruce Stillman's
introduction of Francis Crick's taped remarks on the excitement surrounding the double helix discovery.
2002 Nobel laureate Sydney Brenner spoke after Francis, explaining why the DNA structure revo-
lutionized biology. According to Sydney, it was not the double helix itself, but its immediate implications
that made-and still make-the structure so important. These implications were examined throughout
the course of the meeting including 1959 Nobel laureate Arthur Kornberg's talk on how DNA might be
replicated; 1968 Nobel laureate Marshall Nirenberg's thoughts on how protein sequences are encod-
ed by DNA sequences, how genes are shuffled during sexual reproduction, how mutations occur and
are corrected, how the large-scale structure of DNA impacts its function, human evolution, and even
the origin of life. 1980 Nobel laureate Walter Gilbert, Sir Alec Jeffreys, Eric Lander, and Francis Collins
were also on hand to offer choice comments from their perspectives.
Overall, "The Biology of DNA" was an inspiring celebration of the overwhelmingly positive outcomes
for humanity and human health that have stemmed from Watson and Crick's discovery 50 years ago
and will reverberate for at least another 50. The meeting is available as a video archive at w\m/v.
cshl.edu/leadingstrand/.
Major sponsorship for this meeting was provided by Biogen, Inc. and Virgin Atlantic Airways.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate
Associates, Corporate Contributors, and Foundations also provided core support for this meeting.
P. Schimmel, P. Sharp, H. Smith
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Introduction
B. Stillman, Cold Spring Harbor Laboratory
Replication
Chairpersons: B. Alberts, National Academy of Sciences,
Washington, D.C.; T. Grodzicker, Cold Spring Harbor
Laboratory
Topology and Chromosome Dynamics
Chairperson: A.-M. Skalka, Fox Chase Cancer Center,
Philadelphia, Pennsylvania
Discussion: Biologists' Responsibilities in a Time of Crisis
Chairperson: M. Meselson, Harvard University Cambridge,
Massachusetts
Recombination
Chairpersons: A. Pardee, Dana-Farber Cancer Institute,
Boston, Massachusetts; A. Chakravarti, Johns Hopkins
Hospital, Baltimore, Maryland
Mutagenesis and Repair
Chairperson: M. Radman, INSERM, Paris, France
Genetic Code and the Origins of Life
Chairpersons: C. Debouck, GlaxoSmithKline, King of Prussia,
Pennsylvania; T. Caskey, Cogene Biotech Ventures,
Houston, Texas
Remarkable Things That Could Not Have Been Noticed
Chairpersons: F. Perler, New England Biolabs, Beverly Massa-
chusetts; N. Zinder, The Rockefeller University New York
Remarks
W. Szybalski, University of Wisconsin, Madison
DNA: A Genome-scale Perspective
Chairpersons: S. Lewis, University of California, Berkeley; H.
Smith, Celera Genomics, Rockville, Maryland
Closing Remarks
J.D. Watson, Cold Spring Harbor Laboratory
E. Witkin, E. Friedberg
N. Zinder, G. Walker, M. Capecchi D. Micklos, A. Jeffreys, M. Radman
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Systems Biology: Genomic Approaches to Transcriptional
Regulation
March 6-9 203 participants
ARRANGED BY Philip Benfey, Duke University
Susan Celniker, Lawrence Berkeley National Laboratory
Stephen Small, New York University
Michael Zhang, Cold Spring Harbor Laboratory
Deciphering the regulatory codes that control which genes are expressed in different cells is a major
challenge in the postgenomic era. This problem has been traditionally approached by experimental
biologists, who have identified several hundred DNA elements that exhibit enhancer and insulator activ-
ities. These elements contain specific binding sites for proteins that mediate or prevent transcriptional
activation. More recently, the completion of several genome sequences and compilations of genome-
wide expression data have spawned a series of computational approaches aimed at solving this prob-
lem. This meeting focused on recent advances from both approaches, and provided a forum for cross-
disciplinary interactions. Sessions outlined recent progress in understanding DNA-protein interactions
and new computational approaches for predicting functional motifs in genomic sequences. Other ses-
sions were dedicated to mining regulatory information by examining the regulatory regions of coex-
pressed genes or by analyzing sequence conservation between evolutionary taxa. A final session on
emerging techniques closed the meeting. It was clear that rapid progress has been made in the last
few years and that further interactions between experimental and computational biologists will speed
our understanding of the genome-wide mechanisms that control gene expression. A planning session
was held, and a steering committee was appointed to foster similar interactions in the future.
This meeting was funded in part by the National Science Foundation. Contributions from our
Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core support for this meeting.
M. Candy, V. lyer
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Keynote Address: Global Analysis of Conserved Genetic
Pathways and Molecular Machines
S. Kim, Stanford University Medical Center, California
TF-DNA Interactions
Chairpersons: S. Small, New York University New York; M.
Levine, University of California, Berkeley
Computational Approaches to Identifying CREs I
Chairpersons: M. Eisen, Lawrence Berkeley National
Laboratory, California; G. Stormo, Washington University
School of Medicine, St. Louis, Missouri
R. Weinzierl, M. Frith
Comparative Genomics
Chairpersons: S. Celniker, Lawrence Berkeley National
Laboratory California; E. Rubin, DOE Joint Genome Institute,
Berkeley, California
Computational Approaches to Identifying CREs II
Chairpersons: M. Zhang, Cold Spring Harbor Laboratory; E.
Siggia, The Rockefeller University, New York
Transcriptional Network Modeling
Chairpersons: E. Davidson, California Institute of Technology
Pasadena; S. Leibler, The Rockefeller University, New York
Emerging Technologies
Chairpersons: P Benfey, Duke University Durham, North
Carolina; S. Kim, Stanford University Medical Center,
California
E. Davidson, R. Young
B. Arnow, F. Sladek
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Vector Targeting Strategies for Gene Therapy
March 20-23 102 participants
ARRANGED BY David T. Curie!, University of Alabama, Birmingham
Wayne Marasco, Dana Farber Cancer Institute
Stephen Russell, Mayo Foundation
The paramount requirement for advancement of gene therapy is the development of vector systems
possessing the capacities for efficient and cell-specific gene delivery. The achievement of these goals
requires the vector system to recognize specific cell signatures. In the first regard, both nonviral and
viral vectors have been engineered to address this goal. Furthermore, a variety of high-throughput
methods have been advanced for identification of cell-specific markers. Investigators at this meeting
provided an update of key technologies relevant to these goals. Since the last conference in 2001,
progress has been noted in this field. Especially noteworthy was the progress achieved in the content
of viral vector tropism modifications, targeted gene knockout and imaging technologies. This progress
includes the proposed translation of novel, advanced generation vectors into the human clinical con-
text. Additionally, the means to make targeted vectors available for clinical investigators remains a chal-
lenge. Future work will be required to define the range of cell-specific signatures of relevance in the
clinical context. Nonetheless, the linkage of these relevant technologies-target definition, vector tar-
geting, and imaging-is already yielding important advances in outcomes achievable via gene therapy
methods.
This meeting was funded in part by Cell Genesys; Genzyme; Directgene, Inc.; Lexigen; Onyx
Pharmaceuticals; Vector Logics, Inc., and VirRx, Inc. Contributions from our Corporate Benefactors,
Corporate Sponsors, Plant Corporate Associates, Corporate Associates, Corporate Contributors, and
Foundations also provided core support for this meeting.
W. Marasco, T. Trischl
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Introduction
Chairperson: D. Curiel, University of Alabama, Birmingham
Keynote Speakers
I. Weissman, Stanford University School of Medicine,
California; E. Ruoslahti, Burnham Institute, La Jolla,
California
Target Definition/S1 RNA
Chairpersons: J. Marks, University of California, San
Francisco; G. Hannon, Cold Spring Harbor Laboratory
Vascular Targeting
Chairperson: S. Russell, Mayo Foundation, Rochester,
Minnesota
Transcriptional Targeting/Nonviral Vectors
Chairpersons: M. Yamamoto, University of Alabama,
Birmingham; P. Scaria, lntradigm Corporation, Rockville,
Maryland
RNA Viruses
Chairperson: W. Marasco, Dana-Farber Cancer Institute,
Boston, Massachusetts
Adenoviruses
Chairperson: D. Curiel, University of Alabama, Birmingham
Imaging
Chairperson: S. Gambhir, University of California, Los
Angeles
Cellular Vehicles/AAV
Chairpersons: R. Vile, Mayo Clinic, Rochester; M. Hallek,
University of Munich, Germany
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Learning and Memory
April 9-13 150 participants
ARRANGED BY John Byrne, University of Texas, Houston Medical School
Joseph LeDoux, New York University
Erin Schuman, California Institute of Technology
This year's meeting had a strong focus on the molecular mechanisms underlying plasticity. Two sessions
highlighted local control of plasticity at the synapse. In these sessions, topics such as synaptic tagging,
plasticity-dependent regulation of protein translation at the dendrite, and protein trafficking were discussed.
There was a particular emphasis on regulation of the mTOR translational pathway and the ubiquitin/pre-
oeasome protein degradation pathway at the dendrite. The LTP/LTD session was largely dominated by
presentations on the role of the ERK kinase and PI3 kinase signaling pathways in plasticity. In the Genetics
and Behavior Session, data were presented on the role of molecules such as the phosphatases PP2B (cal-
cineurin) and PP1, the NMDA receptor, and gastrin-releasing peptide (GRP) in learning and memory from
genetically manipulated mice. Analyses or the role of the rutabaga gene in memory in Drosophila was also
presented. A gene chip analysis of genes differentially expressed in the wild-type and mouse model of
Alzheimer's disease following a fear-conditioning paradigm was also presented. The molecular aspect of
the meeting finished up with a session on proteomics in which presentations introduced the technique and
its applicability to questions surrounding analysis of synaptic proteins. In this session, other aspects of pro-
tein regulation in Drosophila and Hermissenda were also presented. There were two more systems-level
sessions on consolidation and reconsolidation and on extinction. Presentations in the Consolidation/
Reconsolidation session discussed topics focusing on the similarity/dissimilarity of mechanisms underlying
the two phenomenona and investigated the role of different molecular pathways involved. Finally, in the
Extinction session, discussion focused on the neural mechanisms of extinction and the extent to which
they involve reversing the processes involved in acquisition. In addition, there was particular focus on
mechanisms of enhancing the extinction of fear responses as a therapeutic strategy for phobias and post-
traumatic stress syndrome.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, a
branch of the National Institutes of Health; and the National Science Foundation. Contributions from
our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core support for this meeting.
J. Dubnau, J. Byrne
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PROGRAM
Local Synaptic Control I
Chairperson: K. Martin, University of California, Los Angeles
Local Synaptic Control II
Chairperson: J. Byrne, University of Texas Medical School,
Houston
Genetics and Behavior
Chairperson: M. Mayford, Scripps Research Institute, La Jolla,
California
LTP/LTD
Chairperson: J. LeDoux, New York University
Proteomics and Other Aspects of Protein Regulation
Chairperson: S. Grant, University of Edinburgh, United
Kingdom
Consolidation and Reconsolidation
Chairperson: Y. Dudal, Weizmann Institute of Science,
Rehovot, Israel
Extinction and Other Dynamics of Learning
Chairperson: M. Mauk, University of Texas Medical School,
Houston
Hippocampus and Other Cortical Systems
Chairperson: M. Wilson, Massachusetts Institute of
Technology Cambridge
S. Grant, L. de Hoz, H. Husi
E. Klann, J.D. Sweatt
S. Cushman, Ellie
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The Ubiquitin Family
April 23-27 306 participants
ARRANGED BY Ray DeShaies, California Institute of Technology
Mark Hochstrasser, Yale University
Peter Howley, Harvard Medical School
This meeting represented a shift in emphasis from previous meetings in the series, formerly titled either
"Biology of Proteolysis" or "Proteolysis and Biological Control." The meeting focused on the central role
of ubiquitin and ubiquitin-like protein modifications in protein regulation and turnover. Research in the
area of proteolysis has expanded to the point where a more defined emphasis was needed, and stud-
ies on ubiquitin and related molecules have grown exponentially in the past few years, with many excit-
ing new findings.
The new meeting attracted more than 300 scientists who discussed the role of ubiquitin and ubiq-
uitin-like molecules in a variety of key cellular processes. These included chromatin structure and tran-
scription, cell cycle, signaling, apoptosis, endocytosis, membrane trafficking, and pathology. The
reported experimental systems ranged from yeast to humans, and the interests of speakers varied
from analysis of protein structure and enzymatic pathways to human cancer and neurodegenerative
diseases. Despite such diversity, the participants commented that the meeting was focused, informa-
tive, and exciting. In summary, The Ubiquitin Family meeting was a unifying forum that is helping us to
understand the key roles that ubiquitin and the related ubiquitin-like molecules have in cellular physiol-
ogy and disease.
This meeting was funded in part by the National Cancer Institute, the National Institute of Aging,
and the National Institute of Child Health and Human Development, branches of the National Institutes
of Health. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate
Associates, Corporate Associates, Corporate Contributors, and Foundations also provided core sup-
port for this meeting.
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PROGAM
Chromatin Structure, Transcription, DNA Repair
Chairpersons: M. Hochstrasser, Yale University New Haven,
Connecticut; W. Tansey, Cold Spring Harbor Laboratory
Ubiquitin Ligases and Deubiquitinating Enzymes
Chairpersons: K. Wilkinson, Emory University School of
Medicine, Atlanta, Georgia; A. Weissman, National Cancer
Institute, Frederick, Maryland
Ubiquitin and Ubiquitin-like Proteins
Chairpersons: F. Melchior, Max-Planck-Institute for
Biochemistry, Martinsried, Germany; C. Pickart, Johns
Hopkins University Baltimore, Maryland
Protein Quality Control
Chairpersons: T. Rapoport, Howard Hughes Medical Institute,
Harvard Medical School, Boston, Massachusetts; R.
Hampton, University of California, San Diego
Cell Cycle, Signaling, Apoptosis
Chairpersons: M. Kirschner, Harvard Medical School,
Boston, Massachusetts; T. Hunter, Salk Institute, La Jolla,
California
Endocytosis and Membrane Trafficking
Chairpersons: L. Hicke, Northwestern University Evanston,
Illinois; Y. Ohsumi, Okazaki National Research Institute,
Japan
Physiology and Disease
Chairpersons: H. Ploegh, Harvard Medical School, Boston,
Massachusetts; R. Kopito, Stanford University California
Proteasome
Chairpersons: T. Baker, Howard Hughes Medical Institute,
Massachusetts Institute of Technology Cambridge; D. Finley,
Harvard Medical School, Boston, Massachusetts
D. Schmidt, G. Moldovan, W. Piwko
J. Feng, B. Kuhlman
K. Yamoah, S. Israeli
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Telomeres and Telomerase
April 30-May 4 286 Participants
ARRANGED BY Titia de Lange, The Rockefeller University
Carol Greider, Johns Hopkins University School of Medicine
Vicki Lundblad, Baylor College of Medicine
The conference consisted of seven sessions of talks as well as three poster sessions. As in 1999 and
2001, the format chosen was to invite two chairs per session, who were either established scientists
in the field or new independent investigators who have already made their mark. Many session chairs
also gave a scientific (12 minutes) presentation. The rest of the presentations (mostly 12 minutes) were
chosen from submitted abstracts, allowing as many presentations as possible. These presentations
were given primarily by graduate students and postdoctoral fellows. Attendance exceeded 300 par-
ticipants, a high fraction of whom presented the 118 posters and 73 talks.
The talks and posters covered all aspects of telomere and telomerase biology, including telomerase
structure, enzymology, and regulation; telomere length regulation, protection, and processing of chro-
mosome ends; the consequences of telomere dysfunction; telomere dynamics in cancer; and telom-
erase-independent telomere maintenance.
The scientific content was very high throughout the conference in both the talks and the posters. A
large body of unpublished data was presented and extensively discussed in an open fashion. Formal
and informal discussions were lively and informative. The conference was judged to be highly suc-
cessful based on verbal and e-mail communications to the organizers. There is strong enthusiasm for
another meeting on the same topic in 2005.
This meeting was funded in part by the National Institute on Aging, and the National Institute of
Child Health and Human Development, branches of the National Institutes of Health. Contributions
from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate
Associates, Corporate Contributors, and Foundations also provided core support for this meeting.
C. Greider, P. Wellinger
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Telomerase Structure and Enzymology
Chairpersons: C. Greider, Johns Hopkins University School of
Medicine, Baltimore, Maryland; K. Freidman, Vanderbilt
University Nashville, Tennessee
Telomerase Recruitment and Regulation
Chairpersons: E. Blackburn, University of California, San
Francisco; A. Lustig, Tulane University Health Science
Center, New Orleans, Louisiana
Telomere Length Regulation
Chairpersons: S. Smith, New York University Medical Center;
V. Zakian, Princeton University New Jersey
End Protection and Resection
Chairpersons: D. Wuttke, University of Colorado, Boulder; V.
Lundblad, Baylor College of Medicine, Houston, Texas
T. de Lange,
J. Shay
Consequences of Telomere Dysfunction
Chairpersons: T. de Lange, The Rockefeller University New
York; S. Jackson, University of Cambridge, United Kingdom
Senescence and Cancer
Chairpersons: R. DePinho, Dana Farber Cancer Institute,
Boston, Massachusetts; R. Weinberg, Whitehead Institute
for Biomedical Research, Cambridge, Massachusetts
Telomere and Subtelomere Chromatin
Chairpersons: J. Shay, University of Texas Southwestern
Medical Center, Dallas; M. Blasco, National Centre of
Biotechnology Madrid, Spain
Telomerase-independent Telomere Maintenance
Chairpersons: R. Reddel, Children's Medical Research
Institute, Westmead, Australia; D. Broccoli, Fox Chase
Cancer Center; Philadelphia, Pennsylvania
G. Parkinson, D. Rhodes
E. Louis, V Zakian
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Genome Informatics
May 7-11 308 participants
ARRANGED BY Ewan Birney, European Bioinformatics Institute
Suzanna Lewis, University of California, Berkeley
Lincoln Stein, Cold Spring Harbor Laboratory
The third Cold Spring Harbor Laboratory-Wellcome Trust Conference on Genome Informatics contin-
ues to highlight the latest developments in genome research and, once again, was a vital and exciting
meeting, despite uncharacteristically rainy weather. This year, the conference was held for the first time
at Cold Spring Harbor Laboratory, a new venue that offered new perspectives. The meeting will now
be held here in upcoming alternating years. The conference followed a traditional format similar to tra-
ditional Cold Spring Harbor meetings, in that the majority of oral presentations were drawn from open-
ly submitted abstracts.
The explosion of biological data requires a concomitant increase in the scale and sophistication of
information technology. This ranges from the storage of data and their associated data models, to the
design of effective algorithms to uncover nonobvious aspects of these data sets, to ontologies to con-
cisely describe biological information, and finally to software systems to support curation, visualization,
and exploration. The conference brought together some of the leading scientists in this growing field,
and researchers from other large-scale information-handling disciplines were also invited to attend.
Topics included Comparative Genomics, Algorithms, Large-scale Genomics, Functional Genomics,
Proteomics, Databases, Knowledgebases, and Ontologies. In all, 308 participants attended, with more
than 27% of delegates coming from outside North America, a highly unusual statistic for a U.S. meet-
ing. The meeting hosted 158 scientific presentations in talks and posters.
This meeting was funded in part by the National Human Genome Research Institute, a branch of
the National Institutes of Health. Contributions from our Corporate Benefactors, Corporate Sponsors,
Plant Corporate Associates, Corporate Associates, Corporate Contributors, and Foundations also pro-
vided core support for this meeting.
M. Yandell, S. Lewis, R Carninici
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Keynote Address
W. Ford Doolittle, Dalhousie University, Halifax, Nova Scotia
Databases and Ontologies I
Chairpersons.' K. Buetow, NCI Center for Bioinformatics,
Bethesda, Maryland; M. Yandell, University of California,
Berkeley
Databases and Ontologies II
Chairpersons: K. Buetow, NCI Center for Bioinformatics,
Bethesda, Maryland; M. Yandell, University of California,
Berkeley
Proteomics
Chairpersons: S. Brenner, University of California, Berkeley;
H. Hermjakob, European Bioinformatics Institute, Hinxton,
United Kingdom
Comparative Genomics I
Chairpersons: E. Rivas, Washington University St. Louis,
Missouri; S. Jones, BC Genome Sciences Center,
Vancouver, Canada
Algorithms I
Chairpersons: R. Guigo, Institut Municipal d'Investigacio
Medica, Barcelona, Spain; G. Myers, University of
California, Berkeley
Functional Genomics I
Chairpersons: M. Eisen, Lawrence Berkeley National
Laboratory California; B.F.F. Ouellette, University of
British Columbia, Vancouver, Canada
Large-scale Genomics I
Chairpersons: E. Stupka, Institute of Molecular and Cell
Biology Singapore; J. Quackenbush, The Institute for
Genomic Research, Rockville, Maryland
Large-scale Genomics II
Chairpersons: E. Stupka, Institute of Molecular and Cell
Biology Singapore; J. Quackenbush, The Institute for
Genomic Research, Rockville, Maryland
Comparative Genomics II
Chairpersons: E. Rivas, Washington University St. Louis,
Missouri; S. Jones, BC Genome Sciences Center,
Vancouver; Canada
Algorithms II
Chairpersons: R. Guigo, Institut Municipal d'lnvestigacio
Medica, Barcelona, Spain; G. Myers, University of
California, Berkeley
Functional Genomics II
Chairpersons: M. Eisen, Lawrence Berkeley National
Laboratory California; B.F.F. Ouellette, University of
British Columbia, Vancouver, Canada
S. Morishita, A. Schlauersbach, D. Leyfer
L. Stein, M. Ayele, J. Wortman
S. Shah, F. Ouellette, B. Butler
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Protein Phosphorylation and Cell Signaling
May 14-18 228 Participants
ARRANGED BY Sara Courtneidge, Van And le Research Institute
Ben Neel, Beth Israel Deaconess Medical Center
Nicholas Tonks, Cold Spring Harbor Laboratory
This fifth Protein Phosphorylation and Cell Signaling meeting brought together 228 scientists from the
United States and abroad. Specifically focused on tyrosine phosphorylation in prior years, we expand-
ed this meeting to include the most current work on the structure, regulation, and function of all pro-
tein kinases and protein phosphatases in biology. The meeting began with two opening Keynote
Addresses by Elaine Fuchs and Phillip Sharp.
Elaine Fuchs reviewed the molecular mechanisms underlying the development and differentiation of
the mammalian skin epidermis and its appendages, and how these processes go awry in various
human diseases of the skin, including genetic diseases and skin cancer. Phillip Sharp reviewed
progress in the field of RNA interference, in which the introduction of homologous short double-strand-
ed RNA (dsRNA) specifically targets a gene's mature mRNA for destruction, thus creating a null or
hypomorphic mutation.
The format of the meeting was designed around areas of biological interest, rather than according
to particular enzymes or enzyme families. A major thrust within the pharmaceutical industry is to exploit
signal transduction pathways as sources of targets for novel therapeutic strategies. The launch of
Gleevec, an inhibitor of the p210 Bcr-Abl protein tyrosine kinase for the treatment of chronic myeloge-
nous leukemia, is a spectacular example of this trend. The program thus addressed the role of protein
phosphorylation in the regulation of signal transduction under normal and pathophysiologoical condi-
tions. In addition, we highlighted recent technical advances that are facilitating the discovery process
in the area of signal transduction, including the development of cell and animal model systems and
recent advances in RNA interference.
The program included scientists from the United States,
Europe, the Far East, and the South Pacific. Forty-nine speak-
ers were selected to present their data in sessions that dealt
with Receptor Signaling, Phosphorylation and Cancer, Signal
Transduction and Control of Proliferation, Cytoskeleton and Cell
Adhesion, Immune Cell Signaling, Cell Cycle and Phosphory-
lation and Disease. A variety of systems were described with
great progress reported in genetic and biochemical approaches
to the characterization of physiological functions for protein
phosphorylation. In particular, exciting insights were provided
into how signaling pathways may be abrogated in a variety of
human disease states and to the identity of novel targets for
therapeutic intervention. The meeting continues to be success-
ful and alternates with a conference with the same format at The
Salk Institute, with the result that there is an annual meeting on
"Tyrosine Phosphorylation" that alternates in venue between
Cold Spring Harbor and The Salk.
This meeting was funded in part by the National Cancer
Institute, a branch of the National Institutes of Health; and Cell
Signaling Technology, Inc. Contributions from our Corporate
Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Associates, Corporate Contributors, and Founda-
tions also provided core support for this meeting.
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Keynote Speakers
E. Fuchs, Howard Hughes Medical Institute/The Rockefeller
University, New York; P. Sharp, Massachusetts Institute of
Technology, Cambridge
Receptor Signaling
Chairperson: M. Park, McGill University, Montreal, Canada
Phosphorylation and Cancer
Chairperson: M. Birnbaum, Howard Hughes Medical
Institute/University of Pennsylvania, Philadelphia
Signal Transduction and Control of Proliferation
Chairperson: H. Piwnica-Worms, Howard Hughes Medical
Institute/Washington University St. Louis, Missouri
Cytoskeleton and Cell Adhesion
Chairperson: M. Frame, Beatson Institute for Cancer
Research, Glasgow, United Kingdom
Immune Cell Signaling
Chairperson: P. Schwartzberg, NHGRI, National Institutes of
Health, Bethesda, Maryland
Cell Cycle
Chairperson: J. Cooper, Fred Hutchinson Cancer Research
Center, Seattle, Washington
Phosphorylation and Disease
Chairperson: M. Tremblay, McGill University Montreal,
Canada
B. Datta, A. Catling
L.A. Garulacan, T. Kline, V. Lamian
W. Swiatek, E. Eide
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Retroviruses
May 20-25 420 participants
ARRANGED BY Suzanne Sandmeyer, University of California, Irvine
Wes Sundquist, University of Utah, Salt Lake City
This 28th annual Retroviruses meeting originated in 1975 as a meeting on RNA Tumor Viruses and
evolved to its current focus on Retroviruses in 1993. In our view, the 28th meeting was highly suc-
cessful and was enriched by two keynote talks. The first Keynote Speaker, Inder Verma, recounted the
history of retroviruses and gave a thoughtful discussion of their future as vehicles for gene manipula-
tion and gene therapy in his talk "From Reverse Transcriptase to Gene Therapy-A 30-year Journey."
The second keynote speaker, Stephen Goff, discussed exciting developments in the problem of iden-
tification of host functions that participate in retrovirus replication in his talk, "Beg, Borrow or Steal-
Exploitation of Host Factors in Retrovirus Replication." Both talks were very well received.
This meeting also included 315 platform and poster presentations, distributed into 13 scientific ses-
sions. Although the focus for many years has been on individual viral functions, the focus in this year's
meeting clearly shifted to the more complex role of the host in promoting and antagonizing different
stages of retroviral replication. This is now possible to study because some of the cellular genes that
affect retrovirus replication have been identified through high-throughput screening efforts in yeast and
mammalian cells. Presentations from retrovirus and retrotransposon laboratories described new host
factors involved in cellular trafficking and viral budding, viral RNA localization, viral DNA synthesis and
mutagenesis, and integrase localization and activity. Particularly exciting research areas included the
roles of endogenous viruses in host-species-specific restriction factors, evidence for a novel "lariat"
structure for the RNA template during reverse transcription of retrotransposons and retroviruses, and
the unveiling of the mechanism of the viral Vif protein and its cellular target, APOBEC15.
In other matters, the pattern of arranging posters alphabetically was continued this year, and two
poster sessions followed keynote talks in the evening (one occurred in the afternoon). We thought that
this format worked well and also got that feedback from others. The cuisine continues at the enjoyable
level noted for last year, which was particularly fortunate this year because it rained every day! Finally,
Tom Hope lightened the general atmosphere by handing out "It's the Cell" buttons to many attendees,
and then presenting a (pretend) digital tracking of their movements at the Sunday morning session.
W. Sundquist, S. Goff
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This certainly enlivened the session, but the Sunday morning session itself continues to be a bit of a
problem as it is difficult for people to stay on, get up, and/or be enthusiastic at this final session. Finally,
we very much appreciated the help and guidance of the CSHL staff, who made the meeting easy and
enjoyable to organize.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Associates, Corporate Contributors, and Foundations provided core support for this meeting.
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Packaging, Dimerization, and Translation
Chairpersons: R. Marquet, CNRS, Strasbourg, France; L.
Kleiman, Jewish General Hospital, Montreal, Canada
Assembly I
Chairpersons: J. Lingappa, University of Washington, Seattle;
H. Gott linger, Dana-Farber Cancer Institute, Boston,
Massachusetts
Assembly II
Chairpersons: W. Mothes, Yale University School of Medicine,
New Haven, Connecticut; M. Thali, University of Vermont,
Burlington
Envelope
Chairpersons: E. Stephens, University of Kansas Medical
Center, Kansas City; M. Roth, UMDNJ-Robert Wood
Johnson Medical School, Piscataway, New Jersey
Viral Entry
Chairpersons: J. Cunningham, Harvard Medical School,
Boston, Massachusetts; P. Cannon, University of Southern
California, Los Angeles
Keynote Speaker: From Reverse Transcriptase to Gene
Therapy-A 30-year Journey
Inder Verma, Salk Institute
Pathogenesis/Host Factors I
Chairpersons: A. Engelman, Dana-Farber Cancer Institute,
Boston, Massachusetts; F. Kirchhoff, Universitatsklinikum
Ulm, Germany
Pathogenesis/Host Factors II
Chairpersons: D. Trono, University of Geneva, Switzerland; M.
Palmarini, University of Georgia, Athens
Keynote Speaker: Beg, Borrow, or Steal-Exploitation of
Host Factors in Retrovirus Replication
Stephen Goff, Columbia University, New York
Reverse Transcription/Recombination
Chairpersons: V Pandey, UMDNJ-New Jersey Medical
School, Newark; K. Musier-Forsyth, University of Minnesota,
Minneapolis
Integration
Chairpersons: A.-M. Skalka, Fox Chase Cancer Center,
Philadelphia, Pennsylvania; G. Kalpana, Albert Einstein
College of Medicine, Bronx, New York
Transcription, RNA Export, and Processing
Chairpersons: T. Hope, University of Illinois, Chicago; A.
Telesnetsky, University of Michigan, Ann Arbor
L. Parent, J. Coffin
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Yeast Cell Biology
August 12-17 292 participants
ARRANGED BY Brenda Andrews, University of Toronto
Chris Kaiser, Massachusetts Institute of Technology
Mark Winey, University of Colorado, Boulder
This conference was the ninth biannual international meeting devoted to major aspects of cell biology
in yeast. It is unusual in that many important areas of cell biology are represented at a single meeting
organized around a simple eukaryotic organism, the budding yeast Saccharomyces cerevisiae. This
year's conference was extraordinary on two fronts. First, the opening session was a celebration of the
science of Ira Herskowitz. It began with outstanding retrospective talks by David Botstein and Jeff
Strathern on Ira's scientific contributions in the areas of phage genetics and yeast-cell-type determi-
nation (these talks are available for viewing on the "The Leading Strand" Web site). Those talks were
followed by research presentations from Herskowitz lab alumni who were attending the meeting. The
second extraordinary event was the blackout of 2003 that occurred at the end of an afternoon poster
session and continued through lunch the following day. The CSHL staff did an outstanding job of on-
the-fly reorganization and powering of Grace Auditorium with generators to keep the meeting moving.
Not a single presentation was cancelled, and the kitchen hustled to keep everyone fed.
A common interest in one organism, instead of one topic in cell biology, encourages extensive
cross-fertilization of ideas, insights, and methodologies, ultimately leading to a more integrated view of
eukaryotic cell structure and function. Important insights were further gained by studies in the fission
yeast Schizosaccharomyces pombe as well as other yeasts. Major areas of interest included the func-
tions of the actin and microtubule cytoskeleton, cell physiology, and the targeting and sorting of pro-
teins in the secretory, endocytotic, and nuclear localization pathways. The coordination of several cel-
lular processes was discussed in the context of the response to the mating pheromone, meiosis, and
the cell cycle, with the exit from mitosis being particularly important. Functional genomics, proteomics,
and bioinformatics have become a routine part of the yeast cell biologist's repertoire, and genome-wide
analysis was featured in many presentations. It is clear that yeast will remain at the forefront of model
systems for technology development and mechanistic advances in integrative cell biology for many
years. All told, this was once again a very rich, exciting, and memorable meeting with more than 290
scientists in attendance presenting some 235 scientific reports in 101 talks and 134 posters.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Associates, Corporate Contributors, and Foundations provided core support for this meeting.
B. Andrews, S. Jaspersen, D. Kellogg
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PROGRAM
A Celebration of the Science of Ira Herskowitz
Chairperson: D. Botstein, Princeton University New Jersey
Retrospective Talks
Chairpersons: D. Botstein, Princeton University' J. Strathern,
National Cancer Institute
Science Talks: Herskowitz Lab and Alumni
Organelle Biogenesis
Chairperson: L. Weisman, University of Iowa, Iowa City
Microtubules and Spindle Pole Bodies
Chairperson: V. Guacci, Fox Chase Cancer Center,
Philadelphia, Pennsylvania
Cell Cycle Regulation and Dynamics
Chairperson: M. Basrai, National Cancer Institute, Frederick,
Maryland
Intracellular Trafficking
Chairperson: C. Stirling, University of Manchester, United
Kingdom
Signaling Cascades, Stress Adaptation, and Cell Polarity
Chairperson: R. Miller, University of Rochester, New York
The Kinetochore
Chairperson: B. Goode, Brandeis University Waltham,
Massachusetts
Physiology and Cell Regulation
Chairperson: J. Thorner, University of California, Berkeley
Chromosomes and Functional Genomics
Chairperson: K. Kaplan, University of California, Davis
Actin Cytoskeleton
Chairperson: S. Lemmon, Case Western Reserve University
Cleveland, Ohio
G. Odorizzi, S. van Kreeveld, M. Winey
C. Stirling, M. Rose
Poster session
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Eukaroytic mRNA Processing
August 20-24 340 participants
ARRANGED BY Elisa Izaurralde, EMBL Heidelberg, Germany
Timothy Nilsen, Case Western Reserve University
Donald Rio, University of California, Berkeley
This fourth meeting focused on multiple aspects of mRNA metabolism including the mechanism of
splicing, the regulation of alternative splicing, the mechanisms of surveillance, transport, and localiza-
tion, RNA interference, 3'-end maturation, and decay. In addition, new insights into the coupling of
transcription and posttranscriptional processes were presented.
In splicing, proteomic analyses of spliceosomes arrested at different stages of the reaction revealed
that the spliceosome is much more dynamic than previously thought; conformational changes are
accompanied by the addition and departure of large numbers of proteins. Additionally, new analyses
now show that protein-free snRNAs can catalyze branching, strengthening the case that the spliceo-
some is fundamentally a ribozyme.
Several new experimental approaches including microarrays have been used to analyze alternative
splicing. Strikingly, specific introns display different dependencies on splicing factors for efficient exci-
sion. Overall, there were few unifying themes for the regulation of splicing; each case seems to be
unique and involve unique factors. There was considerable discussion of the relative contribution of
positive and negative sequence elements to alternative splicing.
The mechanism of RNA interference continues to be unraveled by both genetics and biochemistry;
interesting links between the initiation and effector steps were presented.
In terms of mRNA quality control, several presentations made it quite clear that the cell goes to
great lengths to eliminate defective mRNAs, in both the nucleus and cytoplasm. Whether nuclear sur-
veillance involves reading frame recognition is still a
matter of hot debate. It is now clear that the exon-junc-
tion complex left by the splicing has multiple roles in
mRNA quality control both in mediating NMD and in
enhancing translation.
The functional links between transcription and post-
transcriptional events received much attention. It now
seems clear that transcription rate can have profound
effects on both the pattern of splicing and the efficien-
cy of the 3'-end formation. A major theme was the inte-
gration of all the steps in gene expression.
Other presentations highlighted the impact of the
cells environment (e.g., stress) on RNA processing; a
factor that inhibits splicing during heat shock was iden-
tified, and the differential effect of amino acid starvation
of splicing of introns in yeast was revealed by array
analysis. Finally, several presentations illustrated the
power of informatic approaches in dissecting RNA pro-
cessing-related problems.
This meeting was funded in part by the National Cancer Institute and the National Institute of Child
Health and Human Development, branches of the National Institutes of Health; and by the National
Science Foundation. The Laboratory would, in addition, like to thank the RNA Society for its support
of this meeting. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate
Associates, Corporate Associates, Corporate Contributors, and Foundations also provided core sup-
port for this meeting.
E. Izaurralde
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PROGRAM
Capping-3"-end Formation-Polyadenylation
Chairperson: J. Manley, Columbia University, New York
Splicing Mechanism
Chairperson: R. Luhrmann, Max-Planck-Institute for
Biophysical Chemistry, GOttingen
RNA Trafficking and Localization
Chairperson: P. Silver, Dana Farber Cancer Institute, Boston,
Massachusetts
Regulation of Pre-mRNA Splicing I
Chairperson: J. Valcarcel, Center for Genomic Regulation,
Barcelona, Spain
mRNA Decay-mRNA Surveillance
Chairperson: D. Tollervey, University of Edinburgh, United
Kingdom
RNA Interference-regulated Splicing II
Chairperson: M. Moore, Howard Hughes Medical Institute,
Brandeis University Waltham, Massachusetts
Global Analysis of RNA Processings: Genomics,
Informatics, Evolution
Chairperson: A. Krainer, Cold Spring Harbor Laboratory
R. Singh, J. Valcarcel T. Kashima, F. Kleiman
A. Lingel, L. Unterholzner, G. Tanackovic
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Mechanisms of Eukaryotic Transcription
August 27-31 465 participants
ARRANGED BY Joan Conaway, Stowers Institute for Medical Research
Richard Treisman, CR-UK London Research Institute
Jerry L. Workman, Stowers Institute for Medical Research
The regulation of gene transcription has a central role in the growth and development of eukaryotic
organisms. Transcriptional responses occur as a consequence of cell signaling, environmental stress-
es, and developmental cues. Thus, the field of transcription encompasses a broad range of study from
structural biology to developmental biology. The meeting appropriately covered all aspects of tran-
scription and brought together a diverse group of scientists. It included eight plenary sessions and
three poster sessions and started with a session of the most recent detailed structures of RNA poly-
merase. Two sessions entitled Histone Modification and Chromatin Remodeling covered the role of
chromatin in transcription control. The remaining sessions covered the function of upstream transcrip-
tion activators, transcription complexes, coactivators, elongation, and transcription termination. The
final session discussed regulatory networks and mechanisms including genomic and proteomic analy-
ses.
This meeting was funded in part by the National Cancer Institute and the National Institute of Child
Health and Human Development, branches of the National Institutes of Health; and by the National
Science Foundation. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant
Corporate Associates, Corporate Associates, Corporate Contributors, and Foundations also provided
core support for this meeting.
D. Singer, J. Boss
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PROGRAM
Polymerase Structure and Mechanism
Chairperson: K. Yamamoto, University of California, San
Francisco
Histone Modification
Chairperson: J. Workman, Pennsylvania State University
University Park
Activators I
Chairperson: B. Graves, University of Utah, Salt Lake City
Transcription Complexes/Mediator
Chairperson: W. Herr, Cold Spring Harbor Laboratory
S. Holmberg, H. Spahr, J. Beve
Elongation and Termination
Chairperson: J. Conaway, Stowers Institute for Medical
Research, Kansas City Missouri
Chromatin Remodeling
Chairperson: J. Mellor, University of Oxford, United Kingdom
Activators II
Chairperson: C. Wolberger, Howard Hughes Medical Institute,
Johns Hopkins University School of Medicine, Baltimore,
Maryland
Regulatory Mechanisms and Networks
Chairperson: N. Hernandez, Howard Hughes Medical Institute,
Cold Spring Harbor Laboratory
M. Collart, G. Prelich
K. Struhl, M. Timmers
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Eukaryotic DNA Replication
September 3-7 373 participants
ARRANGED BY Thomas Kelly, Memorial Sloan-Kettering Cancer Center
Bruce Stillman, Cold Spring Harbor Laboratory
This was the eighth biannual meeting on eukaryotic DNA replication. Studies of eukaryotic DNA repli-
cation are advancing rapidly on many fronts, and this meeting is now established as the most impor-
tant in the field. A total of 373 investigators participated in the ten scientific sessions and there were
nearly 259 platform and poster presentations. Thus, interest in the mechanisms and regulation of DNA
replication in eukaryotic cells remains extremely high, and the meeting is playing a key role in fostering
the exchange of new ideas and experimental approaches.
Sessions at the meeting included assembling initiation complexes; timing and origin definition; ori-
gin and chromosome organization; checkpoint control and stalled forks; polymerases and helicases;
fork proteins; and linking replication to other cell division events. Additionally, two poster sessions were
held.
Essential funding for the meeting was provided in part by the National Cancer Institute, a branch of
the National Institutes of Health; and the National Science Foundation. Contributions from our
Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core support for this meeting.
T. Kelly, J. Yates
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G. Freyer, S. Brill
PROGRAM
Assembling Initiation Complexes
Chairperson: J. Campbell, California Institute of Technology,
Pasadena
Timing and Origin Definition
Chairperson: A. Dutta, University of Virginia, Charlottesville
Origin and Chromosome Organization
Chairperson: S. Forsburg, Salk Institute, La Jolla, California
Checkpoint Control and Stalled Forks
Chairperson: H. Araki, National Institute of Genetics, Mishima,
Japan
Polymerases and Helicases
Chairperson: P. Burgers, Washington University School of
Medicine, St. Louis, Missouri
Fork Proteins
Chairperson: J. Hamlin, University of Virginia, Charlottesville
Linking Replication to Other Cell Division Events
Chairperson: J. Rine, University of California, Berkeley
Regulation
Chairperson: S. Brill, Rutgers University Piscataway, New
Jersey
J. Claycomb, B. Aggarwal
T. Broker, M. Botchan
G. Bowman,
V. Bermudez
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Microbial Pathogenesis and Host Response
September 10-14 265 participants
ARRANGED BY James Slauch, University of Illinois
Paula Sundstrom, Ohio State University
Ronald Taylor, Dartmouth Medical School
Throughout recorded history, microbial pathogens have been a major cause of human disease and mor-
tality. However, with the advent of effective antibiotics, it seemed like the war on microbes had been won.
Hence, for several decades, health-related research shifted to topics like cancer, heart disease, and genet-
ic diseases. While research in microbial pathogenesis slowed, the microbes continued to evolve. Microbial
resistance to antibiotics developed faster than new antibiotics could be made available, and the resistance
spread throughout the microbial world. The global expansion of food distribution networks increased the
rapid dissemination of microbial pathogens. Simultaneously, emerging microbial pathogens filled new eco-
logical niches, such as indwelling medical devices that provide a surface for blot Ims and the growing pop-
ulation of patients who are immunocompromised due to primary infections such as HIV or due to thera-
pies for chronic diseases. Furthermore, recent discoveries have demonstrated that some diseases (e.g.,
ulcers and coronary heart disease) previously believed to be caused by a genetic predisposition or envi-
ronmental conditions are actually caused by, or are strongly associated with, microbes. Finally, humans
have facilitated the development of microbial pathogens as agents of bioterrorism.
This microbial offensive has summoned a renewed counterattack on microbial pathogens that has
intensified during the last several years. A variety of new tools have become available that make it possi-
ble to dissect the molecular basis of pathogenesis from both the microbial and host perspectives. This has
yielded exciting rapid advances in understanding the basis of pathogenesis for several important infectious
diseases. Insight into the molecular mechanisms of pathogenesis has predicted new ways to control infec-
tion, including the identification of novel targets for antimicrobials and novel approaches for vaccine devel-
opment. Nevertheless, many more questions remain unanswered and many pathogens are still poorly
understood. Understanding microbial pathogenesis demands a detailed knowledge of the host response
as well as the pathogen itself. Both of these perspectives provide potential strategies for solving important
clinical problems. Elucidating these distinct aspects of micro-
bial pathogenesis requires an interdisciplinary approach, inte-
grating the fields of microbiology, eukaryotic cell biology, and
immunology.
Unlike the previous meeting, which was rescheduled on
short notice because of the September 11, 2001 attack on
the World Trade Center, the 2003 meeting proceeded
smoothly and was well-attended. Recognition of the impor-
tance of program topics by microbial pathogenesis
researchers was reflected in the number of participants,
which reached the level of the 1999 meeting. The program
included Keynote Addresses by Roberto Kolter, Professor of
Microbiology and Molecular Genetics at Harvard University,
who discussed his work on the interactions that bacteria have
with biotic and abiotic surfaces, and A. Casadevall, Albert
Einstein College of Medicine, who elaborated on his work
with vaccines and immune responses. The importance of the
Keynote Address on microbial growth and antibiotic resis-
tance in host niches pointed to the need for new approaches
to combat microbial pathogens.
The meeting attracted a diverse group of international scientists who approach the study of bacte-
rial and fungal pathogens from a broad range of perspectives. In the first session, a new scheme that
R. Taylor, P. Sundstrom
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incorporated the immune status of the host in classifying microorganisms for their ability to induce
damage underscored the increasing numbers of compromised hosts and the importance of emerging
fungal and bacterial pathogens that prey upon them. Other sessions focused on how gene transfer
between distantly related microorganisms contributes to evolution of pathogenic traits; how bacteria
build a variety of secretion systems for attaching to and injecting toxic proteins into the host; how bac-
teria exploit the intracellular environment of host cells; mechanisms of innate host antimicrobial defense
and how nonpathogenic, commensal bacteria of the gut inducenovel antimicrobial defenses in the
host; how yeast can be used to model pathogenic mechanisms of bacteria; how toxins travel within
and affect programmed death of host cells; how specific human diseases can be precisely modeled in
animals for studying vaccine efficacy and pathogenesis; the molecular structure of protective vaccine
antigens; how bacteria and fungi regulate expression of virulence genes; biogenesis of surface struc-
tures bacteria and fungi; and how these structures promote survival in the host. The talks and poster
sessions generated lively, interactive discussions. Many presentations describing the use of a new
method to solve a complex problem led to animated discourse about how the approach could be
applied to answer recalcitrant questions about other host-pathogen interactions. Some of these inter-
actions have already produced fruitful scientific collaborations.
Despite the active scientific research on microbial pathogenesis and the impressive progress in this
field, it is clear that as one problem is solved, another microbial pathogen will rapidly take its place.
Hence, there will be a continual need for the free, interactive exchange of ideas like those that stimu-
lated by this meeting.
This meeting was supported in part by funds from the National Institute of Allergy and Infectious
Diseases and the National Institute of Dental and Craniofacial Research, branches of the National
Institutes of Health; and the Burroughs Wellcome Fund. Contributions from our Corporate Benefactors,
Corporate Sponsors, Plant Corporate Associates, Corporate Associates, Corporate Contributors, and
Foundations also provided core support for this meeting.
PROGRAM
Overview
Chairperson: P. Sundstrom, Ohio State University, Columbus
Horizontal Evolution
Chairperson: S. Maloy, San Diego State University, California
Mechanisms of Protein Secretion
Chairperson: M. Sandkvist, American Red Cross, Rockville,
Maryland
Intracellular Parasites
Chairperson: D. Portnoy, University of California, Berkeley
Cellular Microbiology
Chairperson: A. Jerse, Uniformed Services University
Bethesda, Maryland
Vaccines/Immune Responses
Keynote Speaker: A. Casadevall, Albert Einstein College of
Medicine, Bronx, New York
Gene Regulation
Chairperson: L. Kenney, University of Illinois, Chicago
Microbial Surfaces
B. Cormack, Johns Hopkins University School of Medicine,
Baltimore, Maryland
E. Helmerhorst, E. Rappocciolo, F. Oppenheim
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Programmed Cell Death
September 17- 21 405 participants
ARRANGED BY Hermann Steller, HHMI/Massachusetts Institute of Technology
Craig Thompson, HHMI/University of Chicago
Junying Yuan, Harvard Medical School
This fifth meeting was successful as planned, with only one speaker cancellation due to the threat of
Hurricane Isabel, which turned out to be nothing more than a strong wind during the night. The Keynote
Speaker in the opening session was 2002 Nobel prize winner H. Robert Horvitz, whose reflection on the
explosive growth of the apoptosis field during the last ten years drew much discussion. The opening
session was followed by eight oral sessions on the Bcl -2 family; Caspases and other proteases in apop-
tosis; developmental cell death; signal transduction I; signal transduction II; neuronal cell death; engulf-
ment and alternative pathways of cell death; oncogenes and tumor suppressor genes in apoptosis; and
two poster sessions. The invited session leaders are senior investigators of the field. The 47 speakers
were selected from 301 abstracts with a good representation of senior lab heads (73%), postdoctoral
fellows (13.5%), and graduate students (13.5%). The participants were impressed by the presentation
of a significant amount of unpublished information: 30% of the talks consisted of entirely unpublished
information and 54% of talks consisted of more than 50% of unpublished information.
This meeting was funded in part by the National Cancer Institute, the National Institute of Aging,
and the National Institute of Child Health and Human Development, branches of the National Institutes
of Health; Vertex Pharmaceuticals, Ltd.; !dun Pharmaceuticals, Inc.; Cell Signaling Technology, Inc.;
and Abgent. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate
Associates, Corporate Associates, Corporate Contributors, and Foundations also provided core sup-
port for this meeting.
J. Yuan, H. Steller, C. Thompson
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PROGRAM
Keynote Address: Genetic Control of Programmed Cell
Death in C. elegans
H. Robert Horvitz, Massachusetts Institute of Technology
Cambridge
Bcl -2 Family
Chairpersons: S. Korsmeyer, Dana Farber Cancer Institute,
Harvard Medical School, Boston, Massachusetts; Y.
Tsujimoto, Osaka University Graduate School of Medicine,
Japan
Caspase and Other Proteases in Apoptosis
Chairpersons: Y. Lazebnik, Cold Spring Harbor Laboratory;
E. Alnemri, Thomas Jefferson University Philadelphia,
Pennsylvania
Developmental Cell Death
Chairpersons: M. Hengartner, University of Zurich,
Switzerland; J. Abrams, University of Texas Southwestern
Medical Center, Dallas
Signal Transduction I
Chairpersons: X. Wang, University of Texas Southwestern
K. Edwards,
D. Sogah
Medical Center; Dallas; J. Tschopp, University of Lausanne,
Switzerland
Neuronal Cell Death
Chairpersons: J.M. Hardwick, Johns Hopkins University
Baltimore, Maryland; P. Nicotera, University of Leicester;
United Kingdom
Engulfment and Alternative Pathways of Cell Death
Chairpersons: S. Nagata, Osaka University Medical School,
Japan; K. White, Massachusetts General Hospital, Harvard
Medical School, Charlestown
Signal Transduction II
Chairpersons: S. Kornbluth, Duke University Medical Center,
Durham, North Carolina; D. Green, La Jolla Institute for
Allergy and Immunology San Diego, California
Oncogene/Tumor Suppressor Genes in Apoptosis
Chairpersons: S. Lowe, Cold Spring Harbor Laboratory; E.
White, Rutgers University Piscataway New Jersey
H. Engelberg-Kulka, S. Nagata
J. Eriksson,
A. Meinander
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FIRST CSHL/WELLCOME TRUST CONFERENCE
Pharmacogenomics
September 24-28 140 participants
ARRANGED BY David Bentley, The Sanger Institute, Hinxton
Steve Leeder, Children's Mercy Hospital
Munir Pirmohamed, University of Liverpool
Dick Weinshilboum, Mayo Medical School
Roland Wolf, University of Dundee Biomedical Research Centre
The inaugural meeting on Pharmacogenomics was held at the Wellcome Trust Genome Campus in
Hinxton, U.K. and was a joint project of CSHL and the Wellcome Trust. The meeting was arranged to
have a strong multidisciplinary focus and to address diverse issues related to applying genomics to vari-
able drug response in the human population. Key subject areas of the meeting included genes and
sequence variants, genotype and phenotype correlations, clinical association studies, molecular mecha-
nisms of drug action and response, adverse drug reactions, clinical applications, drug development and
use (including regulatory issues), commercial /economic/ELSI implications, educationaVsoftware/infor-
matics, and disease entities. A prominent emphasis of the meeting was to explore the impact of
genomics on the field of pharmacogenetics and to focus on the benefits and challenges that are currently
most closely relevant to the general public and to the medical field, and to see how these relate to the
goals of pharmaceutical and other commercial entities.
The meeting was subscribed to by 140 attendees and included participants from 15 different coun-
tries representing Australia, North America, Central America, Asia, Europe, and Scandinavia, including
20% representation of students and postdocs. Representation of women at the first meeting was an
encouraging 38% of attendees. The meeting was warmly received by all the participants, with the hope
that there is further opportunity for many younger members of their laboratories and collaborating
groups to attend in the future. Many of these researchers are renowned in their own field but had little
exposure to other disciplines before this meeting.
PROGRAM
Welcome
Chairperson: David Bentley, Wellcome Trust Sanger Institute
Introduction
Chairpersons: A. Breckenridge, University of Liverpool, United
Kingdom; C.R. Wolf, University of Dundee, United Kingdom
Genes and Sequence Variants
Chairpersons: K. Giacomini, University of California, San
Francisco; J. Ljcinio, David Geffen School of Medicine,
University of California, Los Angeles
Drug Response
Chairpersons: A. Somogyi, University of Adelaide, Australia;
G. Smith, University of Dundee, United Kingdom
Hinxton, U.K.
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Adverse Drug Reactions
Chairpersons: M. Eichelbaum, Dr. Margarete Fischer-Bosch-
Institute of Clinical Pharmacology Stuttgart, Germany; D.
Kaufman, Boston University Massachusetts
Genotype to Phenotype
Chairpersons: S. Liggett, University of Cincinnati, Ohio;
A. Rane, Huddinge University Hospital, Stockholm,
Sweden
Diseases and Future Challenges
Chairpersons: B. Ponder, University of Cambridge,
United Kingdom; S. Weiss, Brigham and Women's
Hospital, Boston, Massachusetts
Neurobiology of Drosophila
October 1-5 407 participants
ARRANGED BY Thomas Schwarz, Children's Hospital Harvard
Jessica Treisman, New York University School of Medicine
The goal of this 2003 meeting, as it has been since its inception, was to foster communication of ideas,
techniques, and new discoveries within the field of Drosophila neurobiology. The meeting was struc-
tured with platform and poster presentations by a variety of researchers including graduate students,
postdoctoral fellows, and junior and senior faculty. All platform presentations were selected from the
abstracts submitted by the session chairs. The topics for the platform sessions were chosen from the
areas where exciting advances are being made in understanding molecular and cellular mechanisms:
neurophysiology, behavior, sensory systems, axon guidance, synapse formation and function, neuronal
and glial determination, and neuronal cell biology and pathology. The research reported relied on a
wide range of techniques, including genetic, molecular, cellular, neurophysiological, behavioral, and
genomic approaches to basic questions of nervous system development and function. Among the
highlights of the meeting were presentations of new and exciting developments, including visualization
of synaptic transmission at the level of individual boutons; identification of new molecules contributing
to axon guidance; and genomic analysis of glial cell functions. The Elkins Plenary Lecture, which was
presented by recent Ph.D. graduate Greg Jefferis, described exciting work on the establishment of an
olfactory map in the brain before the arrival of olfactory neuron axons. The environment of the meet-
ing allowed many opportunities for informal discussions among all participants. The high quality of the
presentations, novel findings, and new techniques discussed at the meeting demonstrated the vitality
of Drosophila research. The character of the discussions led to the cross-fostering of ideas that was
valuable to everyone
J. Price, A. Sehgal
J. Treisman, T. Schwarz
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This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, a
branch of the National Institutes of Health; and the National Science Foundation. Contributions from
our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates, Corporate Associates,
Corporate Contributors, and Foundations also provided core support for this meeting.
PROGRAM
Behavior
Chairperson: A. Sehgal, University of Pennsylvania,
Philadelphia
Axon Guidance
Chairperson: D. Van Vactor, Harvard Medical School, Boston,
Massachusets
Elkins Memorial Lecture
G. Jefferis, Stanford University, California
Neuronal Function
Chairperson: L. Griffith, Brandeis University Waltham,
Massachusetts
Formation and Function
Chairperson: A. DiAntonio, Washington University School of
Medicine, St. Louis, Missouri
Sensory Systems
Chairperson: L. Vosshall, The Rockefeller University New York
Neuronal Cell Biology and Pathology
Chairperson: M. Bhat, University of North Carolina, Chapel Hill
Neuronal and Glial Determination
Chairperson: A. Jarman, University of Edinburgh, United
Kingdom
D. Eberl, J. Simpson
Caricaturist in action!
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I. Meinertzhagen,
T. Clandinin
Molecular Approaches to Vaccine Design
December 4-7 99 participants
ARRANGED BY Peter Beverley, Edward Jenner Institute for Vaccine Research
Dennis Burton, Scripps Research Institute
Emilio Emini, Merck Research Laboratories
This third winter conference was held in a snow blizzard that turned the Laboratory into a setting from
a Christmas card. The emphasis of the meeting was on how to exploit the full new developments in
molecular and structural biology, to enable the design of new generations of
vaccines that will be safe and effective in humans. The meeting included ses-
sions on HIV and emerging pathogens, B cells and vaccines, T cells and vac-
cines, new vaccines in late development, the future of vaccines, and new
developments in infectious disease and vaccinology. Much new information
on ingenious replicating or nonreplicating vectors for antigen expression was
presented, as was encouraging data on understanding of T- and B-cell
responses to model antigens and vaccines. Nevertheless, it emerged that
preclinical models do not always predict whether an immunization strategy will
generate a strong immune response in humans. An important step in vaccine
development therefore remains the intensive study of vaccinated humans in
early-phase small-scale trials. A challenging talk given by a vaccine policy
expert outlined the financial hurdles inherent in vaccine development and the
need for imaginative partnerships among industry, governments, international
bodies, and charities to develop vaccines needed in poorer countries.
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant
Corporate Associates, Corporate Associates, Corporate Contributors, and
Foundations provided core support for this meeting.
PROGRAM
HIV and Emerging Pathogens
Chairperson: G. Nabel, NIAID, National Institutes of Health,
Bethesda, Maryland
B Cells and Vaccines
Chairperson: D. Burton, Scripps Research Institute, La Jolla,
California
T Cells and Vaccines
Chairperson: M. Bevan, Howard Hughes Medical Institute,
University of Washington, Seattle
New Vaccines in Late Development
Chairperson: P. Beverley, Edward Jenner Institute for Vaccine
Research, Compton, United Kingdom
Future of Vaccines
Chairperson: P. Beverley, Edward Jenner Institute for Vaccine
Research, Compton, United Kingdom
New Developments in Infectious Disease and Vaccinology
Chairperson: E. Emini, Merck Research Laboratories, West
Point, Pennsylvania
K. Smith, P. Beverley
J. Almond, N. Almond
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Rat Genomics and Models
December 11-14 164 participants
ARRANGED BY Howard Jacob, Medical College of Wisconsin
Douglas Vollrath, Stanford University School of Medicine
This third winter biotechnology conference followed on from the successful inaugural meetings in
December 1999 and 2001. This conference series is the first to focus exclusively on the rat as a model
organism for biological research and seeks to bring together the vast body of research that continues to
be generated in the area of rat physiology, pathophysiology, toxicology, neuroscience, etc., with new
genetic resources and genomic tools now being developed for the rat. Topics at the meeting included
Pharmacogenomics and Risk Assessment; Neuroscience; Toward ES cells and Knockouts; Comparative
Mapping; Models and Analysis; Rat Cloning; Gene Transfer and Transgenesis; and Rat Genome
Sequencing. The meeting also included a special workshop on resources for the community.
This meeting was funded in part from the National Center for Research Resources, a branch of the
National Institutes of Health. Contributions from our Corporate Benefactors, Corporate Sponsors,
Plant Corporate Associates, Corporate Associates, Corporate Contributors, and Foundations also pro-
vided core support for this meeting.
U. Vitt, D. Vollrath
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V. Kren, F. Stahl
PROGRAM
Welcome
Chairpersons: H. Jacob, Medical College of Wisconsin,
Milwaukee; D. Vollrath, Stanford University School of
Medicine, California
Sequencing the Rat
Chairperson: S. Old, NHLBI, National Institutes of Health,
Bethesda, Maryland
Comparative Genomics
Chairperson: D. Vollrath, Stanford University School of
Medicine, California
Models: Neuroscience
Chairperson: M.-T. Perez, Lund University, Sweden
Models: Kidney/Cancer
Chairpersons: P. Harris, Mayo Clinic, Rochester, Minnesota;
G. Levan, GOteborg University, Sweden
Resources
Chairperson: L. Riley, University of Missouri, Columbia
Models: Diabetes/Lipids/Cardiovascular
Chairperson: A. Kwitek, Medical College of Wisconsin,
Milwaukee
Augmenting and Inhibiting Gene Function
Chairpersons: B. Davidson, University of Iowa College of
Medicine, Iowa City; M. Gould, University of Wisconsin,
Madison
Arthritis/Immunity
Chairperson: M. Griffiths, University of Utah, Salt Lake City
Expression Profiling and Pharmacogenomics
Chairperson: C. Kendziorski, University of Wisconsin,
Madison
C. Moreno-Quinn, M. Tschannen, J. Lazar
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that universities
do not adequately treat them. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into research in a particular
area. To ensure up-to-date coverage of current research work, we bring together course faculty from
many laboratories around the world and supplement this staff with a series of seminar speakers.
Acquiring and Analyzing Genomic Sequence Data
March 11-27
INSTRUCTORS E. Mardis, Washington University, St. Louis, Missouri
W.R. McCombie, Cold Spring Harbor Laboratory
J. McPherson, Washington University, St. Louis, Missouri
ASSISTANTS
V. Balija, Cold Spring Harbor Laboratory
L. Courtney, Washington University School of
Medicine, St. Louis, Missouri
W. Courtney, Washington University School of
Medicine, St. Louis, Missouri
M. De la Bastide, Cold Spring Harbor Laboratory
L. Nascimento, Cold Spring Harbor Laboratory
A. O'Shaughnessy, Cold Spring Harbor Laboratory
L. Palmer, Cold Spring Harbor Laboratory
L. Spiegel, Cold Spring Harbor Laboratory
T. Zutavern, Cold Spring Harbor Laboratory
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This year's course consisted of four modules, which featured (1) production sequencing and sequence
finishing, (2) sequence variation analysis, (3) cross-species sequence comparison, and (4) gene pre-
diction and annotation. The first part of the course emphasized the technical and management aspects
of large-scale physical mapping and sequencing projects including polymorphism detection. In the
second part, computational analysis of sequence data was the focus, including sequence variation
(such as single-nucleotide polymorphisms [SNPs]), comparative genomics, gene prediction, and
sequence annotation. Where appropriate, the computational analysis was coupled with data acquisi-
tion. A sequencing project was carried out during the course, with emphasis on the technical nuances
of large-scale sequencing. In past years, this phase has targeted a bacterial artificial chromosome
clone from various species, including Arabidopsis thaliana, mouse, chimpanzee, and human.
Techniques for generating both "working draft" and completely finished genome sequences were cov-
ered. Whole-genome shotgun and clone-based sequencing methods utilizing capillary-based
sequence acquisition was taught.
Sequence variation analysis featured SNP generation and detection methods. A laboratory project
included sequencing of targeted regions from multiple individuals and additional SNP analysis.
Computational analysis focused on using readily available tools for comparative genomics, gene pre-
diction, and annotation methods. Data from the course production sequencing module were utilized,
as well as examples from the publicly accessible sequence archives. Sequence homology was used to
analyze orthologous and parologous sequences. Ab initio gene prediction, as well as supporting evi-
dence using expressed sequence tag (EST), mRNA, and homologous sequences, was profiled. These
modules focused primarily on the use of the tools themselves and only generally on the underlying algo-
rithms.
PARTICIPANTS
Adeniji-Adele, A., B.S., M.S., Lancaster Laboratories,
Richmond, Virginia
Crayton, M., Ill, B.S., University of North Carolina, Chapel Hill
Geng, T, B.A., M.S., Comparative Genomics Lab.,
Blacksburg, Virginia
Gore, M., B.S., M.S., Pioneer, Johnston, Iowa
Jiang, C., B.S., University of Virginia, Charlottesville
Larsen, C., B.S., National Institute for Medical Research,
London, United Kingdom
SEMINARS
Beier, D., Brigham and Women's HospitaVHarvard Medical
School, Boston, Massachusetts: Mouse genomics.
Hannon, G., Cold Spring Harbor Laboratory: RNAi:
Mechanism and application.
Hirschhorn, J., Harvard University, Boston, Massachusetts:
SNPs, patterns of genetic variation, and complex traits.
Martienssen, R., Cold Spring Harbor Laboratory: Chromatin
silencing.
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Long, E., B.A., Virginia Tech, Blacksburg
Mavrodi, D., B.S., Ph.D., Washington State University, Pullman
Mecklenburg Serkovic, E., BA., Universidad Peruana
Cayetano Heredia, Lima, Peru
Raudsepp, T, B.S., Ph.D., Texas A&M University, College
Station
Wang, Q.J., B.M., Ph.D., Lawrence Berkeley National
Laboratory, Berkeley, California
Stein, L., Cold Spring Harbor Laboratory: The generic model
organism database suite of bioinformatics tools.
Vidal, M., Dana-Farber Cancer Institute/Harvard Medical
School, Boston, Massachusetts: From genomes to systems
biology.
Watson, J., Cold Spring Harbor Laboratory: The Human
Genome Project.
Protein Purification and Characterization
April 2-15
INSTRUCTORS R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
K. Severinov, Waksman Institute, Rutgers University, Piscataway, New Jersey
ASSISTANTS V. Bergendahl, University of Wisconsin, Madison
M. Galfione, M.D. Anderson Cancer Center/University of Texas, Houston
N. Thompson, University of Wisconsin, Madison
G. Ratnaparkhi, University of California, Los Angeles
W. Tsai, M.D. Anderson Cancer Center/University of Texas, Houston
C. Winkler, University of California, Los Angeles
N. Zenkin, Waksman Institute, Rutgers University, Piscataway, New Jersey
This course was intended for scientists who are not familiar with techniques of protein
isolation and
characterization. It was a rigorous program that included laboratory work all day and a lecture
with dis-
cussion session every evening. Each student became familiar with each of the major
techniques in pro-
tein purification by actually performing four separate isolations, including (1) a
regulatory protein from
muscle tissue, (2) a sequence-specific, DNA-binding protein, (3) a recombinant
protein overexpressed
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in E. coli, and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic, and
chromatographic techniques included precipitation by salts, pH, and ionic polymers; ion-exchange, gel
filtration, hydrophobic interaction, and reverse-phase chromatography; lectin affinity, ligand affinity,
oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel electrophoresis and
electroblotting; and high-performance liquid chromatography. Procedures were presented for solubi-
lizing proteins from inclusion bodies and refolding them into active monomeric forms. Methods of pro-
tein characterization were utilized to include immunological and biochemical assays, peptide mapping,
amino acid analysis, protein sequencing, and mass spectrometry. Emphasis was placed on strategies
of protein purification and characterization. Guest lecturers discussed protein structure, modification of
proteins, methodologies for protein purification and characterization, and applications of protein bio-
chemistry to cell and molecular biology.
PARTICIPANTS
Apionishev, S., B.S., Ph.D., Columbia University, New York
Belanger, M., B.S., Ph.D., University of Florida, Gainesville
Dale, B., BA., M.S., Columbia University, New York
Grace, W., B.S., USAMRIID, Detrick, Maryland
Guo, H., M.D., Ph.D., Duke University, Durham, North
Carolina
Karger, A., Ph.D., Applied Biosystems, Foster City, California
Lou, J., B.S., Washington University School of Medicine, St.
Louis, Missouri
Miller, D., B.S., Ph.D., National Institute on Aging, Bethesda,
Maryland
Needleman, D., B.A., University of California, Santa Barbara
SEMINARS
Burgess, R., University of Wisconsin: Overview of protein
purification and immunoaffinity purification. Biochemical
studies of RNA polymerase /o factor interactions.
Courey, A., University of California, Los Angeles: Wrestling
with SUMO function.
Guidotti, G., Harvard University, Cambridge, Massachusetts:
Membrane proteins and extracellular ATP.
Hart, G., Johns Hopkins School of Medicine, Baltimore,
Maryland: Dynamic interplay between O- glycosylation and
0-phosphorylation in cell signaling and metabolic regulation.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Proteins in 3-D.
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Petersen, J., B.S., Ph.D., Peterson Institute for Cancer
Research, Manchester, United Kingdom
Sattlegger, E., Ph.D., NICHD, National Institutes of Health,
Bethesda, Maryland
Tsang, P., BA., Ph.D., University of Cincinnati, Ohio
Vullhorst, D., Ph.D., NICHD, National Institutes of Health,
Bethesda, Maryland
Weininger, S., B.S., Ph.D., The Gene Pool, Inc., Seattle,
Washington
Young, I., Ph.D., University of Liverpool, United Kingdom
Zarivach, R., B.S., Ph.D., Weizmann Institute of Science,
Rehovot, Israel
Lin, S., M.D. Anderson Cancer Center, Houston, Texas:
Prostate cancer bone metastasis.
Mische, S., Boehringer-lngelheim Pharmaceuticals, Inc.,
Ridgefield, Connecticut: Proteomics and why pharmaceuti-
cal companies are interested in it.
Severinov, K., Waksman Institute, Rutgers, Piscataway, New
Jersey: Structure-function analysis of transcriptional machin-
ery in bacteria.
Stillman, B., Cold Spring Harbor Laboratory: Understanding
chromosome duplication in human cells: Combining bio-
chemistry, genetics, and cell biology.
Cell and Developmental Biology of Xenopus
April 5-15
INSTRUCTORS K. Cho, University of California, Irvine
J. Christian, Oregon Health Sciences University, Portland
ASSISTANTS I. Blitz, University of California, Irvine
G. Dalgin, Oregon Health and Sciences University, Portland
C. Degnin, Oregon Health and Sciences University, Portland
T. Nakayama, University of Virginia, Charlottesville
The frog Xenopus is an important vertebrate model for studies of maternal factors, regulation and mol-
ecular mechanisms of tissue inductions and regulation of cell-fate decisions. In addition, Xenopus
oocytes and embryos provide a powerful system in which to conduct a number of cell biological and
gene regulation assays. This course provided extensive laboratory exposure to the biology, manipula-
tion, and use of oocytes and embryos of Xenopus. The course consisted of intensive laboratory ses-
sions, supplemented by daily lectures and demonstrations from experts in cellular, experimental, and
molecular development. Areas covered included (1) care of adults; (2) oocyte isolation and embryo pro-
duction; (3) stages of embryonic development and anatomy; (4) whole-mount in situ hybridization and
immunocytochemistry; (5) microinjection of eggs and oocytes with lineage tracers, DNA constructs,
mRNA, and antisense oligonucleotides; (6) micromanipulation of embryos, including explant and trans-
plantation assays; (7) in vivo time-lapse confocal imaging; (8) preparation of transgenic embryos; and
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(9) use of Xenopus tropicalis for genetic analyses. This course was suited both for investigators who
have had no experience with Xenopus and for those who have worked with Xenopus and wished to
learn new and cutting-edge techniques. All applicants had current training in molecular biology and
some knowledge of developmental biology.
PARTICIPANTS
Collart, C., Ph.D., Wellcome Trust, Cambridge, United
Kingdom
Gauley, J., B.S., University of Waterloo, Ontario, Canada
Gorgoni, B., B.S., Ph.D., Medical Research Council,
Edinburgh, United Kingdom
Kennedy, E., B.A., Ph.D., University College Dublin, Belfield,
Ireland
Klisch, T, B.S., University of Goettingen, Germany
Koyabu, Y., B.S., Ph.D., RIKEN Brain Science Institute,
Japan
Kuan, C., M.D., Ph.D., Cincinnati Children's Hospital Research
Foundation, Ohio
Lau, J.M.C., B.A., Ph.D., Washington University, St. Louis,
Missouri
SEMINARS
Cho, K., University of California, Irvine: Phylogenetic footprint-
ing and DNA microarray analysis to study Xenopus develop-
ment.
Christian, J., Oregon Health Sciences University, Portland:
Introduction to early embrylogy and dorsoventral patterning.
Tissue-specific use of an upstream cleavage site within the
prodomain regulates BMP-4 activity and signaling range.
Keller, R., University of Virginia, Charlottesville: Early morpho-
genesis of Xenopus.
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Martinez, S., B.S., Ph.D., Boston College, Chestnut Hill,
Massachusetts
Metcalfe, M.J., M.S., Ph.D., Catholic University of Chile,
Santiago
Pradda, C., M.D., SUNY at Buffalo, New York
Rodrigues, C., Ph.D., St. Jude Children's Research Hospital,
Memphis, Tennessee
Reggiani, L., M.S., Swiss Federal Institute of Technology,
Zurich, Switzerland
Shiotsugu, J., B.S., Ph.D., University of California, Irvine
Stebbins-Boaz, B., B.A., Ph.D., Willamette University, Salem,
Oregon
Woltering, J., M.S., Hubrecht Laboratory, Utrecht, The
Netherlands
King, M.L., University of Miami School of Medicine, Florida: To be
or not to be totipotent: Formation of the Xenopus germ line.
Kroll, K., Washington University School of Medicine, St. Louis,
Missouri: Subdividing the ectoderm: Connecting signals and
responses during neural plate formation.
Whitman, M., Harvard Medical School, Boston, Massa-
chusetts: Studying nodal signaling in the early embryo.
Zorn, A., Children's Hospital Medical Center of Cincinnati,
Ohio: Sox17 in endoderm formation.
Structure, Function, and Development of the Visual System
June 4-17
INSTRUCTORS A.K. McAllister, University of California, Davis
W.M. Usrey, University of California, Davis
ASSISTANT H. Alitto, University of California, Davis
This lecture/discussion course explored the functional organization and development of the visual sys-
tem as revealed by the use of a variety of anatomical, physiological, and behavioral methods. It was
designed for graduate students and more-advanced researchers who wished to gain a basic under-
standing of the biological basis for vision and to share in the excitement of the latest developments in
this field. Topics included phototransduction and neural processing in the retina; functional architecture
of striate cortex; cellular basis of cortical receptive field properties; the anatomy, physiology, and per-
ceptual significance of parallel pathways; functional parcellation of extrastriate cortex; the role of pat-
terned neuronal activity in the development of central visual pathways; and molecular mechanisms of
development and plasticity in the visual system. The course was held at the Laboratory's Banbury
Conference Center.
301
PARTICIPANTS
Akula, J., BA., Northeastern University, Boston, Massa-
chusetts
Blanche, T, B.S., University of British Columbia, Vancouver,
Canada
Chong, S., M.A., Princeton University, New Jersey
Grubb, M., M.S., University of Oxford, United Kingdom
Hansen, C., B.A., University of California, Davis
Heimel, J., Ph.D., Brandeis University, Waltham, Massa-
chusetts
Hofer, S., Ph.D., Max-Planck Institute of Neurobiology,
Martinsried, Germany
Kee, C., M.A., University of Houston, Texas
Kim, M., M.S., University of Minnesota
SEMINARS
Bear, M., Brown University, Providence, Rhode Island: Cellular
mechanisms underlying visual cortical plasticity.
Britten, K., University of California, Davis: Neural mechanisms
for processing of optic flow.
Carandini, M., New York University, New York: A synaptic
explanation of suppression in visual cortex.
Chapman, B., University of California, Davis: How the visual
system got its stripes.
Constantine-Paton, M., Massachusetts Institute of
Technology, Cambridge: Cellular mechanisms of visual sys-
tem development.
Dacey, D., University of Washington, Seattle: Parallel path-
ways for spectral coding in primate.
Dan, Y., University of California, Berkeley: Spike-timing-depen-
dent synaptic plasticity in visual cortex.
Fitzpatrick, D., Duke University, Durham, North Carolina:
Functional maps and patterns of connectivity in primary
visual cortex.
Hirsch, J., University of Southern California, Los Angeles:
Synaptic physiology and receptive field structure in the early
visual pathway of the cat.
Horton, J., University of California, San Francisco:
Development of ocular dominance columns in visual cortex.
Masland, R., Harvard University, Boston, Massachusetts:
Neuronal diversity in the retina.
Mason, C., Columbia University, New York: Retinal develop-
ment and molecular mechanisms governing crossing at the
optic chiasm.
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Krahe, T, Ph.D., Virginia Commonweath University, Richmond
Landi, S., B.S., Scuola Norma le Superiore, Pisa, Italy
Lesica, N., B.S., Harvard University, Cambridge,
Massachusetts
Moore, B., B.A., University of California, Davis
Mueller, I., B.A., Otto-von-Guericke University of Magdeburg,
Germany
Natale, L., M.A., University of Genoa, Italy
Nicol, D., B.S., Glasgow Caledonian University, Scotland
Rathbun, D., B.S., University of California, Davis
Sohn, W., M.A., Rutgers University, Piscataway, New Jersey
Zarrinpar, A., A.B., The Salk Institute for Biological Studies, La
Jolla, California
Maunsell, J., Baylor College of Medicine, Houston, Texas:
Attention and visual responses in extrastriate.
McAllister, K., University of California, Davis: The role of neu-
rotrophins in activity-dependent competition in the visual
cortex.
Miller, K., University of California, San Francisco: Neural mech-
anisms of orientation selectivity in the visual cortex.
Movshon, J.A., New York University, New York: Behavioral
choice and the visual responses of neurons in macaque MT.
Neitz, J., Medical College of Wisconsin, Milwaukee: Evolution
of trichromacy in vertebrates.
Nelson, S., Brandeis University, Waltham, Massachusetts:
Mechanisms of syaptic plasticity in the cerebral cortex.
Ringach, D., University of California, Los Angeles: Response
properties of macaque primary visual cortex.
Shad len, M., University of Washington, Seattle: Neural mecha-
nisms that underlie decisions about sensory stimuli.
Sherman, S.M., Stony Brook University, New York: The func-
tional organization of thalamocortical relays.
Stone, L., NASA Ames Research Center, Moffett Field,
California: Eye movements, visual search, and motion.
Usrey, M., University of California, Davis: Functional properties
of neural circuits in the visual system.
Victor, J., Cornell University Medical College, New York: How
the brain uses time to represent and process visual informa-
tion.
Williams, D., University of Rochester, New York: Functional
properties of the photoreceptor.
Advanced Bacterial Genetics
June 4-24
INSTRUCTORS K. Hughes, University of Washington, Seattle
U. Jenal, University of Basel, Switzerland
K. Pogliano, University of California, San Diego
ASSISTANTS T. Fuchs, University of Basel, Switzerland
A. Rubio, University of California, San Diego
E. Smith, University of Washington, Seattle
The course presented logic and methods used in the genetic dissection of complex biological process-
es in eubacteria. Laboratory methods used included classical mutagenesis using transposons, muta-
tor strains, and chemical and physical mutagens; the mapping of mutations using genetic and physi-
cal techniques; modern approaches to the generation and analysis of targeted gene disruptions and
fusions using polymerase chain reaction (PCR) and cloning methods; epitope insertion mutagenesis;
and, site-directed mutagenesis. Key components of the course were the use of sophisticated genetic
methods in the analysis of model eubacteria and the use of the wealth of new genomic sequence infor-
mation to motivate these methods. Invited lecturers presented various genetic approaches to study
eubacterial mechanisms of metabolism, development, and pathogenesis.
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PARTICIPANTS
Altschuler, S., Ph.D., Harvard University, Cambridge,
Massachusetts
Baltrus, D., B.A., University of Oregon, Eugene
Bouchet, V., B.S., Boston University, Massachusetts
Denef, V., M.S., University of Ghent, Belgium/Michigan State
University, E. Lansing
Gitai, Z., B.S., Stanford University, California
Hekstra, D., M.S., The Rockefeller University, New York
Johnson, A., B.S., Duke University, Durham, North Carolina
Lloyd, L, B.S., Imperial College London, United Kingdom
SEMINARS
Bass ler, B., Princeton University, New Jersey: Tiny conspira-
cies: Cell-to-cell communication in bacteria.
Gottesman, S., National Cancer Institute, Bethesda,
Maryland: Genetic circuits with small RNA switches.
Hengge-Aronis, R., Free University of Berlin, Germany: Cellular
information processing in regulatory networks: The general
stress response in E. coll.
Hughes, K., University of Washington, Seattle: Gene regula-
tion coupled to the development of the flagellar organelle in
Salmonella.
Jena!, U., University of Basel, Switzerland: Polar differentiation
in Caulobacter crescentus.
Kolter, R., Harvard Medical School, Boston, Massachusetts: A
rose is a rose is a rose...but is a biofilm a biofilm?
Manoil, C., University of Washington, Seattle: Genomic genet-
ics of Pseudomonas aeruginosa.
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Marcusson, L., M.S., Uppsala University, Sweden
Persson, 0., M.S., Gothenburg University, Sweden
Purdy, A., Ph.D., Scripps Institution of Oceanography, La Jolla,
California
Rajagopal, S., B.S., University of Nebraska, Lincoln
Se llo, J., Ph.D., Harvard Medical School, Cambridge,
Massachusetts
Vlamis, A., Ph.D., Karolinska Institutet, Stockholm, Sweden
Wilson, M., Ph.D., The Colorado College, Colorado Springs
Yook, K., Ph.D., University of Oxford, United Kingdom
Metcalf, W., University of Illinois, Urbana: Genetic analysis of
methanogenesis in Methanosarcina species.
Olivera, B., University of Utah, Salt Lake City: The marine
Cone snails use a combinatorial library mechanism to gener-
ate a plethora of deadly neuropeptides.
Parkinson, J., University of Utah, Salt Lake City: Bacterial
chemotaxis: Collaborative signaling by chemoreceptor
teams.
Pogliano, K., University of California, San Diego: Dynamic
rearrangement of the bacterial cell during B. subtilis
sporulation.
Slauch, J., University of Illinois, Urbana: Role of Gifsy-2 bacte-
riophage in Salmonella virulence.
Youderian, P., Texas A&M University, College Station: Efflux
pumps and antibiotic resistance in Salmonella.
Molecular Embryology of the Mouse
June 4-24
INSTRUCTORS T. Lufkin, Mt. Sinai School of Medicine, New York
C. Stewart, National Cancer Institute, Frederick, Maryland
CO-INSTRUCTORS B. Capel, Duke University Medical Center, Durham, North Carolina
M. Shen, UMDNJ-Robert Wood Johnson Medical School, Piscataway
ASSISTANTS D. Escalante-Alcalde, Institute De Fisiologia Celular-UNAM, Mexico
R. Robledo, Mt. Sinai School of Medicine, New York
L. Vong, Albany Medical College, New York
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse embryonic development. Laboratory components provided an intro-
duction into the technical aspects of working with and analyzing mouse embryos, and lectures provid-
ed the conceptual basis for contemporary research in mouse development. Experimental techniques
were covered in the practicals including in vitro culture and manipulation of preimplantation and postim-
plantation embryos, transgenesis by DNA microinjection, embryo transfer, establishment, culture and
genetic manipulation of embryonic stem cells, production of chimeras by aggregation with and injec-
tion of embryonic stem cells and the analysis of development by whole-mount in situ hybridization,
skeletal preparation, and transgene expression. This year's speakers were Richard Behringer, Timothy
Bestor, James Cross, Charles Emerson, Thomas Gridley, Brigid Hogan, Monica Justice, Robb
Krumlauf, Mark Lewandoski, Robin Lovell-Badge, Anne McLaren, Andras Nagy, Nadia Rosenthal, John
Schimenti, Heidi Scrable, Austin Smith, Davor Solter, A. Francis Stewart, Patrick Tam, David Threadgill,
and Luk Van Parijs.
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PARTICIPANTS
Agostino, A., B.S., Neurologica Institute, Milan, Italy
Beck, C., Diploma Central Institute for Mental Health,
Mannheim, Germany
Carmell, M., B.A., Cold Spring Harbor Laboratory
Cheloufi, S., B.S., Cold Spring Harbor Laboratory
Ciaudo, C., M.S., L'Institut Pasteur, Paris, France
Jones, E., M.S., California Institute of Technology, Pasadena
Juhl, K., M.S., University of Colorado Health Sciences Center,
Denver
Lanner, F., B.S., Karolinska Institutet, Stockholm, Sweden
SEMINARS
Behringer, R., The University of Texas, Houston: Transgenesis
and gene targeting.
Bestor, T., Columbia University, New York: Epigenetics.
Capel, B., Duke University Medical Center, Durham, North
Carolina: Gonad organogenesis.
Cross, J., University of Calgary, Canada: Development of
extraembryonic tissue.
Emerson, C., University of Pennsylvania, Philadelphia: Muscle
development.
Gridley, T, The Jackson Laboratory, Bar Harbor, Maine: Notch
signaling.
Hogan, B., Duke University Medical Center, Durham, North
Carolina: Genetic regulation of organogenesis.
Justice, M., Baylor College of Medicine, Houston, Texas: ENU
mutagenesis.
Krumlauf, R., Stowers Institute for Medical Research, Kansas
City, Missouri: Patterning in the CNS and vertebrate embryo.
Lewandowski, M., National Cancer Institute, Frederick,
Maryland: Molecular genetics of limb development.
Lovell-Badge, R., MRC National Institute for Medical
Research, United Kingdom: Sex determination: Building
genetic pathways.
Lufkin, T., Mount Sinai School of Medicine, New York:
Homeobox genes and patterning.
Magnuson, T, University of North Carolina, Chapel Hill: Model
system mouse-A synthesis and example.
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McBratney, B., B.A., Harvard University, Cambridge,
Massachusetts
Morris, L., M.S., University of Edinburgh, United Kingdom
Pasqua letti, M., Ph.D., University of Pisa, Italy
Ryan, K., Ph.D., CHOP and University of Pennsylvania,
Philadelphia
Shureiqi, I., M.D., University of Texas/MD Anderson Cancer
Center, Houston
Woodhoo, A., B.S., University College London, United
Kingdom
McLaren, A., Wellcome/CRC Institute, Cambridge, United
Kingdom: Germ cells and imprinting.
Nagy, A., Samuel Lunenfeld Research Institute, Toronto,
Canada: Embryonic stem cells and the biology of
chimeras.
Rosenthal, N., European Molecular Biology Laboratory, Italy:
Heart development.
Schimenti, J., The Jackson Laboratory, Bar Harbor, Maine:
Modern and classical forward approaches in mice for identi-
fying novel developmental genes.
Scrable, H., University of Virginia, Charlottesville: Emerging
technologies in transgenic mice.
Shen, M., UMDNJRobert Wood Johnson Medical School,
Piscataway, New Jersey: Left-right patterning.
Smith, A., University of Edinburgh, United Kingdom: Stem cells.
Solter, D., Max-Planck-Institut fur Immunbiologie, Freiburg,
Germany: Cloning and preimplantation development.
Stewart, C., National Cancer Institute, Frederick, Maryland:
Implantation.
Tam, P., University of Sydney, Australia: Postimplantation
development and body plan. Mouse models and experimen-
tal manipulation.
Threadgill, D., University of North Carolina, Chapel Hill:
Bioinformatics.
Van Parijs, L., Massachusetts Institute of Technology,
Cambridge: Lentivirus-based transgenesis.
Ion Channel Physiology
June 4-24
INSTRUCTORS M. Farrant, University College London, United Kingdom
M. Hausser, University College London, United Kingdom
N. Spruston, Northwestern University, Evanston, Illinois
ASSISTANTS B. Clark, University College London, United Kingdom
T. Jarsky, Northwestern University, Evanston, Illinois
B. Steil, University of California, Los Angeles
The primary goal of this course was to investigate, through lectures and laboratory work, the proper-
ties of ion channels that allow neurons to carry out their unique physiological functions in a variety of
neural systems. Areas of particular interest included channels that (1) are activated by neurotransmit-
ter at central and peripheral synapses, (2) are activated by voltage changes in axons and dendrites, (3)
respond to neuromodulators with changes in functional properties, or (4) are developmentally required
and regulated. The research interests of guest lecturers reflected these areas of emphasis.
The laboratory component of the course introduced students to electrophysiological approaches
for the study of ion channels in their native environments. Hands-on exercises included patch-clamp
recording of ion-channel activity in acutely isolated or cultured cells or neurons in brain slice prepara-
tions. Different recording configurations were used (e.g., whole-cell, cell-free, and nucleated patches)
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to examine macroscopic or single-channel activity. Similarly, various methods of ligand and drug appli-
cation were demonstrated. The advantages and disadvantages of each method, preparation, and
recording technique were considered in relation to the specific scientific questions being asked.
PARTICIPANTS
Biro, A., M.D., Institute of Experimental Medicine, Budapest,
Hungary
Ellis-Davies, G., Ph.D., Drexel University College of Medicine,
Philadelphia, Pennsylvania
Gray, N., B.S., Mayo Graduate School, Rochester, Minnesota
Jiang, J., B.S., Columbia University, New York
Kaczorowski, C., B.A., Northwestern University, Chicago,
Illinois
Keck, T., B.A., Boston University, Massachusetts
SEMINARS
Borst, G., Universiteit van Amsterdam, The Netherlands:
Presynaptic calcium channels and transmitter release.
Jonas, P., Albert-Ludwigs-Universitat, Freiburg, Germany:
Glutamate receptors and synaptic transmission.
Llinas, R., New York University School of Medicine, New York:
Ion channels and integration.
Mackinnon, R., The Rockefeller University, New York:
Structure and function of voltage-gated channels.
Nerbonne, J., Washington University School of Medicine, St.
Louis, Missouri: Voltage-gated K channels in heart and neu-
rons.
Nolan, M., Columbia University, New York: Hyperpolarization-
activated cation channels.
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Mandolesi, G., B.S., Scuola Norma le Superiore, Pisa, Italy
Margolis, D., B.S., University of Washington, Seattle
Marinelli, M., Ph.D., FUHSiThe Chicago Medical School,
Illinois
Moenter, S., Ph.D., University of Virginia, Charlottesville
Phillips, M., B.S., Massachusetts Institute of Technology,
Cambridge
Si, K., Ph.D., Columbia University, New York
Otis, T., University of California, Los Angeles: Glutamate
uptake.
Raman, I., Northwestern University, Evanston, Illinois: Action
potential, Hodgkin-Huxley, Na channels.
Svoboda, K., Cold Spring Harbor Laboratory: Imaging meth-
ods for studying ion channels.
Trimmer, J., Stony Brook University, New York: Accessory
subunits of voltage-gated channels.
Turrigiano, G., Brandeis University, Waltham, Massachusetts:
Homeostatic synaptic plasticity.
Zamponi, G., University of Calgary, Canada: Voltage-gated Ca
channels.
Making and Using DNA Microarrays
June 17-24
INSTRUCTORS V. lyer, University of Texas, Austin
J. Lieb, University of North Carolina, Chapel Hill
ASSISTANTS E. Diaz, University of California, Berkeley, Davis
A. Carroll, University of California, San Francisco
K. Jeffers, University of Texas, Austin
P. Killion, University of Texas, Austin
C. Lee, University of North Carolina, Chapel Hill
M. Llinas, University of California, San Francisco
D. Verdnik, Axon Instruments, Foster City, California
A DNA microarray is a simple, inexpensive, and versatile tool for experimental explorations of genome
structure, gene expression programs, gene function, and cell and organismal biology. In this hands-on
course, students were guided through the process of building a robot for printing DNA microarrays,
preparing DNA samples and slides to be used for printing microarrays, printing DNA microarrays,
designing and conducting experiments for analysis by DNA microarray hybridization, data analysis, dis-
play, and interpretation. Experimental applications covered in the course included systematic studies
of global gene expression programs, inferring gene function using microarrays, genotyping, and mea-
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suring changes in gene copy number. Students who completed this course were able to set up their
own independent facility for printing and experimental use of DNA microarrays. Guest lecturers pre-
sented on state-of-the-art technology, experimental applications, and interpretation of large genomic
data sets.
PARTICIPANTS
Agalioti, T., Ph.D., Columbia University, New York
Agindotan, B., Ph.D., University of Idaho, Moscow
del Pi lar Aguinaga, M., Ph.D., Meharry Medical College,
Nashville, Tenneessee
Alexeyev, M., Ph.D., University of South Alabama, Mobile
Baxi, Mohit, Ph.D., Canadian Food Inspection Agency,
Alberta, Canada
Constancia, J., Ph.D., The Babraham Institute, Cambridge,
United Kingdom
Corley-Smith, G., Ph.D., Oregon State University, Corvallis
Eng len, M., Ph.D., U.S. Department of Agriculture, Athens,
Georgia
Fong, S., Ph.D., California Pacific Medical Center, San
Francisco
Gaitan-Solis, E., B.A., Centro Internacional de Agricultura
Tropical, Cali, Columbia
Hanson, L., Ph.D., Mississippi State University
SEMINARS
Dudoit, S., University of California, Berkeley: The bioconductor
project: Open-source statistical software for the analysis of
microarray data.
Murphy, C., University of California, San Francisco: Using
microarrays to find C. elegans aging genes.
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Levenson, C., Ph.D., Florida State University, Tallahassee
Li, H., B.S., University of California, Los Angeles
Liebana, E., Ph.D., Veterinary Laboratories Agency-Weybridge,
Addelstone, United Kingdom
Pearce, D., Ph.D., British Antarctic Survey, Cambridge, United
Kingdom
Pessler, F., Ph.D., The Children's Hospital of Philadelphia,
Pennsylvania
Ranade, S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Trolliet, M., Ph.D., Boston University School of Medicine,
Massachusetts
Yennu-Nanda, V., Ph.D., University of Texas/M.D. Anderson
Cancer Center, Houston
York, D., M.S., University of Delaware Biotechnology Institute,
Newark
Sherlock, G., Stanford University, California: Organization and
analysis of DNA microarray data.
Skene, P., Duke University, Durham, North Carolina: Old dogs
and microarrays-Bringing microarrays into an established
research program.
Developmental Neurobiology
June 20-July 3
INSTRUCTORS B. Barres, Stanford University School of Medicine, California
J. Sanes, Washington University School of Medicine, St. Louis, Missouri
The aim of this lecture course was to discuss principles and recent advances in developmental neu-
robiology. Major topics considered included determination, proliferation and differentiation of neural
cells; trophic interactions in neural development; guidance of axons to targets; formation and
rearrangement of synapses; activity-dependent synaptic remodeling and development of behavior.
These topics were considered within the context of the development of both invertebrate and verte-
brate neural systems. Prospective students had a background in neurobiology or molecular biology.
The course was held at the Laboratory's Banbury Conference Center.
PARTICIPANTS
Andersson, E., M.S., Lund University, Sweden
Arikkath, J., Ph.D., University of California, San Francisco
Campbell, G., Ph.D., University of California, Berkeley
Choe, K., Ph.D., Stanford University School of Medicine,
California
Daneman, R., B.S., Stanford University, California
Deppmann, C., B.S., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Gelkop-Abramowicz, S., Ph.D., Samuel Lunenfeld Research
Institute, Toronto, Ontario, Canada
Haflidadottir, B., M.S., Harvard Medical School, Boston,
Massachusetts
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Huberman, A., M.A., University of California, Davis
Leung, K., B.S., University of Cambridge, United Kingdom
Karpova, A., Ph.D., Cold Spring Harbor Laboratory
Meletis, K., M.S., Karolinska Institutet, Stockholm, Sweden
Nielsen, M., B.S., University of Copenhagen, Denmark
Pak, W., B.S., The Salk Institute, La Jolla, California
Pham, K., Ph.D., Stanford University School of Medicine,
California
Raveh, T., Ph.D., Stanford University, California
Reis, R., Ph.D., Oxford University, Oxford, United Kingdom
SEMINARS
Barres, B., Stanford University School of Medicine, California:
Trophism. GLIA.
Cline, H., Cold Spring Harbor Laboratory: Axonal arborization.
Davis, G., University of California, San Francisco: Synapse
growth.
Du lac, C., Harvard University, Cambridge, Massachusetts:
Transgenic approaches to behavior.
Feldman, D., University of California, San Diego: Plasticity in
cortex.
Ghosh, A., Johns Hopkins Medical School, Baltimore, Mary-
land: Dendrite guidance.
Jan, Y.N., University of California, San Francisco: Neurogene-
sis and neuronal differentiation.
Jessell, T., Columbia University, New York: Regionalization and
patterning.
Knudsen, E., Stanford University School of Medicine,
California: Auditory learning and plasticity.
Lichtman, J., Washington University, St. Louis, Missouri:
Synaptic rearrangements.
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Thompson, C., MA., Harvard Medical School, Boston,
Massachusetts
Torborg, C., BA., University of California, San Diego
Valente, A., BA., Gulbenkian Institute of Science, Oeiras,
Portugal
Vallstedt, A., M.S., Karolinska Institutet, Stockholm, Sweden
van den Akker, W., Ph.D., Netherlands Institute for
Developmental Biology, Utrecht, The Netherlands
Wu, J., Ph.D., Stanford University, California
Morrison, S., University of Michigan, Ann Arbor: Lineage
and stem cells.
O'Leary, D., Salk Institute, San Diego, California: Cortex-
patterning. Map formation in brain.
Raff, M., University College London, United Kingdom: Cell
survival and growth.
Sanes, J., Washington University School of Medicine, St.
Louis, Missouri: Overview of neural development. Synapse
formation. Synaptic specificity.
Stern, C., University College London, United Kingdom:
Neural induction.
Tessier-Lavigne, Stanford University, California: Axon
guidance and regeneration.
Van Vactor, D., Harvard Medical School, Boston, Massa-
chusetts: Axon growth.
Walsh, C., Beth Israel Deaconess Medical Center,
Boston, Massachusetts: Neuronal migration and its
disorders.
Mouse Behavioral Analysis
June 27-July 10
INSTRUCTORS S. Anagostaras, Emory University, Atlanta, Georgia
M. Mayford, The Scripps Research Institute, La Jolla, California
CO-INSTRUCTOR M. Fanselow, University of California, Los Angeles
ASSISTANTS S. Mitchell, Emory University, Atlanta, Georgia
J. Quinn, University of California, Los Angeles
M. Tinsley, University of California, Los Angeles
A. Wilson, Emory University, Atlanta, Georgia
This course was intended to provide a theoretical and experimental introduction to behavioral analysis
in the mouse, with a focus on learning and memory. It was specially designed for geneticists, molecu-
lar biologists, pharmacologists, and electrophysiologists with a need for a hands-on introduction to
behavioral analysis of the mouse. Additionally, the course covered the principles of using mutant mice
in behavioral studies, as well as the issues involved in integrating behavioral, neuroanatomical, neuro-
physiological, and molecular findings. Among the methods presented were the water maze, cued and
contextual fear conditioning, natural ethologically-relevant learning, open field behavior, the rotor-rod,
and other activity tests.
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PARTICIPANTS
Adachi, N., B.S., Kobe University, Kobe, Japan
Bryceson, Y., M.S., NIH/Karolinska Institutet, Rockville,
Maryland
Deisseroth, K., Ph.D., Stanford University, California
Diana, G., M.D., Higher Institute of Health, Rome, Italy
Fischer, D., Ph.D., Netherlands Institute for Brain Research,
Amsterdam, The Netherlands
Hertz, J., B.S. Massachusetts Institute of Technology,
SEMINARS
Bourtchouladze, R., Helicon Therapeutics, Inc., Woodbury,
New York: cAMP signaling and memory: From genes to
drugs.
Costa, R., Duke University, Durham, North Carolina: Cognitive
dysfunction: From molecules to systems in mouse models.
Holland, P., Johns Hopkins University, Baltimore, Maryland:
Introduction to learning and memory.
Knowlton, B., University of California, Los Angeles: The hip-
pocampus and human memory.
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Cambridge
Hossain, S., Ph.D., Centre for Molecular Medicine &
Therpaeutics, British Columbia, Canada
larkov, A., Ph.D., Sun Health Research Institute, Sun City,
Arizona
Kanisek, M., B.S., Mount Sinai Hospital, Toronto, Canada
Singh, M., Ph.D., Vanderbilt University, Nashville,
Tennessee
Maren, S., University of Michigan, Ann Arbor: Fear memory
circuits in the brain.
Murphy, G., University of California, Los Angeles: Mouse mod-
els of age-related cognitive decline.
Thomas, M., University of Minnesota, Minneapolis:
Psychostimulant-induced plasticity in neural circuitry and
behavior.
Waldman, I., Emory University, Atlanta, Georgia: Dopamine
genes and children's disruptive behavior disorders.
Arabidopsis Molecular Genetics
June 27-July 17
INSTRUCTORS J. Bowman, University of California, Davis
U. Grossniklaus, University of Zurich, Switzerland
R. Pruitt, Purdue University, W. Lafayette, Indiana
ASSISTANTS A. Izhaki, University of California, Davis
R. Lee, Purdue University, W. Lafayette, Indiana
J.M.E. Restrepo, University of Zurich, Switzerland
This course provided an intensive overview of topics in plant growth, physiology, and development,
focusing on molecular genetic approaches to understanding plant biology. It emphasized recent results
from Arabidopsis thaliana and other model plants and provided an introduction to current methods
used in Arabidopsis research. It was designed for scientists with experience in molecular techniques
or in plant biology who wish to work with Arabidopsis. The course consisted of a vigorous lecture
series, a hands-on laboratory, and informal discussions. Discussions of important topics in plant
research were presented by the instructors and by invited speakers. These seminars included plant
morphology and anatomy; plant development (including development of flowers, roots, meristems, and
leaves, male and female gametophytes, and embryos); perception of light and photomorphogenesis;
and synthesis, function, and perception of hormones. Lectures describing bioinformatics tools avail-
able to the Arabidopsis community, and the resources provided by the Arabidopsis genome project to
accelerating Arabidopsis research were also included. Speakers provided overviews of their fields, fol-
lowed by in-depth discussions of their own work. The laboratory sessions provided an introduction to
315
important techniques currently used in Arabidopsis research. These included studies of Arabidopsis
development, mutant analysis, in situ detection of RNA, histochemical staining, transient gene expres-
sion, applications of green fluorescent protein fusions, protein interaction and detection, proteomics
approaches, transcription profiling, techniques commonly used in genetic and physical mapping. The
course also included several short workshops on important themes in genetics.
This year's speakers included Rick Amasino, Jody Banks, Kathryn Barton, David Baum, Winslow
Briggs, James Carrington, Dean DellaPenna, Nancy Deng ler, Hugo Dooner, Ted Farmer, Roger
Hangarter, Jeff Harper, Thomas Jack, David Jackson, Nancy Kerk, Maarten Koornneef, Hong Ma,
Jocelyn Malamy, Ashi Malekafzali, Robert Martienssen, Peter Mc Court, Tim McNellis, June Nasrallah,
Scott Peck, Leonora Reiser, Eric Richards, G. Eric Schaller, and Ian Sussex.
PARTICIPANTS
Bierwagen, T., B.S., Iowa State University, Ames
Blum, E., M.S., Weizmann Institute of Science, Rehovot, Israel
Bouveret, R., M.S., Swiss Federal Institute of Technology,
Zurich, Switzerland
Eren, E., M.S., Worcester Polytechnic Institute,
Massachusetts
Galego, L., Ph.D., Institute de Tecnologia Quimica e Biologica
Oeiras, Portugal
Hansen, B., M.S., Royal Veterinary and Agricultural and
University, Copenhagen, Denmark
Khambatta, Z., M.S., Bali Helix, W. Chicago, Illinois
Martelotto, L., B.S., Institute for Molecular and Cellular Biology
of Rosario, Argentina
SEMINARS
Amasino, R., University of Wisconsin, Madison: Flowering
time.
Banks, J., Purdue University, W. Lafayette, Indiana:
Gametophytes and evolution.
Barton, K., Carnegie Institution of Washington, Stanford,
California: Embryogenesis.
Baum, D., University of Wisconsin, Madison: Evolution.
Bowman, J., University of California, Davis: Leaves.
Briggs, W., Carnegie Institution of Washington, Stanford,
California: The big picture.
Carrington, J., Oregon State University, Corvallis: Epigen-
etics I.
DellaPenna, D., Michigan State University, E. Lansing:
Secondary metabolism.
Deng ler, N., University of Toronto, Ontario, Canada: Plant
anatomy.
Dooner, H., Rutgers University, Piscataway, New Jersey:
Transposons.
Farmer, T., University of Lausanne, Switzerland: Custom
microarrays.
Kerk, N., Yale University, Guilford, Connecticut: Laser capture
microscopy.
Grossniklaus, U., University of Zurich, Switzerland: Female
gametophyte.
Hangarter, R., Indiana University, Bloomington: Light respons-
es.
Harper, J., The Scripps Research Institute, La Jolla, California:
Calcium and signaling.
316
McLean, M., Ph.D., University of Guelph, Ontario,
Canada
Melo, D., B.S., Performance Plants Inc., Ontario,
Canada
Moreau, C., B.S., Umea Plant Science Centre, Sweden
Oono, Y., B.S., RIKEN Tsukuba Institute, Ibaraki, Japan
Sato, M., Ph.D., Hokkaido University, Sapporo, Japan
Sohn, S.O., B.S., Chonnam National University, Gwangju,
South Korea
Somberg, A.M., M.S., Swedish University of Agricultural
Sciences, Uppsala, Sweden
Teixeira, R., B.S., SLU-Swedish University of Agricultural
Sciences, Uppsala, Sweden
Koornneef, M., Wageningen University, The Netherlands:
Quantitative genetics.
Malamy, J., University of Chicago, Illinois: Roots.
Nasrallah, J., Cornell University, Ithaca, New York: Self-incom-
patibility.
Pruitt, B., Purdue University, W. Lafayette, Indiana: Male
gametophyte and signaling.
Sussex, I., Yale University, Guilford, Connecticut: Introduction.
Jack, T, Dartmouth College, Hanover, New Hampshire:
Flowers.
Jackson, D., Cold Spring Harbor Laboratory: Meristem and
leaf.
Ma, H., Pennsylvania State University, University Park: Anther
development and meiosis.
Martienssen, R., Cold Spring Harbor Laboratory: Enhancer
traps.
Mc Court, A, University of Toronto, Ontario, Canada: Hormone
networks.
McNellis, T., Pennsylvania State University, Philadelphia: Plant
pathogen.
Peck, S., Sainsbury Laboratory, Norwich, United Kingdom:
Proteomics.
Reiser, L., The Arabidopsis Information Resource, Stanford,
California: Bioinformatic resources.
Richards, E., Washington University, St. Louis, Missouri:
Epigenetics II.
Schaller, G.E., University of New Hampshire, Durham:
Ethylene.
Neurobiology of Drosophila
June 27-July 17
INSTRUCTORS R. Baines, University of Warwick, Coventry, United Kingdom
S. de Belle, University of Nevada, Las Vegas
D. Van Vactor, Harvard Medical School, Boston, Massachusetts
ASSISTANTS K. Baughman, Harvard Medical School, Boston, Massachusetts
A. Belay, University of Toronto, Mississauga, Canada
E. Pym, University of Warwick, Coventry, United Kingdom
This laboratory/lecture course was intended for researchers at all levels from beginning graduate stu-
dents through established primary investigators who want to use Drosophila as an experimental sys-
tem for nervous system investigation. The three-week course was divided into the study of develop-
ment, physiology/function, and behavior. Daily seminars introduced students to a variety of research
topics and developed those topics by including recent experimental contributions and outstanding
questions in the field. Guest lecturers brought original preparations for viewing and discussion and
direct laboratory exercises and experiments in their area of interest. The course provided students with
hands-on experience using a variety of experimental preparations that were used in the investigation
of current neurobiological questions. The lectures and laboratories focused on both the development
of the nervous system and its role in controlling larval and adult behaviors. In addition to an exposure
to the molecular genetic approaches available in Drosophila, students learned a variety of techniques
including embryo in situ hybridization; labeling of identified neurons; electrophysiological recording from
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nerves and muscles; and the analysis of larval and adult behavior. Collectively, the course provided a
comprehensive and practical introduction to modern experimental methods for studying the
Drosophila nervous system. This year's lecturers included: Vanessa Auld, Ross Cagan, Josh Dubnau,
Daniel Eberl, James Gergel, Tanja Godenschwege, Andreas Keller, Juergen Knoblich, Matthias
Landgraf, Dennis Mathew, Rod Murphey, Howard Nash, Kevin O'Dell, Dietmar Schmucker, Marla
Sokolowski, Bryan Stewart, Roland Strauss, Ulrich Tepass, and JenniferShuler Waters.
PARTICIPANTS
Ball, R., B.S., University of California, Berkeley
Besse, F., Ph.D., European Molecular Biology Laboratory,
Heidelberg, Germany
Bhalerao, S., M.S., Research Institute of Molecular Pathology,
Vienna, Austria
Bolduc, F., M.D., McGill University, Montreal, Canada
Dimitropoulou, A., B.A., University of Miami School of
Medicine, Florida
SEMINARS
Auld, V., University of British Columbia, Vancouver, Canada:
Glial development.
Baines, R., University of Warwick, United Kingdom: Synaptic
plasticity. CNS Electrophysiology.
Budnick, V. University of Massachusetts, Amherst: The
synapse.
Cagan, R., Washington University, St. Louis, Missouri: Death
and the eye.
de Belle, S., University of Nevada, Las Vegas: Introduction to
fly behavior. Learning and memory: Hardware.
Dubnau, J., Cold Spring Harbor Laboratory: Learning and
memory: Software.
Ebert D., University of Iowa, Iowa City: Mechanosensation.
Gergel, J., Cold Spring Harbor Laboratory: Genomics 101.
Genomics 102.
Keller, A., The Rockefeller University, New York: Sensory phys-
iology.
Landgraf, M., Cambridge University, United Kingdom:
Neuronal identity.
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Kaun, K., B.S., University of Toronto, Mississauga, Canada
Kristiansen, L., M.S., University of Michigan, Ann Arbor
Muraro, N., M.S., University Warwick, Coventry, United
Kingdom
Schmidt, M., M.A., Max-Planck-Institut, Gottingen, Germany
Schulz, J., M.D., University of Leuven, Belgium
Thimgan, M., B.S., University of North Carolina, Chapel Hill
Uthaman, S., Ph.D., University of Massachusetts, Amherst
Murphy, R., University of Massachusetts, Amherst: Giant fiber
system.
Nash, H., NIMH, National Institutes of Health, Bethesda,
Maryland: Anesthesia.
O'Dell, K., University of Glasgow, United Kingdom: Courtship.
Schmucker, D., Harvard University, Cambridge,
Massachusetts: Postembryonic PNS.
Shuler Waters, J., Harvard University, Cambridge,
Massachusetts: Confocal microscopy.
Sokolowski, M., University of Toronto, Canada: Foraging.
Stewart, B., University of Toronto, Canada: Electrophysiology
101. Synaptic transmission.
Strauss, R., Theodor-Bovri-lnstitute, Wurzburg, Germany:
Motor behavior. Visual system.
Tepass, U., University of Toronto, Ontario, Canada: The fly
embryo and adult.
Van Vactor, D., Harvard University, Cambridge,
Massachusetts: Fly genetics 101. Axon guidance.
Advanced Techniques in Molecular Neuroscience
July 2-17
INSTRUCTORS J. Boulter, University of California, Los Angeles
L. Henry, Cold Spring Harbor Laboratory
K. Jensen, The Rockefeller University, New York
C. Lai, Scripps Research Institute, La Jolla, California
D. Lavery, Purdue Pharma LP, Cranbury, New Jersey
ASSISTANTS J. Arjomand, University of California, Los Angeles
I. Cheung, Scripps Research Institute, La Jolla, California
K. Dredge, The Rockfeller University, New York
A. Klaassen, University of California, Los Angeles
M. Samson, Harvard Medical School/HHMI, Boston, Massachusetts
W. Walwyn, University of California, Los Angeles
This newly revised laboratory and lecture course was designed to provide neuroscientists at all levels
with a conceptual and practical understanding of several of the most advanced techniques in molec-
ular neuroscience. The course curriculum was divided into three sections: an extensive and up-to-date
set of laboratory exercises; daily lectures covering the theoretical and practical aspects of the various
methods used in the laboratory; and a series of evening research seminars. The informal and interac-
tive evening lectures were given by leading molecular neuroscientists and illustrated the ways in which
the various experimental approaches have been used to advance specific areas of neurobiology. In this
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year's course, the laboratory portion included topics such as an introduction to the design and use of
animal virus vectors in neurobiology; the use of small interfering RNAs (siRNA) for regulating the
expression of specific genes in neurons; practical exercises in gene delivery systems, including mam-
malian cell transfection protocols and single-cell electroporation techniques for targeted gene transfer
in vivo; an introduction to overall strategies, use, and design of bacterial artificial chromosome (BAC)
transgenic vectors; multiplex and whole-genome expression analyses using the most recent DNA
microarray technologies (including labeled probe preparation, data analyses, mining, and interpreta-
tion); quantitative real-time reverse transciptase-polymerase chain reaction (RT-PCR) analyses from
small numbers of cells (RNA purification, PCR optimization, interpretation of results); single-cell PCR
and cDNA library construction; and methods and application of RNA amplification (aRNA). Each labo-
ratory module was followed by comprehensive data analyses and interpretation, protocol trou-
bleshooting, and suggestions for ways to improve or modify the existing technique. Finally, course par-
ticipants were introduced to bioinformatics and a wide range of Internet resources which are available
to molecular neuroscientists.
PARTICIPANTS
Akerman, C., Ph.D., Cold Spring Harbor Laboratory
Baker, C., Ph.D., University of Cambridge, United Kingdom
Chu, J., Ph.D., The Scripps Research Institute, La Jolla,
California
Close, J., B.A., University of Washington, Seattle
Duan, J., Ph.D., University of Chicago, Ilinois
Engstrom, L., M.S., Linkoping University, Sweden
Jakobs, T, M.D., Massachusetts General Hospital, Boston
Jolly, R., M.S., University College London, United Kingdom
Ju, C., B.S., Columbia University, New York
Lambe, E., Ph.D., Yale University, New Haven, Connecticut
SEMINARS
Barres, B., Stanford University, California: Neuron-glial interac-
tions in the developing CNS.
Eberwine, J., University of Pennsylvania, Philadelphia:
Molecular analysis of dendritic functioning: mRNA localiza-
tion, mRNA transport, and local protein synthesis.
Feinstein, P., The Rockefeller University, New York: Axon guid-
ance with odorant receptors.
Fisher', G., Skirba II Institute, New York University, New York:
Experimental genetic and cell biological approaches to pat-
terning, proliferation, and migration in the developing telen-
cephalon.
Patapoutian, A., The Scripps Institute, La Jolla, California: The
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Lopez-Bendito, G., Ph.D., University of Oxford, United
Kingdom
Lukaszewicz, A., M.S., INSERM, Bron, France
McQuiston, R., Ph.D., Virginia Commonwealth University
Medical Campus, Richmond
Ting, J., B.S., University of Washington, Seattle
Watkins, T, A.B., Stanford University School of Medicine,
California
Weiner, J., Ph.D., Washington University School of Medicine,
St. Louis, Missouri
sense of touch: A genomic approach.
Scrable, H., University of Virginia, Charlottesville: Conditional
doesn't have to be forever: Reversible control of gene
expression in the mouse with the lac operator-repressor sys-
tem.
Weinmaster, G., David Geffen School of Medicine at the
University of California, Los Angeles: Modulation of ligand-
induced notch signaling.
Yang, W., David Geffen School of Medicine at the University of
California, Los Angeles: BAC transgenic approach to study
neuronal function and dysfunction.
WORKSHOP ON THEORETICAL NEUROSCIENCE
Optimization and Constraints in the Evolution of Brain Design
July 14-20
INSTRUCTORS D. Chklovskii, Cold Spring Harbor Laboratory
C. Stevens, The Salk Institute
In this workshop, participants presented successful examples of constrained optimization of brain
design and function and debated the virtues and pitfalls of the optimization approach. The brain is a
result of evolution by natural selection, which favors optimal use of limited resources; it is natural to use
constrained optimization as a tool to understand brain design and function. An understanding of what
is being optimized and under which constraints would allow us to unify many disjointed experimental
facts into a single theoretical framework. Such framework can yield a deeper understanding of the
brain and can guide future experiments.
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LECTURERS
Andreau, A., Johns Hopkins University, Baltimore, Maryland:
Optimization of sensory information processing.
Balasubramanian, V, University of Pennsylvania, Philadelphia:
Why the retina uses parallel channels II.
Bialek, W., Princeton University, New Jersey: Optimization in
neurobiology.
Boahen, K., University of Pennsylvania, Philadelphia: Wiring
feature maps by following gradients.
Condron, B., University of Virginia, Charlottesville: Wiring of
serotonergic neurons in development.
Dimitrov, A., University of Montana, Bozeman: Unit failure and
neural circuit complexity.
Koulakov, A., University of Utah, Salt Lake City: How to play
golf with eye balls.
Levy, W., University of Virginia, Charlottesville: Energy-efficient
neuronal computation.
Miller, K., University of California, San Francisco: Model for
PARTICIPANTS
Atwal, G., Princeton University, New Jersey
Buchanan, D., Columbia University, New York
Chigirev, D., Princeton University, New Jersey
Goldberg, D., Johns Hopkins University, Baltimore, Maryland
Howe, C., Duke University, Durham, North Carolina
Mysore, S., California Institute of Technology, Pasadena
Nundy, S., Duke University, Durham, North Carolina
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contrast-invariant orientation tuning in
Mitra, R, Cold Spring Harbor Laboratory, New York: Optical
fiber capacity.
Mokhtarzada, Z., University of Maryland, College Park:
Optimal wiring in neuroanatomy.
Purves, D., Duke University. Chapel Hill, North Carolina: What
do music and vision have in common?
Shefi, 0., Tel-Aviv University, Israel: Biophysical constraints on
neuronal branching.
Stepanyants, A., Cold Spring Harbor Laboratory, New York:
Branching law of axons.
Sterling, R, University of Pennsylvania, Philadelphia: Why the
retina uses parallel channels I.
Wang, S., Princeton University, New Jersey: Speed limits in
mammalian brains: Scaling constraints from biophysics.
White, J., Boston University, Massachusetts: Minimal axon
diameter.
Schneider, K., Princeton University, New Jersey
Snider, J., University of California, Irvine
Taba, B.,University of Pennsylvania, Philadelphia
Wang, J., Stony Brook University, New York
Wyatt, K., Princeton University, New Jersey
Yang, Z., Duke University, Durham, North Carolina
C. elegans
July 22-August 11
INSTRUCTORS B. Bowerman, University of Oregon, Eugene
A. Chisholm, University of California, Santa Cruz
S. Clark, New York University School of Medicine, New York
ASSISTANTS C. Carter, University of Oregon, Eugene
S. Moseley, University of California, Santa Cruz
W. Woo, University of California, Santa Cruz
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans Genome
Project. The course was suited both for those who have a current training in molecular biology and
II
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some knowledge of genetics, but had no experience with C. elegans, and for students with some prior
worm experience who wished to expand their repertoire of expertise. The following topics were cov-
ered both in the laboratory and by lectures from experts in the field: worm pushing, C. elegans data-
bases and worm bioinformatics, anatomy and development, forward genetics, chemical and transpo-
son mutagenesis, generation of transgenic animals, expression pattern analysis, reverse genetics, con-
struction and screening of deletion libraries, and RNA inactivation. The course was designed to impart
sufficient training to students in the most important attributes of the C. elegans system to enable stu-
dents to embark on their own research projects after returning to their home institutions.
PARTICIPANTS
Berkovitz, H., Ph.D., Merrimack College, Andover, Massa-
chusetts
Conner, S., Ph.D., The Scripps Research Institute, La Jolla,
California
Cueva, J., Ph.D., Stanford University, California
Furukawa, T, Ph.D., Osaka Bioscience Institute, Osaka,
Japan
Garvis, S., Ph.D., Centre National de Recherche Scientific,
Marseille, Franc
Glaser, S., B.S., Eidgenossiche Technische Hochschule (ETH)
Hoenggerberg, Zurich, Switzerland
Handwerger, K., Ph.D., Whitehead Institute, Cambridge,
Massachusetts
SEMINARS
Ambros, V, Dartmouth Medical School, Hanover, New
Hampshire: Small RNAs in C. elegans.
Conradt, B., Max-Planck-Institute of Neurobiology,
Martinsried/Munich, Germany: C. elegans neurobiology.
Felix, M.-A., L'Institut Jacques Monod, Paris, France: Genetic
studies of nematode evolution.
Goldstein, B., University of North Carolina, Chapel Hill: Cell
polarity in C. elegans embryos.
Hall, D., Albert Einstein School of Medicine, Bronx, New York:
C. elegans anatomy.
Harris, T, Cold Spring Harbor Laboratory: Wormbase and C.
briggsae.
Jin, Y., University of California, Santa Cruz: C. elegans neuro-
biology.
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Jenna, S., Ph.D., McGill University, Montreal, Canada
Liakopoulos, D., Ph.D., ETH Hoenggerberg, Zurich,
Swtizerland
Lim, R., Ph.D., Whitehead Institute, Cambridge,
Massachusetts
Miranda-Vizuete, A., Ph.D., Karolinska Institutet, Huddinge,
Sweden
Raman, C.S., Ph.D., University of Texas, Houston
Rhoads, R., Ph.D., Louisiana State University Health Sciences
Center, Shreveport
Sasano, Y., B.S., Kobe University, Hyogo, Japan
Taylor, R., Ph.D., University of Dublin, Ireland
Toyoshima, F., Ph.D., Kyoto University, Japan
Mori, I., Nagoya University, Nagoya, Japan: C. elegans neuro-
biology.
Priess, J., Fred Hutchinson Cancer Research Center, Seattle,
Washington: Cell fate patterning in early C. elegans
embryos.
Rose, A., University of British Columbia, Vancouver, Canada:
Essential genes in C. elegans.
Sengupta, P., Brandeis University, Waltham, Massachusetts:
C. elegans neurobiology.
White, J., University of Wisconsin, Madison: Cytokinesis in C.
elegans embryos.
Zarkower, D., University of Minnesota, Minneapolis: Sex deter-
mination in C. elegans.
Eukaryotic Gene Expression
July 22-August 11
INSTRUCTORS L. Attardi, Stanford University, California
W.L. Kraus, Cornell University, Ithaca, New York
M. Timmers, University Medical Centre, Utrecht, The Netherlands
ASSISTANTS S. Jacobs, Stanford University, California
M.Y. Kim, Cornell University, Ithaca, New York
M. Klejman, University Medical Centre, Utrecht, The Netherlands
This course was designed for students, postdocs, and principal investigators who have recently ven-
tured into the exciting area of gene regulation. The course focused on state-of-the-art strategies and
techniques employed in the field. Emphasis was placed on both in vitro and in vivo protein-DNA inter-
actions and on novel methodologies to study gene regulation.
Students made nuclear extracts, performed in vitro transcription reactions, and measured RNA lev-
els using primer extension. Characterization of the DNA-binding properties of site-specific transcription
factors was carried out using electrophoretic mobility-shift and DNase I footprinting assays. In addition,
students learned techniques for the assembly and analysis of chromatin in vitro. This included tran-
scription assays, chromatin footprinting, and chromatin remodeling assays.
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During the past few years, the gene regulation field has developed in vivo approaches to study gene
regulation. Students were exposed to the chromatin immunoprecipitation technique. They also used
RNA interference for specific knockdown experiments in mammalian cells. In addition, determining cel-
lular gene expression profiles has been accelerated tremendously by DNA microarray technology.
Students received hands-on training in performing and interpreting results from DNA microarrays.
Experience with basic recombinant DNA techniques was a prerequisite for admission to this course.
Lectures by the instructors covered the current status of the gene expression field, theoretical aspects
of the methodology, and broader issues regarding strategies for investigating the regulation of gene
expression in eukaryotes.
Guest lecturers discussed contemporary problems in eukaryotic gene regulation and technical
approaches to their solution. The speakers this year included: David Bentley, Shelley Berger, Arnold
Berk, David Botstein, Brian Dynlacht, Barbara Graves, Gregory Hannon, Jacqueline Lees, Anders
Naar, Ali Shilatifard, Laszlo Tora, Peter Verrijzer, and Keith Yamamoto.
PARTICIPANTS
Abdel-Fattah, G., Ph.D., Baylor College of Medicine, Houston,
Texas
Bacanamwo, M., Ph.D., Morehouse School of Medicine,
Atlanta, Georgia
Bansal, P., M.S., University of Pittsburgh, Pennsylvania
Civitareale, D., B.S., Italian National Council of Research,
Rome
De Is Mata, M., M.S., Laboratorio de Fisiologia y Biologia
Molecular, Buenos Aires, Argentina
Izumo, M., Ph.D., Vanderbilt University, Nashville, Tennessee
Kulbokas, E., B.A., Massachusetts Institute of Technology/
Whitehead Institute, Cambridge
SEMINARS
Attardi, L., Stanford University, California: Using mouse mod-
els to understand p53.
Bentley, D., University of Colorado Health Science Center,
Denver: Integration of transcription and pre-mRNA process-
ing.
Berger, S., Wistar Institute, Philadelphia, Pennsylvania:
Histone and factor modifications in gene activation.
Berk, A., University of California, Los Angeles: How does the
interaction between an activation domain and the mediator
complex stimulate transcription?
Botstein, D., Princeton University, New Jersey: Studies of
genome-wide expression in cancer.
Dynlacht, B., New York University Cancer Institute, New York:
Transcriptional control of the cell cycle.
Graves, B., University of Utah, Salt Lake City: Strategies for
specificity among ETS family of transcription factors.
Hannon, G., Cold Spring Harbor Laboratory: RNAi and its
application.
Kraus, L., Cornell University, Ithaca, New York: Molecular
mechanisms of estrogen-dependent transcription.
Lees, J., Massachusetts Institute of Technology Center for
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Li, S., M.S., Marquette University, Milwaukee, Wisconsin
Navarro Gil, P., M.S., Institut Pasteur, Paris, France
Pagano, A., Ph.D., University of Genoa, Italy
Pallafacchina, G., Ph.D., University of Padova, Italy
Parlakian, A., M.A., University Paris 7, France
Prokunina, L., M.S., Uppsala University, Sweden
Ragvin, A., M.S., University of Bergen, Norway
Schuster, M., M.S., Copenhagen University Hospital,
Denmark
Van Laere, A., Ph.D., Swedish University of Agricultural
Sciences, Uppsala, Sweden
Cancer Research, Cambridge: Understanding E2F transcrip-
tion factor function in vivo.
Naar, A., Massachusetts General Hospital Cancer
Center/Harvard Medical School, Charlestown: Functional
and structural characterization of the human ARC/Mediator
transcriptonal coactivator complex.
Shilatifard, A., St. Louis University, Missouri: Biochemical and
proteomic methods in defining molecular mechanisms of
gene expression by RNA polymerase II.
Timmers, M., University Medical Centre, Utrecht, The
Netherlands: Dynamics in RNA polymerase II transcription.
Tora, L., Institut de Genetique et de Biologie Moleculaire et
Cellulaire, Illkirch, France: Gene-specific transcriptional regu-
lation by the diversity in the components of general tran-
scription factors.
Verrijzer, P., Leiden University Medical Centre, The
Netherlands: Chromatin regulation of development and cell
proliferation.
Yamamoto, K., University of California, San Francisco:
Functional probing of transcriptional regulatory complexes.
Imaging Structure and Function in the Nervous System
July 22-August 11
INSTRUCTORS F. Helmchen, Max-Planck-Institut fur Medizinische Forschung, Heidelberg, Germany
D. Kleinfeld, University of California San Diego, La Jolla
T. Murphy, University of British Columbia, Vancouver, Canada
ASSISTANTS T. Nevian, Max-Planck-Institut fur Medizinische Forschung, Heidelberg, Germany
Y. Otsu, University of British Columbia, Vancouver, Canada
R Tsai, University of California, San Diego
W. Tyler, Harvard University, Cambridge, Massachusetts
J. Waters, Max-Planck-Institut, Heidelberg, Germany
S. Zhang, University of British Columbia, Vancouver, Canada
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes present expanding opportunities for investigating the nervous system, from synap-
tic spines to networks in the brain. This intensified laboratory and lecture course provided participants
with the theoretical and practical knowledge to utilize emerging imaging technologies. The primary
emphasis of the course was on vital light microscopy. Students learned the principles of light
microscopy, as well as use of different types of electronic cameras, laser-scanning systems, function-
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al fluorophores, delivery techniques, and digital image-processing software. In addition to transmitted
light microscopy for viewing cellular motility, the course examined a variety of molecular probes of cell
function, including calcium-sensitive dyes, voltage-sensitive dyes, photo-activated ("caged") com-
pounds, and exocytosis tracers. Issues arising in the combination of imaging with electrophysiological
methods were covered. Particular weight was given to multiphoton laser-scanning microscopy and to
newly available biological fluorophores, especially green fluorescent protein (GFP) and its variants. We
used a spectrum of neural and cell biological systems, including living animals, brain slices, and cul-
tured cells. Lecturers included Wolfhard Almers, William Betz, Holly Cline, Winfried Denk, Graham Ellis-
Davies, Jamil Farbes, Joseph Fetcho, Kurt Haas, Ernst Keller, Fred Lanni, Jeff Lichtman, Jerome Mertz,
Gero Miesenboeck, Anneliese Schaefer, Gordon Shepherd, Karel Svoboda, Philbert Tsai, and Roger
Tsien.
PARTICIPANTS
Barbour, D., Ph.D., Johns Hopkins School of Medicine,
Baltimore, Maryland
Cruz, H., M.S., University of Geneva, Switzerland
Gao, W., Ph.D., Yale University School of Medicine, New
Haven, Connecticut
Haggarty, S., B.S., Harvard University, Cambridge,
Massachusetts
Humeau, Y., Ph.D, University of Basel, Switzerland
Kara, P., Ph.D., Harvard Medical School, Boston, Massa-
chusetts
SEMINARS
Almers, W., Oregon Health & Science University, Portland:
Vesicles and TIRF microscopy.
Betz, B., University of Colorado Medical School, Denver:
Imaging secretion, FM-1-43.
Cline, H., Cold Spring Harbor Laboratory: In vivo imaging in
tadpoles.
Denk, W., Max-Planck-Institute for Medical Research,
Heidelberg, Germany: Multiphoton free lecture.
Ellis-Davies, G., MCP Hahnemann University, Philadelphia,
Pennsylvania: Ca and transmitter uncaging.
Fetcho, J., Stony Brook University, New York: In vivo imaging
in zebrafish.
Helmchen, F., Max-Planck-Institut fur Medizinische
Forschung, Heidelberg, Germany: Ca imaging basics, ratio-
ing. Applications of 2-photon microscopy.
Keller, E., Carl Zeiss, Inc., Thornwood, New York: Basic
microscopy.
Kleinfeld, D., University of California, San Diego, and Tsai, R,
University of California, San Diego: Basic optics. Digital
image processing.
Haas, K., Cold Spring Harbor Laboratory: Single-cell electro-
poration.
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Lindskog, M., Ph.D., Stanford University, California
Ringstad, N., Ph.D., Massachusetts Institute of Technology,
Cambridge
Roth-Alpermann, C., M.S., Max-Planck-Institute of
Neurobiology, Muenchen-Martinsried, Germany
Rumpal, N., M.S., University at Albany, New York
Sorensen, L., M.S., Karolinska Institutet, Huddinge,
Sweden
Wadiche, J., BA., Vollum Institute, Portland, Oregon
Lanni, F, Carnegie-Mellon University, Pittsburgh, Pennsylvania:
Fluorescence microscopy.
Lichtman, J., Washington University, St. Louis, Missouri:
Confocal microscopy.
Mertz, J., ESPCI, Paris, France: Nonlinear microscopies
Miesenboeck, G., Memorial Sloan-Kettering Cancer Center,
New York: GFP probes to image exocytosis.
Murphy, T, University of British Columbia, Vancouver, Canada:
Calcium imaging applications.
Shepherd, G., Cold Spring Harbor Laboratory: Glutamate
uncaging.
Sullivan, R., Hamamatsu Photonic Systems, Bridgewater, New
Jersey: CCD cameras intro.
Svoboda, K., Cold Spring Harbor Laboratory: 2-photon
microscopy. Applications of 2-photon microscopy.
Tsai, P., University of California, San Diego: Nonlinear optics
for imaging and ablation.
Tsien, R., University of California, San Diego: Bapta and
synthetic Ca2* indicators. Imaging intracellular
signaling.
Yeast Genetics
July 22-August 11
INSTRUCTORS D. Amberg, SUNY at Syracuse, Health Sciences Center, New York
D. Burke, University of Virginia, Charlottesville
J. Strathern, National Cancer Institute, Frederick, Maryland
ASSISTANTS M. Clark, SUNY Upstate Medical University, Syracuse, New York
C. Copeland, University of Virginia, Charlottesville
F. Malagon, National Cancer Institute, Frederick, Maryland
The Yeast Genetics course is a modern, state-of-the-art laboratory course designed to teach the stu-
dents the full repertoire of genetic approaches needed to dissect complex problems in the yeast
Saccharomyces cerevisiae. Combinations of classical genetic approaches are emphasized, including
the isolation and characterization of mutants; tetrad analysis; complementation; and mitotic recombi-
nation. Molecular genetic techniques, including various types of yeast transformation, gene replace-
ment with plasmids and polymerase chain reaction (PCR), construction and analysis of gene fusions,
and generation of mutations in cloned genes, were also emphasized. Students used classical and mol-
ecular approaches to gain experience in identifying and interpreting various kinds of genetic interac-
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tions, including suppression and synthetic lethality. Students were immersed in yeast genomics and
performed and interpreted experiments with DNA arrays. They gained first-hand experience in modern
cytological approaches such as epitope tagging and imaging yeast cells using indirect immunofluo-
rescence, green fluorescent protein (GFP)-protein fusions, and a variety of fluorescent indicators for
various subcellular organelles. Lectures on fundamental aspects of yeast genetics were presented
along with seminars given by outside speakers on topics of current interest. This year's speakers
included Joaquin Arino, Charlie Boone, Linda Breeden, Orna Cohen-Fix, Thomas Fox, Daniel
Gottschling, Alan Hinnebusch, Thomas Petes, M. Mitchell Smith, George Sprague, Tim Stearns,
Michael Tyers, Reed Wickner and Fred Winston.
PARTICIPANTS
Buchler, N., Ph.D., University of California, San Diego
Carneiro, T., B.S., Institute Medicina Moelcular, Lisboa,
Portugal
Coros, C., Ph.D., Wadsworth Center, Albany, New York
D'Souza, S., Ph.D., Massachusetts Institutes of Technology,
Cambridge
Glick, D., Ph.D., King's College, Wilkes-Barres, Pennsylvania
Johnson, T., Ph.D., University of California, San Diego
Kamvysselis, M., M.Eng., Massachusetts Institute of
Technology/Whitehead Institute, Cambridge
Kervestin, S., Ph.D., University of Massachusetts Medical
School, Worcester
SEMINARS
Arino, J., Universitat Autonoma de Barcelona, Spain:
Phosphatases and salt tolerance.
Boone, C./Tyers, M., University of Toronto, Canada: Large-
scale mapping of genetic interaction networks.
Botstein, D., Princeton University, New Jersey: Genome-scale
analysis of gene expression in yeast.
Breeden, L., Fred Hutchinson Cancer Research Center,
Seattle, Washington: G, progression in budding yeast.
Cohen-Fix, 0., NIDDK, National Institutes of Health,
Bethesda, Maryland: Mitotic regulation from a checkpoint
perspective.
Fox, T., Cornell University, Ithaca, New York: That other genet-
ic system: How yeast mitochondria make proteins and put
them where they belong.
Gottschling, D., Fred Hutchinson Cancer Research Center,
Seattle, Washington
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Krysan, D., M.D., University of Michigan, Ann Arbor
Rouse, A., B.S., Duke University, Durham, North Carolina
Sen, S., Ph.D., National Cancer Institute, Bethesda,
Maryland
Sicard, D., Ph.D., University Paris XI, Gif-sur-Yvette, France
Subramaniyan, M., Ph.D., Oklahoma State University,
Stillwater
Veide, J., M.Edu., Chalmers University of Technology,
Goteborg, Sweden
Virtudazo, E., Ph.D., Chiba University, Japan
Wu, L., Ph.D., Harvard University, Cambridge, Massachusetts
Hinnebush, A., NICHHD, National Institutes of Health,
Bethesda, Maryland: Manifold functions of a multi-initiation
factor complex in the mechanism and regulation of transla-
tion.
Petes, T., University of North Carolina, Chapel Hill: Genetic
regulation of genome stability in yeast.
Smith, M., University of Virginia, Charlottesville
Sprague, G., University of Oregon, Eugene: Yeastcell-type
specification and signal transduction specificity: A look back.
Stearns, T., Stanford University, California: Synthetic lethality:
Then and now.
Wickner, R., National Institutes of Health, Bethesda, Maryland:
Prions in yeast.
Winston, F., Harvard Medical School, Boston, Massachusetts:
Analysis of factors that control transcription andchromatin
structure in yeast.
Molecular Mechanisms of Human Neurological Diseases
July 23-29
INSTRUCTORS A. Aguzzi, University Hospital of Zurich, Switzerland
S. Gandy, Thomas Jefferson University, Philadelphia, Pennsylvania
J. Hardy, NIA, National Institutes of Health, Bethesda, Maryland
How and why do neurons dysfunction or die in specific acute or chronic human neurological disorders?
What are the molecular and biochemical manifestations of specific genetic lesions in specific neuro-
logical disorders? Do different pathological dysfunctions share common mechanisms? What practical
treatments are contemplated? This lecture course explored possible answers to these important ques-
tions. Recent advances in neurogenetics and in molecular and cell biology have begun to shed light on
the mechanisms that underlie nervous system injury in disease states such as stroke, epilepsy, chan-
nelopathies, Alzheimer's disease, Parkinson's disease, frontotemporal dementia, amyotrophic lateral
sclerosis, prion diseases, narcolepsy, and polyglutamine repeat disorders. Taking advantage of small
class size and extensive discussion, invited faculty lecturers examined critical issues in their area of
expertise. Overview was provided and course participants did not have to be familiar with neurological
diseases, although a background in basic nervous system structure and organization was extremely
helpful.
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The course focused principally on the specific hypotheses and approaches driving current research.
Emphasis was placed on the highly dynamic interface between basic and clinical investigation includ-
ing: the interdependence of clinical research and disease model development and the value of disease
research in understanding the function of the normal nervous system. The course was held at the
Laboratory's Banbury Conference Center.
PARTICIPANTS
Alexopoulos, H., Ph.D., University of Oxford, United Kingdom
Antal, E., M.D., University of Oslo, Norway
Ascherio, A., Ph.D., Harvard School of Public Health, Boston,
Massachusetts
Atchison, K., B.S., Wyeth Research, Princeton, New Jersey
Bueler, H., Ph.D., University of Zurich, Switzerland
Carter, T., Ph.D., Thomas Jefferson University, Philadelphia,
Pennsylvania
Causevic, M., Ph.D., Thomas Jefferson University,
Philadelphia, Pennsylvania
Chappell, C., M.A., University of Oklahoma, Edmond
Gafni, J., Ph.D., Buck Institute for Research in Aging, Novato,
California
Hygge Blakeman, K., Ph.D., Karolinska Institutet, Stockholm,
Sweden
LaFevre-Bernt, M., Ph.D., Buck Institute for Age Research,
Novato, California
SEMINARS
Aguzzi, A., University Hospital of Zurich, Switzerland: Prions.
Burke, B., Columbia University, New York: Parkinson's.
Cookson, M., NIA, National Institutes of Health, Bethesda,
Maryland: Mechanisms of neurodegeneration.
Frackowiak, R., Wellcome, London, United Kingdom:
Functional neuroimaging and cerebral localization.
Gandy, S., Thomas Jefferson University, Philadelphia,
Pennsylvania: Alzheimer's.
Hardy, J., NIA, National Institutes of Health, Bethesda,
Maryland: Neurogenetics.
Heutink, P., Erasmus University Rotterdam, The Netherlands:
Novel Parkinson's genes.
Hutton, M., Mayo Clinic Jacksonville, Florida: Tauopathies.
ladecola, C., Weill Cornell Medical Center, New York: Stroke.
MacDonald, M., Massachusetts General Hospital,
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Mapelli, M., Ph.D., European Institute of Oncology, Milan,
Italy
McCarthy, S., B.A., Karolinska Institutet, Stockholm, Sweden
Meltzer, C., M.D., University of Pittsburgh, Pennsylvania
Messmer, K., Ph.D., University of Maryland, Baltimore
Nielsen, M., B.S., University of Copenhagen, Denmark
Orr, A., B.S., Emory University, Atlanta, Georgia
Pedrini, S., Ph.D., Thomas Jefferson University, Philadelphia,
Pennsylvania
Polymenidou, M., B.S., University Hospital of Zurich,
Switzerland
Strom, A., M.A., Umea University, Umea, Sweden
Sveinbjornsdottir, S., M.D., Landspitali University Hospital,
Iceland
Zuzga, D., B.A., Thomas Jefferson University, Philadelphia,
Pennsylvania
Charlestown: Huntington's
McNamara, J., Duke University Medical Center, Durham,
North Carolina: Epilepsy.
Murphy, D., NINDS, National Institutes of Health, Rockville,
Maryland: NINDS Funding.
Nitsch, R., University of Zurich, Switzerland: Alzheimer's.
Orr, H., University of Minnesota, Minneapolis: Trinucleotide
repeat diseases (SCA).
Schofield, P., The Garvan Insitute of Medical Research,
Sydney, Australia: Channelopathies.
Siegel, J., Veterans Affairs Greater Los Angeles Health Care
System, North Hills, California: Hypocretin/orexin physiology
and pathophysiology.
Workshop on Magnetoencephalography
July 29-August 2
INSTRUCTORS R. Llinas, New York University School of Medicine
U. Ribary, New York University School of Medicine
ASSISTANTS S. Jaramillo, New York University School of Medicine
K. Moran, New York University School of Medicine
R. Ramirez, New York University School of Medicine
K. Sauve, New York University School of Medicine
J. Schulman, New York University School of Medicine
Magnetoencephalography (MEG) is a noninvasive, nonhazardous technology allowing for functional
imaging of the human brain's electrophysiology at millisecond temporal resolution. Localization of elec-
trical activity has an accuracy of approximately 2 mm. MEG simultaneously measures neuronal activi-
ty at hundreds of points in the human brain. Measurement preparation and collection times are rela-
tively short and can be applied to spontaneous brain activity or in response to stimuli. Other brain imag-
ing technologies including X-ray computed tomography (CT), fMRI, PET, and SPECT, generally mea-
sure indirect correlates of brain function, such as anatomy, blood flow, and oxygenation state. The core
technology in MEG is based on highly sensitive superconducting quantum interference devices
(SQUIDs) capable of detecting subtle fluctuations in a magnetic field associated directly with the neu-
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ronal electrical activity. MEG is an emerging brain-imaging technology that has application in function-
al imaging in normal and pathological brain function. This five-day workshop included extended lec-
tures and open discussion by leading practitioners in thefield, as well as an extended field trip and
hands-on exposure to the MEG facility at the New York University School of Medicine in New York City.
LECTURERS
Ilmoniemi, R., Nexstim Ltd., Helsinki, Finland: Signal process-
ing and cognitive functions.
loannides, A., Brain Science Institute, Riken, Saitama, Japan:
Magnetic field tomography (MFT) and applications.
Kronberg, E., New York University, School of Medicine: MEG
analysis in time and frequency domain.
Mitra, P., Bell Laboratories, Murray Hill, New Jersey:
Extraction of MEG signals and signal processing tech-
niques.
Mosher, J., Los Alamos National Laboratory, New Mexico:
PARTICIPANTS
Christian, E., AstraZeneca Pharmaceuticals, Wilmington,
Delaware
Best, S.D., The Neuroscience Center, Deerfield, Illinois
Hironaga, N., Brain Science Instititue, Riken, Saitama, Japan
Nurminen, J., BioMag Laboratory, Helsinki, Finland
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Overview: Source localization techniques.
Okada, Y., University of New Mexico, Albuquerque:
Interpretation of MEG signals.
Salenius, S., Helsinki University of Technology, Espoo, Finland:
Sensorimotor oscillations.
Schnitz ler, A., Heinrich-Heine University, Duesseldorf,
Germany: Large-scale oscillatory coupling in the human
brain.
Vrba, J., CTF Systems, Inc., Port Coquitlam, Canada: Signal-
noise cancellation and source localization (SAM).
Poghosyan, V., Brain Science Instititue, Riken, Saitama, Japan
Polyakov, A., Weill Cornell Medical Center, New York
Zaman, S., Guys and Maudsley Hospital, London, United
Kingdom
Cellular Biology of Addiction
August 4-11
INSTRUCTORS B. Madras, Harvard Medical School, Southborough, Massachusetts
M. Von Zastrow, University of California, San Francisco
ASSISTANT G. Miller, Harvard Medical School, Southborough, Massachusetts
Drug addition is the most costly neuropsychiatric disorder faced by our nation. The primary objective
of this workshop was to provide an intense dialogue of the fundamentals, state-of-the-art advances,
and major gaps in the cellular and molecular biology of drug addiction. Targeted to new or experienced
investigators, the workshop combined formal presentations and informal discussions to convey the
merits and excitement of cellular and molecular approaches to drug addiction research.
With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop
comprehensive models of neuroadaptative processes fundamental to addiction, craving, and relapse
to drug use and to brain function, in general. During the workshop, a range of disciplines and topics
were represented, including noninvasive brain imaging to identify drug targets and adaptive process-
es, neuroadaptative processes at the molecular and celllular levels, neural networks and their modula-
tion, the relevance of genotype to susceptibility and drug response, tolerance and adaptation at the
cellular level, and neuroinformatics.
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This workshop provided an integrated view of current and novel research on neuroadaptive
responses to addition, fostered discussion on collaboration and integration, and provided critical infor-
mation needed to construct a model of addiction as a disease and novel molecular targets for biolog-
ical treatments. Beyond the plane of scientific endeavor, the information is vital for formulating public
policy and for enlightening the public to the neurobiological consequences of drug use and addiction.
The workshop was designed to generate interest in this approach, open conduits for collaborations,
and provide novel routes for investigating the neurobiology of addiction.
PARTICIPANTS
Achat, C., B.S., University of Miami School of Medicine,
Florida
Agoston, D., Ph.D., Uniformed Services University of the
Health Sciences, Bethesda, Maryland
Cancela, L., Ph.D., Universidad Nacional de Cordoba,
Argentina
Chiang, L., Ph.D., Purdue Pharma L.P., Cranbury, New Jersey
Du, C., Ph.D., Brookhaven National Laboratory, Upton, New
York
Febo, M., Ph.D., University of Massachusetts Medical School,
Worcester
Gerdeman, G., Ph.D., The University of Arizona Health
Sciences Center, Tucson
Ghitza, U., B.A., Rutgers University, Piscataway, New Jersey
Glaser, S., B.S., Brookhaven National Laboratory, Upton, New
York
Grice, D., M.D., University of Pennsylvania, Philadelphia
Guan, Z., M.D., Columbia University, New York
Kumra, S, M.D., Albert Einstein College of Medicine, Bronx,
New York
SEMINARS
Augustine, G., Duke University Medical Center, Durham, North
Carolina: Synaptic transmission and drug addition.
Breiter, H., Massachusetts General Hospital, Boston
Brown, E., Massachusetts General Hospital, Boston
Edwards, R., University of California, San Francisco
Gasic, G., Massachusetts General Hospital, Boston
George, S., University of Toronto, Canada
Goldman, D., NIAAA/LNG, Rockville, Maryland
Kosofsky, B., Massachusetts General Hospital, Boston:
Developmental aspects of addiction.
Kreek, M.J., The Rockefeller University, New York
Lake, G., Institute for Systems Biology, Seattle, Washington
Madras, B., Harvard Medical School, Southborough,
Massachusetts
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Marini, A., M.D., Uniformed Services University of the Health
Sciences, Bethesda, Maryland
Martell, B., M.D., Yale University School of Medicine, W.
Haven, Connecticut
Milby, J., Ph.D., University of Alabama, Birmingham
Miller, C., M.S., University of California, Irvine
Morrow, E., Ph.D., Massachusetts General Hospital, Boston
Ryan, X., Ph.D., The Rockefeller University, New York
Schiffer, W., B.A., Stony Brook University/Brookhaven National
Laboratory, Upton, New York
Stridh, M., M.S., Karolinska Instituter, Stockholm, Sweden
Thomsen, M., M.S., McLean Hospital/Harvard Medical
School, Belmont, Massachusetts
Torres-Reveron, A., B.S., SUNY Downstate Medical Center,
Brooklyn, New York
Twining, R., B.A., Pennsylvania State College of Medicine,
Hershey
Verrico, C., Ph.D., Harvard Medical School/NEPRC, South-
borough, Massachusetts
Yao, L., Ph.D., University of California, San Francisco
Malenka, R., Stanford University School of Medicine,
California: Role of synaptic plasticity in addiction.
Nest ler, E., University of Texas Southwestern, Dallas
Pollack, J., NIDA, Bethesda, Maryland
Schwartz, J., Columbia University, New York
Uhl, G., NIDA, Bethesda, Maryland
von Zastrow, M., University of California, San Francisco:
Effects of opiate drugs on the cellular regulation of opioid
receptors: Mechanisms and physiological consequences.
Worley, P., Johns Hopkins University School of Medicine,
Baltimore, Maryland
Zhou, R., Rutgers University, Piscataway, New Jersey:
Ontogeny of the midbrain dopaminergic pathways.
Bioinformatics: Writing Software for Genome Research
October 15-28
INSTRUCTORS S. Lewis, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada
G. Hartzell, University of California, Berkeley
L. Stein, Cold Spring Harbor Laboratory
ASSISTANTS
S. Cain, Cold Spring Harbor Laboratory
A. Day, University of California, Los Angeles
R. Halgren, Michigan State University, E. Lansing
J. Kaminker, University of California, Berkeley
J. Kissinger, University of Pennsylvania, Philadelphia
A. Mackey, University of Virginia, Charlottesville
D. Nix, University of California, Berkeley
S. Prochnik, University of California, Berkeley
S. Robb, University of Utah, Salt Lake City
C. Smith, University of California, Berkeley
J. Stajich, Duke University, Durham, North Carolina
L. Teytelman, Cold Spring Harbor Laboratory
J. Tupy, University of California, Berkeley
C. Wiel, University of California, Berkeley
The desktop computer is rapidly becoming an indispensable tool in the biologist's toolchest. The suc-
cess of the Human Genome Project created an explosion of information: billions of bits of biological
information stashed electronically in databases around the globe just waiting for the right key to unlock
them. New technologies such as DNA microarrays and high-throughput genotyping are creating an
information overload that the traditional laboratory notebook cannot handle. To exploit the information
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revolution in biology, biologists moved beyond canned Web interfaces and Excel spreadsheets. They
took charge of the data by creating their own software to fetch, manage, and integrate it. The goal of
this course was to provide biologists with the tools needed to deal with this changing landscape.
Designed for students and researchers with little prior knowledge of programming, this two-week
course taught the fundamentals of the Unix operating system, Pen scripting, dynamic Web page devel-
opment with the CGI protocol, and database design. The course combined formal lectures with hands-
on experience in which students worked to solve a series of problem sets drawn from common sce-
narios in biological data acquisition, integration, and laboratory workflow management. For their final
projects, students posed problems using their own data and worked with each other and the faculty
to solve them.
PARTICIPANTS
Adachi, H., Ph.D., Kyushu University, Japan
Aerts, J., M.S., Wageningen University, The Netherlands
Ambroggio, X., B.S., California Institute of Technology,
Pasadena
Arteaga-Vazquez, B.S., CINVESTAV-IPN, Guanajuato, Mexico
Averof, M., Ph.D., IMBB-FORTH, Greece
Boardman, A., B.S., South African National Bioinformatics
Institute, Bellville, South Africa
Chamnapunt, J., Ph.D., Kasetsart University, Thailand
Childers, C., B.S., Texas A&M University, College Station
Dimova, D., Ph.D., Harvard University, Charlestown,
Massachusetts
Fiedler, T., Ph.D., University of Miami Rosenstiel School,
Florida
Fox, J., Ph.D., UBC Bioinformatics Centre, Vancouver,
Canada
Hayden, K., B.S., Case Western Reserve University,
Cleveland, Ohio
Hild, M., Ph.D., Zentrum fur Molekulare Biologie, University of
Heidelberg, Germany
SEMINARS
Hide, W., University Western Cape, SANBI, Bellville, South
Africa: EST clustering.
Jamison, C., George Mason University, Manassas, Virginia:
Using genomic databases effectively.
Marth, G., NCBI, National Institutes of Health, Bethesda,
Maryland: Sequence variation analysis.
Ostell, J., National Institutes of Health, Bethesda, Maryland:
The NCBI tools.
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Hildebrandt, J., Ph.D., Medical University of South Carolina,
Charleston
Holmes, J., M.P.A., Oklahoma Medical Research Foundation,
Oklahoma City
Hughes, J., Ph.D., Whitehead Institute, Cambridge,
Massachusetts
McMahon, W., B.S., Texas Technical University Health
Sciences Center, Lubbock
Moore, M., M.S., University of Utah, Salt Lake City
Petri, A., M.S., Hagedorn Research Institute, Gentofte,
Denmark
Reyes-Valdes, M., Ph.D., Universidad Autonoma Agraria
Antonio Narro, Coah, Mexico
Telford, M., Ph.D., University of Cambridge, United Kingdom
Tsipouri, V., M.S., National Human Genome Research Institute,
Bethesda, Maryland
Worms ley, S., Ph.D., Yale University, New Haven, Connecticut
Wu, J., M.S., Human Genome Sequencing Center, Houston,
Texas
Xie, Q., Ph.D., GlaxoSmithKline, King of Prussia, Pennsylvania
Pearson, W., University of Virginia, Charlottesville: Sequence
similarity analysis.
Peitzsch, R., Pfizer Global R&D, Groton, Connecticut:
Modeling biological data in relational databases.
Troyanskay, 0., Stanford University, California: Microarray
analysis.
Yandell, M., University of California, Berkeley: The BLAST
algorithm.
X-ray Methods in Structural Biology
October 15-30
INSTRUCTORS W. Furey, V.A. Medical Center, Pittsburgh, Pennsylvania
G. Gilliland, Center for Advanced Research in Biotechnology, Gaithersburg, Maryland
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku/MSC, Inc., The Woodlands, Texas
ASSISTANTS B. Narayanan, Center for Advanced Research in Biotechnology, Gaithersburg, Maryland
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensified laboratory/computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function, but who are new to macromolecular crystallog-
raphy. Topics covered included basic diffraction theory, crystallization (proteins, nucleic acids, and
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complexes), crystal characterization, X-ray sources and optics, synchrotrons, crystal freezing, data col-
lection, data reduction, multiple isomorphous replacement, multiwavelength anomalous diffraction,
molecular replacement, solvent flattening, noncrystallographic symmetry averaging, electron density
interpretation, structure refinement, molecular graphics, and coordinate deposition. Participants
learned through extensive hands-on experiments. They crystallized and determined a protein structure,
in parallel with lectures on the theory and informal discussions behind the techniques. Applicants were
familiar with the creation and editing of simple text files on UNIX workstations using a screen-based
editor (either vi or emacs).
PARTICIPANTS
Bickford, L., B.S., Memorial Sloan-Kettering Cancer Center,
New York
Chiu, C., B.S., University of British Columbia, Vancouver,
Canada
De Marco, V. Ph.D., Netherlands Cancer Institute,
Amsterdam, The Netherlands
Deng, X., M.S., University of Nebraska Medical Center,
Omaha
First, E., Ph.D., Louisiana State University Health Sciences
Center, Shreveport
Garces, R., B.S., University of Toronto, Canada
Hillson, N., BA., Harvard Medical School, Boston,
Massachusetts
SEMINARS
Adams, P., Lawrence Berkeley Laboratory, Berkeley, California:
Introduction to CNS. CNS macromolecular refinement.
Dauter, Z., Brookhaven National Laboratory: Practical consid-
erations for synchrotron data collection and for SAD and
MAD phasing.
Furey, W., V.A. Medical Center, Pittsburgh, Pennsylvania:
Isomorphous replacement and anomalous scattering I.
Isomorphous replacement and anomalous scattering II.
Patterson group therapy. Phase improvement by solvent flat-
tening/negative density transaction. Noncrystallographic
symmetry averaging. Crystallographic symmetry operations
and their application.
Gilliland, G., National Institute of Standards & Technology,
Gaithersburgh, Maryland: The BMCD: Crystallization data
strategies. Molecular replacement.
Hendrickson, W., Columbia University, New York: MAD phas-
ing: Theory and practice.
Hung, L., Brookhaven National Laboratory, Upton, New York:
SOLVE; RESOLVE.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Two intermedi-
ates in the assembly of the papillomavirus replication initia-
tion complex. Structure presentation.
Kjeldgaard, M., Aarhus University, Aarhus, Denmark: Electron
density fitting A to 0.
Kleywegt, G., University of Uppsala, Sweden: Just because
it's in nature, doesn't mean it's true...(macromoleCular struc-
ture validation).
McPherson, A., University of California, Irvine: Crystallization of
macromolecules I and II. Symmetry, pediodicity, unit cells,
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Jenni, S., B.S., Swiss Federal Institute of Technology, Zurich,
Switzerland
Larsen, S., Ph.D., University of Illinois, Chicago
Lougheed, J., Ph.D., Exelixis, Inc., San Francisco, California
Newitt, J., Ph.D., Bristol-Myers Squibb Company, Princeton,
New Jersey
Richter-Addo, G., Ph.D., University of Oklahoma, Norman
Roberts, J., B.S., University of Colorado, Boulder
Strobel, S., Ph.D., Yale University, New Haven, Connecticut
Van Train, K., B.S., Thomas Jefferson University, Philadelphia,
Pennsylvania
Von Koenig, K., B.S., Max-Planck-Institute for Molecular
Physiology, Dortmund, Germany
space groups, miller planes, and lattices. The structure fac-
tor and Friedel's law. Fundamental diffraction relationships
and Bragg's law. Diffraction patterns, reciprocal space, and
Ewald's sphere. Fourier transforms and the electron density
equation. Pattern techniques. Crystallization review and opti-
mization. Heavy atoms and anomalous scatterers.
Perrakis, A., Nederland Kanker Institute, Amsterdam, The
Netherlands: ARP/wARP: The underlying concepts and
algorithms for automated procedures for phase improve-
ment, extension, and model building. ARP/wARP:
Implementation and examples of applications.
Pflugrath, J., Rigaku/MSC, Inc., The Woodlands, Texas: Data
collection: Design and setup I and II. Cryocrystallography.
Scaling and merging synchrotron data. Application of anom-
alous scattering from sulfur atoms.
Richardson, D., Duke University Medical Center, Durham,
North Carolina: Detection and repair of model errors using all
atom contacts.
Sweet, R., Brookhaven National Laboratory, Upton, New York:
Fundamentals of crystallography. X-ray sources and optics.
Tronrud, D., University of Oregon, Eugene: Macromolecular
refinement I and II.
Westbrook, J., Rutgers University, Piscataway, New Jersey:
The protein data bank.
Whitby, F., University of Utah School of Medicine, Salt Lake
City: Crystal structures of uroporphyrinogen decarboxylase
enzyme-product complexes.
Xu, R.-M., Cold Spring Harbor Laboratory: Structural basis of
histone methylation.
Immunocyctochemistry, In Situ Hybridization, and
Live Cell Imaging
October 18-31
INSTRUCTORS A. Dernburg, Lawrence Berkeley National Laboratory, Berkeley, California
J. Murray, University of Pennsylvania School of Medicine, Philadelphia
J. Swedlow, University of Dundee, United Kingdom
ASSISTANTS K. Hu, Scripps Research Institute, La Jolla, California
W. Moore, University of Dundee, United Kingdom
J. Peng, University of California, Berkeley
S. Suravajjala, University of Pennsylvania School of Medicine, Philadelphia
This course focused on specialized techniques in microscopy, in situ hybridization, immunocytochem-
istry, and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells, as well as protein
and RNA dynamics in living cells. The course emphasized the use of the latest equipment and tech-
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niques in fluorescence microscopy, including confocal laser-scanning microscopy, deconvolution
methods, digital image processing, and time-lapse imaging of living specimens. The course was
designed to present students with state-of-the-art technology and scientific expertise in the use of light
microscopy to address basic questions in cellular and molecular biology. The course was designed for
the molecular biologist who is in need of microscopic approaches and for the cell biologist who is not
familiar with the practical application of the advanced techniques presented in the course. Among the
methods presented were the preparation of tagged nucleic acid probes, fixation methods, detection
of multiple DNA sequences in single nuclei or chromosome spreads, comparative genomic hybridiza-
tion, cellular localization of RNA, localization of nucleic acids and proteins in the same cells, use of a
variety of reporter molecules and nonantibody fluorescent tags, indirect antibody labeling, detection of
multiple proteins in a single cell, and the use of GFP (green fluorescent protein) variants to study pro-
tein expression, localization, and dynamics. In each method, several experimental protocols were pre-
sented, allowing the students to assess the relative merits of each and to relate them to their own
research. Students were encouraged to bring their own nucleic acid, protein, or antibody probes to the
course, which were used in addition to those provided by the instructors. The laboratory exercises
were supplemented with lectures given by invited distinguished scientists, who presented up-to-the-
minute reports on current methods and research using the techniques being presented.
PARTICIPANTS
Appolioni, I., Laureate, University of Pisa, Italy
Benko, S., M.S., University of Debrecen, Hungary
Chakravarty, S., B.S., Albert Einstein College of Medicine,
Bronx, New York
D'Agostino, A., Lic, University of Buenos Aires, Argentina
Gould, H., Ph.D., King's College London, United
Kingdom
Hasholt, L., M.S., University of Copenhagen, Denmark
Kies ler, E., M.S., Stockholm University, Sweden
Le Baccon, P., Ph.D., Curie Institute, Paris, France
SEMINARS
Belmont, A., University of Illinois, Urbana: Using GFP marks to
study nuclear dynamics.
Day, R., University of Virginia, Charlottesville: Seeing colors:
Applications and limitations of the fluorescent proteins.
Dernburg, A., Lawrence Berkeley National Laboratory,
Berkeley, California: Basics of FISH.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Basic introduction to light and fluorescence
microscopy. Immunocytochemistry.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Principles of confocal microscopy and decon-
volution techniques.
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Longart, M., Ph.D., NICHD, National Institutes of Health,
Bethesda, Maryland
Minter, L., Ph.D., University of Massachusetts, Amherst
Petrie, R., M.S., McGill University, Montreal, Quebec, Canada
Riazuddin, S., Ph.D., NIDCD, National Institutes of Health,
Rockville, Maryland
Smart, S., Ph.D., University of California, San Francisco
Stansell, E., B.A., University of Alabama, Birmingham
Volpe, T., Ph.D., Cold Spring Harbor Laboratory
Williams, V., B.S., University of California, Riverside
Ried, T., NCI, National Institutes of Health, Bethesda,
Maryland: Mechanisms and consequences of chromosomal
aberrations in cancer cells.
Spector, D., Cold Spring Harbor Laboratory: Localization of
gene expression by FISH and in living cells.
Swedlow, J., University of Dundee, United Kingdom: Live-cell
imaging. Principles of confocal microscopy and deconvolu-
tion techniques.
Tran, P., University of Pennsylvania, Philadelphia: Cameras and
digital imaging fundamentals.
Phage Display of Combinatorial Antibody Libraries
November 4-17
INSTRUCTORS C. Barbas, The Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, San Diego
ASSISTANTS C. Goodyear, University of California, San Diego
K. Noren, New England Biolabs, Beverly, Massachusetts
C. Tuckey, New England Biolabs, Beverly, Massachusetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from the library. Students learned the theoretical and prac-
tical aspects of constructing combinatorial libraries from immune and nonimmune sources, as well as
the construction of synthetic antibody libraries. Antibodies were selected from the library by panning.
Production, purification, and characterization of Fab fragments expressed in E coif were also covered.
Epitopes were selected from peptide libraries and characterized.
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The lecture series was presented by a number of invited speakers, which emphasized polymerase
chain reaction (PCR) of immunoglobulin genes, the biology of filamentous phage and the utility of sur-
face expression libraries, expression of antibodies in E. coli and mammalian cells, antibody structure
and function, catalytic antibodies, directed protein evolution, retroviral and cell display libraries, the
immunobiology of the antibody response, and recent results on the use of antibodies in therapy. The
theory and practical implications for selection from phage displayed libraries of random peptides,
cDNA products, and semisynthetic proteins were also explored.
PARTICIPANTS
Agindotan, B., Ph.D., University of Idaho, Moscow
Andersen, J., Ph.D., Cold Spring Harbor Laboratory
Basquin, D., B.S. University of Geneva, Switzerland
Chen, C., Ph.D., Commonwealth Serum Laboratories, Ltd.,
Parkville, Australia
Clancy, R., Ph.D., Hospital for Joint Diseases, New York
Kjaergaard, K., Ph.D., Hagedorn Research Institute,
Bagsvaerd, Denmark
Larman, B., B.S., University of Southern Maine, Portland
Lee, D., M.B.A., Cedrus Technologies, Inc., Seattle, Washington
SEMINARS
Austin, D., Yale University, New Haven, Connecticut: T7
phage display and interaction cloning.
Barbas, C., The Scripps Research Institute, La Jolla,
California: Software and hardware for genomes: Polydactyl
zinc finger proteins and the control of endogenous genes.
Lowman, H., Genetech, Inc., S. San Francisco, California:
SAR of peptides using phage.
Marks, K., Stanford University School of Medicine, California:
Retroviral libraries.
Noren, C., New England Biolabs, Beverly, Massachusetts:
Phage peptide libraries: The PhD for peptides.
Pasqualini, R., University of Texas, Houston: In vivo panning.
LeMosy, E., Ph.D., Medical Co lige of Georgia, Augusta
O'Nuallain, B., Ph.D., University of Tennessee Medical Center,
Knoxville
Persson, H., M.S., Lund University, Lund, Sweden
Popov, B., Ph.D., Northwestern University, Chicago, Illinois
Song, Z., Ph.D., National University of Singapore, China
Su, S., Ph.D., University of California, Los Angeles
Yang, S., Ph.D., Kimberly-Clark Corporation, Roswell,
Georgia
Sidho, S., Genetech, Inc., S. San Francisco, California: Use of
antibody-phage libraries to develop antibodies as reagents
and potential therapeutics.
Siegel, D., University of Pennsylvania Medical Center, Phila-
delphia: Cell surface selection of combinatorial Fab
libraries.
Silverman, G., University of California, San Diego: Repertoire
cloning of SLE autoantibodies.
Webster, R., Duke University, Durham, North Carolina: The
biology of filamentous phage.
Wilson, I., The Scripps Research Institute, La Jolla, California:
Structural biology of the immune system.
Proteomics
November 4-17
INSTRUCTORS P. Andrews, University of Michigan Medical School, Ann Arbor
J. La Baer, Harvard Medical School, Boston, Massachusetts
B. Phinney, Michigan State University, E. Lansing
ASSISTANTS E. Hainsworth, Harvard Medical School, Boston, Massachusetts
N. Ramachandran, Harvard Institute of Proteomics, Cambridge, Massachusetts
D. Veine, University of Michigan, Ann Arbor
D. Whitten, Michigan State University, E. Lansing
This intensified laboratory and lecture course focused on two major themes in proteomics. In the pro-
filing section of the course, students learned methodologies of protein preparation from diverse sam-
ples, sample analysis by two-dimensional gel electrophoresis, high-sensitivity mass spectrometric
analysis of proteins utilizing both peptide mass mapping and tandem mass spectrometry, and the
application of bioinformatics tools to identify proteins and posttranslational modifications and assess
their relative abundance. In the functional proteomics section of the course, students learned the use
of recombinational cloning to move many genes simultaneously to different expression vectors, and
how to perform high-throughput expression, purification, and characterization of proteins, and how to
produce and analyze protein microarrays. Students learned approaches to identify protein interactions
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utilizing affinity isolation techniques coupled with mass spectrometric protein identification. The overall
aim of the course was to provide students with the fundamental knowledge and hands-on experience
necessary to be able to perform and analyze proteomics experiments, and to learn to identify new
opportunities in applying proteomics approaches to their own research.
PARTICIPANTS
Arrigoni, R., Laureate, Albert Einstein College of Medicine,
Bronx, New York
Bokov, A., B.S., University of Texas Health Science Center,
San Antonio
Bujold, E., M.D., Wayne State University, Detroit, Michigan
Choi, S., M.D., Stony Brook University, New York
Fahrni, M., Ph.D., Center of Disease Control and Prevention,
Atlanta, Georgia
Gazula, V., Ph.D., Yale University, New Haven, Connecticut
Hainsworth, E., M.S. Harvard Medical School, Boston,
Massachusetts
Julin, K., M.S., Norwegian Institute of Fisheries & Aquaculture
SEMINARS
Chait, B., The Rockefeller University, New York:
Phosphoprotein analysis in proteomics.
Chaurand, P. Vanderbilt University School of Medicine,
Nashville, Tennessee: Imaging by mass spectrometry.
Gerber, S., Harvard Medical School, Boston, Massachusetts:
Quantitative methods in mass spectrometry.
Mac Beath, G., Harvard University, Cambridge,
Research, Tromso, Norway
Levert, K., Ph.D., Centers for Diseases Control and
Prevention, Atlanta, Geogia
Montor, W., B.S., University of Sao Paulo, Brazil
Morris, D., M.D., University of California, San Francisco
Ofek, P., M.S., Tel Aviv University, Tel Aviv, Israel
Sanders, P., B.S., University of Cambridge, United Kingdom
Stevens-Truss, R., Ph.D., Kalamazoo College, Michigan
Thierse, H., Ph.D., Max-Planck-Institute for Immunobiology,
Freiburg, Germany
Thomassen, E., M.S., University of Tormso, Norway
Massachusetts: Protein microarrays.
Snyder, M., Yale University, New Haven, Connecticut: Protein
microarrays.
Tempst, P., Memorial Sloan-Kettering Cancer Center, New
York: Biomarker discovery in mass spectrometry.
Washburn, M., Stowers Institute for Medical Research,
Kansas City, Missouri: Ion -trap mass spectrometry.
Computational Genomics
November 5-11
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
ASSISTANTS I. Ovcharenko, Lawrence Livermore National Laboratory, Livermore, California
B. Cantarel, University of Virginia, Charlottesville
Beyond BLAST and FASTA-This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data.
The course focused on approaches for extracting the maximum amount of information from protein
and DNA sequence similarity through sequence database searches, statistical analysis, and multiple
sequence alignment. Additional topics included gene recognition (exon/intron prediction), identifying
signals in unaligned sequences, and integration of genetic and sequence information in biological data-
bases. The course combined lectures with hands-on exercises; students were encouraged to pose
challenging sequence analysis problems using their own data. The course made extensive use of local
WWVV pages to present problem sets and the computing tools to solve them. Students used Windows
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and Mac workstations attached to a UNIX server; participants had to be comfortable using the UNIX
operating system and a UNIX text editor. The course was designed for biologists seeking advanced
training in biological sequence analysis, computational biology core resource directors and staff, and
scientists in other disciplines, such as computer science, who wish to survey current research prob-
lems in biological sequence analysis.
PARTICIPANTS
Chan, A., Ph.D., The Institute for Genomic Reseach,
Germantown, Maryland
De Bondt, A., Ph.D., Johnson & Johnson, Beerse, Belgium
Fiedler, T, Ph.D., University of Miami Rosenstiel School
Marine & Atmosphere Science, Florida
Gallagher, T., B.S., Darmouth Medical School, Hanover, New
Hampshire
Good-Avila, S., Ph.D., Acadia University, Nova Scotia, Canada
Hammer li, A., B.S., Yale University, New Haven, Connecticut
Hansen, N., Ph.D., NIH Intramural Sequencing Center,
Gaithersburg, Maryland
Henthorn, P., Ph.D., University of Pennsylvania School of
Veterinary Medicine, Philadelphia
Hildebrandt, J., Ph.D., Medical University of South Carolina,
Charleston
Karro, J., Ph.D., Yale University, New Haven, Connecticut
Kim, H., M.S., Baylor College of Medicine, Houston, Texas
Larsson, F, M.S., Uppsala University, Sweden
Martinez de la Vega, 0., Ph.D., CINVESTAV, Guanajuato,
Mexico
Matasci, N., B.S., Max-Planck-Institute for Evolutionary
SEMINARS
Altschul, S., National Library of Medicine, Bethesda,
Maryland: Statistics of sequence similarity scores. Iterated
protein database searches with PSI-BLAST.
Brent, M., Washington University, St. Louis, Missouri:
Eukaryotic gene finding; Comparative methods for gene
finding.
Cooper, R, National Center for Biotechnology Information,
Bethesda, Maryland: NCBI Resources for bioinformatics and
computational biology. NCBI genome resources.
Mackey, A., University of Virginia, Charlottesville: Displaying/
examining genomes.
Anthropology, 1 Leipzig, Germany
Mattingly, C., Ph.D., Mt. Desert Island Biological Laboratory,
Salisbury Cove, Maine
Moy, C., B.S., University of Pennsylvania, Philadelphia
Nikolskaya, A., Ph.D., Georgetown University, Washington,
D.C.
Ramamurthy, L., Ph.D., GlaxoSmithKline, Research Triangle
Park, North Carolina
Smits, B., M.Sc., Hubrecht Laboratory, Utrecht, The
Netherlands
Somerville, C., Ph.D., Marshall University, Huntington,
Wyoming
Tang, K., Ph.D., National Center for Infectious
Disease/Centers for Disease Control & Prevention, Atlanta,
Georgia
Trutschl, M., Sc.D., Louisiana State University and Louisiana
State University Health Sciences Center, Shreveport
Viswanathan, R., Ph.D., Beloit College, Wisconsin
Wienholds, E., M.S., Hubrecht Laboratory, Utrecht, The
Netherlands
Pearson, W., University of Virginia, Charlottesville: Protein evo-
lution and sequence similarity searching. Hidden Markov
models and protein profiles. Alignment algorithms-large-
scale alignment. Identifying motifs.
Smith, R., GlaxoSmithKline, King of Prussia, Pennsylvania:
Approaches to multiple sequence alignment. Multiple align-
ment resources.
Stubbs, L., Lawrence Livermore National Laboratory,
Livermore, California: Algorithms for genome comparison.
Genome comparison biology.
Yandell, M., University of California, Berkeley: Chado, ontolo-
gies for annotation. Genome annotation.
The Genome Access Course
February 4-5, April 8-9, June 10-11, September 30-October 1
TRAINERS J. Gergel, M. Katari, L. Palmer, and E. Thomas, Cold Spring Harbor Laboratory
U. Hilgert, Dolan DNA Learning Center
Initiated in 2002, this course is an intensive two-day introduction to bioinformatics that was held mul-
tiple times in 2003 and trained almost 110 participants in total. The core of the course was designed
to cover the manipulation and analysis of sequence information. The course was broken into modules
designed to give a broad overview of a given topic, with ample time for examples chosen by the
instructors. Each module included three parts, consisting of a discussion of theory and methods, cov-
erage of software and Web resources, and use of selected tools with examples (including those sup-
plied by the students). The modular design allowed the instructors to tailor the presentation to the inter-
ests of the students. Modules included Electronic Sequence Information; Pairwise Sequence
Comparisons; Multiple Sequence Alignments; Gene Prediction; Genome Analysis; Sequence Variation;
Protein Classification and Structural Analysis; Proteomics; and Phylogenetic Analysis. The course was
held at the Laboratory's Genome Research Center at Woodbury. Each student was provided with a PC
laptop with wireless modem for the duration of the course. Students were encouraged to supply prob-
lem sets and sequences of interest to the trainers for possible incorporation as examples in the mod-
ules. Materials were made available on the Web and students continued to ask questions of the train-
ers as they applied what they had learned in their individual endeavors.
Genome Access Course, February 2003
February 4-5
Akassoglou, K., Ph.D., New York University Medical Center/
Skirball, New York
Beutler, A., Ph.D., Mount Sinai School of Medicine, New
York
Caporale, L., Ph.D., Independent researcher, New York
Carlson, K., B.S., Concord, Massachusetts
Chen, J., Ph.D., Boston University School of Medicine,
Massachusetts
Deschamps, D.M., B.S., Hopkinton, Massachusetts
Fryer, R., M.D., The Rockefeller University and Columbia
University, New York
Li, Z., Weill Medical College, Cornell University, New York
Lu, L., Ph.D., Dana-Farber Cancer Institute Harvard Medical
School, Boston, Massachusetts
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Malisetty, V., Ph.D., Institute for Cancer Prevention, Valhalla,
New York
McGarry, T., Ph.D., Northwestern University Medical School,
Chicago, Illinois
Pat lolla, J. M., M.D., American Health Foundation, Valhalla,
New York
Rich ler, E., B.S., Mount Sinai School of Medicine, New York
Robins, H., Ph.D., Institute for Advanced Study, Princeton,
New Jersey
Rodriguez-Contreras, A., Ph.D., University of California, Davis
Silva, J., B.S., Karolinska Institutet, Huddinge, Sweden
Singh, M., Ph.D., Vanderbilt University, Nashville, Tennessee
Su, H., Ph.D., Regeneron Phamaceuticals, Tarrytown, New
York
Telesnitsky, A., Ph.D., University of Michigan, Ann Arbor
Vitarius, J., Ph.D., The Rockefeller University, New York
Walter, K., M.D., University of Pittsburgh, Pennsylvania
Wang, B., Ph.D., Weill Medical College, New York
Watson, D., Ph.D., Southern Illinois University, Carbondale
Wong, J., B.S., Brown University, Providence, Rhode Island
Xue, Y., B.S., Regeneron Phamaceuticals, Tarrytown, New
York
Zhang, P., B.S., Harvard University School of Public Health,
Boston, Massachusetts
Genome Access Course, April 2003
April 8-9
DuttaGupta, R., B.S., University of Medicine and Dentistry,
Piscataway, New Jersey
Foster, L., Ph.D., Trinity College, Hartford, Connecticut
Gawel, C., B.S., North Shore-Long Island Jewish Research
Institute, Manhassett, New York
Heath, M., M.D., Columbia University, New York
Huang, Y., B.S., University of Massachusetts Medical School,
Worcester
Kuo, R, Ph.D., Duke University, Durham, North Carolina
Li, X., Ph.D., Senomyx, Inc., La Jolla, California
Li, Y., Ph.D., HHMI and Skirball Institute, New York University
School of Medicine, New York
June 10-11
Aneja, K., B.S., St. John's University, Fresh Meadows, New
York
Aplenc, R., Ph.D., CHOP and University of Pennsylvania,
Philadelphia
Avraham, S., B.S., Cold Spring Harbor Laboratory
Behe, M., Ph.D., Lehigh University, Bethlehem, Pennsylvania
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Lin, J., B.S., Cold Spring Harbor Laboratory
Mail lard, I., B.S., University of Pennsylvania, Philadelphia
May, B., Ph.D., Cold Spring Harbor Laboratory
Ramirez, N., B.S., Ohio State University, Wooster
Santhanam, A., B.S., University of Medicine and Dentistry of
New Jersey, Newark
Singh, S., Ph.D., Weill Medical College, New York
Volk, E., B.S., Ohio State University/OARDC, Wooster
Wang, J., Ph.D., Weill Medical College of Cornell University,
New York
Yu, L., Ph.D., Boston University School of Medicine,
Massachusetts
Citek, R., Ph.D., Orion Genomics, Saint Louis, Missouri
Dauer, W., Ph.D., Columbia University, New York
Ferguson, G., Ph.D., Massachusetts Institute of Technology,
Cambridge
Godoy, V., B.S., Massachusetts Institute of Technology,
Cambridge
Genome Access Course, June 2003
Goodchild, R., Ph.D., Columbia University, New York
Grant, S., Ph.D., BioVentures, Inc., Murfreesboro, Tennessee
Higuchi, D., B.S., HHMI/Washington University School of
Medicine, St. Louis, Missouri
Lawrence, W., B.S., Amgen Corporation, Seattle, Washington
Lazebnik, Y., Ph.D., Cold Spring Harbor Laboratory
Leon, J., Ph.D., Universidad de Cantabria, Santander, Spain
Li, Z., Ph.D., Celera Genomics, Rockville, Maryland
Liu, Y., Ph.D., Cold Spring Harbor Laboratory
Mahnke, L., Ph.D., Washington University School of Medicine,
Saint Louis, Missouri
September 30-October 1
Adkins, D., Ph.D., College of Charleston, South Carolina
Agindotan, B., Ph.D., University of Idaho, Moscow
Bernat, J., B.S., University of Michigan, Ann Arbor
Byrd, B., B.S., Tulane University, New Orleans, Louisiana
O'Brien, M., B.S., Cold Spring Harbor Labortory
Rabinowicz, P., Ph.D., Cold Spring Harbor Laboratory
Scott, Ph.D., C., Cold Spring Harbor Laboratory
Smith, D., B.S., University of California, Los Angeles
von Roeschlaub R., B.S., Cold Spring Harbor Laboratory
Ward, B., B.S., Johns Hopkins University, Baltimore, Maryland
Womble, K., B.S., BioVentures, Inc., Murfreesboro,
Tennessee
Yang, X., Ph.D., National Institutes of Health, Bethesda,
Maryland
Choi, Y., Ph.D., Amherst College, Massachusetts
Chu, I., Ph.D., NCI, National Institutes of Health, Bethesda,
Maryland
Chu, T., B.S., Mount Sinai School of Medicine, New York
Genome Access Course, September/October 2003
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Co lborn, J., B.S., Tulane University, New Orleans, Louisiana
Connett, M., Ph.D., Arbor Gen LLC, Summerville, South
Carolina
Gloesmann, M., Ph.D., Harvard Medical School, Boston,
Massachusetts
Gopinathrao, G., Ph.D., Cold Spring Harbor Laboratory
Hill, S., Ph.D., Environment Canada, Burlington, Canada
Javaherian, A., Ph.D., Cold Spring Harbor Laboratory
Jensen-Pergakes, K., B.S., Celgene, San Diego, California
Khuong, N., Ph.D., California Department of Health Services,
Richmond, California
Kim, S., Ph.D., Amherst College, Massachusetts
Kim, J., Ph.D., NCI, National Institutes of Health, Bethesda,
Maryland
Kontoyianni, M., Ph.D., Johnson & Johnson Pharmaceutical
The Laboratory would like to
reagents to the various cou
acknowledge the generosity
rses:
Research & Development, Plymouth Meeting, Pennsylvania
Kunec, D., B.S. Mississippi State University, Starkville
Leem, S., Ph.D., NCI, National Institutes of Health, Bethesda,
Maryland
Melnick, A., Ph.D., Albert Einstein College of Medicine, Bronx,
New York
Millar, K., B.S., Environment Canada, Burlington, Ontario,
Canada
Nader, G., Ph.D., Children's National Medical Center,
Washington, D.C.
Peram, L, M.D., Eric Williams Medical Sciences Complex,
Trinidad, Champs Fleurs, Trinidad and Tobago
Pratt, L., Ph.D., Rockland Immunochemicals, Boyertown,
Pennsylvania
Walton, M., B.S., Cleveland State University, Ohio
of the following companies who loaned equipment and
Aftymetrix Inc. Codonics Inc. Kinetic Systems Inc. Promega Corp.
Agencourt Bioscience Corning Inc. Kleindiek Nanotechnik Q-Imaging
Corporation Dagan Corporation LC Packings Qiagen Inc.
Agilent Technologies, Inc. Dage-MTI Inc. Leica Microsystems Inc. Robbins Scientific
Ambion Inc. David Kopf Instruments Luigs & Neumann Corporation
Amersham Biosciences Delaware Diamond Knives Majer Precision Engineering Roche Diagnostics
A.M.P.I. Diagnostic Instruments, Inc. Inc. SD Instruments Inc.
Applied Biosystems Dionex Corp. Med Associates Inc. Santa Cruz Biotechnology
Applied Precision Inc. Drummond Scientific MJ Research Inc. Inc.
ASI Inc. Company Modulation Optics, Inc. Schleicher & Schuell Inc.
Astro-Med Inc. Eastman Kodak Company Molecular Devices Sigma-Aldrich
Axon Instruments Erie Scientific Company Corporation Singer Instrument Company
Becton Dickinson Labware E-Y Laboratories Molecular Probes Inc. Ltd.
Bel Ico Glass, Inc. Fotodyne Inc. Nalge Nunc International Stratagene
Berthold Technologies USA,
LLC
Galil Motion Control
Hamamatsu Photonic
Narishige International USA,
Inc.
Stoelting Co.
Sutter Instruments
Bio-Rad Laboratories Systems New England Biolabs, Inc. Tecan US Inc.
Bioptechs Inc. Hampton Research New Objective, Inc. Ted Pella Inc.
BioVision Technologies Harvard Apparatus, Inc. Newport Corp. Thermo Electron Corporation
Brinkmann Instruments IBM Life Sciences Solutions Nikon Inc. Thermo Finnigan
Burleigh Instruments, Inc. Improvision Inc. Novagen Inc. Thermo Labsystems
Cambrex Bio Science Instrutech Corp. Olympus America Inc. TI.L.L. Photonics Gmbh
Rockland, Inc. Intelligent Imaging Innovations Optical Insights, LLC Torrey Pines Scientific
Carl Zeiss, Inc. Inc. Optronics Universal Imaging Corporation
Cell and Molecular Invitrogen Corporation PE Biosystems Vector Laboratories
Technologies, Inc. Jackson lmmunoresearch Perkin Elmer Life Sciences Warner Instruments
Chroma Technology Laboratories Pierce Chemical Co. Vysis Corporation
Corporation Jouan, Inc. PolyLC
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SEMINARS
Invited Speaker Program
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
findings on a weekly basis. These seminars keep the CSHL staff current on the latest developments
and broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar
speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas in
an informal setting.
January
Dr. Charles Sawyers, University of California, Los Angeles,
Hematology-Oncology. Kinase inhibitors in cancer. (Host:
Scott Lowe)
Dr. Helen Saibil, Department of Crystallography, Birkbeck
College, London. GroEL-GroES chaperonins: A protein fold-
ing machine. (Host: Leemor Joshua-Tor)
February
Dr. Constance L. Cepko, Howard Hughes Medical Institute,
Harvard Medical School. Genomics approaches to photore-
ceptor development and disease. (Host: Josh Huang)
Dr. Michael N. Shad len, Howard Hughes Medical Institute,
University of Washington. Banburismus and brain: A neural
mechanism for making decisions. (Host: Tony Zador)
Dr. Robert Eisenman, Fred Hutchinson Cancer Research
Center. The Myc oncogene: Walking through the garden of
forking paths. (Host: Bill Tansey)
March
Dr. John Doebley, University of Wisconsin, Madison. The evolution
of plant form: An example from maize. (Host: David Jackson)
Dr. Harold Varmus, Memorial Sloan-Kettering Cancer Center.
Using mouse models to learn how cancers arise and survive.
(Host: Bruce Stillman)
Dr. Joan W. Conaway, Stowers Institute for Medical Research.
Elongin BC-based ubiquitin ligases and transcriptional regu-
lation. (Host: Nouria Hernandez)
Dr. Anirvan Ghosh, Johns Hopkins School of Medicine,
Department of Neuroscience. Calcium signaling and the
control of cortical connectivity. (Host: Karel Svoboda)
April
Dr. Fred H. Gage, The Salk Institute for Biological Studies,
Laboratory of Genetics. Regulation and function of neuroge-
nesis within the adult mammalian brain. (Host: Tony Zador)
Dr. John D. Scott, Howard Hughes Medical InstituteNollun
Institute, Oregon Health & Science University. The molecular
architecture of signaling complexes. (Host: Nick Tonks)
October
Dr. Gary Ruvkun, Massachusetts General Hospital,
Harvard Medical School. The tiny RNA world. (Host:
Winship Herr)
Dr. Morgan Sheng, Massachusetts Institute of Technology.
Molecular mechanisms of the dynamic synapse. (Host:
Holly Cline)
Dr. Stephen C. Kowalczykowski, Center for Genetics and
Development, University of California, Davis. Visualization
of recombinational DNA repair at the single molecule level.
(Host: Tatsuya Hirano)
Dr. Paul W. Glimcher, Center for Neural Science, New York
University. Neural studies of primate decision making.
(Host: Zach Mainen)
November
Dr. Ronald DePinho, Dana Farber Cancer Institute, Harvard
Medical School. Modeling cancer and cancer genomes.
(Host: Terri Grodzicker)
Dr. Ewan Birney, EMBL-EBI, Welcome Trust Genome
Campus. Inference of biology from data. (Host: Adrian
Krainer)
December
Dr. Mary Ann Os ley, Molecular Genetics and Microbiology,
University of New Mexico Health Sciences Center. Histone
modifications and transcription: The role of histone ubiquity-
lation. (Host: David Spector)
Dr. Jeffrey Friedman, Howard Hughes Medical Institute, The
Rockefeller University. Leptin and the neural circuit regulating
body weight and the adaptive response of starvation. (Host:
Karel Svoboda)
Dr. Jonathan A. Cooper, Fred Hutchinson Cancer Research
Center. Cellular and developmental roles of disabled-related
adaptor proteins, (Host: Nick Tonks)
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In-House Seminar Program
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communica-
tion between the various research groups at the Laboratory. The seminars also afford a necessary
opportunity for the graduate students and postgraduate staff to develop their skills in organizing, pre-
senting, and defending their research.
January
Yi Zhong: Memory, disease genes, and the fly brain.
Hang Shi Vu Lab): Structure of the exon-exon junction com-
plex proteins.
Ryohei Yasuda (Svoboda Lab): Imaging the function and plas-
ticity of synaptic channels.
Mingming Zhao (Van Aelst Lab): p62.1', a scaffolding protein
for negative signaling.
February
Supriya Prasanth (Stillman Lab): ORC, a replication initiator
protein required for multiple aspects of cell division cycle.
Kannan Natarajan (Neuwald Lab): Protein kinase structural
mechanisms.
Ravi Sachidanandam: Networks: Don't believe the hype?/I
March
Josh Huang: Development of GABAergic circuits in neocortex
and cerebellum-In search of a molecular address code for
subcellular synapse targeting.
Tony Zador: The cocktail party problem: Computation in the
auditory cortex.
Andreas Herbst (Tansey Lab): 'Trouble" comes in threes:
Conserved elements and their role in Myc function.
Eric Julien (Herr Lab): Exploring the chromosome cycle with
the herpes simplex virus host-cell factor HCF-1.
April
Ira Hall (Grewal Lab): Role of the RNA' machinery in hetero-
chromatin formation and chromosome dynamics in S. pombe.
Susan Janicki (Spector Lab): Silencing to gene expression:
Real-time analysis in living cells.
October
Karel Svoboda: Imaging synaptic plasticity.
Masashi Narita (Lowe Lab): Rb-mediated heterochromatin for-
mation in cellular senescence.
Ajit Janardhan (Skowronski Lab): HIV-1 Nef binds Rac and its
upstream activators to alter signaling in T lymphocytes.
Masaaki Hamaguchi: Analysis of DBC2, a new tumor suppres-
sor gene.
November
Rob Lucito: ROMA surveying the terrain of cancer genomes.
Fabrice Ango (Huang Lab): Where to put a synapse: Molecular
mechanisms of subcellular synapse targeting in cerebellum.
Leemor Joshua-Tor: PAZ pizazz and El fun-The single
strandedness of it all.
December
Lee Henry: Understanding taste buds at single cell resolution.
Zhenyu Xuan (Zhang Lab): CSHL mammalian promoter data-
base and its applications.
Kurt Haas (Cline Lab): Activity-dependent dendritic arbor
growth.


BANBURY CENTER
DIRECTOR'S REPORT
There were 19 meetings at the Banbury Center in 2003, with 654 participants. Of these, 530 (81%)
came from the United States, drawn from 33 states. As usual, New York, Maryland, Massachusetts,
and California provided most participants (46% of the total), reflecting the many research institutions in
those states. Participants from abroad came from 21 countries, once again showing the high esteem
in which meetings at Banbury are held throughout the world. The Watson School of Biological Sciences
held two week-long "Topics in Biology" courses, and there were five lecture courses in the Laboratory's
Meetings and Courses Program. Finally, two local groups made use of the Center. As usual, the pro-
gram dealt with eclectic, interesting, and often controversial topics. The meetings ranged from discus-
sions of some of the oldest problems in biology, such as What is a species?, through theoretical biol-
ogy, to biomedical topics of the greatest practical importance for many millions of people. There was
also one very special event in 2003-Banbury Center's 25th anniversary.
Our 25th Anniversary
That the Banbury Center exists is due to the foresight
and wisdom of Charles Robertson, a pivotal figure in the
modern development of Cold Spring Harbor Laboratory.
He first made a most generous gift of $7.5 million in 1973
to establish the Robertson Fund, the major part of the
Laboratory's endowment. Two years later, in 1975,
Robertson gifted his Lloyd Harbor estate of some 45
acres and the buildings on it to the Laboratory. These
included the family house and a large garage, together
with an endowment intended to contribute to the
upkeep of the buildings and the estate. It is said that
Robertson wanted laboratories built on the site, but this
was impractical for financial and esthetic reasons.
Instead, Jim Watson suggested that the estate be used
for small, workshop-style meetings to complement the
large meetings held on the main campus.
Robertson agreed and the garage was converted
into a spacious seminar room, with large windows on
two sides and a high, vaulted ceiling. These features
make our Conference Room so unlike the typical sem-
inar room and its ambience contributes significantly
to the success of meetings at Banbury. Another strik-
ing feature is the chalkboard across the full width of
the room. I can remember Jane Gitschier explaining
the polymerase chain reaction to science journalists,
beginning at the left side of the board and drawing a
diagram that took up all 30 feet of the board. The fam-
ily house-now named Robertson House-was mod-
ified to accommodate meetings participants. (Extra
accommodation was provided a few years later when
funding from the Max C. Fleischmann and Kresge
Foundations was used to build Sammis Hall, and
many years later the Meier House was purchased.)
11111111=111111
The garage prior to renovations.
The garage during renovations.
The garage today as a conference room.
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Cocktails during the 25th
Anniversary Party.
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D. West, P. Travaglianti, B. Stillman, G. Stillman, K. Friedman
H. Varmus, J. Watson
On June 14,1977, Francis Crick gave a talk at a small dedication ceremony of what was now called
the Banbury Center. Victor McElheny was appointed the first director in early 1978 and Charles
Robertson's vision for his family's gift to the Laboratory was properly realized when the first meeting
was held in May 1978, on Assessing Chemical Mutagens: The Risk to Humans.
We celebrated the Silver Anniversary of that meeting with a small party on September 12. Guests
included Bill Robertson and Anne Meier (two of Charles and Marie Robertson's children), former directors
Victor McElheny (1978-1982) and Michael Shodell (1982-1986), and friends from Lloyd Harbor. Harold
Varmus, Nobel laureate, former director of the National Institutes of Health, and current President of
Memorial Sloan-Kettering Cancer Research Center, was the guest of honor. The evening began with cock-
tails in the Conference Room, and was followed by dinner at Robertson House. Dr. Varmus, a frequent
participant in Banbury Center meetings, gave a short talk describing the importance of the Banbury Center
in promoting biomedical research. It was a delightful evening and made us look forward to what the next
25 years will bring. (In our first 25 years, there were 380 meetings attended by over 11,000 participants.)
Planning and Promoting Biomedical Research
Without exception, all Banbury Center meetings have a significant effect on those participating in them,
but there are some meetings that have a demonstrated impact far beyond the confines of the
Conference Room. These are fascinating meetings, combining critical reviews of science with discus-
sions of science policy. One example was the 1994 meeting on sequencing the Arabidopsis genome
that ultimately led to the international effort to complete the sequence. There were similar meetings on
three different topics at Banbury in 2003.
L. Joshua-Tor (Cold Spring Harbor Laboratory) and W. Hendrickson (Columbia University) organized
the Scientific Opportunities in Macromolecular Crystallography at NSLS-II meeting in July. NSLS stands
for the National Light Synchrotron Source II that is to be built at Brookhaven National Laboratory. X-ray
crystallography is achieving remarkable results in determining the atomic structures of huge molecular
complexes. These successes are due to technical advances, not the least of which is the use of very
powerful X-rays produced by synchrotrons. This meeting brought together X-ray crystallographers from
the relevant institutions to discuss their needs for the NSLS-II. Notable among these was Rod
McKinnon, who three months later won the Noble Prize for his work on channel complexes.
We now have the complete sequence of the human genome, but a huge amount of work needs to
be done to understand it. A key strategy will be to use other, more tractable experimental animals such
as the mouse and the rat. These have different benefits, but the mouse has the edge in terms of its
genetics. Mutations are key to doing genetics, and a large number of naturally occurring mouse
mutants have been found during the past 100 years. But systematic mutagenesis screens, while
expensive and time-consuming to do, have proved invaluable for other organisms, for example,
zebrafish. R. Woychik (The Jackson Laboratory) and C. Austin (National Human Genome Research
Institute) organized the Mouse Genome-wide Targeted Mutagenesis meeting at Banbury to review the
scientific and financial issues of carrying out a genome-wide mutagenesis of the mouse. This was an
extraordinarily intensive meeting with discussions going on late into the night.
DNA sequence analysis is also being applied to organisms much more esoteric than human and
mouse. For many years, taxonomists have used molecular comparisons of proteins and DNA sequences
to estimate the relatedness of organisms. Now there is a proposal to use DNA sequences as molecular
"bar codes," to use DNA sequences as unique identifiers of species; if a purported new species has the
same bar code as one known already, then it is not a new species. The proposal is controversial on sci-
entific grounds-is it right and will it work?-and because it seems to be replacing the skills of the tax-
onomist with a robotic sequencing machine. The Alfred P Sloan Foundation funded two meetings to
review this proposal. The first meeting, Taxonomy and DNA, was organized by R. De Salle (American
Museum of Natural History), S. Federhen (National Library of Medicine, National Institutes of Health), and
P. Hebert (University of Guelph, Canada). It reviewed some of the fundamental questions: How well do
these molecular approaches conform with current methods for defining species? How can molecular
data be integrated with other taxonomic data? What are the practical issues involved in carrying this out
on a large scale? The second meeting, Taxonomy DNA, and the Bar Code of Life, organized by J. Baker
(Academy of Natural Sciences, Philadelphia) and J. Hanken (Harvard University) was primarily a planning
meeting, focusing on how to proceed with a museum-based, large-scale DNA bar-coding effort, includ-
ing strategy, policy, funding, and organization. These remarkable meetings have led to the establishment
of a "Bar Code of Life Initiative" Consortium to further these plans.
Plant Science
The foundations of developmental biology were laid through observation and experimental manipula-
tion, but now, genomic and comparative genomic approaches are giving us the tools to determine how
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limbs or leaves develop. An inflorescence is a cluster of flowers all arising from the same stem, and
much work has been done on the genetic basis for inflorescence development in Arabidopsis.
However, this meeting, Regulation of Inflorescence Morpholog: Insights from Genetics and Genomics,
organized by E. Kellogg (University of Missouri, St. Louis) and D. Jackson (Cold Spring Harbor
Laboratory) and funded by the Cold Spring Harbor Laboratory Corporate Sponsor Program, focused
on other plant and nonplant developmental systems. Participants explored how developmental genet-
ics, quantitative trait analysis, and comparative biology can help to discover genes that establish and
regulate meristem identity and determine how these gene products interact.
Theoretical Biology
There have been recurring attempts to establish a theoretical biology, in the same way that theoretical
physics exists as a well-defined field. These have not been successful-perhaps all kinds of biologists
have far too much to discover experimentally to need guidance from theorists. Nevertheless, there are
areas where a theoretical approach may well be helpful.
The discussions of species showed how seriously taxonomists take words and descriptions; they
aim for unambiguous definitions of a Monarch butterfly or an Indian elephant. Laboratory scientists
have been less careful with words and descriptions, using names and concepts that may not have con-
sistent definitions in different research fields. The need for consistency and for new descriptive tools is
becoming ever more urgent as the flood of data, and its complexity, continues to increase. The meet-
ing Formal Languages for Biological Processes, organized by Y. Lazebnik (Cold Spring Harbor
Laboratory), D. Endy (Massachusetts Institute of Technology), and A. Finney (California Institute of
Technology) examined some of the approaches being taken to represent biological processes so that
they can be more effectively analyzed and understood. Participants were drawn from three areas:
experimental biologists who should use these methods, biologists who have successfully used formal
approaches, and developers (often mathematicians) of these approaches. The meeting was funded by
the Cold Spring Harbor Laboratory Corporate Sponsor Program.
Robertson House provides housing accommodations at Banbury Center.
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A second meeting tackling theoretical approaches to biological problems examined some of the
simplest gene networks, those of bacteriophage. Organized by S. Adhya (National Cancer Institute), D.
Court (National Cancer Institute), and A. Oppenheim (The Hebrew University), Quantitative Genetic
Networks focused on the quantitative aspects of the genetic and biochemical components underlying
the regulatory networks found governing the alternative lifestyles found in bacteriophages. It was
remarkable the degree to which even these seemingly simple networks pose problems for formualting
theoretical descriptions and devising modern experimental approaches to solve specific complex gene
control processes. The meeting was funded by the National Cancer Institute.
Neuroscience
The two Banbury Center meetings on neuroscience also had strong theoretical underpinnings. Neural
Circuits: Principles of Design and Operation was organized by K.D. Miller (University of California, San
Francisco) and H.S. Seung (Massachusetts Institute of Technology). Funded by the Swartz Foundation,
the meeting brought together experimentalists and theoreticians working on operation of neuronal cir-
cuits. The participants considered results on cortical circuitry, compared and contrasted results from
visual, somatosensory, and auditory cortex and the bird song system, and considered theoretical and
engineering approaches to the construction of neural circuits.
The second meeting, Neural Representation and Processing of Temporal Patterns, was organized
by C. Brody (Cold Spring Harbor Laboratory), D. Buonomano (University of California, Los Angeles),
and J. Hawkins (Redwood Neuroscience Institute). Processing of temporal patterns is a fundamental
component of sensory and motor function. Given the inherent temporal nature of our interaction with
the environment, understanding how the brain processes time is a necessary step toward under-
standing the brain. Participants considered the following fundamental problems: How is time repre-
sented in the brain? How are complex temporal patterns perceived and produced? Participants includ-
ed psychologists, neuroscientists, and theorists working on these problems, and the meeting was
funded by the Redwood Neuroscience Institute.
Human Neurological and Neurodegenerative Disorders
Three meetings dealt with neurological and neurodegenerative disorders. A fourth meeting dealt with
stem cells and is included here, given that stem cells may prove to be effective in neurodegenerative
diseases.
Banbury has regularly held meetings on Fragile-X syndrome, most recently funded by the FRAXA
Research Foundation. Research on Fragile-X is at a most interesting stage, with evidence that abnor-
malities may exist in the formation of contacts between nerve cells. This is generating a large amount
of intense research which was reviewed in the meeting Synaptic Function in Fragile-X, organized by
M. Bear (Brown University) and M. R. Tranfaglia (FRAXA Research Foundation). It focused on the bio-
logical activity of the FMRP protein and on its role in dendrite formation. Most importantly, under-
standing the mechanisms involved will lead to identifying other components which may be therapeu-
tic targets.
Research on amyotrophic lateral sclerosis (ALS)-the most common form of motor neuron dis-
eases-is also at a most interesting stage. From 5% to 10% of ALS is inherited, and in 20% of these
families, there are mutations in the enzyme Cu/Zn Superoxide dismutase 1. This discovery made a
major impact on the field, but the mechanism of SOD1 toxicity remains unclear and the cause(s) of the
remaining ALS cases is unknown. These latter cases were the subject of Finding New Genes Linked
to Amyotrophic Lateral Sclerosis: A Focus on Current Technologies and Their Potential Application,
organized by R. Brown (Massachusetts General Hospital) and L. Bruijn (The ALS Association) and fund-
ed by the ALS Association. It examined how the complete human genome sequence and new tech-
nology advances can be used to look for the genetic components of these unknown cases. The dis-
covery of new genes, either linked to familial disease or susceptibility genes in the sporadic cases, is
critical for a better understanding of the disease and the potential for new therapeutic targets.
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Banbury Center held a meeting on schizophrenia for the first time since the early 1990s. Since then,
several areas of the genome have been suspected of harboring genes contributing to schizophrenia,
but no gene has yet been pinned down. On the other hand, there have been advances in the neu-
ropharmacology of schizophrenia, particularly in the role of a molecule called NMDA. Participants in this
meeting, Integrating Progress in the Genetics and Neuropharmacology of Schizophrenia, organized by
R. Cloninger (Washington University) and J. Coyle (Harvard University), attempted to bring together
both areas of research. The goals of the meeting were to identify new technical and experimental
advances in the fields of genetics, cognitive development, brain imaging, and neuropharmacology that
might be applied to understanding schizophrenia. The meeting was funded by the Cold Spring Harbor
Laboratory Corporate Sponsor Program.
No area of contemporary biomedical research has been more controversial than studies of human
stem cells. The promise of using stem cells for therapy is great, but much still must be learned about
the biology of these remarkable cells. R. McKay (National Institute of Neurological Disorders and Stroke)
organized a meeting, Controlling the Differentiation of Pluripotent Cells, that examined how these cells
differentiate into many cell types, and the ways in which this differentiation might be directed. A key
question is the extent to which work on other organisms, in particular the mouse, can be extrapolated
to human cells. The ethical implications of this work were not ignored; there was an energetic discus-
sion of some of the philosophical underpinnings of people's reactions to human stem cell research. The
meeting was funded by the Cold Spring Harbor Laboratory Corporate Sponsor Program.
Cancer
The meetings on cancer in 2003 all concentrated on clinical issues, rather than on research on the fun-
damental causes of cancer.
Two meetings dealt with very interesting forms of cancer. The first was on The Biology of
Neuroendocrine Tumors, organized by A. Levine (Institute for Advanced Studies), and E. Vosburgh (Verto
Institute), and funded by the Verto Institute. These carcinoid and other neuroendocrine tumors are derived
from cells that share neural and endocrine features. They have a unique biology that determines the clin-
ical features of the tumors and that might be exploited in developing treatments. These treatments might
be very different from those currently available for other cancers. This meeting provided an opportunity to
bring together current and future Verto investigators, and the Scientific Advisors of the Verto Institute.
The second meeting dealt with a related group of unusual cancers, pheochromocytomas, which
secrete catecholamines and cause hypertension. Molecular Differentiation of Benign and Malignant
Pheochromocytomas and Neuroblastomas, organized by G. Eisenhofer (National Institutes of Health),
W.M. Manger (National Hypertension Association, Inc.), and R.M. Weinshilboum (Mayo Foundation),
was funded by the National Hypertension Association, Inc. There are no reliable prognostic markers to
assess whether a pheochromocytoma will metastasize-presumably these differences in behavior
reflect the underlying mutations and differences in expression of genes regulating cellular growth and
survival. An understanding of these pathways of gene expression should therefore allow identification
of molecular markers of malignancy and possible new targets for therapeutic intervention. Participants
reviewed current methods for distinguishing benign from malignant forms of pheochromocytoma and
went on to survey the use of microarrays and other genomics-based tools for detecting malignancy in
these types of tumor.
Finally, T. Kreiner (Affymetrix, Inc.), T. Golub (Whitehead Institute for Biomedical Research), and D.
Dalma-Weiszhausz (Affymetrix, Inc.) organized a meeting, Taking Cancer Genomics to the Clinic, fund-
ed by Affymetrix, Inc. This was a high-level discussion workshop that examined how genomic
approaches to cancer will promote the implementation of new techniques and strategies. In particular,
participants reviewed the current diagnostic and prognostic clinical practices in the treatment of can-
cer and how techniques such as microarrays might change them. Participants included cancer
researchers, clinicians, policy-makers, and members of advocacy groups, and an important goal of the
meeting was to strengthen the relationships in the cancer world among advocacy groups, researchers,
policy-makers, the FDA, and technology providers.
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Infectious Diseases and Chronic Disorders
Toward a More Unified Understanding of Infectious Disease, organized by V McGovern (Burroughs
Wellcome Fund) and S. James (The Ellison Medical Foundation), and funded by the Burroughs Well-
come Fund, reviewed the current state of basic research in the human pathogens. After surveying the
impact and potential of genomic and postgenomic approaches, participants went on to consider where
infectious diseases research is going, and how a more comprehensive understanding of the interface
between pathogens and host can be gained. One goal of the meeting was to explore the desirability
of integrating research across the pathogens, and the difficulties involved in taking this broader
approach. It is a sign of the times that veterinary pathogens were included in the discussions.
Infectious pathogens were also part of the meeting Toward Understanding the Cellular and
Molecular Mechanisms of Medically Unexplained Fatigue. This topic is highly controversial precisely
because it is medically unexplained and so, in the view of many, such fatigue does not exist except in
the mind of the individual. For this reason, the organizers, W.C. Reeves and S.D. Vernon (Centers for
Disease Control & Prevention) and C. Heim (Emory University), covered a remarkably wide range of top-
ics, from infections and toxins, to how the mind influences onset and recovery. Funded by the Centers
for Disease Control & Prevention, it was a thought-provoking meeting that included discussions of
mind/body relationships.
Vaccines
Banbury Center has hosted a series of colloquia sponsored by the Albert B. Sabin Vaccine Institute on
key issues limiting the production and distribution of vaccines, particularly to the most disadvantaged
populations. The 2002 colloquium, Global Vaccine Shortage: The Threat to Children and What to Do
About It, identified the four priority issues for which feasible solutions could be found: Stockpiling,
Meier House Provides housing accommodations for meeting participants at Banbury Center.
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International Commission on Harmonization (ICH) on Vaccines, Financing, and Public Advocacy. L.
Miller (Intermedica, Inc.) and N. Tomich (U.S. Medicine Institute) convened the 2003 colloquium,
Feasible Solutions to Global Vaccine Shortages, to propose ways to tackle these issues. The meeting
was funded by the Albert B. Sabin Vaccine Institute through a grant from the Bill and Melinda Gates
Foundation.
Eugenics
The Ethical, Legal, and Social Issues (ELSI) division of the National Human Genome Research Institute
provided funds for An Image Archive of the American Eugenics Movement (Dolan DNA Learning
Center). Part of the grant was to be used for meetings introducing opinion leaders and policy-makers
from government, science, healthcare, education, and the mass media to this episode in American
social history. The meeting in 2003 was the last in this series. Organized by D. Mick los (Dolan DNA
Learning Center) and myself, the emphasis of the meeting changed a little so as to include contempo-
rary issues. Eugenics, Genes, and Human Behavior ranged from a presentation on Sir Francis Galton,
through the eugenics movement of 1910-1940, to present-day efforts to find genes affecting human
behavior.
Watson School of Biological Sciences
Of the two Topics in Biology Courses for students in the Watson School, the first was a repeat of the
course on Evolution taught by N. Patel (University of Chicago). The second course was a new one on
Animal Behavior, taught by H.K. Reeve from Cornell. This, like the others in the program, was tremen-
dously successful, with students observing the behavior of solitary wasps on the Banbury estate, as
well as the behavior of larger animals at the Bronx Zoo.
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MEETINGS
Toward Understanding the Cellular and Molecular Mechanisms of
Medically Unexplained Fatigue
February 23-26
FUNDED BY
ARRANGED BY
Centers for Disease Control & Prevention and The CFIDS Association of America
W.C. Reeves, Centers for Disease Control & Prevention, Atlanta, Georgia
S.D. Vernon, Centers for Disease Control & Prevention, Atlanta, Georgia
C. Heim, Emory University School of Medicine, Atlanta, Georgia
Introduction: S.D. Vernon, Centers for Disease Control & Prevention, Atlanta, Georgia
SESSION 1: Setting the Stage: Chronic Fatigue and the State-of-the-Science
Chairpersons: B. Evengard, Karolinska Institutet, Stockholm, Sweden; U. Vollmer-Conna, University of
New South Wales, Sydney, Australia
S. Wessely, Institute of Psychiatry, London, United Kingdom:
The spectrum of ailments in medically unexplained fatiguing
illnesses and why a multidisciplinary, integrated approach is
necessary to further our understanding.
W.C. Reeves, Centers for Disease Control & Prevention,
Atlanta, Georgia: Conservative estimates of the magnitude
of medical unexplained fatigue.
P.D. White, St. Bartholomew's Hospital, London, United
Kingdom: Cognitive, behavioral, and emotional factors in
chronic fatigue.
D. Papanicolaou, Emory University School of Medicine,
Atlanta, Georgia: Neuroendocrine perturbations in chronic
fatigue.
A. Lloyd, University of New South Wales, Sydney, Australia:
Acute infection, immunologic perturbations, and chronic
fatigue.
SESSION 2: Influences on the Structure and Function of the Brain
Chairpersons: E.R. Unger, Centers for Disease Control & Prevention, Atlanta, Georgia;
A.H. Miller, Emory University School of Medicine, Atlanta, Georgia
J.C. de Is Torre, University of California, San Diego,
Escondido: Cerebral perfusion and neurometabolic-
synaptic activity in normal and abnormal states:
Relevance to CFS?
C.D. Sladek, University of Colorado Health Sciences Center,
Denver: Regulation of the neurohypophyseal system:
Neurotransmitter, neuropeptide, and steroid hormone
interactions.
S. Vernon
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SESSION 3: Infection, Immunity, Sex, and the Brain
Chairperson: M.A. Fletcher, University of Miami School of Medicine, Florida
E. M. Sternberg, National Institute of Mental Health, Bethesda,
Maryland: Neuroendocrine regulation of immunity.
P.H. Patterson, California Institute of Technology, Pasadena:
Maternal infection, fetal brain development, and health.
I. Hickie, St. George Hospital, Sydney, Australia: Persistent
infection and immunity and chronic consequences.
SESSION 4: In Search of a Marker: Analytical Approaches Applicable to Medically Unexplained
Fatigue
Chairpersons: K. Kenney, The CFIDS Association of America, Charlotte, North Carolina;
E. Hanna, National Institutes of Health, Bethesda, Maryland
A.J. Cleare, Guy's, King's and St. Thomas' School of
Medicine, London, United Kingdom: What pyschopharma-
cology tells us about the pathophysiology of medically
unexplained fatigue.
S. Vernon, Centers for Disease Control & Prevention, Atlanta,
Georgia: Biomarker discovery in illness with no lesion.
S. Shriver, Penn State University, University Park: X versus Y:
Sex-based disease differences.
C. Art lett, Thomas Jefferson University, Philadelphia,
Pennsylvania: Microchimerism: Incidental by-product of
pregnancy or active participant in human health?
SESSION 5: Can We Explain What Might be Happening in the Brain?
Chairperson: J.F. Jones, National Jewish Medical & Research Center, Denver, Colorado
Workshop Committee Chairperson: E.R. Unger, Centers for Disease Control & Prevention, Atlanta,
Georgia
Summary Report: Future Research Directions
P. White, S. Wessely
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Taxonomy and DNA
March 9-12
FUNDED BY Alfred P. Sloan Foundation
ARRANGED BY R. De Salle, American Museum of Natural History, New York
S. Federhen, National Library of Medicine, NIH, Bethesda, Maryland
P. Hebert, University of Guelph, Ontario, Canada
SESSION 1: Species: Biology's Fundamental Particles
Key Questions for Session
N. Knowlton, University of California, San Diego: Marine bio-
diversity: Marrying DNA and natural history.
B. Golding, McMaster University, Hamilton, Canada: The
nature of substitutions that distinguish species.
K.L. Shaw, University of Maryland, College Park: DNA varia-
tion in newly evolved species.
J. Hanken, Harvard University, Cambridge, Massachusetts:
Cryptic biodiversity: Molecular and morphological
approaches.
Discussion of Session
Comments by Discussion Leaders: G. Caccone, Yale
University, New Haven, Connecticut; G. Amato, Wildlife
Conservation Society, Bronx, New York
SESSION 2: Probing Life's Diversity with DNA
Key Questions for Session
N. Pace, University of Colorado, Boulder: The large-scale
structure of the Tree of Life.
M. Sogin, The Marine Biological Society, Woods Hole,
Massachusetts: Molecular evolution of eukaryotes: A protist
perspective.
R Hebert, University of Guelph, Ontario, Canada:
Microgenomics and animal diversity.
Discussion of Session
Comments by Discussion Leaders: K. de Queiroz,
Smithsonian Institution, Washington, D.C.; A. Vogler, The
Natural History Museum, London, United Kingdom
SESSION 3: Large-scale Biology I
R. McCombie, Cold Spring Harbor Laboratory: Genome pro-
jects: A Pl's perspective.
SESSION 4: The Analytical Engines
Key Questions for Session
D. Hillis, University of Texas, Austin: The Tree of Life and its
role in automated species identification.
K. Crandall, Brigham Young University, Provo, Utah:
Bioinformatics methods for large-scale phylogenetics.
R. De Salle, American Museum of Natural History, New York:
Phylogenetic systematics and diagnosis.
Discussion of Session
Comments by Discussion Leaders: A. Buck lin,
University of New Hampshire, Durham; B. Schierwater,
ITZ, Ecology of Evolution, Hanover, Germany
G. Caccone, K. Shaw, K. Crandall
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SESSION 5: Collections of life
Key Questions for Session
B. Thiers, New York Botanical Garden, Bronx, New York:
Herbaria and systematics: Past, present, and future.
S. Federhen, National Library of Medicine, NIH, Bethesda,
Maryland: Linking sequences to specimens.
M. O'Leary, Stony Brook University, New York: MorphoBank.
D. Janzen, University of Pennsylvania, Philadelphia:
Reflections on large-scale biodiversity inventories.
Discussion of Session
Comments by Discussion Leaders: W. Hallwachs,
University of Pennsylvania, Philadelphia; M. Stoeckle,
Cornell University Medical College, Ithaca, New York
SESSION 6: Large-scale Biology II
N. Zinder, The Rockefeller University, New York: Genome pro-
jects: Money and politics.
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SESSION 7: Group Discussions
Introduction to Purpose
Group 1: Acquiring Specimens for DNA Analysis and
Acquiring DNA Sequences
Leaders: F. Grass le, Rutgers University, New Brunswick,
New Jersey; K.L. Shaw, University of Maryland, College
Park
Group 2: Analyzing the DNA Sequences and Project
Delineation
Leaders: D. Hickey, University of Ottawa, Ontario, Canada;
R. De Salle, American Museum of Natural History, New
York
Reports and Discussion
Chairperson: P. Hebert, University of Guelph, Ontario,
Canada
M. Sogin, J. Ausubel
Quantitative Genetic Networks
March 16-19
FUNDED BY Center for Cancer Research, National Cancer Institute
ARRANGED BY S. Adhya, National Cancer Institute, NIH, Bethesda, Maryland
D.L. Court, National Cancer Institute, Frederick, Maryland
A. Oppenheim, Hebrew University, Hadassah Medical School, Jerusalem, Israel
SESSION 1: CII and CIII
Chairperson: A.M. Campbell, Stanford University, California
A.M. Campbell, Stanford University, California: What do we
know-not know about CII?
A. Oppenheim, Hebrew University, Hadassah Medical School,
Jerusalem, Israel: CII and CIII in the genetic networks.
P. Parrack, Bose Institute, Kolkata, India: CII stability and
transcriptional control: Structural insights and functional
implications.
SESSION 2: 2i.: CI and Cro
Chairperson: S. Adhya, National Cancer Institute, NIH, Bethesda,
G. Gussin, University of Iowa, Iowa City: Quantitative aspects
of regulation of the PRM promoter.
J.W. Little, University of Arizona, Tucson: Genetic circuitry:
Are its features essential or refinements to a basic ground
plan?
I. Dodd, University of Adelaide, Australia: Role of Cro in the
R. Weiss, Princeton University, New Jersey: Rational design
and directed evolution strategies for constructing synthetic
gene networks.
S. Adhya, National Cancer Institute, NIH, Bethesda,
Maryland: 2's lifestyle decision: Stochastic or deter-
ministic?
Maryland
bistable switch.
S.L. Svenningsen, University of Copenhagen, Denmark:
Insights into the role of Cro and OL in regulation of PR.
K. Shearwin, University of Adelaide, Australia: The long-
range interaction between OL and OR.
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SESSION 3: k: Genetics Circuitry and Modeling
Chairperson: M. Ptashne, Memorial Sloan-Kettering Cancer Center, New York
S. Brown, University of Copenhagen, Denmark: Single cell
analysis of phophage stability. S. Roy, Bose Institute,
Calcutta, India: CI property: A new look at the genetic
switch.
K. Sneppen, NORDITA, Copenhagen, Denmark: Modeling
SESSION 4: Other Aspects of ?
Chairperson: H. Eisen, Seattle, Washington
M.E. Gottesman, Columbia University, New York: Exclusion of
? by phage HK022.
L. Thomason, National Cancer Institute, Frederick, Maryland:
Role of rex and ren genes.
R. Young, Texas A&M University, College Station: Lysis tim-
ing: Diverse solutions to the paramount regulatory problem.
SESSION 5: Other Phages
Chairperson: A. Das, University of Connecticut, Farmington
L. Orosz, Eotvos Lorand University, Budapest, Hungary:
Rhizobium phage 16-3: DNA looping; two immunity
regions.
E. Haggard, Stockholm University, Sweden: Comparison of
the genetic switches in P2-related phages.
K. Hammer, BioCentrum-DTU, Lyngby, Denmark: The genet-
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OL-OR derepression and stability.
M.B. Elowitz, The Rockefeller University, New York: Synthetic
gene networks and genetic noise in cells.
D.L. Court, National Cancer Institute, Frederick, Maryland:
Effect of genes from PL operon on everything else.
J.R. Roth, University of California, Davis: Effect of prophage
on induction of the SOS system and the activity of RecA
co-protease.
J. Stavans, Weizmann Institute of Science, Rehovot, Israel:
The SOS response of single cells.
is switch in lactococcal phage TP901-1.
R. d'Ari, Institut Jacques Monod, Paris, France: Does phage
Mu gemA gene affect cell cycle?
D. Endy, Massachusetts Institute of Technology, Cambridge:
Phage T7.
J. Roth, M. Gottesman, A. Campbell
Toward a More Unified Understanding of Infectious Disease
March 23-26
FUNDED BY
ARRANGED BY
Opening Remarks:
Burroughs Wellcome Fund
V. McGovern, Burroughs Wellcome Fund, Research Triangle Park, North Carolina
S.L. James, The Ellison Medical Foundation, Bethesda, Maryland
SESSION 1: Overview
V. McGovern, Burroughs Wellcome Fund, Research Triangle Park, North Carolina
E.G. Bond, Burroughs Wellcome Fund, Research Triangle
Park, North Carolina
SESSION 2: Current Needs and Expectations: Pathogenesis
Research and the Development of Vaccines/Drugs/
Diagnostics
A. Mahmoud, Merck & Co., Inc., Whitehouse Station, New
Jersey
SESSION 3: Current Research Perspectives: "Classical"
Infectious Diseases
G.I. Miller, Jr., Yale University School of Medicine, New
Haven, Connecticut
K. Haider, Northwestern University Feinberg, Chicago, Illinois
A. Casadevall, Albert Einstein College of Medicine, Bronx,
New York
P. Small, University of Tennessee, Knoxville
SESSION 4: Current Research Perspectives: Infectious
Roots of Chronic Diseases
M.J. Blaser, New York University School of Medicine, New
York
R.H. Yolken, John Hopkins University, Baltimore, Maryland
M.V. Pletnikov, Johns Hopkins University School of Medicine,
Baltimore, Maryland
SESSION 5: Group Discussion: What Are The Current
Expectations for Infectious Disease Research?
Discussion Leader: G.I. Miller, Jr., Yale University School
of Medicine, New Haven, Connecticut
SESSION 6: What We Heard-Summary of First Day
Discussion Leader: G.I. Miller, Jr., Yale University School
of Medicine, New Haven, Connecticut
SESSION 7: What Could We Gain from a Broader
Perspective: Successes and Barriers
N.M. Agabian, University of California, San Francisco
J. Heitman, Duke University, Durham, North Carolina
E Sher, NIAID, National Institutes of Health, Bethesda,
Maryland
M.K. Hostetter, Yale University School of Medicine, New
Haven, Connecticut
T.L. Doering, Washington University School of Medicine, St.
Louis, Missouri
J.H. McKerrow, University of California, San Francisco
371
SESSION 8: Group Discussion
J. Heitman, Duke University Medical Center, Durham, North
Carolina
F. Sher, NIAID, National Institutes of Health, Bethesda,
Maryland
SESSION 9: What's in the Toolbox?
G.M. Weinstock, Baylor College of Medicine, Houston,
Texas
T.B. Kepler, Duke University, Durham, North Carolina
R Kelling, University of British Columbia, Vancouver, B.C.,
Canada
M.-W. Tan, Stanford University, California
SESSION 10: Group Discussion
Discussion Leader: K. Haider, Northwestern University
Feinberg School of Medicine, Chicago, Illinois
R. Rabinovich, Bill & Melinda Gates Foundation, Seattle,
Washington: Hopes and aspirations of the Bill & Melinda
Gates Foundation.
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SESSION 11: What We Heard
Discussion Leaders: F. Sher, NIAID, National Institutes of
Health, Bethesda, Maryland and K. Haldar, Northwestern
University Feinberg School of Medicine, Chicago, Illinois
SESSION 12: Putting the Ideas into Action-What Can
Funders Do?
R Sager, National Institute of Allergy & Infectious Diseases,
Bethesda, Maryland
W.R. Galey, Howard Hughes Medical Institute, Chevy Chase,
Maryland
V McGovern, Burroughs Wellcome Fund, Research Triangle
Park, North Carolina
S.L. James, The Ellison Medical Foundation, Bethesda,
Maryland
SESSION 13: Group Discussion
A. Mahmoud, Merck & Co., Inc., Whitehouse Station, New
Jersey
S.L. James, The Ellison Medical Foundation, Bethesda,
Maryland
Synaptic Function in Fragile-X
March 30-April 2
FUNDED BY National Institute of Mental Health, NIH, through a grant to FRAXA Research Foundation
ARRANGED BY M.F. Bear, Howard Hughes Medical Institute, Brown University, Providence, Rhode Island
M.R. Tranfaglia, FRAXA Research Foundation, Newburyport, Massachusetts
Opening Remarks: M.R. Tranfaglia, FRAXA Research Foundation, Newburyport,
Massachusetts and K. Clapp, FRAXA Research Foundation
Newburyport, Massachusetts: Patient/clinical perspective
M.F. Bear, Howard Hughes Medical Institute, Brown University, Providence,
Rhode Island: An mGIuR hypothesis of mental retardation
SESSION 1: Dendritic RNA Protein Synthesis and Structural Plasticity
Chairperson: W.T. Greenough, University of Illinois, Urbana
J. Yin, Cold Spring Harbor Laboratory: Synaptic tagging
hypothesis applied to Fragile-X.
G.J. Bassell, Albert Einstein College, Bronx, New York:
Regulation and mechanism of FMRP trafficking in dendrites.
0. Steward, University of California, Irvine: Targeting mRNA
to synaptic sites on dendrites.
J.R. Fallon, Brown University, Providence, Rhode Island:
Translational regulation of the Fragile-X message.
SESSION 2: Dendritic RNA Protein Synthesis and Structural Plasticity (Continued)
Chairperson: M.F. Bear, Howard Hughes Medical Institute, Brown University, Providence, Rhode Island
I.J. Weiler, University of Illinois, Urbana-Champaign:
Regulation of protein synthesis at the synapse.
K.M. Huber, University of Texas Southwestern Medical
Center, Dallas: Effects of mGIR1 and MGIuR5 antagonists
on long-term depression in hippocampal area CA1.
P.W. Vanderklish, Scripps Research Institute, La Jolla,
California: Relationships between synaptic structure and
dendritic translation.
W.T. Greenough, University of Illinois, Urbana: Structural con-
sequences of the absence of FMRP.
B. Oostra, Erasmus Universiteit Rotterdam, The Netherlands:
Role of FMRP in the dendrite.
E. Khandjian, Hospital St. Francois dAssise, Universite Lavel,
Quebec, Canada: Models of Fragile-X syndrome.
D. Stevenson, A. Caudy, M.A. Busby
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SESSION 3: mGluRs
Chairperson: K.M. Huber, University of Texas Southwestern Medical Center, Dallas
R.K.S. Wong, Stony Brook University, New York, Health
Science Center, Brooklyn: Group I metabotropic glutamate-
receptor-mediated epileptogenesis in the cortex.
Bauchwitz, St. Luke's-Roosevelt Institute of Health
Sciences, Columbia University, New York: Effects of the
mGluR antagonist MPEP in the fmr1-tm1Cgr Fragile-X
mouse.
SESSION 4: Ampa Receptor Regulation
Chairperson: 0. Steward, University of California, Irvine
R. Malinow, Cold Spring Harbor Laboratory: AMPA receptor
trafficking and synaptic plasticity.
M.F. Bear, Howard Hughes Medical Institute, Brown
University, Providence, Rhode Island: AMPA receptor regu-
lation during hippocampal LTD.
D.J. Linden, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Molecular basis of cerebellar long-
term synaptic depression.
P.L. Car len, Toronto Western Hospital, Canada: Reduced
SESSION 5: Biology of FMRP
Chairperson: I.J. Weiler, University of Illinois, Urbana
S.T. Warren, Howard Hughes Medical Institute, Emory
University School of Medicine, Atlanta, Georgia:
Introduction to the biology of FMRP.
J. Darnell, The Rockefeller University, New York: RNA targets
of the FMRP protein.
A. Beckel-Mitchener, Beckman Institute, Urbana, Illinois:
FMRP target mRNAs and their potential functions.
D. Zarnescu, Emory University, Atlanta, Georgia: Penelope is
SESSION 6: Conclusion
M.F. Bear, Howard Hughes Medical Institute, Brown
University, Providence, Rhode Island and W.T. Greenough,
University of Illinois, Urbana: Wrap-up and discussion
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W. Spooren, Hoffman-La Roche, Basel, Switzerland:
Behavioral pharmacology of mG1u5 receptor antagonists:
Implications for the treatment of anxiety disorders.
F. Gasparini, Novartis Pharma AG, Basel, Switzerland:
Discovery and characterization of ligands for the group I
mGluRs: Agonists, antagonists, allosteric positive modula-
tors, allosteric negative modulators, neutral ligands.
cortical, but no hippocampal LTP, in the FMR1 gene
knockout mouse is associated with decreased expression
of the cortical GIuR1.
J.R. Larson, University of Illinois, Chicago: Olfactory learning
and memory in a mouse model for Fragile-X.
E. Berry-Kravis, Rush Children's Hospital, Toronto, Canada:
AMPA receptor activator (Ampakine) CX516 and Fragile-X
syndrome.
the major autosomal modifier of Drosophila Fmr1 overex-
pression in the eye.
A. Gaudy, Cold Spring Harbor Laboratory: Drosophila Fragile-
X-related protein associates with the RNA interference
machinery.
D.L. Nelson, Baylor College of Medicine, Houston, Texas:
Developing phenotypic assays in mouse and fly models of
deficiencies in FMR1 and related genes.
B. Oostra, G. Bassell D. Nelson, S. Warren
Taking Cancer Genomics to the Clinic
April 13-15
FUNDED BY Affymetrix, Inc.
ARRANGED BY T. Kreiner, Affymetrix, Inc., Santa Clara, California
T. Golub, Whitehead Institute for Biomedical Research, Cambridge Massachusetts
D. Dalma-Weiszhausz, Affymetrix, Inc., Santa Clara, California
SESSION 1: State of Cancer Genomics
T. Kreiner, Affymetrix, Inc., Santa Clara, California: Back-
ground of meeting.
P. Meltzer, National Human Genome Research Institute, NIH,
Bethesda, Maryland: Translational implications of expres-
sion profiling in sarcomas and breast cancer.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Introductory remarks.
T. Golub, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Overview of the meeting.
SESSION 2: Current State of Cancer Genomics
Chairperson: T. Golub, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
P. Meltzer, National Human Genome Research Institute, NIH,
Bethesda, Maryland: Introduction.
L.M. Staudt, National Cancer Institute, Bethesda, Maryland:
Molecular diagnosis and outcome prediction in lymphoid
malignancies by gene expression profiling.
J.R. Downing, St. Jude Children's Research Hospital,
Memphis, Tennessee: Gene expression profiling in acute
leukemias: Clinical applications.
S. Ramaswamy, Dana- Farber/Whitehead, Cambridge,
Massachusetts: Multiclass molecular diagnosis and staging
of cancer patients.
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SESSION 3: Technology Platform
Chairperson: W.H. Koch, Roche Molecular Systems,
Alameda, California
W.H. Koch, Roche Molecular Systems, Alameda, California:
Introduction.
J. Baker, Genomic Health, Inc., Redwood City, California:
Determination of tumor gene expression profiles using fixed
paraffin-embedded specimens.
R. Carlson, Vysis Inc., Downers Grove, Illinois: Application of
genomic microarrays and FISH to disease management.
T. Orntoft, Aarthus University Hospital, Denmark:
Classification of bladder cancer using gene expression.
M. Rubin, Brigham and Women's Hospital, Boston,
Massachusetts: Development of a prostate cancer bio-
markers to monitor disease progression.
J. Warrington, Affymetrix, Inc., Santa Clara, California: Array-
based treatment management assays.
E.F. Petricoin, Food and Drug Administration, Bethesda,
Maryland: Serum proteomic pattern diagnostics: Moving to
clinical applications.
SESSION 4: FDA Perspectives
E. Mansfield, Food and Drug Administration, Rockville,
Maryland: FDNCDRH Office of in vitro devices: New draft
guidance for microarrays and multiplex tests.
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SESSION 5: Clinical Trials and Validation Challenges
Chairperson: T.J. Triche, Children's Hospital, Los Angeles,
California
T.J. Triche, Children's Hospital, Los Angeles, California:
Introduction.
A.J. Buckler, Ardais Corporation, Lexington, Massachusetts:
Setting standards for clinical genomics in ostic and thera-
peutic discovery and development.
J.M. Olson, Fred Hutchinson Cancer Research Center,
Seattle, Washington: New therapies based on genomic
studies.
M. van de Vijver, The Netherlands Cancer Institute,
Amsterdam: Gene expression profiling to predict outcome
in breast cancer.
E. Feigal, National Cancer Institute, Bethesda, Maryland:
NCI initiatives to accelerate movement of genomics to the
clinic.
SESSION 6: Review and Summary
Discussion Leaders: T. Kreiner, Affymetrix, Inc., Santa
Clara, California; T. Golub, Whitehead Institute for
Biomedical Research, Cambridge, Massachusetts
Formal Languages for Biological Processes
April 20-23
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY D. Endy, Massachusetts Institute of Technology, Cambridge
A. Finney, University of Hertfordshire, Herts, United Kingdom
Y. Lazebnik, Cold Spring Harbor Laboratory
SESSION 1: Do We Need Formal Representations of
Biological Systems?
Chairperson: D. Eddy, Massachusetts Institute of
Technology, Cambridge
R. Brent, The Molecular Sciences Institute, Berkeley, California:
Natural language representations of intracellular biological
processes.
P.A. Silver, Dana Farber Cancer Institute, Boston,
Massachusetts: Connecting the genome to the cytoplasm.
M. Wig ler, Cold Spring Harbor Laboratory: Say What? General Discussion: Challenges Facing Useful
F Cross, The Rockefeller University, New York: Cell cycle Representations
control: Complex, or just complicated?
SESSION 2: Biological Systems and Representations Thereof I
Chairperson: Y. Lazebnik, Cold Spring Harbor Laboratory
R. lyengar, Mount Sinai Medical Center, New York:
The activity of biochemical signaling networks
and the origins of spatial domains.
D. Chklovskii, Cold Spring Harbor Laboratory:
Search for multineuron modules in C. elegans
brain.
S.J. Wodak, Universite Libre de Bruxelles, Brussels,
Belgium: Representing and analyzing molecular
interactions and cellular processes.
K.W. Kohn, National Cancer Institute, Bethesda,
Maryland: Representation of bioregulatory net-
works and the origins of spatial domains.
R. Maimon, Gene Network Sciences, Ithaca, New
York: Diagrammatic notation and computation
grammar for gene networks.
General Discussion: Limits of Current
Representations?
F. Frankel, Massachusetts Institute of Technology,
Cambridge: Envisioning
science.
F. Frankel, M. Hucka, Y. Lazebnik, S. Wodak
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SESSION 3: Biological Systems and Representations Thereof II
Chairperson: R. Brent, The Molecular Sciences Institute, Berkeley, California
H. Bolouri, Institute for Systems Biology, Seattle, Washington:
Appropriate representations for modeling genes and genet-
ic regulatory networks.
D.L. Cook, University of Washington, Seattle: BioD: Basis for
an ontology of biological functions?
V. Schachter, Genoscope, Evry, France: Formal languages for
core molecular biology.
P.F. Nielsen, University of Auckland, New Zealand: Ontologies
for describing biological processes.
A. Gilman, Lawrence Berkeley National Laboratory,
California: The Berkeley BioSPICE conceptual framework:
Representing formal and informal knowledge with multiple
degrees of detail.
A. Regev, Harvard University, Cambridge, Massachusetts:
Life of Pi: Process algebras as calculi for biomolecular
processes.
General Discussion: Limits of Current Representations?
SESSION 4: Integrated Biological Modeling Environments
Chairperson: H. Bolouri, Institute for Systems Biology, Seattle, Washington
T. Sakurada, Keio University, Tsuruoka, Japan: The E-Cell
modeling environment.
J. Schaff, University of Connecticut Health Center,
Farmington: The Virtual Cell project.
C. Shaffer, Virginia Tech, Blacksburg: User interface para-
digms for describing pathway models.
B. Mishra, Courant Institute, New York University, New York: General Discussion: Future Requirements and Path
Cell talk/Sympatica. Forward
SESSION 5: Languages Underlying Representation and Community Issues
Chairperson: A. Finney, University of Hertfordshire, Herts, United Kingdom
A. Finney, University of Hertfordshire, Herts, United Kingdom:
Systems biology markup language: Level 2 and beyond.
J. Ambrosiano, Los Alamos National Laboratory, New
Mexico: Rule-based models: Compact representation of
large cellular networks.
J. Webb, BBN Technologies, Cambridge, Massachusetts:
Language design considerations for composite models of
biological systems.
J. Cassatt, National Institute of General Medical Sciences,
Bethesda, Maryland: Mathematics, engineering, physics,
and biology: Challenges for funding agencies.
General Discussion: Flourishing Orthography?
Closing Remarks:
D. Endy, Massachusetts Institute of Technology,
Cambridge
A. Finney, University of Hertfordshire, Herts, United
Kingdom
Y. Lazebnik, Cold Spring Harbor Laboratory
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D. Chklovskii, J. Ambrosiano
Neural Circuits: Principles of Design and Operation
April 27-30
FUNDED BY The Swartz Foundation
ARRANGED BY K.D. Miller, University of California, San Francisco
H.S. Seung, Massachusetts Institute of Technology, Cambridge
SESSION 1: General Circuit Properties
Chairperson: D. Kleinfeld, University of California, San Diego
D. Chklovskii, Cold Spring Harbor Laboratory: (Potential) con-
nectivity in cortical circuits.
S. Laughlin, University of Cambridge, United Kingdom:
Stochastic limits to the design of energy-efficient neural cir-
cuits.
SESSION 2: General Cortical Properties I
Chairperson: J.A. Hirsch, University Southern California,
Los Angeles
R. Yuste, Columbia University, New York: Imaging the struc-
ture and dynamics of the cortical
microcircuit.
L.F. Abbott, Brandeis University, Waltham, Massachusetts:
Controlling and supervising cortical circuits.
J.C. Hawkins, Redwood Neuroscience Institute, Menlo Park,
California: General mechanisms of neocortical memory.
S. Makeig, University of California, San Diego: Are brain cir-
cuits multiscale?
SESSION 3: General Cortical Properties II
Chairperson: J.A. Hirsch, University of Southern California,
Los Angeles
H. Markram, Brain & Mind Institute, Lausanne, Switzerland:
Molecular basis of electrical diversity of interneurons.
G. Tamas, University of Szeged, Hungary: Sources and tar-
gets of slow inhibition in the neocortex.
A.M. Thomson, University of London School of Pharmacy,
London, United Kingdom: Frequency and pattern filtering at
cortical synapses.
SESSION 4: Visual Cortex I
Chairperson: L.F. Abbott, Brandeis University, Waltham,
Massachusetts
A. Bell, Redwood Neuroscience Institute, Menlo Park,
California: Nonlinear, multilayer ICA and the cortical visual
processing hierarchy.
E.M. Callaway, The Salk Institute for Biological Studies, La
Jolla, California: Functional organization of color-opponent
input to primary visual cortex.
D.L. Ferster, Northwestern University, Evanston, Illinois:
Testing models of visual cortical function.
A. Thomson, D. Chklovskii
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SESSION 5: Visual Cortex II
Chairperson: L.F. Abbott, Brandeis University, Waltham, Massachusetts
Y. Fregnac, Institut Alfred Fessard-CNRS, Gif sur Yvette,
France: Shunting inhibition and computational diversity in
visual cortex.
J.A. Hirsch, University of Southern California, Los Angeles:
Inhibitory circuits at the first stage of visual cortical process-
ing.
J.S. Lund, University of Utah, Salt Lake City: Real-life visual
cortical circuits as substrates for its functional properties.
K.D. Miller, University of California, San Francisco: Role of
dominant feedforward inhibition in cat V1 layer 4.
M. Shelley, New York University, New York: Coarse-graining
of neuronal networks and the visual cortex.
SESSION 6: Nonvisual Cortical/Forebrain Systems
Chairperson: H. Markram, Brain & Mind Institute, Lausanne, Switzerland
D. Kleinfeld, University of California, San Diego: Attention, fil-
tering, and mixing: Nonlinear coding blocks in the rat
somatosensory motor system.
C. Brody, Cold Spring Harbor Laboratory: A computational
model of the mammalian olfactory bulb.
J.J. Hopfield, Princeton University, New Jersey: Deriving
"learning rules" for spike-timing based computation from
the necessity of network self-repair.
M. Fee, Bell Laboratories, Murray Hill, New Jersey: Neural
mechanisms of sequence generation in a songbird.
H.S. Seung, Massachusetts Institute of Technology,
SESSION 7: Silicon/Robotics
Chairperson: J.J. Hopfield, Princeton University, New Jersey
K.A. Boehen, University of Pennsylvania, Philadelphia: From
local microcircuits to cortical maps.
K.K. Likharev, Stony Brook University, New York: Cross Nets:
Possible molecular electronics neural circuits.
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Cambridge: Learning by reinforcement of stochastic synap-
tic transmission in spiking neural network.
H.A. Swadlow, University of Connecticut, Storrs: A thalamo-
cortical feedforward inhibitory network: Principles and
operations in the awake state.
X.-J. Wang, Brandeis University, Waltham, Massachusetts: A
basic cortical microcircuit model of working memory with
three subclasses of inhibitory neurons.
A. Zador, Cold Spring Harbor Laboratory: Computation in
auditory cortex.
S.-C. Liu, University and ETH Zurich, Switzerland: Spike-
based vision system.
R. Sarpeshkar, Massachusetts Institute of Technology,
Cambridge: Biologically inspired electronics.
C. Brody, M. Fee
Scientific Opportunities in Macromolecular Crystallography
at NSLS-II
July 9-10
FUNDED BY Brookhaven National Laboratory
ARRANGED BY W. Hendrickson, Howard Hughes Medical Institute, Columbia University, New York
L. Joshua-Tor, Cold Spring Harbor Laboratory
Opening Remarks: W. Hendrickson, Howard Hughes Medical Institute, Columbia University, New York
L. Joshua-Tor, Cold Spring Harbor Laboratory
SESSION 1
S. Dierker, Light Sources Directorate, Brookhaven National
Laboratory, Upton, New York: New storage ring design and
characteristics.
L. Berman, National Synchrotron Light Source, Brookhaven
National Laboratory, Upton, New York: Beam line optics and
new detector developments.
SESSION 2
R. MacKinnon, Howard Hughes Medical Institute, The
Rockefeller University, New York: Membrane proteins: State
of the art, unique problems, and future needs.
SESSION 3
A. Joachimiak, Argonne National Laboratory, Illinois:
Structural genomics.
Informal discussion: What Can the Structural Biologists Do
to Further Support the Proposal?
SESSION 4
T. Steitz, Howard Hughes Medical Institute, Yale University,
New Haven, Connecticut: Large complexes: Unique issues
and future needs.
J.M. Hog le, Harvard University, Cambridge, Massachusetts:
Virus structures.
R Fitzgerald, Merck Research Laboratories, Rahway, New
Jersey: Structure-assisted drug development.
SESSION 5: Summary and Next Steps
W. Hendrickson, Howard Hughes Medical Institute, Columbia
University, New York
L. Joshua-Tor, Cold Spring Harbor Laboratory
W. Weiss, L. Joshua-Tor
W. Hendrickson, T. Steitz, H. Robinson
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Taxonomy, DNA, and the Bar Code of Life
September 10-12
FUNDED BY Alfred P. Sloan Foundation
ARRANGED BY J. Baker, Academy of Natural Sciences, Philadelphia
J. Hanken, Harvard University, Cambridge, Massachusetts
Welcome and Introduction: J. Baker, Academy of Natural Sciences, Philadelphia, Pennsylvania
J. Hanken, Harvard University, Cambridge, Massachusetts
SESSION 1: DNA-based Species Identification: Conceptual
Foundations
Chairperson: J. Hanken, Harvard University, Cambridge,
Massachusetts
J.C. Venter, The Center for the Advancement of Genomics,
Rockville, Maryland: Environmental shotgun sequencing.
R. De Salle, American Museum of Natural History, New York
Recap of Banbury I.
Discussants
M. Stoeckle, The Rockefeller University, New York
J. Hanken, Harvard University, Cambridge, Massachusetts
P. Hebert, University of Guelph, Ontario, Canada
DNA-based species identification: State of the art.
Discussants
C. Moritz, University of California, Berkeley
G. Caccone, Yale University, New Haven, Connecticut
A. Buck lin, University of New Hampshire
S. Miller, Smithsonian Institution, Washington, D.C.
Are museum collections the appropriate place to begin a
large-scale effort?
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Discussants
R. Lane, The Natural History Museum, London, United
Kingdom
G. Rosenberg, Academy of Natural Sciences, Philadelphia,
Pennsylvania
SESSION 2: Implementing a DNA Bar-coding Initiative:
Strategies, Specimens, Databases, Funding
Chairperson: J. Baker, Academy of Natural Sciences,
Philadelphia, Pennsylvania
M. Stoeckle, The Rockefeller University, New York:
Organizational strategies: Early action plan vs. museum
consortium.
Discussants
R Hastings, Scripps Institution of Oceanography, La Jolla,
California
M. Graham, Canadian Museum of Nature, Ottawa, Ontario,
Canada
G. Caccone, Yale University, New Haven, Connecticut
J.L. Edwards, Global Biodiversity Information Facility,
Copenhagen, Denmark
R. Phelan, G. Caccone
Museum specimens: How many are there, and how are they preserved?
Which types are most appropriate for a DNA bar-coding effort?
Which ones should be avoided?
Discussants
C. Moritz, University of California, Berkeley
S.V. Edwards, University of Washington, Seattle
R. De Salle, American Museum of Natural History, New York
Databases.
Discussants
J.L. Edwards, Global Biodiversity Information Facility, Copenhagen, Denmark
S. Federhen, National Library of Medicine, NIH, Bethesda, Maryland
P. Hebert, University of Guelph, Ontario, Canada
J. Baker, Academy of Natural Sciences, Philadelphia, Pennsylvania
Costs and funding. How much, and who will pay?
Discussants
J. Omura, The Presidio of San Francisco, California
R. Phelan, All Species Foundation, San Francisco, California
SESSION 3: Establishing Consensus Plans
Chairpersons: J. Baker, Academy of Natural Sciences, Philadelphia,
Pennsylvania; J. Hanken, Harvard University, Cambridge,Massachusetts
Is there life after Banbury II and, if so, what is it? What next?
Working groups, initial funding strategies,
statement of purpose.Statement of purpose.
J. Marchioni, D.
Janzen, S. Miller, J. Edwards
Integrating Progress in the Genetics and Neuropharmacology of
Schizophrenia
September 14-17
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY C.R. Cloninger, Washington University Medical School, St. Louis, Missouri
J.T. Coyle, Harvard Medical School, Belmont, Massachusetts
SESSION 1: Overview of Current Status of the Molecular Genetics of Schizophrenia
Chairperson: C.R. Cloninger, Washington University Medical School, St. Louis, Missouri
C.R. Cloninger, Washington University Medical School, St.
Louis, Missouri: General update and overview of the genet-
ics of schizophrenia.
K. Stefansson, De Code Genetics, Reykjavik, Iceland: Studies
of neuregulin 1 by De Code.
A. Corvin, St. James Hospital, Dublin, Ireland and D. Morris,
St. James Hospital, Dublin, Ireland: Refinement of the "at
risk" haplotype for schizophrenia.
I. Chumakov, Genset, Evry, France: Studies of G72 and
DAAO in schizophrenia by Genset.
D.R. Weinberger, National Institute of Mental Health, NIH,
Bethesda, Maryland: Critique of genetics of NMDA hypo-
function in schizophrenia.
SESSION 2: Neural Systems Approaches to the NMDA Hypofunction Model of Schizophrenia
Chairperson: J.T. Coyle, Harvard Medical School, Belmont, Massachusetts
J.T. Coyle, Harvard Medical School, Belmont, Connecticut: Interactions of NMDA and serotonin systems
Massachusetts: Overview of NMDA hypofunction model. and therapeutic targets.
S. Grant, University of Edinburgh, United Kingdom: A core J.W. Newcomer and N.B. Farber, Washington University
molecular mechanism for cognition and its disorders. School of Medicine, St. Louis, Missouri: Developmental
D. Javitt, Nathan Kline Institute for Psychiatric Research, implications of NMDA receptor hypofunction.
Orangeburg, New York: Interactions of NMDA and C.A. Tamminga, University of Texas Southwestern Medical
dopamine systems and therapeutic targets. Center, Dallas: Critique of status of neuropharmacology of
J.H. Krystal, Yale University School of Medicine, West Haven, schizophrenia.
J. Coyle, D. Weinberger
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J. Watson, R. Cloninger
SESSION 3: Other Genetic and Epigenetic Influences on Risk of Schizophrenia
Chairperson: M.T. Tsuang, Harvard Institute of Psychiatric Epidemiology & Genetics, Journal of
Neuropsychiatric Genetics, Boston, Massachusetts
M. Owen, University of Wales College of Medicine, Cardiff,
United Kingdom: Overview of nonglutamate genetic factors
and their interactions influencing the risk of schizophrenia.
D. Blackwood, The Royal Edinburgh Hospital, United
Kingdom: A chromosome 1 q locus for schizophrenia.
S. Leonard, University of Colorado Health Sciences Center,
Denver: a7 nicotinic receptor locus and NMDA interactions
in schizophrenia.
R.E. Straub, National Institute of Mental Health, NIH,
Bethesda, Maryland: Dysbindin (DTNBP1, 6p22.3): SNP
detection, cognitive and fMRI phenotypes, and analysis of
transcript and protein levels.
SESSION 4: Technological Opportunities for Accelerating Progress
Chairperson: J.W. Olney, Washington University Medical School, St. Louis, Missouri
M. Laruelle, New York State Psychiatric Institute, Columbia
University, New York: Imaging NMDA-DA interactions in
working memory and schizophrenia.
R. Schwarcz, Maryland Psychiatric Research Center,
Baltimore: Studying NMDA-a7 nicotinic interactions with
novel mGluR ligands.
S. Heckers, McLean Hospital, Belmont, Massachusetts:
Regulation of hippocampal neurons in schizophrenia.
J. Eberwine, University of Pennsylvania Medical School,
Philadelphia: Single cell chip technologies for genomics
and proteomics.
M.A. Geyer, University of California, San Diego: Gluamatergic
influences on sensorimotor gating in rodents.
SESSION 5: Where Do We Go from Here to Understand the Clinical Reality of Schizophrenia and
Schizotypy?
Chairperson: E.M. Scolnick, Merck Research Laboratories, West Point, Pennsylvania
M.T. Tsuang, Harvard Institute of Psychiatric Epidemiology
& Genetics, Journal of Neuropsychiatric Genetics,
Boston, Massachusetts: A psychiatric geneticist's perspec-
tive.
W.T. Carpenter, University of Maryland, Baltimore: A psy-
chopharmacologist's perspective.
Pablo Gejman, University of Chicago, Illinois: A molecular
geneticist's perspective.
Panel Discussion:
K. Stefansson, De Code Genetics, Reykjavik, Iceland
D.R. Weinberger, National Institute of Mental Health, NIH,
Bethesda, Maryland
J.W. Olney, Washington University Medical School, St.
Louis, Missouri
D. Goldman, National Institute on Alcohol Abuse and
Alcoholism, NIH, Rockville, Maryland
S. Grant, M. Owen
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Regulation of Inflorescence Morphology: Insights from Genetics
and Genomics
September 21-24
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY E.A. Kellogg, University of Missouri, St. Louis
D. Jackson, Cold Spring Harbor Laboratory
SESSION 1: Getting Started: Control of the Floral Transition
Chairperson: T. Rocheford, University of Illinois, Urbana
G. Coup land, Max-Planck-Institute for Plant Breeding D. Laurie, John Innes Centre, Norwich, United Kingdom:
Research, Koeln, Germany: Variation in the mechanisms Genetic control of flowering time in barley and wheat.
that control flowering time. M. Edgerton, Monsanto-Ceregen, St. Louis, Missouri:
T. Brutnell, Boyce Thompson Institute, Ithaca, New York: Alteration of flowering time in corn.
Role of phytochromes in the regulation of flowering time in J. Colasanti, University of Guelph, Ontario, Canada: Leaf-
maize. derived floral inductive signals in maize.
SESSION 2: Development Mechanisms I: Inflorescence Structure and Function
Chairperson: S. Hake, U.S.D.A. Plant Gene Expression Center, Albany, California
E.A. Kellogg, University of Missouri, St. Louis: Grass flowers D. Jackson, Cold Spring Harbor Laboratory: Fasciation and
and inflorescences: New interpretations from comparative control of seed row number in maize.
data. W. Bruce, Pioneer Hi-Bred International, Inc., Johnston,
K. Ikeda, University of Tokyo, Japan: Inflorescence and spike- Iowa: Characterizations of a maize CLAVATA3 functional
let development in rice and functions of the APO gene. homolog.
SESSION 3: QTL and Association Mapping
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
E.S. Buckler, North Carolina State University, Raleigh: Using
diverse maize germplasm to dissect inflorescence traits.
T. Rocheford, University of Illinois, Urbana: QTL approaches
SESSION 4: Molecular Evolution
Chairperson: E. Vollbrecht, Cold Spring Harbor Laboratory
E. Kramer, Harvard University, Cambridge, Massachusetts:
Two roads diverged in a wood: The elusive nature of genet-
ic orthology.
M.D. Purugganan, North Carolina State University, Raleigh:
Molecular evolution of Arabidopsis shoot architecture.
SESSION 5: Developmental Evolution
Chairperson: E.A. Kellogg, University of Missouri, St. Louis
P. Soltis, University of Florida, Gainesville: Sequence analysis
and expression patterns of floral genes in basal
angiosperms.
E. Vollbrecht, Cold Spring Harbor Laboratory: Ramosal and
branching in the grass inflorescence.
SESSION 6: Genomics Approaches
Chairperson: V. Brendel, Iowa State University, Ames
R. Lucito, Cold Spring Harbor Laboratory: ROMA:
Oligonucleotide arrays for the detection of gene copy num-
ber fluctuations.
V. Brendel, Iowa State University, Ames: Computational
approaches to identify candidate genes involved in inflores-
cence development.
to study of maize inflorescence architecture.
D. Zamir, Hebrew University of Jerusalem, Rehovot, Israel:
Real-time QTL of yield.
R.M. Clark, University of Wisconsin, Madison: The complexi-
ty of selection at a major effect QTL in maize, teosinte
branched 1 (tb1).
M. Frohlich, The Natural History Museum, London, United
Kingdom: Suggestions for Evo-devo research.
D. Baum, University of Wisconsin, Madison: Role of meris-
tern identity genes in the parallel evolution of inflorescence
architecture in Brassicaceae.
W. Rottmann, Arbor Gen, Summerville, South Carolina:
Response of sweetgum to overexpression of LEAFY.
G. Chuck, USDA, ARS, Albany, California: Microarray analy-
sis of the spikelet meristem identity mutants branched silk-
less 1 and frizzy panicle1 of maize and rice.
E.D. Brenner, New York University, New York: A genomic
approach to study seed development in the basal gym-
nosperms: Cycads and ginkgo.
SESSION 7: Developmental Mechanisms II: Floral Organ Polarity, Number, and Size
Chairperson: D. Jackson, Cold Spring Harbor Laboratory
E.E. Irish, University of Iowa, Iowa City: Polarity of the maize
flower and its imposition by the inflorescence.
H. Hirano, The University of Tokyo, Japan: Regulation of floral
organ number and identity in rice.
J. Fletcher, USDA Plant Gene Expression Center, Albany,
California: Role of ULTRAPETAL4 in regulating Arabidopsis
shoot and floral meristem activity.
Y. Eshed, Weizmann Institute of Science, Rehovot, Israel:
Regulation of plant organ size: A story of bread and
butter.
S. Hake, USDA Plant Gene Expression Center, Albany,
California: Role of meristem size on developmental
fate.
M. Timmermans. H. Hirano
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The Biology of Neuroendocrine Tumors
September 28-30
FUNDED BY Verto Institute, LLC
ARRANGED BY A.J. Levine, Institute for Advanced Studies, Princeton, New Jersey
E. Vosburgh, Verto Institute, LLC, Stamford, Connecticut
Introductory Remarks: A.J. Levine, Institute for Advanced Studies, Princeton, New Jersey: Verto Research Program Overview
SESSION 1: Neural Crest and Neuroendocrine Development
Chairperson: T. Jacks, Massachusetts Institute of Technology, Cambridge
J.A. Epstein, University of Pennsylvania, Philadelphia: Using
mouse models to elucidate the developmental biology of
the neural crest.
S.K. Kim, Stanford University School of Medicine, California:
Signaling pathways regulating neuroendocrine cell differenti-
ation and proliferation in the developing pancreas.
M.L. Meyerson, Harvard Medical School, Boston,
Massachusetts: Functional studies of the multiple
endocrine neoplasia type I (MEN-1) gene.
Keynote Speaker:
A.J. Levine, Institute for Advanced Studies, Princeton, New
Jersey: Autophagy and cancer.
SESSION 2: Neuroendocrine Receptors
Chairperson: L.B. Chen, Dana-Farber Cancer Institute, Lexington, Massachusetts
G. Rindi, Universita degli Studi, Parma, Italy: VGF expression
in the neuroendocrine system and related growths.
R. Salgia, University of Chicago, Illinois: Role of receptor
kinases in neuroendocrine tumors.
R.V. Lloyd, Mayo Clinic, Rochester, Minnesota: EGFR in neu-
roendocrine (carcinoid) tumors.
V. Giandomenico, Uppsala University, Sweden: Identification
of carcinoid-associated antigens for vaccine development.
D. Agrawal, H. Lee Moffitt Cancer Center and University of
South Florida, Tampa: Development and utilization of card-
n old cell models for molecular analysis.
M. Meyerson, A. Levine, K. Peters
SESSION 3: Genetic Association Studies
Chairperson: J. Hoh, Yale University School of Medicine,
New Haven, Connecticut
J. Ott, The Rockefeller University, New York: Statistical princi-
ples of human gene mapping.
C. Sing, University of Michigan Medical Center, Ann Arbor:
Insights from genome association studies of common dis-
eases.
SESSION 4: Clinical Update on Neuroendocrine Cancers
Chairperson: K. Oberg, University Hospital, Uppsala,
Sweden
K. Oberg, University Hospital, Uppsala, Sweden: Position
emission tomograph (PET) in the management of neuroen-
docrine tumors.
L. Kvols, H. Lee Moffitt Cancer Center and University of
South Florida, Tampa: An update on radiolabled peptide
therapy of carcinoid tumors,
J. Yao, Gastrointestinal Medical Oncology, Houston, Texas:
Phase II study of Imatinib in patients with metastatic or
unresectable carcinoid tumor.
M.H. Kulke, Dana-Farber Cancer Institute, Boston,
Massachusetts: Clinical trials in neuroendocrine tumors:
Role of molecularly targeted therapies.
Discussion on the deck
C. Harris, E. Vosburgh, S. Jin
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Mouse Genome-wide Targeted Mutagenesis
September 30-October 1
FUNDED BY Cold Spring Harbor Laboratory
ARRANGED BY R.P. Woychik, The Jackson Laboratory, Bar Harbor, Maine
C.P. Austin, National Human Genome Research Institute, NIH
Welcome and Summary of Expectations: R.P. Woychik, The Jackson Laboratory, Bar Harbor, Maine
SESSION 1: Define What Type of Mutations Would be Most
Desirable in a Genome-wide Collection
Review nature of mutations created by each gene-based
mutagenesis technology: Debate pros, cons, and costs of
each approach.
Moderator: G.M. Duyk, Exelixis Inc., South San Francisco,
California
Homologous recombination: M.R. Capecchi, University of
Utah, Salt Lake City
Gene-trapping approaches: B. Skarnes, Wellcome Trust
Sanger Institute, Cambridge, United Kingdom, and B.
Zambrowicz, Lexicon Genetics, The Woodlands, Texas
RNA: I.M. Verma, The Salk Institute for Biological Studies,
La Jolla, California
Transgenic approaches/universal integration sites:
N. Heintz, The Rockefeller University, New York
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SESSION 2: Desired Scope of the Project
Is there a compelling scientific case to undertake creating
mutations in all genes in the genome?
To what extent do the currently available resources begin to
address the needs of the biomedical research community?
Are current technologies and approaches efficient enough to
meet the need, and what would be the time frame for com-
pletion?
Moderator: A. Bradley, The Wellcome Trust Sanger
Institute, Cambridge, United Kingdom
High-throughput KO technology: M.W. Moore, Deltagen,
Inc., Redwood City, California
Omnibank approach: A.T. Sands, Lexicon Genetics, The
Woodlands, Texas
Regeneron approach: G.D. Yancopoulos, Regeneron
Pharmaceuticals, Inc. Tarrytown, New York
Summary/Discussion
J. Eppig, R. Woychik
SESSION 3: Define Approaches to Cost Effectively and
Efficiently Maintain a Targeted Mutant Mouse Resource
Which reagents (e.g., DNA targeting constructs, ES cells, and
frozen embryos) would be available for distribution?
What is the cost of maintaining the resource?
To what extent should the mutant lines be phenotyped as
part of a large-scale effort?
Moderator: T. Magnuson, University of North Carolina,
Chapel Hill
ES cells/chimeras/mice: A. Nagy, University of Toronto,
Canada
Cryopreservation (sperm/ICSI/Frozen embryos): K.C.K.
Lloyd, University of California, Davis
High-throughput phenotyping: M.W. Moore, Deltagen, Inc.,
Redwood City, California
Summary/discussion
SESSION 4: Define the Nature of a Project Database, End-
user Needs, Integrating Data into Current Resources, and
Intellectual Property Issues
Moderator: J.T. Eppig, The Jackson Laboratory, Bar
Harbor, Maine
Database needs and integration resources: J.T. Eppig, The
Jackson Laboratory, Bar Harbor, Maine
IP and distribution issues: G.M. Duyk, Exelixis, Inc., San
Fransicso, California
Summary/discussion
SESSION 5: Open Discussion/Debate to Define the Scientific
Nature of a Large-scale Consensus Project
Moderator: F.S. Collins, National Human Genome Research
Institute, NIH, Bethesda, Maryland
We will start with a presentation of a "model project" based
on discussions from the preceding sessions. Participants will
be asked to modify the model during the course of the dis-
cussion to arrive at a final product with which to go forward.
Nature of the mutations to be generated
Scope of the project
Nature of the resources to be distributed
Informatics needs
IP
Cost and time line
SESSION 6: Wrap Up, Next Steps
Moderator: R.P. Woychik, The Jackson Laboratory, Bar
Harbor, Maine
A. Roses, M. Moore
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Feasible Solutions to Global Vaccine Shortages
October 8-10
FUNDED BY Albert B. Sabin Vaccine Institute
ARRANGED BY L.A. Miller, Intermedica, Inc., Darien, Connecticut
N.E. Tomich, U.S. Medicine Institute, Washington, D.C.
Welcome: H.R. Shepherd, Albert B. Sabin Vaccine Institute, New Canaan, Connecticut
SESSION 1:
Introductory Remarks: David Heymann, World Health
Organization, Geneva, Switzerland: Polio surveillance and
immunization program.
Charge to Conference, Conference Co-Chairs:
L.A. Miller, Intermedica, Inc., Darien, Connecticut and
N.E. Tomich, U.S. Medicine Institute, Washington, D.C.
Keynote Speaker: S. Cochi, National Immunization
Program, CDC, Atlanta, Georgia
SESSION 2: Stockpiling
Chairpersons: E. O'Mara, Centers for Disease Control &
Prevention, Atlanta, Georgia; S. Bice, Centers for Disease
Control & Prevention, Atlanta, Georgia
Task Force Report
Task Force Panel:
S. Cochi, National Immunization Program, Centers for
Disease Control & Prevention, Atlanta, Georgia
C.A. deQuadros, Albert B. Sabin Vaccine Institute,
Washington, D.C.
D.C. Peterson, Immunization Action Coalition, St. Paul,
Minnesota
E. Wilder, National Immunization Program, Centers for
Disease Control & Prevention, Atlanta, Georgia
SESSION 3: Open Discussion and Consensus: Stockpiling
Moderators: L.A. Miller, Intermedica, Inc., Darien,
Connecticut; N.E. Tomich, U.S. Medicine Institute,
Washington, D.C.
SESSION 4: International Commission on Harmonization
Chairperson: J. Milstein, University of Maryland School of
Medicine, Montpelier, France
Task Force Report
Task Force Panel:
A. Homma, Bio-Manguiinhos/Fiocruz, Rio de Janeiro, Brazil
S. Jadhav, Serum Institute of India, Pune
S.H. Lee, Center for Biologics Evaluation, Seoul, Korea
J.I. Santos, National Immunization Council, Juarez, Mexico
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SESSION 5: Open Discussion and Consensus: ICH
Moderators: L.A. Miller, Intermedica, Inc., Darien,
Connecticut; N.E. Tomich, U.S. Medicine Institute,
Washington, D.C.
SESSION 6: Public Advocacy
Chairperson: J.E. Fischer, Council on Foreign Relations,
Washington, D.C.
Task Force Report
Task Force Panel:
L. Cooper, Columbia University College of Physicians &
Surgeons, New York
S. Feldman, Aventis USA, Swiftwater, Pennsylvania
C.M. Grant, Aventis USA, Swiftwater, Pennsylvania
H. Larson, UNICEF, New York
R. MacDougall, Albert B. Sabin Vaccine Institute, Inc.,
Washington, D.C.
C. Ruppel, Every Child By Two, Washington, D.C.
SESSION 7: Open Discussion and Consensus: Public
Advocacy
Moderators: L.A. Miller, Intermedica, Inc., Darien,
Connecticut; N.E. Tomich, U.S. Medicine Institute,
Washington, D.C.
R. Giffin, The National Academies, Washington, D.C.: Key
elements of Institute of Medicine Report
SESSION 8: Financing
Chairperson: S. Jarrett, UNICEF, New York
Task Force Report
Task Force Panel:
D. Braga, Aventis USA, Swiftwater, Pennsylvania
A. Robbins, Tufts University School of Medicine, Boston,
Massachusetts
J.C. Sadoff, Aeras Global TB Vaccine Foundation, Rockville,
Maryland
D. Salisbury, Skipton House, London, United Kingdom
L. Tan, American Medical Association, Chicago, Illinois
SESSION 9: Open Discussion and Consensus: Financing
Where Do We Go From Here?
L.A. Miller, Intermedica, Inc., Darien, Connecticut
N.E. Tomich, U.S. Medical Institute, Washington, D.C.
Linking together the consensus statements
Prioritizing the action steps
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Eugenics, Genes, and Human Behavior
October 14-16
FUNDED BY
ARRANGED BY D. Mick los, Dolan DNA Learning Center, Cold
J.A. Witkowski, Banbury Center, Cold Spring
National Human Genome Research Institute, NIH
Introduction: J.A. Witkowski, Banbury Center, Cold Spring
D. Mick los, Dolan DNA Learning Center, Cold
SESSION 1: History
Chairperson: S. Selden, University of Maryland, College
Park
N. Gillham, Duke University, Durham, North Carolina: Sir
Francis Galton and the foundations of eugenics.
E. Carlson, Stony Brook University, New York: Bad seed, cor-
rupted germ plasm, prized pedigrees, and eugenic worth.
SESSION 2: Impacts
Chairperson: D. Mick los, Dolan DNA Learning Center, Cold
Spring Harbor Laboratory
P.A. Lombardo, University of Virginia, Charlottesville:
Immigration and sterilization in the United States.
G.E. Allen, Washington University, St. Louis: The international
influence of the U.S. eugenics movement.
SESSION 3: Behavioral Genetics I
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring
Harbor Laboratory
C. Gilliam, Columbia University, New York: Searching for
genes involved in behavioral disorders.
General Discussion
Moderator: S. Selden, University of Maryland, College Park
Spring Harbor Laboratory
Harbor Laboratory
Harbor Laboratory
Spring Harbor Laboratory
SESSION 4: Resources: Dolan DNA Learning Center
D. Mick los and J.A. Witkowski, Cold Spring Harbor
Laboratory: Introduction to the Image Archive on the
American Eugenics Movement.
SESSION 5: Behavioral Genetics II
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring
Harbor Laboratory
N. Segal, California State University, Fullerton: Twin studies
and heritability of behavioral traits.
K.R. Jamison, Johns Hopkins School of Medicine, Baltimore:
Personal experiences with mental illness and eugenics.
General Discussion
Moderator: S. Selden, University of Maryland, College Park
Participants in a discussion
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N. Gillham, S. Selden
Controlling the Differentiation of Pluripotent Cells
October 19-22
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY R. McKay, National Institute of Neurological Disorders and Stroke, NIH
SESSION 1: Controlling ES Cell Differentiation
Chairperson: N. Benvenisty, The Hebrew University of Jerusalem, Israel
N. Benvenisty, The Hebrew University of Jerusalem, Israel:
Differentiation and genetic manipulation of human embryon-
ic stem cells.
A. Smith, University of Edinburgh, United Kingdom:
Pluripotency and differentiation of embryonic stem cells.
L. Studer, Memorial Sloan-Kettering Cancer Center, New
SESSION 2: Differentiation of Mes Endoderm
Chairperson: G. Keller, Mount Sinai School of Medicine, New York
K. Zaret, Fox Chase Cancer Center, Philadelphia, Pennsyl-
vania: Specification of liver and pancreas progenitors from
the embryonic endoderm.
H. Semb, Gothenburg University, Goteborg, Germany:
Differentiation of human ES cells toward endoderm and
pancreatic cell lineages.
C. Mummery, Netherlands Institute for Developmental Biology,
Utrecht: Cardiomyocyte differentiation of human ES cells.
R. Jaenisch, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Reprogramming the genome.
York: Human ES cell in neural development and repair.
H. Niwa, RIKEN, Hyogo, Japan: Transcriptional regulation for
self-renewal and differentiation of ES cells.
H.R. Scholer, University of Pennsylvania, Kennett Square:
Derivation of germ cells from mouse embryonic stem cells.
A. Wobus, Institute of Plant Genetics Gatersleben, Germany:
ES cell differentiation into functional beta-like cells and the
role of nestin expression.
G. Keller, Mount Sinai School of Medicine, New York:
Lineage induction and specification during embryonic stem
cell differentiation.
R. McKay, National Institute of Neurological Disorders and
Stroke, NIH, Bethesda, Maryland: Deriving the cellular phe-
notype.
L. Zoloth, R. McKay
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SESSION 3: Stem Cells in the Life Cycle
Chairperson: R.A. Pedersen, Addenbrooke's Hospital, Cambridge,
United Kingdom
K. Hochedlinger, Whitehead Institute for Biomedical Research, Cambridge,
Massachusetts: Reprogramming of cancer cells by nuclear transfer.
P. Lanscorp, British Columbia Cancer Research Center, Vancouver:
Telomerase and "self-renewal" of stem cells.
SESSION 4: What Is Ethically Possible?
Chairperson: R. McKay, National Institute of Neurological Disorders and
Stroke, NIH, Bethesda, Maryland
L.S. Zoloth, Northwestern University, Chicago, Illinois: Ethical considerations
in the organization of research in pluripotent cells.
SESSION 5: Implementing the Promise of Pluripotent Cells from Mouse to
Man
Chairperson: R. McKay, National Institute of Neurological Disorders and
Stroke, NIH, Bethesda, Maryland
R.R. Behringer, M.D. Anderson Cancer Center, Houston, Texas: Genetic
studies of early mouse development.
R.A. Pedersen, Addenbrooke's Hospital, Cambridge, United Kingdom:
Taking human ES cells to the clinic.
H. Weber, Medical Research Council, London, United Kingdom: The United
Kingdom Stem Cell Initiative.
J.F. Battey, National Institute on Deafness and Other Communication
Disorders, NIH, Bethesda, Maryland: NIH support for human embryonic
stem cell research.
J. Battey, R. Pedersen, G. Keller, L. Studer
396
Finding New Genes Linked to ALS: A Focus on Current
Technologies and Their Potential Application
October 26-28
FUNDED BY The ALS Association
ARRANGED BY R.N. Brown, Massachusetts General Hospital, Charlestown
L. Bruijn, The ALS Association, Guilford, Connecticut
SESSION 1: Opening Remarks
Chairperson: L. Bruijn, The ALS Association, Guilford, Connecticut
R.V. Abendroth, The ALS Association, Milwaukee, Wisconsin:
Opening remarks.
R.H. Brown, Massachusetts General Hospital, Charlestown:
Introduction to ALS and ALS genetics.
D. Altshuler, Massachusetts General Hospital, Boston: The challenge
of complex genetics: Overview.
SESSION 2: Statistical Approaches to Complex Genetics
Chairperson: A. Al Chalabi, Institute of Psychiatry, London, United
Kingdom
E. Martin, Duke University Medical Center, Durham, North Carolina:
Theoretical considerations: TDT, case control, other models.
D.B. Goldstein, University College London, United Kingdom:
Approaches to haplotype reduction.
J. Haines, Vanderbilt University Medical Center, Nashville, Tennessee:
Practical considerations: Size and power calculations.
R. Brown, K. Fischbeck
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SESSION 3: Techniques
Chairperson: R. Baughman, National Institute of
Neurological Disorders and Stroke, NIH, Bethesda,
Maryland
D.R. Cox, Perlegen Sciences, Inc. Mountain View, California:
Chip-based SNP analysis.
P.J. de Jong, Children's Hospital Oakland Research Institute,
California: Cloning approaches toward the sequencing of
disease haplotypes.
SESSION 4: Precedents in Complex Analyses of Human
Diseases
Chairperson: J. Haines, Vanderbilt University Medical
Center, Nashville, Tennessee
S. Hauser, University of California, San Francisco:
Investigations of selected neurological disorders.
D. Goldman, National Institute on Alcohol Abuse &
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Alcoholism, Rockville, Maryland: Genetic and functional
analyses of serotonin transporter in affective disorders.
SESSION 5: Application of Complex Genetics to ALS
Chairpersons: R.H. Brown, Massachusetts General
Hospital, Charlestown, and P.J. de Jong, Children's
Hospital Oakland Research Institute, California
L. Bruijn, The ALS Association, Guilford, Connecticut: The
challenge.
A. Al Chalabi, Institute of Psychiatry, London, United
Kingdom: Complex genetics in ALS: Studies to date.
G.A. Rouleau, Montreal General Hospital, Canada: How do
we proceed?
Discussion
Moderators: K.H. Fischbeck, National Institute of
Neurological Disorders and Stroke, NIH, Bethesda,
Maryland, and G.A. Rouleau, Montreal General Hospital,
Canada
D. Altshuler, D. Cox
Molecular Differentiation of Benign and Malignant
Pheochromocytomas and Neuroblastomas
November 16-18
FUNDED BY National Hypertension Association, Inc.
ARRANGED BY G. Eisenhofer, National Institute of Neurological Disorders & Stroke, NIH, Bethesda, Maryland
W.M. Manger, National Hypertension Association, New York
Introductory Remarks and Summary of Expectations:
W.M. Manger, National Hypertension Association, New York
SESSION 1: Current Status of Diagnosis, Localization, Clinical Management, and Treatment
Chairperson: W.M. Manger, National Hypertension Association, New York
D.S. Goldstein, National Institute of Neurological Disorders N.-K.V. Cheung, Memorial Sloan-Kettering Cancer Center,
and Stroke, NIH, Bethesda, Maryland: Diagnostic markers New York: Neuroblastoma: A clinical enigma.
of malignancy in pheochromocytoma: Issues for biochemi- B.L. Shulkin, University Hospital, Ann Arbor, Michigan:
cal and imaging approaches. 1311-MIBG therapy and new radiopharmaceuticals for
WE Young, Mayo Clinic, Rochester, Minnesota: Management pheochromocytoma.
of malignant pheochromocytoma.
SESSION 2: Tumor Genetics
Chairperson: H. Lehnert, University of Magdeburg, Germany
D. Smith, Mayo Clinic, Rochester, Minnesota: Microarrays
and advanced technologies for the study of cancer.
H.P.H. Neumann, Medizinische Universitatsklinik, Freiburg,
Germany: Malignant pheochromocytoma: Role of genetic
screening.
P. Dahia, Dana-Farber Cancer Institute, Boston,
Massachusetts: The growing complexity of the genetics of
pheochromocytoma.
J.M. Maris, Children's Hospital of Philadelphia, Pennsylvania:
Genetic basis for neuroblastoma heterogeneity.
G. Eisenhofer, National Institute of Neurological Disorders
and Stroke, NIH, Bethesda, Maryland: Distinct gene
expression profiles in hereditary and sporadic pheochromo-
cytoma.
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SESSION 3: Malignant Pheochromocytoma
Chairperson: H.P.H. Neumann, Medizinische Universitatsklinik, Freiburg, Germany
T.J. Giordano, University of Michigan Health System, Ann
Arbor: Distinct transcriptional profiles of metastasizing and
nonmetastasizing adrenal and extra-adrenal paragan-
gliomas uncovered by DNA microarray analysis.
H. Lehnert, University of Magdeburg, Germany: Expression
patterns of the telomeric complex and somatostatin recep-
tor subtypes in benign and malignant pheochromocytoma:
Implications for diagnosis and treatment.
SESSION 4: Models, Pathways, and Mechanisms of Tumorigenesis
Chairperson: S. Bornstein, University of Dusseldorf, Germany
A. Tisch ler, New England Medical Center, Boston, Massa-
chusetts: Experimental models of pheochromocytoma.
L.A. Greene, Columbia University, New York: Regulation of
pheochromocytoma differentiation and proliferation by ATF5.
SESSION 5: Review of Presentations
Chairpersons: G. Eisenhofer, National Institute of
Neurological Disorders & Stroke, NIH, Bethesda, Maryland;
W.M. Manger, National Hypertension Association, New
York
R. Lucito, Cold Spring Harbor Laboratory: High-resolution
gene-copy-number detection using ROMA, representational
oligonucleotide microarray analysis.
SESSION 6: Open Discussion Session
Moderator: S. Bornstein, University of Dusseldorf, Germany
Topic 1: Prognostic Markers and Targets for Treatment
H. Lehnert, University of Magdeburg, Germany
A. Tisch ler, New England Medical Center, Boston,
Massachusetts
Topic 2: Gene Expression Profiling and Proteomics
D. Smith, Mayo Clinic, Rochester, Minnesota
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R.R. de KrWer, Erasmus MC, Rotterdam, The Netherlands:
Candidate gene and global genetic approaches to malig-
nancy in pheochromocytoma.
K. Pacak, National Institute of Neurological Disorders and
Stroke, NIH, Bethesda, Maryland: Proteomics, microarrays,
and model systems for improved diagnosis and treatment
of malignant pheochromocytoma.
A. lavarone, Columbia University, New York: The N-myc-ID2-
Rb pathway in neuroblastoma.
D. Yamashiro, Columbia University, New York: Angiogenic
factors in neuroblastoma.
Topic 3: Tissue Banks and Tissue Sharing
T.J. Giordano, University of Michigan Health System, Ann Arbor
P. Dahia, Dana-Farber Cancer Institute, Boston
Massachusetts
Topic 4: Tissue Procurement and Data Management
F. Brouwers, National Institute of Child Health and Human
Development, NIH, Bethesda, Maryland
H.P.H. Neumann, Medizinische Universitat-sklinik, Freiburg,
Germany
Topic 5: Models
A. Tisch ler, New England Medical Center, Boston,
Massachusetts
Topic 6: Pheochromocytoma Research Consortium
K. Pacak, National Institute of Neurological Disorders &
Stroke, NIH, Bethesda, Maryland
Topic 7: Funding, Future Interactions, and Directions
W.M. Manger, National Hypertension Association, New York
G. Eisenhofer, National Institute of Neurological Disorders &
Stroke, NIH, Bethesda, Maryland
G. Eisenhofer, R. Lucito, W. Manger
Neural Representation and Processing of Temporal Patterns
December 14-17
FUNDED BY Redwood Neuroscience Institute
ARRANGED BY C. Brody, Cold Spring Harbor Laboratory
D. Buonomano, University of California, Los Angeles
J.C. Hawkins, Redwood Neuroscience Institute, Menlo Park, California
SESSION 1
J.C. Hawkins, Redwood Neuroscience Institute, Menlo Park,
California: Temporal processing: Questions and definitions.
M.N. Shad len, Howard Hughes Medical Institute, University
of Washington, Seattle: Representation of elapsed time and
hazard rates in parietal cortex of the macaque.
P.A. Tal lal, Rutgers University, Newark, New Jersey: Neural
SESSION 2
D. Buonomano, University of California, Los Angeles:
Psychophysical and theoretical studies of simple and com-
plex temporal processing.
M.P. Kilgard, University of Texas, Dallas: Temporal coding and
plasticity in auditory cortex.
J.J. Hopfield, Princeton University, New Jersey: Encoding/
signature of rapid auditory processing disorders in dyslexia:
Insights from fMRI and remediation studies.
C. Brody, Cold Spring Harbor Laboratory: Timing and the
neural representation of short-term memories.
X.-J. Wang, Brandeis University, Waltham, Massachusetts: A
biophysical model of robust scalar timing.
recognizing short dynamic trajectories: Audition.
E. Ahissar, The Weizmann Institute, Rehovot, Israel: Temporal
encoding and decoding in vibrissal active touch.
J.C. Hawkins, Redwood Neuroscience Institute, Menlo Park,
California: Time, sequences, and movement in perception.
M. Kilgard, P. Tallal
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SESSION 3
R. Ivry, University of California, Berkeley: The cerebellum and
event timing.
M.D. Mauk, University of Texas, Houston Medical School:
Timing in the cerebellum.
M. Fee, Bell Laboratories, Murray Hill, New Jersey: Neural
representation of time in the songbird.
SESSION 4
S. Hooper, Ohio University, Athens: Temporal processing by
single neurons.
P. Verschure, Institute of Neuroinformatics, Zurich, Switzer-
land: Decoding information in a temporal pattern code.
R. Granger, University of California, Irvine: Derivation and
analysis of sequential processing algorithms in thalamocor-
tical circuitry.
SESSION 5
D. Levitin, McGill University, Montreal, Canada: Temporal
coherence in music and the prefrontal cortex.
M.R. Jones, Ohio State University, Columbus: The dynamics
of attending to auditory events.
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W.H. Meck, Duke University, Durham, North Carolina:
Coincidence-detection models of interval timing.
R. Gallistel, University of California, Los Angeles: The tempo-
ral information content of a protocol as a determinant of
acquisition latency.
T Rammsayer, University of Goettingen, Germany:
Neuropharmacological dissociation of distinct timing mech-
anisms in the brain.
D.L. Harrington, Veterans Affairs Medical Center,
Albuquerque, New Mexico: Neural representation of interval
encoding and decision making.
B.H. Repp, Haskins Laboratories, New Haven, Connecticut:
Accentuation and coordination.
A. Kepecs, Cold Spring Harbor Laboratory: A model of
dynamics of graded persistent activity.
M. Jones, J. Hopfield

--
DOLAN DNA LEARNING CENTER
Preparing students and families to thrive in the gene age
ADMINISTRATION INSTRUCTION BIOMEDIA TECHNOLOGY
DEVELOPMENT
Judy Cumella-Korabik Elna Carrasco Shirley Chan Jennifer Aizenman
Nancy Daidola Kimberly Kessler Darius Farraye Adrian Arva
Mary Lamont Erin Maroney Eun-Sook Jeong Scott Bronson
David Mick los Amanda Mc Brien Susan Lauter Uwe Hilgert
Carolyn Reid Michael O'Brien Bronwyn Terrill
Erin Wahlgren Danielle Sixsmith Chun-hua Yang
The sequencing of the human genome, and the genomes of other model organisms, largely has been
justified on predicted benefits to human health and agricultural productivity. Beyond these practical
objectives is the larger goal of unifying diverse biological disciplines at the molecular level. In the
genome age, biologists of all persuasions must learn to grapple with large-scale data sets-and
become adept at moving between biological sequence, structure, function, and systematics.
Evolution has been called the only organizing theory in biology, and the National Science Education
Standards specifically acknowledge that molecular and evolutionary biology are among the "small num-
ber of general principles that can serve as the basis for teachers and students to develop further under-
standing of biology." Now, the new discipline of comparative genomics offers a natural bridge between
molecular and evolutionary biology. By working first-hand with genome data, students can gain a deep-
er understanding of evolutionary processes, the use of model systems in biology, and the close genet-
ic relationships that exist between seemingly diverse organisms. Students may be rewarded with new
and sometimes surprising insights into species relatedness, such as the recent demonstration that
humans share a significant number of genes with corals!
Genomic sequences from hundreds of organisms are available to anybody with an Internet con-
nection-as are bioinformatics tools that allow one to explore sequence data, predict the presence
of genes, and compare features shared between different organisms. These freely available
resources hold out the great promise of making modern biology an egalitarian pursuit open to virtu-
ally any biologist or student with a question to ask. Indeed, for the first time in the history of biology,
novices can work with the same information, at the same time, and with the same tools as research
scientists.
Although biological sequences and bioinformatics tools may be free, there are significant barriers to
their widespread use by bioinformatics novices, including mid-career researchers, junior faculty, and
students. There is a bewildering array of tools for analyzing sequence information, each with particular
strengths and weaknesses. The larger "portal" sites may host a dozen or more tools and databases.
The "nested" construction of these Internet sites often means that a particular tool or function is buried
under several layers of organization. Effective use of many tools also requires the user to keep track of,
and move between, several open browser windows. Most database and tool sites are starkly utilitari-
an, making few concessions to design or ease of use. Thus, one of the greatest challenges of the
genome era is to get sequence data and tools into the hands of a broader base of biologists and to
directly involve students in genome bioinformatics. This will require the creation of more intuitive, visu-
ally pleasing computer tools that engage novices and allow them to quickly learn the rudiments of
genome browsing and sequence analysis.
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Flash Tools for Genome Bioinformatics
The DNALC began to rise to the challenge of bioinformatics in the mid 1990s, when we developed the
first polymerase chain reaction (PCR)-based experiments to allow students to analyze their own DNA
differences (polymorphisms) using simple agarose gel systems. This led to the development of the
Student Allele Database, which allowed students to enter their class polymorphism data and compare
it with research data from world populations. By the late 1990s, we had developed a simple system for
amplifying mitochondrial (mt) DNA, and began to sequence DNA samples submitted from students
around the country.
Our current Bioservers site (www.bioservers.org), released in 1999, introduced separate tools for
analyzing allele data and sequence data in human populations. These intuitive interfaces allow students
to enter their own data and draw data from a number of research sources, and then to manipulate the
data sets in a common workspace. The Allele Server stores results of student experiments with the Alu
insertion polymorphism PV92, and provides graphical tools for testing Hardy-Weinberg equilibrium and
comparing allele and genotype frequencies. Sequence Server stores student mitochondrial control
region sequences and provides tools for CLUSTALW analysis and BLAST searches. Registered users
can save files of interest and return to their workspace to continue with projects they have initiated.
Each of these tools conforms to several simple rules for constructing intuitive Internet tools: consistent
and logical placement of tool bars, minimum use of submenus or "nested" screens, and minimal text.
In 2003, we began to experiment with "wrapping" sophisticated algorithms in an attractive multi-
media "skin." In striving to create a simple and engaging interface, we finally gave in to our own anal-
ogy to a computer game. The result was Gene Boy (www.dnai.org/geneboy), a program with what we
call "thingness"-the sense of being a real, onscreen object. One draws sequence data from buttons
on the left side of the console and performs bioinformatic functions with buttons on the right: trans-
form/format DNA sequence, analyze nucleotide composition, search for restriction sites or other short
motifs, and find open reading frames. A "clone screen" feature allows the user to duplicate a result in
a new screen for comparison with a second result, while "skin" color can be changed in the manner of
desktop wallpaper.
Working with The Mill-a London post-production house that won an Academy Award for special
effects in Gladiator and produced animated sequences for Harry Potter I and //-we also developed a
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new way to visualize genome data. We color-coded all of the features of a 650,000-nucleotide region
of human chromosome 11-gene exons and introns, as well as four classes of transposons ("jumping
genes") and repeated DNA. We then created a three-dimensional (3-D) "perspective" view in which
each feature of 100 nucleotides or longer is rendered as a colored key in a DNA "keyboard." The result
is a narrated tour (www.dnalc.org/chr11/) that includes gene clusters encoding blood components
(globins), transcription factors, and olfactory receptors. The 3-D tour makes it sensationally apparent
that genes and intergenic regions are chock full of transposons. Because repetitive DNA is typically
"masked" from genome presentations, this view is striking even for those who know that transposons
account for about 50% of the human genome. Visualizing the extent of transposon intrusion on our
genome makes it difficult not to be moved to ask the question: "Why?"
The development of Gene Boy and the Chromosome 11 Tour was made possible by the tight inte-
gration of design, programming, and biological knowledge in our Biomedia Group. We want to build
upon these design prototypes to develop a set of full-functioned Flash Tools that provide new ways to
visualize, manipulate, and compare genome data. The term Flash Tools embodies the fact that inter-
faces are built using the new-generation multimedia design software Flash MX, as well as their speed
and ease of use. We envision a sequence analyzer with the ability to "decorate" a DNA sequence with
features from successive analyses, as well as a 3-D genome browser that will literally add a new dimen-
sion to large-scale gene analysis. The interface will integrate with standard algorithms and reusable
software components of the Generic Genome Browser at the Generic Model Organism Database
(GMOD), which is co-managed by CSHL scientist Lincoln Stein.
HHMI Bioinformatics
In 2003, we concluded a four-year project, funded by the Howard Hughes Medical Institute (HHMI), to
introduce students and teachers to principles of genome analysis. At the heart of the program is
Vector Net, a portable computer laboratory consisting of 12 laptops linked to a laptop server via a wire-
less local area network (LAN). The server can distribute live Internet access through a single fast con-
nection, or it can rely on its own mirror of the DNALC Internet site and local copies of bioinformatics
tools and GenBank data sets. Fitting entirely in two plastic trunks, VectorNet converts any classroom
or lecture space into a fully functional computer lab in minutes.
In the project's local program, New York City Genes, we worked intensively with 1965 students and
316 teachers from public high schools representing each of the five boroughs of New York City. In the
national program, the Vector Bioinformatics Workshop, we provided training for 320 educators in 16
different locations:
Blood Center of Southeastern Wisconsin, Milwaukee, WI
Contra Costa County Office of Education, Pleasant Hill, CA
Coriell Institute for Medical Research, Camden, NJ
CDT Center for Health Research, Research Triangle Park, NC
Fred Hutchinson Cancer Research Center, Seattle, WA
Foundation for Blood Research, Scarborough, ME
Kaiser Permanente Center for Health Research, Portland, OR
National Center for Biotechnology Information, Bethesda, MD
Oklahoma Medical Research Foundation, Okalahoma City, OK
Rockefeller University, New York, NY
Salk Institute for Biological Studies, La Jolla, CA
Southwest Foundation for Biomedical Research, San Antonio, TX
Stowers Institute for Medical Research, Kansas City, MO
Trudeau Institute, Saranac Lake, NY
Harbor-UCLA Research and Education Institute, Torrance, CA
Whitehead Institute for Biomedical Research, Cambridge, MA
During the teacher workshop, participants made extensive use of computer tools to learn principles
of gene analysis including DNA sequence annotation, gene structure and regulatory elements, gene
families and whole-gene analysis, functional genomics and DNA arrays, and gene discovery using sin-
gle nucleotide polymorphisms (SNPs) and other markers. Participants also amplified two DNA poly-
morphisms and used their own data as a starting point to investigate DNA data sets, population genet-
ics, human origins, and disease mechanisms-illustrating the crossover between DNA experiments
done in vitro (test tubes) and in silico (computers).
Our experience with this course has shown that bioinformatics analysis is more difficult to teach than
are the seemingly complex lab procedures of molecular genetic analysis. Experience with the CSHL
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postgraduate Genome Access course confirmed that novice postgraduates face the same difficulties
in utilizing Internet resources as do the innovative teaching faculty who participated in the HHMI course.
Thus, DNALC staff member Uwe Hilgert was invited to become a co-instructor of the postgraduate
Genome Access course-to integrate many of the instructional methods we developed for the HHMI
bioinformatics course.
To gauge the impact of the Vector Bioinformatics Workshop on course participants, we conducted
a follow-up survey of our 2001 alumni. Most participants reported that the workshop had enabled them
to integrate into their own teaching instruction on the Human Genome Project (94.7%), bioinformatics
(80%), DNA-typing/polymorphisms (78.2%), gene organization (76.4%), and human origins, evolution,
and migration (80%). A significant number had integrated workshop content in hands-on computer
exercises with their students (85.5%), including analysis of DNA sequence composition (73.3%),
sequence searches (60%), sequence alignments (51.5%), construction of phylogenetic trees (46.7%),
and gene prediction and/or protein structure examination (26.7%). A majority of respondents had also
disseminated information about genomic biology/bioinformatics among colleagues, local teachers, and
at workshops or meetings (73%).
Bioinformatics Lab Field Trips and Sequencing Service
The octagonal Bioinformatics Laboratory is the symbolic heart of our facility and is emblematic of the
central role of computation in modern biology. A visit to the Bioinformatics Lab has been a key element
of field trips for students doing PCR amplification of their own DNA polymorphisms. Middle school stu-
dents have also used the laboratory for multimedia explorations of the forensic and DNA evidence used
to identify the remains of the Romanov family (the last ruling family of Tsarist Russia), and to test
whether or not claimant Anna Anderson was Anastasia Romanov. In 2003, we first offered a menu of
pure bioinformatics field trips targeted at high school students:
Gene Sleuthing Discover gene features that allow one to "mine" genes from the genomes of
humans and other organisms.
Of Maize and Men: Jumping Genes Across Kingdoms Uncover transposons in the genomes of
corn and humans, discover how they "jump," and how they can contribute to disease.
Gfeevec: A Smart Bomb in the War on Cancer Discover how the rational development of anti-
cancer drugs critically depends on a thorough understanding of cell signaling pathways.
HIV: The Co-Evolution of Virus and Man Discover how HIV evolved, how specific mutations lead to
viral drug resistance, and why some people have natural resistance to infection.
Sickle Cell Anemia: A Disease of Diverse
Populations Discover the evolution of
sickle cell disease, how the mutation
affects red blood cells, and why the muta-
tion persists in human populations.
Human Origins and the Story of Mitochon-
drial Eve Reconstruct the human family
tree to track down our most recent com-
mon maternal ancestor, and to discover
where and when she lived.
During the year, our Sequencing Service
processed more than 4000 student mito-
chondria) DNA samples submitted by 98 high
schools and 56 universities and colleges.
These sequences were then placed on our
Sequence Server, where they can be viewed
Michael O'Brien leads a polymerase chain reaction (PCR)
laboratory.
and analyzed by the students. The gift of a 377 DNA sequencer in 2000 by Applied Biosystems, plus
continued donation of technical support and reagents, has allowed us to offer this service free-of-
charge. However, demand is so great that this year we partnered with Dick McCombie's group at the
Lita Annenberg Hazen Genome Sequencing Center to give us access to a fast, 96-capillary instrument.
We are thankful for technical assistance from a number of Genome Center staff: Theresa Zutavern,
Beth Miller, Andrew O'Shaughnessy, Lori Grady, and Jody Barditch.
New NSF Grants Increase Collaboration with CSHL Staff
Since its inception, the DNALC has looked to the research at CSHL for inspiration and a window on
modern biology. On one hand, we attempt to predict which new areas of research may be important
for students to learn about in the future. On the other hand, we try to identify "iconographic" lab exper-
iments that illustrate new methods and subsume important biological principles. For example, our
friendship with Doug Hanahan, in the mid 1980s, led us to adapt one of his simple methods to put DNA
into bacteria. Today, this method is commonly used by high school and college students around the
United States and Europe. The technique is so simple that we have been using it with 5th and 6th
graders for several years.
Recently, we have been strengthening our ties to the main Laboratory campus, to the extent of sub-
mitting joint grants with CSHL researchers. The effort resulted in four awards from the National Science
Foundation (NSF) on plant genetics and genomics, which represent a new degree of integration
between high-level science and education outreach.
Plant molecular genetic and genomic research still lags behind medically oriented research on
microbes and higher animals. As a result, there are relatively few lab experiences that expose college-
level students to the growing insights into plants offered by genomic biology. Thus, our proposal to NSF
to develop a laboratory- and Internet-based curriculum to bring college students up-to-the-minute with
modern plant research struck a common chord with the six reviewers-all of whom rated it as "excel-
lent." This is the first time in 15 years that any proposal we have submitted has received such a unan-
imous vote of confidence from NSF reviewers.
During the first year of this project, we developed a set of laboratories illustrating key concepts of
gene analysis in plants, including the relationship between phenotype and molecular genotype, genet-
ic modification of plants and detection of transgenes in foods, and linkage and bioinformatics methods
for gene mapping. Key to the project are lab and bioinformatics exercises that will give students the
unique opportunity to work with CSHL researcher David Jackson in determining the cellular analysis of
Arabidopsis genes of unknown function. An Internet "super site," Greenomes, supports the laborato-
ries with online protocols, custom analysis tools, shared databases, and collaborative bulletin boards.
The new materials were introduced to Advisory Panel members at a workshop held June 16-20.
Feedback from the Advisory Panel workshop is being used to refine curricula prior to initiating nation-
al dissemination workshops in 2004-2005. Faculty members from a number of key institutions attend-
ed the workshop:
Unnea Fletcher and Margaret Maher, Austin Community College
Robed Ballard and Barbara Spezia le, Clemson University
Theresa Fulton and Sharon Mitchell, Cornell University
Erin Dalai, Fra lin Biotechnology Center, Virginia Tech
Ed Himelblau, Long Island University at Southampton
Elizabeth Rosen and Noreen Warren, Madison Area Technical College
Katy Korsmeyer, Santa Clara Biotechnology Education Partnership
Leonore Reiser, The Arabidopsis Information Resource
Christine Pfund and Federico Luy, University of Wisconsin-Madison
David Jackson and Catherine Kidner, Lincoln Stein, CSHL
Later in the year, we received the news that the DNALC was co-awardee on three NSF research
grants to sequence and annotate plant genomes. Under grants to Dick McCombie and Marja
Timmermans, faculty/student pairs from universities serving predominantly underrepresented minorities
will be awarded summer Fellowships at CSHL. During this intensive residence, Fellows will participate
in plant research at the Woodbury Genome Sequencing Center and learn effective teaching strategies
at the DNALC. Upon returning to their institutions, Fellows will work with DNALC staff to offer a train-
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ing workshop on plant genomics for local biology faculty.
Under a grant to Lincoln Stein, DNALC staff will work with faculty Fellows to develop a Student
Genome Viewer, an educational interface for annotating and comparing grain genomes. Then, a series
of nationwide workshops will be held to train high school and college faculty to use Genome Viewer to
detect potential errors and inaccuracies in gene predictions. Upon returning to their schools, faculty
members will download a set of ab initio gene predictions from the DNALC server. They will then guide
students in using Genome Viewer to evaluate predicted genes and to flag potential errors in exon/intron
boundaries and other gene features. Student observations will be sent to database curators, whose
suggested fixes and other comments will be shared with them.
DNA Interactive Completed
During the year, we completed DNA Interactive (DNAi, www.dnai.org), an Internet site to commemo-
rate the 50th anniversary of the discovery of the structure of DNA. As executive producer of this $1.8
million project, the DNALC coordinated contributions from producers and designers in the United
Kingdom and Australia-Windfall Films, The Red Green & Blue Company Ltd., The Mill, and The Walter
and Eliza Hall Institute. The Internet site was part of a larger DNA project developed by an internation-
al collaboration of scientists, educators, and filmmakers. Other DNA products include a five-part TV
series airing on PBS in 2004; DNA: The Secret of Life book coauthored by Nobel Laureate James D.
Watson; a half-hour video for museums and science centers; and DVDs of the television series and
DNAi teacher resources.
Funded by the Howard Hughes Medical Institute (HHMI), DNAi comprises six major topic areas:
Timeline, Code, Manipulation, Genome, Applications, and Chronicle. The topics were serially released
over a five-month period. By year's end DNAi had received 377,000 visits-making it our fastest-grow-
ing release to date. The topic areas (with the exception of Timeline) loosely follow the DNA: The Secret
of Life television series. DNAi includes five hours of video footage drawn from extensive interviews with
more than 70 scientists (including 11 Nobel laureates). More than 150 animations illuminate key exper-
iments in the history of DNA and bring to life the molecular processes that govern DNA replication and
expression.
In producing DNAi, the Biomedia Group joined the upper echelon of multimedia design groups in
the world. The site was produced entirely in Flash MX, which has the advantage of playing its own for-
matted video files, allowing for seamless
integration of a video player into the
Internet page itself. When coupled with
video encoders, Flash formatting allows us
to achieve 100-fold compression of video
file size with surprisingly little loss of quality.
Flash MX files require only a single plug-in
for both animation and video playback, and
98% of Internet users already have a Flash-
enabled browser. DNAi's high level of mul-
timedia design and technology integration
was recognized when it was named "Site
of the Day" by Macromedia, the manufac-
turer of Flash MX. The site also won
ScientificAmerican. coin's 2003 Sciffech
Web Award for biology resources, the
Exploratorium's "Ten Cool Sites" Award for sO
education excellence, and the Yahoo! Pick r----117-30;dan Cd. a.]
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sets the standard against which other Internet science education resources must be measured.
In November, we released myDNAi (www.dnai.org/members), a package of classroom resources
and tools that allow teachers to create their own materials. Working closely with expert Teacher
Fellows, we developed 15 lesson plans that include objectives, correlations to National Science
Education Standards, student worksheets, preparation notes, and supplemental materials. The cus-
tomized DNAi experience begins with the creation of a myDNAi homepage. This easily editable page
includes a greeting, access to DNAi lesson plans, and Internet links. The customized homepage is
stored on the DNALC server and is accessed by a unique URL.
myDNAi is also the access point for Lesson Builder, our unique editor that allows teachers to build
custom lessons from more than 1000 multimedia objects (video, animations, photos, transcripts, text)
used to construct the DNAi Internet site. A keyword search looks for matches among more than 20
metadata fields that describe each object. Then, using a simple "drag-and-drop" editor, the teacher
selects and organizes the multimedia objects into a lesson. Each teacher lesson is then saved on the
DNALC server and accessed by students using a unique URL associated with the teacher's profile. A
lesson can be modified and saved in different versions for use in different classes. In the final two
months of 2003, more than 2400 people had registered as myDNAi members, and nearly 400 custom
lessons had been developed.
Eugenics Image Archive Nearly Completed
The Image Archive on the American Eugenics Movement Internet site was conceived in 1995, soon
after the DNALC launched its first primitive home page. We saw the Internet as the perfect medium to
introduce students, teachers, and the public to this hidden period in scientific history. After several tries,
we were ultimately awarded a two-year grant from the Ethical, Legal, and Social Issues (ELSI) Program
of the National Human Genome Research Institute in early 1998; a continuation grant extended sup-
port to March 2004.
The Archive now contains more than 2200 images of photographs, slides, correspondence,
journals, texts, manuscripts, charts, and data. About 900 text-rich images have been transcribed as
text-only files, which allow the content to be searched by our database engine. The images represent
collections from 11 institutions: American Philosophical Society Library, Philadelphia; Cold Spring
Harbor Laboratory Archives, New York; Ellis Island/Statue of Liberty National Monument, New York;
International Center of Photography, New York; Max Planck Society Historical Archives, Berlin;
Rockefeller University Archive Center, New York; State University of New York at Albany; Truman State
University Archives, Missouri; University College, London; University of Tennessee at Knoxville; and
University of Virginia.
The content of the Archive was significantly bolstered in 2003 by the addition of the Flash MX mod-
ule Chronicle (www.dnai.org/e/index.html), developed as part of the DNAi project. Using mental illness
as a common thread of eugenic concern during the first half of the 20th century, Chronicle fuses a lin-
ear narrative with browsable "exhibits" drawn from the Archive. The presentation highlights the experi-
ences of five individuals-four who became objects of the eugenic movement's zeal to cleanse society
of "bad" genes, and one modern-day heroine who provides a personal account of mental illness and
the lesson it holds for living in the "gene age." Paul Lombardo, of the University of Virginia, provides a
narrated tour of the people and places involved in the pivotal trial of Carrie Buck, which legalized
eugenic sterilization in the United States. In another moving sequence, Benno Muller-Hill takes James
Watson on a tour of a gas chamber in Bernberg psychiatric hospital, where the Nazis enforced a "final
solution" to mental illness.
Since its public launch in 2000, the Eugenics Archive has received 580,000 visitors. Visitation
increased 32% in 2003, with nearly a quarter of a million people spending an average of 13 minutes at
the site (equivalent to over six person-years of viewing!). The Archive has been recognized as a USA
Today "Hot Site" and one of the Exploratorium's "Ten Cool Sites"; it recently received a high rating in
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an in-depth review of Internet sites on the Progressive Era by the Public History Resource Center (pub-
lichistory.org/reviews/view_issue.asp?IssueNumber=9). We regularly receive requests for use of
Archive images from traditional and online publications and broadcast media. Most notably, Archive
images have been seen in "Race and Membership in American History: The Eugenics Movement" from
Facing History and Ourselves, "How to Build a Human" broadcast on BBC television, "American
Gothic" by Christopher Reardon for Teaching Tolerance Magazine, "Race Cleansing in America" by
Peter Quinn for American Heritage Magazine, "Never Again" by Ward Harkavy for The Village Voice,
"Breeding Better Citizens" by Valerie Parker for ABC News, and "Race: The Power of an Illusion" by
California Newsreel for PBS.
The last in a series of three meetings funded under our National Institutes of Health (NIH) grant,
American Eugenics and the New Biology: Perspectives and Parallels, was held at Banbury Center
October 14-16. Archive advisors Garland Allen (Washington University of St. Louis), Elof Carlson (Stony
Brook University, New York), Paul Lombardo (University of Virginia), and Steve Selden (University of
Maryland) were joined by Nicholas Gillham (Duke University), Conrad Gilliam (Columbia University),
Nancy Segal (California State University, Fullerton), and Kay R. Jamison (Johns Hopkins School of
Medicine) in speaking on a range of topics designed to provoke thinking about the "old" and potentially
"new" eugenics. Talks moved from an in-depth look at the founder of British eugenics, Francis Galton,
to eugenic sterilization in the United States, to twin studies and the modern search for genes behind
mental illness. The series drew 80 opinion leaders from diverse fields, including family genetics, edu-
cation, ethics, journalism, government, industry, and philanthropy.
Participants in the Eugenics and
the New Biology: Perspectives
and Parallels Banbury meeting
have an informal discussion
between sessions.
Inside Cancer in Full Production
Upon completion of the DNAi project, the focus of the Biomedia Group turned to Inside Cancer-a
multimedia Internet site for teachers, students, and family members who want authoritative information
on how knowledge of the cancer cell is changing cancer diagnosis and treatment. Funded by an NIH
Science Education Partnerships Award (SEPA), Inside Cancer is benefiting from the Flash MX technol-
ogy we mastered in building DNAi. With Flash MX, we can now build presentations that focus on telling
the story with the most appropriate media, or combination of media types.
Inside Cancer will feature interviews with cancer researchers and other experts to help people
understand the complex science and issues of cancer. These interviews will appear both as stand-
alone features on the site and as integrated presentations with the interviewees narrating animations
that show the inner workings of cancer cells. More than 15 cancer researchers, clinicians, and epi-
demiologists have been interviewed to date-including pioneers Judah Folkman, Doug Hanahan,
Edward Harlow, Arnold Levine, Harold Varmus, and Robert Weinberg.
The content is broken into five modules. Hallmarks of Cancer emphasizes cancer as a genetic dis-
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One of the first completed components of the Inside Cancer Internet site is the Pathways to Cancer 3-D ani-
mation. In this clip, the signal is conducted through the cell membrane, into the cytoplasm. The PDGF recep-
tor is the large molecule just to the right of center.
ease and highlights the common features of a cancer cell. Causes & Prevention uses epidemiological
data to highlight behaviors and environmental factors that increase cancer risk. Diagnosis & Treatment
shows how new molecular techniques are being used to diagnose and tailor cancer treatment accord-
ing to specific genetic changes in the patient's tumor. Cancer in the Laboratory introduces major can-
cer researchers and the importance of their discoveries in understanding cancer at the molecular level.
Pathways to Cancer is a 3-D tour of a cell that focuses on the signaling pathway through which growth
commands are transmitted from the cell surface to the nucleus. All of the modules will be linked through
a "molecule menu" that acts as an illustrated glossary for quick reference information on specific genes
and proteins involved in oncogenesis.
A major development effort has focused on finishing high-resolution 3-D animations of a cell's sig-
naling pathway for the Pathways to Cancer module. These animations, produced with Interactive
Knowledge, Inc., enable users to follow a pathway initiated by platelet-derived growth factor (PDGF) to
illustrate the key points at which cellular growth control can be lost during oncogenesis. The impor-
tance of protein products of proto-oncogenes c-sis, ras, c-fos, c-jun, and the role of phosphorylation
in the regulation of protein function are illustrated. Since the PDGF receptor is a target for the new
Novartis drug GleevecTM, the pharmacological action of cell signaling inhibitors will also be stressed.
The signaling animations will be completed early in 2004, when voiceover artist Doug Thomas records
a narration track. Doug is the son of Peter Thomas, who did voiceover for the award-winning video,
The Biological Revolution, produced as part of the Laboratory's centennial celebration. A 12-minute
version of the animation, entitled Cell Signals, will be produced in wide-screen format for presentation
in the DNALC's auditorium.
DNA Science 2nd Edition
In mid-January, we received the first copies of the second edition of our popular lab text, DNA Science.
The 2nd edition preserves the successful formula of the 1st edition: one part well-tested laboratories
and one part insightful, explanatory text. First published in mimeographed form in 1988 and formally
published in 1990, this book was largely responsible for bringing DNA experiments within reach of
advanced high school and beginning college students.
The core laboratory sequence, developed by myself and Greg Freyer in the laboratory of CSHL
Nobel Laureate Richard Roberts, introduces the basic techniques of DNA restriction, transformation,
isolation, and analysis-and then applies these techniques to the construction and analysis of a sim-
ple recombinant DNA molecule. We resisted the temptation to tinker very much with the laboratories,
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since they are the best-tested and most widely used teaching labs available on the basic techniques
of gene manipulation. Two new labs were added that focus on gene products: a colorimetric assay for
the activity of 13-lactamase, the enzyme produced by the ampicillin resistance gene, and expression and
purification of green fluorescent protein.
The text portion has been entirely reorganized and updated, increasing from 200 to 300 pages. As
before, the narrative takes students behind the scenes of modern research to show them the evolution
of concepts and methods. The first three chapters cover essential principles of genetics, and DNA
structure and function. The next three chapters introduce small- and large-scale methods for analyz-
ing DNA, culminating in the race to sequence the human genome and new methods for working with
hundreds of genes simultaneously. The final two chapters focus on the applications of molecular tech-
niques to understand cancer, human variation, and our emergence as a species. The human genetics
chapter also contains the first substantial treatment of the American eugenics movement available in a
general biology text.
Although much has changed in biology since the first edition, the ideas and techniques in this book
are still the minimum requirements for any degree in DNA manipulation. We hope that DNA Science
continues to provide a simple roadmap for beginning an exploration of the molecule of life-one that
will take on added importance as more and more biology teachers around the world realize the value
of giving students freedom to get their hands dirty with DNA.
DNALCs to the North, South, East, and West
Over the years, the DNALC has been the direct model for a number of teaching laboratories estab-
lished at museums and higher education institutions in the United States and abroad, including Biogen
Community Laboratory (Boston, Massachusetts), Tech Museum of Innovation (San Jose, California),
Life Science Centre (Newcastle, England), Visible Laboratory (Berlin, Germany), DNA School
(Montpelier, France), and Life Learning Center (Bologna, Italy). In 2001, the DNALC initiated a formal
program to assist institutions and to quickly and efficiently implement a "hands-
on" science center devoted to modern biology education. Under the licensing scheme, institutions
have transparent access to teaching methods, Internet technology, and intellectual property ("know-
how") developed at a cost of more than $25 million.
In 2003, Clemson University and Roberson Museum and Science Center joined the ranks of cur-
rent licensees: North ShoreLong Island Jewish (LIJ) Health System, Singapore Ministry of Education,
Students in the DNA Learning Lab at the Singapore
Science Centre participate in hands-on activities.
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and Science Epicenter and DNA Learning Center. Clemson initiated the South Carolina DNA Learning
Center with an initial grant of $500,000, with the intent to focus on agricultural genetics. Working with
a consortium of local business people and educators at the University of Binghamton, Roberson had
raised nearly $1 million to support development of its Life Science Learning Center.
The DNALC West facility, adjacent to North ShoreLIJ's clinical testing laboratory in Lake Success,
served 2050 students during its first full year of operation. Located 18 miles west of Cold Spring
Harbor, this facility was designed to serve students in western Nassau County and New York City.
Within a year of signing a licensing agreement, two facilities based on the DNALC model came online
in the Republic of Singapore-one to serve teachers and the other to serve students. The DNA Centre
at the National Institute of Education (NIE)-with two teaching labs, a bioinformatics lab, and small
exhibit space-provided workshops for 625 teachers in 2003. The DNA Learning Lab at the Singapore
Science Centre-with dual "Watson" and "Crick" teaching labs surrounded by a "DNA Trail" exhibit-
conducted experiments with 6356 visitors and held orientations for 1200 educators. Science Epicenter
and DNA Learning Center-across Long Island Sound in Groton, Connecticut-equipped its first
teaching lab with the help of Pfizer, Inc. and began offering field trips in the fall.
Real and Virtual Programs Continue to Grow
Thanks to the availability of new lab space at the West facility, the number of students participating in
lab field trips rose 8% in 2003, to 15,604. The 798 students who participated in summer "DNA camps"
represented a similar increase over the previous year. Gratis labs and summer camps were provided to
nearly 800 students from public schools in Nassau County, Suffolk County, Brooklyn, Manhattan, and
the Bronx. We had another busy summer, instructing more than 600 student participants in 26 work-
shops sited at the DNALC and at Central Islip High School (Suffolk County), Bard High School Early
College (Manhattan), and Science Epicenter and DNA Learning Center (Groton, Connecticut). Nearly
250 teachers participated in training workshops (two or more days long) conducted by DNALC staff
here, in Singapore, and at locations around the United States. This brings the total number of teach-
ers that we have trained since 1985 to 3500. Nearly 8000 visitors viewed Cablevision's Long Island
Discovery and The Genes We Share exhibit. All told, DNALC visitation reached a new peak of 33,351.
Although DNALC visitation is limited by space, time, and staff, our capacity for "virtual" visitors via
the Internet is essentially unlimited. Thus, the family of Internet sites reached through the DNALC's por-
tal, Gene Almanac, provide us with a large and growing clientele of students, teachers, medical con-
sumers, and concerned lay people. Traffic at DNALC Internet sites increased 23%, with 4.85 million
visitors each spending an average of 11 minutes.
Genetics as a Model for Whole Learning (GMWL), our program of in-school instruction and lab field
trips for 4th-8th graders, reached 16,000 students in 60 school districts and private schools during the
year. Middle school students continued to enjoy a variety of laboratory experiences-from making cell
models of gelatin and dry foodstuffs to producing glowing bacteria using GFP (green fluorescent pro-
tein) transformation. The instructional staff used the DNAi Lesson Builder to create a new computer lab
in which students compare fossils of ancient hominids and explore the diversity of mitochondrial DNA.
This complements a student's visit to the adjacent exhibit on Common Origins.
High school students enjoyed the debut of two new labs. In Doggy DNA, students isolate DNA
from cheek cells of their favorite pooch (or prepared cells provided by staff) and then use PCR to
amplify a short region of the mitochondria' chromosome. Several days after the visit, DNALC staff post
the sequences on our Sequence Server, where teachers and students can retrieve their canine DNA
and use it to study the evolution of domesticated dogs. In the Genetically Modified Organisms lab,
students use PCR and gel electrophoresis to detect transgenes in genetically modified soybeans and
common foodstuffs.
The long-running Curriculum Study Program attracted 37 member districts and schools, from which
come a majority of student lab participants. Curriculum Study members have preferred access to the
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DNALC and select from a "menu" of benefits and services-including free and reduced-rate lab field trips, first option
on summer workshops, seminars by world class scientists, and teacher in-service training. Great Moments in DNA
Science, the Curriculum Study honors seminar series, hosted 442 students over three evenings of talks presented by
CSHL scientists Thomas Volpe, Richard McCombie, and Yuri Lazebnik.
We continued to welcome families from the local area to the DNALC for the Saturday DNA! program. In 2003,
more than 300 children, teens, and adults participated in 90-minute laboratory- or computer-based sessions offered
by DNALC staff. During lab sessions, participants compared DNA samples at mock crime scenes, mapped DNA
mutations, and experimented with jumping genes. In computer-based sessions, participants learned how to create
scientific animations, explored molecular biology resources on the Web, and searched for meaning in DNA
sequences. In addition, more than 900 members of the public attended "DNA at 50," a series of nine special lectures
given by CSHL Chancellor James Watson to commemorate the 50th anniversary of his own discovery of the struc-
ture of DNA.
Pfizer Leadership Institute
The highlight of the summer was the Pfizer Leadership Institute in Human and Plant Genomics. Nicknamed "DNA Boot
Camp," the three-week institute drew together 19 of the very best biology teachers from around the United States, as
well as five teachers from the Republic of Singapore. Staying on the CSHL campus is a dream come true for these
teachers. Here, they literally walk in the shadows of heroes-living, eating, and breathing science. For most, it is a
defining moment in their careers. The participating teachers have already implemented major genetics/biotechnology
teaching programs at their schools prior to attending the Pfizer Institute. The Institute honors their past creativity and
prepares them to take their innovative classroom teaching and peer training to even higher levels.
The 2003 Institute focused on the study of human and plant genomes, and included a section on site-directed
mutagenesis and genetically altered food crops. All topics were addressed in a three-pronged approach of lec-
tures/seminars, wet-labs, and computer work. Five CSHL research scientists gave seminars on topics that extended
participants' understanding of the course materials. Participants also visited CSHL's Uplands Farm field station for
plant genetics and the newly completed Genome Sequencing Center. Finally, teachers were provided with indepen-
dent time to begin developing curriculum materials for use in their own classrooms, as well as for the training of col-
leagues in their local regions.
A survey of past Leadership participants revealed that they, indeed, are living up to their role as educational leaders.
Participants reported that they
had provided 227 hours of in-ser-
vice training for 400 precollege
faculty-an average of 11 hours
and 19 faculty trainees per partic-
ipant. These events provided fac-
ulty hands-on experience in
many lab and computer meth-
ods, including gel electrophoresis
(211 teachers), bioinformatics
(111 teachers), PCR (98 teach-
ers), protein purification (50
teachers), and bacterial transfor-
mation (34 teachers). Leadership
faculty also reported receiving
more than $80,000 in funding to
purchase lab equipment and
supplies, to provide in-service
training, and to attend profes-
sional meetings.
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2003 Leadership Institute participants and DNALC staff.
Staff and Interns
In 2003, we welcomed two new members to our Administrative staff: Carolyn Reid and Mary
Lamont. Carolyn joined us in May as an Administrative Assistant at the DNALC, helping with
schools administration and our Saturday DNA! program. A Long Island native, Carolyn has expe-
rience in the travel, cable television, and publishing industries. Mary began in September as an
Administrative Assistant for the growing operation at the DNALC West. Prior to joining CSHL,
Mary worked in entertainment management, magazine publishing, and insurance-related com-
panies.
In 2003, we bid farewell to three staff members. After making valuable contributions to the
DNA Interactive project, science writer Beverly Tomov left in September to look after her new
baby, Sophia. Designer Karwai Pun also left the Biomedia Group, but continues her relationship
with CSHL as a member of the Media Arts & Visualization Department. After returning to the
DNALC following maternity leave, Tricia Maskiell took a position as a 6th grade science special-
ist at Oldfield Middle School, in the neighboring Harborfields School District.
High school interns continue to provide key support for our teaching labs, as well as con-
ducting independent research projects under the direction of Scott Bronson and Jennie
Aizenman. Intern Michelle Louie (Kings Park High School) was selected as an Intel semifinalist for
her work on tagging Arabidopsis genes of unknown function with green fluorescent protein (GFP).
Benjamin Blond (Syosset High School) is attempting to use RNA interference (RNAi) to "silence"
a C. elegans gene believed to be involved in the aging process. Two DNALC West interns moved
on to pursue higher-level research: Robert Weintraub (Walt Whitman High School) is working on
DNA polymorphisms in Arabidopsis with Zachary Lippman at CSHL. Alinea Noronha (Herricks
High School) was accepted into the Young Investigators Internship at the Research Institute of
NS-LIJ Health System.
Regina Hui (Northport High School), Ariel Gitlin (Cold Spring Harbor High School), and Watson
School student Elizabeth Thomas continued to assist the Biomedia group with Internet site devel-
opment.
Joining the intern program in 2003 were Carisa Bautista (Cold Spring Harbor High School), Joe
Hakoopian (Walt Whitman High School), Zach Goldberg (Half Hollow Hills East High School), Amy
Richards (Kings Park High School), George Roche (Cold Spring Harbor High School) and Greg
Rosen (MacArthur High School). Jason Wittenstein (Herricks High School) and Zeba lzhar
(Queensborough Community College) joined the intern crew at DNALC West. Several interns
returned from college to assist with summer workshops: Yan Liang Huang (Notre Dame
University), Janice Lee (Boston University), and Alex Witkowski (SUNY Albany).
In August, we bid farewell to a number of interns as they began their freshman year at college:
Lara Abramowitz (Half Hollow Hills West High School) at the University of Rochester; Kunal
Kadakia (Syosset High School) at Northwestern University; Shirish Kondabolu (Half Hollow Hills
West High School) at the University of Rochester; Jared Winoker (Syosset High School) at Cornell
University, and Jonathan Mogen (Half Hollow Hills West High School) at Brown University. Pushpa
Abraham (Kings Park High School) traveled to India to attend medical school, and Rebecca Yee
entered a Masters-level program in genetic counseling at Virginia Commonwealth University.
Dave Mick los
Executive Director
Mary Lamont and
Carolyn Reid joined
the administrative
staff in 2003.
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2003 Workshops, Meetings, and Collaborations
January 2
January 13
January 17
January 21
January 24-25
January 24
January 25
January 27
January 29
January 29-31
January 31
February 4
February 8
February 14
February 15
February 20-21
February 25-27
February 27-
March 1
February 28
March 5
March 8
March 17-24
March 19-22
March 22
March 25
March 27-30
March 28
March 31
April 1
April 2
April 3
April 5
April 8
April 11
April 15
April 16
April 19
April 30
May 3
May 6
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Site visit by Barry Aprison, Museum of Science and Industry, Chicago, Illinois
Site visit by Barbara Suhr, New York Public Library, New York, New York
Site visit by Phil Lamesch, Harvard Medical School, Boston, Massachusetts
Site visit by Anna Nasmyth and Gustav Ammerer, Mendel Museum of Genetics, Brno,
Czech Republic
European Molecular Biology Laboratory Education Advisory Board Meeting, Heidelberg,
Germany
Site visit by Mark Bloom, Biological Sciences Curriculum Study, Colorado Springs,
Colorado
DNA at 50: Finding the Double Helix, talks by James D. Watson, DNALC
Site visit by the Bruce Museum, Greenwich, Connecticut
National Institute of Social Sciences Issues Discussion Group, Colony Club, New York,
New York
National Coalition for Health Professional Education in Genetics Annual Meeting,
Bethesda, Maryland
Site visit to Roberson Museum and Science Center, Binghamton, New York
Site visit to Molloy College, Rockville Centre, New York
DNA at 50: Finding the Double Helix, talks by James D. Watson, DNALC
Site visit by Mark Hertle, Precollege Science Education Program, Howard Hughes
Medical Institute, Chevy Chase, Maryland
DNA at 50: Finding the Double Helix, talks by James D. Watson, DNALC
National Institutes of Health Science Education Partnerships Award Directors Meeting, La
Jolla, California
National Institutes of Health Science Education Partnerships Award Review Panel,
Bethesda, Maryland
Meeting the Challenges in Emerging Areas: Education Across the Life, Mathematical, and
Computer Sciences Meeting, Bethesda, Maryland
Site visit by Jon King, National Human Genome Research Institute, Bethesda, Maryland
Site visit by Hutton House faculty and members, C.W. Post Campus, Long Island
University, Brookville, New York
Saturday DNA! Seminar, DNALC
Teacher-training workshops, National Institute of Education and Singapore Science
Centre, Singapore
Museums and the Web Meeting, Charlotte, North Carolina
Saturday DNA! Seminar, DNALC
Great Moments in DNA Science Honors Students Seminar, CSHL
Exhibit at National Science Teachers Association Annual Meeting, Philadelphia,
Pennsylvania
Site visit by News 12 Long Island, to film high school field trip
Site visit by Kathy Belton, Audrey Cohan, Valerie Collins, Jodi Kilgannon, Ed Thompson,
and Ron Zanni, Molloy College, Rockville Centre, New York
Great Moments in DNA Science Honors Students Seminar, CSHL
Eugenics Seminar at Lycoming College Genome Symposium, Williamsport, Pennsylvania
Site visit by Jennifer Cordi and Judy Cohen, Bard High School Early College, Manhattan,
New York
Presentation at Sayville High School Career Café, West Sayville, New York
Saturday DNA! Seminar, DNALC
Great Moments in DNA Science Honors Students Seminar, CSHL
Site visit by Fran Balkwill, Baits & The London, Queen Mary's School of Medicine and
Dentistry, London, United Kingdom
Site visit by Callie Brunelli, Aubrey Clark, Denise Gay-Alden, Kristen Gordon, Jim Griffin,
Jim Lee, and Nancy Scales, Roberson Museum and Science Center, and Tom
O'Brien and Theresa Partell, SUNY Binghamton
Science Epicenter and DNA Learning Center Board Meeting, New London, Connecticut
Saturday DNA! Seminar, DNALC
National Institute of Social Sciences Issues Discussion Group, Harvard Club, New York,
New York
Saturday DNA! Seminar, DNALC
Presentation to Academy of Professional Law Enforcement, CSHL
May 13 Site visit by members of the Huntington Rotary Club, Huntington, New York
May 17 Saturday DNA! Seminar, DNALC
May 19 Site visit by Robert Ballard, Richard Hilderman, and Calvin Schoulties, Clemson
University, Clemson, South Carolina
May 22 Sayville School Business Advisory Board Meeting, Sayville High School, West Sayville,
New York
May 27 Site visit by Estelle Perera, The Tech Museum of Innovation, San Jose, California
National Institute of Social Sciences Annual Board Meeting, Colony Club, New York, New York
May 30 Site visit by participants in the CSHL Symposium The Genome of Homo Sapiens
May 31 Saturday DNA! Seminar, DNALC
June 3 Site visit by Linnea Fletcher, Austin Community College, and Sue Gravett, Brandon
Janes, and Charles Lutz, Austin Chamber of Commerce, Texas
June 9 DNA: The Secret of Life book signing, James D. Watson, DNALC
June 10 Site visit by Jean Caron and Carol Milne, Science Epicenter and DNA Learning Center,
New London, Connecticut
June 13 Site visit by Jim Lee, Ann Van Atta, Miranda Green-Barteet, and Nancy Scales, Roberson
Museum and Science Center, Binghamton, New York
June 14 Saturday DNA! Seminar, DNALC
June 16-20 National Science Foundation Advisory Panel Workshop, DNALC
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, CIIT Center for
Health Research, Research Triangle Park, North Carolina
June 23-27 Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Blood Center of
Southeastern Wisconsin, Milwaukee
June 26 Site visit by Horst Seelbach and Berndt Kynast, Faustus Forschungs Compagnie, Leipzig
June 26-July 2 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
July 1-3 DNA polymorphisms workshop, International Genetics Congress, Melbourne, Australia
July 6-11 International Congress of Genetics, Melbourne, Australia
July 7-11 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNA Learning Center West
DNA Science Minority Workshop, Central Islip High School
July 7-25 Pfizer Leadership Institute in Human and Molecular Genomics, DNALC
Training for Singapore collaborators, Muhammad Shahrin, Nai Sok Khoon Karine, Elaine
Tan Pei Lee, and Florence Francis
July 8 Seminar at Human Genetics and Global Healthcare Symposium, Melbourne, Australia
July 14-18 Fun With DNA Workshop, DNA Learning Center West
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
Training for Science Epicenter and DNA Learning Center collaborators, Pat Quinn and
Nancy Scales
July 15 Site visit by Alan Fleischman and Leslie Goldman, New York Academy of Medicine, New
York, and Lawrence Sherr, North Shore-Long Island Jewish Health System,
Manhasset, New York
July 18 Site visit by the Alliance for Graduate Education and Professionals, Stony Brook
University, New York
July 21 Presentation at National Institutes of Health workshop, Genes, Schemes, and Molecular
Machines, Schenectady, New York
July 21-25 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNA Learning Center West
DNA Science Workshop, DNALC
DNA Science Minority Workshop, Bard High School Early College
DNA Science Workshop, Science Epicenter and DNA Learning Center, New London,
Connecticut
July 28-August 1 World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
Genetic Horizons Workshop, DNALC
DNA Science Workshop, DNA Learning Center West
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Coriell Institute for
Medical Research, Camden, New Jersey
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August 4-8 Fun With DNA Workshop, DNALC
Fun With DNA Workshop, DNA Learning Center West
World of Enzymes Workshop, DNALC
Genomic Biology and PCR Workshop, DNALC
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Harbor-UCLA
Research and Education Institute, Torrance, California
August 4-22 Training for Singapore collaborators, Chow Wai Hoong, Ramiah Kama la, and Yam Wei
Ling Agnes
August 11-15 Fun With DNA Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
Genomic Biology and PCR Workshop, DNA Learning Center West
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Kaiser Permanente
Center for Health Research, Portland, Oregon
Training for Science Epicenter and DNA Learning Center collaborator, Nancy Scales
August 12 Site visit by alumni group from Brandeis University, Waltham, Massachusetts
August 13 Site visit by Karl Kuchler, University of Vienna, Austria
August 18-22 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
DNA Science Workshop, DNA Learning Center West
Howard Hughes Medical Institute, Vector Bioinformatics Workshop, Rockefeller
University, New York, New York
August 25-29 Fun With DNA Workshop, DNALC
Genetic Horizons Workshop, DNALC
Genomic Biology and PCR Workshop, DNALC
September 3 Site visit by Henry Yang, Beijing Genomics Institute, China
September 9 Dedication of Joan and Arthur M. Spiro Auditorium, Nature, Nurture & Mental Illness,
talks by Matt Ridley, Kay Redfield Jamison, and Andrew Solomon, DNALC
September 10 Presentation at Melbourne Museum, Australia
September 20 Saturday DNA! Seminar, DNALC
September 25 Eugenics seminar at the New York Public Library, New York
September 26 Site visit and curriculum development meeting, Southampton College-Long Island
University, New York
September 30 Inside Cancer interview, Arnold Levine, Princeton University, Princeton, New Jersey
October 1-3 Site visits to China Academy of Science and Technology and Natural History Museum,
Beijing, China
October 2 Sayville School Business Advisory Board Meeting, Sayville High School, West Sayville,
New York
October 4 Saturday DNA! Seminar, DNALC
October 6 Dedication of James D. Watson Institute of Genome Sciences, Zhejiang University,
Hangzhou, China
October 8-11 Exhibit at National Association of Biology Teachers Annual Meeting, Portland, Oregon
October 11 Site visit and tour by students and faculty from the Center for Talented Youth, Johns
Hopkins University, Baltimore, Maryland
October 13-16 National Institutes of Health ELSI conference, American Eugenics and the New Biology:
Perspectives and Parallels, Banbury Center, CSHL
October 15 Site visit to Roberson Museum and Science Center, Binghamton, New York
October 16-17 National Human Genome Research Institute ELSI Project, Eugenics Image Archive,
Editorial Working Group Meeting
Bio 21: Teaching Biology With Bioinformatics Meeting, University of North Carolina at
Chapel Hill
October 18 Saturday DNA! Seminar, DNALC
October 20-23 Site visit by Yan Yaw Kai, National Institute of Education, Singapore
October 22 Site visit by members of the National Institute of Social Sciences, New York, New York
October 24 Inside Cancer interview, Harold Varmus, Memorial Sloan-Kettering Cancer Center, New
York
Site visit by Dixie Scovel and Tony Wills, Newsday, Melville, New York
October 28-31 Site visit to International Centre for Life, Newcastle, National Centre for Biotechnology
Education, Reading, and The Mill, London, United Kingdom
October 29 Teacher-training workshop, Erasmus Hall High School and STAR High School, Brooklyn,
New York
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November 1 Saturday DNA! Seminar, DNALC
November 3 Site visit by Arthur Spiro, CSHL Trustee and DNALC Committee Chairman, and James
and Marcia Barker, Calvin Schultheis, Mendel Bouknight, and Robert Ballard,
Clemson University, Clemson, South Carolina
Inside Cancer interview, Larry Norton, Memorial Sloan-Kettering Cancer Center, New
York
November 4 Inside Cancer interview, Bob Weinberg, Whitehead Institute, Cambridge, Massachusetts
Inside Cancer interview, Stanley Korsmeyer, Dana-Farber Cancer Institute, Boston,
Massachusetts
Teacher-training workshop, Erasmus Hall High School and STAR High School, Brooklyn,
New York
November 5 Site visit by Don Colbert, State University of New York at Binghamton
Inside Cancer interview, Ed Harlow, Harvard Medical School, Boston, Massachusetts
Teacher-training workshop, Biogen, Cambridge, Massachusetts
November 6 Inside Cancer interview, Marianne Berwick, Memorial Sloan-Kettering Cancer Center,
New York
November 7 Videoconference with James D. Watson and National Institute of Education, Singapore
November 10-22 Teacher-training workshops, National Institute of Education, Singapore
November 11 Site visit by Jiaan Cheng, Zhejiang University, Hangzhou, China, and Sun Zhongsheng,
Cornell University, Ithaca, New York
November 15 Saturday DNA! Seminar, DNALC
November 19 American Association of University Women Excellence in Science Awards Reception and
Meeting, DNALC
Teacher-training workshop, Erasmus Hall High School and STAR High School, Brooklyn,
New York
November 20 Site visit by Curt Engelhorn, Monte Carlo, Monaco
Site visit by Kent Anderson and Bette Phimister, New England Journal of Medicine,
Waltham, Massachusetts
December 1-12 Training for Singapore collaborators, Wong Poh San, Ng Huey Bian, Evan Yap Boon
Heng, Teo Lay Yen, Tan Wei Ling, Wong Mei Leng, and Tan Woei Yng
December 2 Site visit by Clare Lin, national winner of the GenETHICS Competition, Melbourne,
Australia
December 13 Saturday DNA! Seminar, DNALC
December 15 Presentation at Garcia Center open house and science fair, Queens College, Flushing,
New York
Inside Cancer interview, Richard Stanley, The Albert Einstein College of Medicine, Bronx,
New York
December 17 Site visit by Bruce Kovner, Chairman of the Board of Trustees of The Juilliard School,
New York, New York
December 27 Saturday DNA! Seminar, DNALC
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Sites of Major Faculty Workshops 1985-2003
Key: High School College Middle School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA Foothill College, Los Altos Hills 1997
University of California, Davis 1986
San Francisco State University 1991
University of California, Northridge 1993
Canada College, Redwood City 1997
Pierce College, Los Angeles 1998
California Lutheran University, Thousand Oaks 1999
Laney College, Oakland 1999
California State University, Fullerton 2000
Salk Institute for Biological Studies, La Jolla 2001
Contra Costa County Office of Education, Pleasant Hill 2002
Harbor-UCLA Research & Education Institute, Torrance 2003
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University 1992, 1996
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
University of Miami School of Medicine 2000
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991, 1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986, 1987
University of Chicago 1992, 1997
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
National Center for Biotechnology Information, Bethesda 2002
MASSACHUSETTS Beverly High School 1986
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Boston University 1994, 1996
Whitehead Institute for Biomedical Research, Cambridge 2002
Biogen, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990, 1991
MISSOURI Washington University, St. Louis 1989
Washington University, St. Louis 1997
Stowers Institute for Medical Research, Kansas City 2002
NEW HAMPSHIRE St. Paul's School, Concord 1986, 1987
New Hampshire Community Technical College, Portsmouth 1999
NEVADA University of Nevada, Reno 1992
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
NEW YORK Albany High School 1987
Bronx High School of Science 1987
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Columbia University, New York
Cold Spring Harbor High School
DeWitt Middle School, Ithaca
1993
1985, 1987
1991, 1993
DNA Learning Center 1988-1995, 2001-2003
DNA Learning Center 1990, 1992, 1995, 2000
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
Stony Brook University, New York 1987-1990
Titusville Middle School, Poughkeepsie 1991,1993
Wheatley School, Old Westbury 1985
US Military Academy, West Point 1996
Stuyvesant High School, New York 1998-1999
Trudeau Institute, Lake Saranac 2001
Rockefeller University, New York 2003
NORTH CAROLINA North Carolina School of Science, Durham 1987
CIIT Center for Health Research, Triangle Park 2003
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
Oklahoma City Community College 2000
Oklahoma Medical Research Foundation, Oklahoma City 2001
OREGON Kaiser Permanente-Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
University of Texas, Austin 1999
Austin Community College-Rio Grande Campus 2000
Southwest Foundation for Biomedical Research, San Antonio 2002
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998
University of Utah, Salt Lake City 2000
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
WASHINGTON University of Washington, Seattle 1993, 1998
Fred Hutchinson Cancer Research Center, Seattle 1999, 2001
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
Madison Area Technical College 1999
Blood Center of Southeastern Wisconsin, Milwaukee 2003
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001-2003
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
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2003 PUBLICATIONS
SERIALS
Genes and Development, Volume 17, 1-3170
Genome Research, Volume 13, 1-2786
Learning and Memory, Volume 10, 1-540
Protein Science, 12, 1-2886
RNA, Volume 9, 1-1592
Cold Spring Harbor Symposia on Quantitative Biology:
Volume 67: The Cardiovascular System
LABORATORY MANUALS AND HANDBOOKS
RNAi: A Guide to Gene Silencing, Greg Hannon (ed.)
PCR Primer (2nd ed.), Carl Dieffenbach and Gabriela
Dveksler
Purifying Proteins for Proteomics: A Laboratory Manual,
Richard Simpson (ed.)
Lab Math: A Handbook of Measurements, Calculations,
and Other Quantitative Skills for Use at the Bench,
Dany Spencer Adams
TEXTBOOKS
DNA Science: A First Course (2nd ed.), David Mick los
and Greg Freyer
Molecular Biology of the Gene (5th ed.), James D.
Watson, Richard Losick, Michael Levine, Alex Gann,
Tania A. Baker, and Stephen P. Bell
MONOGRAPHS
Prion Biology and Diseases (2nd ed.), Stanley B.
Prusiner (ed.)
GENERAL INTEREST AND CHILDREN'S BOOKS
The Molecular Gaze: Art in the Genetic Age, Dorothy
Nelkin and Suzanne Anker
Inspiring Science: Jim Watson and the Age of DNA,
John Inglis, Joseph Sambrook, and Jan Witkowski
(eds.)
George Beadle, An Uncommon Farmer: The
Emergence of Genetics in the 20th Century, Paul Berg
and Maxine Singer
Reader's Guide: Abraham Lincoln's DNA and Other
Adventures in Genetics, Philip R. Reilly
OTHER
CSHL Annual Report 2002: Yearbook Edition
CSHL Annual Report 2002
Banbury Center Annual Report 2002
Watson School of Biological Sciences Annual Report 2002
WEB SITES
Dna-microarrays.org, a companion Web site to DNA
Microarrays: A Laboratory Manual
Proteinsandproteomics.org, a companion Web site to
Proteins and Proteomics: A Laboratory Manual
MEDIA
"Selected Songs for Cynical Scientists" (CD), Ron Laskey
A selection of recently published books
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The journal publishing program
COLD SPRING HARBOR LABORATORY PRESS
Cold Spring Harbor Laboratory Press contributes in important ways to the Laboratory's educational
mission, with an international publishing program for three distinct audiences. Research journals,
monographs, handbooks, and laboratory manuals assist the continuing professional education of
working scientists and help train graduate students for advanced degrees. Textbooks are created for
college undergraduates majoring in the life sciences. In addition, general interest and historical books
are published for readers not technically trained in science but interested in its practice and personali-
ties and how research advances are influencing medicine, industrial development, and social policy.
Financially, the year was a disappointing one for the Press. Total income from the publishing pro-
gram increased by 11%, but there was a net operating deficit after deductions for depreciation and
Laboratory overhead. The journal program performed to expectation, but several factors combined to
lower the margins on book sales, including pressure for increased discounts from retail and wholesale
distributors, declines in sales of larger more expensive books, and increased sales in foreign markets
where deep discounts are required.
Books and Electronic Media
Scientists worldwide rely on technical manuals published by the Press, with their outstanding reputation
for clarity and accuracy. The list of more than 25 current titles includes Molecular Cloning, the world's
most widely used source of techniques for working with DNA. The three new manuals published in 2003
included Richard Simpson's Purifying Proteins for Proteomics, a companion to his previous proteomics
manual, and a second edition of the best-selling guide to PCR technology PCR Primer by Carl
Dieffenbach and Gabriella Dveksler. The most immediate success was RNAi (RNA interference), which
describes a new, powerful, and swiftly adopted way of silencing genes. Cold Spring Harbor scientists
have been pioneers of RNAi, and one of them, Gregory Hannon, edited what became the first authori-
tative book on the biology of the interference process and its practical applications.
Laboratory procedures such as RNAi require specialized equipment and reagents. Ten years ago, we
assembled databases of such materials and their suppliers and created directories that were published
in print and on-line. After becoming the foundation of a private company that was bought by the Internet
commerce pioneer, SciQuest.com, the BioSupplyNet databases were reaquired by the Press late in
2003. They are being retooled, enhanced, and integrated into our techniques publishing program.
Recognizing the enthusiasm of scientists for information available on-line, we have created in recent
years a number of Web sites that support individual books by providing additional content not available
in print and downloadable versions of the artwork. We also continue to collaborate with the National
Center for Biotechnology Information in presenting books in an on-line format, this year adding the suc-
cessful advanced textbook Essentials in Glycobiology first published in 1999.
Our series of short, inexpensive handbooks continues to be very popular, and Kathy Barker's
books-At The Bench, for laboratory novices, and At The Helm, for aspiring principal investigators-
maintained strong sales. The collection grew in 2003 with the addition of Dany Spencer Adams' Lab
Math, a book with a purpose spelled out in the subtitle: A Handbook of Measurements, Calculations,
and Other Quantitative Skills for Use at the Bench. Life scientists are not always confident in their math-
ematical abilities, and it was satisfying to see the book being eagerly seized on our exhibit stands.
The Cold Spring Harbor Monograph Series, begun in 1970 at Jim Watson's instigation with a vol-
ume entitled The Lactose Operon, has expanded to 41 volumes, many of them classics of molecular
biology. The books' appearance had not changed in 30 years and this year, the interior design was
modified slightly and a new cover design imposed, which retains the familiar black spine of the origi-
nal, but now includes a striking color image. The first book to benefit was the second edition of Prion
Biology and Diseases, the definitive monograph on the causative agents of bovine spongiform
encephalopathy and other degenerative disorders, edited by the discoverer of prions, Nobel prize win-
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ner Stanley Prusiner By chance, its publication coincided almost exactly with the first appearance in
the United States of "mad cow disease."
Textbooks for undergraduates are a recent addition to the publishing program. Both titles published
in 2003 had strong Cold Spring Harbor connections. The second edition of DNA Science, by David
Mick los and Greg Freyer, combines laboratory protocols developed at the Dolan DNA Learning Center
with a lively narrative about current molecular biology and its applications in medicine and industry. A
unique educational contribution, it has been extensively adopted in foundation courses in high schools
and junior colleges in the United States and abroad.
James Watson's classic textbook Molecular Biology of the Gene was first published in 1965 and for
25 years was the book of choice for advanced undergraduate teaching in genetics. The fourth edition
was published in 1987, and two years ago, we undertook to publish a completely revised edition in
2003, recruiting as authors Richard Losick from Harvard University, Tania Baker and Stephen Bell from
Massachusetts Institute of Technology, Alex Gann from Cold Spring Harbor Laboratory, and Michael
Levine from University of California, Berkeley. Our partner in this venture was the book's original pub-
lisher, Benjamin Cummings, a textbook-specialist division of Pearson Plc. with national and interna-
tional marketing strengths. The time specified for this giant task was short, but the authors, with a large
support team from Cold Spring Harbor, Benjamin, and other companies, sacrificed family and profes-
sional commitments in order to achieve the goal and the book was published to acclaim in December
2003. Advance sales were brisk, and we anticipate that the new and handsome edition will restore the
book to a central place in the teaching curriculum.
In a year in which many scientific conferences, cultural events, and news reports around the world
were devoted to the 50th anniversary of Watson and Crick's proposal for the structure of DNA, a book
was assembled in some secrecy to honor Jim Watson, for whom 2003 was also a 35th year of distin-
guished Laboratory leadership. With more than 40 essays by people who have worked with him in all
kinds of contexts, Inspiring Science: Jim Watson and the Age of DNA, edited by myself, Joe Sambrook,
and Jan Witkowski, succeeded handily in presenting a multidimensional sketch of Dr. Watson and his
diverse and extraordinary achievements. The first copy of the book was presented to Jim at a dinner held
during a meeting at Cold Spring Harbor to which many of the Laboratory's scientist-alumni returned.
Another notable, if more conventionally structured, biographical portrait was created by Paul Berg
and Maxine Singer in An Uncommon Farmer, the life of George Beadle, the Nobel prize winning corn
geneticist who created a powerhouse department at Caltech and became President of the University
of Chicago. Their book was widely reviewed and it was gratifying to see equally warm reviews by sci-
entists close to the subject matter and professional historians of science-two groups who do not
always share the same opinion of what they read.
Our general interest books included The Molecular Gaze: Art in the Genetic Age, a strikingly illus-
trated survey of artists' responses to the exhilaration and anxieties provoked by gene technologies. It
was written by Suzanne Anker, a professor of art history at New York's School of Visual Arts, and the
distinguished sociologist of science, Dorothy Nelkin. Sadly, Dot died in June after a short illness and
did not see the published book, but she was highly involved in its creation.
The power of a book about science that truly engages the public was vividly illustrated by Ann Arbor's
community reading program featuring our 2000 book Abraham Lincoln's DNA and Other Adventures in
Genetics. For three months, the book and its contents were the focus of discussion groups, university
lectures, high school projects, and public appearances by author Philip Reilly, with the result that at times
in local stores, it competed successfully in sales with the adventures of Harry Potter.
During the year as a whole, a larger number of Cold Spring Harbor books-79,000 copies-were
sold than ever before. This achievement results in part from strengthened relationships with major book
wholesalers, high street bookshops, book clubs, and on-line stores such as Amazon.com. Our cus-
tomer service and warehouse staff rose to the challenge, assisted by improvements in technology such
as electronic data interchange that allows automated order processing for corporate customers.
These sales channels widen our audience but exact a price in the form of larger discounts, smaller
margins, and, in some cases, unpredictable numbers of returned copies, factors that contributed to
missed income projections from U.S. sales. The expansion of international sales that began several
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free of charge. As a not-for-profit publisher, we support the principle of open access to an extent that
maintains our journals' growth as high-quality publications. New journals have been launched on the
business model and so far require support by foundation funds or private wealth.
The development of centralized, free databases of published papers is important in making research
results available to both working scientists and the public. Papers published in Cold Spring Harbor jour-
nals more than one year previously are already freely accessible at the journals' Web sites, and these
papers also appear on the PubMedCentral database at the National Library of Medicine. For Genome
Research, the availability of these archive papers was reduced to six months and other journals will fol-
low suit if subscriptions are not threatened. Agreements were made with two international initiatives,
HINARI and AGORA, to make the Cold Spring Harbor journals freely available on-line to scientists in
low- and lower-middle-income countries. In addition, an agent was engaged in China, with the respon-
sibility for providing reduced-price subscriptions to institutions there.
For the Cold Spring Harbor Laboratory Press, in summary, 2003 was a year of financial challenges
but significant accomplishments in our mission of bringing important and reliable scientific information
to a broad audience of scientists, students, and the public worldwide.
Staff
The staff members of the Press (as of December 2003) are listed elsewhere in this volume. They
deserve much credit for the care and commitment they bring to their duties and it is a pleasure to work
with them.
In 2003, we welcomed six new colleagues: Colleen Becker, Laureen Connell, Maria Falasca, Keith
Kalinoski, Mary Mulligan, Corrisa Salzman, and Rena Steuer. We also said goodbye to Elizabeth
Fitzpatrick, Candice Foresta, Keith Kalinoski, Michele McDonough, Maureen Megonigal, and Nora Rice.
At a special luncheon in September, we honored Dorothy Brown as she retired from the Laboratory
staff after 22 years of dedicated and cheerful service. During this time, Dotty edited scores of Cold
Spring Harbor books and for many years has had the major share of responsibility for preparing the
contents of the Laboratory's Annual Reports for publication. As a plaque in St Paul's Cathedral says of
its architect: "If you seek a memorial, look around you."
Alexander Gann, who joined the Press as Senior Editor in 1999, assumed the new role of Editorial
Director, with responsibility for managing the acquisition of new books. He joined a group of senior staff
whose talent and dedication are essential elements in continued growth and innovation at the Press:
Jan Argentine, Editorial Development Manager; Ingrid Benirschke, Marketing Manager; Kathy Cirone,
Circulation Manager; Kathryn Fitzpatrick, Marketing Manager; Nancy Hodson, Operations Manager;
Geraldine Jaitin, Customer Service Manager; Bill Keen, Finance Director; Guy Keyes, Sales Manager;
Marcie Siconolfi, Advertising Manager; Linda Sussman, Journal Production Manager; Denise Weiss,
Book Production Manager; and the editors of our journals, Terri Grodzicker at Genes & Development
and Laurie Goodman at Genome Research. And it is a pleasure as always to thank my Executive
Assistant, Elizabeth Powers, for her continued grace in juggling tasks and responsibilities in our office.
In a year that was unsatisfactory from a financial perspective, much pleasure could be taken from the
fact that a large proportion of our new titles were reviewed in prominent science journals, and in very flat-
tering terms. Since there are few sources of science book reviews these days, and their space is limit-
ed, this outcome demonstrates the special regard scientists have for our publications. We are fortunate
to have expert scientists as authors and editors who care strongly about what they do. We also have a
group of talented, sympathetic but demanding in-house editors at the Press-Kaaren Janssen, Judy
Cuddihy, and Michael Zierler-who relentlessly strive to make our books the best they can be.
John R. Inglis
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years ago took a significant step forward with the signing of an agreement with a new Oxford, U.K. -
based private company-Scion Publishing. Trading as Cold Spring Harbor Laboratory Press Europe,
this group will have responsibility for all European sales and marketing of Cold Spring Harbor books
and the fulfillment of orders through the warehouse already established in Oxford. With this initiative and
the addition of sales representation in several additional European and Middle and Far East countries,
our books have never been more available worldwide. There is also increasing demand to translate our
books from publishers abroad, particularly in China, Taiwan, and Japan, owing to our increased inter-
national visibility at events such as the Frankfurt Book Fair and the efforts of our International Rights
Manager, Anu Hanson.
In South Africa, one book has received particular attention. During 2002, 19,000 copies of the short,
colorful Staying Alive: Fighting HIV/AIDS, by our celebrated children's book authors Fran Balkwill and
Mic Rolph, were given free to young people, teachers, and community workers in three of the coun-
try's provinces. In activities coordinated in 2003 by Linzi Rabinovitz, a colleague based in Cape Town,
many of the book's recipients read it, discussed it, used it in classrooms, and told us how to make it
even more useful. The impetus for this book, first proposed to us by Siamon Gordon of Oxford
University, is the belief that people who truly understand the nature and behavior of the AIDS virus will
also realize they have the power to act to protect themselves. Thanks to the advice of the many South
Africans who helped us with the book, we are now more confident that its lively drawings and uncom-
plicated text do convey that knowledge. With the support of a generous grant from the Bill and Melinda
Gates Foundation, received in March, we will be able to distribute a much larger number of copies of
an extensively revised edition of the book, translated into four more of the 11 official languages of South
Africa, and create other materials to assist teachers in improving the HIV/AIDS curriculum.
We continue to use a variety of ways to promote our books nationally and internationally. A hand-
some catalog and two issues of our eye-catching newsletter were selectively mailed, and many thou-
sands of scientists elected to receive e-mail alerts about new titles. Our exhibit stand was busy at all
the major American scientific society meetings, as well as, this year, at the conference of the National
Science Teachers Association, the International Genetics Congress in Melbourne, Australia, and the
Congress of the newly formed Human Proteomics Organization. Bookstore signings were arranged for
some authors, and signings at our exhibit stand were popular among conference attendees, especial-
ly Jim Watson's signing at the American Society for Cell Biology, where he was kept busy for more than
90 minutes by a long line of eager autograph seekers.
Journals
Journal publishing, which began 16 years ago with one title, is now a core competence of the Press.
In 2003, the journal program grew to a total of five publications with the addition of RNA, the journal of
The RNA Society. In the first year with Cold Spring Harbor, this eight-year-old journal benefited from
significant additions to its subscription base and advertising revenue.
The journal program as whole was financially affected by the bankruptcy early in the year of a large
subscription agent and the loss of more than 100 institutional subscriptions. In other respects, institu-
tional subscriptions held steady and there was a substantial increase in the number of multisubscrip-
tion licenses bought by companies and library consortia. Genes & Development and Genome
Research achieved impact factors of 18.77 and 9.86, respectively, that placed them among the hand-
ful of most important journals in their fields.
These journals also received unprecedently large numbers of manuscript submissions, and since
Protein Science and Learning & Memory also expanded in size, the journal staff produced over 30% more
pages than in the previous year. They were assisted by technological improvements in handling digital art-
work and the flow of materials for both print and on-line publication. Advertising sales in the journals
improved by 12% on the previous year, assisted by the new classified advertising program Career Tracks.
During the year, we paid close attention to the momentum of the concept of "open access" in jour-
nal publishing. The phrase refers both to a principle-that scientific information should be freely avail-
able to all after publication-and to a business model, in which authors pay to publish and readers read
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HISTORY OF THE COLD SPRING HARBOR LABORATORY
ENDOWMENT
G. Morgan Browne served as the Administrative Director and, later, as
Chief Financial Officer of Cold Spring Harbor Laboratory for more than 19
years. Upon his retirement in 2003, he compiled the following history of the
Cold Spring Harbor Laboratory Endowment, a fund he was largely respon-
sible for growing and maintaining.
In the early months of 2004, the Laboratory's endowment, consisting primarily of the Robertson and
Cold Spring Harbor Funds, is valued at more than $225 million, and this year, it will provide nearly $7
million of financial support for the Lab's research and education programs. It is an extraordinary
resource for a relatively small-sized institution. The endowment is a major source of long-term stability
for the senior staff. It funds critical scientific equipment and building projects and is key to attracting
promising young scientists and students from all over the world to Cold Spring Harbor. The endow-
ment also makes it possible to opportunistically pursue unexpected and promising new ideas and pro-
grams when other sources of funding are not available. It also allows the Lab's senior leadership to
sleep nights while placing major bets on breakthrough science.
But it was not always so at Cold Spring Harbor and the history of the endowment is an interesting
story. Some 30 years ago in 1963, John Cairns came here from Australia to be the first Director of the
Cold Spring Harbor Laboratory of Quantitative Biology (now the present CSHL) which had been newly
formed to consolidate and run the operations of the laboratories previously operated at Cold Spring
Harbor by the Carnegie Institution of Washington and the Long Island Biological Association (LIBA). In
his first Director's Report, Cairns listed some "conspicuous deficiencies of the new Institution-name-
ly, a deficit budget, a dilapidated plant, inadequate operating cash and a complete absence of any
endowment." Although various directors at Cold Spring Harbor had been vainly seeking endowment
for more than 70 years, Cairns urged that it now be given the highest priority. Several years later he
was to say, "It would be fitting to be able to state that some start had been made in the quest for
endowment. There is, however, no such news to report nor, even the prospect of it."
By 1968, the finances of the Lab had improved only marginally, primarily due to profitable sales of
the annual volume of Symposium proceedings. James Watson was the new Director and, like Cairns,
faced daunting financial problems. "There remains the fact," he wrote in his first Director's Report, "that
the Lab badly needs a real benefactor, but with much love it will probably survive without one. Of
course, I dream an angel will appear soon and make me free of any serious worries for at least a
month." It would take another four years before there was any such help. For Jim, the good news
arrived during the summer of 1972 when he and his wife Liz were in California. Edward Pulling, then
Vice Chairman of the Laboratory telephoned to say that Charles Robertson, a long time resident of
Lloyd Harbor, was interested in making a substantial donation. Would Jim meet with him and tell him
of his future plans for the Lab?
Mr. Robertson had married Marie Hoffman in 1936. She was a member of the Hartford family that
had founded the Great Atlantic and Pacific Tea Company. Charles and Marie, who died in the summer
of 1972, did not believe in spreading their philanthropy around to a large number of worthy institutions.
Instead, they concentrated their resources, "striving for excellence and hoping to win the big prize..."
Charles Robertson had previously made a gift of $35 million to his alma mater, Princeton University,
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which was subsequently used to endow the Woodrow Wilson School of Public and International Affairs.
He wrote later that Cold Spring Harbor Laboratory was "right at our front door and had been a vital part
of our community for over eighty years," and that it was a logical and appropriate choice.
Mr. Robertson's proposed gift was the $8 million Robertson Research Fund, to be used for the pur-
pose of basic research. He described the Fund as the result of the many gifts made by Marie during
her lifetime to the Robertson Family's Banbury Fund, which would now be the source of funding for the
Research Fund. Jim Watson wrote that, "the creation of this Fund ranks as one of the most important
events in our Lab's history."
The Robertson Research Fund Inc.
At the end of 1972, Mr. Robertson established a tax-exempt 501 (c) (3) corporation, The Robertson
Research Fund Inc., which was "at all times thereafter to be operated, exclusively for the benefit of ...
and to carry out the purposes of the Cold Spring Harbor Laboratory." There were to be nine directors,
five representing the Laboratory and four representing members or agents of the Robertson family.
Mr. Robertson would later donate his Lloyd Harbor Estate to the Lab as a conference center (now our
Banbury Center). He also established the Robertson Maintenance Fund, an additional $1.5 million
endowment, to cover the costs of maintaining the buildings and grounds of the property in perpetuity.
Mr. Robertson had been a long-time admirer of Walter H. Page II, who was then President of J.P.
Morgan & Co. and had been Chairman and a member of the Long Island Biological Association, until
the pressure of Bank business took him to London. Now at the urging of Mr. Robertson, who greatly
admired his financial acumen, Mr. Page agreed to again join the Lab's Board of Trustees, serving later
as its Chairman from 1980 to 1986.
The Robertson Research and Maintenance Funds
Discussions with lawyers and the Internal Revenue Service took more than two years, and it was not
until June of 1975 that the Board of Trustees was able to pass a resolution formally accepting the
Robertson Funds as the Lab's first endowment. In the meantime, Mr. Robertson's gift had been invest-
ed, and $751,000 of income was distributed during the 1973-1975 period in support of the Lab. The
first investment advisor for the Fund was the New York City firm of John W. Bristol & Co. An investment
proposal from Bruce D. Bent, a Vice President of Bristol & Co., proposed a 50/50 ratio of debt to equi-
ty, yielding interest income of 8% from the debt portion in AAA-rated obligations and dividend income
of 7% from a variety of blue chip stocks. How times have changed! Many of these equities were mem-
bers of the then so-called "nifty fifty"-companies that supposedly could be counted on to grow by
10-20% every year and raise their dividends ad infinitum. Some of them lost as much as 90% of their
value during 1974. From a market value at the end of 1973 of $8.3 million, the Robertson gift plum-
meted to $6.3 million by the end of 1974.
Investment Management Advice
It could have been much worse, but Charles Robertson had never been a fan of the "nifty fifty" con-
cept and a 50% fixed-income allocation saved the portfolio from more severe damage. As 1975 ended,
it had recovered to $7.3 million. The Investment Committee for the Robertson Funds, then consisting
of Mr. Robertson, James Watson, Angus McIntyre, Clarence Galston, Townsend Knight, and William R.
Udry, initiated a search for alternative investment management. No less than 11 firms were interviewed,
and thanks in particular to the hard work of Bud Galston and Angus McIntyre, the Committee chose
the Bala Cynwyd, Pennsylvania firm of Miller Anderson & Sherrerd. Mr. Robertson marked the occa-
sion with a note to each of the Committee members saying in part, "Only the future will tell whether you
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have chosen wisely and well with Miller Anderson and Sherrerd, but I'll certainly doff my Bona lino to
you for having tried and hard. My deep appreciation to each one of you for your dedication to duty."
Miller Anderson & Sherrerd
In January of 1976, A. Morris Williams, then a 35-year-old account executive at Miller Anderson,
assumed responsibility for the Robertson Funds account. Morris was hardly a newcomer to the invest-
ment business. After earning both a B.A. and M.A. at Duke University, he attended the Stanford
Investment Management Program and the Harvard University Investment Management Workshop. It
was the start of a fortuitous relationship for the Lab with Miller Anderson. From the close of 1975 to
1996, when the firm was acquired by Morgan Stanley Dean Witter, the Research Fund appreciated
from $7.3 million to $62.1 million and the Maintenance Fund appreciated from $1.5 million to $10 mil-
lion. The only additions to the Funds were reinvested income and $643,000 of remaining proceeds
from a Trust that Mr. Robertson had established on behalf of his second wife, Jane Cain Robertson.
This Trust reverted to the Research Fund upon her death in Florida in 1993. The $63.3 million increase
in the total value of the Funds was after distributions to the Laboratory totaling just over $20 million. Of
these 20 years, only 4 years showed a decline in the value of the Funds, and if calculated before the
annual distributions of income, there was only one such year, 1977, and that by just 1.2%. When Morris
Williams retired from Miller Anderson in 1991, he made a gift on that occasion to the Laboratory of
$100,000 in support of our then new neuroscience program.
Credit for the 21-year good market performance of the Robertson Funds should properly be shared,
and not least with the mostly strong equity markets of the period. The Robertson Funds Investment
Committee, later replaced by the Laboratory's Finance and Investment Committee, also had an impor-
tant role. The members met regularly with Morris Williams for luncheon three or four times a year, ini-
tially at the Princeton Club and later at the Sky Club at the Pan Am Building (now Met Life). Attendance
at these luncheons was nearly always excellent, perhaps also prompted by the members' personal
interest in the ready availability of good investment advice.
The Committee established basic policy, namely, that the Funds were to be managed conservatively
both for income and for sufficient growth to keep pace with inflation. There was to be a maximum 65%
and a minimum of 40% equity allocation, with the balance to be in fixed income. Miller Anderson was
responsible for changes in asset allocation, which were generally reviewed by the Committee with a
minimum of second-guessing. Investments were to include a balanced mix of large- and small-cap
equities with a growth bias and high-quality domestic-only fixed-income securities. Morris Williams and
the Miller Anderson investment analysts made the selections of individual stocks and bonds, with at
times lively advice from Committee members. At one memorable meeting, Jim Watson objected vocif-
erously to an intended investment in McDonalds Corporation, stating that he had recently lunched at
Burger King and it was much better than McDonalds. McDonalds became part of the portfolio anyway,
and not too long afterward, Jim stopped coming to the meetings.
David L. Luke III, who as Treasurer of the Laboratory from 1986 became Chairman of the
Committee, opposed investments in foreign equities on the grounds that large American companies
had more than sufficient foreign exposure from their own overseas business activities. A small invest-
ment in an international fund recommended by Miller Anderson was quickly liquidated after a few
months of down performance. Despite its excellent growth record, Westvaco Corporation, of which Mr.
Luke was then Chairman, never appeared in the portfolio-much to the wonderment of some
Committee members. When Morris was complimented on the performance of the portfolio, he never
tired of letting the Committee know how much additional appreciation would have resulted had he been
permitted to buy Philip Morris shares. The Committee felt strongly that it would be inappropriate for an
Institution aiming to cure cancer to be investing in tobacco companies.
The Lab's very conservative drawdown policy was certainly a very major factor in the growth of the
Funds. At a time when most colleges and universities were drawing 5% or 6% annually from their
endowments, the Lab disciplined itself to draw just 4%, based on a three-year moving average of year-
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end market values. Since the three-year moving average in a generally up market was almost always
lower than the most recent year, this policy resulted in an even lower drawdown than 4%, more often
in the area of 3.5%. All dividends, interest income and capital gains, net of expenses, and distributions
were reinvested in the Funds.
The Second Century Capital Campaign and the Cold Spring Harbor Fund
In 1986, the year after I joined the Laboratory as Administrative Director, the Robertson Funds contin-
ued to be the primary internal source of funding for Lab science, but they were no longer to be the sole
endowment. That year, the Lab's first major capital fund-raising campaign, the Second Century Fund,
was launched under the leadership of David Luke. The initial goal for the private phase of the campaign
was $30 million. In April of 1989, with $28 million pledged or in hand from Trustees, private founda-
tions, and a few corporations, the goal was raised to $44 million and the public phase began. The
campaign included a mix of money for capital construction, primarily the Beckman Neuroscience
Center, and both restricted and unrestricted endowment for faculty chairs, fellowships, and programs.
At its conclusion in 1992, the Second Century Fund campaign had raised a grand total of $51 million.
As the new monies flowed in during 1986 and 1987, the Lab's Board of Trustees established the
Cold Spring Harbor Fund, which was to hold the new, and one previously received, endowment-type
donations. The new Cold Spring Harbor Fund and the Robertson Funds would thereafter constitute the
Lab's overall endowment. They would be managed jointly and be subject to the same general policies
concerning investment management and annual distributions.
The Doubleday Professorship of Cancer Research
The Laboratory's first endowed faculty Chair-the Doubleday Professorship of Cancer Research-was
the initial component of the Cold Spring Harbor Fund. It resulted from a gift actually received in 1984
of 500 shares of Doubleday & Co. from the Russell and Janet Doubleday Fund, then thought to be
worth a few hundred thousand dollars. To the amazement of all concerned, following the sale of
Doubleday & Co. to the publishing giant, Bertelsmann, Inc., the Lab received $2.1 million for the shares
in 1987 and used $1.5 million of this amount to establish the Chair. The Lab's Board of Trustees had
determined that named endowed chairs should be funded at this level. Mike Wig ler has been the
Doubleday Professor from the inception of the Chair. The remainder was used to purchase a house,
now known as Doubleday, that abutted Lab property.
The Grace Director's Chair
The Oliver and Lorraine Grace Director's Chair followed soon after the same year. The Grace Chair was
established by a $1.5 million series of gifts from the Helen Coley Nauts & Oliver R. Grace Endowed
Chairs at the Cancer Research Institute and from Oliver R. Grace personally. Mr. Grace was Chairman
of the Cancer Research Institute at the time. Dr. Watson was the first recipient of the Chair and has
held it ever since. Currently, the Doubleday and Grace Chairs are each valued at more than $4 million.
The 20th Century Undesignated Fund
During the first year of the Cold Spring Harbor Fund, the 20th Century Undesignated Fund was estab-
lished as one of its components. This Fund was made up of a remarkable number of unrestricted indi-
vidual donations from Laboratory and LIBA Trustees and from employees and friends, which from 1987
to 1998, amounted to $4.9 million in total, with the great majority received in the earlier years. These
unrestricted gifts have been particularly valuable to the Lab over the years in enabling the Trustees to
opportunistically purchase properties adjoining the Lab, which have become available from time to
time. One house on Ridge Road had been seized by a federal marshal from an incarcerated drug deal-
er and was being sold at auction. This was to be the site of Ballybung, Jim Watson's residence, who
donated the monies to the Laboratory for its construction. The neighboring Chernick House, now
Olmsted House, where Scott Lowe, Associate Director of our Cancer Center, and his family now live,
was purchased by the Fund. It also helped acquire the Kelman House (now the Townsend Knight
House), which is home for the first-year graduate students of the Watson School, as well as the
Galehouse adjacent to Airs lie. The Undesignated Fund was also used to help scientists purchase local
homes and for various investment management and development expenses. Just recently, the donor
of a new endowed Chair conditioned the grant on the Lab's participation in the amount of $250,000.
Once again these unrestricted moneys were called on for an important opportunity. Thanks to market
appreciation and reinvested income, the Fund today stands at more than $3.5 million without counting
the present value of the real estate purchased by the Lab.
The Cold Spring Harbor Fund continued to grow rapidly with new additions during 1988 and 1989.
The Charles Robertson Neuroscience Chair was created with an initial gift of $300,000 from the
Banbury Fund under the sponsorship of its Trustees-the Ernsts, Meiers, and Robertsons. Charles
Robertson was the father of Katherine Ernst, Anne Meier, and Bill Robertson. A series of annual addi-
tional gifts and market appreciation soon brought the funding to beyond the $1.5 million target. Another
addition was the Posy White Memorial Fund, established by Elinor Montgomery in memory of her
mother, Posy White, who had served on the LIBA and Laboratory Boards for some 25 years. Elinor was
a Trustee of the Lab from 1988 until her death in 1992. The Senior Staff Research Fellowships were
created in 1990 by the Gladys and Roland Harriman Foundation with a two-for-one challenge grant
that was soon satisfied by individual donations.
In 1992, the W.M. Keck Chair was funded by a $1.5 million grant from the W.M. Keck Foundation
for the support of research in the Keck Structural Biology Laboratory, which was established in con-
junction with a previous grant for construction of the Beckman Neuroscience Center. Also that year, the
Harrison Chair for the Study of Molecular Neuroscience was established from the estate of Maxine
Harrison in memory of her mother, Ally Davis Harrison. Ms. Harrison served as a foreign news corre-
spondent during World War II for an English language newspaper in the Philippines. She lived the final
years of her life as a resident at the Piping Rock Club in Locust Valley and was a frequent visitor to the
Lab's Carnegie Library where she enjoyed reading and researching newspaper and other archives.
In 1993, the William J. Matheson Professorship was created based on a $500,000 challenge grant
from the Fort Hill Foundation. The Lab raised the additional $1,000,000 needed for full $1.5 million
funding from the Mary C. Turner Charitable Trust, other outside donations, and internal funds, as well
as from market appreciation. This was the Lab's sixth fully endowed faculty chair. The Matheson
Professorship was intended as a tribute to the memory of William J. Matheson, who was an important
member of the local community and in 1905 was President of the Bio-Lab's Board of Managers. The
Bio-Lab was one of the predecessors of the present Cold Spring Harbor Laboratory. The Chair is cur-
rently held by Bruce Stillman.
Tax-exempt Financing and the 20th Century New Endowment Fund
Another important early component of the Cold Spring Harbor Fund was the 20th Century New
Endowment Fund, which was made possible by the availability to the Lab of tax-exempt financing for
capital construction. In the mid-1980s, the Lab's need for a modernized plant, facilities, and infra-
structure had become increasingly urgent. With much trepidation at the time, it was decided to take
advantage of the availability of very low-cost debt financing through the sale of daily-rated tax-exempt
bonds authorized by the Nassau and Suffolk County Industrial Development Agencies, backed by a let-
ter of credit from the Morgan Guaranty Trust Company. The interest rate has been remarkably low,
about 3% over the life of the bonds, about 1% recently. The primary purchasers have been New York
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State tax-exempt money market funds. The initial issuance in 1984 of $8 million of Civic Facility
Revenue Bonds helped speed additions to James and Demerec laboratories, the construction of Grace
Auditorium, modernization of Blackford Hall, and sorely needed additional parking areas. In 1988, an
additional $20 million issuance of similar bonds provided us with great flexibility in managing the cash
flow and timing of a then very large construction program. More recently in 1998, a third issuance of
$42 million refinanced $27 million of the previous debt and provided $15.2 million toward construction
of the Woodbury Cancer Genome Research Center. Today, there are $45.2 million of bonds outstand-
ing-$3 million maturing in 2023 and $42.2 million in 2034. A rating of Al + was obtained from
Standard & Poor's, made possible in part by the Lab's then nine consecutive years of operating sur-
pluses and positive cash flow. This enabled the bonds to be backed by a liquidity facility from Morgan
Guaranty Bank at half the cost of the previous letter of credit.
Early in the Second Century Fund campaign, it became clear that some donors preferred having
their gifts used to endow research projects, rather than directly finance new buildings. By funding con-
struction costs with tax-exempt bonds, the Lab could add such gifts to the Cold Spring Harbor Fund
as endowment, and so the 20th Century New Endowment Fund was born. The Fund was segregated
according to the interests of the donors as to cancer, neuroscience, education, and infrastructure. The
Board of Trustees has felt strongly about maintaining the integrity of the Lab's finances and directed
that these funds be managed very conservatively so as to provide the greatest possible flexibility. The
Fund is therefore invested in very short-term high-quality fixed-income securities supervised by the U.S.
Trust Company. The Fund has increased to approximately $32 million after reimbursing the Lab for
bond interest and associated expenses and provides strong support for our balance sheet. The
Howard Hughes Medical Institute, in arranging financing for their new Janelia Farm Research Campus,
due to open in Washington D.C. in 2006, used the Laboratory's most recent tax-exempt financing as
a model, and Morgan Guaranty Bank has become by far the largest underwriter of tax-exempt financ-
ing for 501(c)(3) institutions such as Cold Spring Harbor Laboratory.
The Science Fund and the Quest Fund
Two other specialized funds that are components of the Cold Spring Harbor Fund are worthy of special
mention. The basic research and teaching at Cold Spring Harbor Laboratory helped make possible the
birth of the biotechnology industry, and since the early 1990s, venture capitalists and others interested
in starting biotech companies were much interested in the intellectual property developed and owned
by the Lab. The intellectual property could be licensed to the new start-up companies in return for equi-
ty and the promise of future royalties. So it was that our Board of Trustees in 1992 established the
Science Fund and designated it as solely for the future support of science. All equity and royalties
received from the Lab's technology transfer activities have been accumulated in this Fund. In this man-
ner, all financial gains from Laboratory research financed by federal and other grants are recycled back
into future science. In the early years, the various equity holdings were carried at nominal valuations, and
the Fund grew slowly to $490,000 at the end of 1996. Thereafter, many of the equities became publicly
traded. John Phelan, Chairman of the Lab's Commercial Relations Committee, led a subcommittee that
authorized the sale of some portions of the Lab's holdings, with the proceeds henceforth to be managed
by our investment managers. Included in the Lab holdings today are positions in public companies such
as Exelexis (Genomica), Geron, Icos, Pharmacopeia, Tularik, and the European company GPC Biotech
(Mitotix), as well as approximately six still-private companies. By year-end 1997, 1998, 1999, and 2000,
the Science Fund was valued at approximately $4.8, $6.8, $15.9, and $30.2 million, respectively. The
comparable values at the end of the 2001 and 2002 bear market years were much reduced at $26.7
and $18 million, respectively. The Fund has now recovered to near $25 million-$7 million of this amount
representing public and nominally valued private biotech holdings and $17 million representing proceeds
of past sales and royalty income-all of which is now invested in conventional investments managed by
the Lab's investment managers.
The Science Fund was also established with the hope that it might one day replace some portion of
a large royalty income, which the Lab had been receiving since 1991 from the Axel-Wigler patent issued
to Columbia University. This patent was the basis for manufacturing many early genetically engineered
biotech drugs and was to expire June 30 of 1999. Some additional income continued to be received
through 2001, and over the life of the patent, the Lab received a total of $24,614,000. Although the
Science Fund cannot fully replace such a sum, it has already far exceeded our expectations.
The second specialized fund-the Quest Fund-was established by the Lab's Executive Committee
in December 1999 and designated for the support of both science and education programs at the Lab.
This Fund consisted of equity ownership in SciQuest Corporation-a start-up "B to B" commerce
Internet company specializing in scientific supplies and equipment-that the Lab received from the sale
of the Cold Spring Harbor Laboratory Press "Source Book" (catalog) and BioSupplyNet (on-line ver-
sion) to SciQuest in 1998. In 1999, SciQuest had a successful IPO, and by March 31 of that year, our
shares were valued at $4.7 million. All of the Lab's shares were restricted from sale for 6 months under
the terms of the underwriting agreement. Only when SciQuest freed 10% of all holdings in an attempt
to slow the then meteoric rise of the stock was the Lab able to sell $1.6 million of shares. When the
balance of the shares were freed from restriction, the price had declined from about $90 to $10 and
later to less than $2. It is entertaining to dream of "what might have been"-at one point, the Lab's
restricted position was worth nearly $25 million. Last year all the remaining shares were sold back to
SciQuest in return for the rights to the Source Book and BioSupply Net, which it is believed may have
a brighter future in the regular business of the Press. The Quest Fund currently has a value of about $2
million, representing the now conventionally managed proceeds of the early sales.
The Science and Quest Funds have allowed the Lab to participate in venture-capital-type biotech
and Internet holdings on a meaningful and very profitable basis without investing a penny. Recently, in
2001, the Investment Committee authorized investment of up to $1 million in a new venture capital fund
of funds organized by senior members of the finance and investment department at Massachusetts
Institute of Technology. To date, only about a third of the money has been invested, and it is too early
on the J-shaped curve typical of such investments to judge the outcome.
More Additions to the Cold Spring Harbor Fund
The Cold Spring Harbor Fund continued to grow with substantial new additions throughout the 1990s.
The Undergraduate Research Program (URP) Fund is a grouping of fellowships established by good
friends of the Lab such as the Libby, Olney, and Darrell families, and $100,000 donations each from the
Estate of Joan Read and from the Garfield Foundation of Princeton, New Jersey. Noted diva Frederica
Von Stade established a named Internship with the proceeds of two marvelous concerts at the Lab, the
first entitled "Mozart to Gershwin" in 1990 at the Lab's Centennial celebration, and a second in 1995 that
was a wonderful blend of ethnic folk, bluesy jazz, and ragtime. Likewise in 1996, the renowned concert
pianist Emanuel Ax performed brilliantly in Grace Auditorium, and the proceeds were used for an Ax
Fellowship. The URP Fund endowment was completed by a $1 million grant from the Burroughs
Welcome Company later the same year, thanks to the good relations established there by Jill Clark, then
a very talented member of our Development Department. The URP Fund now totals over $3 million.
The Marjorie Matheson Neuroscience Fund
The 1995-1996 period was highlighted by extraordinary gifts from the Marjorie A. and William L.
Matheson Charitable Trust, which funded the $3 million Marjorie Matheson Neuroscience Fund. The
Mathesons were extremely generous and made the gift at the perfect time. The Lab's neuroscience
program was just then gaining momentum, and the Matheson's vote of confidence helped enormous-
ly. Today, the Lab neuroscience program is among the best in the world. The Marjorie Matheson
Neuroscience Fund is now valued at more than $6 million.
During this period, Jim Watson established the Gavin Borden Fund to honor and remember his
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good friend and publisher of The Molecular Biology of the Cell. Each year, it funds a lecture and dinner
at the Lab featuring a prominent visiting scientist. The Nat Sternberg Thesis Prize Fund was established
to honor the life and accomplishments of Nat Sternberg, a scientist who worked for many years at the
DuPont Merck Pharmaceutical Company on many aspects of phage biology. This endowment was
funded by DuPont and more than 100 individuals, families, foundations, and companies. Each year, it
funds a cash award to a student with the year's outstanding Ph.D. thesis in the field of prokaryotic mol-
ecular genetics at the annual Molecular Genetics of Bacteria and Phages Meeting held every other year
at Cold Spring Harbor.
The Watson School Fund
In November of 1998, a long-standing initiative came to fruition when the New York State Board of
Regents accredited Cold Spring Harbor Laboratory as a Ph.D.-granting institution. Early the next year,
our new graduate school, the Watson School of Biological Sciences, was born. In addition to an inno-
vative curriculum, the new school would have two distinctive feature: Ph.D. candidates would be
expected to graduate in four years and each would be fully endowed. To accomplish the latter, the
Board determined that a $32 million endowment would be needed. It was to include a $5 million
Founders Endowment, individual $1 million named fellowships, a Dean's Chair, endowed core courses
of study, lectureships for Watson School and visiting faculty, and other special-purpose funds.
In November of 1998, David Luke retired from his 12-year tenure as Chairman of the Board and was
named an Honorary Trustee. William R. Miller was chosen as his successor. When David Luke then
agreed to chair the campaign for the Graduate School, all of us knew it would be a great success. The
private phase of the campaign was conducted in the closing months of 1998 and early 1999. As one
would expect with any endeavor led by David Luke, the effort was intense and progress was rapid and
gratifying. In this short time, nearly $12 million was pledged or in hand.
The Founders Endowment, the Dean's Chair, and Six Fellowships
In July, Marjorie Matheson made another magnificent gift, this time funding the Founders Endowment
in honor of her parents George A. and Marjorie H. Anderson. This Endowment would cover many of
the School's start-up expenses and also provide for five named fellowships. Through the efforts of Leon
and Cynthia Polsky, the Dean's Chair was established with gifts of $1,175,000 from the Lita Annenberg
Hazen Charitable Trust and of $500,000 from the Annenberg Foundation. Named student fellowships
were established by past and present Lab Trustees: Bill Miller, David Luke, David Koch, Martha Gerry
(through the William Stamps Farish Fund), Leslie Quick, and Bob Lindsay. Alan Goldberg, a close friend
of Bob Lindsay, also pledged a Fellowship.
David Luke was honored at a dinner on April 23, 1999 at the Piping Rock Club in Locust Valley in
appreciation of his years of service, and the occasion also served as a launching platform for the pub-
lic phase of the campaign. Vartan Gregorian, President of the Carnegie Corporation of New York and
past President of Brown University, was the keynote speaker.
During the public phase, Mr. And Mrs. Leslie C. Quick, Jr. established the Fund for Innovative
Graduate Education. Kurt Engelhorn, who had come to know the Lab well through years of attendance
at annual Banbury Center corporate conferences, established five fellowships for European students to
be known as Engelhorn Scholars through the European Foundation for the Advancement of Medicine.
The Arnold 0. and Mabel M. Beckman Foundation provided $1 million for student and core course
support. Bill Miller and David Deming devoted much effort to approaching the pharmaceutical industry
for endowment. Bristol-Myers Squibb Company, of which Bill Miller had been Vice Chairman, respond-
ed favorably with a $1 million named fellowship and Pfizer funded a named lectureship. Otherwise, it
was a hard sell due to then poor economic conditions and policies within many companies prohibiting
donations for endowments.
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Named fellowships were provided by the Charles Dana Foundation, the Florence Gould Foundation,
and the Hearst Foundation. The Estate of Elisabeth (Betty) Sloan Livingston, a very good friend of the
Lab and an enthusiast of the new Graduate School, provided two $1 million named fellowships. Four
Faculty and Visiting Lectureships were funded by Edward and Martha Gerry. The Rathman Family
Foundation donated a $300,000 Lectureship. Others were donated by the Klingenstein Foundation
and by John and Rita Cleary, George and Lucy Cutting, Mary Lindsay, Henry Harris, and the Ziering
Family. Norris Darrell funded the Core Course in Exposition and Ethics. There were additional generous
gifts from Lazard Frere & Co., the Koshland Foundation, Mike Wig ler, Karen and Mark Zoller, and many
others. In the final year of the campaign, the $1 million Watson Fund for Innovative Education was
assembled with the help of a $350,000 challenge grant from the Gladys and Roland Harriman
Foundation and $100,000 from a fund in honor of David Pall (past Lab Trustee and founder of the Pall
Corporation), as well as from countless other generous gifts.
The Watson School Gala: Emanuel Ax, Midori, and Yo-Yo Ma
Although not strictly for endowment, the Watson School Gala held in Grace Auditorium on October 5,
1999 must be mentioned for its role in creating a tone of unmistakable quality and excitement that per-
meated the entire fund-raising effort for the Watson School. This memorable event, masterfully chaired
by Trustee Lola Grace, was made possible through the efforts of Trustee Mark Ptashne who persuad-
ed three of the world's foremost classical musicians-pianist Emanuel Ax, violinist Midori, and cellist
Yo-Yo Ma-to perform a joint program of Mendelsohn. More than $750,000 was raised that evening
and subsequently used toward the renovation of the Knight House, first-year residence for the students
of the Watson School.
The Robertson and Cold Spring Harbor Funds Add Investment Managers
Although the Robertson Funds had continued to perform well after Morris William's retirement in 1991,
the Finance and Investment Committee by 1996 was not pleased that the account was now being
invested on a commingled basis with other accounts at Miller Anderson, rather than in individually
selected securities as in the past. Moreover, the Robertson Funds had grown substantially, and with
the addition of the new moneys of the Cold Spring Harbor Fund, the Investment and Finance
Committee decided that it would be prudent to have more than a single investment manager. Under
the leadership of John Reese, then Lab Treasurer and Chairman of the Committee, a search was insti-
tuted to select two or more additional managers with an emphasis on large- and small-cap growth
stocks. Miller Anderson would be retained for their deep-value equity product and also as fixed-income
manager. With regard to the latter, we were most fortunate in having the individual attention of the very
capable Ellen Harvey, a relative of David Luke, as our fixed-income manager. Not only did Ellen deliver
first-rate investment performance, but she was also capable of making understandable and interesting
presentations to the Committee on the intricacies of derivatives, swaps, and other new fixed-income
products then coming into vogue.
Vanguard PRIMECAP and Essex Investment Management
The New Jersey investment management consulting firm of Hamilton & Co. was engaged following
interviews with many of the other important names in the field. Hamilton was to conduct the search
and make recommendations from among the highest-rated managers in their universe of managers.
Hamilton was also to provide monthly performance reports comparing managers with their peers and
keep the Committee current on any important style or personnel changes among the managers. An
interview process extending over several months ended with the selection of the San-Francisco-based
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PRIMECAP Fund of the Vanguard Group and Boston-based Essex Investment Management. Only then
was it discovered that PRIMECAP had just recently closed its doors to new investors as a result of
recent very rapid growth in the size of the Fund driven by its outstanding performance, which the prin-
cipals feared would hinder future results. Fortunately, the Robertson Family's Banbury Fund had been
a long-time investor in PRIMECAP, and Bill Robertson was able to intercede and persuade PRIMECAP
to be receptive to accepting funds from the Lab. PRIMECAP's success was built on selecting high-
quality medium- to large-cap growth companies and staying with them long term or until there was a
major change in outlook or management strategy. Essex Investment Management had become suc-
cessful by identifying new high-tech companies with exceptional promise. Joe Mc Nay, a senior Essex
partner, agreed to personally manage the Lab's accounts. His biannual presentations of new technol-
ogy business models were invariably the highlight of Finance and Investment Committee meetings. Joe
not only was very good at stock selection, but made effective use of taking only small initial positions
and adding to them if they performed well, and quickly liquidating them while they were small if they
performed poorly.
With new investment managers in place, the Robertson and Cold Spring Harbor Funds participat-
ed happily in the four-year Alan-Greenspan-dubbed "irrational exuberance" bull market which was to
finally culminate in 1999. That year, Essex returned 111%, exceeding 99% of all comparable invest-
ment managers. PRIMECAP returned an impressive 42%. Only the performance of the Miller Anderson
value fund was disappointing. The firm seemed to have lost much of its identity and many of its top
people in the merger with Morgan Stanley Dean Witter. On the advice of Hamilton & Co., the
Committee chose to replace Miller Anderson with the highly regarded Diversified Value Portfolio man-
aged by Dave Williams at the U.S. Trust Company. Although only having the Lab's money for less than
six months, Dave was able to comfortably outperform the Standard and Poor's 500 Index for the year.
In the early months of 2000, the value of the Lab's overall endowment reached an all time high of near-
ly $240 million. The Robertson Funds were valued at $110 million and the Cold Spring Harbor Fund at
$130 million. There was to follow a brutal almost three-year bear market. From March 10, 2000 and
September 14, 2000, respectively, the NASDAQ and Standard & Poor's 500 Indexes declined by 78%
and 49% until the market reached bottom on October 9, 2002.
As in 1973, the Lab's portfolio was saved from severe damage by a 50% fixed-income allocation
through much of the period. Nevertheless, the endowment suffered its first ever consecutive years of
decline. Essex stumbled badly in not liquidating in time the portfolio's volatile high-tech positions.
PRIMECAP held to its positions in high-quality growth companies, and many of these in the telecom-
munications, semiconductor, and airline industries were ravaged by economic conditions and world
events. At the bottom of the bear market in October of 2002, the Lab's overall endowment had
declined to approximately $181 million.
The bear market experience has provided a good lesson in the importance of having in place an
asset allocation policy that forces the reduction of equity when bull markets drive values above target-
ed levels and forces purchases when bear markets have the opposite effect. It is unrealistic to expect
Investment Committees to effectively do asset allocation when meeting only several times a year or
more frequently by telephone. Too late we also recognized that the Lab's equity managers may have
been too highly correlated for adequate diversification. An asset allocation and investment strategy
review is under way. Significantly, the Investment Committee has recently contracted for investment
management consultative services from Merrill Lynch and authorized an initial investment in a very
promising high-quality new "fund of funds" hedge fund-Blue Orchid Capital.
A Solid Future
This story of the Lab's endowment ends with the very good news that its value is again near an all time
high. Dill Ayres, now Chief Operating Officer, notes that the Investment Committee, chaired by Lab
Treasurer Lola Grace, had the courage in March of 2003 to recommit to equities and increased that
asset allocation to 60%. Our investment managers all handsomely outperformed the Standard and
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Poor's 500 Index, allowing our equity portfolio to appreciate by 39% for the calendar year as compared
with 28% for the Standard and Poor's. The fixed-income portfolio now managed by Pimco Investment
Management also did well, increasing 5%, somewhat ahead of the benchmarks.
In addition, after a gap of several years, there was an important addition. The Lab's seventh
endowed professorship, the St. Giles Chair of Neuroscience Research, was established and will be fully
funded over the next several years.
In the years ahead, the need for endowment can only continue to grow, and probably at an accel-
erating pace. Our ambitious program of new science buildings, a campus for the Watson School, and
requisite infrastructure all carry with them an ongoing burden of overhead in addition to their construc-
tion cost. Overhead associated with science buildings and their infrastructure can be at least partially
defrayed by indirect cost recoveries on government grants. But this is not the case with the Watson
School for which a new funding source must be found.
During the past year, there has been much talk at meetings with a number of investment consul-
tants about reduced expectations for market returns over the next decade, and the likelihood that even
a 4% drawdown from endowment may be too high if principal is to be fully preserved on an inflation-
adjusted basis. The recent rally in the equity markets has reduced some of the gloom, but this is a sub-
ject to take very seriously.
I fear the end result must be still more work for the Laboratory's Board of Trustees in ensuring that
the past remarkable pace of new additions to the Cold Spring Harbor Laboratory Endowment contin-
ues, and for the Administration in making sure that the Endowment continues to be managed careful-
ly and well. Only then will it be certain that this invaluable resource continues to fully serve the needs
of this great Institution.
G. Morgan Browne
March, 2004
FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2003
With comparative financial information for the year ended December 31, 2002
Assets: 2003 2002
Cash and cash equivalents $ 28,971,185 15,998,950
Accounts receivable:
Publications 1,257,221 1,507,910
Other 1,332,279 621,788
Grants receivable 7,068,387 5,155,499
Contributions receivable, net 11,452,991 4,485,178
Publications inventory 2,206,640 2,214,499
Prepaid expenses and other assets 1,566,991 1,630,366
Investments 198,696,165 174,146,179
Investment in employee residences 4,774,834 4,347,627
Restricted use assets 2,240,000 2,240,000
Land, buildings, and equipment, net 109,253,408 108,416,078
Total assets $ 368,820,101 320,764,074
Liabilities and net assets:
Liabilities:
Accounts payable and accrued expenses $ 5,505,705 4,347,089
Notes payable 140,958 170,119
Bonds payable 45,200,000 45,200,000
Deferred revenue 4,067,960 3,648,453
Total liabilities 54,914,623 53,365,661
Net assets:
Unrestricted 178,415,767 154,939,682
Temporarily restricted 14,223,309 10,132,940
Permanently restricted 121,266,402 102,325,791
Total net assets 313,905,478 267,398,413
Total liabilities and net assets $ 368,820,101 320,764,074
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2003
With comparative totals for the year ended December 31, 2002
Unrestricted
Temporarily
Restricted
Permanently
Restricted
2003
Total
2002
Total
Revenue and other support:
Public support (contributions and
nongovernment grant awards) $ 13,391,893 14,223,309 4,822,932 32,438,134 25,057,008
Government grant awards 24,231,989 24,231,989 22,680,109
Indirect cost allowances 18,000,004 18,000,004 15,073,780
Program fees 3,134,443 3,134,443 2,910,787
Publications sales 10,052,963 - 10,052,963 9,050,738
Dining services 2,927,668 - - 2,927,668 2,850,201
Rooms and apartments 2,347,090 - 2,347,090 2,222,483
Royalty and licensing fees 869,826 869,826 1,173,659
Investment income (interest and
dividends) 4,141,495 - 4,141,495 5,515,942
Miscellaneous 616,755 616,755 583,033
Total revenue 79,714,126 14,223,309 4,822,932 98,760,367 87,117,740
Net assets released from restrictions 10,132,940 (10,132,940) -
Total revenue and other support 89,847,066 4,090,369 4,822,932 98,760,367 87,117,740
Expenses:
Research 45,619,807 - 45,619,807 42,240,020
Educational programs 12,917,185 - 12,917,185 12,105,086
Publications 10,631,334 - 10,631,334 9,345,581
Banbury Center conferences 1,136,159 1,136,159 1,141,308
Dolan DNA Learning Center programs 1,809,174 - 1,809,174 2,368,850
Watson School of Biological Sciences
programs 2,029,275 2,029,275 1,648,168
General and administrative 11,976,718 11,976,718 10,562,264
Dining services 4,262,515 - 4,262,515 4,146,716
Total expenses 90,382,167 - 90,382,167 83,557,993
(Deficiency) excess of revenue and
other support over expenses (535,101) 4,090,369 4,822,932 8,378,200 3,559,747
Other changes in net assets:
Net appreciation (depreciation) in fair
value of investments
24,011,186 14,117,679 38,128,865 (27,887,903)
Increase (decrease) in net assets 23,476,085 4,090,369 18,940,611 46,507,065 (24,328,156)
Net assets at beginning of year 154,939,682 10,132,940 102,325,791 267,398,413 291,726,569
Net assets at end of year $ 178,415,767 14,223,309 121,266,402 313,905,478 267,398,413
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CONSOLIDATED STATEMENTS OF CASH FLOWS
Year ended December 31, 2003
With comparative financial information for the year ended December 31, 2002
2003 2002
Cash flows from operating activities:
Increase (decrease) in net assets $ 46,507,065 (24,328,156)
Adjustments to reconcile increase (decrease) in net assets
to net cash (used for) provided by operating activities:
Depreciation and amortization 5,458,719 5,165,482
Net (appreciation) depreciation in fair value of investments (37,868,190) 27,594,426
Contributions restricted for long-term investment (13,460,462) (5,020,793)
Restricted use asset (840,000)
Changes in assets and liabilities:
(Increase) decrease in accounts receivable (459,802) 1,337,585
(Increase) decrease in grants receivable (1,912,888) 39,125
(Increase) decrease in contributions receivable (875,375) 1,754,273
Decrease (increase) in publications inventory 7,859 (187,369)
Decrease in prepaid expenses and other assets 63,375 806,071
Increase (decrease) in accounts payable and accrued expenses 1,158,616 (1,581,205)
Increase in deferred revenue 419,507 1,033,081
Net cash (used for) provided by operating activities (961,576) 5,772,520
Cash flows from investing activities:
Capital expenditures (6,296,049) (5,476,620)
Proceeds from sales and maturities of investments 135,393,757 185,039,464
Purchases of investments (122,075,553) (200,832,292)
Net change in investment in employee residences (427,207) 148,147
Net cash provided by (used for) investing activities 6,594,948 (21,121,301)
Cash flows from financing activities:
Permanently restricted contributions 4,822,932 3,605,790
Contributions restricted for investment in land, buildings,
and equipment 8,637,530 1,415,003
(Increase) decrease in contributions receivable (6,092,438) 441,643
Repayment of notes payable (29,161) (32,035)
Net cash provided by financing activities 7,338,863 5,430,401
Net increase (decrease) in cash and cash equivalents 12,972,235 (9,918,380)
Cash and cash equivalents at beginning of year 15,998,950 25,917,330
Cash and cash equivalents at end of year $28,971,185 15,998,950
Supplemental disclosures:
Interest paid $ 1,014,956 1,132,279
Noncash investing and financing activities:
Contributed property 840,000
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COMPARATIVE OPERATING HISTORY 1999-2003
(Dollars in Thousands)
1999 2000 2001 2002 2003
Revenue:
Main Lab:
Grants and contracts $ 27,179 30,345 34,716 37,872 41,749
Indirect cost allowances 11,207 12,718 14,134 14,987 17,869
Other 9,426 10,618 12,528 10,918 10,524
CSHL Press 6,400 8,684 9,941 9,051 10,053
Banbury Center 1,848 1,856 1,666 1,763 1,729
Dolan DNA Learning Center 1,392 1,471 1,878 2,978 2,564
Watson School of Biological Sciences 218 682 927 1,496 1,769
Total revenue 57,670 66,374 75,790 79,065 86,257
Expenses:
Main Lab:
Research and training 27,179 30,345 34,716 37,872 41,749
Operation and maintenance of plant 5,765 6,589 7,027 8,661 8,702
General and administrative 3,844 6,162 6,492 6,395 7,507
Other 7,863 7,075 9,505 8,550 8,959
CSHL Press 6,077 8,186 9,515 8,962 10,234
Banbury Center 1,614 1,702 1,536 1,597 1,616
Dolan DNA Learning Center 1,280 1,362 1,801 2,780 2,257
Watson School of Biological Sciences 218 682 927 1,496 1,769
Total expenses, excluding depreciation
and amortization 53,840 62,103 71,519 76,313 82,793
Excess before depreciation, amortization,
and designation of funds 3,830 4,271 4,271 2,752 3,464
Depreciation and amortization (3,526) (3,974) (4,620) (5,165) (5,459)
(Designation) release of funds' (297) 349 1,848
Net operating excess (deficit) $ 304 (565) (1,995)
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
'Funds designated to underwrite future direct and indirect expenses of new research programs.
Auxiliary Activities
18.7%
COLD SPRING HARBOR LABORATORY
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DECEMBER 31, 2003
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a sub-
stantial portion of their funding through grants from the Federal Government and through grants, cap-
ital gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 2003.
GRANTS January 1, 2003-December 31, 2003
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2003 Funding*
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Equipment Dr. Stillman 09/01/03 08/31/04 491,782
Program Projects Dr. Herr 01/01/77 12/31/06 4,895,303
Dr. Stillman 08/01/87 07/31/05 3,742,281
Research Support Dr. Cline 12/06/95 11/30/04 493,903
Dr. Cline 03/01/98 03/31/06 530,316
Dr. Enikolopov 08/01/99 05/31/04 434,547
Dr. Enikolopov 09/12/94 11/30/04 409,907
Dr. Enikolopov 03/11/02 12/31/03 207,500
Dr. Grewal 03/01/00 08/31/03 64,821
Dr. Hannon 09/01/00 08/31/05 307,600
Dr. Hannon 03/01/01 02/28/03 166,000
Dr. Hellman 09/01/99 06/30/04 409,631
Dr. Hernandez 07/01/99 06/30/04 220,427
Dr. Herr 03/01/02 02/28/06 298,800
Dr. Hirano 07/01/01 06/30/05 296,348
Dr. Hirano 05/01/96 04/30/04 417,585
Dr. Huang 08/01/01 06/30/06 415,000
Dr. Joshua-Tor 05/01/01 03/31/06 373,500
Dr. Joshua-Tor 02/15/02 01/31/07 378,080
Dr. Joshua-Tor 08/01/96 11/30/04 245,473
Dr. Krainer 07/01/03 06/30/07 517,746
Dr. Krainer 06/01/01 05/31/06 408,400
Dr. Lazebnik 09/01/03 08/31/05 207,500
Dr. Lowe 07/01/99 06/30/04 344,863
Drs. Mainen/Brody 09/23/02 08/31/07 381,005
Dr. Malinow 05/01/92 04/30/05 560,109
Dr. Malinow 04/01/03 02/29/08 535,157
Dr. Martienssen 08/01/03 07/31/07 337,166
Drs. McCombie/Wigler/Zhang 01/01/99 12/31/03 471,428
Dr. Muthuswamy 03/01/03 02/28/07 374,171
Dr. Neuwald 09/30/98 08/31/06 373,500
Dr. Skowronski 04/01/03 03/31/03 622,495
Dr. Spector 04/01/03 03/31/07 605,785
Dr. Stein 09/01/02 06/30/05 778,415
Dr. Stein 09/24/02 09/25/03 130,253
Dr. Stillman 07/01/91 05/31/04 552,156
*New grants awarded in 2003.
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*
Dr. Svoboda 12/01/98 11/30/03 338,325
Dr. Svoboda 12/01/02 11/30/07 385,034
Dr. Svoboda 06/01/03 03/31/08 315,351 *
Dr. Tansey 05/01/03 04/30/07 328,250 *
Dr. Tonks 08/01/91 03/31/06 627,701
Dr. Tonks 05/01/97 06/30/05 348,600
Dr. Tully 03/01/03 02/29/08 420,416 *
Dr. Tully 08/01/03 05/31/07 379,125 *
Drs. Tully/Zhang 09/28/00 06/30/03 283,149
Dr. Van Aelst 05/01/03 04/30/08 337,088 *
Dr. Wig ler 05/01/03 04/30/07 485,815 *
Dr. Wig ler 09/30/02 07/31/04 166,000
Dr. Wig ler 05/01/99 07/31/03 996,358
Dr. Xu 01/01/03 08/31/03 44,379 *
Dr. Xu 08/01/01 07/31/05 317,320
Dr. Xu 08/01/03 03/31/07 258,759 *
Dr. Yin 09/30/02 07/31/04 166,000
Dr. Yin 04/08/03 03/31/08 420,625 *
Dr. Zador 01/23/03 12/31/07 420,000 *
Dr. Zhang 08/01/00 07/31/04 403,616
Dr. Zhang 09/30/97 08/31/03 768,529 *
Dr. Zhong 02/01/96 05/31/04 292,073
Dr. Zhong 07/01/03 06/30/08 345,000 ''
Fellowships E. Govek 05/01/01 04/30/03 24,766
Dr. Kuhlman 12/01/02 11/30/05 46,420
Dr. Lucito 06/01/02 05/31/07 146,534
Dr. Ronemus 12/01/01 11/30/04 51,904
Dr. Song 09/16/03 09/15/06 41,608 *
Training Support Dr. Krainer 09/01/84 12/31/03 344,135
Course Support X-ray Methods in Structural Biology 09/01/00 08/31/05 55,902
Neurobiology Short-term Training Courses 07/01/01 06/30/06 160,528
Cell and Developmental Biology of 04/01/93 03/31/04 19,484
Xenopus
Cancer Center Research Workshops 01/01/83 03/31/05 386,275
Acquiring and Analyzing Genomic 04/01/95 03/31/04 93,069
Sequence Data
Immunocytochemistry, In Situ Hybridization 07/01/98 08/31/05 83,128
C. elegans 08/01/98 07/31/06 73,382
Bioinformatics: Writing Software for 07/01/00 06/30/05 75,156
Genome Research
Making and Using DNA Microarrays 09/30/99 06/30/04 55,551
Computational Genomics 06/06/91 08/31/07 46,567
Cellular Biology of Addiction 05/15/03 05/14/04 44,000
Microarrays 09/30/99 06/30/04 55,551
Proteomics 07/01/03 06/30/06 65,150
Meeting Support Neurobiology of Drosophila 08/01/01 07/31/06 28,352
Protein Phosphorylation and Cell Signaling 04/01/01 03/31/06 7,839
68th Symposium: The Genome of Homo
sapiens
05/15/01 04/30/06 5,000
68th Symposium: The Genome of Homo
sapiens
06/20/03 05/31/04 41,715 *
The Ubiquitin Family 04/01/01 03/31/06 9,000
Eukaryotic DNA Replication 08/01/01 07/31/06 10,000
Mechanism of Eukaryotic Transcription 08/03/01 07/31/06 8,000
Programmed Cell Death 08/01/01 07/31/06 12,000
Telomeres and Telomerase 03/15/03 02/29/04 22,050 *
*New grants awarded in 2003.
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Learning and Memory
Genome Informatics
Eukaryotic mRNA Processing
Rat Genomics and Models
04/05/03
04/01/03
08/01/03
09/30/03
03/31/08
03/31/04
07/31/08
09/29/04
5,850 *
20,850 *
9,000 *
19,990
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Cline 09/01/99 08/31/04 117,137
Dr. Helfman 02/01/99 01/31/04 118,662
Dr. Jackson 08/01/02 07/31/05 116,659
Drs. Martienssen/McCombie/Stein/Lucito 09/01/01 08/31/05 645,365
Dr. McCombie 09/01/03 08/31/06 1,958,794 *
Dr. Stein 09/01/02 08/31/04 360,148
Dr. Stein 09/01/03 08/31/06 541,381 *
Dr. Stein 12/15/03 11/30/07 676,203 *
Dr. Stein 01/15/03 12/31/03 88,010 *
Dr. Timmermans 07/01/02 06/30/05 119,967
Dr. Timmermans 09/01/03 08/31/06 116,121 *
Dr. Ware 09/01/03 08/31/08 339,522 *
Dr. Zhang 09/15/03 08/31/08 195,000 *
Training Support Undergraduate Research Program 01/01/03 12/31/03 50,000
Dr. Sumazhim 09/01/03 08/31/05 50,000 *
Dr. Vaughn 07/01/03 06/30/05 50,000 *
Course Support Advanced Bacterial Genetics 05/01/99 04/30/04 90,494
Arabidopsis Molecular Genetics 07/15/03 06/30/04 69,895 *
Cell and Developmental
Biology of Xenopus 09/01/02 08/31/06 22,159
Meeting Support Genomics of Transcription Regulation 03/15/03 02/28/05 15,000 *
04/01/03 03/31/04 11,206 *
Telomeres and Telomerase 04/15/03 03/31/04 2,500 *
Mechanisms of Eukaryotic
Transcription 07/01/03 06/30/04 5,000 '
Eukaryotic mRNA Processing 07/01/03 06/30/04 5,000 *
Eukaryotic DNA Replication 09/01/03 08/31/04 5,000 *
Neurobiology of Drosophila 09/15/03 08/31/04 15,987 *
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 09/01/01 08/31/03 98,250
Dr. Jackson 09/01/03 08/31/06 73,210 *
Drs. Martienssen/McCombie 09/01/01 09/30/03 250,000
Dr. Martienssen 12/01/00 11/30/03 85,000
Dr. Martienssen 08/01/03 07/31/05 93,598 *
Dr. Stein 09/01/00 08/31/04 838,016
Dr. Stein 09/15/00 09/14/04 783,785
Dr. Stein 10/01/02 09/30/04 220,000
Dr. Stein 09/22/03 09/21/05 290,000 *
Dr. Timmermans 09/01/01 08/31/03 65,960
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Conklin 09/30/02 09/29/03 121,554 *
Dr. Hamaguchi 04/15/00 05/15/04 61,165
Dr. Hannon 06/01/00 07/01/04 121,554
Dr. Hannon 04/01/02 03/31/06 721,742
Dr. Hannon 06/01/00 05/31/04 71,134
*New grants awarded in 2003.
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Drs. Hannon/Lowe
Dr. Lazebnik
Dr. Van Aelst
Dr. Zhong
09/01/02 08/31/05
06/01/01 05/31/04
09/01/01 08/31/03
04/01/02 03/31/04
166,598
203,699
182,662
166,000
Fellowship Support M. Carmell 05/01/02 04/30/05 22,000
Dr. Du 06/01/02 05/31/05 50,000
Dr. Kannanganattu 01/01/01 12/31/04 49,796
E. Kim 04/01/03 03/31/06 28,500
A. Lucs 04/01/03 03/31/06 29,162
M. Moore 08/16/03 08/15/06 29,162
Z. Nahle 07/01/02 06/30/05 22,000
Dr. Narita 07/01/01 06/30/04 51,601
P. Paddison 07/01/03 06/30/06 28,528
Y. Seger 07/01/01 06/30/04 22,000
K. Siddiqui 04/01/03 03/31/06 29,162
Dr. Silva 11/01/01 10/31/03 49,000
Dr. Xiang 06/01/03 05/31/06 55,372
MISCELLANEOUS GRANTS
Research Support
American Cancer Society Dr. Wig ler 01/01/96 12/31/03 10,000
American Cancer Society Dr. Wig ler 01/01/01 12/31/05 70,000
AKC Canine Health Foundation Dr. McCombie 04/01/03 03/31/05 33,085
ALS Association Dr. Enikolopov 04/01/03 03/31/04 50,000
Anonymous Dr. Malinow 12/01/03 11/30/04 150,000
Breast Cancer Research Foundation Dr. Wig ler 10/01/03 09/30/04 250,000
Gladys Brooks Foundation Library Support 01/01/03 12/31/03 83,393
The Charles A. Dana Foundation, Inc. Dr. Cline 10/01/03 03/31/05 65,994
Dr. Van Aelst 04/01/03 08/31/04 66,227
The Dart Foundation Dr. Tully 05/01/03 04/30/06 2,233,333
DARPA/NYU Consortium Agreement Drs. Wigler/Mittal 09/18/01 09/17/03 226,127
Find a Cure Today (FACT) Dr. Muthuswamy 07/01/03 06/30/04 22,400
Fraxa Research Foundation Dr. Yin 08/01/03 02/29/04 25,000
Irving Hansen Foundation Dr. Tansey 08/01/02 07/31/04 20,000
Jo-Ellen and Ira Hazan Dr. Enikolopov 12/01/03 11/30/04 200,000
Helicon Dr. Tully 07/01/02 06/30/03 168,000
Human Frontier of Science Program Dr. Mitra 6/15/03 06/14/05 96,473
Organization (HFSPO) Dr. Spector 05/01/03 04/30/06 112,500
lmmuno-RX Dr. Mittal 08/01/02 07/31/04 57,869
Juventis Dr. Enikolopov 01/01/03 05/13/04 210,000
L.I.A.B.C. (Long Islanders Against Dr. Wig ler 01/01/03 12/31/03 127,437.33
Breast Cancer)
The Leukemia & Lymphoma Society Dr. Lowe 10/01/03 09/30/08 1,000,000
Long Beach Breast Cancer Coalition Dr. Muthuswamy 09/01/03 08/31/04 1,000
The Lustgarten Foundation Dr. Lucito 01/01/03 12/31/03 250,000
The Michael Scott Barish Human Cancer Dr. Wig ler 01/01/03 12/31/03 16,002
Grant sponsored by 1 in 9: The Long
Island Breast Cancer Action Coalition
The G. Harold & Leila Y. Mathers Dr. Zador 07/01/03 06/30/06 163,144 *
Charitable Foundation
The March of Dimes Dr. Mills 06/01/03 05/31/06 68,686 *
McFarland Breast Cancer Dr. Wig ler 10/01/03 09/30/04 22,080 *
Merck & Co., Inc Dr. Hannon 04/16/03 04/15/05 1,500,000 *
Met Life Foundation Dr. Malinow 11/01/03 10/31/04 200,000 "
McKnight Endowment Dr. Svoboda 08/01/02 07/31/04 100,000
Miracle Foundation Dr. Wig ler 07/16/03 07/15/04 100,000 *
Louis Morin Charitable Trust Drs. Joshua-Tor/Dubnau 01/01/00 11/30/03 120,000
*New grants awarded in 2003.
451
NAAR Dr. Hatchwell 07/01/03 06/30/04 60,000 *
NIH/Baylor College of Medicine Dr. Mills 09/01/01 08/31/06 214,356
Consortium Agreement NIH/CalTech Dr. Stein 07/01/03 06/30/08 548,831 *
Consortium Agreement Dr. Stein 07/01/02 06/30/04 283,548
Dr. Stein 07/01/02 06/30/04 186,841
Dr. Svoboda 04/04/03 02/29/08 149,661 *
NIH/Columbia University Consortium Dr. Lowe 09/30/00 07/31/05 502,210
Agreement
NIH/Memorial Sloan-Kettering Dr. Van Aelst 07/10/03 06/30/08 317,965 *
Consortium Agreement
NIH/Northwestern University Dr. Zhang 09/10/03 06/30/06 134,058 *
Consortium Agreement
NIH/SUNY-Downstate Medical School Dr. Yin 09/01/01 06/30/06 90,000
Consortium Agreement
NIH/Stony Brook University Dr. Jackson 09/01/02 08/31/04 229,100
Consortium Agreement
NIH/University of Virginia Consortium Dr. Stein 08/01/02 07/31/05 228,615
Agreement
NIH/University of California-San Diego Dr. Zhang 09/01/01 08/31/04 130,315
Consortium Agreement
NIH/Washington University Consortium Dr. Stein 03/01/99 10/31/03 45,348
Agreement
NIH/Washington University Consortium Dr. Stein 09/30/99 10/31/03 17,058
Agreement
NIH/Washington University Consortium Dr. Stein 11/01/03 10/31/06 38,109 "
Agreement
Mr. and Mrs. Edmond J. Nouri Dr. Tully 01/01/03 12/31/03 40,193 *
NSF/DOE/USDA/University of Arizona Drs. McCombie/Martienssen/Stein 09/15/02 09/14/03 380,407
Consortium Agreement
NSF/University of Arizona Consortium Dr. Stein 10/01/03 09/30/07 200,456 *
Agreement
NSF/University of California-Berkeley Drs. Jackson/Martienssen 10/01/01 09/30/06 275,785
Consortium Agreement
NSF/North Carolina State University Dr. Martienssen 09/15/03 08/31/04 20,000 *
Consortium Agreement
NSF/University of Georgia Consortium Dr. Timmermans 09/01/03 08/31/07 152,578 *
Agreement
NSF/Rutgers University Consortium Drs. Spector/Martienssen/ 10/01/00 09/30/05 418,392
Agreement McCombie
NSF/Stony Brook University Dr. Jackson 09/01/02 08/31/04 229,099
Consortium Agreement
NSF/University of Wisconsin Dr. Martienssen 09/01/00 08/31/05 245,808
Consortium Agreement
New York State Funds Library Support 07/01/02 06/30/03 4,409
NYSTAR/Mt. Sinai School of Medicine Dr. Svoboda 10/01/02 06/30/04 175,000
Consortium Agreement
NY Botanic Garden Plant Consortium Dr. McCombie 03/01/02 12/31/03 9,335
OSI Pharmaceuticals Dr. Hannon 10/21/03 10/20/05 450,000
Manyu Oga le Dr. Wig ler 07/01/03 06/30/04 250,000
The David & Lucille Packard Foundation Drs. Chklovskii/Mainen/Zador 07/01/01 06/30/04 366,581
The Perkin Fund Women's Partnership for Science 06/01/02 05/31/04 37,500
Pfizer, Inc. Dr. Hannon 12/01/03 11/30/05 312,000
Rockefeller University Agreement Dr. Mills 09/01/03 08/31/04 77,930
SAIC-NCI Dr. Hannon 10/21/02 04/20/04 1,000,000
The SNP Consortium, Ltd. Dr. Stein 02/24/03 02/23/05 389,981
Seraph Foundation Dr. Enikolopov 10/01/03 09/30/04 48,000
Dr. Lazebnik 10/01/03 09/30/04 35,000
The Simons Foundation Dr. Wig ler 11/01/03 10/31/05 1,200,000
St. Giles Foundation Dr. Hatchwell 03/01/03 02/29/04 150,000
Sungene Plant Consortium Dr. Martienssen 07/01/00 06/30/05 135,000
*New grants awarded in 2003.
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Tularik, Inc. Dr. Wig ler 11/01/97 10/31/03 660,000
Tularik, Inc. Dr. Wig ler 01/01/02 12/31/03 500,000
USDA/University of Arizona Dr. McCombie 09/15/03 09/14/04 223,758 *
Consortium Agreement
The V Foundation Dr. Muthuswamy 05/01/02 04/30/04 50,000
Whitehall Foundation, Inc. Dr. Huang 08/16/01 08/15/04 75,000
Zeneca Plant Consortium Dr. Martienssen 07/20/99 07/19/04 135,000
Fellowships
AACH Amgen Fellowship Dr. Wendel 07/01/02 06/30/03 30,000
Alzheimer's Association Dr. Boehm 10/01/03 09/30/05 50,000 *
Dr. ljima 10/01/03 09/30/05 50,000 *
Burghart Turner Fellowship M. Juarez 06/01/03 08/31/03 3,000 *
Burroughs Wellcome Dr. Yasuda 01/01/03 12/31/07 80,000 *
Dr. Zito 09/01/02 07/31/04 58,000
CAP Cure Prostate Cancer Dr. Lucito 01/01/02 12/31/03 100,000
CSHL Association Funds Labwide Support 04/01/03 03/31/04 257,132 *
Cure Autism Now Dr. Takahashi 06/01/02 05/31/04 49,201
Damon Runyon Cancer Research Dr. Zuo 04/01/03 03/31/06 41,000 *
Foundation
Demerec/Kaufmann/Hollaender Dr. Timmermans 01/01/03 12/31/03 13,310 *
Fellowship
Epilepsy Foundation Dr. Haas 07/01/02 06/30/03 40,000
Fraxa Research Foundation Dr. Bestman 09/01/03 08/31/04 35,000 *
Goldring Fellowship Dr. Stillman 09/01/00 08/31/04 60,000 *
Helen Hay Whitney Foundation Dr. Hemann 09/01/03 08/31/06 42,500 *
Dr. Karpova 07/01/02 06/30/03 44,500
Dr. Sheu 04/01/01 03/31/04 45,000
Dr. Zito 07/01/00 06/30/03 45,000
Howard Hughes Medical Institute Graduate Student Support 09/01/94 08/31/04 27,060 *
Human Frontier Science Program Dr. Ango 04/01/02 03/31/05 42,000
Organization (HFSPO) Dr. Became! 04/01/03 03/31/06 42,000 *
Dr. Cuvier 06/20/01 05/31/03 41,000
Dr. lijima 04/26/02 04/25/05 42,000
Jane Coffin Childs Dr. Gillespie 07/01/02 06/30/03 42,500
Johns Hopkins/ Ellison Foundation Dr. Kass-Eisler 01/01/02 03/31/03 126,359
Consortium Agreement
Laurie Strauss Dr. Hemann 04/01/03 03/31/04 15,000 "
Leukemia Research Foundation Dr. Dickins 06/01/03 05/31/05 30,000 *
The Leukemia & Lymphoma Society Dr. Buckley 11/01/03 10/31/06 40,000 *
Dr. Duelli 12/31/00 12/30/03 35,000
Dr. Losada 07/01/01 06/30/04 50,000
Dr. Noma 07/01/02 06/30/03 17,750
Dr. Scott 07/01/03 06/30/06 50,000 *
Dr. Speck 07/01/01 06/30/04 40,000
Dr. Tansey 07/01/01 06/30/06 100,000
Maxfield Foundation Dr. Lazebnik 12/01/00 11/30/04 5,000 *
NARSAD Dr. Barria-Roman 07/01/02 06/30/04 30,000
Dr. Haas 07/01/02 06/30/04 39,110
Dr. Piccini 07/01/03 06/30/05 30,000 *
NYSTAR Dr. Henry 01/01/03 12/31/04 71,747 *
Pew Charitable Trust Dr. Huang 07/01/02 06/30/06 60,053
Rita Allen Foundation Dr. Hannon 10/01/00 09/30/03 50,000
Searle Scholars Program Dr. Mainen 07/01/01 06/30/04 80,000
Seligson Special Fellow Award Dr. Scott 03/17/03 03/16/04 75,000 *
Women's Partnership for Science Dr. Timmermans 01/01/03 12/31/03 14,921 *
Wellcome Trust Dr. Akerman 10/01/01 09/30/03 29,513
Wellcome Trust Dr. Newey 10/01/01 09/30/03 26,306
*New grants awarded in 2003.
Course Support
Eppley Foundation Magnetoencephalography Workshop 07/01/03 06/30/04 33,650 *
Howard Hughes Medical Institute Neurobiology Courses 01/01/03 12/31/09 330,000 *
Esther A. & Joseph Klingenstein Neurobiology Courses 03/01/02 02/28/05 50,000
Fund, Inc.
Meeting Support
Abbott Laboratories Microbial Pathogenesis Conference 2003 500
Abgent Programmed Cell Death 2003 2,000
Amersham Biosciences Corp. Structural Biology Discussion Group 2003 1,000
Biogen Double Helix Conference 2003 25,000
Boston Biochem, Inc. Ubiquitin and Ubiquitin-like 2003 1,500
Molecules
Bruker AXA Inc. Structural Biology Discussion Group 2003 1,000
Burroughs Wellcome Microbial Pathogenesis Conference 2003 5,000
Cell Genesys, Inc. Vector Targeting Strategies for 2003 1,500
Therapeutic Gene Delivery
Cell Signaling Technology, Inc. Protein Phosphorylation and Cell Signaling 2003 2,000
Programmed Cell Death 2003 1,000
Directgene, Inc. Therapeutic Gene Delivery 2003 1,500
Discovery Partners International, Inc. Structural Biology Discussion Group 2003 500
Genzyme Therapeutic Gene Delivery 2003 1,500
Hampton Research Corp Structural Biology Discussion Group 2003 1,000
!dun Pharmaceuticals, Inc. Programmed Cell Death 2003 1,000
Institute for Biological Recognition
and Catalysis, Inc.
Structural Biology Discussion Group 2003 1,500
Lexigen Pharmaceuticals Corp Therapeutic Gene Delivery 2003 1,500
Lynn Caporale 68th Symposium: The Genome of Homo
sapiens 2003 2,000
MSC Molecular Structure Corp Structural Biology Discussion Group 2003 750
NSF/NYU Consortium Agreement Genomics of Transcriptional Regulation 2003 16,889
Onyx Pharmaceuticals Vector Targeting Strategies for
Therapeutic Gene Delivery 2003 1,500 *
Rigaku/MSC, Inc. Structural Biology Discussion Group 2003 750 *
Tecan U.S. Inc. Structural Biology Discussion Group 2003 1,000 *
Vector logics, Inc. Vector Targeting Strategies for
Therapeutic Gene Delivery 2003 1,500 *
Vertex Programmed Cell Death 2003 1,000 *
VirRX, Inc. Vector Targeting Strategies for
Therapeutic Gene Delivery 2003 2,000 *
Training Support
Bliss Fund Undergraduate Research Program 2003 5,000
Dorcas Cummings Undergraduate Research Program 2003 8,449 *
Dr. Ira Herskowitz Undergraduate Research Program 2003 5,000 *
Jephson Education Trust Undergraduate Research Program 2003 10,000 *
DNA 50TH GALA & EXHIBIT
The Charles A. Dana Foundation, Inc. DNA 50th Gala 2003 100,000
Camille & Henry Dreyfus Foundation NY Public Library DNA Exhibit 2003 35,000
The Ellison Medical Foundation NY Public Library DNA Exhibit 2003 25,000 *
Morgan & Finnegan, L.L.P. NY Public Library DNA Exhibit 2003 3,000 *
The Rockefeller University NY Public Library DNA Exhibit 2003 10,000 *
The Rockefeller Foundation NY Public Library DNA Exhibit 2003 25,000 *
Alfred P. Sloan Foundation DNA 50th Gala 2003 25,000 *
*New grants awarded in 2003.
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BANBURY CENTER
Grantor Program/Principal Investigator
Duration
of Grant 2003 Funding'
FEDERAL SUPPORT
Brookhaven National Scientific Opportunities in 2003 $ 5,256*
Laboratory Macromolecular Crystallography
at NSLS-II
Centers for Disease Control Toward Understanding the 2003 22,000*
and Prevention (CDC) Cellular and Molecular
Mechanisms of Medically
Unexplained Fatigue
NIH Quantitative Genetic Networks 2003 25,000*
NIH-National Human Genome Eugenics, Genes, and Human 2003 23,202
Research Institute Behavior
NIH-National Institute of Synaptic Function in Fragile-X 2003 32,848*
Mental Health (through
a grant to FRAXA Research
Foundation)
NONFEDERAL SUPPORT
Meeting Support
Affymetrix, Inc. Taking Cancer Genomics 2003 37,280*
to the Clinic
The ALS Association Finding New Genes Linked to 2003 17,809*
Amyotrophic Lateral Sclerosis:
A Focus on Current Technologies
and Their Potential Application
Burroughs Wellcome Fund Toward a More Unified Understanding 2003 30,847*
of Infectious Disease
CFIDS Association of Toward Understanding the 2003 5,000*
America Cellular and Molecular
Mechanisms of Medically
Unexplained Fatigue
National Hypertension Molecular Differentiation of 2003 3,760*
Association Benign and Malignant
Pheochromocytomas and
Neuroblastomas
Redwood Neuroscience Institute Neural Representation and 2003 41,632*
Processing of Temporal Patterns
Albert B. Sabin Vaccine Feasible Solutions to Global 2003 33,595*
Institute, Inc. Vaccine Shortages
Alfred P. Sloan Foundation Taxonomy and DNA 2003 37,500*
Taxonomy, DNA, and the
Bar Code of Life
The Swartz Foundation Neural Circuits: Principles of 2003 42,632*
Design and Operation
Vert° Institute, LLC The Biology of Neuroendocrine 2003 28,798*
Tumors
*New grants awarded in 2003.
DOLAN DNA LEARNING CENTER
Grantor Program/Principal Investigator Duration of Grant 2003 Funding
FEDERAL GRANTS
National Institutes of Health Creation of a Digital Image Archive on 3/98-3/04 $ 187,773
ELSI Research Program the American Eugenics Movement
National Institutes of Health Creation of Inside Cancer 1/01-12/04 267,472
National Science Foundation Developing and Disseminating New 2/03-1/06 124,390
Laboratories on Plant Molecular
Genetics and Genomics
NONFEDERAL GRANTS
Howard Hughes Medical Institute Precollege Science Education Initiative 9/99-8/03 118,666
for Biomedical Research Institutions
Howard Hughes Medical Institute DNA Interactive Education Program 1/02-6/04 546,825
Pfizer Foundation Leadership Institute in Human and 2/01-2/04 80,382
Molecular Genetics
The following schools each awarded a grant for the Genetics as a Model for Whole Learning Program:
Allen Christian School $ 350 Levittown Union Free School District 525
Bay Shore Union Free School District 1,920 Locust Valley Central School District 13,130
Baldwin Union Free School District 1,200 Long Beach City School District 700
Bellmore Union Free School District 2,550 Lynbrook Union Free School District 1,030
Bellmore-Merrick Central School District 12,400 Merrick Union Free School District 960
Bethpage Union Free School District 1,800 New York State School for the Deaf 240
Bnos Bais Yaakov 850 North Bellmore Union Free School District 1,050
Commack Union Free School District 2,131 Northport-East Northport Union Free School District 360
Crestwood Country Day School 350 North Shore Hebrew Academy 425
Crotona Achievement Center 75 Old Westbury School of the Holy Child 2,115
DGK Parochial School 125 Plainedge Union Free School District 1,375
East Williston Union Free School District 2,040 Port Washington Union Free School District 700
Elwood Union Free School District 3,400 Queens District #29 41,025
Farmingdale Union Free School District 2,585 Rockville Center Union Free School District 7,020
Friends Academy 3,790 Sand Creek Middle School 1,492
Garden City Union Free School District 9,765 Sayville Union Free School District 480
Great Neck Union Free School District 8,875 South Huntington Union Free School District 425
Grover Cleveland Middle School 960 St. Alden School 700
Half Hollow Hills Central School District 5,250 St. Anne School 350
Harbor-fields Central School District 9,960 St. Edward the Confessor School 2,650
Hebrew Academy of Nassau County 850 St. Joseph School 350
Hempstead Union Free School District 350 St. Mary School 590
Herricks Union Free School District 1,750 St. Nicholas of Tolentine School 350
Holy Family Regional School 350 St. Peter's Kids 175
Huntington Union Free School District 480 Syosset Central School District 25,775
Jericho Union Free School District 7,025 Three Village Central School District 1,475
Kings Park Central School District 1,245 United Nations School 700
Laurel Hill School 350 West Babylon Union Free School District 350
Lawrence Union Free School District 7,010 Yeshiva Darchei Torah 850
Lawrence Woodmere Academy 240
The following schools each awarded a grant for Curriculum Study:
Bellmore-Merrick Central High School District $ 1,500 Locust Valley Central School District 1,250
Bethpage Union Free School District 2,350 Long Beach City School District 1,100
Commack Union Free School District 1,250 Oceanside Union Free School District 1,100
East Meadow Union Free School District 1,100 Portledge School 1,250
Elwood Union Free School District 1,100 Ramaz School 2,350
Friends Academy 2,350 Roslyn Union Free School District 1,250
Half Hollow Hills Central School District 2,350 Sachem Central School District 1,250
Herricks Union Free School District 1,100 South Huntington Union Free School District 1,250
Lawrence Union Free School District 1,250 Syosset Central School District 1,100
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INSTITUTIONAL ADVANCEMENT
I have written in past annual reports about the philanthropy of individuals, corporations, and foundations
making such a difference at Cold Spring Harbor Laboratory by increasing the pace of breakthrough sci-
ence. This past year provides further testimony to this statement. The innovation in our education and
research programs was propelled by an outstanding increase in the generosity of our supporters.
The gifts reported here are making substantial impact, enabling some of the best minds in biomed-
ical discovery to advance the work to control cancer and to understand psychiatric and other disorders
of the brain and neurological system, as well as educating tomorrow's research leaders. At such an
important time in biomedicine, the increases in philanthropy reported here are particularly appreciated.
With basic research becoming more closely linked with clinical improvements, this is a time when your
generosity will bring real returns for our families and future generations.
Rod Miller, Vice President for Institutional Advancement
Cold Spring Harbor Laboratory is a nonprofit research and educational institution, chartered by the State
of New York. Less than half of the Laboratory's annual revenues are derived from Federal grants and
contracts, and thus we rely heavily on support from the private sector: foundations, corporations, and
individuals. Contributions from the private sector are tax-exempt under the provisions of Section
501(c)(3) of the Internal Revenue Code. In addition, the Laboratory is designated a "public charity" and,
therefore, is enabled to receive funds resulting from the termination of "private foundations."
Foundations, corporations, and individuals can give to Cold Spring Harbor through a variety of meth-
ods:
Gifts of Money can be made directly to Cold Spring Harbor Laboratory.
Securities: Stock certificates may be reassigned directly or transferred through your broker. Appreciated
securities should be given outright, which will avoid capital gains taxes on the appreciated value.
Securities that have decreased in value should be sold, and the proceeds donated. In this way, a donor
will receive a deduction for both the loss and the charitable contribution.
Life Insurance: You may designate the Laboratory as the beneficiary of an existing or new policy, or
irrevocably assign ownership of the policy. There are estate tax benefits in either case. If ownership is
assigned, there is an immediate tax deduction.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive investment and
tax purposes.
Appreciated Real Estate or Personal Property: Sizable tax benefits can result from such donations;
the Laboratory can use some in its program and can sell others.
Charitable Remainder Trusts can be structured to suit the donor's specific desires as to extent, tim-
ing, and tax needs.
Bequests: Designating Cold Spring Harbor Laboratory as beneficiary ensures that a bequest will be uti-
lized as specified.
Conversion of Private Foundation to "Public" Status on Termination: This may be done by creat-
ing a separate fund within Cold Spring Harbor Laboratory whereby the assets of the private foundation
are accounted for as a separate fund and used for the purposes specified by the donor. Alternatively,
the private foundation can be established as a supporting organization of Cold Spring Harbor
Laboratory.
Matching Gifts: Many employers will match gifts to Cold Spring Harbor Laboratory and/or the Watson
School of Biological Sciences. Please check with your employer to augment your gift.
For additional information, please contact the Office of the Vice President for Institutional Advancement, Cold Spring
Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, New York 11724. Phone number: 516-367-6858.
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CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 2003-December 31, 2003
Contributions of $5,000 and above, exclusive of Annual Fund
In 2003, Cold Spring Harbor Laboratory received significant support in the form of capital, program,
and gifts-in-kind contributions from individuals, foundations, and corporations.
Anonymous (2)
Arrow Electronics
Holly H. Bard Fund
Michael Scott Barish Human Cancer Grant
sponsored by 1 in 9: The Long Island Breast
Cancer Action Coalition
The Breast Cancer Research Foundation"
Bristol-Myers Squibb Pharmaceutical
Research Institute and Bristol-Myers
Squibb Foundation
British Embassy
Carnegie Corporation of New York
Find a Cure Today (F.A.C.T.)
The Dana Foundation*
The Dart Foundation*
The Camille and Henry Dreyfus Foundation
The Ellison Medical Foundation
Mr. and Mrs. Alan E. Goldberg
The Goldring Family Foundation
The Irving A. Hansen Memorial Foundation
Jo-Ellen and Ira Hazan
David H. Koch
Laurie J. Landeau, V.M.D.
Estate of Elisabeth S. Livingston
Long Islanders Against Breast Cancer (L.I.A.B.C.)
The Lustgarten Foundation for Pancreatic
Cancer Research
The G. Harold and Leila Y. Mathers Charitable
Foundation*
William L. and Majorie A. Matheson"
Estate of William L. Matheson
The Maxfield Foundation
Breast Cancer Awareness Day in memory of
Elizabeth McFarland
Total
New pledges for 2003.
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Merck & Co., Inc.
The Miracle Foundation
Louis Morin Charitable Trust
Mr. and Mrs. Edmond J. Nouri
Manyu Oga le
The David and Lucile Packard Foundation
Pall Corporation
The Perkin Fund
Pfizer Inc.
William and Maude Pritchard Charitable Trust
Namar Prouty
Mark and Lucy Ptashne and the Jefferson
Foundation
Redwood Neuroscience Institute
Mr. and Mrs. John R. Reese
The Rockefeller Foundation
The Rockefeller University
Mr. and Mrs. Anthony Sbarro
The Seligson Foundation
The Seraph Foundation
The Simons Foundation"
Howard Solomon
Joan and Arthur M. Spiro"
St. Giles Foundation"
The Starr Foundation
Grace and Bruce Stillman
Lauri Strauss Leukemia Foundation
Dr. Waclaw Szybalski
The V Foundation
Dr. and Mrs. James D. Watson
The Whitehall Foundation
Women in Science Luncheon
$29,699,250.29
WATSON SCHOOL OF BIOLOGICAL SCIENCES
CAPITAL CAMPAIGN
January 1, 2003-December 31, 2003
Contributions and pledges, exclusive of Annual Fund
The Watson School of Biological Sciences at Cold Spring Harbor Laboratory was established in 1998
to provide graduate education in the biological sciences at the Ph.D. level. The mission of the doctor-
al program is for students to gain extensive knowledge in biology through a combined research and
education experience, with strong guidance from the faculty, and to complete the program in approx-
imately four years. This accelerated program is designed to increase the number of highly skilled biol-
ogists available to apply the wealth of data from the human genome and other biological discoveries.
In its fifth year, the Watson School matriculated nine additional students, bringing the total number
to 35. In 2003, the Watson School received significant support from individuals, foundations, trusts,
and corporations.
Purpose Donor
Beckman Graduate Arnold and Mabel Beckman Foundation
Studentships
Core Course Arnold and Mabel Beckman Foundation
Dean's Chair Annenberg Foundation
Lita Annenberg Hazen Foundation
Fellowships Curt Engelhorn*
Bristol-Myers Squibb Company
The Dana Foundation
Mr. and Mrs. Alan E. Goldberg
The Florence Gould Foundation
Mr. and Mrs. Robert D. Lindsay and Family
The Miller Family Foundation
Lectureships The William Stamps Farish Fund
Ziering Family Foundation
Student Support Annette Kade Charitable Trust
The Watson Fund Robert J. Glaser, M.D.
for Innovative Graduate Mr. and Mrs. J. Tomilson Hill, Ill
Education Dr. Mark Hoffman
The Millipore Foundation
David and Lucile Packard Foundation
Joy and George Rathmann/The Rathmann Family Foundation
Textor Family Foundation
Mr. and Mrs. Robert H. Witmer, Jr.
Mark and Karen Zoller
Total $2,407,450.00
New pledges for 2003.
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ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings pro-
gram held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory
campus or at the Banbury Center. Without the strong foundation provided by the Program, we could
neither plan with confidence for the year's meetings nor introduce new and unusual topics.
The Corporate Benefactor level continues to be attractive. The introduction of this upper level was
stimulated by the continuing mergers in the pharmaceutical world, which have created very large com-
panies and, at the same time, removed companies that had been contributors to the Program. Pfizer
Inc. was the first company to join at this level and six other of the most notable pharmaceutical and
biotechnology companies have contributed as Corporate Benefactors. The Corporate Sponsor con-
tributors are no less important and we are especially proud that many of our current members have
been long-term contributors. In 2003, we welcomed a new member, Lexicon Genetics, Inc., which
stepped up from the Affiliate level.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for 16 representatives of the Corporate Benefactors and eight representatives
of the Corporate Sponsors at our meetings. In 2003, no fewer than 20 meetings took place in Grace
Auditorium. Six and three scientists, respectively, from Benefactors and Sponsors may attend meet-
ings at the Banbury Center, where attendance is otherwise only by invitation of the organizers. Member
companies receive gratis copies of Cold Spring Harbor Laboratory Press publications, including the
journals Genes & Development, Learning & Memory, Protein Science, Genome Research, and RNA.
We acknowledge our Sponsors in all relevant publications, including the books of abstracts given to
each of the 7000 participants who come to the meetings each year. The names of the sponsoring com-
panies are listed on the poster describing the meetings, and this is mailed to approximately 17,000 sci-
entists throughout the world. In addition, the companies are listed on the Cold Spring Harbor
Laboratory Web site on the Meetings Office and Banbury Center pages. Members for 2003 included:
CORPORATE BENEFACTORS
Amgen Inc. GlaxoSmithKline Novartis Pharma AG
Aventis Pharma AG Eli Lilly and Company Pfizer Inc.
Bristol-Myers Squibb Company
CORPORATE SPONSORS
Applied Biosystems Genentech, Inc. Merck Research Laboratories
AstraZeneca Hoffmann-La Roche Inc. New England BioLabs, Inc.
BioVentures, Inc. Johnson & Johnson Pharmaceutical Research OSI Pharmaceuticals, Inc.
Cogene BioTech Ventures, Ltd. & Development, L.L.C. Pall Corporation
Diagnostic Products Corporation Kyowa Hakko Kogyo Co., Ltd. Schering-Plough Research Institute
Forest Laboratories, Inc. Lexicon Genetics Inc. Wyeth Research
PLANT CORPORATE ASSOCIATES
Mead Westvaco Corporation
Monsanto Company
Pioneer Hi-Bred International, Inc.
FOUNDATIONS
Albert B. Sabin Vaccine Institute, Inc.
Total $859,000
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Dolan DNALC Corporate Advisory Board Annual Fund
The Corporate Advisory Board, established in 1992, serves the Dolan DNA Learning Center as a liai-
son to the corporate community and assists in securing unrestricted support. As a means of raising
support and awareness, the Corporate Advisory Board conducts the annual Golf Tournament and the
Annual Fund.
Chairman: Edward A. Chernoff, Motors & Armatures, Inc.
CSHL Trustee Liaison: Arthur M. Spiro
Michael Aboff, Aboff's Inc.
Brett Ashley, Cole Communications
Rocco S. Barrese, Dilworth & Barrese
Thomas J. Calabrese, Daniel Gale Real Estate
Richard A. Catalano, KPMG LLP
Robert E. Diller, Brinkmann Instruments
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business Products
Centre
Lawrence Goodman, Curtis, Mallet-Prevost,
Colt & Mos le LLP
ANNUAL FUND CONTRIBUTIONS
GENOME SUPPORTERS
Contributions of $10,000 or more
Mr. Edward A. Chernoff, Motors & Armatures
Pall Corporation
CHROMOSOME SUPPORTERS
Contributions of $5,000 or more
J.P. Morgan Chase & Co.
KPMG LLP
Laurie J. Landeau, V.M.D.
The Elena Melius Foundation
OSI Pharmaceuticals, Inc
Topspin Partners, LP
GENE SUPPORTERS
Contributions of $2,500 or more
Daniel Gale Real Estate
Luitpold Pharmaceuticals Inc.
EXON SUPPORTERS
Contributions of $1,000 or more
Aboff's, Inc.
Brinkmann Instruments, InciEppendorf AG
Mr. and Mrs. Thomas J. Calabrese, Jr.
Dr. R. Brandon Fradd
Harweb Foundation
Mr. Arthur D. Herman
Lilo and Gerard Leeds
Mr. and Mrs. George A. Roche
Wendy Vander Poel Russell
The Schiff Foundation
Arthur D. Herman, Herman Development
Corporation
John C. Kean III, Kean Development Corporation
Laurie J. Landeau, V.M.D.
John J. Leahy, Citibank, N.A.
Lilo Leeds, Institute for Student Achievement
James E. Mattutat, ACI Capital Company, Inc.
Patricia Petersen, Daniel Gale Real Estate
Christiaan B. Reynolds, Merrill Lynch
William D. Roche
Wendy VanderPoel Russell, CSHL Honorary
Trustee
INTRON SUPPORTERS
Contributions of $500 or more
Ms. Rosemary Bourne
Dr. and Mrs. Burke A. Cunha
Dr. and Mrs. Candido E. Fuentes-Felix
Ms.Clare T. Lo Cicero
Lynn and Stan Orczyk
John G. Passarelli, M.D.
Petunia Productions LLC
Mr. and Mrs. William D. Roche
TRIPLE CODON SUPPORTERS
Contributions of $250 or more
Mr. and Mrs. Martin W. Bernard
Mr. and Mrs. Michael J. Boylan
Dunetz Marcus, LLC
Dr. and Mrs. Steven M. Goldberg
Mr. and Mrs. Rod Miller
Mr. and Mrs. William K. Oelsner
John and Cheryl Pufahl
Bernard and Anne Reynolds
Grace and Bruce Stillman
Sutton & Edwards, Inc.
Ms. Wendy Wang
NUCLEOTIDE PAIR SUPPORTERS
Contributions of $100 or more
Ashish M. Bakshi
Mr. Fred H. Baron
Dr. and Mrs. Pierre R. Beaubrun
Dr. Patricia E. Bossert
Ms. Nancy Calomiris
Mr. Daniel Chang
Total $103,931.00
Horst Saalbach, Ph.D., Festo Corporation
Peter G. Schiff, Northwood Ventures LLC
Charles R. Schueler, Cablevision
Tony Wills, Newsday
Kevin Seeley, Ph.D., Pall Corporation
Kurt Timmel, Marsh, Inc.
Jeffrey K. Tupper, U.S. Trust Company
Robert Van Nostrand, OSI Pharmaceuticals, Inc.
Frederick Volp, Ph.D., CSH Central School
District
William N. Wham, ISC, Inc.
Dr. and Mrs. George Costar.
Mr. and Mrs. Thomas H. Debow
Mr. Kevin Dougherty
Souhad A. Hassan, M. D. and Family
Warren and Valerie Herman
Stephen and Deborah Hershowitz
Mr. Camillus Hughes
Magdalen E. Hull, M.D.
Mr. and Mrs. Richard Johnston
Neil Kaufman-Kaufman & Associates LLC
Mr. and Mrs. John Kelly
Mr. Steven A. Klar
Mr. Warren B. Lane
Mr. and Mrs. Frederick J. Magovern
Mr. and Mrs. James E. Mattutat
Mr. and Mrs. Kevin McCarthy
Jim and Patti McNulty
Cynthia and Donald Morrongiello
Pacific Parts Sales Co.
Luis, Eugenia & Eric Paniagua
Mr. and Mrs. Christiaan B. Reynolds
Nancy Sakaduski/Sakaduski Marketing
Solutions
Richard and Mary Satin
Mr. Marc W. Schafler
Seniuk Family
Sheriff Family
Mr. and Mrs. Dennis Smiler
Mr. and Mrs. Alexander Smith
Michael and Carol Spahn
Mr. and Mrs. Garry Switala
Mr. and Mrs. Thomas H. Tucker
Leslie Kim Williams and James A. Atwood, Jr.
The Yu Family
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TENTH ANNUAL GOLF TOURNAMENT SPONSORS
FOUNDING TOURNAMENT SPONSOR
J.P. Morgan Chase & Co.
MAJOR CORPORATE SPONSORS
Fortunato Sons, Inc.
Marsh, Inc.
Motors & Armatures, Inc.
Thomas C. Quick
CORPORATE SPONSORS
Badge Agency, Inc.
Pall Corporation
BRUNCH SPONSOR
Luitpold Pharmaceuticals
BREAKFAST SPONSOR
Fleet Bank
PRIZE SPONSOR
Fisher Scientific International Inc.
REGISTRATION TABLE SPONSOR
U.S. Trust Company of New York
PUTTING GREEN SPONSORS
Daniel Gale Real Estate
Elena Melius Foundation
State Bank of Long Island
TEE/GREEN SPONSORS
D. Reis Contracting Corp.
Electronix Systems Central Station Alarms
Jostens, Inc.
New York Biotechnology Association, Inc.
Rivkin Radler LLP
The Sheridan Press
GOLF CART SPONSORS
A Partymaker, Inc.
Lewisy Fuel Oil
HOLE-IN-ONE SPONSORS
Badge Agency, Inc.
Competition BMW of Smithtown
Total
Gold Package Sponsors
All-Pro Carpet
Barnes & Noble College Bookstores, Inc.
Brinkmann Instruments, Inc./Eppendorf
AG
Brownstone Agency, Inc.
Ciardullo Landscapes & Designs
Citigroup Private Bank
Corte! Business Systems, Inc.
Curtis, Mallet-Prevost, Colt & Mos le LLP
Daniel Gale Real Estate
Davis & Gilbert LLP
Dilworth & Barrese
Arthur D. Herman
Huntington Business Products Centre, Inc.
KPMG LLP
Northwood Ventures
OSI Pharmaceuticals, Inc.
Bernard F. Reynolds
Ginette and Christiaan B. Reynolds
Rivkin Radler, LLP
Alan Seligson
Tilles Family Foundation
U.S. Trust Company of New York
SILVER PACKAGE SPONSORS
ACI Capital Co., Inc.
Mr. and Mrs. Thomas J. Calabrese, Jr.
Chaves Chaves & Perlowitz LLP
Curtis, Mallet-Prevost, Colt & Mos le LLP
Peter Marsh
John Passarelli-Long Island Eye Surgical
Care, PC
Syosset Limousine Service, Inc.
U.S. Trust Company of New York
BRONZE PACKAGE SPONSORS
Aboff's Paints & Wallcoverings
Advantage Title
Mark Brooks
Burt Building Materials
Callan, Koster, Brady & Brennan LLP
Curtis, Mallet-Prevost, Colt & Mos le
Margolin & Margolin, Esqs.
Dr. Bradley Marsh
Jack Ross
Robert Sires, Leach Holding Corporation
$134,311.05
RAFFLE AND LIVE AUCTION DONORS
Aboff's Paints & Wallcoverings
Aix en-Provence
Brett Ashley
Barney's Restaurant
Bryant & Cooper Steakhouse
Edward A. Chernoff
Competition BMW of Smithtown
Cool Fish
Danfords on the Sound
Foxwoods Resort & Casino
Dr. Candido Fuentes-Felix, The CFF Skin
Care Center
Graffiti Restaurant
Arthur D. Herman
Images & Details
Lilo and Gerard Leeds
Lion in the Sun
Marquis Wines & Spirits
Marsh's Mens Store
Mr. and Mrs. James E. Mattutat
Mill River Inn
The Quick Family
St. Andrews Restaurant
Tilles Center for the Performing Arts
FAVOR BAG SUPPLIERS
Barnes & Noble College Bookstores, Inc.
Citibank Private Bank
Mallet-Prevost, Colt, & Mos le LLP
Huntington Business Products Centre
Daniel Gale Real Estate
Newsday
GOLF CHAIRMAN
Lawrence Goodman
AUCTIONEER
Francis Wahlgren, Senior Vice President,
Christie's
THANK YOU
Howard M. Blankman
Cold Spring Harbor Laboratory volunteers
Dolan DNA Learning Center volunteers
Piping Rock Club staff
Total Dolan DNALC Annual Fund $238,242.05
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Cold Spring Harbor Laboratory Association (CSHLA)
Officers
Trudy H. Calabrese, President
Joseph T. Donohue, Vice President
John S. Grace, Vice President
Henry E. Salzhauer, Treasurer
Cathy Cyphers Soref, Secretary
Directors
David L. Banker
Timothy S. Broadbent
George W. Cutting, Jr.
David H. Deming
Frances N. Elder
Lori Garofalo
Robert A. Gay
Honorary Directors
John P. Cleary, Esq.
Mary D. Lindsay
Anne R. Meier
William F Gerry
Lynn M. Gray
Allen D. Jebsen
Alan M. Kisner, M.D.
Mary Alice Kolodner
Michael S. O'Brien
Jay C. Plourde
Association President's Report
Lawrence Remmel
Ann C. Seifert
John S. Stevenson, Ph.D.
Bruce Stillman, Ph.D.
Lynn McGrath Tone
Marjorie von Stade
James D. Watson, Ph.D.
2003 was a banner year for the Association. We celebrated the 50th Anniversary of the discovery of
the double helix structure of DNA with the strongest community outreach effort to date. Our member-
ship is now almost 800 strong and growing.
Thanks to this gratifying community support, we have raised more than $1,000,000 in unrestricted
donations to advance the Association's mission of helping young scientists. Since the Laboratory
receives only 40% of its funding from the government, Association support remains critical for the finan-
cial health of the institution. This year, the Laboratory once again won the second highest rating in the
nation from The Non-Profit Times and a four-star rating from Charity Navigator for prudent and respon-
sible operational and fiscal management. As donors, we can be assured that our donation dollars are
being wisely used.
The Association gained strong new leadership in 2003 with the election of Directors Timothy S.
Broadbent, Jay C. Plourde, John C. Stevenson, Ph.D., and Lynn McGrath Tone. Retiring Directors David
Deming, Francis Elder, Bob Gay, Allen Jebsen, Ann Seifert, and Marjorie von Stade have enriched the
Laboratory with their hard work and genuine commitment to the our mission. Each has been an inspir-
ing and enthusiastic ambassador. A very special thanks to David, retired President of the Association,
for his dynamic and wise leadership. It has been a privilege for me to work with him.
One of the perks of serving as Director is learning much more about our scientists' research. Several
times a year, we enjoy informal lectures from young investigators, usually those whose work is sup-
ported by the Annual Fund. During the past year, we heard from:
Rachel von Roeschlaub, a cancer researcher and genetics teacher, who discussed her recent trip
to the foothills of the Himalayas to teach Tibetan monks about genes and DNA. Rachel, also a fine
artist, supports her teaching in India with her painting sales.
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Sandy Kuhlman, a neuroscientist, who discussed how small changes in vision can have long-last-
ing effects on brain function in the young.
Mary Byrne, a plant biologist, who discussed plant variation in form, i.e., branching patterns and leaf
shape, showing how in studies with Arabidopsis and maize, her laboratory identifies genes involved
in developmental processes for eventual application to crop propagation.
Mike Packer, a cell biologist, who discussed his work with nitric oxide on control of stem cell prolif-
eration with therapeutic possibilities for chemotherapy and transplantation. Mike was joined by his
wife Jeana, another fine artist, whose varied and impressive canvases were presented at a show at
the Laboratory in November.
Events for the year began on Sunday, February 9, with the Annual Meeting of the Association,
chaired by Directors Lori Garofalo and Michael O'Brien. Harvard anthropologist Dr. Richard Wrangham
presented his intriguing theory on the more rapid development of Homo sapiens after the discovery of
fire, when cooked food was digested in significantly less time than raw food. The meeting was followed
by a lively cocktail reception.
April 5 was the high point of the Association calendar with Jazz at the Lab. Special thanks for an
exceptionally beautiful and well-organized evening go to Chairwoman Kate Friedman. Now in its fifth
year, Jazz netted more than $70,000 for the annual fund, with record attendance topping 400 guests.
We were fortunate to feature for the second year the legendary Joe Bushkin on piano, with Bob Merrill's
vocals and trumpet. Others in the ensemble included Joe Cohn, John Colianni, Wycliffe Gordon, Jay
Leonhart, Eddie Locke, and Karolina Strassmayer who played to exuberant encore requests from a
packed house. The evening's financial success was due primarily to the generosity of our Underwriters,
listed below:
Premier Underwriters
Anonymous
Jamie and David Deming
Helen and Charles Dolan
Barbara and Tom Dooley
Diane and Bob Fagiola
Dorian and Norman Feckl
Kate and John Friedman
Lori and Stephen Garofalo
Ginny and David Knott
Sandra and Steve Lessing
Terry and Bob Lindsay
The Litwin Foundation
Hildegarde Mahoney
Gillian and Eduardo Mestre
Julie and Luis Rinaldini
Laurie and Harry Rosenberg
Edith and Alan Seligson
Cathy and Douglas Soref
Michelle amd Bob Wallach
Diane and Bernie Yatauro
Mary Lindsay and Jim Large at Jazz at the Lab.
Bruce Stillman, Ginger Lucas, and Sandra and Steve Lessing at Jazz at the Lab.
Lead Underwriters
Banfi Vintners*
Laurie and John Barry
Pien and Hans Bosch
Lisa and Tim Broadbent
Jo Ann and Morgan Browne
Trudy and Tom Calabrese
Ken and Eric Carlstrom
Ann and Elliot Conway
Lucy Cutting
Daniel Gale Real Estate
Mary Beth and Joe Donohue
Lola and John Grace
Robin Hadley
Tracy and Bill Hamilton
Linda and Frank Hanan
Barbara and Jim Hoover
Polly Kahn
Dawn and Alan Kisner
Andrea and Peter Klein
Laureen and Ragnar Knutsen
Mary Alice and Michael Kolodner
Regina and Warren Kraft
Eric Krasnoff, Pall Corporation
Mary Lindsay
Stacey and Isidore Mayrock
Cora and Clarence Michalis
Karen and Walter Morris
Andrea and Barry Newburger
William and Joyce O'Neil
Charitable Trust
Lee and Steve Pao lino
Mary and Howard Phipps
Terry and Howard Phipps
Douglas Pollock, Studio
Fitness
Adrienne O'Brien and David Salten
Susan and Hank Salzhauer
Vicki and Anthony Sbarro
Randy Statham, Scarsella's"
Lisa and Peter Schiff
Promila Shastri*
Cynthia and Jim Stebbins
Grace and Bruce Stillman
Janine and Roland Tatzel
Dori and Peter -lilies
Lynn and Pat Tone
First graders from the Goose Hill Primary School enjoyed two days of in-depth exploration with sci-
entists in Bush Hall at six booths representing varying research during the second annual Science Fair
in early May. More than 100 children enjoyed peering through microscopes, touching mammalian
brains, viewing colorful protein structures through 3-D glasses, comparing mutant to nonmutant plants,
and more.
The 26th annual Dorcas Cummings Memorial Lecture was held on Sunday, June 1, at the culmina-
tion of the CSHL Annual Symposium. Our good friend, Francis Collins, Ph.D., Director of The National
Human Genome Research Institute, gave an especially entertaining lecture entitled, "The Human
Genome, Where Do We Go from Here?" The timely lecture was one of the highlights of our 50th
*In kind.
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Goose Hill first graders at CSHLA Science Fair.
Anniversary Double Helix celebration. It was at the 1953 Symposium at which James D. Watson
announced his discovery of the structure of DNA. Following the lecture, 27 local families opened their
homes for dinner parties for friends and scientists from around the world who had attended the week-
long Symposium. Once again we had co-chairs Lynn Gray and Cynthia Stebbins to thank for their ener-
getic and time-consuming outreach in organizing the dinner parties. Special thanks go to all our gra-
cious and generous hosts and co-hosts, listed below, who continue one of the Laboratory's warmest
traditions:
Marion and Frank Ahmed
Sophie and Dill Ayres
Mary Lenore Blair
Amy and Gerald Brogan
Barbara and Jim Brundige
Leah and Alan Butler
Trudy and Tom Calabrese
Rita and John Cleary
Joan and Peter Cohn
Megan and Dan deRoulet
Diane and Bob Fagiola
Dorian and Norman Feckl
Lori and Stephen Garofalo
Lynn and Towny Gray
Cathy and Chris Hogg
Mark and Sealy Hopkinson
Alan and Dawn Kisner
Elise and Towny Knight
Mary Alice and Michael Kolodner
Fanny and David Luke
Terri and Bill Muran
Lois and Mike O'Brien
Noelle and Robert O'Connor
Joyce and John Phelan
Julie and Luis Rinaldini
Cathy and Doug Soref
Jane and Jim Spingarn
Cynthia and Jim Stebbins
Janet and John Stevenson
Ingrid and Niklaus Vetsch
Elise and Hugh Wallace
Terry and Robert Walton
Kathy and Scott Wells
Our Partnership Picnic this year was hosted by Lola and John Grace. John, Association Vice-
President, and Lola, Treasurer of the Board of Trustees, opened their lovely Oyster Bay Cove home and
gardens to scientists and their "Partners." Partners are community families who befriend our young sci-
entists, inviting them on occasion to their homes, sharing theatre tickets, books, etc. The sunny autumn
day and setting were both picture perfect, as children romped and played on the rolling lawn over-
looking Long Island Sound and grownups savored a delicious lunch.
September ended with our Annual Cocktail Party for major donors, hosted this year by Director Lori
Garofalo and her husband Stephen, at their sprawling Mill Neck estate, La Reserve. Helping was their
adorable daughter, Olivia, who charmed all the guests. A wonderful collection of many of the
Laboratory's best friends mingled while enjoying the exquisite view from the Garofalos' balcony. Sandy
Kulman, a CSHLA Fellow, spoke briefly to the group about her research and her life at Cold Spring
Harbor Laboratory, thanks to the Association's support, and Bruce Stillman provided an update on
Laboratory research.
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Trudy Calabrese, Edith Seligson, and John and Kate Friedman
at the Major Donor Party.
Major Donor Party hosts Lori and
Stephen Garofalo.
The New York Committee is focusing outreach increasingly on individual major donors. To that end,
Director David Banker and his wife Pamela put together a luncheon in honor of Jim Watson at the
Knickerbocker Club in October. The Bankers' thoughtful guest list included old friends of the
Laboratory as well as a number of new people with philanthropic inclinations. They all enjoyed an
update on the Lab from Bruce Stillman and Jim Watson's insights for future implications of biomedical
research.
Larry Remmel was the catalyst in November for Jim Watson's lecture at the Collegiate School on
the Upper West Side. The daytime lecture for the student body was extremely well received and fol-
lowed by a lively question and answer session.
The year ended with a holiday celebration at The Mary D. Lindsay Child Care Center. Several
Directors participated, including the best Santa Claus ever, John Stevenson. It was touching to see the
happy faces of so many "Lab Family" children. One of the missions of the Association is to help sup-
port the Child Care Center through a scholarship program funded by donations to the Annual Fund.
Special kudos go to Cathy Soref, our fellow Director, for her brainchild DNA STUFF She conceived
this idea of opening an independent, solely owned retail venture, stocked with creative and interesting
merchandise related to the double helix. Cathy and her family will turn over the profits from their com-
pany as a contribution to the CSHL Annual Fund. We are indebted to Cathy for her creativity and ener-
gy on behalf of the Lab. Click on www.dnastuff.com/.
On a personal note, I wish to thank everyone at the Laboratory, neighbors, and friends for support-
ing the Association. We, in this community, are fortunate to have the Laboratory in our midst. It is a very
special institution of scientific research and education, and an invaluable local resource. I am grateful
for the opportunity and privilege of being a Cold Spring Harbor Laboratory volunteer.
Trudy H. Calabrese
President
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Monica and Brent Mowery
Tess Mullarkey
Theresa and Bill Muran
Mrs. Allen E. Murray
Galina and Joseph Muscatel lo
Jackie and Tom Nastos
Dr. and Mrs. Benny Ng
Jeanne Niven
Dr. and Mrs. Allan Garb
Mr. and Mrs. Francis E. O'Connor
Mr. and Mrs. Robert O'Connor
Kelly and Christopher O'Hara
Geraldine E. O'Kane
Mr. and Mrs. Frank O'Keefe
Ms. Sandy Oringer
Mr. and Mrs. Innis O'Rourke, Jr.
Lon and Michelle Otremba
Doris Pailet
Lauryl and Robert Palatnick
Michael and Nancy Paloian
Constance Papandrew
Mr. and Mrs. C. Allen Parker
Mr. and Mrs. William Parsons, Jr.
Mr. and Mm. Scott L Paterson
Sarah Plimpton
Drs. Judith and Thoru Pederson
Anne and Nathaniel Peirce
Cecily and Paul Pennoyer
Personal Touch Home Care L.I.
Ms. Jane M. Pflug
Kathy and Peter Pico li
Mr. and Mrs. R. S. Pierrepont
Ann and Graham Platt
Judge and Mrs. Thomas C. Platt
Ellen M. Goodwin and Kurt S.
Patricia and Francis Roberts
Kathy and Doug Robinson
Dr and Mr Robert J. Roelle
Elizabeth E. Roosevelt
Elaine and Ron Rosman
Mr. Spencer Ross
Pamela and Richard Rubinstein
Mr. and Mrs. Robert C. Ruocco
Hon. Lea and Mr Melvin Ruskin
Charlene Russell
Ruth Ryan
Marilyn Moffat Salant
Patricia P. Sands
Carol and Jon Santemma
Ms. Carol L Scal
Julia C. Schieffelin
Dara and Christian Schlesinger
Mr. and Mrs. Douglas Schloss
Dr. and Mrs. Seymour Schpoont
Carol and Norman Schulman
Julie and Mike Schwerin
Ann Scolnick and Bernard Musso
Robbin Mitchell and Jeff Scruggs
Mr. and Mrs. Daniel M. Searby, Jr.
Mr. and Mrs. Donald Shakeshaft
Dr. and Mrs. George J. Sheehan
Susan and Bill Sheeline
Dr. and Mrs. Edward M. Shepard
Col. and Mrs. Robert E. Sheridan
Mr. and Mrs. John P. Sherlock
Mr. and Mrs. Irwin Sicherman
Dorothy and Eliot Silverman
Lisa and David Simek
Mr. and Mrs. John D. Simpson
Mrs. William C. Simpson
Mr. and Mrs. Bernard Sklar
Suzanne Slocum
Mr. and Mrs. Albert Harrison Small
Pohmer Patti M. Smith
Mr. and Mrs. Charles A. Powers, Jr. Stan Smith
Frances and Richard Powers Tiny and Chick Smith
Mr. and Mrs. John C. Smith
Joan and James Sommermeyer
Debbie and Cliff Sondock
Mr. and Mrs. Robert N. Soviero
Dr. and Mrs. Barry Spass
Jackie and Hal Spielman
Sam Spinowitz
Dr. and Mrs. David Stacy
Susan and Tom Staudt
Peter H. Stehli
Valarie and Michael Steinberg
M. Wynona Powers
Charlie Prizzi
Scott L Probasco
Pamela and William Randall
Daren A. Rathkopf
Edgar Lee Rawlings IV
Mrs. Ewing Reilley
Mr. and Mrs. Charles J. Reina
Arlene and Bernard Richards
Corinne Richards
Robert J. Riedy
CORPORATE AND FOUNDATION MATCHING CONTRIBUTORS
Alliance Capital Management LP
Bank of America
Bristol-Myers Squibb Foundation, Inc.
Computer Associates International, Inc.
Dow Jones & Company, Inc.
General Electric Fund
Green Point Financial
The J.P. Morgan Chase Foundation
CSHLA Annual Fund
CSHLA Membership and Other Support
Angels, Benefactors, Patrons, Associates*
Neighbors, Friends, Basic*
Nonmember Gifts
Endowment Income
The Henry Luce Foundation, Inc
Pfizer Matching Gift Center
Truland Service Corp.
United Way of Long Island
$ 868,773.79
$ 119,218.17
$ 3,187.00
$ 8,825.00
Total $1,000,003.96
*Jazz expenses deducted
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Mr. and Mrs. James Stewart
The Stone Family
Nicole and Christopher Suozzi
Mrs. David S. Taylor
Julie and Marc Tell
Mr. and Mrs. Dudley B. Tenney
Anne M. Thomas
Mr. and Mrs. Edward M. Thomas
Mr. and Mrs. George M. Thomas
Adaire M. Thompson
Mr. and Mrs. George H. Tilghman
Christine and John M. Townsend
Dr. and Mrs. Alex Traykovski
Mr. and Mrs. Neill F. Trimble
Mr and Mrs. Godfrey Truslow
Dr. and Mrs. Lawrence Tydings
Mr. and Mrs. Stephen Van R.
Ulman
Barbara and Cornelius Ulman
Ms. Illiana Kerckerinck van
Meeteren
Mr. and Mrs. Richard van de
Stouwe
Beverly S. VanderPoel
Dr. and Mrs. Thornton A. Vandersall
Mr. and Mrs. Niklaus Vetsch
Mr. and Mrs. Joseph C. Viviani
Hattie and Arthur Vogel
Rachel von Roeschlaub
Nancy and Gary Wadler
Mr. and Mrs. Nelson S. Walsh
Sally Wardwell
Ms. Anna J. Watson
Mr. and Mrs. Stephen H. Walters
Carley and Carl Weatherley-White
Mr. and Mrs. Richard J. Weghorn
Mr. and Mrs. L.B. Wehle, Jr.
Judith Weintraub
Mr. and Mrs. Robert L. Wendt
Mr. and Mrs. Martin Wenz
Edward C.R. Whitcraft
Mrs. J.F. Whitehead, Jr
Mary Louise Whitmarsh
Mr. and Mrs. Malcolm D. Widenor
Mr. and Mrs. John R. Wierdsma
Cackie and Harrison Wilson
Mr. and Mrs. James E Wilson
Richard and Dawn Winkoff
Mr. and Mrs. Frederick C. Witsell, Jr.
Mr. and Mrs. Robert L Woods
Margaret W. Wright
Joan C. Zulch
MEMORIAL AND GIFT IN HONOR CONTRIBUTORS
Alley, Maass, Rogers & Lindsay, P.A.
Mr. and Mrs. Joseph F. Alonge
Mr. and Mrs. Vincent J. Amato
Marilyn and Bryan Anthony
Mrs. S. Reed Anthony
Esteban Araya
Eva Banta
Mr. and Mrs. Mike Beck
Mr and Mrs. Copeland G. Bertsche
Marge Bevad
Mr. and Mrs. Vito Biondo
Mr. and Mrs. Jay Birns
Mr. and Mrs. Geoffrey T. Bolsi
Julie Bostwick
Rosemary Bourne
Mr. and Mrs. Leonard M. Bryant, Jr.
Mr. and Mrs. Wallace Bunn
John and Betty Busby
Mr. and Mrs. Thomas J.
Calabrese, Jr.
Karen and Jay Case
Mr. and Mrs. Chiarappa
Elvira Cody and Family
Mr. and Mrs. John Coffey
Patricia W. Collier
Mr. and Mrs. Charles S. Colson
Kenneth Connors
Eck ley B. Coxe
Rosolino Cracchiolo, Josephine
Cracchiolo, Joseph Ghetto and
Family
Mr. and Mrs. Michael Crosby
Marolyn Davenport
Mr. and Mrs. Robert G. Davidoff
Mr. and Mrs. John Debellis
Mr. and Mrs. Gary Di Maria
The Dooley Family
Mr. and Mrs. John A. Dudzik
Mr. and Mrs. Leo J. Dunn
Mr. and Mrs. William T. Dunn
Mrs. William S. Eakins
Debi and Jeff Feinstein
Mr. and Mrs. Robert I. Fisher
Helene and Bernie Flynn
Mr. and Mrs. Bruce R. Fox
Dr. and Mrs. Jerry R. Frank
Mr. and Mrs. John French
Friedman Properties Ltd.
Mr. and Mrs. Irwin A. Frisk
Mr. and Mrs. Ralph A. Fumante, Jr.
James C. Furlong
Anthony and Luisa Gambino
Wendy and John Gambling
Lori and Stephen Garofalo
IN MEMORY OF
Frances L. Gersten
Helen and Monte Get ler
Lucille Taverna Giardina, M.D. and
Family
Mr. and Mrs. Joseph H. Gilbreth,
Robert J. Glaser, M.D.
Robert Goeckel
Mr. and Mrs. Alan Goldberg
Mr. and Mrs. Allen A. Goldring
Mr. and Mrs. Pierre Gonthier
Frederic Goodman Jewelers
Leonard Goodman
Suzie and Gary Goodman
Helen Grace Spencer
The Green Vale School
Hagedorn & Company
Mr. and Mrs. Gordon S. Hargraves
Mr. and Mrs. Charles E. Harris II
Mrs. Chester Hartenstein
The Hatch Family
Mr. and Mrs. Robert Hazen
John C. Hein
Steve and Mary Jo Herseth
Stephen and Deborah Hershowitz
Mr. and Mrs. Philip R. Herzig
Doris Heyenoort
Mark S. Hochberg, D.M.D.
Marion and Conrad Hom ler
Mr. and Mrs. Winchester
Hotchkiss
Mr. and Mrs. Jeff Hunter
Mr. and Mrs. Richard Hyman
Mr. and Mrs. Slawomir Ibelhaupt
Ivor Foundation-Mr. and Mrs.
George B. Moore, Mr. and Mrs.
Thomas A. Saunders III, and Taz
Saunders
Cell and Bob Jacobs
Linda Jena
John W. Jordan, II
JP Morgan Private Bank
Mr. and Mrs. Richard Kaplan
Mr. and Mrs. Peter Karches
Amy and Lenny Katz and Nancy
and David Katz
Elaine P. Kend
Dr. and Mrs. Evan Klass
Mr. and Mrs. John Klingenstein
Mr. and Mrs. Sanjay Kumar
Michael Kurtzon
Peter F. Lamb
Mrs. Mary Ann Hamilton Lamont
LaSalle Bank National Association
Mr. and Mrs. Gerald LeBoff
Lorenzo Alcamo Sharon Goldstein Henrietta Mulligan
Naomi Antonoff Oliver Grace Denis O'Kane
J. Kevin Brdey Albert Greenhouse Hugh O'Kane, Sr.
Ronald Calabrese Daniel Heymann Kathy Pufahl
Benedetto Di Pietro Mary Jagoda Randy Ratner
Ann West Elms Angela Katsakis Jack Richards
Edith Ruth Epstein Dino Mancini Mr. Rudes
John Ferguson Edwin S. Marks Andrew Seligson
Mary Lou Galston Wendy Mars Milton Shapiro
Elfriede Geuss Grace Maslow Fran Stack
Faye Goldstein William L. Matheson Mary Szames
Dr. Stewart Levine
Mr. and Mrs. Mario Lipari
Joan Lipson
The Liss Family
Mr. and Mrs. Martin Lizt
Mr. and Mrs. Patrick K. Long
Domingo Lopez and M. Teresa
Fernandez
Mr. and Mrs. David L. Luke III
Lynx Investment Management,
L.P.
Mrs. William E. Mahoney
Mr. and Mrs. Anthony Maiorana
Mr. and Mrs. Howard C. Manus
Mr. and Mrs. Paul D. Martens
Grace H. Max
Mayer, Brown, Rowe & Maw LLP
Mentoring Partnership of Long
Island
Thomasina Michalik
Midwood High School at Brooklyn
College
Claire and Noah Miller
Mr. and Mrs. Walter Mondschein
Mr. and Mrs. Lester S. Morse, Jr.
Mary A. Mullin
Mr. and Mrs. Ron E. Murphy
Mrs. Allen E. Murray
Mr. and Mrs. Basil F. Northam
Bob O'Brien
Mr. and Mrs. Edward O'Donnell
Geraldine A. O'Kane
Geraldine E. O'Kane
Mr. and Mrs. Frank J. Olt, Jr.
H. Patricia O'Neill
Mr. and Mrs. George D. O'Neill
Mr. and Mrs. Robert G. Packer
Charlotte Leffler Palmer
Constance Papandrew
Janice Pargh and June Polak
Mr. and Mrs. Thomas Petrovitch
Mr. and Mrs. Peter Pixel
Kurt S. Rosen and Ellen M. Goodwin
Mr. and Mrs. Grant A. Porter
M. Wynona Powers
Scott L Probasco, Jr.
Mr. and Mrs. Paul W. Prochilo
Joseph Pufahl
Mr. and Mrs. Thomas L Pulling
Joanne and Bill Quinn
Henry W. Rappuhn
Mr. and Mm. Gerald Raskin
Mr. and Mrs. Raymond J.
Rasmussen
IN HONOR OF
Dill Ayres
Mr. and Mrs. Lee Friedman
Dr. and Mrs. S. Klausner
Michael Maned
Robert and Joyce Marcus
Jeannie Schnupp
Mr. and Mrs. Douglas S. Soref
Jake Trues
Dr. and Mrs. James D. Watson
Edgar Lee Rawlings IV
Mr. and Mrs. Scott Rechier
Mr. and Mrs. John Reese
Martha and Keith Regelmann
Mr. and Mrs. Donald I. Resnick
Corinne Richards
Mr. and Mrs. Anthony Riggio
Mr. and Mrs. Arthur F. Rizzi, Jr.
Mr. and Mrs. Joseph J. Rode Ili
Dr. Barbara and Mr. David Rosen
Mr. and Mrs. Milton Rosenfeld
Jodi and Bob Rosenthal
Mr. and Mrs. Derek S. Roudebush
Mr. and Mrs. Bruce Rudin
Mr. and Mrs. Robert C. Ruocco
Ruth Ryan
Audrey and Marvin Schein and
Family
Jack and Linda Schoppmeyer
Carol and Norman Schulman
Mr. and Mrs. Bernard Start
George Sikorski
Mr. and Mrs. Albert Harrison Small
Mr. and Mrs. Douglas S. Soref
Nita Soref
Mr. and Mrs. James Stark
The Stone Family
Mr. and Mrs. Thomas Sullivan
Marcia W. Sullivan and Steven D.
Jansen
Mrs. David S. Taylor
Mr. and Mrs. Dean C. Trautmann
The Trautwig Family
U.S. Trust Company
Judith M. Upright
Drs. Scott Ratner and Marjorie
van de Stouwe
II liana Kerckerinck van Meeteren
Mr. and Mrs. Richard van de
Stouwe
Jackie and Warren Wasp
Anna J. Watson
Rick and Sissy Weinberg
Judith Weintraub
Marsha K. Weiss
Mr. and Mrs. Richard Weiss
Felicia and Perry Weitz
Kathleen Wellenbrink
Mrs. J.F. Whitehead, Jr.
Mr. and Mrs. John R. Wierdsma
Mr. and Mrs. James A. Willson
Harrison and Cackle Wilson
Mr. and Mrs. James F. Wilson
Mr. and Mrs. John C. Yandrasits
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President's Council
The President's Council was formed ten years ago to bring together leaders from business, research,
and biotechnology who share an interest in science and Cold Spring Harbor Laboratory's research.
President's Council members contribute $25,000 or more annually to support the Laboratory's Cold
Spring Harbor Fellows-exceptional young Ph.D.s and M.D.s who are making great strides toward
independent and important research. The 2003 meeting took place on May 17 and 18 and explored
the topic, The Mind of the Bird. Our presenting scientists were engaging speakers and leaders in their
field: John W. Fitzpatrick, Ph.D., Sidney Gauthreaux, Ph.D., Timothy Birkhead, Ph.D., and Irene
Pepperberg, Ph.D. The following were members of the 2003 President's Council:
Mr. and Mrs. Abraham Appel
Mr. and Mrs. Donald Everett Minn
Mr. and Mrs. Roderick H. Cushman
Mr. Michel David-Weill
Mr. and Mrs. John H. Friedman
Dr. and Mrs. Leo A. Guthart
Mr. and Mrs. Charles E. Harris
William A. Haseltine, Ph.D.
Total
Ms. Wendy Keys and Mr. Donald Pels
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. Thomas J. McGrath
Mr. and Mrs. James H. Simons
Dr. and Mrs. Charles L. Stone, Jr.
Dr. and Mrs. James M. Stone
Swartz Charitable Lead Trust/Jerome and
Starnette Swartz
$305,004.03
Charlie Harris, Dill Ayres, John H. Friedman Hillie Mahoney, Jim Watson
Hillie Mahoney, Liz Watson, Pat Patterson, Mrs. Jack Massey
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The Harbor Society
Through thoughtful estate planning, the Harbor Society is ensuring a better quality of life for our fami-
lies and future generations. This distinguished group of men and women helps extend the dramatic
advances in molecular biology at Cold Spring Harbor with estate planning vehicles that maximize gift
or estate tax benefits. Members of the Harbor Society have made bequests in wills or planned gifts of
real estate, marketable securities, retirement plan assets, and art or antiques for tax-wise philanthropy
that advances biomedical discovery.
In 2003, the Laboratory was delighted to record with appreciation a substantial charitable remain-
der trust for the benefit of the Watson School of Biological Sciences from the Chairman of the Board
of Trustees, William Miller, and his wife Irene. The Estate of William L. Matheson and the Estate of
Elisabeth Sloan Livingston also provided further support for the Laboratory. In the fall, Estate and Tax
Planning seminars were held at the Woodbury Cancer Genome Research Center with many attendees
subsequently visiting specific research laboratories.
The Laboratory also appreciates the support of the Planned Giving Advisory Group whose mem-
bers provide ongoing advice in estate and tax planning matters.
Undergraduate Research Program
Founded in 1959, the Undergraduate Research Program allows college students from around the
world to participate in hands-on inquiry-based avenues of exploration. This educational approach
increases students' understanding of science, nurtures their enthusiasm about science,exposes them
to the excitement of scientific discovery, and stimulates their curiosities, while interesting them in pur-
suing research careers. Twenty-five participants 14 men and 11
women stemming from Canada, Ireland, Lithuania, The Netherlands, Poland, Slovenia, the United
Kingdom, and the United States spent ten weeks during the summer at Cold Spring HarborLaboratory
conducting research under the guidance of staff scientists.
CONTRIBUTORS ENDOWMENTS
Mr. and Mrs. Cornelius N. Bliss III
Dorcas Cummings
Reverend Linda P Hancock
Dr. Ira Herskowitz
Jephson Educational Trust
National Science Foundation
Mrs. Pamela P. Post
Mrs. Joan P Tilney
Emanuel Ax Fund
Burroughs Wellcome Fund
Garfield Fellowship
H. Bentley Glass Fellowship
Libby Fellowship
Robert H. R Memorial Olney Fund
Joan Redmond Read Fund
William Shakespeare Fellowship
Frederica von Stade Fund
Total $243,330
Total Private Contributions $34,752,280.33
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LABORATORY STAFF
Bruce W. Stillman, President and Chief Executive Officer
James D. Watson, Chancellor
Winship Hen; Dean, Watson School of Biological Sciences
Hollis Cline, Director of Research
W. Dil laway Ayres, Jr., Chief Operating Officer
G. Morgan Browne, Chief Financial Officer
Lad Russo, Comptroller
John Maroney, Director, Office of Technology Transfer/ In-
House Council
FACULTY
Professors
Gregory Harmon
David Helfman
Nouria Hernandez*
Tatsuya Hirano
Adrian Krainer
Yuri Lazebnik
Scott Lowe
Roberto Malinow
Robert Martienssen
W. Richard McCombie
Partha Mitra
David Spector
Karel Svoboda*
Nicholas Tonks
Timothy Tully
Michael Wig ler
Michael Zhang
Associate Professors
Grigori Enikolopov
David Jackson
Leemor Joshua-Tor
Zachary Mainen
Andrew Neuwald
Jacek Skowronski
Lincoln Stein
Arne Stenlund
William Tansey
Linda Van Aelst
Rui-Ming Xu
Jerry Yin
Anthony Zador
Yi Zhang
Assistant Professors
Carlos Brody
Dmitri Chklovskii
Joshua Dubnau
Masaaki Hamaguchi
Z. Josh Huang
Alexei Koulakov
Robert Lucito
Wolfgang Lukowitz
Alea Mills
Vivek Mittal
Senthil Muthuswamy
Michael Myers
Marja Timmermans
Investigator
Eli Hatchwell
Senior Computer
Scientist
Andrew Reiner
Computer Scientists
John Healy
Lakshmi Muthuswamy
Ravi Sachidanandam
CSHL Fellows
Gilbert Lee Henry
Terence Stick
Research Investigators
Kenneth Chang
Nei lay Dedhia
Erik Enemark
Diane Esposito
Natalia Peunova
Cordula Schulz
Mona Spector
Adjunct Professor
Bhubaneswar Mishra
Adjunct Associate
Professors
Roussoudan Bourtschouladze
Scott Powers
*Employee of the Howard Hughes Medical Institute.
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Tern I. Grodzicker, Assistant Director for Academic
Affairs
Jan A. Witkowski, Executive Director, Banbury Center
David A. Mick los, Executive Director, Dolan DNA
Learning Center
John R. Inglis, Executive Director, CSHL Press
David J. Stewart, Executive Director, Meetings and
Courses
Adjunct Assistant
Professor
Craig Ogata*
Visiting Professor
Matthew Ridley
Visiting Scientists
Hemant Bokil
Tao Hu
Boris Kuzin
Mirjana Maletic-Savatic
Tatyana Michurina
Takao Ono
Vladimir Scheinker
Clinical Fellow
Clare Scott
Postdoctoral Fellows
Carlos Aizenman
Colin Akerman
Eric Allemand
Jannik Andersen
Jean-Raymond Ango
Anindya Bagchi
Andres Barria-Roman
Carine Becamel
Jennifer Bestman
Jannic Boehm
Benjamin Boettner
Anka Bric
Athanasios Bubulya
Paula Bubulya
Deirdre Buckley
Ingrid Bureau
Mary Byrne
Enrique Cepero
Anna Lena Chabes
Nansheng Chen
Debopriya Das
Rajdeep Das
Anne Daulny
Vincenzo De Paola
Elisa De Stanchina
Robert Del Vecchio
Wim Karel Paul Deleu
Laurence Denis
Michael Deweese
Graziella Di Cristo
Ross Dickins
Haiyuan Ding
Eric Drier
Jian Du
Dominik Due Ili
James Egan
Ingrid Ehrlich
Viola Ellison
Juan Encinas
Yuda Fang
Supriya Gangadharan
Fuqiang Geng
Peter Gillespie
Naira Gorovits
Derek Goto
Francois Grenier
Hui-Fu Guo
Sunita Gupta
Kurt Haas
Ira Hall
Frances Hannan
Todd Harris
Michelle Hastings
Hongzhen He
Lin He
Michael Hemann
Andreas Herbst
Shanta Hinton
Maarten Hoek
Antonius Holtmaat
Hao-Chi Hsu
Ping Hu
Ying Huang
Kanae lijima
Koichi lijima
Susan Janicki
Ashkan Javaherian
Natarajan Kannan
Prasanth Kumar
Kannanganattu
Sibel Kantarci Vatsala Thirumalai Hilde Grasmo-Wendler Visiting Undergraduate
Rotem Karni Dmitry Tsigankov Christoph Grunwald Student
Alla Karpova
Adam Kepecs
Mitsuko Uchida
Naoshige Uchida
Christopher Harvey
Jill Hemish Andrey Nikitchenko
William Keyes Santhosh Vadivelu Shun Ho Research ProgrammersCatherine Kidner Caroline van der Meijden Ikuko Hotta
Sandra Kuhlman Matthew Vaughn Katarzyna Hrecka Shulamit Avraham
Prakash Kumar Vanisree Velamoor Tomas Hromadka Rafael Baptista
John Kurland Jinhua Wang Helen Hsieh Scott Cain
Bo Li Yalin Wang Justyna Janas Gengxin Chen
Jidong Liu Michael Wehr Kendall Jensen Maoyen Chi
Yingfang Liu Hans Guido Wendel Michelle Juarez Fiona Cunningham
Ana Losada Joseph West Jeong Gu Kang Sujit Dike
Christian Machens Linda Wilbrecht Manpreet Katari Gopalakrishnan Gopinathrao
Akira Mamiya Caizhi Wu Noriko Kobayashi Geeta Joshi-Tope
Hiren Maniar Shouzhen Xia Charles Kopec Ardavan Kanani
Carla Margulies Bin Xiang Jonathan Kui Gupreet Katari
Bruce May Zhenyu Xuan Michael Kwofie Sohail Khan
Shanmugam Mayilvahanan* Hong Yang Arlinda Lee Upal Nath
Anthony Mazurek Zhong Yao Sungwoo Lee Andrew O'Shaughnessy
Juan Mendez Ryohei Yasuda Pei-Chun Lin Kiran Kumar Ratnapu
Jinrong Min Maria Yuneva Shih-Chieh Lin Liya Ren
Amitabh Mohanty Lifang Zhang Zachary Lippman Steven Schmidt
Mara Moita Qing-Shuo Zhang Alexandra Lucs Gudmundur Thorisson
Masashi Narita Zuo Zhang Christopher Maher Guanming Wu
Sarah Newey Fang Zhao Marco Mangone Charles Youens-Clark
Pol O'Fearghail Ming Ming Zhao Anagha Matapurkar Wei Zhao
Gonzalo Hugo Xuemei Zhao Masafumi Muratani
Otazu Aldana Jack Zilfou Marissa Moore Research Assistant
Lance Palmer Karen Zito Elizabeth Murchison Timothy O'Connor
Amandine Penal Sabrina Nunez
Leopoldo Petreanu*
Tara Phelps-Durr Graduate Students
Hazeem Okunola
Togay Oztaskin
Research Associates
Antonella Piccini Hiroki Asari Patrick Paddison Carmelita Bautista
Michael Quirk Nilanjana Banerjee Cristian Papazoglu-Statescu Lisa Manche
Pablo Rabinowicz Rebecca Bish Thomas Pologruto Mila McCurrach
Ileng Ramachandran Allison Blum Sachin Ranade Linda Rodgers
Kandasamy Ravi Francois Bolduc Emiliano Rial Verde Simone Salghetti
Michael Regulski Kasandra Burgos Avi Rosenberg Patricia Wendel
Fabiola Rivas Darren Burgess Mar lies Rossmann
Francesc Roca Michelle Carmell Ashish Saxena Laboratory Facility
Jose Roig Santanu Chakraborty Dustin Schones Managers
Michael Ronemus Bidisha Chattopadhyaya Yvette Seger Stephen Hearn
Simon Rumpel Sihem Cheloufi Stephanie Shaw Sang Yong Kim
Edward Ruthazer Beth Chen Khalid Siddiqui Pamela McCloskey
Kalpana Samudre* Hsu Hsin Chen Despina Siolas Timothy Mulligan
Namiko Satoh Yi-Chun Chen Aleksander Sobczyk Joseph Simorowski
Volker Scheuss Shu-Ling Chiu Ji-Joon Song Spencer Teplin
Jonathan Sebat Michelle Cilia Izabela Sujka Rachel von Roeschlaub
Andrey Shabes Laureen Connell Lung-Hao Tai Ming Wang
Pranav Sharma Catherine Cormier Dougal Tervo Regina Whitaker
Gordon Shepherd* Ahmet Den li Zankhana Thakkar
Yi-Jun Sheu Monica Dus Ellizabeth Thomas Laboratory Manager
Ryushi Shudo Farida Emran Niraj Tolia
Jose Silva Rebecca Ewald Andriy Tovkach Martha Daddario
Philip Smith Elena Ezhkova Kathryn Tworkowski
Sen Song Claudia Feierstein Wei Wei Scientific Administrators
Christian Speck Elvin Garcia Quan Wen Sadie Arana
Armen Stepanyants Magdalena Gierszewska Min Yu Patricia Bird
Pavel Sumazhin Angelique Girard Chih-Chi Yuan Natalie Hodge
Takuya Takahashi Eve-Ellen Govek Hatim Zariwala Jo Leonardo
'Employee of the Howard Hughes Medical Institute.
475
Idee Mallardi
Carol Marcincuk
Anita Matthes*
Barbara Matusik
Sandra Michelsen
Jane Reader
Carol Sekunda*
Lyzette Williams
Madeline Wisnewski
Laboratory Technicians
Fahad Ahmed
Joan Alexander
Esteban Araya
Juana Arroyo
Shola Aruleba
Deborah Aufiero
Vivekanand Balija
Jody Barditch
Sabrina Boettcher
Amy Brady
Kimberly Bronson
Barry Burbach*
Grace Chan
Chih-Ming Chen
Nancy Dawkins-Pisani
Melissa de la Bastide
Ostap Dovirak
So-Young Eom
Margaret Falkowski
Eugenia Friedman
Lori Grady
Inessa Hakker
Michiko Hirano
Christina Nutter
Frederick Katzenberger
Tsai-Ling Lee
Caroline Li
Zhi Zhong Li
Junyi Luo
Beicong Ma*
Carolyn Marsden
Jennifer Meth
Beth Miller
Barbara Mish
Stephanie Muller
Masako Narita
Lidia Nascimento
Nicholas Navin
Aigoul Nourjanova
Ximena Opitz-Araya
Ronnie Packer
Daniel Perkowski
Sagarika Ray
Michael Riggs
Dongyon Roh
Christine Rosenthal
Lise Lotte Schmidt
Stephen Schuck
Kimberly Scobie
*Employee of the Howard Hughe
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Lauren Se Ides
Maria Siddiqui
Veeraiah Siripurapu
Stephanie Smith
Lori Spiegel
Yu ling Sun*
Julie Thomas
Jennifer Troge
Jing Wang
Jeanne Wiggins
Priscilla Wu
Si Wu
Ying Wu
Miao-Miao Yang
Mianjia Ye
Lewis Yesner
Xiaoqun Zhang*
Hong Zhou
Theresa Zutavern
Media Makers/Laboratory
Aides
Maria Andrade
June Blanchford
Patricia Brady
Florinda Chaves
Terrance Chisum
Salvador Henriquez
Marcela Lara
Vincent Meschan
Maria Mosquera
Umamaheswari Ramu
Hong Jie Shen
Rulan Shen
Jinghong Tang-Qiu
Margaret Wallace
Xiu-Xia Zhang
Research Administration
Maureen Bell
Denise Roberts
Watson School of
Biological Sciences
Winship Herr, Dean
Lilian Gann
Mark Beavers
Alyson Kass-Eisler
Dawn Meehan
DEPARTMENTS
Comptrollers Office and
Accounting
Lari Russo, Comptroller
Sharon Bense
Karine Boyce
Helen Chase
Damian Desiderio
s Medical Institute.
Karen Filasky
Mary Ellen Goldstein
Laura Guterman
Elizabeth Janow
Patricia Maroney
Alison McDermott
Mary Ann Miceli
Kari Pavlovsky
Patricia Urena
Noreen Vance
Matthew Voss
Banbury Center
Jan Witkowski, Executive
Director
Katya Davey
Eleanor Sidorenko
Beatrice To liver
Central Administration
Maureen Berejka
Delia King
Nora Rice
Judith Smith
CSHL Press
John Inglis, Executive Director
Director's Office
Elizabeth Powers
Acquisitions
David Crotty
Alexander Gann
Finance
William Keen
Colleen Becker
Nancy Hodson
Books: Editorial
Janet Argentine
Mary Cozza
Judith Cuddihy
Maryliz Dickerson
Joan Ebert
Maria Falasca
Kaaren Janssen
Inez Sialiano
Books: Production
Denise Weiss
Patricia Barker
Daniel deBruin
Melissa Frey
Ma la Mazzullo
Susan Schaefer
Rena Steuer
Journals: Editorial
Laurie Goodman
Terri Grodzicker
Margaret Calicchia
Heather Cosel-Pieper
Bibiane Garite
Michele McDonough
Journals: Production
Linda Sussman
Debra Banninger
Cynthia Blaut
Pauline Henick
Rita Wallace
Advertising
Marcie Siconolfi
Corrisa Salzman
Customer Service
Geraldine Jaitin
Kathleen Cirone
Jill Manero
Jacqueline Matura
Joan Pepperman
Mary Saba la
Marketing
Ingrid Benirschke Perkins
Kathryn Fitzpatrick
Sales
Guy Keyes
Katya Gurbeloshvili
Warehouse and Distribution
Sharon Story
Christopher Vacca
Dolan DNA Learning
Center
David Mick los, Executive
Director
Jennifer Aizenman
Adrian Arva
Scott Bronson
Elna Carrasco
Shirley Chan
Judy Cumella-Korabik
Nancy Daidola
Darius Farraye
Uwe Hilgert
Eun-Sook Jeong
Kimberly Kessler
Mary Lamont
Susan Lauter
Colleen Maroney
Amanda Mc Brien
Michael O'Brien
Carolyn Reid
Danielle Sixsmith
Bronwyn Terrill
Chun-hua Yang
Facilities
Arthur Brings, Chief Facilities
Officer
Faculties Administration
Christopher Hubert
Frank Russo
Peter Stahl
Leslie Allen
Janet Duffy
Daniel la Ferreira Cunha
Christine Hurson
Randal Jones
Marlene Rubino
Charles Schneider
Carpentry and Painting
Peter Schwind
Edwin Bennett
Oliver Berner
Paul Edwards
Romulo Estrella
John Meyer
Wilson Ramones
John Schindler
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